data_1gh8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1gh8 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.4 ' HB ' HG23 ' A' ' 57' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.58 0.228 . . . . 0.0 110.591 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 55.2 t -111.95 122.91 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.752 0.311 . . . . 0.0 111.745 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.556 ' HB1' HG22 ' A' ' 55' ' ' VAL . . . -97.41 167.49 10.97 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.619 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 5.3 m -141.94 127.55 19.07 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.596 0.712 . . . . 0.0 112.164 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.699 HG23 HG23 ' A' ' 80' ' ' ILE . 4.3 mm -122.08 108.45 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.578 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.624 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -98.31 96.71 8.24 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.518 ' O ' HG21 ' A' ' 10' ' ' VAL . 1.4 m -91.39 135.5 26.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.841 0.353 . . . . 0.0 111.519 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.658 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.3 ptm -145.05 125.36 7.27 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 121.109 0.48 . . . . 0.0 111.648 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.635 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 14.6 Cg_exo -71.45 128.4 14.45 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.487 2.791 . . . . 0.0 112.404 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -35.51 71.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.347 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.74 154.87 78.41 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.346 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 56.1 Cg_endo -69.95 -3.24 11.74 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.554 2.17 . . . . 0.0 111.961 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -90.93 44.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.738 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.635 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 98.1 t -63.8 78.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.321 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -69.91 95.13 0.9 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.12 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.666 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -62.98 -43.75 97.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.394 -178.265 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.773 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 10.1 tt0 -70.6 -35.63 73.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 0.0 110.762 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.4 ' CB ' ' HB2' ' A' ' 18' ' ' ASP . . . -68.55 -37.23 79.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.486 ' CD2' ' HG3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -65.95 -28.73 69.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.011 177.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.773 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -55.93 -46.88 78.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.596 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -65.1 -42.86 93.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.421 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 2.4 mt-10 -66.4 -31.54 72.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.285 0.564 . . . . 0.0 110.598 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.785 HG23 HG22 ' A' ' 53' ' ' VAL . 9.5 mt -61.88 -42.94 96.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.709 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -62.29 -39.32 92.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.939 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 9.2 pt-20 -77.41 -20.97 53.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.59 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.807 ' HD2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.14 -11.94 39.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.194 -178.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.67 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.1 mm -60.26 137.87 91.71 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.326 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.625 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 9.9 Cg_endo -52.34 114.85 1.84 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.686 2.257 . . . . 0.0 112.113 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.52 3.01 0.05 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.362 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.51 -43.94 7.63 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.88 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.61 -135.47 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.718 0.259 . . . . 0.0 111.136 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -135.01 169.47 17.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -176.13 3.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.964 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.49 ' HB2' HG21 ' A' ' 56' ' ' VAL . 83.8 t60 -130.79 -77.51 0.53 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.251 0.548 . . . . 0.0 111.102 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.613 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -165.07 129.94 2.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.829 -178.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.775 HD12 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -92.66 158.23 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.715 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 2.0 t0 -123.7 131.47 53.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.632 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -91.1 71.36 6.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.354 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -103.68 146.78 33.14 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.64 -178.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.738 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.0 Cg_endo -88.91 157.45 5.95 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.123 2.549 . . . . 0.0 112.974 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.448 ' HB ' ' H ' ' A' ' 45' ' ' ALA . 4.7 mm -127.15 -83.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.458 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . . . -67.34 -150.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -71.89 -28.45 63.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.846 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.62 5.93 0.45 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.646 -0.787 . . . . 0.0 113.099 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.54 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 3.4 mt -93.03 106.29 18.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 111.108 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.738 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 60.3 t -93.7 127.55 45.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.72 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.658 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -94.6 166.63 11.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.391 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.715 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.1 mp -120.38 118.28 29.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.099 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.504 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.0 OUTLIER -89.61 92.09 8.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.333 0.587 . . . . 0.0 110.32 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.785 HG22 HG23 ' A' ' 26' ' ' ILE . 4.6 t -86.83 101.85 11.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.543 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.491 ' HG3' HG22 ' A' ' 7' ' ' THR . 2.6 mtt -84.6 165.18 18.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.34 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.556 HG22 ' HB1' ' A' ' 6' ' ' ALA . 3.0 m -139.43 135.14 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.394 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.48 116.91 39.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.022 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.4 HG23 ' HB ' ' A' ' 4' ' ' VAL . 10.6 m -130.21 148.26 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.084 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -167.22 -69.56 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.297 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -81.44 -5.68 58.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.989 0.423 . . . . 0.0 110.579 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.67 -149.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.318 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.57 -165.53 2.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.793 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.22 15.06 24.87 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.639 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.49 -3.94 49.95 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.574 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p -74.28 -3.74 31.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.91 0.386 . . . . 0.0 110.142 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.15 -23.93 23.82 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.353 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.53 -25.77 52.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.164 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.625 ' HB1' ' HB3' ' A' ' 31' ' ' PRO . . . -61.44 -55.9 26.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.351 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -58.64 -34.6 71.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.44 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.29 -51.81 67.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.347 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.443 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.7 p -63.8 -20.13 65.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.424 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.73 HD13 HG21 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.87 -28.24 62.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.551 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.54 -13.26 51.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.957 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.31 26.1 0.98 Allowed Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.742 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.807 HD11 ' HD2' ' A' ' 29' ' ' ARG . 2.6 tt -73.38 -163.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.449 -0.376 . . . . 0.0 111.127 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.538 ' N ' HG22 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -51.29 94.2 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.843 0.354 . . . . 0.0 111.009 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.13 -26.91 68.16 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.233 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 p -88.6 -38.3 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.188 0.518 . . . . 0.0 110.232 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 11' ' ' MET . 0.7 OUTLIER -96.69 89.94 5.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.324 179.399 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.516 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.2 136.87 38.59 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.803 HG23 HG22 ' A' ' 82' ' ' VAL . 2.3 mp -101.91 147.91 8.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.397 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.624 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 3.8 tt0 -86.05 70.73 10.62 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 173.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.803 HG22 HG23 ' A' ' 80' ' ' ILE . 60.6 t -80.54 51.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.009 -174.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.78 3.84 3.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.328 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.619 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 4.1 m-20 . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 111.247 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.514 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.3 t . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.644 0.259 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 86.9 t -119.5 116.67 51.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.067 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -92.35 166.93 12.33 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.776 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 9.0 m -142.2 130.7 22.5 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.535 0.684 . . . . 0.0 112.129 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.703 HG22 HG23 ' A' ' 80' ' ' ILE . 9.8 mm -121.75 106.64 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.512 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.599 ' O ' HG22 ' A' ' 80' ' ' ILE . 0.4 OUTLIER -96.83 96.13 8.34 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.841 0.353 . . . . 0.0 111.866 -177.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.815 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.5 m -93.65 137.3 23.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.939 -177.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.599 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -146.05 123.82 6.21 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 121.249 0.547 . . . . 0.0 111.412 178.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.652 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 11.5 Cg_exo -73.2 120.92 6.84 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.591 2.861 . . . . 0.0 111.979 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -56.44 -31.57 64.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 p -78.28 154.85 79.58 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.202 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.585 ' HA ' HD23 ' A' ' 48' ' ' LEU . 53.8 Cg_endo -69.31 -2.55 10.05 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.301 2.001 . . . . 0.0 111.695 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.43 41.15 1.04 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.237 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.727 HG21 HD22 ' A' ' 48' ' ' LEU . 91.1 t -65.93 77.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.493 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -69.49 95.04 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.656 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -63.82 -44.24 93.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.175 -178.469 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.656 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 5.1 tp10 -68.47 -40.05 81.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.613 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.742 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -70.85 -35.81 72.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.128 0.49 . . . . 0.0 110.504 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -66.13 -31.71 72.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.803 178.257 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.433 ' HA ' HD12 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -56.27 -45.21 80.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.68 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.742 ' HE2' ' HA ' ' A' ' 21' ' ' ALA . 1.9 mtmm -67.09 -43.57 82.22 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.518 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 21' ' ' ALA . 26.1 mt-10 -65.95 -27.14 67.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.634 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.703 HG21 HG21 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -61.81 -46.58 96.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.412 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.552 ' NE2' HG23 ' A' ' 26' ' ' ILE . 25.3 mm-40 -63.06 -31.89 73.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 0.0 110.969 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 5.6 mm-40 -73.25 -22.42 60.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.137 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.716 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.15 -18.6 25.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.381 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.641 HD13 HG13 ' A' ' 53' ' ' VAL . 27.6 mm -57.18 137.46 80.62 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.205 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.496 ' N ' HG22 ' A' ' 30' ' ' ILE . 8.7 Cg_endo -48.9 118.75 3.69 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.902 2.401 . . . . 0.0 112.191 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -4.61 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.137 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.66 -35.01 17.64 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.152 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.509 ' OG1' HG21 ' A' ' 64' ' ' THR . 0.2 OUTLIER -130.61 -148.66 0.37 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 111.215 -179.324 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -136.71 171.33 14.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.93 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.521 ' C ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -75.35 -176.17 3.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.427 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.567 ' ND1' HG21 ' A' ' 56' ' ' VAL . 71.7 t60 -130.84 -74.85 0.53 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.796 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 mmtm -161.68 129.38 4.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.051 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.741 HD12 HG21 ' A' ' 53' ' ' VAL . 2.7 mt -92.33 160.75 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.985 0.421 . . . . 0.0 111.803 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.62 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -128.42 123.2 33.16 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.511 -178.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -85.06 72.12 10.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.783 0.325 . . . . 0.0 110.502 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -99.28 134.5 21.24 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.83 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.768 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 73.3 Cg_endo -88.1 156.94 7.05 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.553 2.168 . . . . 0.0 112.757 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mm -124.64 -82.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.323 -177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.602 ' HB1' ' HG ' ' A' ' 48' ' ' LEU . . . -67.52 -152.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.86 -28.6 63.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.595 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.77 5.44 0.5 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.979 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.727 HD22 HG21 ' A' ' 17' ' ' VAL . 4.7 mt -91.73 101.84 14.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.911 0.386 . . . . 0.0 110.76 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.768 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 89.2 t -93.75 128.45 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.853 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 11' ' ' MET . . . -95.64 153.33 17.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.923 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.1 mp -113.34 119.86 39.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.507 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.555 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.6 m120 -90.44 91.26 8.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.187 0.518 . . . . 0.0 110.207 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.741 HG21 HD12 ' A' ' 39' ' ' ILE . 6.0 t -87.45 106.29 16.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.547 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -84.64 165.5 17.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.283 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.588 HG21 HG12 ' A' ' 57' ' ' VAL . 3.2 m -139.98 137.97 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 111.446 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.567 HG21 ' ND1' ' A' ' 37' ' ' HIS . 0.5 OUTLIER -94.68 110.77 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.853 179.052 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.588 HG12 HG21 ' A' ' 55' ' ' VAL . 13.1 m -130.13 148.01 33.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.949 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.73 -68.12 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.383 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -81.73 -3.07 52.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.934 0.397 . . . . 0.0 110.579 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.22 -146.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.119 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -147.34 -163.19 1.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.776 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.79 12.49 35.14 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.604 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.67 -6.16 58.34 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.617 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.509 HG21 ' OG1' ' A' ' 34' ' ' THR . 3.6 p -74.94 -7.26 53.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.609 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -54.89 -24.39 23.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.274 0.559 . . . . 0.0 110.226 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.32 -27.75 62.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.229 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.488 ' HB1' HH22 ' A' ' 29' ' ' ARG . . . -60.77 -55.68 30.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.384 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.69 -35.09 73.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.455 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -49.92 75.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.28 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 p -64.17 -18.97 64.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.454 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.708 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -74.04 -28.96 61.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.605 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -14.42 54.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.46 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.28 32.96 0.93 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.448 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.716 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -72.68 -163.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.215 -0.492 . . . . 0.0 111.075 -178.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.5 OUTLIER -50.91 98.65 0.02 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.913 0.387 . . . . 0.0 110.968 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.35 -33.88 66.79 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.797 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.1 t -87.12 -39.63 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.984 0.421 . . . . 0.0 110.524 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.616 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 40.5 t -96.23 92.3 6.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.796 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.578 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.63 134.2 38.24 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.815 HG12 ' HB ' ' A' ' 10' ' ' VAL . 15.6 mt -101.41 147.05 8.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.584 -175.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -85.64 71.08 10.77 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 173.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.744 HG22 HG23 ' A' ' 80' ' ' ILE . 58.2 t -81.02 52.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.241 -174.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.94 4.34 3.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.458 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.776 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 39.5 t0 . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.899 0.38 . . . . 0.0 111.405 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.872 HG13 HG23 ' A' ' 57' ' ' VAL . 1.1 t . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 42.1 t -110.83 112.86 42.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.716 0.293 . . . . 0.0 111.242 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.546 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -94.67 142.5 27.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.227 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.676 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 7.8 m -122.53 129.25 51.76 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.621 0.724 . . . . 0.0 112.032 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.756 HG22 HG23 ' A' ' 80' ' ' ILE . 1.4 mm -120.44 108.3 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.713 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.58 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -95.29 93.72 7.44 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.403 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.4 m -92.49 136.02 25.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.791 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.658 ' O ' ' HG3' ' A' ' 11' ' ' MET . 1.7 ptm -144.4 124.73 7.51 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 121.058 0.456 . . . . 0.0 111.349 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' HD2' HG13 ' A' ' 17' ' ' VAL . 12.3 Cg_exo -70.9 125.1 11.21 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.246 2.631 . . . . 0.0 112.075 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.07 -33.85 69.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.639 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.433 ' O ' HG21 ' A' ' 17' ' ' VAL . 19.8 m -78.01 153.4 80.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.583 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 42.4 Cg_endo -67.59 -3.47 10.28 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.402 2.068 . . . . 0.0 111.955 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.79 43.52 1.15 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.755 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.634 HG13 ' HD2' ' A' ' 12' ' ' PRO . 87.2 t -65.52 75.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.385 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.628 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -71.48 88.11 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.948 177.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.685 ' HB2' HD13 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -63.81 -39.18 93.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.065 -178.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.533 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -68.16 -39.13 82.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.971 -178.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -72.05 -36.06 69.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.134 0.493 . . . . 0.0 110.282 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -67.37 -28.22 67.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.979 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -57.73 -43.75 85.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.325 179.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -66.53 -43.34 85.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.528 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -66.31 -28.07 68.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.169 0.509 . . . . 0.0 110.531 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.771 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.6 mt -61.86 -44.7 99.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.008 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.88 -36.88 77.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.939 0.399 . . . . 0.0 110.417 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -75.35 -24.09 57.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.747 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.771 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.95 -14.17 37.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.713 0.292 . . . . 0.0 111.291 -178.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.2 mm -59.79 139.0 90.21 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.26 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.756 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.4 Cg_endo -51.54 111.69 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.769 2.312 . . . . 0.0 112.076 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.43 2.88 0.05 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.494 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.71 -41.08 9.11 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.821 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.471 ' OG1' HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.19 -133.56 0.21 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.435 0.16 . . . . 0.0 110.794 -179.787 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -140.0 162.92 34.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.826 0.346 . . . . 0.0 110.978 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -76.47 -173.23 2.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.495 ' ND1' HG21 ' A' ' 56' ' ' VAL . 76.7 t60 -130.83 -77.62 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 111.334 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 3.0 mmtp -160.07 132.08 6.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.333 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.803 HD12 HG23 ' A' ' 53' ' ' VAL . 2.6 mt -93.57 160.01 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.608 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.643 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -128.17 125.12 38.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.647 -178.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -85.74 74.16 10.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.835 0.35 . . . . 0.0 110.438 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.3 OUTLIER -100.45 134.88 20.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.8 Cg_endo -84.97 156.01 11.41 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.589 2.193 . . . . 0.0 112.556 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mm -124.76 -82.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.163 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.27 -153.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.994 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -71.97 -26.59 62.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.663 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.73 3.07 0.41 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.122 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.583 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.1 mt -91.65 103.22 15.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.785 0.326 . . . . 0.0 110.786 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.752 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 93.6 t -94.1 129.06 44.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.746 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.22 162.71 13.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.906 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.685 HD13 ' HB2' ' A' ' 19' ' ' LEU . 11.0 mp -120.4 120.23 35.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.398 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.448 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.1 m120 -89.66 91.5 8.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.216 0.532 . . . . 0.0 109.792 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.803 HG23 HD12 ' A' ' 39' ' ' ILE . 14.1 t -86.32 105.84 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.434 -177.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.546 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 13.0 mtt -84.94 160.58 20.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.14 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.0 m -139.09 137.87 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.212 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.495 HG21 ' ND1' ' A' ' 37' ' ' HIS . 2.7 t -93.0 98.16 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.883 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.872 HG23 HG13 ' A' ' 4' ' ' VAL . 34.9 m -130.4 138.21 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.124 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.33 -59.66 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.49 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.14 -8.19 59.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.994 0.426 . . . . 0.0 110.503 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.56 -139.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.122 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -147.11 -162.38 1.53 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.783 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -80.2 11.49 36.51 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.702 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.43 -12.21 69.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.474 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 p -74.31 -4.25 35.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.03 0.443 . . . . 0.0 110.278 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -24.32 22.18 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.072 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.63 -27.92 52.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.02 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.756 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.83 -57.89 10.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.372 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -58.45 -34.37 70.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.522 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.77 -52.33 64.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.058 0.456 . . . . 0.0 110.371 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.424 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -64.05 -20.75 66.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.475 178.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.808 HD23 HD12 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.99 -28.05 62.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.675 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.59 -16.6 61.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.767 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.53 31.0 0.94 Allowed Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.834 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.808 HD12 HD23 ' A' ' 71' ' ' LEU . 2.9 tt -73.21 -161.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.511 -0.344 . . . . 0.0 111.11 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.711 ' HG2' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -51.82 90.69 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.121 0.486 . . . . 0.0 110.714 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.53 -24.93 62.43 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.107 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.647 HG13 ' N ' ' A' ' 78' ' ' SER . 2.8 p -86.95 -34.67 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.352 0.596 . . . . 0.0 110.307 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.647 ' N ' HG13 ' A' ' 77' ' ' VAL . 29.0 t -96.71 92.3 6.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.697 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.566 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -76.23 132.2 39.76 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.146 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.771 HG23 HG22 ' A' ' 82' ' ' VAL . 2.1 mt -101.03 148.16 7.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.493 -175.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.58 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 2.4 tp10 -85.86 71.11 10.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 172.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.771 HG22 HG23 ' A' ' 80' ' ' ILE . 68.4 t -79.95 55.89 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.947 -174.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -133.05 1.87 3.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.81 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.676 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.0 m-20 . . . . . 0 N--CA 1.454 -0.242 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.256 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.51 ' HB ' HG22 ' A' ' 57' ' ' VAL . 1.5 t . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.685 0.279 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 53.5 t -105.1 112.02 36.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.51 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.605 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -95.84 142.6 27.91 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.764 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.3 m -122.75 129.4 51.71 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.72 0.771 . . . . 0.0 112.563 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.811 ' HB ' HH22 ' A' ' 29' ' ' ARG . 3.2 mm -121.12 108.71 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.731 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.568 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -97.96 96.22 8.02 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -177.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 10' ' ' VAL . 1.3 m -93.21 136.67 24.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.513 ' O ' ' HA ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -146.26 124.97 6.43 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.296 178.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.643 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.2 Cg_exo -71.38 120.35 6.9 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.137 2.558 . . . . 0.0 111.694 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.74 -31.34 64.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.285 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.477 ' O ' HG21 ' A' ' 17' ' ' VAL . 23.5 p -77.88 154.21 80.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.985 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.552 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 54.5 Cg_endo -69.01 -1.14 7.31 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.223 1.949 . . . . 0.0 111.493 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.18 41.98 1.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.116 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.643 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 84.8 t -65.8 79.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.368 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 67.3 m-20 -68.11 101.12 1.09 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.16 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.758 HD13 HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -61.41 -53.2 59.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.773 -178.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.647 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 13.6 pt-20 -71.06 -34.47 71.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.214 -176.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.512 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -68.17 -36.45 79.64 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.581 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -65.17 -34.0 77.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.389 176.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.647 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -57.14 -47.38 81.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.407 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.512 ' HE2' ' HA ' ' A' ' 21' ' ' ALA . 2.5 mtmt -64.47 -42.91 95.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.61 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.601 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 2.1 mt-10 -66.55 -32.91 74.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.204 0.526 . . . . 0.0 110.811 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.718 HG22 HD12 ' A' ' 39' ' ' ILE . 3.0 mt -61.78 -43.04 96.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.008 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -62.53 -40.41 96.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.683 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 9.0 pt-20 -78.49 -19.22 53.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.832 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.811 HH22 ' HB ' ' A' ' 8' ' ' ILE . 26.8 ptt85 -89.9 -11.44 41.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.255 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.654 HD13 HG12 ' A' ' 53' ' ' VAL . 20.9 mm -59.91 138.85 90.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.525 ' N ' HG22 ' A' ' 30' ' ' ILE . 8.5 Cg_endo -49.13 117.07 2.57 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.872 2.381 . . . . 0.0 112.256 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -59.71 2.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.433 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.03 -46.18 6.33 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.122 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.534 HG21 ' HB2' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -130.07 -134.74 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.624 0.25 . . . . 0.0 110.998 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -137.1 166.41 23.77 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.812 0.339 . . . . 0.0 110.73 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -76.4 -171.91 1.95 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.241 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.492 ' ND1' HG21 ' A' ' 56' ' ' VAL . 85.7 t60 -130.55 -77.69 0.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.376 0.608 . . . . 0.0 111.101 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 2.0 tptp -164.47 129.83 2.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.668 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.831 HD12 HG21 ' A' ' 53' ' ' VAL . 2.6 mt -91.78 160.88 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -176.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.607 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -126.4 120.71 30.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.383 -179.271 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -84.32 72.59 10.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.917 0.389 . . . . 0.0 110.465 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.479 ' C ' HG11 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -99.13 135.35 20.83 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.951 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.773 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 62.2 Cg_endo -86.47 157.22 9.33 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.596 2.197 . . . . 0.0 112.515 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.449 HD13 ' HB2' ' A' ' 50' ' ' ALA . 2.5 mm -126.63 -83.19 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.532 -177.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.573 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . . . -67.62 -149.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.188 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -70.5 -32.12 69.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.361 . . . . 0.0 110.549 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.69 7.63 0.59 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.658 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.576 ' HA ' HG23 ' A' ' 17' ' ' VAL . 4.9 mt -91.25 101.71 14.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.81 0.338 . . . . 0.0 110.793 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 73.9 t -92.53 129.54 42.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.739 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.489 ' C ' HD11 ' A' ' 51' ' ' LEU . . . -96.03 160.28 14.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.675 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.758 HD12 HD13 ' A' ' 19' ' ' LEU . 11.1 mp -120.45 119.54 33.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.5 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.533 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.4 m120 -89.73 90.74 8.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.268 0.556 . . . . 0.0 110.024 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.831 HG21 HD12 ' A' ' 39' ' ' ILE . 10.0 t -87.89 104.74 14.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.478 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.56 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 2.0 mtt -85.39 163.82 18.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.35 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.605 HG22 ' HB2' ' A' ' 6' ' ' ALA . 3.4 m -140.24 136.04 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.984 0.421 . . . . 0.0 111.394 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.492 HG21 ' ND1' ' A' ' 37' ' ' HIS . 1.9 t -95.35 112.08 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.017 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.51 HG22 ' HB ' ' A' ' 4' ' ' VAL . 21.4 m -130.17 139.11 52.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.897 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.78 -61.06 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.551 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -81.4 -14.43 57.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.014 0.435 . . . . 0.0 110.718 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.534 ' HB2' HG21 ' A' ' 34' ' ' THR . . . -67.56 -139.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.092 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.9 -168.82 3.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.525 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.84 13.55 30.05 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.553 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.44 -1.73 38.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.663 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -74.29 -3.92 33.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.857 0.36 . . . . 0.0 110.374 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -55.18 -23.68 23.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.233 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.2 -24.59 42.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.155 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' A' ' 31' ' ' PRO . . . -61.39 -56.13 23.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.263 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.3 -34.75 70.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.342 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.53 -52.33 64.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.442 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.43 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.5 p -64.21 -19.11 65.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.629 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.808 HD12 HG22 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.52 -29.91 62.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.749 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.81 -12.06 43.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.9 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.21 26.02 0.99 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.862 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.808 HG22 HD12 ' A' ' 71' ' ' LEU . 2.7 tt -73.1 -163.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.774 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.637 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 0.0 OUTLIER -51.68 96.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.036 0.446 . . . . 0.0 110.665 179.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.97 -30.77 76.33 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.367 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 t -85.49 -33.32 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.885 0.374 . . . . 0.0 110.505 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.637 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 11.6 t -95.42 91.23 6.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.717 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.553 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -75.43 132.78 41.08 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.773 HG21 HG22 ' A' ' 82' ' ' VAL . 3.2 mp -101.09 148.85 6.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.607 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.568 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 38.7 tt0 -85.85 69.49 10.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 173.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.773 HG22 HG21 ' A' ' 80' ' ' ILE . 61.8 t -79.97 54.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.732 -175.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.89 0.57 3.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.567 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.764 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 10.2 t0 . . . . . 0 N--CA 1.452 -0.366 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.859 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.589 ' HB ' HG23 ' A' ' 57' ' ' VAL . 1.5 t . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.618 0.247 . . . . 0.0 110.703 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.5 t -109.96 119.97 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.699 0.285 . . . . 0.0 111.555 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.483 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -98.72 166.65 11.22 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.694 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 14.7 m -143.23 137.49 28.98 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.644 0.735 . . . . 0.0 112.43 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.763 HG22 HG22 ' A' ' 80' ' ' ILE . 4.2 mm -127.11 106.35 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.274 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.625 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -96.58 96.19 8.49 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -176.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.551 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.5 m -93.37 134.13 32.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.909 0.385 . . . . 0.0 111.822 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.581 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.3 OUTLIER -146.3 124.91 6.4 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 121.094 0.473 . . . . 0.0 111.24 179.04 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.643 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.5 Cg_exo -72.51 122.67 8.47 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.467 2.778 . . . . 0.0 112.026 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -56.76 -32.13 65.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.235 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.91 153.58 80.37 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.037 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.651 ' HA ' HD22 ' A' ' 48' ' ' LEU . 53.6 Cg_endo -69.46 -2.86 10.69 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.403 2.068 . . . . 0.0 112.305 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.61 45.74 1.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.996 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.643 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 92.7 t -64.96 76.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.708 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.556 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -71.12 89.71 0.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.692 ' H ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -63.53 -37.17 86.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.541 -178.17 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.756 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -70.61 -35.58 73.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.992 0.425 . . . . 0.0 110.077 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.556 ' HB1' ' HB2' ' A' ' 18' ' ' ASP . . . -69.05 -37.52 78.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.485 ' CD2' ' HG3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -65.92 -30.07 70.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.014 177.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.756 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -55.22 -46.71 75.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.663 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -65.84 -43.59 88.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.537 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.707 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 1.3 mm-40 -66.05 -29.32 69.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.266 0.555 . . . . 0.0 110.56 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.702 HG12 HG21 ' A' ' 53' ' ' VAL . 3.8 mt -60.94 -46.4 96.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.932 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -62.37 -38.74 90.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.208 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.707 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -78.33 -20.55 51.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.546 -178.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.778 ' HD2' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -89.05 -10.58 46.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.141 -179.222 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.642 HG12 ' O ' ' A' ' 26' ' ' ILE . 33.3 mm -60.89 138.12 93.74 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.265 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.686 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 9.3 Cg_endo -51.59 114.54 1.62 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.668 2.246 . . . . 0.0 112.126 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.17 -2.58 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.225 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.27 -39.25 10.08 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.875 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.737 ' HG1' HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.51 -145.21 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.634 0.254 . . . . 0.0 110.977 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -133.25 164.82 26.23 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.892 0.377 . . . . 0.0 110.795 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.417 ' O ' HG22 ' A' ' 56' ' ' VAL . 1.1 pt? -76.31 -175.09 3.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.389 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.621 ' ND1' HG23 ' A' ' 56' ' ' VAL . 85.3 t60 -130.7 -76.95 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.308 0.575 . . . . 0.0 111.345 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.441 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 1.1 tptt -163.54 132.66 3.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.959 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.667 HD13 HG23 ' A' ' 26' ' ' ILE . 2.6 mt -92.65 159.35 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.108 0.48 . . . . 0.0 112.172 -176.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.645 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -126.73 117.2 22.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.545 -178.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -82.7 69.9 9.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.941 0.4 . . . . 0.0 110.376 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.457 ' O ' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -97.23 138.21 21.21 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.887 -179.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.773 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 71.1 Cg_endo -85.43 156.27 10.76 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.535 2.156 . . . . 0.0 112.632 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.403 ' HB ' ' H ' ' A' ' 45' ' ' ALA . 3.1 mm -125.76 -83.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.505 -177.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.52 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.42 -147.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.218 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -70.98 -33.87 70.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.403 . . . . 0.0 110.752 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.48 8.4 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.738 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.651 HD22 ' HA ' ' A' ' 15' ' ' PRO . 4.3 mt -91.04 102.31 15.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.902 0.382 . . . . 0.0 110.791 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 70.7 t -92.78 127.5 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.882 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 11' ' ' MET . . . -95.56 150.49 20.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.045 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.658 HD22 ' HB2' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -112.2 116.23 30.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.158 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 4.6 m-20 -89.76 94.11 9.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.654 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.702 HG21 HG12 ' A' ' 26' ' ' ILE . 3.7 t -86.45 104.19 13.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.277 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.418 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 3.8 mtt -84.52 167.52 16.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.207 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 6' ' ' ALA . 3.1 m -139.93 138.05 38.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.56 -178.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.621 HG23 ' ND1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -95.35 111.09 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.736 178.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.737 HG13 ' HG1' ' A' ' 34' ' ' THR . 12.8 m -130.05 148.07 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.001 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.29 -72.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.451 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -81.39 -0.3 40.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.917 0.389 . . . . 0.0 110.553 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.21 -152.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.234 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 1.3 pt-20 -147.55 -162.69 1.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.729 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -80.94 14.49 26.09 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.565 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.35 -7.22 60.0 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.498 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.415 HG22 ' OG1' ' A' ' 34' ' ' THR . 1.4 p -74.12 -4.63 36.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.978 0.418 . . . . 0.0 110.261 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -54.83 -23.87 20.37 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.289 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.89 -29.21 62.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.031 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.686 ' HB1' ' HB3' ' A' ' 31' ' ' PRO . . . -62.09 -55.15 31.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.812 0.339 . . . . 0.0 110.212 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -58.99 -34.31 71.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.213 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.18 -51.24 68.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.127 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.8 p -63.78 -17.27 62.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.221 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.704 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.58 -29.85 62.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.368 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.07 -12.09 35.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.658 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.24 28.87 0.98 Allowed Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.463 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.778 HD12 ' HD2' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -72.59 -164.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.338 -0.431 . . . . 0.0 111.062 -178.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.634 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.5 OUTLIER -51.15 99.7 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.938 0.399 . . . . 0.0 110.81 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.93 -33.44 73.84 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.924 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.7 t -87.16 -38.61 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.984 0.421 . . . . 0.0 110.594 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.634 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 40.8 t -96.13 92.31 6.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.875 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.549 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -78.2 135.38 37.6 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.442 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.779 HG22 HG22 ' A' ' 82' ' ' VAL . 2.9 mt -101.57 148.63 7.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.514 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.625 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 15.8 tp10 -86.02 69.43 10.52 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 173.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.779 HG22 HG22 ' A' ' 80' ' ' ILE . 55.1 t -80.93 51.62 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.024 -174.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -133.03 9.25 4.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.919 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.694 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.1 m-20 . . . . . 0 N--CA 1.452 -0.365 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.297 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.526 0.055 0 CA-C-O 120.58 0.228 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 4.7 t -132.75 127.04 55.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.758 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -94.13 168.92 10.63 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.77 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 6.2 m -142.81 129.76 20.64 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.466 0.65 . . . . 0.0 112.164 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.738 ' HB ' HH22 ' A' ' 29' ' ' ARG . 5.7 mm -121.21 108.03 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.677 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.562 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.54 96.18 8.13 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -177.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.823 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.9 m -94.8 137.37 23.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.707 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.6 OUTLIER -147.67 121.65 4.94 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 121.205 0.526 . . . . 0.0 111.999 179.179 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 17.0 Cg_exo -71.34 121.15 7.51 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.417 2.745 . . . . 0.0 111.973 178.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.66 -30.56 63.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.317 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -78.0 153.93 80.18 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.965 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.624 ' HA ' HD23 ' A' ' 48' ' ' LEU . 7.3 Cg_exo -70.39 -6.13 18.21 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.536 2.157 . . . . 0.0 111.719 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -91.17 33.62 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.284 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.694 HG12 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.29 85.68 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.738 0.78 . . . . 0.0 109.98 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.538 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 24.9 m-20 -69.96 106.13 3.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.352 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.866 ' HG ' HD21 ' A' ' 51' ' ' LEU . 1.5 tt -62.12 -48.91 78.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.17 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -68.48 -37.95 80.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.94 -34.57 71.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.0 0.429 . . . . 0.0 110.591 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.652 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -65.28 -32.25 73.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.655 178.164 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -45.21 86.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.554 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -42.21 88.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.593 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.583 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 10.3 mt-10 -66.49 -30.23 70.52 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.321 0.581 . . . . 0.0 110.477 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.685 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 3.4 mt -62.06 -43.57 97.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.766 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -60.89 -38.48 85.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.109 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 10.2 pt-20 -77.49 -21.69 52.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.306 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.738 HH22 ' HB ' ' A' ' 8' ' ' ILE . 21.1 ptt85 -91.1 -9.92 43.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.253 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.673 HG12 ' O ' ' A' ' 26' ' ' ILE . 31.5 mm -59.24 137.78 88.48 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.136 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.668 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.8 Cg_endo -51.54 115.02 1.83 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.743 2.296 . . . . 0.0 112.151 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.07 0.55 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.357 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.99 -53.55 3.46 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.858 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.672 ' HG1' HG22 ' A' ' 64' ' ' THR . 0.2 OUTLIER -117.02 -137.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.664 0.232 . . . . 0.0 111.116 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.401 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 3.8 pt-20 -137.48 169.14 18.3 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.915 0.388 . . . . 0.0 110.992 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.17 177.86 6.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.977 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.433 ' HB2' HG22 ' A' ' 56' ' ' VAL . 71.0 t60 -131.21 -76.28 0.52 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.047 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -161.37 131.78 5.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.402 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.656 HG12 HG13 ' A' ' 53' ' ' VAL . 2.8 mt -93.57 159.23 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.905 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.642 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -129.59 119.31 23.41 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.474 -178.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -82.75 75.52 9.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.91 0.386 . . . . 0.0 110.731 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.478 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -98.56 134.5 21.7 Favored Pre-proline 0 C--O 1.225 -0.205 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.757 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 57.3 Cg_endo -86.53 156.87 9.23 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.499 2.133 . . . . 0.0 112.815 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.463 HG13 ' SD ' ' A' ' 11' ' ' MET . 2.5 mm -124.92 -83.52 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.24 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.741 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.85 -152.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.118 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -71.94 -28.38 63.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.726 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.61 4.31 0.47 Allowed Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.046 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.741 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.5 mt -91.67 101.94 14.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.825 0.345 . . . . 0.0 110.764 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.757 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 87.6 t -94.39 129.61 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.975 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.581 ' HB3' ' HB3' ' A' ' 11' ' ' MET . . . -95.43 157.11 16.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.457 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.866 HD21 ' HG ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -120.23 121.17 38.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.634 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.49 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.2 m120 -89.89 92.79 9.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.257 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.656 HG13 HG12 ' A' ' 39' ' ' ILE . 10.3 t -86.03 104.73 13.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.212 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.44 ' HG3' HG21 ' A' ' 7' ' ' THR . 1.8 mtt -84.58 164.52 18.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.234 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.0 m -139.27 139.52 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.164 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -92.18 112.15 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.794 0.33 . . . . 0.0 110.887 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.471 HG13 ' OG1' ' A' ' 34' ' ' THR . 28.3 m -128.34 140.52 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.999 0.428 . . . . 0.0 111.176 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.43 -69.8 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.235 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.75 -4.96 58.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.409 . . . . 0.0 110.509 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.06 -152.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.302 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.65 -162.96 1.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.803 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.09 14.24 28.23 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.557 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.27 -5.9 51.13 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.247 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.672 HG22 ' HG1' ' A' ' 34' ' ' THR . 1.5 p -74.6 -3.18 29.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.102 0.477 . . . . 0.0 109.97 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.24 -23.71 23.93 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.161 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.33 -28.28 58.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.74 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.668 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.44 -56.78 16.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.156 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -58.49 -34.48 70.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.387 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.68 -52.2 65.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.305 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.408 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 3.1 p -64.08 -17.83 63.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.302 178.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.85 HD22 HD13 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.64 -28.56 62.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.356 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -12.96 49.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.18 26.02 0.99 Allowed Glycine 0 N--CA 1.453 -0.207 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.805 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.85 HD13 HD22 ' A' ' 71' ' ' LEU . 1.1 tt -73.47 -162.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.535 -0.332 . . . . 0.0 110.865 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.453 ' N ' HG23 ' A' ' 74' ' ' ILE . 1.4 mp0 -50.41 93.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.831 0.348 . . . . 0.0 110.932 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.57 -26.35 56.93 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.952 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.43 -39.81 12.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.113 0.482 . . . . 0.0 110.493 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -96.47 91.0 5.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.698 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.567 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -78.2 136.53 37.83 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.823 HG12 ' HB ' ' A' ' 10' ' ' VAL . 14.9 mt -101.48 145.87 10.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.604 -176.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.456 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -85.85 71.47 10.65 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.76 HG22 HG21 ' A' ' 80' ' ' ILE . 64.3 t -80.09 50.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.207 -173.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -132.99 6.39 3.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.18 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.77 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 31.4 t0 . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.037 0.446 . . . . 0.0 110.999 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.071 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 43.4 t -104.85 122.98 58.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.887 0.375 . . . . 0.0 111.806 -178.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -97.96 163.2 12.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.735 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.734 ' HG1' ' HG2' ' A' ' 54' ' ' MET . 5.6 m -139.7 123.12 17.15 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.642 0.734 . . . . 0.0 111.625 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.737 ' HB ' HH22 ' A' ' 29' ' ' ARG . 17.6 mt -122.13 107.62 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.734 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.658 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -96.89 95.99 8.23 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -176.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -91.43 136.3 24.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.875 0.369 . . . . 0.0 111.738 -177.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.681 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 2.2 ptm -144.14 124.97 7.79 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 121.036 0.446 . . . . 0.0 111.485 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.611 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 14.2 Cg_exo -69.7 124.54 11.21 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.173 2.582 . . . . 0.0 112.099 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -57.9 -32.6 67.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.457 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.552 ' HG ' ' HB2' ' A' ' 16' ' ' ASP . 3.6 p -77.34 152.94 81.76 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.119 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.562 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 46.8 Cg_endo -68.19 -3.11 10.13 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.216 1.944 . . . . 0.0 111.572 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.552 ' HB2' ' HG ' ' A' ' 14' ' ' SER . 2.1 m-20 -90.74 43.63 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.835 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.703 HG23 HD21 ' A' ' 48' ' ' LEU . 90.0 t -65.8 75.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.65 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.535 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -71.74 92.94 1.23 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.027 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.698 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -63.24 -42.06 99.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.596 -178.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.868 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 10.8 tt0 -69.96 -36.5 75.3 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.955 0.407 . . . . 0.0 110.292 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.535 ' HB1' ' HB2' ' A' ' 18' ' ' ASP . . . -69.21 -37.75 78.23 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -67.11 -27.01 66.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.004 177.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.868 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -56.2 -46.8 79.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.371 179.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 2.0 mtmt -66.86 -39.86 87.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.766 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -65.5 -33.8 76.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.213 0.53 . . . . 0.0 110.095 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.639 ' O ' HG12 ' A' ' 30' ' ' ILE . 1.8 mt -62.75 -39.01 83.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.935 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -42.35 91.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.639 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 13.3 mt-10 -76.01 -20.92 57.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.814 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.737 HH22 ' HB ' ' A' ' 8' ' ' ILE . 20.8 ptt85 -88.76 -15.63 34.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.484 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.683 HD12 HG13 ' A' ' 53' ' ' VAL . 22.4 mm -59.4 137.48 89.0 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.917 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.489 ' N ' HG23 ' A' ' 30' ' ' ILE . 8.0 Cg_endo -50.18 124.85 13.63 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.824 2.349 . . . . 0.0 112.521 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -60.79 -3.68 0.8 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.893 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.24 -61.7 1.88 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.991 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.24 -145.56 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.835 0.35 . . . . 0.0 111.296 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -132.05 172.01 12.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.614 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.605 ' HB3' HD11 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -74.97 -173.67 1.99 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.007 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.582 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.5 t60 -130.58 -74.81 0.54 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.426 0.631 . . . . 0.0 110.782 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -165.03 125.9 1.99 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.796 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.87 HD11 HG22 ' A' ' 53' ' ' VAL . 2.7 mt -92.4 154.35 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.848 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.707 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.8 t0 -121.25 129.2 53.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.488 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -89.69 69.76 7.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.86 0.362 . . . . 0.0 110.202 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -100.15 148.26 34.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.595 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.729 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.0 Cg_endo -91.07 156.19 3.88 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.026 2.484 . . . . 0.0 113.209 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.406 ' HB ' ' H ' ' A' ' 45' ' ' ALA . 4.6 mm -125.89 -82.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.063 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.406 ' H ' ' HB ' ' A' ' 44' ' ' ILE . . . -67.41 -151.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -72.07 -28.55 63.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.755 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.54 4.79 0.5 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.942 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.703 HD21 HG23 ' A' ' 17' ' ' VAL . 5.2 mt -91.43 103.44 16.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 110.968 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.729 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 36.7 t -92.3 128.58 43.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.694 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.681 ' HB1' ' HB3' ' A' ' 11' ' ' MET . . . -95.0 165.68 12.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.094 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.707 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.0 mp -120.26 119.93 34.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.234 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.51 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -89.52 90.96 8.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.225 0.536 . . . . 0.0 109.915 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.87 HG22 HD11 ' A' ' 39' ' ' ILE . 10.0 t -86.91 98.86 7.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.705 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.734 ' HG2' ' HG1' ' A' ' 7' ' ' THR . 35.7 mtt -84.54 162.56 19.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.096 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.7 m -138.92 134.71 42.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.536 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.582 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.66 113.55 31.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.127 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 57' ' ' VAL . 4.4 m -129.63 143.63 40.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.934 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.57 -65.98 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.454 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -80.96 -8.21 59.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.996 0.427 . . . . 0.0 110.648 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.84 -146.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.21 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.62 -164.18 1.94 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.749 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.89 13.6 30.08 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.545 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.08 -5.62 53.89 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.54 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.58 -5.22 41.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.957 0.408 . . . . 0.0 110.338 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -54.9 -23.15 17.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.148 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.89 -29.08 62.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.968 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 31' ' ' PRO . . . -61.65 -52.65 63.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.403 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.66 -37.27 75.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.309 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -50.21 74.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.312 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.419 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.1 p -64.0 -21.04 66.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.685 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.75 HD13 HG23 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.54 -29.36 62.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.827 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -13.74 53.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.888 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.36 28.57 0.97 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.871 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.75 HG23 HD13 ' A' ' 71' ' ' LEU . 3.6 tt -73.28 -163.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.61 -0.295 . . . . 0.0 111.067 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.764 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 1.2 pm0 -51.55 91.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.975 0.416 . . . . 0.0 110.877 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.83 -25.58 67.83 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.756 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.27 -34.67 8.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.289 0.566 . . . . 0.0 110.132 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.764 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -95.83 90.36 5.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.569 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.408 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -74.5 131.09 40.72 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.807 HG22 HG23 ' A' ' 82' ' ' VAL . 3.0 mp -100.83 149.21 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.524 -175.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.658 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 31.5 tp10 -85.79 70.33 10.67 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.807 HG23 HG22 ' A' ' 80' ' ' ILE . 52.8 t -81.06 54.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.857 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 m -132.65 1.97 3.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.689 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.695 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.2 m-20 . . . . . 0 N--CA 1.452 -0.339 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.753 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.899 HG13 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 121.023 0.44 . . . . 0.0 110.136 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 3.9 t -105.31 120.41 55.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.072 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -94.09 157.22 16.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.745 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 4.5 m -138.24 125.52 21.7 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.702 0.763 . . . . 0.0 111.979 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.723 HG21 HG21 ' A' ' 80' ' ' ILE . 6.7 mm -120.55 108.31 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.943 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.546 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.31 95.57 8.17 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.014 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.664 ' HB ' HG12 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -92.66 135.95 26.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.787 -178.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.637 ' O ' ' HG3' ' A' ' 11' ' ' MET . 1.0 OUTLIER -145.75 127.0 7.5 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 120.964 0.411 . . . . 0.0 111.361 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.641 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 8.7 Cg_exo -73.4 120.19 6.38 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.252 2.635 . . . . 0.0 112.127 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -56.76 -32.19 65.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.303 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 p -78.45 154.01 79.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.012 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.554 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 56.1 Cg_endo -68.9 -2.09 8.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.213 1.942 . . . . 0.0 111.508 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.88 42.52 1.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.121 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.641 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 96.2 t -64.88 77.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.125 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.714 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.1 m-20 -68.35 98.6 0.85 Allowed 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.708 HD12 HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -61.49 -51.35 69.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.659 -178.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -68.06 -37.95 81.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.619 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.637 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . . . -70.52 -38.32 74.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.063 0.459 . . . . 0.0 110.6 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.854 HD23 HD11 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -66.8 -30.14 70.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.189 178.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -44.6 93.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.43 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.637 ' HE3' ' HA ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -65.94 -41.94 90.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.587 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -64.76 -32.42 74.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.074 0.464 . . . . 0.0 110.635 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.854 HD11 HD23 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -62.14 -44.89 99.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.473 -179.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.629 ' NE2' HD21 ' A' ' 36' ' ' LEU . 7.2 mm100 -63.35 -33.41 75.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.82 0.343 . . . . 0.0 110.737 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 27.6 mt-10 -74.44 -23.2 58.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.088 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.727 ' HB2' HD13 ' A' ' 74' ' ' ILE . 28.7 ptt85 -89.26 -15.79 32.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.552 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 26' ' ' ILE . 24.2 mm -57.97 136.74 83.84 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.456 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.527 ' HD2' HG22 ' A' ' 30' ' ' ILE . 18.4 Cg_endo -56.81 116.73 3.41 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.274 1.983 . . . . 0.0 112.073 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.81 0.64 0.08 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.405 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.46 -37.03 15.23 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.575 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.28 -144.06 0.26 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.647 0.26 . . . . 0.0 110.871 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -136.74 167.8 20.74 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.881 0.372 . . . . 0.0 111.031 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.629 HD21 ' NE2' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -75.26 -177.23 3.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.007 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.43 ' HB2' HG22 ' A' ' 56' ' ' VAL . 73.0 t60 -131.49 -75.64 0.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.205 0.526 . . . . 0.0 111.047 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 11.9 mmtt -161.25 129.37 4.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.222 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.762 HD13 HG21 ' A' ' 53' ' ' VAL . 3.2 mt -94.42 158.51 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.073 0.463 . . . . 0.0 111.989 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.692 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -126.49 118.69 25.44 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.98 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -85.7 71.24 10.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.905 0.383 . . . . 0.0 110.261 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.525 ' O ' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -100.73 149.54 36.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.628 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.751 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 29.6 Cg_endo -91.92 158.88 3.35 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.074 2.516 . . . . 0.0 113.331 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.502 HD13 ' HB2' ' A' ' 50' ' ' ALA . 3.3 mm -128.89 -83.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.348 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.535 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . . . -67.79 -148.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.184 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -71.17 -32.61 69.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.81 0.338 . . . . 0.0 110.808 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.67 8.85 0.64 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.493 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.612 HD21 HG23 ' A' ' 17' ' ' VAL . 5.3 mt -91.39 103.1 15.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.82 0.343 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.751 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 38.1 t -92.7 127.53 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.898 -178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.599 ' HB3' ' HB3' ' A' ' 11' ' ' MET . . . -95.13 159.03 15.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.69 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.708 HD12 HD12 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -118.82 119.56 34.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.494 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.483 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.2 m120 -89.49 90.26 8.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.709 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.762 HG21 HD13 ' A' ' 39' ' ' ILE . 14.6 t -86.52 104.23 13.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.529 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.561 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 2.8 mtt -84.57 160.64 20.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.16 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.629 HG22 HG12 ' A' ' 57' ' ' VAL . 2.8 m -139.53 140.93 36.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.178 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.43 HG22 ' HB2' ' A' ' 37' ' ' HIS . 0.4 OUTLIER -92.11 101.8 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.836 179.342 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.899 HG23 HG13 ' A' ' 4' ' ' VAL . 31.8 m -130.72 137.2 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.499 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.62 -59.37 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.423 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -81.7 -7.78 59.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.038 0.447 . . . . 0.0 110.444 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.5 -140.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.178 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.17 -162.35 1.52 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.814 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.23 11.71 35.62 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.741 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.43 ' C ' ' HA3' ' A' ' 33' ' ' GLY . . . -70.02 -11.4 66.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.615 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.435 ' HA ' ' HB2' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -73.68 -2.41 23.06 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.966 0.412 . . . . 0.0 110.103 179.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -54.5 -23.8 17.83 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.926 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.07 -31.38 63.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.891 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.467 ' HB3' ' CG ' ' A' ' 31' ' ' PRO . . . -59.72 -56.32 23.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.449 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.45 -35.98 75.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.547 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -48.97 79.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.347 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.66 -22.88 67.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.566 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.57 HD11 HG23 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -72.9 -27.42 61.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.681 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -18.25 64.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.519 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.47 35.88 0.87 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.688 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.727 HD13 ' HB2' ' A' ' 29' ' ' ARG . 0.6 OUTLIER -72.88 -164.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.493 -0.354 . . . . 0.0 111.047 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.7 OUTLIER -50.95 101.52 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.964 0.411 . . . . 0.0 111.154 -179.094 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.09 -33.33 79.07 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.51 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.4 t -86.98 -39.15 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 0.0 110.501 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.629 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 22.0 t -95.5 90.93 5.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.609 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.559 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -76.9 136.79 38.84 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.098 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.771 HG21 HG23 ' A' ' 82' ' ' VAL . 17.7 mt -101.45 146.91 8.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.743 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.405 ' N ' HG23 ' A' ' 80' ' ' ILE . 2.2 tp10 -85.84 71.72 10.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.771 HG23 HG21 ' A' ' 80' ' ' ILE . 73.6 t -79.96 54.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.08 -174.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -133.08 2.73 3.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.418 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.745 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 20.6 t0 . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 120.8 0.333 . . . . 0.0 110.961 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.56 ' HB ' HG21 ' A' ' 57' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.634 0.254 . . . . 0.0 110.756 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -114.87 113.21 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.973 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.469 ' HB3' HG21 ' A' ' 55' ' ' VAL . . . -94.55 165.99 12.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.332 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.762 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 7.4 m -143.41 130.71 20.91 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.658 0.742 . . . . 0.0 112.187 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.743 ' HB ' HH22 ' A' ' 29' ' ' ARG . 5.7 mm -122.15 107.38 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.728 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.571 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.19 95.34 8.06 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.491 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.9 m -94.27 137.85 22.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.899 0.381 . . . . 0.0 111.841 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.65 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 1.1 ptm -147.43 127.61 6.76 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 121.177 0.513 . . . . 0.0 111.455 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.642 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 13.3 Cg_exo -72.37 124.74 10.14 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.525 2.817 . . . . 0.0 112.141 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.91 -33.54 67.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.274 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.94 151.9 79.48 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.992 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.575 ' HA ' HD11 ' A' ' 48' ' ' LEU . 45.8 Cg_endo -67.95 -2.54 8.91 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.407 2.071 . . . . 0.0 111.978 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.39 44.23 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.025 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.642 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 74.3 t -64.86 77.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.625 -178.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 19.3 m-20 -70.86 91.44 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.916 177.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.655 ' H ' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -64.67 -36.08 83.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.353 -178.235 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.505 ' H ' HD13 ' A' ' 19' ' ' LEU . 8.7 pt-20 -69.91 -38.83 76.38 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.91 0.386 . . . . 0.0 110.177 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.63 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . . . -71.82 -33.9 68.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.341 0.591 . . . . 0.0 109.526 177.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.505 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -66.04 -32.93 74.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.305 177.272 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -57.14 -45.53 83.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.419 178.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.63 ' HE3' ' HA ' ' A' ' 21' ' ' ALA . 2.0 mtmt -65.85 -43.25 89.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.582 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -65.54 -30.06 70.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.474 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.649 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 5.7 mt -60.83 -45.85 97.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.957 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.459 ' NE2' HD23 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -61.07 -38.0 84.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.947 0.403 . . . . 0.0 110.688 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -75.55 -23.07 56.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.333 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.743 HH22 ' HB ' ' A' ' 8' ' ' ILE . 23.6 ptt85 -90.99 -11.84 37.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.116 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 26' ' ' ILE . 27.6 mm -60.02 137.33 90.92 Favored Pre-proline 0 N--CA 1.463 0.21 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.019 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.535 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 4.1 Cg_endo -46.89 120.82 4.41 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.853 2.368 . . . . 0.0 112.296 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -55.95 -11.02 0.91 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.832 -179.094 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.7 -41.84 10.58 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.901 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.583 ' OG1' HG23 ' A' ' 64' ' ' THR . 0.2 OUTLIER -130.38 -148.45 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.69 0.281 . . . . 0.0 110.995 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -137.23 175.02 9.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.836 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.459 HD23 ' NE2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -74.69 -176.07 2.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.237 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.411 ' ND1' HG23 ' A' ' 56' ' ' VAL . 79.5 t60 -131.04 -69.78 0.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.662 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 1.2 mmtt -161.31 127.13 3.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.1 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.737 HD12 HG21 ' A' ' 53' ' ' VAL . 2.9 mt -91.78 158.01 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.626 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.641 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -128.78 119.23 24.15 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.461 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -82.46 72.01 9.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.985 0.421 . . . . 0.0 110.401 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -97.05 132.85 24.98 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.816 -179.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.761 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 58.9 Cg_endo -87.68 155.83 7.58 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.527 2.151 . . . . 0.0 112.8 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.445 HG13 ' SD ' ' A' ' 11' ' ' MET . 1.8 mm -124.43 -82.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.098 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 48' ' ' LEU . . . -67.66 -153.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.951 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -71.98 -27.88 63.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 110.709 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.64 5.83 0.53 Allowed Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.581 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.647 ' N ' HD13 ' A' ' 48' ' ' LEU . 8.2 mp -91.1 97.5 11.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.791 0.329 . . . . 0.0 110.645 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.761 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 95.4 t -93.97 127.36 46.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.085 0.469 . . . . 0.0 112.163 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.65 ' HB3' ' HB3' ' A' ' 11' ' ' MET . . . -95.82 142.4 28.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.795 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.641 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -105.98 120.72 42.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.377 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.498 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.3 m120 -89.61 91.85 8.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.374 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.737 HG21 HD12 ' A' ' 39' ' ' ILE . 9.4 t -86.41 107.46 16.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.264 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.435 ' HG3' HG22 ' A' ' 7' ' ' THR . 12.5 mtt -84.46 168.28 15.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.168 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 6' ' ' ALA . 2.8 m -141.48 136.04 31.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.922 0.391 . . . . 0.0 111.312 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.411 HG23 ' ND1' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -96.12 112.76 28.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.769 178.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.56 HG21 ' HB ' ' A' ' 4' ' ' VAL . 19.9 m -130.46 138.06 54.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.897 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.66 -60.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.322 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.89 -13.9 58.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.021 0.439 . . . . 0.0 110.376 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.91 -146.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.029 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.401 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 1.0 OUTLIER -147.61 -160.37 1.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.717 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -80.66 13.21 30.61 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.36 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.21 -1.92 37.51 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.54 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.583 HG23 ' OG1' ' A' ' 34' ' ' THR . 1.8 p -75.34 -6.41 49.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.975 0.417 . . . . 0.0 110.264 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.83 -23.48 18.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.341 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.02 -27.5 61.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.996 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 31' ' ' PRO . . . -61.41 -55.59 29.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.31 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -58.99 -34.85 72.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.573 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.58 -50.44 71.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.343 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.472 ' HG ' HD12 ' A' ' 74' ' ' ILE . 14.5 p -63.39 -18.86 64.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.211 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.812 HD13 HG22 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -72.9 -30.71 64.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.559 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -12.14 33.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.72 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.26 26.44 0.99 Allowed Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.829 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.812 HG22 HD13 ' A' ' 71' ' ' LEU . 2.4 tt -73.21 -160.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.671 -0.264 . . . . 0.0 110.873 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 0.4 OUTLIER -51.01 99.9 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.842 0.353 . . . . 0.0 110.98 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.52 -32.58 78.42 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.596 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.2 t -88.25 -38.39 11.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.939 0.399 . . . . 0.0 110.543 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.592 ' HB2' ' HB3' ' A' ' 75' ' ' GLU . 6.1 m -95.81 90.65 5.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.76 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.543 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -79.43 137.75 37.37 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.781 HG21 HG22 ' A' ' 82' ' ' VAL . 1.7 mt -101.74 147.24 8.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.575 -176.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.4 ' N ' HG23 ' A' ' 80' ' ' ILE . 2.3 tp10 -86.01 72.02 10.51 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 172.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.781 HG22 HG21 ' A' ' 80' ' ' ILE . 62.9 t -80.79 56.66 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.124 -174.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -133.05 0.34 3.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.762 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.762 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 40.2 t0 . . . . . 0 N--CA 1.455 -0.213 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.229 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.062 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 41.1 t -109.96 118.41 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 0.0 111.755 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.692 ' HB2' HG23 ' A' ' 55' ' ' VAL . . . -94.04 161.76 14.16 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.634 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 6.2 m -140.97 131.41 25.24 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.682 0.753 . . . . 0.0 112.687 -178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.767 HG21 HG23 ' A' ' 80' ' ' ILE . 3.8 mm -121.03 105.78 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.367 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.521 ' O ' HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -93.69 93.4 8.0 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -177.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.488 HG21 ' HG ' ' A' ' 78' ' ' SER . 1.9 m -92.44 136.0 25.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.826 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.603 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.6 OUTLIER -146.55 123.94 5.98 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-O 121.235 0.54 . . . . 0.0 111.444 179.288 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.64 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 14.1 Cg_exo -70.4 120.99 7.57 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.305 2.67 . . . . 0.0 111.854 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -56.69 -31.2 64.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.405 ' O ' HG21 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -77.62 153.19 81.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.983 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.577 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 46.4 Cg_endo -68.58 -2.9 10.08 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.446 2.097 . . . . 0.0 112.366 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -91.71 43.12 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.248 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.64 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 97.0 t -65.64 76.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.408 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 3.7 m-20 -70.03 97.65 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.609 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -63.23 -45.74 90.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.816 -177.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.79 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 28.3 tt0 -70.7 -35.62 72.85 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.759 0.314 . . . . 0.0 110.678 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 24' ' ' LYS . . . -67.52 -39.2 85.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -66.57 -31.5 72.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.836 177.02 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.79 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -55.46 -48.61 74.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.115 -179.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -68.16 -40.76 82.26 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.522 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 29.8 mm-40 -64.75 -30.02 71.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.07 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.672 HG12 HG22 ' A' ' 53' ' ' VAL . 1.2 mt -62.61 -46.4 96.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.988 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -60.94 -36.19 78.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.413 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 9.9 pt-20 -77.16 -22.36 52.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.433 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.78 ' HB2' HD11 ' A' ' 74' ' ' ILE . 8.6 ptp180 -89.55 -9.19 50.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.253 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 26' ' ' ILE . 34.6 mm -57.82 138.89 82.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.466 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.586 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 10.2 Cg_endo -50.91 117.23 3.17 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.711 2.274 . . . . 0.0 111.972 178.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -59.12 1.76 0.06 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.12 -62.54 1.81 Allowed Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.83 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.428 ' OG1' HG11 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -109.43 -139.26 0.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.591 0.234 . . . . 0.0 110.844 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -134.9 166.16 23.65 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.868 0.366 . . . . 0.0 110.839 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.494 ' HB3' HD13 ' A' ' 30' ' ' ILE . 0.5 OUTLIER -75.56 -175.97 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.093 -179.369 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.581 ' ND1' HG23 ' A' ' 56' ' ' VAL . 73.7 t60 -131.25 -79.08 0.52 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 10.1 mmtt -161.69 137.81 7.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.687 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 53' ' ' VAL . 2.4 mm -92.11 166.63 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.452 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.608 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -130.03 123.22 30.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.165 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -84.88 67.67 10.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.875 0.369 . . . . 0.0 110.518 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.421 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -95.44 133.9 25.16 Favored Pre-proline 0 C--O 1.225 -0.205 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.579 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.761 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 60.6 Cg_endo -87.12 155.65 8.32 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.62 2.213 . . . . 0.0 112.686 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.412 HG13 ' SD ' ' A' ' 11' ' ' MET . 2.8 mm -124.81 -82.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.378 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.533 ' HB1' ' HG ' ' A' ' 48' ' ' LEU . . . -67.4 -150.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -71.87 -29.95 64.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.587 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.71 6.36 0.54 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.736 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.577 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 4.8 mt -91.45 100.91 13.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.975 0.417 . . . . 0.0 110.835 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.761 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 78.3 t -92.96 128.52 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.72 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 11' ' ' MET . . . -95.35 143.0 27.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.103 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.608 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 10.9 mp -101.53 119.46 38.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.251 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.8 m120 -91.66 96.19 10.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.312 0.577 . . . . 0.0 111.011 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.672 HG22 HG12 ' A' ' 26' ' ' ILE . 39.6 t -84.51 103.12 11.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.15 -177.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.564 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 18.5 mtt -86.3 161.63 18.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.101 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.692 HG23 ' HB2' ' A' ' 6' ' ' ALA . 3.3 m -139.32 135.12 40.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 111.193 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.581 HG23 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -95.04 115.78 34.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.006 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.428 HG11 ' OG1' ' A' ' 34' ' ' THR . 13.8 m -130.35 151.1 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.983 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.53 -74.22 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.534 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -81.38 -3.01 51.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 0.0 110.713 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.21 -147.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.366 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -147.57 -166.08 2.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.855 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.69 15.62 24.35 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.668 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.82 -5.19 50.85 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.528 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.72 -3.76 33.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.94 0.4 . . . . 0.0 110.296 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -55.19 -23.11 20.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.142 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.19 -27.34 61.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.121 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.586 ' HB1' ' HB3' ' A' ' 31' ' ' PRO . . . -61.16 -55.09 36.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.482 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -58.21 -36.11 72.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.458 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.36 -51.03 70.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.345 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -19.16 64.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.443 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.66 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.34 -29.55 62.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.602 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.68 -12.07 31.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.772 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.15 25.82 1.0 Allowed Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.619 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.78 HD11 ' HB2' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -73.48 -164.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.476 -0.362 . . . . 0.0 111.187 -178.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.642 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.6 OUTLIER -50.37 100.78 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.006 0.431 . . . . 0.0 111.114 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.28 -31.54 79.37 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.873 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.3 t -85.84 -35.79 9.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.006 0.432 . . . . 0.0 110.307 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.642 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 43.8 t -95.77 90.5 5.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.614 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.555 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.24 133.2 38.93 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.767 HG23 HG21 ' A' ' 8' ' ' ILE . 3.2 mp -101.56 148.76 7.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.686 -175.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.442 ' N ' HG22 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -85.81 71.36 10.67 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 172.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.757 HG23 HG23 ' A' ' 80' ' ' ILE . 57.9 t -79.82 50.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.079 -174.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -133.13 7.18 3.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.359 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.634 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.5 m-20 . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.994 0.426 . . . . 0.0 111.207 -178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.615 ' HB ' HG21 ' A' ' 57' ' ' VAL . 2.5 t . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.764 0.316 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 53.1 t -105.3 114.78 45.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.588 -178.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -97.01 165.74 11.93 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.712 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 13.4 m -143.25 128.84 19.15 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.542 0.687 . . . . 0.0 111.859 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.74 HG22 HG23 ' A' ' 80' ' ' ILE . 3.4 mm -120.54 107.7 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.759 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.649 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -97.58 95.46 7.63 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.523 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.8 m -93.28 135.86 26.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.733 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.59 119.31 4.58 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 121.279 0.561 . . . . 0.0 111.97 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.1 Cg_exo -69.99 119.14 6.13 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.197 2.598 . . . . 0.0 112.034 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -56.91 -29.13 62.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.172 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.43 148.98 74.75 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.046 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.517 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 35.9 Cg_endo -64.69 -7.38 14.52 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.303 2.002 . . . . 0.0 111.804 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.63 34.78 0.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.6 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.4 87.25 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.776 0.798 . . . . 0.0 109.892 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.598 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 55.3 m-20 -67.9 104.59 1.75 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.139 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.79 HD13 HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -60.93 -53.47 56.94 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.445 -178.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 35.7 tt0 -69.75 -36.5 75.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.046 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.61 -35.16 76.96 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.779 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.598 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -65.36 -33.36 75.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.518 177.237 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HD3' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -55.98 -46.74 78.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.471 178.768 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -66.12 -42.81 88.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.41 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.721 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 51.0 mm-40 -65.34 -30.23 71.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.37 0.605 . . . . 0.0 110.438 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.815 HG22 HG22 ' A' ' 53' ' ' VAL . 3.4 mt -60.69 -47.05 94.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.597 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.78 -38.11 89.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.387 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.721 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -77.32 -21.08 54.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.48 -178.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.703 ' HD3' HD11 ' A' ' 74' ' ' ILE . 3.3 ptp85 -89.15 -13.45 38.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.077 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.668 HG12 ' O ' ' A' ' 26' ' ' ILE . 34.4 mm -61.08 136.92 93.99 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.57 ' HD2' HG23 ' A' ' 30' ' ' ILE . 15.7 Cg_endo -55.88 129.49 35.24 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.334 2.023 . . . . 0.0 112.614 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.6 0.1 0.22 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.125 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.58 -56.69 2.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.977 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.11 -144.74 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.321 . . . . 0.0 111.416 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -133.83 170.1 16.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.957 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.444 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -75.32 -173.83 2.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.217 -179.134 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.566 ' ND1' HG21 ' A' ' 56' ' ' VAL . 85.3 t60 -130.9 -75.48 0.53 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.423 0.63 . . . . 0.0 110.944 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.489 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER -164.45 129.37 2.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.788 -178.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.641 HD12 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -92.59 158.23 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.166 0.508 . . . . 0.0 112.362 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.599 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 5.1 m-20 -123.41 124.72 43.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.517 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -86.78 72.58 10.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.782 0.325 . . . . 0.0 110.624 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.05 136.0 20.25 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.93 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.757 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 64.2 Cg_endo -86.25 158.08 9.71 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.71 2.274 . . . . 0.0 112.629 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mm -127.28 -83.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.657 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.543 ' HB1' ' HG ' ' A' ' 48' ' ' LEU . . . -67.83 -148.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.283 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -71.58 -32.81 68.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.826 0.346 . . . . 0.0 110.591 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.65 7.23 0.58 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.638 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.586 ' HA ' HG11 ' A' ' 17' ' ' VAL . 3.3 mt -91.41 102.33 15.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.905 0.383 . . . . 0.0 110.814 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.757 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 75.3 t -92.64 130.03 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.848 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.605 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -94.94 159.27 15.11 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.814 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.79 HD12 HD13 ' A' ' 19' ' ' LEU . 10.5 mp -117.93 119.12 33.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.397 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.586 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.7 m120 -89.66 91.13 8.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.35 0.595 . . . . 0.0 110.159 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.815 HG22 HG22 ' A' ' 26' ' ' ILE . 5.9 t -87.04 103.24 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.418 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.469 ' HG2' ' HG1' ' A' ' 7' ' ' THR . 15.1 mtt -84.63 166.13 17.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.237 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.437 HG21 HG12 ' A' ' 57' ' ' VAL . 3.6 m -140.0 135.21 37.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.868 0.366 . . . . 0.0 111.616 -178.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.566 HG21 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.79 110.62 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.759 178.483 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.615 HG21 ' HB ' ' A' ' 4' ' ' VAL . 11.3 m -130.3 144.71 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.043 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.24 -64.14 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.417 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -80.94 -6.92 59.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.882 0.372 . . . . 0.0 110.635 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.88 -147.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.058 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -147.69 -161.65 1.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.78 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.56 13.08 30.6 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.579 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.26 -7.65 60.59 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.511 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -4.5 36.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.892 0.377 . . . . 0.0 110.216 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.64 -23.69 18.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.03 177.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.88 -28.83 62.34 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.038 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 31' ' ' PRO . . . -59.87 -56.5 21.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.577 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -58.58 -35.51 72.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.492 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -61.33 -51.11 70.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.438 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.1 p -64.01 -17.9 63.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.533 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.819 HD13 HG23 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.25 -31.13 62.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.533 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.93 -10.24 27.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.687 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.02 26.76 1.01 Allowed Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.819 HG23 HD13 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -73.2 -169.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.291 -0.455 . . . . 0.0 111.087 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -50.58 97.93 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 111.193 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.99 -31.68 81.51 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.778 -0.647 . . . . 0.0 112.927 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.59 -37.27 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.137 0.494 . . . . 0.0 109.982 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 1.5 m -95.37 87.8 4.91 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.039 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.533 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -76.45 135.62 39.4 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.103 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.795 HG23 HG23 ' A' ' 82' ' ' VAL . 2.6 mt -101.45 148.58 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.566 -175.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.649 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 33.6 tp10 -85.95 69.89 10.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.795 HG23 HG23 ' A' ' 80' ' ' ILE . 61.7 t -80.69 57.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.679 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -132.76 -2.56 3.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.874 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.712 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 2.6 m-20 . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.267 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.519 0.199 . . . . 0.0 111.32 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 83.2 t -129.54 115.25 33.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.055 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.494 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -95.56 165.98 12.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.76 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.759 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.9 m -141.99 127.01 18.36 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.588 0.709 . . . . 0.0 111.898 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.695 HG21 HG22 ' A' ' 80' ' ' ILE . 8.3 mm -120.57 108.85 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.925 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.663 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -97.77 96.85 8.52 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.603 ' CB ' HG12 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -92.85 139.98 17.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -176.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.818 ' HE2' HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -146.14 122.57 5.82 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.249 179.328 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.587 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 11.6 Cg_exo -72.9 120.86 6.89 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.462 2.775 . . . . 0.0 112.383 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.57 -31.21 65.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.338 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.47 ' O ' HG21 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -77.58 151.02 79.95 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.039 -179.551 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.696 ' HA ' HD21 ' A' ' 48' ' ' LEU . 41.9 Cg_endo -66.86 -3.32 9.27 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.421 2.081 . . . . 0.0 112.003 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.16 42.69 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.353 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.587 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 95.7 t -65.02 77.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.068 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 62.7 m-20 -68.93 100.86 1.26 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.165 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.771 ' HG ' HD11 ' A' ' 51' ' ' LEU . 3.1 tt -62.96 -49.21 75.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.481 -178.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -68.15 -38.26 81.94 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.739 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 18' ' ' ASP . . . -69.78 -37.13 76.25 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.011 177.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.584 HD13 ' NH2' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -65.42 -34.12 77.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.697 177.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -47.26 85.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.088 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.478 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -69.32 -37.15 77.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.188 0.518 . . . . 0.0 110.388 179.146 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.478 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 12.5 mt-10 -66.26 -31.02 71.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.017 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.729 HG12 HG21 ' A' ' 53' ' ' VAL . 2.1 mt -62.38 -42.69 96.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.444 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.498 ' NE2' HG23 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -57.72 -39.66 77.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.443 179.343 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -74.83 -24.24 58.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.708 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.836 ' HD3' HD13 ' A' ' 74' ' ' ILE . 2.4 ptp180 -88.56 -12.84 41.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.758 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.481 HG21 ' HD2' ' A' ' 31' ' ' PRO . 22.7 mm -57.65 135.44 82.58 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.577 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.481 ' HD2' HG21 ' A' ' 30' ' ' ILE . 10.5 Cg_endo -53.07 126.63 22.11 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.509 2.139 . . . . 0.0 112.335 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -58.05 -2.01 0.15 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.401 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -81.83 -46.36 6.77 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.515 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.494 ' HG1' HG23 ' A' ' 64' ' ' THR . 0.2 OUTLIER -130.55 -142.51 0.24 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.672 0.272 . . . . 0.0 110.993 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -139.44 173.09 11.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.022 0.439 . . . . 0.0 110.855 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -74.44 -176.75 2.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.236 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.519 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 83.4 t60 -131.73 -71.92 0.55 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.475 0.655 . . . . 0.0 111.167 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.515 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -162.72 128.62 3.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.992 -177.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.698 HD12 HG23 ' A' ' 53' ' ' VAL . 2.5 mt -94.77 160.1 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.118 -177.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.655 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.1 t0 -127.38 128.79 46.44 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.633 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -87.34 73.38 9.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.789 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.48 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -98.88 133.43 22.33 Favored Pre-proline 0 C--O 1.225 -0.22 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.309 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.771 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 62.6 Cg_endo -87.56 157.03 7.79 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.519 2.146 . . . . 0.0 113.086 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.46 HG22 HD13 ' A' ' 44' ' ' ILE . 3.3 mm -124.74 -83.01 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.245 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.4 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.3 -156.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.034 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -71.94 -25.1 61.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.625 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.51 0.98 0.33 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.119 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.818 HD11 ' HE2' ' A' ' 11' ' ' MET . 6.0 mt -92.01 100.24 12.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.887 0.375 . . . . 0.0 110.765 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 70.0 t -92.52 132.8 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.646 -178.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 11' ' ' MET . . . -95.86 162.0 13.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.006 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.771 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.2 mp -120.63 121.15 37.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.546 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.548 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.2 m120 -90.11 91.66 8.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.207 0.527 . . . . 0.0 110.042 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.729 HG21 HG12 ' A' ' 26' ' ' ILE . 11.3 t -86.73 104.34 13.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.531 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.623 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -85.01 162.89 19.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.905 178.186 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 4.6 m -136.86 127.02 39.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.949 0.404 . . . . 0.0 111.116 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.519 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 0.4 OUTLIER -94.36 109.86 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.938 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 4' ' ' VAL . 2.3 m -128.24 146.63 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.664 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.28 -61.94 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.536 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -80.21 -11.26 59.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.092 0.472 . . . . 0.0 110.239 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.89 -144.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.935 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.45 -166.52 2.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.813 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.86 15.16 22.28 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.534 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.08 -0.54 28.56 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.521 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.494 HG23 ' HG1' ' A' ' 34' ' ' THR . 1.3 p -73.45 -3.45 27.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.944 0.402 . . . . 0.0 110.355 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.92 -23.72 20.22 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.163 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.17 -27.53 61.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.074 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.412 ' N ' ' HB3' ' A' ' 31' ' ' PRO . . . -59.58 -56.28 23.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.488 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -57.88 -36.88 73.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.612 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.93 -51.86 67.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.552 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.418 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 54.7 p -64.59 -20.29 66.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.85 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.685 HD23 HD11 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -73.09 -27.96 62.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.834 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -14.38 55.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.707 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.35 28.16 0.97 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.819 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.836 HD13 ' HD3' ' A' ' 29' ' ' ARG . 1.2 tt -72.97 -160.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.497 -0.351 . . . . 0.0 110.933 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.68 ' HB2' HH12 ' A' ' 29' ' ' ARG . 0.1 OUTLIER -50.07 91.15 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.993 0.425 . . . . 0.0 111.011 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.3 -26.54 66.28 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.337 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.8 p -86.62 -39.59 13.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.282 0.563 . . . . 0.0 110.09 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.62 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 11.9 t -95.96 90.35 5.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.331 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.571 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -75.77 132.29 40.35 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.779 HG22 HG22 ' A' ' 82' ' ' VAL . 12.5 mt -101.08 147.3 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.479 -175.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.663 ' HG2' ' HB2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -85.62 73.69 10.4 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.106 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.779 HG22 HG22 ' A' ' 80' ' ' ILE . 90.5 t -80.97 55.55 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.743 -174.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.68 2.91 3.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.403 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.759 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 30.3 t0 . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.778 0.323 . . . . 0.0 110.854 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.609 ' HB ' HG21 ' A' ' 57' ' ' VAL . 15.8 t . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.709 0.29 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 38.8 t -104.76 115.19 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.343 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.501 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -93.07 166.19 12.47 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.698 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 10.1 m -142.12 136.52 30.16 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.542 0.687 . . . . 0.0 112.44 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.745 HG21 HG21 ' A' ' 80' ' ' ILE . 8.3 mm -125.53 105.55 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.991 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.604 ' HD2' ' HB3' ' A' ' 52' ' ' ASN . 2.2 mmmt -97.38 96.97 8.73 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -176.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 10' ' ' VAL . 1.5 m -94.02 136.15 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.875 0.369 . . . . 0.0 111.931 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.802 ' HE1' HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -146.9 123.16 5.58 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.314 179.306 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.642 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 10.2 Cg_exo -73.86 122.25 7.58 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.562 2.841 . . . . 0.0 112.077 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -57.47 -32.04 66.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.448 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.45 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -77.35 152.32 81.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.032 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 42.2 Cg_endo -67.55 -3.23 9.79 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.417 2.078 . . . . 0.0 112.154 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.8 43.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.103 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.642 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 93.7 t -65.29 75.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.389 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 3.8 m-20 -70.33 88.88 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.74 HD13 ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.18 -38.43 91.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.825 -177.187 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.944 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 1.4 tt0 -70.67 -36.23 73.23 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.05 0.452 . . . . 0.0 110.086 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.61 -37.54 76.92 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.497 ' CD2' ' HG3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -66.45 -30.19 70.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.909 177.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.944 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -54.53 -46.41 73.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.437 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 7.2 mtmt -67.14 -44.53 79.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.513 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -65.19 -25.96 67.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.566 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.774 HG12 HG22 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -60.47 -49.65 83.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.361 -179.368 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.615 ' NE2' HD22 ' A' ' 36' ' ' LEU . 6.1 mm-40 -62.97 -32.48 73.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.155 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 15.3 mt-10 -74.62 -24.08 58.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.024 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.601 ' HB2' HD13 ' A' ' 74' ' ' ILE . 1.2 ptp85 -91.95 -13.51 31.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.362 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.541 HG21 ' N ' ' A' ' 31' ' ' PRO . 10.1 mm -59.49 140.16 88.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.911 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.541 ' N ' HG21 ' A' ' 30' ' ' ILE . 9.4 Cg_endo -51.44 112.7 0.87 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.744 2.296 . . . . 0.0 112.119 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.77 -0.87 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.253 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.03 -35.95 16.76 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.956 -178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.545 HG22 ' HB3' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.3 -142.96 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.694 0.247 . . . . 0.0 110.96 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -135.12 167.01 21.75 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.883 0.373 . . . . 0.0 111.116 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.615 HD22 ' NE2' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -75.32 -179.89 4.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.384 -179.033 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.518 ' HB2' HG23 ' A' ' 56' ' ' VAL . 79.4 t60 -130.77 -75.81 0.53 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.96 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.603 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -165.43 131.84 2.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.744 -178.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.718 HD13 HG22 ' A' ' 26' ' ' ILE . 2.5 mt -91.41 155.93 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 112.362 -176.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 61.0 m-20 -120.42 126.68 51.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.692 -178.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.39 71.38 9.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.819 0.343 . . . . 0.0 110.304 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.442 ' C ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.81 134.25 21.14 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.796 -179.619 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.779 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 73.7 Cg_endo -87.07 157.69 8.5 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.575 2.184 . . . . 0.0 112.608 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.415 HD13 ' HB2' ' A' ' 50' ' ' ALA . 3.5 mm -125.65 -82.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.36 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.536 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.05 -153.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -71.74 -28.22 63.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.637 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.45 4.58 0.5 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.97 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.802 HD11 ' HE1' ' A' ' 11' ' ' MET . 5.7 mt -92.34 102.61 15.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.859 0.361 . . . . 0.0 110.975 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.779 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 76.6 t -93.0 130.47 42.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.792 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 11' ' ' MET . . . -96.21 153.31 17.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.916 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.596 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 10.5 mp -111.53 117.18 32.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.33 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.604 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.2 m120 -89.79 92.48 9.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.208 0.528 . . . . 0.0 110.379 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.774 HG22 HG12 ' A' ' 26' ' ' ILE . 4.0 t -86.81 105.82 15.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.274 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -84.62 166.56 17.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.432 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.567 HG21 HG13 ' A' ' 57' ' ' VAL . 2.9 m -138.99 139.3 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.223 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 37' ' ' HIS . 1.9 t -93.57 106.61 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.137 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.609 HG21 ' HB ' ' A' ' 4' ' ' VAL . 2.8 m -127.82 155.61 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.793 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.79 -73.41 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.087 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.67 0.89 36.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.994 0.426 . . . . 0.0 110.494 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.545 ' HB3' HG22 ' A' ' 34' ' ' THR . . . -67.02 -146.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.019 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.82 -165.35 2.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.936 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.3 13.34 33.97 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.433 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.01 -4.23 47.75 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.536 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.46 HG23 ' OG1' ' A' ' 34' ' ' THR . 1.6 p -75.04 -3.92 35.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.966 0.412 . . . . 0.0 110.105 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -55.43 -23.55 25.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.258 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.11 -29.63 60.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.874 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.78 -56.29 21.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.337 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 3.3 mt-10 -58.57 -33.92 70.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.431 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -51.85 65.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.261 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.58 -16.83 61.93 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.028 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.69 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 2.1 mt -72.3 -33.52 67.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.374 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -9.7 15.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.0 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.08 26.73 1.0 Allowed Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.69 ' HB ' ' HA ' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -73.3 -166.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.153 -0.523 . . . . 0.0 111.407 -178.437 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 2.7 mm-40 -51.61 101.65 0.04 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.878 0.371 . . . . 0.0 110.901 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.75 -33.95 88.33 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.776 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -86.02 -39.45 13.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 0.0 110.346 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.589 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 48.3 t -96.06 91.22 5.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.782 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.568 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.79 134.02 38.11 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.79 HG21 HG21 ' A' ' 82' ' ' VAL . 2.9 mp -101.38 148.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.379 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.506 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.3 tp10 -86.02 69.32 10.51 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.79 HG21 HG21 ' A' ' 80' ' ' ILE . 47.7 t -81.12 51.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.18 -174.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.82 6.64 4.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.542 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.698 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.3 m-20 . . . . . 0 N--CA 1.454 -0.243 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.441 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.107 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 42.1 t -128.62 128.09 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.701 0.286 . . . . 0.0 111.652 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -99.4 167.04 10.88 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.789 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.4 m -142.83 133.2 24.79 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.594 0.712 . . . . 0.0 112.386 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.734 ' HB ' HH22 ' A' ' 29' ' ' ARG . 5.9 mm -125.89 108.43 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.777 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.603 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -98.7 96.69 8.09 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.376 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.79 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.9 m -94.0 138.02 21.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.65 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.76 119.57 4.57 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 121.157 0.503 . . . . 0.0 111.806 179.41 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.54 ' O ' HD23 ' A' ' 48' ' ' LEU . 21.1 Cg_exo -69.71 123.64 10.32 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.464 2.776 . . . . 0.0 112.007 178.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.17 -30.52 64.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.508 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 m -77.6 148.52 76.74 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.053 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.562 ' HA ' HD13 ' A' ' 48' ' ' LEU . 38.8 Cg_endo -65.64 -6.6 14.21 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.419 2.079 . . . . 0.0 111.779 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -93.44 36.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.605 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.685 HG11 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.72 88.49 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.78 0.8 . . . . 0.0 110.134 -179.569 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 32.9 m-20 -68.25 104.27 1.79 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.034 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.821 ' HG ' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -61.24 -52.2 65.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.707 -178.146 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.725 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -71.2 -34.37 70.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.277 -177.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.528 ' N ' ' HG2' ' A' ' 20' ' ' GLU . . . -68.28 -35.93 78.61 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -66.16 -33.53 75.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.384 176.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.725 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -55.92 -46.61 78.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.132 178.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -43.31 90.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.798 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 11.3 mt-10 -66.55 -30.73 71.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.257 0.551 . . . . 0.0 110.722 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.732 HG12 HG23 ' A' ' 53' ' ' VAL . 1.6 mt -61.75 -43.92 97.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.816 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.21 -38.8 90.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.063 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 10.6 pt-20 -77.84 -21.16 51.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.553 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.802 ' HB2' HD13 ' A' ' 74' ' ' ILE . 20.0 ptt85 -89.86 -9.57 48.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.19 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.662 HG12 ' O ' ' A' ' 26' ' ' ILE . 32.6 mm -59.7 138.16 89.92 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.281 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.488 ' N ' HG22 ' A' ' 30' ' ' ILE . 10.2 Cg_endo -50.83 118.86 4.56 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.868 2.378 . . . . 0.0 112.279 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -59.13 -1.2 0.16 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.116 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.26 -42.82 8.39 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.918 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.51 ' HG1' HG21 ' A' ' 64' ' ' THR . 0.2 OUTLIER -130.49 -144.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.685 0.279 . . . . 0.0 110.951 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -133.35 167.08 21.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.874 0.368 . . . . 0.0 110.807 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.421 ' O ' HG21 ' A' ' 56' ' ' VAL . 1.8 pt? -75.92 -176.01 3.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.23 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.485 ' HB2' HG22 ' A' ' 56' ' ' VAL . 84.8 t60 -130.85 -76.46 0.53 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.369 0.604 . . . . 0.0 111.195 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 2.2 tptt -164.53 133.52 3.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.794 -178.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.757 HD11 HG22 ' A' ' 53' ' ' VAL . 1.7 mt -93.09 158.2 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.591 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -123.79 125.51 44.83 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.318 -178.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.12 73.84 10.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.93 0.395 . . . . 0.0 110.508 178.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.533 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -98.94 131.02 26.27 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.295 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.778 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 59.0 Cg_endo -87.53 157.57 7.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.485 2.123 . . . . 0.0 112.949 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.413 ' HB ' ' H ' ' A' ' 45' ' ' ALA . 2.4 mm -124.34 -82.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.107 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.413 ' H ' ' HB ' ' A' ' 44' ' ' ILE . . . -67.25 -157.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.84 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -72.28 -22.82 61.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.666 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.57 -1.18 0.25 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.039 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.685 ' HA ' HG11 ' A' ' 17' ' ' VAL . 8.8 mp -90.7 100.99 13.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.81 0.305 . . . . 0.0 110.966 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.778 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 93.4 t -94.57 132.94 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.971 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB3' ' HB2' ' A' ' 11' ' ' MET . . . -96.38 162.9 13.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.847 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.821 HD12 ' HG ' ' A' ' 19' ' ' LEU . 11.2 mp -121.12 120.36 35.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.716 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.557 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.2 m120 -90.92 91.18 8.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.281 0.562 . . . . 0.0 110.027 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.757 HG22 HD11 ' A' ' 39' ' ' ILE . 5.0 t -87.48 104.11 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.32 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.58 ' HG3' HG21 ' A' ' 7' ' ' THR . 0.3 OUTLIER -84.69 165.28 18.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.339 179.187 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.5 m -138.41 137.47 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.451 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -94.35 118.19 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.911 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.422 HG12 ' HG1' ' A' ' 34' ' ' THR . 35.4 m -130.2 142.4 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.95 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.4 -70.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.455 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -81.41 -5.76 58.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 0.0 110.5 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.67 -152.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.196 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.01 -162.35 1.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.803 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.07 14.07 28.93 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.276 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.0 -3.73 45.42 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.36 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.51 HG21 ' HG1' ' A' ' 34' ' ' THR . 1.1 p -74.67 -3.39 31.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.016 0.436 . . . . 0.0 110.097 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.99 -23.47 19.44 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.045 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.0 -26.87 60.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.11 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.6 -52.79 62.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.107 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -59.21 -37.32 77.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.308 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -49.05 78.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.137 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.42 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -63.85 -19.78 65.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.327 178.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.773 HD13 HG21 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.0 -30.7 62.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.422 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 p -64.51 -9.52 19.43 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.739 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.14 22.05 0.98 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.108 -0.567 . . . . 0.0 111.968 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.802 HD13 ' HB2' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -72.82 -164.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 122.3 0.24 . . . . 0.0 110.666 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 0.4 OUTLIER -50.81 100.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.929 0.395 . . . . 0.0 110.981 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.4 -27.03 68.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.048 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.4 p -90.15 -36.83 8.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.094 0.473 . . . . 0.0 110.824 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 1.6 m -95.6 89.26 5.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.602 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.417 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -76.32 132.1 39.59 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.655 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.79 HG12 ' HB ' ' A' ' 10' ' ' VAL . 15.7 mt -101.18 147.16 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.469 -175.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.603 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 16.3 tp10 -85.53 69.93 10.71 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 173.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 80' ' ' ILE . 62.0 t -80.17 48.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.001 -174.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.85 9.29 4.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.291 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.789 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 8.6 t70 . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.856 0.36 . . . . 0.0 111.082 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.557 ' HB ' HG23 ' A' ' 57' ' ' VAL . 1.7 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.671 0.272 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 9.7 t -104.88 110.78 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.12 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -101.2 166.86 10.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.338 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.675 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 8.5 m -143.33 129.16 19.41 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.699 0.762 . . . . 0.0 112.251 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.821 ' HB ' HH22 ' A' ' 29' ' ' ARG . 6.3 mm -121.91 107.97 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.523 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.533 ' O ' HG21 ' A' ' 80' ' ' ILE . 2.8 mmmt -97.28 94.56 7.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.456 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 2.0 m -93.37 137.84 21.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.682 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.7 OUTLIER -147.31 119.53 4.72 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 121.306 0.574 . . . . 0.0 111.915 178.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 22.2 Cg_exo -68.51 121.89 8.85 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.372 2.715 . . . . 0.0 111.982 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -56.25 -29.61 61.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.269 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.477 ' HG ' ' H ' ' A' ' 16' ' ' ASP . 1.3 p -76.97 151.16 81.81 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.173 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.591 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 48.4 Cg_endo -67.85 -6.47 17.0 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.165 1.91 . . . . 0.0 111.387 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.477 ' H ' ' HG ' ' A' ' 14' ' ' SER . 47.6 m-20 -92.6 33.92 1.1 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.565 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.727 HG13 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.05 87.15 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.8 0.809 . . . . 0.0 110.015 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 15.6 m-20 -70.08 106.99 3.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.47 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.905 ' HG ' HD12 ' A' ' 51' ' ' LEU . 2.2 tt -62.16 -49.58 75.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.226 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -68.67 -37.55 79.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.864 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.95 -34.0 71.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.58 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -65.34 -32.62 74.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.574 177.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -44.49 88.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.604 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.5 -42.49 92.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.337 178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.63 -32.12 73.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.179 0.514 . . . . 0.0 110.337 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.656 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 9.7 mt -60.94 -44.35 97.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.745 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.96 -39.65 86.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.542 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -74.73 -24.31 58.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.379 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.821 HH22 ' HB ' ' A' ' 8' ' ' ILE . 24.7 ptt85 -91.06 -14.02 32.08 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.697 HD13 HG12 ' A' ' 53' ' ' VAL . 12.1 mm -58.16 137.78 84.38 Favored Pre-proline 0 C--N 1.332 -0.186 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.481 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.512 ' N ' HG22 ' A' ' 30' ' ' ILE . 5.2 Cg_endo -45.3 119.03 2.34 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.807 2.338 . . . . 0.0 112.231 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -57.3 -4.55 0.23 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.076 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.95 -45.15 6.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.516 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.43 -142.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.765 0.316 . . . . 0.0 111.135 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -138.7 175.55 9.47 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.968 0.413 . . . . 0.0 110.748 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.449 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -74.69 -175.69 2.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.342 -178.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.561 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 85.5 t60 -131.35 -68.87 0.64 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.095 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -159.34 121.27 3.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.257 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.818 HD13 HG23 ' A' ' 53' ' ' VAL . 2.5 mt -91.72 157.5 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.513 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.639 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.64 123.66 36.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.804 -178.164 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.425 ' HB3' HD13 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -85.22 70.71 10.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.927 0.394 . . . . 0.0 110.426 177.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.428 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -97.41 135.73 21.65 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.767 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.776 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 64.3 Cg_endo -86.62 157.73 9.16 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.609 2.206 . . . . 0.0 112.739 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.425 HG13 ' SD ' ' A' ' 11' ' ' MET . 2.8 mm -126.56 -83.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.444 -177.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.506 ' HB1' ' HG ' ' A' ' 48' ' ' LEU . . . -67.52 -149.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -70.75 -32.85 70.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.638 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.56 7.76 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.631 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.727 ' HA ' HG13 ' A' ' 17' ' ' VAL . 3.7 mt -90.9 101.56 14.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 110.685 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.776 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 73.8 t -93.0 128.99 44.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.923 -178.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.581 ' HB1' ' HB3' ' A' ' 11' ' ' MET . . . -95.64 156.6 16.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.853 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.905 HD12 ' HG ' ' A' ' 19' ' ' LEU . 11.1 mp -115.76 119.97 37.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.461 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.513 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.6 m120 -89.82 91.0 8.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.337 0.589 . . . . 0.0 110.016 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.818 HG23 HD13 ' A' ' 39' ' ' ILE . 14.2 t -87.37 102.35 12.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.539 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.615 ' HG3' HG22 ' A' ' 7' ' ' THR . 0.1 OUTLIER -84.61 166.93 16.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.852 178.102 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 4.4 m -138.72 126.4 27.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.089 0.471 . . . . 0.0 111.431 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.561 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 1.3 p -99.06 106.85 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.696 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.557 HG23 ' HB ' ' A' ' 4' ' ' VAL . 1.3 m -124.99 166.6 20.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.649 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.25 -64.93 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.729 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.41 -5.8 57.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.943 0.401 . . . . 0.0 110.58 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.66 -147.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.037 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.62 -162.56 1.57 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.764 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.8 14.11 27.11 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.429 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.83 -4.28 46.7 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.46 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -74.31 -7.3 52.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.923 0.392 . . . . 0.0 110.26 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.93 -23.38 31.52 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.984 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.3 -24.52 55.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.847 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.11 -55.93 26.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.137 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.25 -34.96 72.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.408 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -60.9 -50.97 71.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.387 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.456 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 5.0 p -64.0 -20.92 66.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.544 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.893 HD11 HG22 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.11 -27.44 62.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.565 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -14.37 58.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.749 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.41 26.34 0.97 Allowed Glycine 0 N--CA 1.451 -0.3 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.897 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.893 HG22 HD11 ' A' ' 71' ' ' LEU . 2.8 tt -73.24 -163.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.55 -0.325 . . . . 0.0 110.906 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.711 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -52.16 90.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.989 0.423 . . . . 0.0 110.862 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.08 -24.86 59.01 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.844 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.96 -35.76 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.174 0.511 . . . . 0.0 110.251 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.711 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -95.63 90.39 5.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.771 -179.498 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.406 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.7 OUTLIER -75.06 130.25 38.99 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.766 HG22 HG21 ' A' ' 82' ' ' VAL . 3.0 mp -100.93 149.12 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.38 -175.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.447 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 28.4 tt0 -85.69 68.99 10.58 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 173.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.766 HG21 HG22 ' A' ' 80' ' ' ILE . 48.7 t -80.47 58.34 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.728 -175.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.36 -3.9 3.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.879 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.675 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 8.3 m-20 . . . . . 0 N--CA 1.453 -0.294 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.03 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.5 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 1.8 t . . . . . 0 C--O 1.231 0.103 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 14.5 t -104.31 115.05 45.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.874 0.368 . . . . 0.0 111.752 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -97.31 165.05 12.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.668 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 8.5 m -140.67 131.45 25.81 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.643 0.735 . . . . 0.0 112.019 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.696 HG13 HH21 ' A' ' 29' ' ' ARG . 2.6 mm -124.32 106.0 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.667 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.728 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.55 95.26 7.86 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.766 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.4 m -92.89 136.05 26.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.804 0.335 . . . . 0.0 111.897 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.782 ' HE1' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -146.41 120.1 5.18 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 121.142 0.496 . . . . 0.0 111.81 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.593 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.4 Cg_exo -69.34 122.88 9.67 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.419 2.746 . . . . 0.0 111.9 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.57 -29.63 64.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.291 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 p -76.34 151.09 83.19 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.143 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 46.5 Cg_endo -67.41 -6.77 17.26 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.237 1.958 . . . . 0.0 111.457 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.17 35.63 0.99 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.435 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.546 HG11 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -68.12 83.8 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.93 0.871 . . . . 0.0 110.588 -179.046 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.557 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 19.4 m-20 -73.08 98.38 2.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.902 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.777 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -63.66 -43.81 95.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.589 -178.068 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.879 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 4.1 tp10 -69.23 -37.0 77.8 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.85 0.357 . . . . 0.0 110.321 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.561 ' O ' ' HD3' ' A' ' 24' ' ' LYS . . . -68.8 -38.12 79.72 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.557 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -68.12 -24.82 65.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.2 177.218 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.879 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -58.59 -44.9 89.99 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.24 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.561 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -68.62 -40.01 80.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.762 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.715 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 4.9 mm-40 -67.8 -29.4 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.336 0.588 . . . . 0.0 110.302 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.701 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.2 mt -63.92 -38.38 82.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.036 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.517 ' NE2' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -60.85 -40.95 94.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.221 -179.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.715 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -77.77 -20.8 52.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.514 -178.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.701 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.23 -11.95 45.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.342 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.708 HG13 HD21 ' A' ' 36' ' ' LEU . 20.4 mm -60.11 138.28 91.26 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.239 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.532 ' N ' HG23 ' A' ' 30' ' ' ILE . 9.2 Cg_endo -50.68 114.71 1.59 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.793 2.328 . . . . 0.0 112.062 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.33 2.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.47 -45.73 6.78 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.789 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.669 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -130.36 -133.35 0.21 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.664 0.232 . . . . 0.0 111.175 -179.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -136.63 170.08 16.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.905 0.383 . . . . 0.0 110.941 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.708 HD21 HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -75.59 -174.09 2.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.108 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.515 ' ND1' HG22 ' A' ' 56' ' ' VAL . 85.2 t60 -130.45 -76.03 0.53 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.328 0.585 . . . . 0.0 110.939 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.544 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -164.91 126.67 2.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.868 -178.594 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.75 HD12 HG23 ' A' ' 53' ' ' VAL . 2.8 mt -90.8 159.82 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.986 0.422 . . . . 0.0 111.865 -177.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.629 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.12 124.75 39.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.946 -178.147 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.67 68.82 10.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.914 0.388 . . . . 0.0 110.216 177.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.11 137.41 21.24 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.616 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.773 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 73.7 Cg_endo -86.03 156.72 9.93 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.486 2.124 . . . . 0.0 112.738 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.414 HG21 HD11 ' A' ' 44' ' ' ILE . 4.1 mm -124.56 -82.23 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.3 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.521 ' HB1' ' HG ' ' A' ' 48' ' ' LEU . . . -67.02 -152.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.992 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -71.8 -28.12 63.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.707 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.92 4.62 0.46 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.101 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.782 HD13 ' HE1' ' A' ' 11' ' ' MET . 5.5 mt -92.43 104.24 16.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.842 0.353 . . . . 0.0 110.966 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 76.3 t -93.12 131.35 40.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.858 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.489 ' HB1' ' HB2' ' A' ' 11' ' ' MET . . . -96.25 164.19 12.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.072 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.777 HD12 ' HB2' ' A' ' 19' ' ' LEU . 11.3 mp -120.63 117.69 28.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.211 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.529 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.2 m120 -90.47 92.05 8.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.254 0.55 . . . . 0.0 110.422 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.75 HG23 HD12 ' A' ' 39' ' ' ILE . 4.3 t -87.31 101.96 11.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.583 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.469 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 33.4 mtt -84.71 165.91 17.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.218 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.1 m -139.63 133.76 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.38 . . . . 0.0 111.678 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.515 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -98.36 113.47 33.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 178.474 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.5 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 7.7 m -130.49 142.54 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.979 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.38 -62.12 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.583 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.92 -12.19 59.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.002 0.43 . . . . 0.0 110.706 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.669 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -68.07 -144.53 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.106 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.29 -166.82 2.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.72 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.71 15.28 20.7 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.682 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.67 -0.51 32.69 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.602 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.427 HG23 ' HG1' ' A' ' 34' ' ' THR . 1.9 p -74.16 -2.21 23.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.972 0.415 . . . . 0.0 110.148 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -55.07 -24.41 25.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.348 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.78 -27.27 59.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.08 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.526 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.51 -56.12 23.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.809 0.338 . . . . 0.0 110.362 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -58.75 -34.22 71.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.362 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.53 -51.45 68.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.325 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.7 p -63.19 -19.05 64.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.561 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.731 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.59 -28.79 61.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.59 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -13.51 47.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.531 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.9 30.92 1.0 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.392 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.731 ' HB ' ' HA ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -72.85 -166.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.165 -0.517 . . . . 0.0 111.173 -178.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.66 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 1.4 mp0 -51.05 100.33 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.888 0.375 . . . . 0.0 111.007 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.15 -30.83 71.41 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.794 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 t -87.92 -37.27 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.803 0.335 . . . . 0.0 110.744 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.66 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 32.2 t -95.77 92.42 6.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.844 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.427 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -76.58 132.26 39.37 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.306 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.766 HG12 ' HB ' ' A' ' 10' ' ' VAL . 8.0 mt -100.58 144.7 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.088 -175.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.493 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.3 tt0 -85.24 69.56 10.76 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.585 ' CG2' ' HB ' ' A' ' 80' ' ' ILE . 48.0 t -81.43 56.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 113.92 -1.491 . . . . 0.0 111.249 -174.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -132.44 -0.12 3.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.929 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.668 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 5.5 m-20 . . . . . 0 N--CA 1.455 -0.208 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.251 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 2.7 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.672 0.272 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 21.7 t -113.92 109.74 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.427 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.582 ' HB2' HG23 ' A' ' 55' ' ' VAL . . . -94.66 165.41 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 177.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.783 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.6 m -141.9 132.63 25.62 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.715 0.769 . . . . 0.0 112.273 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.76 HG22 HG22 ' A' ' 80' ' ' ILE . 4.3 mm -123.77 106.79 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.457 -178.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.542 ' C ' HG21 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.62 96.45 8.65 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.221 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.481 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.6 m -94.62 137.62 22.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.904 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.664 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.2 OUTLIER -147.39 121.72 5.06 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 121.264 0.554 . . . . 0.0 111.984 179.251 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 18.7 Cg_exo -71.02 124.11 10.28 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.599 2.866 . . . . 0.0 112.15 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -57.9 -31.42 66.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.444 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.2 m -77.64 150.64 79.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.04 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.683 ' HA ' HD23 ' A' ' 48' ' ' LEU . 40.1 Cg_endo -66.66 -6.51 15.6 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.379 2.052 . . . . 0.0 111.942 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.53 34.0 0.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.405 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.675 HG12 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.52 84.54 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 121.774 0.797 . . . . 0.0 110.111 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 11.5 m-20 -71.64 108.73 5.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.197 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.592 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -63.45 -43.62 96.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.793 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.592 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 20.6 tp10 -68.95 -39.19 79.68 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.655 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.485 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -69.92 -36.54 75.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.44 0.638 . . . . 0.0 109.93 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -66.48 -33.89 76.71 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.48 177.383 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.528 ' HA ' HD11 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -58.82 -45.65 89.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.079 -179.737 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.512 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -68.88 -39.85 79.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.138 0.494 . . . . 0.0 110.385 179.121 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.512 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 31.9 mm-40 -66.01 -29.34 69.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.254 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.738 HG21 HG21 ' A' ' 53' ' ' VAL . 2.1 mt -62.22 -44.42 99.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.964 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.72 -36.72 77.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.985 0.421 . . . . 0.0 110.539 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -75.37 -23.93 57.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.687 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.715 ' HB2' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.05 -14.27 39.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.524 -178.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.599 HG23 ' HD2' ' A' ' 31' ' ' PRO . 39.1 mm -58.55 136.82 86.04 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.461 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.599 ' HD2' HG23 ' A' ' 30' ' ' ILE . 17.7 Cg_endo -58.89 131.24 40.72 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.372 2.048 . . . . 0.0 112.534 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -61.0 0.53 0.22 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.962 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.52 -59.03 2.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.708 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.9 -143.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.668 0.27 . . . . 0.0 110.885 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -136.41 167.8 20.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.87 0.367 . . . . 0.0 110.711 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -75.08 -175.71 2.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.108 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.523 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 81.4 t60 -131.52 -75.88 0.52 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.315 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -159.37 132.08 6.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.048 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.741 HD12 HG21 ' A' ' 53' ' ' VAL . 1.7 mt -93.37 161.23 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.013 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.618 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.76 123.52 35.5 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.593 -178.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -85.56 71.16 10.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.897 0.38 . . . . 0.0 110.674 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.65 136.28 20.8 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.739 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.754 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 61.5 Cg_endo -87.64 157.26 7.69 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.662 2.241 . . . . 0.0 112.877 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.428 HG13 ' SD ' ' A' ' 11' ' ' MET . 3.2 mm -125.41 -82.75 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.428 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.653 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.26 -150.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.16 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -71.36 -31.49 67.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.592 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.43 6.73 0.58 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.771 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.683 HD23 ' HA ' ' A' ' 15' ' ' PRO . 3.9 mt -91.11 102.26 15.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.822 0.344 . . . . 0.0 110.771 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 70.2 t -93.32 129.65 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.966 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.54 ' HB3' ' HB3' ' A' ' 11' ' ' MET . . . -95.42 155.96 16.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.889 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.618 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.3 mp -114.45 118.09 32.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.392 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.517 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.2 m120 -89.9 92.56 9.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.245 0.545 . . . . 0.0 110.09 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.741 HG21 HD12 ' A' ' 39' ' ' ILE . 6.3 t -86.54 105.77 15.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.445 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 50.6 mtt -84.46 166.67 17.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.409 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.582 HG23 ' HB2' ' A' ' 6' ' ' ALA . 3.5 m -138.78 127.57 29.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.237 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.523 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 0.7 OUTLIER -95.68 108.25 20.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.598 179.254 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.405 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 3.3 m -125.41 167.03 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.817 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.73 -75.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.842 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -81.3 2.57 27.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 0.0 110.99 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.78 -147.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.116 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.74 -166.48 2.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.683 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.91 15.16 22.54 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.591 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.39 -5.56 55.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.549 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.08 -4.6 36.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.908 0.385 . . . . 0.0 110.383 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.02 -23.65 20.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.044 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.18 -27.78 62.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.937 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.42 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . . . -60.54 -56.54 20.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.353 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -58.74 -34.83 71.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.447 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -60.71 -51.96 67.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.471 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.412 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -64.04 -19.33 65.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.572 178.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.851 HD11 HG22 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -72.92 -28.76 62.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.559 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -11.88 43.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.954 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.2 25.29 0.99 Allowed Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.75 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.851 HG22 HD11 ' A' ' 71' ' ' LEU . 2.6 tt -73.32 -163.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.47 -0.365 . . . . 0.0 111.059 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.513 ' H ' HG12 ' A' ' 74' ' ' ILE . 1.8 mp0 -51.01 96.51 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.81 0.338 . . . . 0.0 111.003 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.43 -27.34 69.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.281 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 78' ' ' SER . 2.0 p -88.27 -37.94 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.173 0.511 . . . . 0.0 110.435 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 11' ' ' MET . 0.7 OUTLIER -96.23 90.0 5.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.424 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.566 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.57 134.77 38.18 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.472 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.808 HG22 HG21 ' A' ' 82' ' ' VAL . 1.7 mt -101.54 147.42 8.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.563 -176.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.504 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 9.7 tp10 -86.02 70.39 10.6 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 173.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.808 HG21 HG22 ' A' ' 80' ' ' ILE . 58.2 t -80.46 52.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.999 -174.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -133.0 3.61 3.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.575 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.783 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 18.8 t0 . . . . . 0 N--CA 1.453 -0.291 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.052 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.463 ' O ' HG21 ' A' ' 57' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.108 0 CA-C-O 120.575 0.226 . . . . 0.0 110.741 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 13.1 t -125.54 118.34 52.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.039 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -94.74 169.76 9.93 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.676 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 10.0 m -143.04 131.85 22.71 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.587 0.708 . . . . 0.0 112.011 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.747 HG23 HG22 ' A' ' 80' ' ' ILE . 7.3 mm -122.98 107.52 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.896 -177.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.567 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -97.28 95.28 7.6 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -177.7 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.533 ' HB ' HG12 ' A' ' 80' ' ' ILE . 2.0 m -94.64 136.71 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.78 ' HE1' HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -147.53 121.11 4.88 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 121.036 0.446 . . . . 0.0 111.76 179.475 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 17.2 Cg_exo -71.82 118.64 5.74 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.522 2.815 . . . . 0.0 111.946 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -56.21 -28.36 58.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.133 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.38 149.21 78.49 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.106 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.536 ' HA ' HD22 ' A' ' 48' ' ' LEU . 37.9 Cg_endo -66.03 -7.68 17.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.401 2.068 . . . . 0.0 111.92 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.1 36.06 1.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.698 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.16 87.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.79 0.805 . . . . 0.0 110.09 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.604 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 28.0 m-20 -68.32 107.19 2.74 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.336 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.712 HD23 HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -60.45 -54.81 41.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.66 -178.619 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.525 ' HG2' ' N ' ' A' ' 21' ' ' ALA . 7.6 pm0 -71.29 -34.46 70.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.279 -177.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.604 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . . . -67.92 -35.71 78.92 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.604 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -65.77 -35.25 80.19 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.234 176.159 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.539 ' NZ ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -55.93 -46.83 78.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.034 178.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.604 ' HE3' ' HA ' ' A' ' 21' ' ' ALA . 2.6 mtmt -66.41 -43.8 84.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.815 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.72 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 52.9 mt-10 -67.58 -27.0 66.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.247 0.546 . . . . 0.0 110.969 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.67 HG12 HG23 ' A' ' 53' ' ' VAL . 1.1 mt -63.06 -43.14 98.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.951 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -62.56 -37.57 86.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.26 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.72 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 1.4 pp20? -77.21 -22.67 51.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.405 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.767 ' HB2' HD12 ' A' ' 74' ' ' ILE . 4.3 ptp85 -90.6 -11.95 38.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.088 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.626 HG12 ' O ' ' A' ' 26' ' ' ILE . 10.9 mm -61.57 139.29 95.13 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.87 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.578 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 7.3 Cg_endo -47.88 115.87 1.67 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.854 2.37 . . . . 0.0 112.445 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -59.38 0.74 0.1 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.105 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.92 -43.15 7.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.003 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.473 HG21 ' HB3' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.15 -139.01 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.712 0.292 . . . . 0.0 111.246 -179.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -135.64 169.9 16.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.881 0.372 . . . . 0.0 110.932 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.444 ' O ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -76.38 -175.91 3.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.229 -179.532 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.442 ' HB2' HG23 ' A' ' 56' ' ' VAL . 84.3 t60 -131.01 -74.74 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.412 0.625 . . . . 0.0 110.952 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.44 ' HB3' ' CD2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -163.88 129.27 2.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.667 -178.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.66 HG12 HG12 ' A' ' 53' ' ' VAL . 2.8 mt -93.08 155.85 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -176.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.627 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.7 m-20 -117.97 123.0 44.69 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.971 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -88.34 67.68 8.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.96 0.409 . . . . 0.0 110.142 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.533 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.98 148.54 34.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.368 -178.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.729 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 30.6 Cg_endo -92.49 160.53 2.97 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.996 2.464 . . . . 0.0 113.266 -177.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.426 ' HB ' ' H ' ' A' ' 45' ' ' ALA . 4.2 mm -128.85 -82.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.248 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . . . -66.91 -151.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.924 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -72.27 -28.55 63.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.67 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.07 4.99 0.46 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.1 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.78 HD11 ' HE1' ' A' ' 11' ' ' MET . 5.9 mt -92.1 106.1 18.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.89 0.345 . . . . 0.0 110.906 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.729 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 24.2 t -92.59 132.22 37.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.814 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.569 ' C ' HD11 ' A' ' 51' ' ' LEU . . . -96.18 163.29 13.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.85 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.712 HD12 HD23 ' A' ' 19' ' ' LEU . 11.0 mp -120.57 116.17 24.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.513 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.583 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.7 m120 -89.65 91.0 8.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.379 0.609 . . . . 0.0 110.046 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.67 HG23 HG12 ' A' ' 26' ' ' ILE . 3.8 t -87.16 105.65 15.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.576 -177.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.455 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 62.8 mtt -84.71 165.31 17.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.937 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.3 m -138.69 136.77 43.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.886 0.374 . . . . 0.0 111.581 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -94.74 108.42 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.778 178.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 4' ' ' VAL . 21.9 m -125.39 137.96 55.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.855 0.359 . . . . 0.0 110.975 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.89 -58.72 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.331 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -81.08 -16.58 52.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.084 0.469 . . . . 0.0 110.4 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.473 ' HB3' HG21 ' A' ' 34' ' ' THR . . . -68.15 -144.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.17 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.5 -163.35 1.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.785 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.9 13.75 29.42 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.544 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.37 -1.24 34.65 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.639 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.419 HG23 ' OG1' ' A' ' 34' ' ' THR . 3.1 p -74.75 -4.14 35.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.968 0.413 . . . . 0.0 110.205 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -54.96 -23.91 21.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.337 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.07 -25.6 58.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.159 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.48 -56.59 18.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.8 0.334 . . . . 0.0 110.244 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -58.97 -34.0 71.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.276 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.94 -51.02 69.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.307 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -18.23 63.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.263 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.836 HD11 HG21 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.65 -29.7 62.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.482 179.401 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -10.74 31.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.782 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.1 25.08 1.0 Allowed Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.836 HG21 HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -73.32 -168.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.338 -0.431 . . . . 0.0 111.235 -179.04 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.416 ' H ' ' CG1' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -51.09 93.5 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.353 179.137 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.2 -26.32 61.23 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.018 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -87.99 -41.16 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.181 0.515 . . . . 0.0 110.186 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -95.9 87.97 4.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.122 178.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.545 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.81 135.74 38.0 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.263 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.786 HG22 HG22 ' A' ' 82' ' ' VAL . 1.7 mt -101.5 147.72 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.469 -176.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.567 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 7.2 tp10 -86.07 71.09 10.62 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 172.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.786 HG22 HG22 ' A' ' 80' ' ' ILE . 59.0 t -80.68 52.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.063 -174.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 m -132.8 4.57 3.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.402 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.676 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.2 m-20 . . . . . 0 N--CA 1.452 -0.358 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.169 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.865 HG12 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 121.048 0.452 . . . . 0.0 110.17 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 40.8 t -109.71 120.36 60.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.492 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -95.03 167.91 11.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.669 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 11.4 m -141.65 131.37 24.18 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.6 0.714 . . . . 0.0 112.185 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.672 HG21 HG23 ' A' ' 80' ' ' ILE . 2.1 mm -120.56 105.01 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.688 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.727 ' C ' HG21 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -96.38 93.98 7.16 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.738 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.4 m -92.02 136.91 23.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.84 -177.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.784 ' HE3' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -147.32 119.26 4.67 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 121.131 0.491 . . . . 0.0 111.878 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 17.8 Cg_exo -70.96 122.22 8.59 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.49 2.794 . . . . 0.0 112.198 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.89 -30.3 65.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.388 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.8 148.32 75.73 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.012 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 36.8 Cg_endo -64.74 -6.56 12.65 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.399 2.066 . . . . 0.0 111.774 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -92.03 34.05 1.03 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.6 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.3 87.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.832 0.825 . . . . 0.0 110.124 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.604 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 74.2 m-20 -69.11 104.14 2.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.127 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.86 ' HG ' HD11 ' A' ' 51' ' ' LEU . 1.4 tt -61.05 -52.17 66.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.539 -178.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.688 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -70.5 -36.32 73.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.079 -177.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.2 -34.63 76.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.157 0.503 . . . . 0.0 109.758 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.604 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -65.68 -32.12 73.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.861 177.687 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.688 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -54.71 -47.65 73.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.505 179.01 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -66.6 -42.48 86.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.736 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -65.55 -29.3 69.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.185 0.516 . . . . 0.0 110.391 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.731 HG22 HD12 ' A' ' 39' ' ' ILE . 2.0 mt -61.83 -45.58 98.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.217 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -60.49 -35.86 76.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.717 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 17.5 mm-40 -74.17 -23.74 59.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.559 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.762 ' HD3' HD11 ' A' ' 74' ' ' ILE . 2.4 ptp180 -92.57 -14.54 28.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.842 -178.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 31' ' ' PRO . 15.2 mm -58.74 139.82 86.07 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.102 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.714 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.4 Cg_endo -50.82 112.16 0.71 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.838 2.359 . . . . 0.0 112.348 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 0.6 0.11 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.341 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.08 -40.01 9.62 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.042 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.36 -137.8 0.21 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.647 0.223 . . . . 0.0 110.882 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -136.63 166.9 22.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 111.048 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.484 ' HB3' HD11 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -76.01 -175.45 3.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.269 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.551 ' ND1' HG22 ' A' ' 56' ' ' VAL . 82.4 t60 -130.73 -74.97 0.53 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.315 0.578 . . . . 0.0 110.829 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.577 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -164.22 132.6 3.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.998 -178.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.743 HD12 HG22 ' A' ' 53' ' ' VAL . 2.8 mt -94.39 158.38 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.683 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.1 t0 -123.88 128.55 49.63 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.381 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.474 ' HG2' HD22 ' A' ' 19' ' ' LEU . 13.4 mt-10 -90.8 69.06 6.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.228 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -100.92 148.03 34.51 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.264 -178.437 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.735 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 21.2 Cg_endo -91.7 159.75 3.48 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.043 2.495 . . . . 0.0 113.362 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.446 ' HB ' ' H ' ' A' ' 45' ' ' ALA . 5.0 mm -127.95 -83.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.248 -178.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.449 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.34 -151.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.031 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -72.11 -28.76 63.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.73 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.2 3.98 0.41 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.126 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.784 HD13 ' HE3' ' A' ' 11' ' ' MET . 6.9 mt -91.21 106.09 18.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.892 0.377 . . . . 0.0 110.777 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.735 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 40.7 t -92.95 132.06 38.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.694 -178.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.526 ' C ' HD13 ' A' ' 51' ' ' LEU . . . -96.27 164.09 12.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.093 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.86 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.3 mp -120.64 116.0 24.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.28 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.629 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.1 m120 -89.86 91.93 8.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.315 0.579 . . . . 0.0 110.378 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.743 HG22 HD12 ' A' ' 39' ' ' ILE . 4.6 t -86.8 105.21 14.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.536 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.544 ' HG3' HG21 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.6 164.61 18.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.169 178.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.1 m -139.24 141.06 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 111.572 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.551 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.9 t -93.07 100.4 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.668 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.865 HG23 HG12 ' A' ' 4' ' ' VAL . 27.2 m -130.15 140.35 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.046 0.45 . . . . 0.0 111.544 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.32 -61.67 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.51 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -81.34 -7.68 59.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.038 0.446 . . . . 0.0 110.625 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.77 -139.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.132 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -147.01 -166.27 2.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.77 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.58 12.88 31.79 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.638 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.15 -9.54 63.87 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.512 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.426 HG22 HG12 ' A' ' 57' ' ' VAL . 1.1 p -74.48 -5.99 45.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.857 0.361 . . . . 0.0 110.42 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -54.72 -23.79 19.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.056 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.93 -28.59 57.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.952 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.714 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.09 -57.59 11.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.401 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -59.53 -33.59 71.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.451 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.85 -51.42 68.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.238 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.404 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.3 t -63.48 -18.03 63.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.139 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.662 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.23 -29.91 63.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.478 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -12.86 44.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.709 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.26 27.41 0.99 Allowed Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.642 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.762 HD11 ' HD3' ' A' ' 29' ' ' ARG . 1.3 tt -73.17 -162.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.411 . . . . 0.0 111.187 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 1.7 mm-40 -50.89 94.13 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.141 0.496 . . . . 0.0 110.792 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.06 -32.42 62.8 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.692 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.552 HG11 ' N ' ' A' ' 78' ' ' SER . 0.4 OUTLIER -87.44 -36.82 10.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 0.0 110.364 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.552 ' N ' HG11 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -96.0 89.01 5.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.206 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.569 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -75.88 133.87 40.44 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.369 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.738 HG12 ' HB ' ' A' ' 10' ' ' VAL . 6.2 mt -101.12 144.82 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.068 -175.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.561 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 19.4 tp10 -85.34 69.96 10.77 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.595 HG23 ' HB ' ' A' ' 80' ' ' ILE . 49.1 t -80.8 48.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.035 -174.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 m -132.34 8.14 4.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.23 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.669 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.3 m-20 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.88 0.371 . . . . 0.0 110.928 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.6 0.238 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 2.6 t -107.59 113.53 43.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.657 0.265 . . . . 0.0 111.369 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -94.68 167.17 11.63 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.257 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.783 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 7.5 m -143.15 131.19 21.76 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.537 0.684 . . . . 0.0 112.312 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.692 HG22 HG23 ' A' ' 80' ' ' ILE . 3.5 mm -125.01 108.29 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.763 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.648 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -96.15 95.05 7.88 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.553 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.4 m -93.89 138.49 20.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.632 ' O ' ' HG3' ' A' ' 11' ' ' MET . 1.2 ptm -145.49 125.37 7.03 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.353 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.623 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.1 Cg_exo -71.47 121.92 8.16 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.155 2.57 . . . . 0.0 112.077 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.32 -32.36 66.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.345 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.25 152.57 79.09 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.078 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.576 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 41.1 Cg_endo -67.31 -3.36 9.81 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.388 2.059 . . . . 0.0 112.204 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -90.87 43.89 1.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.927 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.628 HG21 HD22 ' A' ' 48' ' ' LEU . 93.1 t -65.59 75.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.37 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.568 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 81.9 m-20 -70.49 95.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.915 177.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.514 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -64.1 -43.63 94.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.5 -178.351 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.514 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 5.3 tp10 -68.36 -38.16 81.17 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.744 0.307 . . . . 0.0 110.412 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' A' ' 24' ' ' LYS . . . -69.62 -39.82 76.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.372 0.606 . . . . 0.0 109.815 177.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.568 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -67.62 -30.66 70.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.035 177.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -46.75 81.7 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.775 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -69.26 -40.45 77.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.571 179.531 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.519 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 1.3 mt-10 -65.24 -28.04 69.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.117 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.787 HG23 HE21 ' A' ' 27' ' ' GLN . 0.5 OUTLIER -62.44 -47.12 94.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.354 179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.787 HE21 HG23 ' A' ' 26' ' ' ILE . 6.2 mm-40 -62.68 -31.61 72.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.829 0.347 . . . . 0.0 110.721 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 17.7 mm-40 -74.72 -24.84 58.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.007 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.654 HH11 HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.46 -14.52 37.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.333 -179.128 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.815 HG13 HD11 ' A' ' 36' ' ' LEU . 24.8 mm -57.61 137.29 82.37 Favored Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.716 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.497 ' N ' HG21 ' A' ' 30' ' ' ILE . 4.5 Cg_endo -45.66 122.01 4.57 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.885 2.39 . . . . 0.0 112.169 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.37 -4.82 0.25 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.046 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.03 -41.4 8.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.73 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.43 -146.54 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.674 0.273 . . . . 0.0 111.198 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -138.62 177.58 7.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.242 0.544 . . . . 0.0 111.185 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.815 HD11 HG13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -74.96 -178.24 3.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.434 -179.183 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.57 ' ND1' HG12 ' A' ' 56' ' ' VAL . 72.4 t60 -131.13 -71.24 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.66 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 7.2 mmtm -161.64 125.16 3.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.081 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.81 HD11 HG23 ' A' ' 53' ' ' VAL . 2.8 mt -92.1 160.49 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.781 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.644 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -129.17 125.0 36.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.726 -178.311 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -85.43 72.03 10.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.841 0.353 . . . . 0.0 110.548 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -98.09 134.73 21.82 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.621 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.749 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 56.8 Cg_endo -86.53 155.0 9.11 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.577 2.185 . . . . 0.0 112.782 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mm -123.87 -82.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.403 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.21 -153.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.054 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -71.81 -27.99 63.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.805 0.336 . . . . 0.0 110.593 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.62 5.12 0.51 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.951 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.628 HD22 HG21 ' A' ' 17' ' ' VAL . 5.8 mt -92.22 101.36 13.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.784 0.326 . . . . 0.0 110.839 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.749 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 90.4 t -93.38 129.36 43.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.783 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.568 ' HB1' ' HB3' ' A' ' 11' ' ' MET . . . -95.24 162.94 13.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.022 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.644 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.2 mp -120.53 120.27 35.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.435 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.539 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.3 m120 -89.66 91.71 8.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.271 0.558 . . . . 0.0 109.813 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.81 HG23 HD11 ' A' ' 39' ' ' ILE . 12.4 t -86.82 106.35 15.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.793 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 6.2 mtt -85.63 165.23 17.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.031 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.1 m -140.3 134.35 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.903 0.383 . . . . 0.0 111.245 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.57 HG12 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.55 113.21 30.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.06 179.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.35 144.8 36.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.885 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.07 -63.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.25 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -81.09 -7.9 59.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 110.402 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.27 -147.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.992 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.56 -162.02 1.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.343 . . . . 0.0 110.782 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.62 11.91 37.16 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.38 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.43 -3.01 45.72 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.585 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 p -74.03 -5.49 41.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.934 0.397 . . . . 0.0 110.358 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -55.13 -24.36 25.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.193 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.2 -25.45 59.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.105 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.77 -57.26 13.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.164 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.37 -33.63 71.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.325 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -61.11 -52.13 66.21 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.501 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.78 -19.86 65.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.621 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.701 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.63 -28.08 62.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.69 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -15.1 57.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.731 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.39 29.33 0.96 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.701 ' HB ' ' HA ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -73.08 -165.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.253 -0.474 . . . . 0.0 111.279 -178.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.776 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 3.0 pm0 -51.63 89.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.658 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 74' ' ' ILE . . . -59.46 -26.99 62.75 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.937 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 78' ' ' SER . 2.7 p -86.06 -34.76 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.254 0.549 . . . . 0.0 110.2 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.776 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -95.71 89.07 5.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.626 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.403 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -74.68 128.86 36.58 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.206 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.786 HG23 HG22 ' A' ' 82' ' ' VAL . 1.9 mp -101.11 148.88 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.576 -175.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.648 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.1 tp10 -85.78 71.44 10.67 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 172.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.786 HG22 HG23 ' A' ' 80' ' ' ILE . 62.5 t -80.06 50.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.036 -173.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -132.93 7.12 4.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.176 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.783 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 26.8 t0 . . . . . 0 N--CA 1.451 -0.381 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.934 -178.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.869 HG11 HG22 ' A' ' 57' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 4.8 t -106.96 117.26 52.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 121.046 -0.261 . . . . 0.0 111.66 -178.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -92.68 162.27 14.22 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.782 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 11.3 m -143.16 131.06 21.58 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.592 0.71 . . . . 0.0 112.309 -178.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.746 HG21 HG22 ' A' ' 80' ' ' ILE . 2.7 mm -120.22 106.05 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.628 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.666 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -93.62 92.35 7.49 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.326 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -92.42 138.13 20.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.117 -177.019 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.78 ' HE3' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -145.73 119.05 5.29 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.074 179.312 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.525 ' HB2' HG23 ' A' ' 17' ' ' VAL . 14.9 Cg_exo -69.23 120.25 7.14 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.252 2.635 . . . . 0.0 112.137 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -57.42 -30.33 64.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.475 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.79 151.62 79.73 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.078 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.536 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 40.8 Cg_endo -66.81 -4.28 10.93 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.41 2.074 . . . . 0.0 112.001 179.65 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -91.84 42.35 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.321 179.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.686 HG22 HD21 ' A' ' 48' ' ' LEU . 90.9 t -65.14 78.17 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.166 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.575 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -67.82 100.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.134 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.749 HD12 HD22 ' A' ' 51' ' ' LEU . 1.3 tp -61.54 -51.87 66.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.488 -178.125 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.762 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 8.6 pt-20 -71.54 -34.55 70.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.261 -177.33 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -67.82 -36.21 79.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -64.86 -34.74 79.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.363 176.557 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.762 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -55.59 -48.11 75.38 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.296 178.649 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 3.6 mtmt -65.25 -44.18 88.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.967 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -66.32 -28.72 68.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.172 0.51 . . . . 0.0 110.444 -179.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.719 HG21 HD12 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -61.39 -47.46 93.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.495 -179.62 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.557 ' NE2' HD23 ' A' ' 36' ' ' LEU . 7.0 mm100 -63.53 -33.29 75.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.829 0.347 . . . . 0.0 110.798 -178.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 15.4 mt-10 -75.19 -23.56 57.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.925 179.216 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 26' ' ' ILE . 3.2 ptp180 -91.83 -14.66 29.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.414 -179.122 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.669 HD13 HG11 ' A' ' 53' ' ' VAL . 11.0 mm -59.35 141.25 87.7 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.025 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.562 ' N ' HG23 ' A' ' 30' ' ' ILE . 9.2 Cg_endo -51.25 113.55 1.16 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.844 2.363 . . . . 0.0 112.431 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.2 -1.61 0.21 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.328 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.11 -36.89 13.62 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.066 -178.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.54 -140.31 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.725 0.263 . . . . 0.0 111.077 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -136.67 166.11 24.33 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.852 0.358 . . . . 0.0 110.892 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.557 HD23 ' NE2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -76.09 -175.03 2.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.355 -179.262 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.59 ' ND1' HG22 ' A' ' 56' ' ' VAL . 79.8 t60 -131.29 -76.78 0.52 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.278 0.561 . . . . 0.0 110.937 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.499 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -165.27 132.7 3.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.048 -178.793 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.767 HD12 HG23 ' A' ' 53' ' ' VAL . 2.6 mt -93.77 156.18 3.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.065 0.46 . . . . 0.0 112.197 -177.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.643 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 74.8 m-20 -122.72 119.2 29.97 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.465 -178.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -83.21 73.42 10.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.032 0.444 . . . . 0.0 110.608 178.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -97.33 132.95 24.48 Favored Pre-proline 0 C--O 1.225 -0.224 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.628 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.75 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 44.2 Cg_endo -85.33 155.21 10.81 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.449 2.099 . . . . 0.0 112.875 -178.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mm -124.03 -83.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.411 -177.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.16 -154.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.018 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.97 -26.54 62.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.579 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.65 1.78 0.36 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.23 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.78 HD12 ' HE3' ' A' ' 11' ' ' MET . 5.6 mt -92.44 102.41 14.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.851 0.358 . . . . 0.0 110.875 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.75 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 73.4 t -93.34 132.15 38.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.035 -178.126 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.526 ' HB1' ' HB2' ' A' ' 11' ' ' MET . . . -95.93 153.77 17.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.816 177.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.749 HD22 HD12 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -117.39 120.8 39.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.518 179.377 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.602 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.3 m120 -89.73 93.89 9.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.109 -179.231 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.767 HG23 HD12 ' A' ' 39' ' ' ILE . 17.3 t -85.95 105.58 14.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.558 -177.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.556 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 44.2 mtt -86.52 160.51 18.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.35 178.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.483 HG22 HG13 ' A' ' 57' ' ' VAL . 2.8 m -139.05 140.7 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.101 -178.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.59 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.1 t -92.49 100.09 10.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.764 179.111 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.869 HG22 HG11 ' A' ' 4' ' ' VAL . 27.3 m -130.48 139.08 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.988 0.423 . . . . 0.0 111.473 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.73 -61.67 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.557 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.96 -5.4 58.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 110.575 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.41 -139.52 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.125 179.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -146.83 -165.92 2.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.762 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.32 11.09 39.4 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.691 179.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.2 -11.32 67.23 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.526 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -4.45 36.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 0.0 110.319 179.441 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -54.56 -23.9 18.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.387 0.613 . . . . 0.0 109.869 177.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.04 -28.17 56.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.94 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.406 ' HB1' ' HD3' ' A' ' 31' ' ' PRO . . . -60.96 -57.61 11.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.425 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -58.94 -34.06 71.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.455 178.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.96 -52.18 66.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.267 178.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -20.38 65.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.508 179.034 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.828 HD21 HD13 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.84 -26.1 61.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.659 -179.653 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.61 -17.02 63.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.556 178.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.48 31.74 0.93 Allowed Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.704 179.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.828 HD13 HD21 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -73.08 -161.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.278 -0.461 . . . . 0.0 111.24 -178.431 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.687 ' HG3' ' O ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -51.55 88.13 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.219 0.533 . . . . 0.0 110.437 178.935 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 74' ' ' ILE . . . -60.26 -26.63 64.16 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.308 -177.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 p -85.44 -34.7 8.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.412 0.625 . . . . 0.0 110.177 179.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.687 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -95.57 90.02 5.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.588 -179.314 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.583 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -73.49 128.38 35.34 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.153 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.767 HG22 HG21 ' A' ' 82' ' ' VAL . 2.1 mp -101.16 149.31 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.648 -174.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.666 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 5.8 tp10 -85.65 71.91 10.65 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.767 HG21 HG22 ' A' ' 80' ' ' ILE . 75.7 t -79.73 48.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.93 -173.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -133.1 7.26 3.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.93 178.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.782 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 22.0 t0 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.977 -178.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.861 HG11 HG21 ' A' ' 57' ' ' VAL . 1.0 OUTLIER . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 120.56 0.219 . . . . 0.0 110.958 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 57.5 t -124.06 120.18 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.746 0.308 . . . . 0.0 111.605 179.233 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -98.05 166.44 11.43 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.689 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 14.2 m -140.52 136.48 32.94 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.6 0.714 . . . . 0.0 112.267 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.786 HG22 HG21 ' A' ' 80' ' ' ILE . 2.3 mm -125.71 106.94 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.573 -178.055 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.555 ' C ' HG23 ' A' ' 80' ' ' ILE . 1.6 mmmt -95.79 93.83 7.31 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.816 0.341 . . . . 0.0 111.892 -178.075 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.488 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 1.9 m -93.71 135.4 28.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -176.521 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.524 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -145.36 124.88 6.91 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.038 178.363 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.65 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.7 Cg_exo -71.79 117.3 5.08 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.147 2.565 . . . . 0.0 111.747 179.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -30.25 59.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.95 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -77.96 155.1 80.39 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.72 179.454 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.561 ' HA ' HD23 ' A' ' 48' ' ' LEU . 3.8 Cg_exo -72.3 -0.96 9.42 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.562 2.175 . . . . 0.0 111.683 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -92.29 42.97 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.049 178.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.65 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 88.4 t -64.85 78.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.089 -178.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.576 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 2.3 m-20 -68.56 101.84 1.35 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.322 178.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.78 HD13 HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -61.58 -53.43 56.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.68 -179.004 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.537 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 23.5 tt0 -69.76 -35.33 74.85 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 -176.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 25' ' ' GLU . . . -68.57 -36.81 79.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.57 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.576 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.1 OUTLIER -64.74 -34.11 77.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.469 177.071 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -57.41 -47.22 82.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.571 179.008 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 7.4 mttt -65.64 -41.92 92.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.649 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 21' ' ' ALA . 33.8 mt-10 -65.74 -31.49 72.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.197 0.523 . . . . 0.0 110.477 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.671 HG22 HD13 ' A' ' 39' ' ' ILE . 6.9 mt -61.38 -44.71 98.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.053 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -61.48 -38.41 87.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.951 0.405 . . . . 0.0 110.772 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 4.7 mm-40 -76.09 -21.94 56.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.689 -178.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.622 ' NH2' ' HB ' ' A' ' 8' ' ' ILE . 22.1 ptt85 -90.35 -13.59 34.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.643 -177.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.658 HG12 ' O ' ' A' ' 26' ' ' ILE . 29.4 mm -59.73 138.6 90.03 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.176 -179.438 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.558 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.1 Cg_endo -51.89 123.77 13.14 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.726 2.284 . . . . 0.0 112.496 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -62.25 2.92 0.21 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.262 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.36 -64.51 1.64 Allowed Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.01 -178.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.6 -131.43 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.348 0.118 . . . . 0.0 110.913 -179.17 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -139.21 166.63 24.03 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.947 0.404 . . . . 0.0 111.013 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -75.9 -172.41 1.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.971 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.501 ' HB2' HG21 ' A' ' 56' ' ' VAL . 84.0 t60 -130.36 -78.85 0.54 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.27 0.557 . . . . 0.0 111.481 -178.15 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.417 ' HB3' ' CD2' ' A' ' 37' ' ' HIS . 1.5 tptp -164.49 130.89 2.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.843 -178.322 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.702 HD13 HG23 ' A' ' 53' ' ' VAL . 2.6 mt -92.0 159.62 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -176.715 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.632 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -127.48 117.08 21.42 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.247 -179.39 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -81.87 72.6 8.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.991 0.424 . . . . 0.0 110.396 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.51 ' O ' HG11 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -97.0 134.86 22.39 Favored Pre-proline 0 C--O 1.225 -0.222 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.69 -179.595 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.75 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 53.7 Cg_endo -85.43 155.4 10.69 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.39 2.06 . . . . 0.0 112.837 -178.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.6 mm -124.88 -83.42 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.269 -177.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.74 -155.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.764 179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -72.47 -22.93 60.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.72 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.62 0.93 0.26 Allowed Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.443 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 15' ' ' PRO . 5.6 mt -92.83 103.59 15.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.072 0.436 . . . . 0.0 111.138 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.75 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 72.8 t -93.5 129.14 44.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.891 -179.015 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.576 ' C ' HD23 ' A' ' 51' ' ' LEU . . . -96.1 151.8 19.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.943 178.168 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.78 HD11 HD13 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -115.14 121.27 42.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.538 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.7 m120 -90.51 92.33 8.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.363 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.702 HG23 HD13 ' A' ' 39' ' ' ILE . 5.9 t -87.49 103.27 13.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.375 -178.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.482 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.7 mpt? -84.41 164.89 18.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.268 178.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.2 m -137.73 136.89 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.365 -178.002 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.501 HG21 ' HB2' ' A' ' 37' ' ' HIS . 1.7 t -94.33 99.13 8.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.744 178.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.861 HG21 HG11 ' A' ' 4' ' ' VAL . 33.3 m -130.47 139.89 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.213 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.86 -57.8 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.595 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -80.85 -11.04 59.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.513 179.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.62 -138.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.109 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.401 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 1.6 pt-20 -146.79 -164.38 1.98 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.757 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -80.36 13.07 29.5 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.738 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.44 -11.49 68.27 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.609 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -74.46 -4.1 34.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.802 0.335 . . . . 0.0 110.422 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -55.19 -23.86 23.97 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.399 0.618 . . . . 0.0 110.055 177.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.11 -25.09 58.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.174 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.54 -57.03 13.71 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.327 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -58.77 -34.06 71.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.218 178.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -62.17 -51.57 67.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.43 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.69 -18.95 64.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.401 178.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.611 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.19 -29.53 62.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.512 179.835 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -13.47 51.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.74 179.162 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.27 28.73 0.98 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.672 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.613 HD12 ' HD2' ' A' ' 29' ' ' ARG . 1.2 tt -73.19 -164.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.445 -0.377 . . . . 0.0 110.854 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.629 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -51.96 95.3 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.089 0.471 . . . . 0.0 110.648 179.61 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.74 -30.84 69.98 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.452 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.2 t -85.16 -35.12 9.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.921 0.391 . . . . 0.0 110.38 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.629 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 8.0 m -95.7 88.87 5.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.683 -179.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.57 129.97 38.06 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.491 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.786 HG21 HG22 ' A' ' 8' ' ' ILE . 3.2 mp -101.3 150.05 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.748 -175.269 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.5 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 52.4 tt0 -85.91 70.75 10.67 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 173.016 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.764 HG22 HG21 ' A' ' 80' ' ' ILE . 62.0 t -80.94 50.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.083 -174.53 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 m -132.9 10.5 4.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.891 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.689 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.3 m-20 . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 121.162 0.506 . . . . 0.0 111.227 -178.447 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.461 0.078 0 CA-C-O 120.71 0.29 . . . . 0.0 110.708 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 53.7 t -109.57 120.64 61.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.596 -178.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -96.39 166.0 11.91 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.087 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.785 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.1 m -143.04 130.09 20.69 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.57 0.7 . . . . 0.0 112.361 -179.196 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.76 HG22 HG22 ' A' ' 80' ' ' ILE . 6.7 mm -121.61 107.08 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.554 -179.11 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.54 ' O ' HG21 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -95.6 94.15 7.57 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.933 0.396 . . . . 0.0 111.946 -177.87 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.488 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 1.7 m -93.54 136.54 24.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -176.502 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.641 ' O ' ' HG3' ' A' ' 11' ' ' MET . 1.2 ptm -144.72 126.15 7.84 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.303 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.623 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 10.4 Cg_exo -73.46 124.53 9.45 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.399 2.732 . . . . 0.0 112.37 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.99 -33.82 69.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.357 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 17' ' ' VAL . 4.4 m -78.28 154.41 79.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.213 -179.289 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.579 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 52.9 Cg_endo -69.66 -3.41 11.88 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.428 2.085 . . . . 0.0 112.146 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.76 44.03 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.826 178.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.648 HG22 HD22 ' A' ' 48' ' ' LEU . 81.0 t -64.98 76.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.558 -178.418 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 6.3 m-20 -71.61 92.44 1.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.626 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -63.97 -42.08 97.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.303 -178.478 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.615 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 26.7 tt0 -68.3 -39.11 82.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.794 0.331 . . . . 0.0 110.253 -178.506 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 18' ' ' ASP . . . -71.55 -36.75 71.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.053 0.454 . . . . 0.0 110.384 177.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -67.79 -28.75 67.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.976 178.026 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -42.48 87.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.321 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -43.82 86.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.246 178.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 2.2 mm-40 -65.79 -30.38 71.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.342 0.592 . . . . 0.0 110.207 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.788 HG21 HG23 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -60.66 -47.14 94.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.073 179.724 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.624 HE22 HD13 ' A' ' 36' ' ' LEU . 7.2 mm-40 -64.71 -35.24 80.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.193 -178.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 8.4 pt-20 -77.0 -20.79 55.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.907 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.788 ' HD3' HD11 ' A' ' 74' ' ' ILE . 4.2 ptp180 -90.51 -13.55 34.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.045 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 26' ' ' ILE . 14.2 mm -59.82 138.67 90.31 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.92 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.526 ' N ' HG22 ' A' ' 30' ' ' ILE . 9.6 Cg_endo -50.81 119.3 5.07 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.708 2.272 . . . . 0.0 112.112 178.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -59.23 -1.27 0.18 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.24 -179.597 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -81.49 -39.64 12.1 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.968 -178.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER -130.54 -147.41 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.668 0.271 . . . . 0.0 111.118 -179.714 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -131.9 170.06 15.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.998 0.428 . . . . 0.0 110.927 -179.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.624 HD13 HE22 ' A' ' 27' ' ' GLN . 0.5 OUTLIER -75.12 -177.2 3.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.123 -179.331 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.509 ' HB2' HG22 ' A' ' 56' ' ' VAL . 82.1 t60 -130.91 -76.38 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.294 0.569 . . . . 0.0 111.085 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.471 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 2.0 tptt -164.64 130.34 2.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.996 -178.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.645 HG23 HG22 ' A' ' 53' ' ' VAL . 2.2 mt -94.13 160.99 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -127.35 122.54 33.99 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.485 -179.182 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -84.83 74.06 10.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.602 178.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -101.23 136.16 19.74 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.969 -179.6 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.773 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 61.4 Cg_endo -86.43 155.49 9.29 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.793 2.328 . . . . 0.0 112.724 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.423 HD13 ' HB3' ' A' ' 50' ' ' ALA . 3.0 mm -124.55 -83.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.614 -177.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.589 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . . . -67.42 -148.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.355 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -70.45 -33.54 71.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.61 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.39 8.22 0.64 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.606 179.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.648 HD22 HG22 ' A' ' 17' ' ' VAL . 4.1 mt -91.41 102.02 14.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.876 0.369 . . . . 0.0 110.748 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 87.3 t -93.23 128.89 44.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.94 -178.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.598 ' HB1' ' HB3' ' A' ' 11' ' ' MET . . . -95.19 161.01 14.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.071 178.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.626 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.2 mp -120.27 119.96 34.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.405 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.533 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 2.0 m120 -89.74 91.4 8.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.305 0.574 . . . . 0.0 110.066 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.788 HG23 HG21 ' A' ' 26' ' ' ILE . 6.1 t -87.5 104.67 14.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.736 -177.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.488 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 27.8 mtt -86.54 164.38 16.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.277 178.458 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.2 m -139.26 136.15 41.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.845 0.355 . . . . 0.0 111.354 -178.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -95.69 114.94 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.311 179.733 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.41 ' O ' HG21 ' A' ' 57' ' ' VAL . 3.6 m -130.24 148.59 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.694 178.579 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.92 -67.65 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.356 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -80.71 -7.43 59.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.094 0.473 . . . . 0.0 110.64 179.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.66 -147.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.107 179.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.5 -165.33 2.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.875 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.13 14.04 29.47 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.523 178.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.9 -2.84 40.32 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.483 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 p -74.08 -3.66 30.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.359 . . . . 0.0 110.265 179.306 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -23.91 27.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.326 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.97 -25.7 58.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.262 -179.223 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.68 -49.3 78.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.635 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.682 ' HG3' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -61.72 -42.05 98.43 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.67 0.748 . . . . 0.0 109.53 176.996 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.682 ' N ' ' HG3' ' A' ' 68' ' ' GLU . 2.3 tm-20 -55.25 -46.62 76.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.821 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.2 p -68.42 -24.32 64.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.231 177.184 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.754 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.53 -30.23 62.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.608 179.901 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 p -63.41 -11.46 23.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.776 179.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.24 26.66 0.99 Allowed Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.788 HD11 ' HD3' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -73.33 -166.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.224 -0.488 . . . . 0.0 111.408 -178.606 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -50.75 92.17 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.096 179.0 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.55 -26.16 64.19 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.476 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.07 -37.88 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.142 0.496 . . . . 0.0 110.114 178.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.582 ' HB2' ' HB3' ' A' ' 75' ' ' GLU . 1.5 m -96.15 89.92 5.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.531 179.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.48 130.0 37.33 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.465 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.76 HG22 HG22 ' A' ' 8' ' ' ILE . 3.4 mp -101.35 149.55 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.539 -175.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.508 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.1 tt0 -85.75 71.15 10.72 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.744 HG21 HG22 ' A' ' 80' ' ' ILE . 58.3 t -80.26 50.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.031 -174.269 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.87 5.74 3.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.285 178.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.785 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 35.4 t0 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.985 0.421 . . . . 0.0 111.008 -178.451 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.502 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 1.9 t . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 120.575 0.226 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 1.0 OUTLIER -109.43 117.05 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.688 0.28 . . . . 0.0 111.754 -178.995 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' A' ' 55' ' ' VAL . . . -98.54 165.69 11.7 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.314 178.055 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.671 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 6.0 m -143.24 132.96 23.81 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.632 0.729 . . . . 0.0 112.407 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.693 HG23 HG23 ' A' ' 80' ' ' ILE . 7.1 mm -126.28 108.12 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.499 -178.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.541 ' O ' HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.25 95.0 7.81 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.011 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 10' ' ' VAL . 1.5 m -92.56 136.83 23.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.116 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.771 ' HE2' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -146.3 118.48 4.97 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 121.07 0.462 . . . . 0.0 111.717 179.896 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 21.1 Cg_exo -68.29 121.58 8.56 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.36 2.707 . . . . 0.0 111.822 178.529 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.89 -29.16 64.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.325 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.84 150.37 78.42 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.545 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 37.7 Cg_endo -65.88 -7.85 18.02 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.463 2.109 . . . . 0.0 112.075 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -91.81 35.97 0.96 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.502 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.657 HG13 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -68.17 82.58 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.814 0.816 . . . . 0.0 110.532 -179.378 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.5 m-20 -73.74 99.31 3.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.805 178.038 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.811 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -63.33 -44.11 95.83 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.025 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.784 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 4.4 tp10 -70.03 -36.15 74.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.868 0.366 . . . . 0.0 110.342 -178.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.96 78.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.381 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.8 OUTLIER -67.72 -26.67 66.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.971 177.23 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.784 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -56.13 -46.13 79.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.235 179.13 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -41.22 85.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.705 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.71 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 52.9 mt-10 -66.74 -28.63 68.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.426 0.631 . . . . 0.0 110.151 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.823 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.2 mt -63.29 -39.2 84.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.163 178.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.557 ' NE2' HG21 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -60.66 -41.72 95.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.075 -179.85 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.71 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -77.62 -21.32 52.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.937 -178.101 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.823 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.01 -12.43 44.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.061 -179.001 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.684 HG12 ' O ' ' A' ' 26' ' ' ILE . 22.6 mm -60.46 137.53 92.31 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.872 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.482 ' N ' HG22 ' A' ' 30' ' ' ILE . 7.0 Cg_endo -47.45 121.5 5.56 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.748 2.298 . . . . 0.0 112.256 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.15 0.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.238 -179.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.0 -62.96 1.78 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.866 -179.023 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.476 ' OG1' HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -111.77 -142.01 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.682 0.277 . . . . 0.0 111.183 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -133.39 172.98 11.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.974 0.416 . . . . 0.0 111.069 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.654 HD22 HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -75.39 -177.65 3.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.329 -178.958 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.514 ' ND1' HG11 ' A' ' 56' ' ' VAL . 80.0 t60 -131.02 -76.29 0.53 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.062 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 20.2 mmtt -160.21 129.25 4.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.089 -178.732 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.776 HD12 HG22 ' A' ' 53' ' ' VAL . 1.6 mt -92.0 160.93 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 111.616 -178.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.632 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -129.06 124.47 34.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.64 -178.606 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -85.85 71.93 10.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 0.0 110.653 178.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.22 136.21 20.55 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.593 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.769 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 59.7 Cg_endo -86.99 158.02 8.62 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.565 2.176 . . . . 0.0 112.785 -178.661 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mm -126.16 -82.69 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.421 -177.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.488 ' HB1' ' HG ' ' A' ' 48' ' ' LEU . . . -67.41 -151.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.167 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -71.35 -30.22 65.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.668 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.55 5.2 0.51 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.899 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.771 HD12 ' HE2' ' A' ' 11' ' ' MET . 5.1 mt -91.78 103.13 15.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.938 0.399 . . . . 0.0 110.708 179.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.769 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 76.0 t -92.92 131.76 39.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.88 -178.381 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 11' ' ' MET . . . -96.03 162.29 13.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.831 178.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.811 HD12 ' HB2' ' A' ' 19' ' ' LEU . 11.2 mp -120.66 119.7 33.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.333 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.486 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.3 m120 -89.88 91.83 8.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.255 0.55 . . . . 0.0 110.134 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.776 HG22 HD12 ' A' ' 39' ' ' ILE . 12.4 t -86.5 102.3 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.583 -177.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.564 ' HG2' ' HG1' ' A' ' 7' ' ' THR . 24.8 mtt -84.59 164.46 18.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.169 178.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.473 HG21 ' HB1' ' A' ' 6' ' ' ALA . 3.0 m -139.35 135.86 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.456 -178.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.514 HG11 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -98.61 115.98 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.211 178.932 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.502 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 2.8 m -130.67 148.14 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.702 178.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.6 -68.06 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.578 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -80.42 -8.51 59.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.059 0.457 . . . . 0.0 110.607 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.86 -144.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.057 179.21 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.52 -167.34 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.815 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.86 16.35 15.8 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.562 178.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.5 -1.36 36.32 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.491 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 p -74.81 -4.23 36.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.874 0.368 . . . . 0.0 110.246 179.228 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -55.05 -23.37 19.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.182 177.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.29 -26.29 60.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.134 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.92 -55.94 27.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.338 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -58.33 -35.91 72.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.561 178.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -51.55 68.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.427 178.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.603 ' HG ' HD13 ' A' ' 74' ' ' ILE . 12.2 p -63.98 -20.81 66.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.487 179.023 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.537 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.22 -25.94 61.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.602 -179.802 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.01 -17.73 63.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.638 179.124 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.77 30.67 0.92 Allowed Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.05 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.762 HD11 ' HD2' ' A' ' 29' ' ' ARG . 4.3 tt -72.99 -160.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.571 -0.314 . . . . 0.0 111.01 -178.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.651 ' HG2' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -51.61 94.96 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.035 0.445 . . . . 0.0 110.63 179.77 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.16 -30.85 71.5 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.485 -177.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.5 t -85.02 -33.9 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.943 0.401 . . . . 0.0 110.578 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 28.1 t -95.77 91.53 6.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.937 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.5 128.84 36.2 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.012 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.786 HG23 HG23 ' A' ' 82' ' ' VAL . 3.4 mp -101.01 149.31 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.423 -174.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.536 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.7 tt0 -85.66 70.41 10.72 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 173.07 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.786 HG23 HG23 ' A' ' 80' ' ' ILE . 59.9 t -79.92 50.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.881 -174.393 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.66 6.54 4.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.351 179.272 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.671 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.5 m-20 . . . . . 0 N--CA 1.452 -0.361 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.913 -178.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.646 0.26 . . . . 0.0 110.609 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 78.9 t -119.85 122.52 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.49 -179.063 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -95.37 168.39 10.75 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.75 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 5.7 m -143.17 133.6 24.8 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.595 0.712 . . . . 0.0 112.235 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.788 HG22 HG23 ' A' ' 80' ' ' ILE . 3.8 mm -126.52 106.51 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.24 -178.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.524 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 2.5 mmmt -96.21 96.02 8.52 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -176.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.56 HG23 ' HG ' ' A' ' 78' ' ' SER . 0.9 OUTLIER -94.23 135.71 27.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -177.537 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.702 ' HE3' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -147.77 117.97 4.35 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 120.993 0.425 . . . . 0.0 111.414 178.97 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.3 Cg_exo -69.72 120.44 7.23 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.253 2.636 . . . . 0.0 111.964 178.515 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -57.61 -29.06 64.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.068 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.55 150.57 79.52 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.882 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 38.4 Cg_endo -66.34 -8.29 20.14 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.432 2.088 . . . . 0.0 112.063 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.92 36.51 0.97 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.634 179.313 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.644 HG11 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.8 86.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.811 0.815 . . . . 0.0 110.196 -179.87 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.582 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 55.9 m-20 -69.43 104.92 2.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.213 179.259 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.747 ' HG ' HD21 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -60.74 -52.52 64.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.548 -178.341 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.792 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 9.9 pt-20 -71.03 -34.51 71.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.257 -177.716 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.0 -35.7 78.76 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.622 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -66.03 -33.61 76.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.423 176.463 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.792 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -55.91 -46.38 78.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.112 178.529 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -66.14 -43.65 86.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.72 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.754 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 5.1 mm-40 -66.12 -28.06 68.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.404 0.621 . . . . 0.0 110.576 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.65 ' O ' HG12 ' A' ' 30' ' ' ILE . 1.1 mt -61.8 -46.54 96.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.267 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.568 ' NE2' HD23 ' A' ' 36' ' ' LEU . 5.9 mm100 -63.9 -35.32 80.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.297 -178.053 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.754 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.6 OUTLIER -76.63 -21.55 55.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.821 179.953 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.671 ' NH2' HG13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -90.25 -15.12 31.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.793 179.249 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.65 HG12 ' O ' ' A' ' 26' ' ' ILE . 15.8 mm -58.93 138.28 87.37 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.97 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.508 ' N ' HG21 ' A' ' 30' ' ' ILE . 10.3 Cg_endo -50.27 117.23 3.0 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.884 2.389 . . . . 0.0 112.309 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -58.84 -2.07 0.21 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.182 -179.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.79 -57.52 2.54 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.794 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.76 -142.62 0.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.694 0.283 . . . . 0.0 111.064 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -135.65 170.0 16.65 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.929 0.395 . . . . 0.0 110.761 -179.411 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.568 HD23 ' NE2' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -75.3 -178.31 3.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.062 -179.333 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.509 ' HB2' HG23 ' A' ' 56' ' ' VAL . 84.5 t60 -130.85 -77.01 0.53 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.41 0.624 . . . . 0.0 110.926 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -164.83 130.87 2.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.791 -178.893 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.75 HD13 HG21 ' A' ' 53' ' ' VAL . 2.7 mt -92.67 157.92 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.039 0.447 . . . . 0.0 112.098 -177.097 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.62 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -124.75 117.32 23.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.379 -179.106 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.544 ' HG2' HD21 ' A' ' 19' ' ' LEU . 1.4 mt-10 -82.8 70.91 9.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.952 0.406 . . . . 0.0 110.514 178.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.481 ' O ' HG12 ' A' ' 49' ' ' VAL . 1.7 mt-10 -95.66 135.84 22.77 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.356 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.747 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 56.7 Cg_endo -86.21 156.73 9.68 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.433 2.089 . . . . 0.0 112.933 -178.039 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' A' ' 50' ' ' ALA . 2.8 mm -125.53 -82.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.451 -177.168 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.593 ' HB1' ' HG ' ' A' ' 48' ' ' LEU . . . -67.22 -150.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.006 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -72.04 -30.52 65.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.848 0.356 . . . . 0.0 110.69 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.28 4.97 0.53 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.804 179.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.702 HD12 ' HE3' ' A' ' 11' ' ' MET . 4.5 mt -91.31 102.88 15.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.893 0.377 . . . . 0.0 110.732 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.747 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 75.7 t -93.3 131.29 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.059 -177.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 11' ' ' MET . . . -96.08 150.72 20.18 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.719 177.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.747 HD21 ' HG ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -113.84 117.91 32.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.358 179.6 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.45 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 6.8 m-20 -89.87 92.83 9.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.223 -178.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.75 HG21 HD13 ' A' ' 39' ' ' ILE . 5.1 t -86.85 102.11 11.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.624 -177.757 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.605 ' HG3' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.54 163.59 19.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.054 178.253 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.5 m -138.21 136.9 44.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.765 0.317 . . . . 0.0 111.367 -178.373 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.509 HG23 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -94.63 116.38 35.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.086 179.559 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.2 m -130.27 148.36 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.966 179.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.64 -72.79 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.419 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.66 -2.7 51.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 110.789 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.31 -150.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.303 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.58 -165.19 2.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.792 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.16 14.72 26.25 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.619 178.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.12 -3.33 44.56 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.495 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -74.42 -3.2 29.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.941 0.401 . . . . 0.0 110.274 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -25.04 24.66 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.691 177.663 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.43 -25.16 59.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.953 -179.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.405 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -62.4 -55.25 29.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 110.073 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 58.5 mt-10 -58.6 -33.55 70.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.286 178.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -62.51 -52.59 62.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.256 178.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.65 -16.62 61.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.117 178.308 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.742 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 1.3 mt -73.38 -33.11 64.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.49 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.75 -10.29 18.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.792 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.08 28.6 1.0 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 178.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.742 ' HB ' ' HA ' ' A' ' 71' ' ' LEU . 7.3 tt -73.56 -166.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.834 -0.683 . . . . 0.0 111.269 -178.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.645 ' H ' HG12 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -52.01 101.39 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.986 0.422 . . . . 0.0 111.042 -179.658 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.52 -32.42 83.27 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.812 -179.004 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -86.44 -36.38 10.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.421 . . . . 0.0 110.242 179.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.627 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 10.3 t -95.67 92.39 6.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.462 179.332 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.566 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.32 130.74 37.56 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.325 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.792 HG23 HG23 ' A' ' 82' ' ' VAL . 2.7 mp -101.4 148.73 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.413 -175.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.524 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.2 tp10 -85.65 70.25 10.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 173.105 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.792 HG23 HG23 ' A' ' 80' ' ' ILE . 55.2 t -79.7 44.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.055 -174.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -132.32 9.84 4.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.522 177.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.75 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 34.5 t0 . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.828 0.346 . . . . 0.0 110.869 -178.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.659 0.266 . . . . 0.0 111.381 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 84.8 t -113.43 114.16 46.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.271 179.218 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -93.1 168.23 11.26 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.731 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.756 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 11.2 m -142.56 132.42 24.21 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.585 0.707 . . . . 0.0 112.505 -179.231 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.787 HG22 HG22 ' A' ' 80' ' ' ILE . 3.8 mm -120.61 105.24 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.276 -179.426 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.511 ' O ' HG21 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -93.56 93.82 8.29 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.941 0.401 . . . . 0.0 112.009 -177.657 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 22' ' ' LEU . 1.2 m -92.96 136.28 25.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.036 -177.211 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.672 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.6 OUTLIER -147.7 119.27 4.54 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 121.265 0.555 . . . . 0.0 111.508 178.712 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.818 ' HG3' HD12 ' A' ' 22' ' ' LEU . 19.1 Cg_exo -68.38 120.86 7.79 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.13 2.553 . . . . 0.0 111.622 178.688 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.93 -29.11 62.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.271 -179.222 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 p -77.78 153.25 80.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.127 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 51.3 Cg_endo -68.54 -7.21 19.68 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.178 1.919 . . . . 0.0 111.31 178.144 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.47 34.49 0.88 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.282 178.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.711 HG11 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -68.24 81.78 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.889 0.852 . . . . 0.0 110.523 -179.363 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.485 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 1.1 m-20 -74.05 97.96 2.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.897 177.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.726 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -64.53 -38.49 91.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.398 -178.473 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.655 ' H ' HD11 ' A' ' 19' ' ' LEU . 2.7 tp10 -69.11 -38.69 79.05 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' A' ' 18' ' ' ASP . . . -70.59 -38.24 73.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.414 0.626 . . . . 0.0 109.713 176.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.818 HD12 ' HG3' ' A' ' 12' ' ' PRO . 1.1 mt -68.08 -28.98 67.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.082 178.095 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.463 ' HA ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -56.67 -46.66 80.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.032 -179.59 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -68.94 -40.91 78.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.186 0.517 . . . . 0.0 110.387 179.319 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.435 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 6.1 mm-40 -65.32 -28.05 69.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.359 179.524 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.716 HG22 HD13 ' A' ' 39' ' ' ILE . 2.1 mt -62.65 -45.66 98.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.106 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -34.67 72.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.654 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -75.02 -22.47 58.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.466 -179.378 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.731 ' HD3' HD11 ' A' ' 74' ' ' ILE . 1.9 ptp180 -88.55 -15.21 35.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.504 -178.697 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 26' ' ' ILE . 43.5 mm -58.07 137.57 84.07 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.568 179.132 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HB3' ' N ' ' A' ' 67' ' ' ALA . 18.6 Cg_endo -58.05 130.71 39.46 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.506 2.137 . . . . 0.0 112.837 -179.501 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.32 0.12 0.31 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.0 179.49 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -81.98 -60.88 2.1 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.566 -178.987 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER -113.96 -143.69 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.707 0.289 . . . . 0.0 111.08 -179.867 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -135.73 167.63 20.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.775 -179.671 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.532 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.8 pt? -75.16 -176.16 2.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.04 -179.469 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.572 ' ND1' HG21 ' A' ' 56' ' ' VAL . 84.8 t60 -130.64 -77.43 0.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.374 0.606 . . . . 0.0 111.4 -178.195 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.539 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER -163.98 129.42 2.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.656 -178.417 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.786 HD13 HG22 ' A' ' 53' ' ' VAL . 2.5 mt -91.15 155.66 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.07 0.462 . . . . 0.0 112.145 -176.632 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.644 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -121.9 118.77 29.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.367 -179.025 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -82.19 71.71 9.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.055 0.455 . . . . 0.0 110.183 178.187 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.499 ' O ' HG12 ' A' ' 49' ' ' VAL . 1.2 mt-10 -96.46 135.06 22.63 Favored Pre-proline 0 C--O 1.224 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.607 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.754 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 52.8 Cg_endo -86.07 156.24 9.84 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.513 2.142 . . . . 0.0 112.796 -178.925 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 44' ' ' ILE . 2.7 mm -125.83 -83.32 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.543 -177.447 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.517 ' HB1' ' HG ' ' A' ' 48' ' ' LEU . . . -67.37 -151.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 -179.861 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -71.91 -29.49 64.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.606 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.63 4.79 0.49 Allowed Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.932 179.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.711 ' HA ' HG11 ' A' ' 17' ' ' VAL . 4.1 mt -91.72 102.54 15.16 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.856 0.36 . . . . 0.0 110.787 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 69.6 t -93.7 129.62 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.913 -178.462 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.64 150.04 20.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.025 178.116 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.726 HD21 ' HB2' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -113.09 119.38 37.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.245 179.054 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 1.5 m120 -89.81 94.43 9.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.522 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.786 HG22 HD13 ' A' ' 39' ' ' ILE . 5.5 t -86.21 102.93 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.342 -178.663 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.529 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.69 167.73 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.455 179.208 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 4.2 m -139.28 135.01 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.449 -178.251 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.572 HG21 ' ND1' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -95.7 113.89 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.824 178.843 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 4' ' ' VAL . 2.9 m -129.52 154.98 40.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.841 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.43 -68.07 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.195 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.63 -6.35 58.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.108 0.48 . . . . 0.0 110.366 179.027 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.426 ' HB1' HG21 ' A' ' 34' ' ' THR . . . -67.82 -151.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.125 179.443 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.27 -159.12 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.856 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.41 12.47 32.87 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.44 178.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.96 -8.0 60.36 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.43 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.27 -3.36 29.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.983 0.42 . . . . 0.0 110.087 179.006 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -54.71 -24.07 20.42 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.99 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.25 -27.26 61.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.897 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.462 ' N ' ' HB3' ' A' ' 31' ' ' PRO . . . -60.23 -56.92 15.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.364 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -58.89 -34.97 72.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.405 178.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -51.23 70.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.383 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 t -63.7 -19.77 65.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.48 178.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.743 HD13 HG23 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -72.83 -28.39 62.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.651 179.957 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.82 -14.23 51.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.766 179.157 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.26 28.69 0.98 Allowed Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.743 HG23 HD13 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -73.41 -163.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.293 -0.453 . . . . 0.0 111.282 -178.698 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.635 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.7 OUTLIER -50.21 98.67 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.943 0.401 . . . . 0.0 110.918 179.513 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.62 -32.46 84.27 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.21 -178.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -85.66 -36.48 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.055 0.455 . . . . 0.0 110.205 179.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.635 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 42.4 t -95.64 90.08 5.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.455 179.225 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.557 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.17 133.34 38.97 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.1 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.787 HG22 HG22 ' A' ' 8' ' ' ILE . 2.2 mt -101.65 149.3 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.863 -175.485 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.504 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 5.3 tp10 -86.1 71.52 10.55 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 172.406 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.77 HG22 HG22 ' A' ' 80' ' ' ILE . 62.2 t -80.35 50.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.104 -174.216 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.92 5.96 3.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.349 178.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.756 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 46.9 t0 . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.984 0.421 . . . . 0.0 111.3 -178.147 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.624 0.25 . . . . 0.0 110.615 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.48 116.41 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.73 179.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -96.37 166.3 11.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.28 178.897 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.67 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 25.6 m -142.05 132.6 25.31 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.569 0.7 . . . . 0.0 111.779 179.768 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.752 HG21 HG23 ' A' ' 80' ' ' ILE . 1.8 mm -120.46 106.46 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.615 -178.375 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.754 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -95.24 93.36 7.25 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -177.573 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -92.38 135.93 26.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.729 -177.667 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.733 ' O ' ' HG3' ' A' ' 11' ' ' MET . 1.0 OUTLIER -147.5 114.79 4.14 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 121.389 0.614 . . . . 0.0 111.974 179.801 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.502 ' HD2' ' CG2' ' A' ' 17' ' ' VAL . 35.5 Cg_exo -63.39 124.64 14.14 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.153 2.569 . . . . 0.0 112.055 178.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -57.52 -30.78 65.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.378 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.32 150.81 77.49 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.205 -179.304 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.563 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 40.9 Cg_endo -66.67 -6.29 15.09 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.38 2.053 . . . . 0.0 111.89 179.211 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -92.01 32.7 1.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.586 179.211 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -66.82 85.82 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.65 0.738 . . . . 0.0 110.064 179.929 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 12.1 m-20 -70.76 104.21 2.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.278 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.599 HD13 HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -61.67 -49.56 76.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.237 -178.666 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.664 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 2.5 tp10 -70.11 -35.48 74.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.111 -178.163 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.606 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -69.06 -35.93 77.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.294 0.569 . . . . 0.0 109.809 177.548 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -66.54 -27.56 67.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.038 177.831 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.664 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -56.33 -46.72 79.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.44 179.051 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.606 ' HE2' ' HA ' ' A' ' 21' ' ' ALA . 1.2 mtmm -65.64 -41.86 92.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.847 179.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.697 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 33.3 mt-10 -66.71 -31.14 71.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.431 0.634 . . . . 0.0 110.356 179.526 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.791 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 3.2 mt -62.91 -41.62 93.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.93 179.757 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -62.64 -39.13 92.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.158 -179.222 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.697 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -78.0 -21.02 51.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.669 -178.499 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.791 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.51 -12.11 43.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.273 -178.955 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.685 HG13 HD22 ' A' ' 36' ' ' LEU . 28.5 mm -61.0 138.09 94.09 Favored Pre-proline 0 N--CA 1.463 0.2 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.089 179.626 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.671 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 9.5 Cg_endo -51.19 125.26 15.9 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.744 2.296 . . . . 0.0 112.478 179.211 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -60.72 -2.86 0.6 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.039 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.22 -62.34 1.82 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.896 -178.82 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.499 ' HG1' HG23 ' A' ' 64' ' ' THR . 0.2 OUTLIER -111.01 -143.67 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.692 0.282 . . . . 0.0 111.152 -179.462 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -133.93 172.57 12.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.941 0.401 . . . . 0.0 110.823 -179.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.685 HD22 HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -74.43 -177.05 2.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.667 -179.811 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.456 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 66.5 t60 -131.3 -73.58 0.53 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.146 0.498 . . . . 0.0 111.059 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 29.1 mmtm -161.46 127.55 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.417 -178.733 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.728 HD12 HG22 ' A' ' 53' ' ' VAL . 2.9 mt -93.55 154.34 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.817 -178.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.633 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.2 m-20 -119.36 124.22 46.07 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.317 -178.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -89.17 66.5 7.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.96 0.41 . . . . 0.0 110.083 177.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.562 ' O ' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.96 147.86 34.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.702 -178.035 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.747 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 35.1 Cg_endo -91.79 158.43 3.44 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.016 2.477 . . . . 0.0 112.861 -178.32 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.401 ' HB ' ' H ' ' A' ' 45' ' ' ALA . 4.0 mm -127.59 -82.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.334 -178.177 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' H ' ' HB ' ' A' ' 44' ' ' ILE . . . -67.15 -150.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.988 179.728 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -71.88 -27.46 62.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.737 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.28 7.89 0.3 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.157 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.563 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.0 mt -92.39 105.41 17.6 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.784 0.326 . . . . 0.0 110.885 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.747 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 25.6 t -92.92 128.07 44.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.886 -178.477 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.07 148.94 21.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.275 179.163 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.653 HD23 ' HD2' ' A' ' 23' ' ' LYS . 11.1 mp -106.48 114.74 29.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.019 177.706 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.615 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 3.9 m-20 -89.28 92.31 9.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.231 0.539 . . . . 0.0 109.938 -179.422 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.728 HG22 HD12 ' A' ' 39' ' ' ILE . 11.3 t -85.79 106.35 15.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.625 -177.292 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.533 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 37.4 mtt -85.24 164.15 18.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.078 178.499 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.71 136.77 35.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.31 -178.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.46 111.95 26.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.715 178.738 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.21 143.58 40.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.095 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.42 -64.51 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.314 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.75 -8.29 59.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 110.495 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.59 -146.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.248 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -147.69 -163.12 1.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.783 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.419 ' O ' ' HG2' ' A' ' 65' ' ' GLU . . . -80.45 12.2 34.51 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.559 178.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.11 -9.05 62.83 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.507 179.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.499 HG23 ' HG1' ' A' ' 34' ' ' THR . 1.2 p -74.57 -5.15 41.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.861 0.362 . . . . 0.0 110.29 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 3.7 pt-20 -54.94 -24.09 22.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.405 0.621 . . . . 0.0 110.11 177.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.04 -28.21 62.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.969 -179.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 31' ' ' PRO . . . -60.67 -56.4 21.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.271 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -59.37 -35.02 73.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.469 178.447 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -50.91 70.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.415 178.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.442 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 5.1 t -64.65 -20.32 66.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.56 178.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.6 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -72.69 -28.31 62.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.71 -179.678 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -15.61 58.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.793 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.37 29.2 0.97 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.791 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.6 ' HB ' ' HA ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -73.5 -161.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.451 -0.374 . . . . 0.0 111.142 -178.933 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 2.7 pm0 -51.6 91.45 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 121.063 0.459 . . . . 0.0 110.749 179.358 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.17 -24.05 62.75 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.833 -0.621 . . . . 0.0 113.04 -178.334 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.58 -36.64 10.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.234 0.54 . . . . 0.0 110.381 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.569 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 4.2 t -95.88 93.01 6.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.592 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.582 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -75.94 131.0 39.34 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.438 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.782 HG23 HG23 ' A' ' 82' ' ' VAL . 3.5 mp -101.19 148.1 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.559 -174.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.754 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -85.87 71.4 10.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 173.256 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.782 HG23 HG23 ' A' ' 80' ' ' ILE . 58.6 t -80.71 52.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.076 -174.302 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 m -133.32 5.73 3.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.902 179.426 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.67 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.1 m-20 . . . . . 0 N--CA 1.456 -0.158 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.379 -177.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.553 ' HB ' HG21 ' A' ' 57' ' ' VAL . 2.9 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.561 0.22 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 84.7 t -104.8 107.58 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.268 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.561 ' HB1' HG21 ' A' ' 55' ' ' VAL . . . -97.12 141.04 30.74 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 177.753 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.769 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 16.2 m -122.49 133.03 54.6 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.749 0.785 . . . . 0.0 112.251 -178.229 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.73 ' HB ' HH22 ' A' ' 29' ' ' ARG . 5.6 mm -123.99 109.17 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.677 -178.173 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.528 ' HD2' ' HB3' ' A' ' 52' ' ' ASN . 2.1 mmmt -99.57 95.61 7.1 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -177.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.417 ' HB ' HG13 ' A' ' 80' ' ' ILE . 1.4 m -93.32 136.73 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.533 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.691 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.4 OUTLIER -147.78 120.57 4.7 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 121.17 0.509 . . . . 0.0 111.72 178.751 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 20.6 Cg_exo -69.78 121.75 8.43 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.366 2.711 . . . . 0.0 112.143 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -30.58 64.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.207 -179.674 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.9 m -77.97 148.94 76.18 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.999 -179.732 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.628 ' HA ' HD23 ' A' ' 48' ' ' LEU . 38.1 Cg_endo -65.57 -6.79 14.5 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.416 2.077 . . . . 0.0 111.881 179.423 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -91.59 35.42 0.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.518 179.111 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.558 HG11 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.46 87.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.817 0.818 . . . . 0.0 110.184 -179.797 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.555 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -67.69 105.28 1.86 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.926 178.824 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.772 HD23 HG13 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -60.65 -54.25 47.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.748 -177.96 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.647 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -70.85 -34.23 71.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.133 -177.43 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.536 ' N ' ' HG2' ' A' ' 20' ' ' GLU . . . -68.74 -35.6 77.31 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.305 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -64.96 -35.53 81.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.138 176.524 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.647 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -55.44 -49.08 73.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.252 178.201 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -39.34 85.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.092 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.68 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 2.9 mt-10 -66.51 -32.34 73.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.383 0.611 . . . . 0.0 110.166 179.099 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.73 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -63.55 -38.47 82.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.925 178.565 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -43.27 92.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.108 -179.72 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.68 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -78.06 -21.37 50.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.755 -178.575 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.73 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 18.9 ptt85 -89.06 -8.65 53.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.411 -178.488 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.709 HD13 ' HB3' ' A' ' 36' ' ' LEU . 19.8 mm -60.11 137.55 91.21 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.966 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.505 ' N ' HG22 ' A' ' 30' ' ' ILE . 9.1 Cg_endo -48.75 117.65 2.87 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.897 2.398 . . . . 0.0 112.206 178.929 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.47 1.09 0.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.391 -179.395 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.51 -63.95 1.73 Allowed Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.752 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.648 HG21 ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -110.24 -134.05 0.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.628 0.251 . . . . 0.0 111.086 -179.531 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -138.62 171.06 14.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.931 0.396 . . . . 0.0 110.669 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.709 ' HB3' HD13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -74.85 -177.57 3.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.018 -179.447 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.513 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 86.3 t60 -131.01 -73.31 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.322 0.582 . . . . 0.0 111.081 -179.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.499 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -163.46 126.64 2.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.046 -178.433 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.766 HD11 HG21 ' A' ' 53' ' ' VAL . 2.9 mt -94.13 157.04 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.161 -177.342 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.628 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 77.4 m-20 -122.62 124.17 42.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.384 -179.206 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.94 66.3 6.86 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.364 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -98.23 147.12 32.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.538 -177.539 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.761 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.6 Cg_endo -89.63 159.5 5.27 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.12 2.547 . . . . 0.0 113.211 -177.718 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.432 HG22 HD11 ' A' ' 44' ' ' ILE . 3.9 mm -129.03 -82.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.169 -178.121 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.556 ' HB1' ' HG ' ' A' ' 48' ' ' LEU . . . -67.07 -153.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.844 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -72.04 -24.65 61.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.51 3.74 0.25 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.285 179.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.628 HD23 ' HA ' ' A' ' 15' ' ' PRO . 5.3 mt -92.32 106.95 18.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.021 0.41 . . . . 0.0 111.045 -179.798 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.772 HG13 HD23 ' A' ' 19' ' ' LEU . 52.8 t -94.28 130.37 43.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.95 -178.314 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.572 ' HB3' ' HB3' ' A' ' 11' ' ' MET . . . -95.46 162.01 13.83 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.567 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.628 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.4 OUTLIER -116.05 113.77 23.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.283 179.501 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.56 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.6 m120 -90.04 90.32 8.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.286 0.565 . . . . 0.0 110.011 178.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.766 HG21 HD11 ' A' ' 39' ' ' ILE . 5.5 t -88.63 102.17 12.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.809 -177.716 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 14.3 mtt -86.36 163.57 17.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.066 178.183 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.561 HG21 ' HB1' ' A' ' 6' ' ' ALA . 4.2 m -137.01 127.44 39.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.923 0.392 . . . . 0.0 111.216 -178.88 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.513 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 1.1 p -98.15 111.86 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 179.603 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.553 HG21 ' HB ' ' A' ' 4' ' ' VAL . 1.2 m -127.4 169.9 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.965 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.89 -69.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.467 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -80.92 0.24 36.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.969 0.414 . . . . 0.0 110.6 179.585 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.648 ' HB1' HG21 ' A' ' 34' ' ' THR . . . -67.5 -154.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.272 179.722 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.65 -161.29 1.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.865 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.87 13.56 30.2 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.477 178.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.52 -9.1 61.02 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.541 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -74.23 -4.0 33.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.04 0.448 . . . . 0.0 110.157 179.12 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -55.39 -23.37 24.24 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.072 177.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.86 -27.04 49.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.919 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.5 -56.32 21.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.401 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -58.42 -34.58 70.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.541 178.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.25 -51.76 66.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.397 178.471 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.416 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -63.42 -17.85 63.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.318 179.013 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.634 HD12 HG21 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.39 -30.56 63.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.652 179.71 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -11.47 35.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.93 179.452 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.38 26.13 0.97 Allowed Glycine 0 N--CA 1.453 -0.198 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.711 HD11 ' HD2' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -73.28 -164.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.459 -0.371 . . . . 0.0 111.012 -179.27 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.8 OUTLIER -51.73 96.81 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.775 0.322 . . . . 0.0 111.106 179.586 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.33 -23.07 61.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.079 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.409 HG13 ' N ' ' A' ' 78' ' ' SER . 4.6 p -89.42 -40.0 12.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.036 0.446 . . . . 0.0 110.648 179.323 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 8.5 t -95.51 92.19 6.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.519 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.544 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -76.82 132.53 39.25 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.311 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.772 HG22 HG23 ' A' ' 82' ' ' VAL . 3.6 mp -101.15 149.68 6.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.447 -175.333 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.458 ' N ' HG21 ' A' ' 80' ' ' ILE . 6.8 tt0 -85.78 69.56 10.6 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.331 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.772 HG23 HG22 ' A' ' 80' ' ' ILE . 54.5 t -80.87 55.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.805 -175.096 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -132.51 -1.37 3.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.61 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.769 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 11.4 t0 . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.738 -178.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.844 HG12 HG21 ' A' ' 57' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 22.3 t -109.17 119.12 58.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.705 0.288 . . . . 0.0 111.484 -178.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.552 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.02 145.36 25.0 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.463 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.76 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 10.0 m -122.73 133.72 54.48 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.608 0.718 . . . . 0.0 112.427 -177.566 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.574 ' CG2' HG22 ' A' ' 80' ' ' ILE . 4.5 mm -123.01 104.68 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.386 -179.475 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.78 ' HB2' ' HG3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -95.94 98.18 10.2 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -177.217 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.783 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.5 m -96.18 138.4 21.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.82 -177.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.689 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 2.1 ptm -147.25 121.22 5.01 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-O 121.182 0.515 . . . . 0.0 111.878 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.518 ' O ' HD23 ' A' ' 48' ' ' LEU . 22.8 Cg_exo -68.02 126.93 15.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.362 2.708 . . . . 0.0 112.173 179.116 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -32.2 68.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.454 -179.882 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.7 m -77.42 146.88 74.68 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.625 ' HA ' HD13 ' A' ' 48' ' ' LEU . 35.2 Cg_endo -64.53 -6.93 13.02 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.402 2.068 . . . . 0.0 111.801 179.207 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -92.3 38.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.073 178.556 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.795 HG12 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -68.03 85.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 122.013 0.911 . . . . 0.0 110.712 -178.52 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 17.1 m-20 -73.07 96.63 2.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.056 177.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.836 ' HB2' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -63.77 -41.36 97.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.637 -178.362 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.876 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 5.5 tp10 -69.8 -36.23 75.5 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.872 0.368 . . . . 0.0 110.371 -179.058 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.81 -37.43 76.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.452 0.644 . . . . 0.0 109.309 176.272 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -68.18 -25.81 65.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.064 177.164 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.876 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -56.31 -44.14 79.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.193 179.627 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -44.81 83.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.451 178.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.569 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 40.8 mt-10 -65.09 -28.18 69.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.466 0.65 . . . . 0.0 110.44 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.758 HG23 HD11 ' A' ' 39' ' ' ILE . 1.7 mt -60.21 -49.62 83.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.403 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.583 ' NE2' HD21 ' A' ' 36' ' ' LEU . 6.9 mm-40 -64.92 -32.95 74.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.476 -178.233 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 11.5 pt-20 -76.74 -21.27 55.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 110.751 179.617 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.794 ' HB2' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.55 -12.06 38.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.013 179.914 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.59 HD13 HG11 ' A' ' 53' ' ' VAL . 27.2 mm -58.94 138.42 87.42 Favored Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.256 179.684 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.513 ' N ' HG22 ' A' ' 30' ' ' ILE . 11.0 Cg_endo -52.82 118.23 4.54 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.898 2.399 . . . . 0.0 112.433 178.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -59.67 1.21 0.1 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.321 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.04 -43.73 7.43 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.181 -178.441 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.32 -139.75 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.621 0.248 . . . . 0.0 111.192 -178.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -133.55 168.58 18.4 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.947 0.403 . . . . 0.0 111.255 -178.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.583 HD21 ' NE2' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -75.91 -178.79 4.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.274 -179.299 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.454 ' HD2' ' HB2' ' A' ' 38' ' ' LYS . 59.1 t60 -131.4 -77.47 0.52 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.176 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.454 ' HB2' ' HD2' ' A' ' 37' ' ' HIS . 30.7 mmtm -162.0 133.02 5.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.205 -179.035 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.758 HD11 HG23 ' A' ' 26' ' ' ILE . 2.7 mt -93.97 158.25 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.021 0.439 . . . . 0.0 112.108 -178.009 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.704 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 2.6 m-20 -122.77 120.77 34.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.122 -179.498 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.45 67.77 10.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.866 0.365 . . . . 0.0 110.057 178.698 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.556 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.2 148.81 35.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.671 -177.889 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.751 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 50.4 Cg_endo -94.34 159.12 2.03 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.117 2.545 . . . . 0.0 113.347 -177.553 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.435 HD12 ' HB2' ' A' ' 50' ' ' ALA . 3.0 mm -128.9 -81.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.997 -178.707 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -67.73 -149.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.196 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -72.23 -30.14 64.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.875 0.369 . . . . 0.0 110.615 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.7 6.26 0.54 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.621 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.795 ' HA ' HG12 ' A' ' 17' ' ' VAL . 9.6 mp -89.25 101.07 13.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.912 0.387 . . . . 0.0 110.854 -179.271 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.751 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 11.3 t -91.97 127.83 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.129 -177.659 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.689 ' HB3' ' HB3' ' A' ' 11' ' ' MET . . . -95.35 144.35 25.97 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.829 177.695 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.836 HD22 ' HB2' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -106.07 116.9 32.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.419 178.836 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.619 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -89.58 93.42 9.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.178 -178.893 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.758 HG23 HD11 ' A' ' 39' ' ' ILE . 5.7 t -85.98 106.19 15.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.527 -178.187 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.457 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 34.9 mtt -84.53 162.92 19.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.136 178.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.9 m -140.13 141.24 33.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.087 -178.789 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.04 101.51 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.491 179.096 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.844 HG21 HG12 ' A' ' 4' ' ' VAL . 29.7 m -129.99 140.9 47.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.068 0.461 . . . . 0.0 111.597 -179.14 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.42 -60.66 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.334 178.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -81.73 -7.56 59.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 0.0 110.429 179.099 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.4 -143.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.163 179.52 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -147.29 -165.27 2.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.803 -179.848 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.61 12.87 32.0 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.653 179.041 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.85 -6.84 57.53 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.44 179.621 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -74.44 -3.89 33.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 110.228 179.248 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -54.63 -24.08 19.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.114 177.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.79 -29.24 62.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.103 -179.465 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 31' ' ' PRO . . . -61.61 -55.14 33.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.381 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.1 -34.95 72.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.357 178.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.86 -50.36 72.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.336 178.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 t -62.94 -18.28 62.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.349 178.608 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.715 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.37 -29.37 61.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.487 179.505 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -11.62 36.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.598 178.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.1 27.57 1.0 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.429 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.794 HD12 ' HB2' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -72.78 -166.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.366 -0.417 . . . . 0.0 111.099 -179.008 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 2.3 mm-40 -50.96 97.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.941 0.401 . . . . 0.0 110.81 179.222 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.71 -27.06 61.02 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.369 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.443 HG13 ' OE1' ' A' ' 75' ' ' GLU . 1.2 p -89.22 -38.21 10.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.977 0.418 . . . . 0.0 110.741 179.579 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.646 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 30.7 t -96.14 93.05 6.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.814 -179.712 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.431 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -76.52 130.88 38.55 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.161 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.783 HG12 ' HB ' ' A' ' 10' ' ' VAL . 5.2 mt -100.23 140.9 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.666 -176.094 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.78 ' HG3' ' HB2' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -84.86 74.04 10.55 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 174.648 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.606 HG22 ' HB ' ' A' ' 80' ' ' ILE . 86.5 t -81.55 51.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.187 -173.341 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.8 6.99 4.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.505 179.264 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.76 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 38.3 t0 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.807 0.337 . . . . 0.0 111.082 -178.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.566 0.222 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 14.2 t -106.15 108.76 25.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.053 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.554 ' HB2' HG23 ' A' ' 55' ' ' VAL . . . -95.01 165.12 12.6 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.013 177.898 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.667 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 7.8 m -142.14 129.04 20.65 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.762 0.792 . . . . 0.0 112.276 179.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.794 HG23 HG23 ' A' ' 80' ' ' ILE . 3.1 mm -120.72 105.61 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.249 -179.445 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.579 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . 1.0 OUTLIER -94.12 93.64 7.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -177.218 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 m -93.63 138.85 19.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.839 -177.258 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.707 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 2.6 ptm -146.19 123.27 5.97 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.27 179.374 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.52 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 18.6 Cg_exo -67.68 125.96 14.03 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.064 2.509 . . . . 0.0 112.217 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.35 -32.48 66.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.276 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.5 m -77.71 150.13 78.5 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.03 -179.55 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.544 ' HA ' HD11 ' A' ' 48' ' ' LEU . 50.1 Cg_endo -67.97 -4.62 12.81 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.486 2.124 . . . . 0.0 111.774 178.933 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -91.6 45.91 1.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.747 178.32 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.577 HG23 ' HG ' ' A' ' 48' ' ' LEU . 69.8 t -63.96 78.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.505 -178.189 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -71.32 93.87 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.263 177.957 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.623 ' HB2' HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -64.35 -41.53 96.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.622 0.249 . . . . 0.0 111.134 -179.333 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.544 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 4.6 tp10 -68.05 -38.17 82.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.22 -178.404 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.567 ' HA ' ' HZ1' ' A' ' 24' ' ' LYS . . . -70.92 -38.51 72.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.285 0.564 . . . . 0.0 110.112 177.541 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.953 HD21 ' HG2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -65.86 -28.07 68.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.213 178.411 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -58.89 -46.57 87.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.922 -179.718 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.567 ' HZ1' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -63.92 -41.02 97.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.683 -179.598 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.953 ' HG2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.07 -38.35 90.5 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.731 0.776 . . . . 0.0 110.012 179.756 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.829 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 4.2 mt -58.84 -40.88 81.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.838 -176.809 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -62.6 -37.02 84.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.461 . . . . 0.0 110.178 178.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 3.2 mm-40 -76.05 -23.72 55.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.628 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.829 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.73 -11.92 43.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.663 -178.198 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.48 HG21 ' N ' ' A' ' 31' ' ' PRO . 24.8 mm -58.11 136.6 84.35 Favored Pre-proline 0 C--N 1.333 -0.138 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.48 ' N ' HG21 ' A' ' 30' ' ' ILE . 1.3 Cg_endo -45.13 122.59 4.53 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.88 2.387 . . . . 0.0 112.134 179.186 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -6.0 0.3 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.131 -178.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.55 -58.02 2.48 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.575 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.45 HG21 ' HB2' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -115.44 -146.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.666 0.27 . . . . 0.0 111.001 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -136.78 175.82 9.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 110.881 -179.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.29 -175.47 2.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.423 -178.798 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.538 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 85.0 t60 -130.94 -72.12 0.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.755 -179.544 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.514 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -163.83 128.54 2.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.986 -178.92 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.769 HD11 HG23 ' A' ' 53' ' ' VAL . 2.9 mt -93.56 155.13 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.17 -177.104 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.691 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.2 t0 -119.43 121.6 39.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.046 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -86.28 67.77 10.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.931 0.396 . . . . 0.0 110.174 178.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.522 ' O ' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -98.34 148.89 35.14 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.621 -177.887 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.754 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 31.6 Cg_endo -93.47 157.86 2.46 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.052 2.501 . . . . 0.0 113.443 -177.269 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.453 HD12 ' HB3' ' A' ' 50' ' ' ALA . 3.5 mm -128.42 -82.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.024 -178.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.64 -149.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -71.47 -31.85 67.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.609 179.646 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.34 7.39 0.62 Allowed Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.413 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.614 ' HB3' ' HE2' ' A' ' 11' ' ' MET . 8.8 mp -90.17 100.08 12.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.985 0.421 . . . . 0.0 110.799 -179.626 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 17.7 t -91.43 127.88 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.928 -177.765 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.707 ' HB1' ' HB3' ' A' ' 11' ' ' MET . . . -95.16 143.85 26.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.135 178.415 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.691 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.6 OUTLIER -104.92 117.69 34.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.201 178.507 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.579 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.7 m120 -89.41 93.0 9.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.141 -178.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.769 HG23 HD11 ' A' ' 39' ' ' ILE . 10.9 t -85.9 102.63 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.67 -177.721 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.618 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.1 OUTLIER -84.76 166.1 17.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.18 178.517 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.554 HG23 ' HB2' ' A' ' 6' ' ' ALA . 3.9 m -138.89 126.53 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.055 0.455 . . . . 0.0 111.231 -179.059 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.538 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -97.72 107.49 20.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.836 179.363 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.66 171.79 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.568 179.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.04 -73.45 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.839 179.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -80.35 2.49 24.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.9 0.381 . . . . 0.0 110.795 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.45 ' HB2' HG21 ' A' ' 34' ' ' THR . . . -67.14 -151.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.97 179.339 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.56 -161.9 1.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.807 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.58 12.32 34.76 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.488 178.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.07 -7.64 60.0 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.362 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 p -74.3 -5.35 41.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 110.239 179.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -23.91 22.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.227 177.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.97 -26.37 59.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.136 -179.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 31' ' ' PRO . . . -60.91 -56.63 18.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.267 179.49 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.92 -34.63 71.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.573 178.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -51.55 68.43 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.444 178.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.459 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 7.6 p -64.17 -20.42 65.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.649 179.005 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.61 HD22 HD12 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.34 -27.11 62.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.623 -179.727 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.1 -16.23 61.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.805 179.435 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.53 29.34 0.95 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.728 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.802 HD11 ' HD2' ' A' ' 29' ' ' ARG . 1.7 tt -73.38 -162.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.524 -0.338 . . . . 0.0 111.213 -178.704 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.633 ' HG2' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -51.39 90.21 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.084 0.468 . . . . 0.0 110.745 179.257 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.32 -24.71 67.72 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.927 -178.282 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -85.69 -35.92 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.408 0.623 . . . . 0.0 109.985 179.1 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.632 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 1.4 m -96.0 90.52 5.6 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.405 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.583 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -74.8 129.85 38.42 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.692 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.794 HG23 HG23 ' A' ' 8' ' ' ILE . 1.8 mp -101.12 148.81 6.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.47 -175.319 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.565 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 2.8 tt0 -85.8 70.14 10.65 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 173.129 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.745 HG23 HG23 ' A' ' 80' ' ' ILE . 57.7 t -80.0 53.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.999 -174.411 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.92 2.29 3.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.454 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.667 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.453 -0.294 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.313 -178.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.878 0.37 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.5 -8.64 0.03 OUTLIER Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.197 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 11.1 p-10 -90.03 145.69 24.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.795 0.331 . . . . 0.0 111.423 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.4 ' HB ' HG23 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -97.16 112.58 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.591 177.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 55.2 t -111.95 122.91 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.752 0.311 . . . . 0.0 111.745 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.556 ' HB1' HG22 ' A' ' 55' ' ' VAL . . . -97.41 167.49 10.97 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.619 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 5.3 m -141.94 127.55 19.07 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.596 0.712 . . . . 0.0 112.164 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.699 HG23 HG23 ' A' ' 80' ' ' ILE . 4.3 mm -122.08 108.45 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.578 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.624 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -98.31 96.71 8.24 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.518 ' O ' HG21 ' A' ' 10' ' ' VAL . 1.4 m -91.39 135.5 26.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.841 0.353 . . . . 0.0 111.519 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.658 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.3 ptm -145.05 125.36 7.27 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 121.109 0.48 . . . . 0.0 111.648 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.635 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 14.6 Cg_exo -71.45 128.4 14.45 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.487 2.791 . . . . 0.0 112.404 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -35.51 71.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.347 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.74 154.87 78.41 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.346 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.54 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 56.1 Cg_endo -69.95 -3.24 11.74 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.554 2.17 . . . . 0.0 111.961 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -90.93 44.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.738 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.635 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 98.1 t -63.8 78.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.321 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 0.6 OUTLIER -69.91 95.13 0.9 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.12 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.666 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -62.98 -43.75 97.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.394 -178.265 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.773 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 10.1 tt0 -70.6 -35.63 73.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 0.0 110.762 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.4 ' CB ' ' HB2' ' A' ' 18' ' ' ASP . . . -68.55 -37.23 79.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.486 ' CD2' ' HG3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -65.95 -28.73 69.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.011 177.507 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.773 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -55.93 -46.88 78.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.596 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -65.1 -42.86 93.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.421 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 2.4 mt-10 -66.4 -31.54 72.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.285 0.564 . . . . 0.0 110.598 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.785 HG23 HG22 ' A' ' 53' ' ' VAL . 9.5 mt -61.88 -42.94 96.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.709 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -62.29 -39.32 92.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.939 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 9.2 pt-20 -77.41 -20.97 53.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.59 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.807 ' HD2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.14 -11.94 39.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.194 -178.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.67 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.1 mm -60.26 137.87 91.71 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.326 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.625 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 9.9 Cg_endo -52.34 114.85 1.84 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.686 2.257 . . . . 0.0 112.113 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.52 3.01 0.05 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.362 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.51 -43.94 7.63 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.88 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.61 -135.47 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.718 0.259 . . . . 0.0 111.136 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -135.01 169.47 17.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.15 -176.13 3.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.964 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.49 ' HB2' HG21 ' A' ' 56' ' ' VAL . 83.8 t60 -130.79 -77.51 0.53 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.251 0.548 . . . . 0.0 111.102 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.613 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -165.07 129.94 2.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.829 -178.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.775 HD12 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -92.66 158.23 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.715 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 2.0 t0 -123.7 131.47 53.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.632 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -91.1 71.36 6.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.354 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -103.68 146.78 33.14 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.64 -178.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.738 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.0 Cg_endo -88.91 157.45 5.95 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.123 2.549 . . . . 0.0 112.974 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.448 ' HB ' ' H ' ' A' ' 45' ' ' ALA . 4.7 mm -127.15 -83.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.458 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.457 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . . . -67.34 -150.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -71.89 -28.45 63.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.846 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.62 5.93 0.45 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.646 -0.787 . . . . 0.0 113.099 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.54 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 3.4 mt -93.03 106.29 18.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 111.108 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.738 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 60.3 t -93.7 127.55 45.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.72 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.658 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -94.6 166.63 11.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.391 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.715 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.1 mp -120.38 118.28 29.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.099 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.504 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.0 OUTLIER -89.61 92.09 8.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.333 0.587 . . . . 0.0 110.32 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.785 HG22 HG23 ' A' ' 26' ' ' ILE . 4.6 t -86.83 101.85 11.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.543 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.491 ' HG3' HG22 ' A' ' 7' ' ' THR . 2.6 mtt -84.6 165.18 18.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.34 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.556 HG22 ' HB1' ' A' ' 6' ' ' ALA . 3.0 m -139.43 135.14 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.394 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.49 HG21 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.48 116.91 39.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.022 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.4 HG23 ' HB ' ' A' ' 4' ' ' VAL . 10.6 m -130.21 148.26 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.084 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -167.22 -69.56 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.297 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -81.44 -5.68 58.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.989 0.423 . . . . 0.0 110.579 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.67 -149.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.318 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.57 -165.53 2.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.793 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.22 15.06 24.87 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.639 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.49 -3.94 49.95 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.574 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p -74.28 -3.74 31.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.91 0.386 . . . . 0.0 110.142 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.15 -23.93 23.82 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.353 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.53 -25.77 52.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.164 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.625 ' HB1' ' HB3' ' A' ' 31' ' ' PRO . . . -61.44 -55.9 26.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.351 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -58.64 -34.6 71.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.44 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.29 -51.81 67.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.347 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.443 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.7 p -63.8 -20.13 65.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.424 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.73 HD13 HG21 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.87 -28.24 62.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.551 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.54 -13.26 51.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.957 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.31 26.1 0.98 Allowed Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.742 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.807 HD11 ' HD2' ' A' ' 29' ' ' ARG . 2.6 tt -73.38 -163.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.449 -0.376 . . . . 0.0 111.127 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.538 ' N ' HG22 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -51.29 94.2 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.843 0.354 . . . . 0.0 111.009 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.13 -26.91 68.16 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.233 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 p -88.6 -38.3 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.188 0.518 . . . . 0.0 110.232 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 11' ' ' MET . 0.7 OUTLIER -96.69 89.94 5.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.324 179.399 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.516 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.2 136.87 38.59 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.803 HG23 HG22 ' A' ' 82' ' ' VAL . 2.3 mp -101.91 147.91 8.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.397 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.624 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 3.8 tt0 -86.05 70.73 10.62 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 173.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.803 HG22 HG23 ' A' ' 80' ' ' ILE . 60.6 t -80.54 51.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.009 -174.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.78 3.84 3.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.328 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.619 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 4.1 m-20 -85.48 143.28 28.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 111.247 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 p -148.26 158.12 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.408 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 86' ' ' ARG . 10.4 mtt-85 -148.84 84.92 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.471 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.37 89.04 4.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.175 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.592 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 11.1 mp -81.53 82.3 7.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.555 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 5.9 mtp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.088 -179.599 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 121.048 0.452 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.97 6.96 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.673 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.405 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 6.7 m-20 -91.6 162.74 14.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 111.421 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.514 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.3 t -107.28 128.88 61.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.222 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 86.9 t -119.5 116.67 51.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.067 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -92.35 166.93 12.33 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.776 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 9.0 m -142.2 130.7 22.5 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.535 0.684 . . . . 0.0 112.129 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.703 HG22 HG23 ' A' ' 80' ' ' ILE . 9.8 mm -121.75 106.64 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.512 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.599 ' O ' HG22 ' A' ' 80' ' ' ILE . 0.4 OUTLIER -96.83 96.13 8.34 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.841 0.353 . . . . 0.0 111.866 -177.798 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.815 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.5 m -93.65 137.3 23.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.939 -177.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.599 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -146.05 123.82 6.21 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 121.249 0.547 . . . . 0.0 111.412 178.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.652 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 11.5 Cg_exo -73.2 120.92 6.84 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.591 2.861 . . . . 0.0 111.979 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -56.44 -31.57 64.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 p -78.28 154.85 79.58 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.202 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.585 ' HA ' HD23 ' A' ' 48' ' ' LEU . 53.8 Cg_endo -69.31 -2.55 10.05 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.301 2.001 . . . . 0.0 111.695 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.43 41.15 1.04 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.237 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.727 HG21 HD22 ' A' ' 48' ' ' LEU . 91.1 t -65.93 77.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.493 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -69.49 95.04 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.495 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.656 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -63.82 -44.24 93.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.175 -178.469 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.656 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 5.1 tp10 -68.47 -40.05 81.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.613 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.742 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -70.85 -35.81 72.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.128 0.49 . . . . 0.0 110.504 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -66.13 -31.71 72.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.803 178.257 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.433 ' HA ' HD12 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -56.27 -45.21 80.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.68 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.742 ' HE2' ' HA ' ' A' ' 21' ' ' ALA . 1.9 mtmm -67.09 -43.57 82.22 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.518 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 21' ' ' ALA . 26.1 mt-10 -65.95 -27.14 67.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.634 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.703 HG21 HG21 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -61.81 -46.58 96.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.412 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.552 ' NE2' HG23 ' A' ' 26' ' ' ILE . 25.3 mm-40 -63.06 -31.89 73.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 0.0 110.969 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 5.6 mm-40 -73.25 -22.42 60.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.137 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.716 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.15 -18.6 25.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.381 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.641 HD13 HG13 ' A' ' 53' ' ' VAL . 27.6 mm -57.18 137.46 80.62 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.205 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.496 ' N ' HG22 ' A' ' 30' ' ' ILE . 8.7 Cg_endo -48.9 118.75 3.69 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.902 2.401 . . . . 0.0 112.191 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -4.61 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.137 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.66 -35.01 17.64 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.152 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.509 ' OG1' HG21 ' A' ' 64' ' ' THR . 0.2 OUTLIER -130.61 -148.66 0.37 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 111.215 -179.324 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -136.71 171.33 14.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.93 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.521 ' C ' HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -75.35 -176.17 3.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.427 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.567 ' ND1' HG21 ' A' ' 56' ' ' VAL . 71.7 t60 -130.84 -74.85 0.53 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.796 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 mmtm -161.68 129.38 4.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.051 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.741 HD12 HG21 ' A' ' 53' ' ' VAL . 2.7 mt -92.33 160.75 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.985 0.421 . . . . 0.0 111.803 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.62 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -128.42 123.2 33.16 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.511 -178.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -85.06 72.12 10.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.783 0.325 . . . . 0.0 110.502 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -99.28 134.5 21.24 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.83 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.768 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 73.3 Cg_endo -88.1 156.94 7.05 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.553 2.168 . . . . 0.0 112.757 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 mm -124.64 -82.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.323 -177.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.602 ' HB1' ' HG ' ' A' ' 48' ' ' LEU . . . -67.52 -152.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.86 -28.6 63.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.595 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.77 5.44 0.5 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.979 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.727 HD22 HG21 ' A' ' 17' ' ' VAL . 4.7 mt -91.73 101.84 14.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.911 0.386 . . . . 0.0 110.76 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.768 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 89.2 t -93.75 128.45 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.853 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 11' ' ' MET . . . -95.64 153.33 17.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.923 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.1 mp -113.34 119.86 39.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.507 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.555 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.6 m120 -90.44 91.26 8.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.187 0.518 . . . . 0.0 110.207 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.741 HG21 HD12 ' A' ' 39' ' ' ILE . 6.0 t -87.45 106.29 16.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.547 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -84.64 165.5 17.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.283 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.588 HG21 HG12 ' A' ' 57' ' ' VAL . 3.2 m -139.98 137.97 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 111.446 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.567 HG21 ' ND1' ' A' ' 37' ' ' HIS . 0.5 OUTLIER -94.68 110.77 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.853 179.052 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.588 HG12 HG21 ' A' ' 55' ' ' VAL . 13.1 m -130.13 148.01 33.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.949 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.73 -68.12 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.383 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -81.73 -3.07 52.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.934 0.397 . . . . 0.0 110.579 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.22 -146.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.119 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -147.34 -163.19 1.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.776 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.79 12.49 35.14 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.604 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.67 -6.16 58.34 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.617 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.509 HG21 ' OG1' ' A' ' 34' ' ' THR . 3.6 p -74.94 -7.26 53.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.609 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -54.89 -24.39 23.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.274 0.559 . . . . 0.0 110.226 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.32 -27.75 62.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.229 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.488 ' HB1' HH22 ' A' ' 29' ' ' ARG . . . -60.77 -55.68 30.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.384 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.69 -35.09 73.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.455 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -49.92 75.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.28 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 p -64.17 -18.97 64.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.454 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.708 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -74.04 -28.96 61.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.605 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -14.42 54.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.46 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.28 32.96 0.93 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.448 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.716 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -72.68 -163.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.215 -0.492 . . . . 0.0 111.075 -178.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.5 OUTLIER -50.91 98.65 0.02 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.913 0.387 . . . . 0.0 110.968 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.35 -33.88 66.79 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.797 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.1 t -87.12 -39.63 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.984 0.421 . . . . 0.0 110.524 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.616 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 40.5 t -96.23 92.3 6.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.796 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.578 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.63 134.2 38.24 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.815 HG12 ' HB ' ' A' ' 10' ' ' VAL . 15.6 mt -101.41 147.05 8.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.584 -175.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -85.64 71.08 10.77 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 173.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.744 HG22 HG23 ' A' ' 80' ' ' ILE . 58.2 t -81.02 52.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.241 -174.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.94 4.34 3.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.458 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.776 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 39.5 t0 -85.68 136.72 33.25 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.899 0.38 . . . . 0.0 111.405 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 p -148.42 152.97 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.964 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.501 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -149.53 97.83 2.69 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.134 0.493 . . . . 0.0 110.552 -178.488 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.64 109.73 17.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.424 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -82.21 90.26 6.59 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.551 178.159 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 30.0 mmt . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.935 179.696 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.814 0.34 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.39 0.23 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.161 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -89.04 154.93 19.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 111.423 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.872 HG13 HG23 ' A' ' 57' ' ' VAL . 1.1 t -106.39 121.7 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.045 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 42.1 t -110.83 112.86 42.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.716 0.293 . . . . 0.0 111.242 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.546 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -94.67 142.5 27.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.227 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.676 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 7.8 m -122.53 129.25 51.76 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.621 0.724 . . . . 0.0 112.032 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.756 HG22 HG23 ' A' ' 80' ' ' ILE . 1.4 mm -120.44 108.3 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.713 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.58 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -95.29 93.72 7.44 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.403 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.4 m -92.49 136.02 25.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.791 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.658 ' O ' ' HG3' ' A' ' 11' ' ' MET . 1.7 ptm -144.4 124.73 7.51 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 121.058 0.456 . . . . 0.0 111.349 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' HD2' HG13 ' A' ' 17' ' ' VAL . 12.3 Cg_exo -70.9 125.1 11.21 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.246 2.631 . . . . 0.0 112.075 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.07 -33.85 69.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.639 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.433 ' O ' HG21 ' A' ' 17' ' ' VAL . 19.8 m -78.01 153.4 80.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.583 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 42.4 Cg_endo -67.59 -3.47 10.28 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.402 2.068 . . . . 0.0 111.955 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.79 43.52 1.15 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.755 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.634 HG13 ' HD2' ' A' ' 12' ' ' PRO . 87.2 t -65.52 75.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.385 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.628 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 1.0 OUTLIER -71.48 88.11 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.948 177.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.685 ' HB2' HD13 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -63.81 -39.18 93.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.065 -178.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.533 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -68.16 -39.13 82.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.971 -178.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -72.05 -36.06 69.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.134 0.493 . . . . 0.0 110.282 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -67.37 -28.22 67.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.979 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -57.73 -43.75 85.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.325 179.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -66.53 -43.34 85.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.528 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -66.31 -28.07 68.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.169 0.509 . . . . 0.0 110.531 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.771 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.6 mt -61.86 -44.7 99.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.008 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.88 -36.88 77.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.939 0.399 . . . . 0.0 110.417 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -75.35 -24.09 57.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.747 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.771 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.95 -14.17 37.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.713 0.292 . . . . 0.0 111.291 -178.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.2 mm -59.79 139.0 90.21 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.26 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.756 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.4 Cg_endo -51.54 111.69 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.769 2.312 . . . . 0.0 112.076 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.43 2.88 0.05 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.494 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.485 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.71 -41.08 9.11 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.821 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.471 ' OG1' HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.19 -133.56 0.21 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.435 0.16 . . . . 0.0 110.794 -179.787 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -140.0 162.92 34.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.826 0.346 . . . . 0.0 110.978 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -76.47 -173.23 2.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.495 ' ND1' HG21 ' A' ' 56' ' ' VAL . 76.7 t60 -130.83 -77.62 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 111.334 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 3.0 mmtp -160.07 132.08 6.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.333 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.803 HD12 HG23 ' A' ' 53' ' ' VAL . 2.6 mt -93.57 160.01 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.608 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.643 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -128.17 125.12 38.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.647 -178.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -85.74 74.16 10.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.835 0.35 . . . . 0.0 110.438 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 0.3 OUTLIER -100.45 134.88 20.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.752 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.8 Cg_endo -84.97 156.01 11.41 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.589 2.193 . . . . 0.0 112.556 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mm -124.76 -82.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.163 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.27 -153.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.994 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -71.97 -26.59 62.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.663 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.73 3.07 0.41 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.122 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.583 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.1 mt -91.65 103.22 15.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.785 0.326 . . . . 0.0 110.786 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.752 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 93.6 t -94.1 129.06 44.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.746 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.22 162.71 13.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.906 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.685 HD13 ' HB2' ' A' ' 19' ' ' LEU . 11.0 mp -120.4 120.23 35.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.398 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.448 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.1 m120 -89.66 91.5 8.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.216 0.532 . . . . 0.0 109.792 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.803 HG23 HD12 ' A' ' 39' ' ' ILE . 14.1 t -86.32 105.84 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.434 -177.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.546 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 13.0 mtt -84.94 160.58 20.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.14 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.0 m -139.09 137.87 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.212 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.495 HG21 ' ND1' ' A' ' 37' ' ' HIS . 2.7 t -93.0 98.16 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.883 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.872 HG23 HG13 ' A' ' 4' ' ' VAL . 34.9 m -130.4 138.21 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.124 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.33 -59.66 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.49 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.14 -8.19 59.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.994 0.426 . . . . 0.0 110.503 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.56 -139.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.122 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 0.5 OUTLIER -147.11 -162.38 1.53 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.783 -179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.405 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -80.2 11.49 36.51 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.702 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.43 -12.21 69.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.474 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 p -74.31 -4.25 35.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.03 0.443 . . . . 0.0 110.278 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -24.32 22.18 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.072 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.63 -27.92 52.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.02 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.756 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.83 -57.89 10.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.372 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -58.45 -34.37 70.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.522 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.77 -52.33 64.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.058 0.456 . . . . 0.0 110.371 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.424 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -64.05 -20.75 66.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.475 178.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.808 HD23 HD12 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.99 -28.05 62.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.675 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.59 -16.6 61.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.767 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.53 31.0 0.94 Allowed Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.834 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.808 HD12 HD23 ' A' ' 71' ' ' LEU . 2.9 tt -73.21 -161.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.511 -0.344 . . . . 0.0 111.11 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.711 ' HG2' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -51.82 90.69 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.121 0.486 . . . . 0.0 110.714 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.53 -24.93 62.43 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.107 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.647 HG13 ' N ' ' A' ' 78' ' ' SER . 2.8 p -86.95 -34.67 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.352 0.596 . . . . 0.0 110.307 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.647 ' N ' HG13 ' A' ' 77' ' ' VAL . 29.0 t -96.71 92.3 6.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.697 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.566 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -76.23 132.2 39.76 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.146 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.771 HG23 HG22 ' A' ' 82' ' ' VAL . 2.1 mt -101.03 148.16 7.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.493 -175.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.58 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 2.4 tp10 -85.86 71.11 10.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 172.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.771 HG22 HG23 ' A' ' 80' ' ' ILE . 68.4 t -79.95 55.89 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.947 -174.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -133.05 1.87 3.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.81 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.676 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.0 m-20 -85.06 138.82 32.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.256 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.2 p -148.96 155.92 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.192 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.505 ' HB3' HD23 ' A' ' 88' ' ' LEU . 6.5 mtt85 -148.93 85.37 1.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.018 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -79.28 88.7 4.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.215 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.505 HD23 ' HB3' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -82.21 91.89 6.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.585 179.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 6.4 mtm . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.976 179.885 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.961 0.41 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.59 -14.08 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.849 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -92.35 147.8 22.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 111.556 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.51 ' HB ' HG22 ' A' ' 57' ' ' VAL . 1.5 t -100.07 113.17 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.869 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.69 ' HB ' ' HB2' ' A' ' 86' ' ' ARG . 53.5 t -105.1 112.02 36.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.51 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.605 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -95.84 142.6 27.91 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.764 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.3 m -122.75 129.4 51.71 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.72 0.771 . . . . 0.0 112.563 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.811 ' HB ' HH22 ' A' ' 29' ' ' ARG . 3.2 mm -121.12 108.71 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.731 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.568 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -97.96 96.22 8.02 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -177.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 10' ' ' VAL . 1.3 m -93.21 136.67 24.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.513 ' O ' ' HA ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -146.26 124.97 6.43 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.296 178.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.643 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.2 Cg_exo -71.38 120.35 6.9 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.137 2.558 . . . . 0.0 111.694 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.74 -31.34 64.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.285 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.477 ' O ' HG21 ' A' ' 17' ' ' VAL . 23.5 p -77.88 154.21 80.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.985 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.552 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 54.5 Cg_endo -69.01 -1.14 7.31 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.223 1.949 . . . . 0.0 111.493 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.18 41.98 1.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.116 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.643 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 84.8 t -65.8 79.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.368 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.581 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 67.3 m-20 -68.11 101.12 1.09 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.16 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.758 HD13 HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -61.41 -53.2 59.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.773 -178.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.647 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 13.6 pt-20 -71.06 -34.47 71.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.214 -176.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.512 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -68.17 -36.45 79.64 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.581 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -65.17 -34.0 77.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.389 176.645 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.647 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -57.14 -47.38 81.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.407 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.512 ' HE2' ' HA ' ' A' ' 21' ' ' ALA . 2.5 mtmt -64.47 -42.91 95.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.61 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.601 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 2.1 mt-10 -66.55 -32.91 74.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.204 0.526 . . . . 0.0 110.811 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.718 HG22 HD12 ' A' ' 39' ' ' ILE . 3.0 mt -61.78 -43.04 96.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.008 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -62.53 -40.41 96.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.683 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.601 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 9.0 pt-20 -78.49 -19.22 53.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.832 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.811 HH22 ' HB ' ' A' ' 8' ' ' ILE . 26.8 ptt85 -89.9 -11.44 41.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.255 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.654 HD13 HG12 ' A' ' 53' ' ' VAL . 20.9 mm -59.91 138.85 90.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.525 ' N ' HG22 ' A' ' 30' ' ' ILE . 8.5 Cg_endo -49.13 117.07 2.57 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.872 2.381 . . . . 0.0 112.256 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -59.71 2.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.433 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.03 -46.18 6.33 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.122 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.534 HG21 ' HB2' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -130.07 -134.74 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.624 0.25 . . . . 0.0 110.998 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -137.1 166.41 23.77 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.812 0.339 . . . . 0.0 110.73 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -76.4 -171.91 1.95 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.241 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.492 ' ND1' HG21 ' A' ' 56' ' ' VAL . 85.7 t60 -130.55 -77.69 0.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.376 0.608 . . . . 0.0 111.101 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.475 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 2.0 tptp -164.47 129.83 2.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.668 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.831 HD12 HG21 ' A' ' 53' ' ' VAL . 2.6 mt -91.78 160.88 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -176.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.607 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -126.4 120.71 30.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.383 -179.271 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -84.32 72.59 10.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.917 0.389 . . . . 0.0 110.465 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.479 ' C ' HG11 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -99.13 135.35 20.83 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.951 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.773 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 62.2 Cg_endo -86.47 157.22 9.33 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.596 2.197 . . . . 0.0 112.515 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.449 HD13 ' HB2' ' A' ' 50' ' ' ALA . 2.5 mm -126.63 -83.19 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.532 -177.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.573 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . . . -67.62 -149.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.188 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -70.5 -32.12 69.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.361 . . . . 0.0 110.549 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.69 7.63 0.59 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.658 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.576 ' HA ' HG23 ' A' ' 17' ' ' VAL . 4.9 mt -91.25 101.71 14.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.81 0.338 . . . . 0.0 110.793 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 73.9 t -92.53 129.54 42.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.739 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.489 ' C ' HD11 ' A' ' 51' ' ' LEU . . . -96.03 160.28 14.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.675 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.758 HD12 HD13 ' A' ' 19' ' ' LEU . 11.1 mp -120.45 119.54 33.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.5 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.533 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.4 m120 -89.73 90.74 8.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.268 0.556 . . . . 0.0 110.024 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.831 HG21 HD12 ' A' ' 39' ' ' ILE . 10.0 t -87.89 104.74 14.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.478 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.56 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 2.0 mtt -85.39 163.82 18.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.35 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.605 HG22 ' HB2' ' A' ' 6' ' ' ALA . 3.4 m -140.24 136.04 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.984 0.421 . . . . 0.0 111.394 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.492 HG21 ' ND1' ' A' ' 37' ' ' HIS . 1.9 t -95.35 112.08 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.017 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.51 HG22 ' HB ' ' A' ' 4' ' ' VAL . 21.4 m -130.17 139.11 52.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.897 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.78 -61.06 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.551 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -81.4 -14.43 57.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.014 0.435 . . . . 0.0 110.718 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.534 ' HB2' HG21 ' A' ' 34' ' ' THR . . . -67.56 -139.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.092 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.9 -168.82 3.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.525 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.84 13.55 30.05 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.553 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.44 -1.73 38.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.663 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -74.29 -3.92 33.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.857 0.36 . . . . 0.0 110.374 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -55.18 -23.68 23.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.233 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.2 -24.59 42.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.155 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.42 ' HB1' ' HB3' ' A' ' 31' ' ' PRO . . . -61.39 -56.13 23.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.263 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.3 -34.75 70.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.342 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.53 -52.33 64.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.442 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.43 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.5 p -64.21 -19.11 65.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.629 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.808 HD12 HG22 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.52 -29.91 62.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.749 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.81 -12.06 43.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.9 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.21 26.02 0.99 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.862 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.808 HG22 HD12 ' A' ' 71' ' ' LEU . 2.7 tt -73.1 -163.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.774 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.637 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 0.0 OUTLIER -51.68 96.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.036 0.446 . . . . 0.0 110.665 179.351 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.97 -30.77 76.33 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.367 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 t -85.49 -33.32 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.885 0.374 . . . . 0.0 110.505 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.637 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 11.6 t -95.42 91.23 6.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.717 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.553 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -75.43 132.78 41.08 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.773 HG21 HG22 ' A' ' 82' ' ' VAL . 3.2 mp -101.09 148.85 6.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.607 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.568 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 38.7 tt0 -85.85 69.49 10.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 173.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.773 HG22 HG21 ' A' ' 80' ' ' ILE . 61.8 t -79.97 54.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.732 -175.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.89 0.57 3.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.567 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.764 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 10.2 t0 -85.66 136.72 33.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.859 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.522 ' C ' ' HG2' ' A' ' 86' ' ' ARG . 4.4 p -148.38 158.0 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.333 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.69 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -145.53 81.35 1.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.224 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.51 76.96 6.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.373 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -82.66 91.91 7.07 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 121.056 -0.257 . . . . 0.0 110.527 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.947 0.403 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.56 -6.63 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.205 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.696 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.72 149.63 21.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.552 -0.324 . . . . 0.0 111.396 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.589 ' HB ' HG23 ' A' ' 57' ' ' VAL . 1.5 t -97.91 115.53 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.703 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.471 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 55.5 t -109.96 119.97 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.699 0.285 . . . . 0.0 111.555 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.483 ' HB2' HG22 ' A' ' 55' ' ' VAL . . . -98.72 166.65 11.22 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.694 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 14.7 m -143.23 137.49 28.98 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.644 0.735 . . . . 0.0 112.43 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.763 HG22 HG22 ' A' ' 80' ' ' ILE . 4.2 mm -127.11 106.35 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.274 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.625 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -96.58 96.19 8.49 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -176.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.551 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.5 m -93.37 134.13 32.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.909 0.385 . . . . 0.0 111.822 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.581 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.3 OUTLIER -146.3 124.91 6.4 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 121.094 0.473 . . . . 0.0 111.24 179.04 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.643 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.5 Cg_exo -72.51 122.67 8.47 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.467 2.778 . . . . 0.0 112.026 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -56.76 -32.13 65.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.235 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.91 153.58 80.37 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.037 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.651 ' HA ' HD22 ' A' ' 48' ' ' LEU . 53.6 Cg_endo -69.46 -2.86 10.69 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.403 2.068 . . . . 0.0 112.305 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.61 45.74 1.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.996 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.643 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 92.7 t -64.96 76.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.708 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.556 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -71.12 89.71 0.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.692 ' H ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -63.53 -37.17 86.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.541 -178.17 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.756 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -70.61 -35.58 73.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.992 0.425 . . . . 0.0 110.077 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.556 ' HB1' ' HB2' ' A' ' 18' ' ' ASP . . . -69.05 -37.52 78.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.485 ' CD2' ' HG3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -65.92 -30.07 70.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.014 177.359 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.756 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -55.22 -46.71 75.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.663 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -65.84 -43.59 88.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.537 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.707 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 1.3 mm-40 -66.05 -29.32 69.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.266 0.555 . . . . 0.0 110.56 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.702 HG12 HG21 ' A' ' 53' ' ' VAL . 3.8 mt -60.94 -46.4 96.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.932 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -62.37 -38.74 90.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.208 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.707 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -78.33 -20.55 51.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.546 -178.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.778 ' HD2' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -89.05 -10.58 46.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.141 -179.222 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.642 HG12 ' O ' ' A' ' 26' ' ' ILE . 33.3 mm -60.89 138.12 93.74 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.265 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.686 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 9.3 Cg_endo -51.59 114.54 1.62 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.668 2.246 . . . . 0.0 112.126 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.17 -2.58 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.225 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.27 -39.25 10.08 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.875 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.737 ' HG1' HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.51 -145.21 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.634 0.254 . . . . 0.0 110.977 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -133.25 164.82 26.23 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.892 0.377 . . . . 0.0 110.795 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.417 ' O ' HG22 ' A' ' 56' ' ' VAL . 1.1 pt? -76.31 -175.09 3.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.389 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.621 ' ND1' HG23 ' A' ' 56' ' ' VAL . 85.3 t60 -130.7 -76.95 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.308 0.575 . . . . 0.0 111.345 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.441 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 1.1 tptt -163.54 132.66 3.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.959 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.667 HD13 HG23 ' A' ' 26' ' ' ILE . 2.6 mt -92.65 159.35 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.108 0.48 . . . . 0.0 112.172 -176.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.645 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -126.73 117.2 22.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.545 -178.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -82.7 69.9 9.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.941 0.4 . . . . 0.0 110.376 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.457 ' O ' HG11 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -97.23 138.21 21.21 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.887 -179.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.773 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 71.1 Cg_endo -85.43 156.27 10.76 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.535 2.156 . . . . 0.0 112.632 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.403 ' HB ' ' H ' ' A' ' 45' ' ' ALA . 3.1 mm -125.76 -83.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.505 -177.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.52 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.42 -147.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.218 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -70.98 -33.87 70.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.403 . . . . 0.0 110.752 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.48 8.4 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.738 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.651 HD22 ' HA ' ' A' ' 15' ' ' PRO . 4.3 mt -91.04 102.31 15.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.902 0.382 . . . . 0.0 110.791 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 70.7 t -92.78 127.5 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.882 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.51 ' HB1' ' HB3' ' A' ' 11' ' ' MET . . . -95.56 150.49 20.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.045 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.658 HD22 ' HB2' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -112.2 116.23 30.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.158 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 4.6 m-20 -89.76 94.11 9.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.654 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.702 HG21 HG12 ' A' ' 26' ' ' ILE . 3.7 t -86.45 104.19 13.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.277 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.418 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 3.8 mtt -84.52 167.52 16.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.207 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 6' ' ' ALA . 3.1 m -139.93 138.05 38.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.56 -178.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.621 HG23 ' ND1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -95.35 111.09 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.736 178.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.737 HG13 ' HG1' ' A' ' 34' ' ' THR . 12.8 m -130.05 148.07 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.001 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.29 -72.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.451 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -81.39 -0.3 40.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.917 0.389 . . . . 0.0 110.553 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.21 -152.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.234 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 1.3 pt-20 -147.55 -162.69 1.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.729 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -80.94 14.49 26.09 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.565 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.35 -7.22 60.0 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.498 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.415 HG22 ' OG1' ' A' ' 34' ' ' THR . 1.4 p -74.12 -4.63 36.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.978 0.418 . . . . 0.0 110.261 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -54.83 -23.87 20.37 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.289 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.89 -29.21 62.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.031 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.686 ' HB1' ' HB3' ' A' ' 31' ' ' PRO . . . -62.09 -55.15 31.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.812 0.339 . . . . 0.0 110.212 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -58.99 -34.31 71.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.213 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.18 -51.24 68.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.127 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.8 p -63.78 -17.27 62.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.221 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.704 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.58 -29.85 62.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.368 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.07 -12.09 35.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.658 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.24 28.87 0.98 Allowed Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.463 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.778 HD12 ' HD2' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -72.59 -164.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.338 -0.431 . . . . 0.0 111.062 -178.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.634 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.5 OUTLIER -51.15 99.7 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.938 0.399 . . . . 0.0 110.81 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.93 -33.44 73.84 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.924 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.7 t -87.16 -38.61 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.984 0.421 . . . . 0.0 110.594 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.634 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 40.8 t -96.13 92.31 6.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.875 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.549 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -78.2 135.38 37.6 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.442 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.779 HG22 HG22 ' A' ' 82' ' ' VAL . 2.9 mt -101.57 148.63 7.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.514 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.625 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 15.8 tp10 -86.02 69.43 10.52 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 173.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.779 HG22 HG22 ' A' ' 80' ' ' ILE . 55.1 t -80.93 51.62 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.024 -174.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -133.03 9.25 4.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.919 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.694 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.1 m-20 -83.2 146.66 28.48 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.297 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.6 t -148.9 144.18 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.866 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.517 ' HB3' HD23 ' A' ' 88' ' ' LEU . 9.7 mtt180 -146.4 79.52 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.622 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.432 ' HD3' HG11 ' A' ' 4' ' ' VAL . 0.1 OUTLIER -78.68 84.91 4.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.026 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -81.45 91.99 6.39 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.461 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.971 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.433 ' SD ' ' HB3' ' A' ' 88' ' ' LEU . 2.7 mtm . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.989 0.423 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 89' ' ' MET . . . 173.82 -0.68 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.581 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.408 ' H ' ' H ' ' A' ' 2' ' ' GLY . 2.4 p-10 -92.68 164.65 13.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.581 -0.31 . . . . 0.0 111.154 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.57 136.87 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.181 178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.515 HG22 HD13 ' A' ' 88' ' ' LEU . 4.7 t -132.75 127.04 55.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.758 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -94.13 168.92 10.63 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.77 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 6.2 m -142.81 129.76 20.64 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.466 0.65 . . . . 0.0 112.164 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.738 ' HB ' HH22 ' A' ' 29' ' ' ARG . 5.7 mm -121.21 108.03 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.677 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.562 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.54 96.18 8.13 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -177.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.823 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.9 m -94.8 137.37 23.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.707 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.6 OUTLIER -147.67 121.65 4.94 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 121.205 0.526 . . . . 0.0 111.999 179.179 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.579 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 17.0 Cg_exo -71.34 121.15 7.51 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.417 2.745 . . . . 0.0 111.973 178.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.66 -30.56 63.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.317 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -78.0 153.93 80.18 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.965 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.624 ' HA ' HD23 ' A' ' 48' ' ' LEU . 7.3 Cg_exo -70.39 -6.13 18.21 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.536 2.157 . . . . 0.0 111.719 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -91.17 33.62 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.284 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.694 HG12 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.29 85.68 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.738 0.78 . . . . 0.0 109.98 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.538 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 24.9 m-20 -69.96 106.13 3.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.352 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.866 ' HG ' HD21 ' A' ' 51' ' ' LEU . 1.5 tt -62.12 -48.91 78.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.17 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -68.48 -37.95 80.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.94 -34.57 71.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.0 0.429 . . . . 0.0 110.591 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.652 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -65.28 -32.25 73.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.655 178.164 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -45.21 86.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.554 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -42.21 88.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.593 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.583 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 10.3 mt-10 -66.49 -30.23 70.52 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.321 0.581 . . . . 0.0 110.477 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.685 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 3.4 mt -62.06 -43.57 97.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.766 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -60.89 -38.48 85.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.109 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 10.2 pt-20 -77.49 -21.69 52.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.306 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.738 HH22 ' HB ' ' A' ' 8' ' ' ILE . 21.1 ptt85 -91.1 -9.92 43.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.253 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.673 HG12 ' O ' ' A' ' 26' ' ' ILE . 31.5 mm -59.24 137.78 88.48 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.136 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.668 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.8 Cg_endo -51.54 115.02 1.83 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.743 2.296 . . . . 0.0 112.151 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.07 0.55 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.357 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.99 -53.55 3.46 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.858 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.672 ' HG1' HG22 ' A' ' 64' ' ' THR . 0.2 OUTLIER -117.02 -137.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.664 0.232 . . . . 0.0 111.116 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.401 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 3.8 pt-20 -137.48 169.14 18.3 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.915 0.388 . . . . 0.0 110.992 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.17 177.86 6.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.977 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.433 ' HB2' HG22 ' A' ' 56' ' ' VAL . 71.0 t60 -131.21 -76.28 0.52 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.047 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -161.37 131.78 5.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.402 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.656 HG12 HG13 ' A' ' 53' ' ' VAL . 2.8 mt -93.57 159.23 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.905 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.642 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -129.59 119.31 23.41 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.474 -178.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -82.75 75.52 9.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.91 0.386 . . . . 0.0 110.731 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.478 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -98.56 134.5 21.7 Favored Pre-proline 0 C--O 1.225 -0.205 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.757 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 57.3 Cg_endo -86.53 156.87 9.23 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.499 2.133 . . . . 0.0 112.815 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.463 HG13 ' SD ' ' A' ' 11' ' ' MET . 2.5 mm -124.92 -83.52 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.24 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.741 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.85 -152.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.118 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -71.94 -28.38 63.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.726 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.61 4.31 0.47 Allowed Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.046 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.741 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.5 mt -91.67 101.94 14.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.825 0.345 . . . . 0.0 110.764 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.757 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 87.6 t -94.39 129.61 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.975 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.581 ' HB3' ' HB3' ' A' ' 11' ' ' MET . . . -95.43 157.11 16.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.457 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.866 HD21 ' HG ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -120.23 121.17 38.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.634 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.49 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.2 m120 -89.89 92.79 9.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.257 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.656 HG13 HG12 ' A' ' 39' ' ' ILE . 10.3 t -86.03 104.73 13.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.212 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.44 ' HG3' HG21 ' A' ' 7' ' ' THR . 1.8 mtt -84.58 164.52 18.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.234 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.0 m -139.27 139.52 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.164 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -92.18 112.15 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.794 0.33 . . . . 0.0 110.887 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.471 HG13 ' OG1' ' A' ' 34' ' ' THR . 28.3 m -128.34 140.52 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.999 0.428 . . . . 0.0 111.176 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.43 -69.8 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.235 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.75 -4.96 58.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.409 . . . . 0.0 110.509 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.06 -152.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.302 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.65 -162.96 1.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.803 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.09 14.24 28.23 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.557 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.27 -5.9 51.13 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.247 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.672 HG22 ' HG1' ' A' ' 34' ' ' THR . 1.5 p -74.6 -3.18 29.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.102 0.477 . . . . 0.0 109.97 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.24 -23.71 23.93 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.161 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.33 -28.28 58.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.74 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.668 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.44 -56.78 16.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.156 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -58.49 -34.48 70.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.387 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.68 -52.2 65.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.305 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.408 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 3.1 p -64.08 -17.83 63.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.302 178.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.85 HD22 HD13 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.64 -28.56 62.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.356 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -12.96 49.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.18 26.02 0.99 Allowed Glycine 0 N--CA 1.453 -0.207 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.805 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.85 HD13 HD22 ' A' ' 71' ' ' LEU . 1.1 tt -73.47 -162.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.535 -0.332 . . . . 0.0 110.865 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.453 ' N ' HG23 ' A' ' 74' ' ' ILE . 1.4 mp0 -50.41 93.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.831 0.348 . . . . 0.0 110.932 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.57 -26.35 56.93 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.952 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.43 -39.81 12.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.113 0.482 . . . . 0.0 110.493 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.579 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -96.47 91.0 5.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.698 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.567 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -78.2 136.53 37.83 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.823 HG12 ' HB ' ' A' ' 10' ' ' VAL . 14.9 mt -101.48 145.87 10.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.604 -176.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.456 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -85.85 71.47 10.65 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.76 HG22 HG21 ' A' ' 80' ' ' ILE . 64.3 t -80.09 50.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.207 -173.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -132.99 6.39 3.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.18 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.77 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 31.4 t0 -85.32 144.65 27.94 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.037 0.446 . . . . 0.0 110.999 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.444 HG23 ' H ' ' A' ' 86' ' ' ARG . 2.9 p -147.29 164.91 6.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.01 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.453 ' O ' HD22 ' A' ' 88' ' ' LEU . 4.4 mtt180 -149.92 95.58 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.289 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 87' ' ' ARG . 3.7 mmt85 -81.69 88.5 6.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.942 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.515 HD13 HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -81.91 92.92 6.81 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.786 179.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.455 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.003 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ptp . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.935 0.397 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.72 -2.65 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.125 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.621 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 4.7 m-20 -91.63 130.47 37.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.743 0.306 . . . . 0.0 111.522 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.15 101.81 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.321 177.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 43.4 t -104.85 122.98 58.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.887 0.375 . . . . 0.0 111.806 -178.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -97.96 163.2 12.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.735 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.734 ' HG1' ' HG2' ' A' ' 54' ' ' MET . 5.6 m -139.7 123.12 17.15 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.642 0.734 . . . . 0.0 111.625 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.737 ' HB ' HH22 ' A' ' 29' ' ' ARG . 17.6 mt -122.13 107.62 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.734 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.658 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -96.89 95.99 8.23 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -176.643 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 10' ' ' VAL . 0.9 OUTLIER -91.43 136.3 24.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.875 0.369 . . . . 0.0 111.738 -177.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.681 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 2.2 ptm -144.14 124.97 7.79 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 121.036 0.446 . . . . 0.0 111.485 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.611 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 14.2 Cg_exo -69.7 124.54 11.21 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.173 2.582 . . . . 0.0 112.099 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -57.9 -32.6 67.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.457 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.552 ' HG ' ' HB2' ' A' ' 16' ' ' ASP . 3.6 p -77.34 152.94 81.76 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.119 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.562 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 46.8 Cg_endo -68.19 -3.11 10.13 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.216 1.944 . . . . 0.0 111.572 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.552 ' HB2' ' HG ' ' A' ' 14' ' ' SER . 2.1 m-20 -90.74 43.63 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.835 178.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.703 HG23 HD21 ' A' ' 48' ' ' LEU . 90.0 t -65.8 75.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.65 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.535 ' HB2' ' HB1' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -71.74 92.94 1.23 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.027 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.698 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -63.24 -42.06 99.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.596 -178.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.868 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 10.8 tt0 -69.96 -36.5 75.3 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.955 0.407 . . . . 0.0 110.292 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.535 ' HB1' ' HB2' ' A' ' 18' ' ' ASP . . . -69.21 -37.75 78.23 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.483 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -67.11 -27.01 66.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.004 177.483 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.868 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -56.2 -46.8 79.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.371 179.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.41 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 2.0 mtmt -66.86 -39.86 87.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.766 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -65.5 -33.8 76.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.213 0.53 . . . . 0.0 110.095 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.639 ' O ' HG12 ' A' ' 30' ' ' ILE . 1.8 mt -62.75 -39.01 83.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.935 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -42.35 91.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.639 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 13.3 mt-10 -76.01 -20.92 57.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.814 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.737 HH22 ' HB ' ' A' ' 8' ' ' ILE . 20.8 ptt85 -88.76 -15.63 34.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.484 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.683 HD12 HG13 ' A' ' 53' ' ' VAL . 22.4 mm -59.4 137.48 89.0 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.917 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.489 ' N ' HG23 ' A' ' 30' ' ' ILE . 8.0 Cg_endo -50.18 124.85 13.63 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.824 2.349 . . . . 0.0 112.521 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -60.79 -3.68 0.8 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.893 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.24 -61.7 1.88 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.991 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.24 -145.56 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.835 0.35 . . . . 0.0 111.296 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -132.05 172.01 12.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.614 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.605 ' HB3' HD11 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -74.97 -173.67 1.99 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.007 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.582 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.5 t60 -130.58 -74.81 0.54 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.426 0.631 . . . . 0.0 110.782 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -165.03 125.9 1.99 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.796 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.87 HD11 HG22 ' A' ' 53' ' ' VAL . 2.7 mt -92.4 154.35 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.848 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.707 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.8 t0 -121.25 129.2 53.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.488 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -89.69 69.76 7.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.86 0.362 . . . . 0.0 110.202 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.447 ' O ' ' N ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -100.15 148.26 34.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.595 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.729 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.0 Cg_endo -91.07 156.19 3.88 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.026 2.484 . . . . 0.0 113.209 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.406 ' HB ' ' H ' ' A' ' 45' ' ' ALA . 4.6 mm -125.89 -82.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.063 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.406 ' H ' ' HB ' ' A' ' 44' ' ' ILE . . . -67.41 -151.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -72.07 -28.55 63.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.755 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.54 4.79 0.5 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.942 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.703 HD21 HG23 ' A' ' 17' ' ' VAL . 5.2 mt -91.43 103.44 16.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 110.968 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.729 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 36.7 t -92.3 128.58 43.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.694 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.681 ' HB1' ' HB3' ' A' ' 11' ' ' MET . . . -95.0 165.68 12.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.094 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.707 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.0 mp -120.26 119.93 34.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.234 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.51 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -89.52 90.96 8.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.225 0.536 . . . . 0.0 109.915 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.87 HG22 HD11 ' A' ' 39' ' ' ILE . 10.0 t -86.91 98.86 7.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.705 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.734 ' HG2' ' HG1' ' A' ' 7' ' ' THR . 35.7 mtt -84.54 162.56 19.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.096 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.7 m -138.92 134.71 42.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.536 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.582 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.66 113.55 31.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.127 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 57' ' ' VAL . 4.4 m -129.63 143.63 40.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.934 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.57 -65.98 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.454 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -80.96 -8.21 59.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.996 0.427 . . . . 0.0 110.648 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.84 -146.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.21 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.62 -164.18 1.94 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.749 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.89 13.6 30.08 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.545 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.08 -5.62 53.89 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.54 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.58 -5.22 41.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.957 0.408 . . . . 0.0 110.338 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -54.9 -23.15 17.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.148 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.89 -29.08 62.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.968 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.488 ' HB1' ' HB3' ' A' ' 31' ' ' PRO . . . -61.65 -52.65 63.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.403 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.66 -37.27 75.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.309 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -50.21 74.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.312 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.419 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.1 p -64.0 -21.04 66.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.685 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.75 HD13 HG23 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.54 -29.36 62.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.827 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -13.74 53.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.888 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.36 28.57 0.97 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.871 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.75 HG23 HD13 ' A' ' 71' ' ' LEU . 3.6 tt -73.28 -163.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.61 -0.295 . . . . 0.0 111.067 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.764 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 1.2 pm0 -51.55 91.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.975 0.416 . . . . 0.0 110.877 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.83 -25.58 67.83 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.756 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.27 -34.67 8.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.289 0.566 . . . . 0.0 110.132 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.764 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -95.83 90.36 5.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.569 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.408 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -74.5 131.09 40.72 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.807 HG22 HG23 ' A' ' 82' ' ' VAL . 3.0 mp -100.83 149.21 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.524 -175.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.658 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 31.5 tp10 -85.79 70.33 10.67 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.807 HG23 HG22 ' A' ' 80' ' ' ILE . 52.8 t -81.06 54.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.857 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 m -132.65 1.97 3.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.689 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.695 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.2 m-20 -84.62 141.63 30.52 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.753 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -147.58 149.98 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.002 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 5.5 mtt180 -145.46 73.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.502 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.28 87.0 3.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.09 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.621 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 11.0 mp -82.16 82.35 7.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.626 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.9 ptp . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.979 -179.8 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.812 0.339 . . . . 0.0 111.41 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.66 -6.15 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.733 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.44 159.67 15.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.006 0.431 . . . . 0.0 111.279 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.899 HG13 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -99.16 116.54 42.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.136 177.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.486 HG22 HD11 ' A' ' 88' ' ' LEU . 3.9 t -105.31 120.41 55.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.072 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.561 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -94.09 157.22 16.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.745 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 4.5 m -138.24 125.52 21.7 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.702 0.763 . . . . 0.0 111.979 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.723 HG21 HG21 ' A' ' 80' ' ' ILE . 6.7 mm -120.55 108.31 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.943 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.546 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.31 95.57 8.17 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.014 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.664 ' HB ' HG12 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -92.66 135.95 26.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.787 -178.101 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.637 ' O ' ' HG3' ' A' ' 11' ' ' MET . 1.0 OUTLIER -145.75 127.0 7.5 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 120.964 0.411 . . . . 0.0 111.361 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.641 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 8.7 Cg_exo -73.4 120.19 6.38 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.252 2.635 . . . . 0.0 112.127 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -56.76 -32.19 65.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.303 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 p -78.45 154.01 79.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.012 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.554 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 56.1 Cg_endo -68.9 -2.09 8.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.213 1.942 . . . . 0.0 111.508 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.88 42.52 1.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.121 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.641 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 96.2 t -64.88 77.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.125 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.714 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.1 m-20 -68.35 98.6 0.85 Allowed 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.708 HD12 HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -61.49 -51.35 69.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.659 -178.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -68.06 -37.95 81.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.619 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.637 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . . . -70.52 -38.32 74.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.063 0.459 . . . . 0.0 110.6 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.854 HD23 HD11 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -66.8 -30.14 70.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.189 178.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -44.6 93.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.43 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.637 ' HE3' ' HA ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -65.94 -41.94 90.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.587 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -64.76 -32.42 74.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.074 0.464 . . . . 0.0 110.635 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.854 HD11 HD23 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -62.14 -44.89 99.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.473 -179.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.629 ' NE2' HD21 ' A' ' 36' ' ' LEU . 7.2 mm100 -63.35 -33.41 75.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.82 0.343 . . . . 0.0 110.737 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 27.6 mt-10 -74.44 -23.2 58.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.088 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.727 ' HB2' HD13 ' A' ' 74' ' ' ILE . 28.7 ptt85 -89.26 -15.79 32.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.552 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 26' ' ' ILE . 24.2 mm -57.97 136.74 83.84 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.456 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.527 ' HD2' HG22 ' A' ' 30' ' ' ILE . 18.4 Cg_endo -56.81 116.73 3.41 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.274 1.983 . . . . 0.0 112.073 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.81 0.64 0.08 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.405 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.472 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.46 -37.03 15.23 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.575 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -130.28 -144.06 0.26 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.647 0.26 . . . . 0.0 110.871 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -136.74 167.8 20.74 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.881 0.372 . . . . 0.0 111.031 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.629 HD21 ' NE2' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -75.26 -177.23 3.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.007 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.43 ' HB2' HG22 ' A' ' 56' ' ' VAL . 73.0 t60 -131.49 -75.64 0.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.205 0.526 . . . . 0.0 111.047 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 11.9 mmtt -161.25 129.37 4.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.222 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.762 HD13 HG21 ' A' ' 53' ' ' VAL . 3.2 mt -94.42 158.51 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.073 0.463 . . . . 0.0 111.989 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.692 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -126.49 118.69 25.44 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.98 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -85.7 71.24 10.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.905 0.383 . . . . 0.0 110.261 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.525 ' O ' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -100.73 149.54 36.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.628 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.751 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 29.6 Cg_endo -91.92 158.88 3.35 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.074 2.516 . . . . 0.0 113.331 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.502 HD13 ' HB2' ' A' ' 50' ' ' ALA . 3.3 mm -128.89 -83.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.348 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.535 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . . . -67.79 -148.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.184 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -71.17 -32.61 69.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.81 0.338 . . . . 0.0 110.808 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.67 8.85 0.64 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.493 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.612 HD21 HG23 ' A' ' 17' ' ' VAL . 5.3 mt -91.39 103.1 15.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.82 0.343 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.751 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 38.1 t -92.7 127.53 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.898 -178.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.599 ' HB3' ' HB3' ' A' ' 11' ' ' MET . . . -95.13 159.03 15.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.69 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.708 HD12 HD12 ' A' ' 19' ' ' LEU . 0.4 OUTLIER -118.82 119.56 34.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.494 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.483 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.2 m120 -89.49 90.26 8.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.709 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.762 HG21 HD13 ' A' ' 39' ' ' ILE . 14.6 t -86.52 104.23 13.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.529 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.561 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 2.8 mtt -84.57 160.64 20.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.16 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.629 HG22 HG12 ' A' ' 57' ' ' VAL . 2.8 m -139.53 140.93 36.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.178 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.43 HG22 ' HB2' ' A' ' 37' ' ' HIS . 0.4 OUTLIER -92.11 101.8 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.836 179.342 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.899 HG23 HG13 ' A' ' 4' ' ' VAL . 31.8 m -130.72 137.2 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.499 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.62 -59.37 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.423 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -81.7 -7.78 59.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.038 0.447 . . . . 0.0 110.444 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.5 -140.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.178 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.17 -162.35 1.52 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.814 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.23 11.71 35.62 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.741 179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.43 ' C ' ' HA3' ' A' ' 33' ' ' GLY . . . -70.02 -11.4 66.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.615 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.435 ' HA ' ' HB2' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -73.68 -2.41 23.06 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.966 0.412 . . . . 0.0 110.103 179.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -54.5 -23.8 17.83 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.926 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.07 -31.38 63.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.891 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.467 ' HB3' ' CG ' ' A' ' 31' ' ' PRO . . . -59.72 -56.32 23.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.449 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.45 -35.98 75.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.547 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -48.97 79.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.347 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.66 -22.88 67.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.566 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.57 HD11 HG23 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -72.9 -27.42 61.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.681 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -18.25 64.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.519 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.47 35.88 0.87 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.688 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.727 HD13 ' HB2' ' A' ' 29' ' ' ARG . 0.6 OUTLIER -72.88 -164.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.493 -0.354 . . . . 0.0 111.047 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.629 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.7 OUTLIER -50.95 101.52 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.964 0.411 . . . . 0.0 111.154 -179.094 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.09 -33.33 79.07 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.51 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.4 t -86.98 -39.15 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 0.0 110.501 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.629 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 22.0 t -95.5 90.93 5.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.609 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.559 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -76.9 136.79 38.84 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.098 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.771 HG21 HG23 ' A' ' 82' ' ' VAL . 17.7 mt -101.45 146.91 8.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.743 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.405 ' N ' HG23 ' A' ' 80' ' ' ILE . 2.2 tp10 -85.84 71.72 10.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.771 HG23 HG21 ' A' ' 80' ' ' ILE . 73.6 t -79.96 54.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.08 -174.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -133.08 2.73 3.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.418 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.745 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 20.6 t0 -85.3 140.11 31.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.8 0.333 . . . . 0.0 110.961 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.69 HG23 ' HD2' ' A' ' 87' ' ' ARG . 4.7 p -147.82 163.75 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.385 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.503 ' O ' HD22 ' A' ' 88' ' ' LEU . 4.1 mtt180 -148.62 87.45 1.57 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.614 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.69 ' HD2' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -79.64 81.79 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.704 -0.226 . . . . 0.0 111.587 -179.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.503 HD22 ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.29 89.19 7.31 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.775 178.687 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.2 mtm . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.961 179.953 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.527 ' HG2' ' HB3' ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.925 0.393 . . . . 0.0 111.252 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -173.07 3.0 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.748 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -94.4 160.89 14.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.851 0.358 . . . . 0.0 111.481 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.579 HG13 ' HD3' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -102.52 119.11 50.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.756 177.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.415 HG21 HD11 ' A' ' 88' ' ' LEU . 3.1 t -114.87 113.21 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.973 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.469 ' HB3' HG21 ' A' ' 55' ' ' VAL . . . -94.55 165.99 12.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.332 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.762 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 7.4 m -143.41 130.71 20.91 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.658 0.742 . . . . 0.0 112.187 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.743 ' HB ' HH22 ' A' ' 29' ' ' ARG . 5.7 mm -122.15 107.38 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.728 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.571 ' O ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.19 95.34 8.06 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.491 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.9 m -94.27 137.85 22.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.899 0.381 . . . . 0.0 111.841 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.65 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 1.1 ptm -147.43 127.61 6.76 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 121.177 0.513 . . . . 0.0 111.455 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.642 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 13.3 Cg_exo -72.37 124.74 10.14 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.525 2.817 . . . . 0.0 112.141 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.91 -33.54 67.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.274 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.94 151.9 79.48 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.992 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.575 ' HA ' HD11 ' A' ' 48' ' ' LEU . 45.8 Cg_endo -67.95 -2.54 8.91 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.407 2.071 . . . . 0.0 111.978 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.39 44.23 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.025 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.642 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 74.3 t -64.86 77.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.625 -178.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 19.3 m-20 -70.86 91.44 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.916 177.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.655 ' H ' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -64.67 -36.08 83.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.353 -178.235 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.505 ' H ' HD13 ' A' ' 19' ' ' LEU . 8.7 pt-20 -69.91 -38.83 76.38 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.91 0.386 . . . . 0.0 110.177 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.63 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . . . -71.82 -33.9 68.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.341 0.591 . . . . 0.0 109.526 177.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.505 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -66.04 -32.93 74.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.305 177.272 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -57.14 -45.53 83.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.419 178.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.63 ' HE3' ' HA ' ' A' ' 21' ' ' ALA . 2.0 mtmt -65.85 -43.25 89.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.582 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -65.54 -30.06 70.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.474 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.649 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 5.7 mt -60.83 -45.85 97.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.957 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.459 ' NE2' HD23 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -61.07 -38.0 84.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.947 0.403 . . . . 0.0 110.688 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -75.55 -23.07 56.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.333 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.743 HH22 ' HB ' ' A' ' 8' ' ' ILE . 23.6 ptt85 -90.99 -11.84 37.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.116 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 26' ' ' ILE . 27.6 mm -60.02 137.33 90.92 Favored Pre-proline 0 N--CA 1.463 0.21 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.019 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.535 ' HB3' ' HB3' ' A' ' 67' ' ' ALA . 4.1 Cg_endo -46.89 120.82 4.41 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.853 2.368 . . . . 0.0 112.296 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -55.95 -11.02 0.91 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.832 -179.094 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.7 -41.84 10.58 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.901 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.583 ' OG1' HG23 ' A' ' 64' ' ' THR . 0.2 OUTLIER -130.38 -148.45 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.69 0.281 . . . . 0.0 110.995 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -137.23 175.02 9.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.836 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.459 HD23 ' NE2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -74.69 -176.07 2.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.237 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.411 ' ND1' HG23 ' A' ' 56' ' ' VAL . 79.5 t60 -131.04 -69.78 0.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.662 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 1.2 mmtt -161.31 127.13 3.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.1 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.737 HD12 HG21 ' A' ' 53' ' ' VAL . 2.9 mt -91.78 158.01 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.626 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.641 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -128.78 119.23 24.15 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.461 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -82.46 72.01 9.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.985 0.421 . . . . 0.0 110.401 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.406 ' O ' ' N ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -97.05 132.85 24.98 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.816 -179.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.761 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 58.9 Cg_endo -87.68 155.83 7.58 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.527 2.151 . . . . 0.0 112.8 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.445 HG13 ' SD ' ' A' ' 11' ' ' MET . 1.8 mm -124.43 -82.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.098 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 48' ' ' LEU . . . -67.66 -153.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.951 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -71.98 -27.88 63.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 110.709 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.64 5.83 0.53 Allowed Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.581 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.647 ' N ' HD13 ' A' ' 48' ' ' LEU . 8.2 mp -91.1 97.5 11.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.791 0.329 . . . . 0.0 110.645 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.761 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 95.4 t -93.97 127.36 46.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.085 0.469 . . . . 0.0 112.163 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.65 ' HB3' ' HB3' ' A' ' 11' ' ' MET . . . -95.82 142.4 28.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.795 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.641 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -105.98 120.72 42.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.377 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.498 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.3 m120 -89.61 91.85 8.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.374 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.737 HG21 HD12 ' A' ' 39' ' ' ILE . 9.4 t -86.41 107.46 16.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.264 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.435 ' HG3' HG22 ' A' ' 7' ' ' THR . 12.5 mtt -84.46 168.28 15.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.168 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.469 HG21 ' HB3' ' A' ' 6' ' ' ALA . 2.8 m -141.48 136.04 31.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.922 0.391 . . . . 0.0 111.312 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.411 HG23 ' ND1' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -96.12 112.76 28.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.769 178.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.56 HG21 ' HB ' ' A' ' 4' ' ' VAL . 19.9 m -130.46 138.06 54.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.897 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.66 -60.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.322 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.89 -13.9 58.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.021 0.439 . . . . 0.0 110.376 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.91 -146.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.029 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.401 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 1.0 OUTLIER -147.61 -160.37 1.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.717 179.828 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -80.66 13.21 30.61 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.36 178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.21 -1.92 37.51 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.54 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.583 HG23 ' OG1' ' A' ' 34' ' ' THR . 1.8 p -75.34 -6.41 49.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.975 0.417 . . . . 0.0 110.264 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.83 -23.48 18.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.341 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.02 -27.5 61.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.996 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 31' ' ' PRO . . . -61.41 -55.59 29.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.31 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -58.99 -34.85 72.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.573 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.58 -50.44 71.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.343 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.472 ' HG ' HD12 ' A' ' 74' ' ' ILE . 14.5 p -63.39 -18.86 64.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.211 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.812 HD13 HG22 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -72.9 -30.71 64.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.559 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -12.14 33.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.72 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.26 26.44 0.99 Allowed Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.829 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.812 HG22 HD13 ' A' ' 71' ' ' LEU . 2.4 tt -73.21 -160.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.671 -0.264 . . . . 0.0 110.873 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.592 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 0.4 OUTLIER -51.01 99.9 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.842 0.353 . . . . 0.0 110.98 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.52 -32.58 78.42 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.596 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.2 t -88.25 -38.39 11.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.939 0.399 . . . . 0.0 110.543 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.592 ' HB2' ' HB3' ' A' ' 75' ' ' GLU . 6.1 m -95.81 90.65 5.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.76 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.543 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -79.43 137.75 37.37 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.092 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.781 HG21 HG22 ' A' ' 82' ' ' VAL . 1.7 mt -101.74 147.24 8.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.575 -176.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.4 ' N ' HG23 ' A' ' 80' ' ' ILE . 2.3 tp10 -86.01 72.02 10.51 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 172.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.781 HG22 HG21 ' A' ' 80' ' ' ILE . 62.9 t -80.79 56.66 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.124 -174.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -133.05 0.34 3.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.762 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.762 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 40.2 t0 -86.09 127.21 34.64 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.229 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.3 p -151.9 147.45 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 121.033 0.444 . . . . 0.0 111.792 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.73 100.82 4.89 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.216 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.579 ' HD3' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -82.01 83.46 7.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.964 178.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 0.0 OUTLIER -81.11 92.17 6.22 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.686 179.6 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.5 ptp . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.989 179.712 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttm . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.957 0.408 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.54 -12.72 0.03 OUTLIER Glycine 0 CA--C 1.516 0.126 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.158 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 2.9 m-20 -94.08 161.51 14.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.933 0.397 . . . . 0.0 111.59 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -98.62 118.15 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.364 177.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.495 HG22 HD13 ' A' ' 88' ' ' LEU . 41.1 t -109.96 118.41 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 0.0 111.755 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.692 ' HB2' HG23 ' A' ' 55' ' ' VAL . . . -94.04 161.76 14.16 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.634 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 6.2 m -140.97 131.41 25.24 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.682 0.753 . . . . 0.0 112.687 -178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.767 HG21 HG23 ' A' ' 80' ' ' ILE . 3.8 mm -121.03 105.78 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.367 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.521 ' O ' HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -93.69 93.4 8.0 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -177.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.488 HG21 ' HG ' ' A' ' 78' ' ' SER . 1.9 m -92.44 136.0 25.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.826 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.603 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.6 OUTLIER -146.55 123.94 5.98 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-O 121.235 0.54 . . . . 0.0 111.444 179.288 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.64 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 14.1 Cg_exo -70.4 120.99 7.57 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.305 2.67 . . . . 0.0 111.854 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -56.69 -31.2 64.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.405 ' O ' HG21 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -77.62 153.19 81.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.983 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.577 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 46.4 Cg_endo -68.58 -2.9 10.08 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.446 2.097 . . . . 0.0 112.366 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -91.71 43.12 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.248 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.64 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 97.0 t -65.64 76.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.408 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 3.7 m-20 -70.03 97.65 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.609 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -63.23 -45.74 90.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.816 -177.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.79 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 28.3 tt0 -70.7 -35.62 72.85 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.759 0.314 . . . . 0.0 110.678 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.468 ' O ' ' HG2' ' A' ' 24' ' ' LYS . . . -67.52 -39.2 85.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -66.57 -31.5 72.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.836 177.02 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.79 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -55.46 -48.61 74.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.115 -179.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -68.16 -40.76 82.26 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.522 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.566 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 29.8 mm-40 -64.75 -30.02 71.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.07 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.672 HG12 HG22 ' A' ' 53' ' ' VAL . 1.2 mt -62.61 -46.4 96.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.988 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -60.94 -36.19 78.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.413 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 9.9 pt-20 -77.16 -22.36 52.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.433 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.78 ' HB2' HD11 ' A' ' 74' ' ' ILE . 8.6 ptp180 -89.55 -9.19 50.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.253 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 26' ' ' ILE . 34.6 mm -57.82 138.89 82.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.466 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.586 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 10.2 Cg_endo -50.91 117.23 3.17 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.711 2.274 . . . . 0.0 111.972 178.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -59.12 1.76 0.06 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.12 -62.54 1.81 Allowed Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.83 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.428 ' OG1' HG11 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -109.43 -139.26 0.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.591 0.234 . . . . 0.0 110.844 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -134.9 166.16 23.65 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.868 0.366 . . . . 0.0 110.839 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.494 ' HB3' HD13 ' A' ' 30' ' ' ILE . 0.5 OUTLIER -75.56 -175.97 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.093 -179.369 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.581 ' ND1' HG23 ' A' ' 56' ' ' VAL . 73.7 t60 -131.25 -79.08 0.52 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 10.1 mmtt -161.69 137.81 7.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.687 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 53' ' ' VAL . 2.4 mm -92.11 166.63 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.452 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.608 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -130.03 123.22 30.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.165 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -84.88 67.67 10.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.875 0.369 . . . . 0.0 110.518 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.421 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -95.44 133.9 25.16 Favored Pre-proline 0 C--O 1.225 -0.205 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.579 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.761 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 60.6 Cg_endo -87.12 155.65 8.32 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.62 2.213 . . . . 0.0 112.686 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.412 HG13 ' SD ' ' A' ' 11' ' ' MET . 2.8 mm -124.81 -82.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.378 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.533 ' HB1' ' HG ' ' A' ' 48' ' ' LEU . . . -67.4 -150.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -71.87 -29.95 64.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.587 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.71 6.36 0.54 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.736 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.577 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 4.8 mt -91.45 100.91 13.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.975 0.417 . . . . 0.0 110.835 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.761 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 78.3 t -92.96 128.52 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.72 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 11' ' ' MET . . . -95.35 143.0 27.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.103 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.608 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 10.9 mp -101.53 119.46 38.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.251 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.8 m120 -91.66 96.19 10.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.312 0.577 . . . . 0.0 111.011 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.672 HG22 HG12 ' A' ' 26' ' ' ILE . 39.6 t -84.51 103.12 11.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.15 -177.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.564 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 18.5 mtt -86.3 161.63 18.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.101 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.692 HG23 ' HB2' ' A' ' 6' ' ' ALA . 3.3 m -139.32 135.12 40.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 111.193 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.581 HG23 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -95.04 115.78 34.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.006 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.428 HG11 ' OG1' ' A' ' 34' ' ' THR . 13.8 m -130.35 151.1 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.983 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.53 -74.22 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.534 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -81.38 -3.01 51.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 0.0 110.713 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.21 -147.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.366 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -147.57 -166.08 2.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.855 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.69 15.62 24.35 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.668 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.82 -5.19 50.85 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.528 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.72 -3.76 33.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.94 0.4 . . . . 0.0 110.296 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -55.19 -23.11 20.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.142 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.19 -27.34 61.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.121 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.586 ' HB1' ' HB3' ' A' ' 31' ' ' PRO . . . -61.16 -55.09 36.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.482 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -58.21 -36.11 72.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.458 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.36 -51.03 70.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.345 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.5 -19.16 64.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.443 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.66 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.34 -29.55 62.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.602 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.68 -12.07 31.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.772 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.15 25.82 1.0 Allowed Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.619 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.78 HD11 ' HB2' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -73.48 -164.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.476 -0.362 . . . . 0.0 111.187 -178.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.642 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.6 OUTLIER -50.37 100.78 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.006 0.431 . . . . 0.0 111.114 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.28 -31.54 79.37 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.873 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.3 t -85.84 -35.79 9.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.006 0.432 . . . . 0.0 110.307 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.642 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 43.8 t -95.77 90.5 5.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.614 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.555 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.24 133.2 38.93 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.767 HG23 HG21 ' A' ' 8' ' ' ILE . 3.2 mp -101.56 148.76 7.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.686 -175.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.442 ' N ' HG22 ' A' ' 80' ' ' ILE . 0.5 OUTLIER -85.81 71.36 10.67 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 172.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.757 HG23 HG23 ' A' ' 80' ' ' ILE . 57.9 t -79.82 50.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.079 -174.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -133.13 7.18 3.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.359 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.634 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.5 m-20 -84.33 142.55 30.11 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.994 0.426 . . . . 0.0 111.207 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.7 p -147.51 157.03 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.057 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -145.32 105.09 4.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.41 -178.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' HD2' ' HE1' ' A' ' 89' ' ' MET . 0.0 OUTLIER -83.7 83.56 7.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.921 178.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 10.5 mp -81.21 85.26 6.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.516 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.508 ' HE1' ' HD2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.942 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttm . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.976 0.417 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.38 -2.42 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.375 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.663 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 2.1 m-20 -93.6 127.24 39.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.733 0.301 . . . . 0.0 111.712 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.615 ' HB ' HG21 ' A' ' 57' ' ' VAL . 2.5 t -97.43 104.03 15.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.764 0.316 . . . . 0.0 110.565 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 53.1 t -105.3 114.78 45.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.588 -178.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -97.01 165.74 11.93 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.712 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 13.4 m -143.25 128.84 19.15 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.542 0.687 . . . . 0.0 111.859 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.74 HG22 HG23 ' A' ' 80' ' ' ILE . 3.4 mm -120.54 107.7 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.759 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.649 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -97.58 95.46 7.63 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.523 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.8 m -93.28 135.86 26.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.733 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.59 119.31 4.58 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 121.279 0.561 . . . . 0.0 111.97 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.63 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.1 Cg_exo -69.99 119.14 6.13 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.197 2.598 . . . . 0.0 112.034 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -56.91 -29.13 62.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.172 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.43 148.98 74.75 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.046 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.517 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 35.9 Cg_endo -64.69 -7.38 14.52 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.303 2.002 . . . . 0.0 111.804 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.63 34.78 0.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.6 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.4 87.25 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.776 0.798 . . . . 0.0 109.892 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.598 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 55.3 m-20 -67.9 104.59 1.75 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.139 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.79 HD13 HD12 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -60.93 -53.47 56.94 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.445 -178.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 35.7 tt0 -69.75 -36.5 75.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.046 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.61 -35.16 76.96 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.779 177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.598 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -65.36 -33.36 75.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.518 177.237 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HD3' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -55.98 -46.74 78.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.471 178.768 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -66.12 -42.81 88.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.41 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.721 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 51.0 mm-40 -65.34 -30.23 71.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.37 0.605 . . . . 0.0 110.438 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.815 HG22 HG22 ' A' ' 53' ' ' VAL . 3.4 mt -60.69 -47.05 94.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.597 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.78 -38.11 89.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.387 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.721 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -77.32 -21.08 54.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.48 -178.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.703 ' HD3' HD11 ' A' ' 74' ' ' ILE . 3.3 ptp85 -89.15 -13.45 38.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.077 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.668 HG12 ' O ' ' A' ' 26' ' ' ILE . 34.4 mm -61.08 136.92 93.99 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.57 ' HD2' HG23 ' A' ' 30' ' ' ILE . 15.7 Cg_endo -55.88 129.49 35.24 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.334 2.023 . . . . 0.0 112.614 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.6 0.1 0.22 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.125 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.58 -56.69 2.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.977 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.11 -144.74 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.321 . . . . 0.0 111.416 -179.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -133.83 170.1 16.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.957 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.444 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -75.32 -173.83 2.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.217 -179.134 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.566 ' ND1' HG21 ' A' ' 56' ' ' VAL . 85.3 t60 -130.9 -75.48 0.53 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.423 0.63 . . . . 0.0 110.944 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.489 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER -164.45 129.37 2.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.788 -178.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.641 HD12 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -92.59 158.23 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.166 0.508 . . . . 0.0 112.362 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.599 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 5.1 m-20 -123.41 124.72 43.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.517 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -86.78 72.58 10.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.782 0.325 . . . . 0.0 110.624 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -100.05 136.0 20.25 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.93 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.757 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 64.2 Cg_endo -86.25 158.08 9.71 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.71 2.274 . . . . 0.0 112.629 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.9 mm -127.28 -83.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.657 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.543 ' HB1' ' HG ' ' A' ' 48' ' ' LEU . . . -67.83 -148.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.283 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -71.58 -32.81 68.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.826 0.346 . . . . 0.0 110.591 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.65 7.23 0.58 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.638 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.586 ' HA ' HG11 ' A' ' 17' ' ' VAL . 3.3 mt -91.41 102.33 15.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.905 0.383 . . . . 0.0 110.814 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.757 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 75.3 t -92.64 130.03 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.848 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.605 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -94.94 159.27 15.11 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.814 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.79 HD12 HD13 ' A' ' 19' ' ' LEU . 10.5 mp -117.93 119.12 33.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.397 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.586 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.7 m120 -89.66 91.13 8.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.35 0.595 . . . . 0.0 110.159 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.815 HG22 HG22 ' A' ' 26' ' ' ILE . 5.9 t -87.04 103.24 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.418 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.469 ' HG2' ' HG1' ' A' ' 7' ' ' THR . 15.1 mtt -84.63 166.13 17.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.237 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.437 HG21 HG12 ' A' ' 57' ' ' VAL . 3.6 m -140.0 135.21 37.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.868 0.366 . . . . 0.0 111.616 -178.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.566 HG21 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.79 110.62 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.759 178.483 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.615 HG21 ' HB ' ' A' ' 4' ' ' VAL . 11.3 m -130.3 144.71 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.043 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.24 -64.14 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.417 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -80.94 -6.92 59.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.882 0.372 . . . . 0.0 110.635 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.88 -147.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.058 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -147.69 -161.65 1.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.78 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.56 13.08 30.6 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.579 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.26 -7.65 60.59 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.511 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -4.5 36.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.892 0.377 . . . . 0.0 110.216 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.64 -23.69 18.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.03 177.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.88 -28.83 62.34 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.038 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 31' ' ' PRO . . . -59.87 -56.5 21.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.577 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -58.58 -35.51 72.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.492 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -61.33 -51.11 70.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.438 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.1 p -64.01 -17.9 63.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.533 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.819 HD13 HG23 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.25 -31.13 62.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.533 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.93 -10.24 27.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.687 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.02 26.76 1.01 Allowed Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.819 HG23 HD13 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -73.2 -169.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.291 -0.455 . . . . 0.0 111.087 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -50.58 97.93 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 111.193 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.99 -31.68 81.51 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.778 -0.647 . . . . 0.0 112.927 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.59 -37.27 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.137 0.494 . . . . 0.0 109.982 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 1.5 m -95.37 87.8 4.91 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.039 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.533 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -76.45 135.62 39.4 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.103 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.795 HG23 HG23 ' A' ' 82' ' ' VAL . 2.6 mt -101.45 148.58 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.566 -175.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.649 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 33.6 tp10 -85.95 69.89 10.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.795 HG23 HG23 ' A' ' 80' ' ' ILE . 61.7 t -80.69 57.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.679 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -132.76 -2.56 3.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.874 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.712 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 2.6 m-20 -85.3 131.51 34.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.267 -178.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.752 HG23 ' HD2' ' A' ' 87' ' ' ARG . 2.6 p -150.74 158.04 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.017 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 4.9 mtt180 -148.27 81.79 1.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.013 0.435 . . . . 0.0 111.06 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.752 ' HD2' HG23 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -78.16 82.28 4.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.132 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.663 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 10.3 mp -80.7 84.11 6.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.294 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.926 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.617 ' HG2' ' HB3' ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.986 0.422 . . . . 0.0 111.311 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -173.54 10.97 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.581 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.665 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -89.76 160.93 16.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.908 0.385 . . . . 0.0 111.49 -179.427 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.467 ' O ' HG23 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -107.87 128.65 62.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.32 177.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 83.2 t -129.54 115.25 33.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.055 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.494 ' H ' HG23 ' A' ' 55' ' ' VAL . . . -95.56 165.98 12.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.76 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.759 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.9 m -141.99 127.01 18.36 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.588 0.709 . . . . 0.0 111.898 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.695 HG21 HG22 ' A' ' 80' ' ' ILE . 8.3 mm -120.57 108.85 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.925 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.663 ' HB2' ' HG2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -97.77 96.85 8.52 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.603 ' CB ' HG12 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -92.85 139.98 17.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -176.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.818 ' HE2' HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -146.14 122.57 5.82 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.249 179.328 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.587 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 11.6 Cg_exo -72.9 120.86 6.89 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.462 2.775 . . . . 0.0 112.383 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.57 -31.21 65.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.338 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.47 ' O ' HG21 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -77.58 151.02 79.95 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.039 -179.551 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.696 ' HA ' HD21 ' A' ' 48' ' ' LEU . 41.9 Cg_endo -66.86 -3.32 9.27 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.421 2.081 . . . . 0.0 112.003 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.16 42.69 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.353 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.587 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 95.7 t -65.02 77.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.068 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 62.7 m-20 -68.93 100.86 1.26 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.165 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.771 ' HG ' HD11 ' A' ' 51' ' ' LEU . 3.1 tt -62.96 -49.21 75.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.481 -178.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -68.15 -38.26 81.94 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.739 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 18' ' ' ASP . . . -69.78 -37.13 76.25 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.011 177.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.584 HD13 ' NH2' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -65.42 -34.12 77.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.697 177.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -47.26 85.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.088 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.478 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -69.32 -37.15 77.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.188 0.518 . . . . 0.0 110.388 179.146 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.478 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 12.5 mt-10 -66.26 -31.02 71.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.017 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.729 HG12 HG21 ' A' ' 53' ' ' VAL . 2.1 mt -62.38 -42.69 96.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.444 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.498 ' NE2' HG23 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -57.72 -39.66 77.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.443 179.343 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -74.83 -24.24 58.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.708 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.836 ' HD3' HD13 ' A' ' 74' ' ' ILE . 2.4 ptp180 -88.56 -12.84 41.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.758 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.481 HG21 ' HD2' ' A' ' 31' ' ' PRO . 22.7 mm -57.65 135.44 82.58 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.577 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.481 ' HD2' HG21 ' A' ' 30' ' ' ILE . 10.5 Cg_endo -53.07 126.63 22.11 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.509 2.139 . . . . 0.0 112.335 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -58.05 -2.01 0.15 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.401 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -81.83 -46.36 6.77 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.515 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.494 ' HG1' HG23 ' A' ' 64' ' ' THR . 0.2 OUTLIER -130.55 -142.51 0.24 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.672 0.272 . . . . 0.0 110.993 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -139.44 173.09 11.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.022 0.439 . . . . 0.0 110.855 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -74.44 -176.75 2.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.236 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.519 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 83.4 t60 -131.73 -71.92 0.55 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.475 0.655 . . . . 0.0 111.167 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.515 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -162.72 128.62 3.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.992 -177.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.698 HD12 HG23 ' A' ' 53' ' ' VAL . 2.5 mt -94.77 160.1 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.118 -177.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.655 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.1 t0 -127.38 128.79 46.44 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.633 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -87.34 73.38 9.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.789 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.48 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -98.88 133.43 22.33 Favored Pre-proline 0 C--O 1.225 -0.22 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.309 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.771 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 62.6 Cg_endo -87.56 157.03 7.79 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.519 2.146 . . . . 0.0 113.086 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.46 HG22 HD13 ' A' ' 44' ' ' ILE . 3.3 mm -124.74 -83.01 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.245 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.4 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.3 -156.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.034 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -71.94 -25.1 61.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.625 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.51 0.98 0.33 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.119 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.818 HD11 ' HE2' ' A' ' 11' ' ' MET . 6.0 mt -92.01 100.24 12.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.887 0.375 . . . . 0.0 110.765 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 70.0 t -92.52 132.8 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.646 -178.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.53 ' HB3' ' HB2' ' A' ' 11' ' ' MET . . . -95.86 162.0 13.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.006 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.771 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.2 mp -120.63 121.15 37.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.546 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.548 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.2 m120 -90.11 91.66 8.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.207 0.527 . . . . 0.0 110.042 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.729 HG21 HG12 ' A' ' 26' ' ' ILE . 11.3 t -86.73 104.34 13.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.531 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.623 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -85.01 162.89 19.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.905 178.186 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 4.6 m -136.86 127.02 39.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.949 0.404 . . . . 0.0 111.116 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.519 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 0.4 OUTLIER -94.36 109.86 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.938 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 4' ' ' VAL . 2.3 m -128.24 146.63 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.664 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.28 -61.94 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.536 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -80.21 -11.26 59.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.092 0.472 . . . . 0.0 110.239 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.89 -144.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.935 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.45 -166.52 2.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.813 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.86 15.16 22.28 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.534 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.08 -0.54 28.56 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.521 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.494 HG23 ' HG1' ' A' ' 34' ' ' THR . 1.3 p -73.45 -3.45 27.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.944 0.402 . . . . 0.0 110.355 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.92 -23.72 20.22 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.163 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.17 -27.53 61.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.074 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.412 ' N ' ' HB3' ' A' ' 31' ' ' PRO . . . -59.58 -56.28 23.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.488 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -57.88 -36.88 73.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.612 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.93 -51.86 67.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.552 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.418 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 54.7 p -64.59 -20.29 66.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.85 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.685 HD23 HD11 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -73.09 -27.96 62.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.834 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -14.38 55.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.707 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.35 28.16 0.97 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.819 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.836 HD13 ' HD3' ' A' ' 29' ' ' ARG . 1.2 tt -72.97 -160.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.497 -0.351 . . . . 0.0 110.933 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.68 ' HB2' HH12 ' A' ' 29' ' ' ARG . 0.1 OUTLIER -50.07 91.15 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.993 0.425 . . . . 0.0 111.011 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.3 -26.54 66.28 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.337 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.8 p -86.62 -39.59 13.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.282 0.563 . . . . 0.0 110.09 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.62 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 11.9 t -95.96 90.35 5.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.331 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.571 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -75.77 132.29 40.35 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.779 HG22 HG22 ' A' ' 82' ' ' VAL . 12.5 mt -101.08 147.3 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.479 -175.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.663 ' HG2' ' HB2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -85.62 73.69 10.4 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.106 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.779 HG22 HG22 ' A' ' 80' ' ' ILE . 90.5 t -80.97 55.55 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.743 -174.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.68 2.91 3.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.403 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.759 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 30.3 t0 -85.5 137.4 32.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.778 0.323 . . . . 0.0 110.854 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 p -146.66 160.6 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.1 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.5 mtt-85 -148.92 89.29 1.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.839 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -78.8 109.42 13.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.723 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.665 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 10.2 mp -81.83 77.8 8.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.81 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 17.1 ptp . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.859 179.736 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.601 ' HG2' ' H ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 121.078 0.466 . . . . 0.0 111.027 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.601 ' H ' ' HG2' ' A' ' 1' ' ' MET . . . -161.17 -9.6 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.192 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -95.19 154.09 17.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.209 -0.495 . . . . 0.0 111.421 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.634 HG12 ' HA ' ' A' ' 87' ' ' ARG . 15.8 t -98.48 114.0 34.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.798 177.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.512 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 38.8 t -104.76 115.19 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.343 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.501 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -93.07 166.19 12.47 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.698 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 10.1 m -142.12 136.52 30.16 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.542 0.687 . . . . 0.0 112.44 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.745 HG21 HG21 ' A' ' 80' ' ' ILE . 8.3 mm -125.53 105.55 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.991 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.604 ' HD2' ' HB3' ' A' ' 52' ' ' ASN . 2.2 mmmt -97.38 96.97 8.73 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -176.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 10' ' ' VAL . 1.5 m -94.02 136.15 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.875 0.369 . . . . 0.0 111.931 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.802 ' HE1' HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -146.9 123.16 5.58 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.314 179.306 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.642 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 10.2 Cg_exo -73.86 122.25 7.58 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.562 2.841 . . . . 0.0 112.077 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -57.47 -32.04 66.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.448 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.45 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -77.35 152.32 81.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.032 -179.594 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 42.2 Cg_endo -67.55 -3.23 9.79 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.417 2.078 . . . . 0.0 112.154 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.8 43.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.103 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.642 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 93.7 t -65.29 75.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.389 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 3.8 m-20 -70.33 88.88 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.74 HD13 ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.18 -38.43 91.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.825 -177.187 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.944 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 1.4 tt0 -70.67 -36.23 73.23 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.05 0.452 . . . . 0.0 110.086 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.61 -37.54 76.92 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.497 ' CD2' ' HG3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -66.45 -30.19 70.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.909 177.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.944 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -54.53 -46.41 73.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.437 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 7.2 mtmt -67.14 -44.53 79.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.513 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -65.19 -25.96 67.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.566 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.774 HG12 HG22 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -60.47 -49.65 83.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.361 -179.368 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.615 ' NE2' HD22 ' A' ' 36' ' ' LEU . 6.1 mm-40 -62.97 -32.48 73.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.155 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 15.3 mt-10 -74.62 -24.08 58.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.024 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.601 ' HB2' HD13 ' A' ' 74' ' ' ILE . 1.2 ptp85 -91.95 -13.51 31.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.362 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.541 HG21 ' N ' ' A' ' 31' ' ' PRO . 10.1 mm -59.49 140.16 88.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.911 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.541 ' N ' HG21 ' A' ' 30' ' ' ILE . 9.4 Cg_endo -51.44 112.7 0.87 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.744 2.296 . . . . 0.0 112.119 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.77 -0.87 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.253 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.03 -35.95 16.76 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.956 -178.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.545 HG22 ' HB3' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.3 -142.96 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.694 0.247 . . . . 0.0 110.96 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -135.12 167.01 21.75 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.883 0.373 . . . . 0.0 111.116 -179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.615 HD22 ' NE2' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -75.32 -179.89 4.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.384 -179.033 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.518 ' HB2' HG23 ' A' ' 56' ' ' VAL . 79.4 t60 -130.77 -75.81 0.53 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.96 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.603 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -165.43 131.84 2.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.744 -178.51 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.718 HD13 HG22 ' A' ' 26' ' ' ILE . 2.5 mt -91.41 155.93 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 112.362 -176.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 61.0 m-20 -120.42 126.68 51.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.692 -178.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.39 71.38 9.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.819 0.343 . . . . 0.0 110.304 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.442 ' C ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.81 134.25 21.14 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.796 -179.619 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.779 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 73.7 Cg_endo -87.07 157.69 8.5 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.575 2.184 . . . . 0.0 112.608 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.415 HD13 ' HB2' ' A' ' 50' ' ' ALA . 3.5 mm -125.65 -82.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.36 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.536 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.05 -153.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -71.74 -28.22 63.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.637 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.45 4.58 0.5 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.97 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.802 HD11 ' HE1' ' A' ' 11' ' ' MET . 5.7 mt -92.34 102.61 15.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.859 0.361 . . . . 0.0 110.975 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.779 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 76.6 t -93.0 130.47 42.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.792 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 11' ' ' MET . . . -96.21 153.31 17.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.916 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.596 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 10.5 mp -111.53 117.18 32.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.33 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.604 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.2 m120 -89.79 92.48 9.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.208 0.528 . . . . 0.0 110.379 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.774 HG22 HG12 ' A' ' 26' ' ' ILE . 4.0 t -86.81 105.82 15.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.274 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.453 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 0.1 OUTLIER -84.62 166.56 17.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.432 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.567 HG21 HG13 ' A' ' 57' ' ' VAL . 2.9 m -138.99 139.3 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.223 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 37' ' ' HIS . 1.9 t -93.57 106.61 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.137 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.609 HG21 ' HB ' ' A' ' 4' ' ' VAL . 2.8 m -127.82 155.61 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.793 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.79 -73.41 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.087 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.67 0.89 36.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.994 0.426 . . . . 0.0 110.494 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.545 ' HB3' HG22 ' A' ' 34' ' ' THR . . . -67.02 -146.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.019 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.82 -165.35 2.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.936 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.3 13.34 33.97 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.433 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.01 -4.23 47.75 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.536 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.46 HG23 ' OG1' ' A' ' 34' ' ' THR . 1.6 p -75.04 -3.92 35.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.966 0.412 . . . . 0.0 110.105 179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -55.43 -23.55 25.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.258 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.11 -29.63 60.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.874 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.78 -56.29 21.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.337 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.531 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 3.3 mt-10 -58.57 -33.92 70.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.431 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -51.85 65.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.261 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.58 -16.83 61.93 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.028 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.69 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 2.1 mt -72.3 -33.52 67.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.374 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -9.7 15.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.0 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.08 26.73 1.0 Allowed Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.69 ' HB ' ' HA ' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -73.3 -166.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.153 -0.523 . . . . 0.0 111.407 -178.437 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 2.7 mm-40 -51.61 101.65 0.04 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.878 0.371 . . . . 0.0 110.901 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.75 -33.95 88.33 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.776 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -86.02 -39.45 13.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 0.0 110.346 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.589 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 48.3 t -96.06 91.22 5.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.782 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.568 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.79 134.02 38.11 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.556 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.79 HG21 HG21 ' A' ' 82' ' ' VAL . 2.9 mp -101.38 148.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.379 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.506 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.3 tp10 -86.02 69.32 10.51 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.79 HG21 HG21 ' A' ' 80' ' ' ILE . 47.7 t -81.12 51.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.18 -174.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.82 6.64 4.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.542 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.698 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.3 m-20 -85.29 138.2 32.47 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.441 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.45 151.63 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.151 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.664 ' HB3' HD21 ' A' ' 88' ' ' LEU . 5.8 mtt180 -149.53 78.2 1.36 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.018 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.634 ' HA ' HG12 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -79.63 79.67 6.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.52 -179.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.664 HD21 ' HB3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -81.06 93.82 6.47 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.369 178.734 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.3 mtm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.245 -0.884 . . . . 0.0 111.005 -179.924 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 121.424 0.63 . . . . 0.0 112.115 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.76 -13.19 0.04 OUTLIER Glycine 0 C--N 1.331 0.261 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.409 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 1.6 m-20 -94.72 174.98 6.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.182 0.515 . . . . 0.0 111.943 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -103.17 132.22 49.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.361 177.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.61 ' HB ' ' HB2' ' A' ' 86' ' ' ARG . 42.1 t -128.62 128.09 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.701 0.286 . . . . 0.0 111.652 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -99.4 167.04 10.88 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.789 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.4 m -142.83 133.2 24.79 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.594 0.712 . . . . 0.0 112.386 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.734 ' HB ' HH22 ' A' ' 29' ' ' ARG . 5.9 mm -125.89 108.43 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.777 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.603 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -98.7 96.69 8.09 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.376 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.79 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.9 m -94.0 138.02 21.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.65 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.76 119.57 4.57 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 121.157 0.503 . . . . 0.0 111.806 179.41 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.54 ' O ' HD23 ' A' ' 48' ' ' LEU . 21.1 Cg_exo -69.71 123.64 10.32 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.464 2.776 . . . . 0.0 112.007 178.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.17 -30.52 64.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.508 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 m -77.6 148.52 76.74 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.053 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.562 ' HA ' HD13 ' A' ' 48' ' ' LEU . 38.8 Cg_endo -65.64 -6.6 14.21 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.419 2.079 . . . . 0.0 111.779 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -93.44 36.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.605 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.685 HG11 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.72 88.49 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.78 0.8 . . . . 0.0 110.134 -179.569 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 32.9 m-20 -68.25 104.27 1.79 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.034 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.821 ' HG ' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -61.24 -52.2 65.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.707 -178.146 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.725 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -71.2 -34.37 70.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.277 -177.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.528 ' N ' ' HG2' ' A' ' 20' ' ' GLU . . . -68.28 -35.93 78.61 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -66.16 -33.53 75.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.384 176.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.725 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -55.92 -46.61 78.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.132 178.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -43.31 90.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.798 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 11.3 mt-10 -66.55 -30.73 71.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.257 0.551 . . . . 0.0 110.722 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.732 HG12 HG23 ' A' ' 53' ' ' VAL . 1.6 mt -61.75 -43.92 97.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.816 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.21 -38.8 90.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.063 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 10.6 pt-20 -77.84 -21.16 51.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.553 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.802 ' HB2' HD13 ' A' ' 74' ' ' ILE . 20.0 ptt85 -89.86 -9.57 48.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.19 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.662 HG12 ' O ' ' A' ' 26' ' ' ILE . 32.6 mm -59.7 138.16 89.92 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.281 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.488 ' N ' HG22 ' A' ' 30' ' ' ILE . 10.2 Cg_endo -50.83 118.86 4.56 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.868 2.378 . . . . 0.0 112.279 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -59.13 -1.2 0.16 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.116 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.26 -42.82 8.39 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.918 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.51 ' HG1' HG21 ' A' ' 64' ' ' THR . 0.2 OUTLIER -130.49 -144.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.685 0.279 . . . . 0.0 110.951 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -133.35 167.08 21.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.874 0.368 . . . . 0.0 110.807 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.421 ' O ' HG21 ' A' ' 56' ' ' VAL . 1.8 pt? -75.92 -176.01 3.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.23 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.485 ' HB2' HG22 ' A' ' 56' ' ' VAL . 84.8 t60 -130.85 -76.46 0.53 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.369 0.604 . . . . 0.0 111.195 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 2.2 tptt -164.53 133.52 3.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.794 -178.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.757 HD11 HG22 ' A' ' 53' ' ' VAL . 1.7 mt -93.09 158.2 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.591 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -123.79 125.51 44.83 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.318 -178.635 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.12 73.84 10.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.93 0.395 . . . . 0.0 110.508 178.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.533 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -98.94 131.02 26.27 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.295 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.778 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 59.0 Cg_endo -87.53 157.57 7.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.485 2.123 . . . . 0.0 112.949 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.413 ' HB ' ' H ' ' A' ' 45' ' ' ALA . 2.4 mm -124.34 -82.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.107 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.413 ' H ' ' HB ' ' A' ' 44' ' ' ILE . . . -67.25 -157.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.84 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -72.28 -22.82 61.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.666 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.57 -1.18 0.25 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.039 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.685 ' HA ' HG11 ' A' ' 17' ' ' VAL . 8.8 mp -90.7 100.99 13.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.81 0.305 . . . . 0.0 110.966 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.778 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 93.4 t -94.57 132.94 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.971 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.528 ' HB3' ' HB2' ' A' ' 11' ' ' MET . . . -96.38 162.9 13.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.847 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.821 HD12 ' HG ' ' A' ' 19' ' ' LEU . 11.2 mp -121.12 120.36 35.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.716 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.557 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.2 m120 -90.92 91.18 8.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.281 0.562 . . . . 0.0 110.027 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.757 HG22 HD11 ' A' ' 39' ' ' ILE . 5.0 t -87.48 104.11 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.32 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.627 ' HE2' ' HE ' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -84.69 165.28 18.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.339 179.187 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.5 m -138.41 137.47 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.451 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -94.35 118.19 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.911 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.422 HG12 ' HG1' ' A' ' 34' ' ' THR . 35.4 m -130.2 142.4 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.95 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.4 -70.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.455 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -81.41 -5.76 58.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 0.0 110.5 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.67 -152.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.196 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.01 -162.35 1.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.803 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.07 14.07 28.93 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.276 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.0 -3.73 45.42 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.36 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.51 HG21 ' HG1' ' A' ' 34' ' ' THR . 1.1 p -74.67 -3.39 31.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.016 0.436 . . . . 0.0 110.097 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.99 -23.47 19.44 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.045 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.0 -26.87 60.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.11 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.6 -52.79 62.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.107 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -59.21 -37.32 77.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.308 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -49.05 78.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.137 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.42 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -63.85 -19.78 65.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.327 178.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.773 HD13 HG21 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.0 -30.7 62.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.422 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 p -64.51 -9.52 19.43 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.739 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.14 22.05 0.98 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.108 -0.567 . . . . 0.0 111.968 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.802 HD13 ' HB2' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -72.82 -164.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 122.3 0.24 . . . . 0.0 110.666 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 0.4 OUTLIER -50.81 100.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.929 0.395 . . . . 0.0 110.981 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.4 -27.03 68.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.048 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.4 p -90.15 -36.83 8.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.094 0.473 . . . . 0.0 110.824 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 1.6 m -95.6 89.26 5.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.602 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.417 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -76.32 132.1 39.59 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.655 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.79 HG12 ' HB ' ' A' ' 10' ' ' VAL . 15.7 mt -101.18 147.16 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.469 -175.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.603 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 16.3 tp10 -85.53 69.93 10.71 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 173.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.751 HG22 HG22 ' A' ' 80' ' ' ILE . 62.0 t -80.17 48.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.001 -174.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.85 9.29 4.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.291 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.789 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 8.6 t70 -85.92 151.42 23.78 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.856 0.36 . . . . 0.0 111.082 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.479 HG21 ' H ' ' A' ' 86' ' ' ARG . 3.1 p -147.82 160.04 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.17 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.627 ' HE ' ' HE2' ' A' ' 54' ' ' MET . 0.3 OUTLIER -146.32 95.24 2.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.048 -179.498 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -79.1 86.97 4.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.335 178.446 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 11.2 mp -81.96 76.78 8.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.86 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.1 mmt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.946 179.906 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.786 0.327 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 89' ' ' MET . . . 173.42 -10.09 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.38 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.413 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 11.6 p-10 -88.92 140.78 29.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 111.382 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.557 ' HB ' HG23 ' A' ' 57' ' ' VAL . 1.7 t -96.83 107.0 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.724 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 9.7 t -104.88 110.78 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.12 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -101.2 166.86 10.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.338 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.675 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 8.5 m -143.33 129.16 19.41 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.699 0.762 . . . . 0.0 112.251 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.821 ' HB ' HH22 ' A' ' 29' ' ' ARG . 6.3 mm -121.91 107.97 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.523 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.533 ' O ' HG21 ' A' ' 80' ' ' ILE . 2.8 mmmt -97.28 94.56 7.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.456 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 2.0 m -93.37 137.84 21.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.682 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.7 OUTLIER -147.31 119.53 4.72 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 121.306 0.574 . . . . 0.0 111.915 178.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 22.2 Cg_exo -68.51 121.89 8.85 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.372 2.715 . . . . 0.0 111.982 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -56.25 -29.61 61.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.269 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.477 ' HG ' ' H ' ' A' ' 16' ' ' ASP . 1.3 p -76.97 151.16 81.81 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.173 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.591 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 48.4 Cg_endo -67.85 -6.47 17.0 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.165 1.91 . . . . 0.0 111.387 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.477 ' H ' ' HG ' ' A' ' 14' ' ' SER . 47.6 m-20 -92.6 33.92 1.1 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.565 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.727 HG13 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.05 87.15 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.8 0.809 . . . . 0.0 110.015 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.527 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 15.6 m-20 -70.08 106.99 3.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.47 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.905 ' HG ' HD12 ' A' ' 51' ' ' LEU . 2.2 tt -62.16 -49.58 75.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.226 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -68.67 -37.55 79.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.864 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.95 -34.0 71.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.58 178.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -65.34 -32.62 74.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.574 177.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.37 -44.49 88.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.604 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.5 -42.49 92.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.337 178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.63 -32.12 73.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.179 0.514 . . . . 0.0 110.337 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.656 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 9.7 mt -60.94 -44.35 97.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.745 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.96 -39.65 86.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.542 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -74.73 -24.31 58.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.379 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.821 HH22 ' HB ' ' A' ' 8' ' ' ILE . 24.7 ptt85 -91.06 -14.02 32.08 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.697 HD13 HG12 ' A' ' 53' ' ' VAL . 12.1 mm -58.16 137.78 84.38 Favored Pre-proline 0 C--N 1.332 -0.186 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.481 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.512 ' N ' HG22 ' A' ' 30' ' ' ILE . 5.2 Cg_endo -45.3 119.03 2.34 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.807 2.338 . . . . 0.0 112.231 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -57.3 -4.55 0.23 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.076 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.95 -45.15 6.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.516 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.43 -142.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.765 0.316 . . . . 0.0 111.135 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -138.7 175.55 9.47 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.968 0.413 . . . . 0.0 110.748 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.449 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -74.69 -175.69 2.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.342 -178.862 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.561 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 85.5 t60 -131.35 -68.87 0.64 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.095 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -159.34 121.27 3.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.257 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.818 HD13 HG23 ' A' ' 53' ' ' VAL . 2.5 mt -91.72 157.5 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.513 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.639 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.64 123.66 36.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.804 -178.164 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.425 ' HB3' HD13 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -85.22 70.71 10.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.927 0.394 . . . . 0.0 110.426 177.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.428 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -97.41 135.73 21.65 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.767 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.776 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 64.3 Cg_endo -86.62 157.73 9.16 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.609 2.206 . . . . 0.0 112.739 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.425 HG13 ' SD ' ' A' ' 11' ' ' MET . 2.8 mm -126.56 -83.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.444 -177.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.506 ' HB1' ' HG ' ' A' ' 48' ' ' LEU . . . -67.52 -149.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -70.75 -32.85 70.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.638 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.56 7.76 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.631 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.727 ' HA ' HG13 ' A' ' 17' ' ' VAL . 3.7 mt -90.9 101.56 14.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 110.685 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.776 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 73.8 t -93.0 128.99 44.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.923 -178.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.581 ' HB1' ' HB3' ' A' ' 11' ' ' MET . . . -95.64 156.6 16.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.853 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.905 HD12 ' HG ' ' A' ' 19' ' ' LEU . 11.1 mp -115.76 119.97 37.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.461 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.513 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.6 m120 -89.82 91.0 8.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.337 0.589 . . . . 0.0 110.016 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.818 HG23 HD13 ' A' ' 39' ' ' ILE . 14.2 t -87.37 102.35 12.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.539 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.615 ' HG3' HG22 ' A' ' 7' ' ' THR . 0.1 OUTLIER -84.61 166.93 16.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.852 178.102 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 4.4 m -138.72 126.4 27.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.089 0.471 . . . . 0.0 111.431 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.561 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 1.3 p -99.06 106.85 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.696 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.557 HG23 ' HB ' ' A' ' 4' ' ' VAL . 1.3 m -124.99 166.6 20.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.649 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.25 -64.93 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.729 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.41 -5.8 57.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.943 0.401 . . . . 0.0 110.58 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.66 -147.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.037 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.62 -162.56 1.57 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.764 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.8 14.11 27.11 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.429 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.83 -4.28 46.7 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.46 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -74.31 -7.3 52.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.923 0.392 . . . . 0.0 110.26 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.93 -23.38 31.52 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.984 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.3 -24.52 55.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.847 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.11 -55.93 26.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.137 179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.25 -34.96 72.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.408 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -60.9 -50.97 71.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.387 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.456 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 5.0 p -64.0 -20.92 66.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.544 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.893 HD11 HG22 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.11 -27.44 62.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.565 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -14.37 58.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.749 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.41 26.34 0.97 Allowed Glycine 0 N--CA 1.451 -0.3 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.897 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.893 HG22 HD11 ' A' ' 71' ' ' LEU . 2.8 tt -73.24 -163.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.55 -0.325 . . . . 0.0 110.906 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.711 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -52.16 90.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.989 0.423 . . . . 0.0 110.862 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.08 -24.86 59.01 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.844 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.96 -35.76 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.174 0.511 . . . . 0.0 110.251 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.711 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -95.63 90.39 5.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.771 -179.498 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.406 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.7 OUTLIER -75.06 130.25 38.99 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.9 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.766 HG22 HG21 ' A' ' 82' ' ' VAL . 3.0 mp -100.93 149.12 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.38 -175.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.447 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 28.4 tt0 -85.69 68.99 10.58 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 173.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.766 HG21 HG22 ' A' ' 80' ' ' ILE . 48.7 t -80.47 58.34 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.728 -175.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.36 -3.9 3.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.879 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.675 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 8.3 m-20 -85.15 124.3 31.66 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.03 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.2 p -148.83 136.58 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.241 0.543 . . . . 0.0 111.653 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.549 HH21 ' HB3' ' A' ' 84' ' ' ASP . 1.1 mpt_? -134.52 87.42 2.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.919 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.42 82.2 7.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.301 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.445 HD21 ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -82.93 90.46 6.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.663 179.26 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.44 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.476 ' H1 ' ' HB2' ' A' ' 88' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -159.93 -3.27 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.646 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.525 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 3.5 p30 -94.85 142.89 26.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.329 -0.435 . . . . 0.0 111.46 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.627 HG13 ' HA ' ' A' ' 87' ' ' ARG . 1.8 t -98.14 103.01 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.329 177.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.525 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 14.5 t -104.31 115.05 45.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.874 0.368 . . . . 0.0 111.752 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -97.31 165.05 12.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.668 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 8.5 m -140.67 131.45 25.81 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.643 0.735 . . . . 0.0 112.019 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.696 HG13 HH21 ' A' ' 29' ' ' ARG . 2.6 mm -124.32 106.0 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.667 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.728 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.55 95.26 7.86 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.766 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.4 m -92.89 136.05 26.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.804 0.335 . . . . 0.0 111.897 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.782 ' HE1' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -146.41 120.1 5.18 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 121.142 0.496 . . . . 0.0 111.81 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.593 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.4 Cg_exo -69.34 122.88 9.67 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.419 2.746 . . . . 0.0 111.9 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.57 -29.63 64.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.291 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.5 p -76.34 151.09 83.19 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.143 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 46.5 Cg_endo -67.41 -6.77 17.26 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.237 1.958 . . . . 0.0 111.457 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.17 35.63 0.99 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.435 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.546 HG11 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -68.12 83.8 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.93 0.871 . . . . 0.0 110.588 -179.046 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.557 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 19.4 m-20 -73.08 98.38 2.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.902 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.777 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -63.66 -43.81 95.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.589 -178.068 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.879 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 4.1 tp10 -69.23 -37.0 77.8 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.85 0.357 . . . . 0.0 110.321 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.561 ' O ' ' HD3' ' A' ' 24' ' ' LYS . . . -68.8 -38.12 79.72 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.557 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -68.12 -24.82 65.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.2 177.218 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.879 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -58.59 -44.9 89.99 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.24 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.561 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -68.62 -40.01 80.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.762 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.715 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 4.9 mm-40 -67.8 -29.4 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.336 0.588 . . . . 0.0 110.302 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.701 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.2 mt -63.92 -38.38 82.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.036 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.517 ' NE2' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -60.85 -40.95 94.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.221 -179.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.715 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -77.77 -20.8 52.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.514 -178.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.701 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.23 -11.95 45.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.342 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.708 HG13 HD21 ' A' ' 36' ' ' LEU . 20.4 mm -60.11 138.28 91.26 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.239 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.532 ' N ' HG23 ' A' ' 30' ' ' ILE . 9.2 Cg_endo -50.68 114.71 1.59 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.793 2.328 . . . . 0.0 112.062 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.33 2.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.47 -45.73 6.78 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.789 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.669 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -130.36 -133.35 0.21 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.664 0.232 . . . . 0.0 111.175 -179.515 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -136.63 170.08 16.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.905 0.383 . . . . 0.0 110.941 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.708 HD21 HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -75.59 -174.09 2.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.108 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.515 ' ND1' HG22 ' A' ' 56' ' ' VAL . 85.2 t60 -130.45 -76.03 0.53 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.328 0.585 . . . . 0.0 110.939 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.544 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -164.91 126.67 2.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.868 -178.594 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.75 HD12 HG23 ' A' ' 53' ' ' VAL . 2.8 mt -90.8 159.82 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.986 0.422 . . . . 0.0 111.865 -177.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.629 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.12 124.75 39.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.946 -178.147 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.67 68.82 10.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.914 0.388 . . . . 0.0 110.216 177.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.11 137.41 21.24 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.616 -179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.773 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 73.7 Cg_endo -86.03 156.72 9.93 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.486 2.124 . . . . 0.0 112.738 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.414 HG21 HD11 ' A' ' 44' ' ' ILE . 4.1 mm -124.56 -82.23 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.3 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.521 ' HB1' ' HG ' ' A' ' 48' ' ' LEU . . . -67.02 -152.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.992 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -71.8 -28.12 63.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.707 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.92 4.62 0.46 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.101 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.782 HD13 ' HE1' ' A' ' 11' ' ' MET . 5.5 mt -92.43 104.24 16.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.842 0.353 . . . . 0.0 110.966 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 76.3 t -93.12 131.35 40.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.858 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.489 ' HB1' ' HB2' ' A' ' 11' ' ' MET . . . -96.25 164.19 12.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.072 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.777 HD12 ' HB2' ' A' ' 19' ' ' LEU . 11.3 mp -120.63 117.69 28.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.211 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.529 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.2 m120 -90.47 92.05 8.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.254 0.55 . . . . 0.0 110.422 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.75 HG23 HD12 ' A' ' 39' ' ' ILE . 4.3 t -87.31 101.96 11.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.583 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.469 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 33.4 mtt -84.71 165.91 17.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.218 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.1 m -139.63 133.76 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.38 . . . . 0.0 111.678 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.515 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -98.36 113.47 33.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 178.474 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.5 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 7.7 m -130.49 142.54 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.979 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.38 -62.12 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.583 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.92 -12.19 59.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.002 0.43 . . . . 0.0 110.706 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.669 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -68.07 -144.53 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.106 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.29 -166.82 2.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.72 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.71 15.28 20.7 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.682 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.67 -0.51 32.69 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.602 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.427 HG23 ' HG1' ' A' ' 34' ' ' THR . 1.9 p -74.16 -2.21 23.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.972 0.415 . . . . 0.0 110.148 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -55.07 -24.41 25.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.348 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.78 -27.27 59.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.08 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.526 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.51 -56.12 23.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.809 0.338 . . . . 0.0 110.362 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -58.75 -34.22 71.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.362 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.53 -51.45 68.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.325 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.7 p -63.19 -19.05 64.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.561 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.731 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.59 -28.79 61.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.59 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -13.51 47.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.531 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.9 30.92 1.0 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.392 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.731 ' HB ' ' HA ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -72.85 -166.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.165 -0.517 . . . . 0.0 111.173 -178.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.66 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 1.4 mp0 -51.05 100.33 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.888 0.375 . . . . 0.0 111.007 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.15 -30.83 71.41 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.794 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 t -87.92 -37.27 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.803 0.335 . . . . 0.0 110.744 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.66 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 32.2 t -95.77 92.42 6.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.844 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.427 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -76.58 132.26 39.37 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.306 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.766 HG12 ' HB ' ' A' ' 10' ' ' VAL . 8.0 mt -100.58 144.7 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.088 -175.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.493 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.3 tt0 -85.24 69.56 10.76 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.585 ' CG2' ' HB ' ' A' ' 80' ' ' ILE . 48.0 t -81.43 56.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 113.92 -1.491 . . . . 0.0 111.249 -174.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -132.44 -0.12 3.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.929 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.668 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 5.5 m-20 -85.45 135.82 33.7 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.251 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.3 p -149.57 152.1 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.554 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.587 ' HB3' HD23 ' A' ' 88' ' ' LEU . 6.8 mtt180 -149.41 75.2 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.264 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.627 ' HA ' HG13 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -81.48 78.27 8.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.557 -178.847 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.587 HD23 ' HB3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -82.8 102.62 11.71 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.417 178.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.969 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ttm . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.663 0.268 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.57 -10.04 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.49 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 12.4 p-10 -90.17 147.12 23.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 111.26 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 2.7 t -98.18 125.88 51.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.35 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.452 HG22 HD13 ' A' ' 88' ' ' LEU . 21.7 t -113.92 109.74 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.427 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.582 ' HB2' HG23 ' A' ' 55' ' ' VAL . . . -94.66 165.41 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 177.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.783 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.6 m -141.9 132.63 25.62 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.715 0.769 . . . . 0.0 112.273 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.76 HG22 HG22 ' A' ' 80' ' ' ILE . 4.3 mm -123.77 106.79 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.457 -178.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.542 ' C ' HG21 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.62 96.45 8.65 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.221 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.481 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.6 m -94.62 137.62 22.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.904 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.664 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.2 OUTLIER -147.39 121.72 5.06 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 121.264 0.554 . . . . 0.0 111.984 179.251 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.497 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 18.7 Cg_exo -71.02 124.11 10.28 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.599 2.866 . . . . 0.0 112.15 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -57.9 -31.42 66.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.444 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.2 m -77.64 150.64 79.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.04 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.683 ' HA ' HD23 ' A' ' 48' ' ' LEU . 40.1 Cg_endo -66.66 -6.51 15.6 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.379 2.052 . . . . 0.0 111.942 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.53 34.0 0.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.405 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.675 HG12 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.52 84.54 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 121.774 0.797 . . . . 0.0 110.111 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 11.5 m-20 -71.64 108.73 5.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.197 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.592 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -63.45 -43.62 96.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.793 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.592 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 20.6 tp10 -68.95 -39.19 79.68 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.655 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.485 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -69.92 -36.54 75.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.44 0.638 . . . . 0.0 109.93 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -66.48 -33.89 76.71 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.48 177.383 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.528 ' HA ' HD11 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -58.82 -45.65 89.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.079 -179.737 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.512 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -68.88 -39.85 79.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.138 0.494 . . . . 0.0 110.385 179.121 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.512 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 31.9 mm-40 -66.01 -29.34 69.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.254 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.738 HG21 HG21 ' A' ' 53' ' ' VAL . 2.1 mt -62.22 -44.42 99.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.964 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.72 -36.72 77.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.985 0.421 . . . . 0.0 110.539 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -75.37 -23.93 57.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.687 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.715 ' HB2' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.05 -14.27 39.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.524 -178.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.599 HG23 ' HD2' ' A' ' 31' ' ' PRO . 39.1 mm -58.55 136.82 86.04 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.461 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.599 ' HD2' HG23 ' A' ' 30' ' ' ILE . 17.7 Cg_endo -58.89 131.24 40.72 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.372 2.048 . . . . 0.0 112.534 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -61.0 0.53 0.22 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.962 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.52 -59.03 2.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.708 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.9 -143.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.668 0.27 . . . . 0.0 110.885 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -136.41 167.8 20.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.87 0.367 . . . . 0.0 110.711 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -75.08 -175.71 2.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.108 -179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.523 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 81.4 t60 -131.52 -75.88 0.52 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.315 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -159.37 132.08 6.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.048 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.741 HD12 HG21 ' A' ' 53' ' ' VAL . 1.7 mt -93.37 161.23 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.013 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.618 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.76 123.52 35.5 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.593 -178.639 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -85.56 71.16 10.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.897 0.38 . . . . 0.0 110.674 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -98.65 136.28 20.8 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.739 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.754 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 61.5 Cg_endo -87.64 157.26 7.69 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.662 2.241 . . . . 0.0 112.877 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.428 HG13 ' SD ' ' A' ' 11' ' ' MET . 3.2 mm -125.41 -82.75 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.428 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.653 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.26 -150.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.16 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -71.36 -31.49 67.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.592 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.43 6.73 0.58 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.771 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.683 HD23 ' HA ' ' A' ' 15' ' ' PRO . 3.9 mt -91.11 102.26 15.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.822 0.344 . . . . 0.0 110.771 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 70.2 t -93.32 129.65 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.966 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.54 ' HB3' ' HB3' ' A' ' 11' ' ' MET . . . -95.42 155.96 16.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.889 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.618 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.3 mp -114.45 118.09 32.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.392 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.517 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.2 m120 -89.9 92.56 9.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.245 0.545 . . . . 0.0 110.09 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.741 HG21 HD12 ' A' ' 39' ' ' ILE . 6.3 t -86.54 105.77 15.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.445 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.45 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 50.6 mtt -84.46 166.67 17.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.409 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.582 HG23 ' HB2' ' A' ' 6' ' ' ALA . 3.5 m -138.78 127.57 29.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.237 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.523 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 0.7 OUTLIER -95.68 108.25 20.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.598 179.254 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.405 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 3.3 m -125.41 167.03 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.817 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.73 -75.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.842 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -81.3 2.57 27.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 0.0 110.99 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.78 -147.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.116 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.74 -166.48 2.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.683 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.91 15.16 22.54 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.591 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.39 -5.56 55.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.549 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.08 -4.6 36.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.908 0.385 . . . . 0.0 110.383 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.02 -23.65 20.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.044 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.18 -27.78 62.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.937 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.42 ' HB2' ' HD3' ' A' ' 31' ' ' PRO . . . -60.54 -56.54 20.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.353 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -58.74 -34.83 71.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.447 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -60.71 -51.96 67.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.471 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.412 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -64.04 -19.33 65.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.572 178.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.851 HD11 HG22 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -72.92 -28.76 62.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.559 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -11.88 43.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.954 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.2 25.29 0.99 Allowed Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.75 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.851 HG22 HD11 ' A' ' 71' ' ' LEU . 2.6 tt -73.32 -163.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.47 -0.365 . . . . 0.0 111.059 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.513 ' H ' HG12 ' A' ' 74' ' ' ILE . 1.8 mp0 -51.01 96.51 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.81 0.338 . . . . 0.0 111.003 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.43 -27.34 69.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.281 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.464 HG12 ' N ' ' A' ' 78' ' ' SER . 2.0 p -88.27 -37.94 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.173 0.511 . . . . 0.0 110.435 179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 11' ' ' MET . 0.7 OUTLIER -96.23 90.0 5.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.424 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.566 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.57 134.77 38.18 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.472 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.808 HG22 HG21 ' A' ' 82' ' ' VAL . 1.7 mt -101.54 147.42 8.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.563 -176.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.504 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 9.7 tp10 -86.02 70.39 10.6 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 173.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.808 HG21 HG22 ' A' ' 80' ' ' ILE . 58.2 t -80.46 52.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.999 -174.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -133.0 3.61 3.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.575 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.783 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 18.8 t0 -85.4 130.64 34.54 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.052 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.486 HG21 ' HD2' ' A' ' 87' ' ' ARG . 4.7 p -148.08 146.04 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.022 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.26 95.15 2.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.149 0.5 . . . . 0.0 109.967 -178.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.486 ' HD2' HG21 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -85.13 106.15 16.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.399 -177.316 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.452 HD13 HG22 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -86.7 89.17 7.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.172 176.171 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.6 ttm . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.026 179.984 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.425 ' HB3' ' OXT' ' A' ' 89' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.862 0.363 . . . . 0.0 111.298 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 89' ' ' MET . . . 173.72 -0.59 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.153 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.692 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -90.19 156.8 18.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 111.464 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.463 ' O ' HG21 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -100.88 128.69 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.741 178.136 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 13.1 t -125.54 118.34 52.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.039 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -94.74 169.76 9.93 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.676 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 10.0 m -143.04 131.85 22.71 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.587 0.708 . . . . 0.0 112.011 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.747 HG23 HG22 ' A' ' 80' ' ' ILE . 7.3 mm -122.98 107.52 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.896 -177.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.567 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -97.28 95.28 7.6 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -177.7 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.533 ' HB ' HG12 ' A' ' 80' ' ' ILE . 2.0 m -94.64 136.71 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.78 ' HE1' HD11 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -147.53 121.11 4.88 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 121.036 0.446 . . . . 0.0 111.76 179.475 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 17.2 Cg_exo -71.82 118.64 5.74 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.522 2.815 . . . . 0.0 111.946 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -56.21 -28.36 58.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.133 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.38 149.21 78.49 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.106 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.536 ' HA ' HD22 ' A' ' 48' ' ' LEU . 37.9 Cg_endo -66.03 -7.68 17.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.401 2.068 . . . . 0.0 111.92 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.1 36.06 1.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.698 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.16 87.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.79 0.805 . . . . 0.0 110.09 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.604 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 28.0 m-20 -68.32 107.19 2.74 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.336 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.712 HD23 HD12 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -60.45 -54.81 41.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.66 -178.619 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.525 ' HG2' ' N ' ' A' ' 21' ' ' ALA . 7.6 pm0 -71.29 -34.46 70.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.279 -177.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.604 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . . . -67.92 -35.71 78.92 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.604 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -65.77 -35.25 80.19 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.234 176.159 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.539 ' NZ ' HD13 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -55.93 -46.83 78.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.034 178.541 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.604 ' HE3' ' HA ' ' A' ' 21' ' ' ALA . 2.6 mtmt -66.41 -43.8 84.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.815 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.72 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 52.9 mt-10 -67.58 -27.0 66.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.247 0.546 . . . . 0.0 110.969 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.67 HG12 HG23 ' A' ' 53' ' ' VAL . 1.1 mt -63.06 -43.14 98.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.951 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -62.56 -37.57 86.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.26 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.72 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 1.4 pp20? -77.21 -22.67 51.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.405 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.767 ' HB2' HD12 ' A' ' 74' ' ' ILE . 4.3 ptp85 -90.6 -11.95 38.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.088 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.626 HG12 ' O ' ' A' ' 26' ' ' ILE . 10.9 mm -61.57 139.29 95.13 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.87 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.578 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 7.3 Cg_endo -47.88 115.87 1.67 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.854 2.37 . . . . 0.0 112.445 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -59.38 0.74 0.1 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.105 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.92 -43.15 7.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.003 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.473 HG21 ' HB3' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.15 -139.01 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.712 0.292 . . . . 0.0 111.246 -179.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -135.64 169.9 16.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.881 0.372 . . . . 0.0 110.932 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.444 ' O ' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -76.38 -175.91 3.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.229 -179.532 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.442 ' HB2' HG23 ' A' ' 56' ' ' VAL . 84.3 t60 -131.01 -74.74 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.412 0.625 . . . . 0.0 110.952 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.44 ' HB3' ' CD2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -163.88 129.27 2.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.667 -178.926 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.66 HG12 HG12 ' A' ' 53' ' ' VAL . 2.8 mt -93.08 155.85 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -176.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.627 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.7 m-20 -117.97 123.0 44.69 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.971 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -88.34 67.68 8.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.96 0.409 . . . . 0.0 110.142 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.533 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.98 148.54 34.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.368 -178.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.729 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 30.6 Cg_endo -92.49 160.53 2.97 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.996 2.464 . . . . 0.0 113.266 -177.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.426 ' HB ' ' H ' ' A' ' 45' ' ' ALA . 4.2 mm -128.85 -82.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.248 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.479 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . . . -66.91 -151.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.924 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -72.27 -28.55 63.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.67 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.07 4.99 0.46 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.1 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.78 HD11 ' HE1' ' A' ' 11' ' ' MET . 5.9 mt -92.1 106.1 18.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.89 0.345 . . . . 0.0 110.906 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.729 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 24.2 t -92.59 132.22 37.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.814 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.569 ' C ' HD11 ' A' ' 51' ' ' LEU . . . -96.18 163.29 13.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.85 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.712 HD12 HD23 ' A' ' 19' ' ' LEU . 11.0 mp -120.57 116.17 24.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.513 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.583 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.7 m120 -89.65 91.0 8.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.379 0.609 . . . . 0.0 110.046 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.67 HG23 HG12 ' A' ' 26' ' ' ILE . 3.8 t -87.16 105.65 15.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.576 -177.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.455 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 62.8 mtt -84.71 165.31 17.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.937 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.3 m -138.69 136.77 43.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.886 0.374 . . . . 0.0 111.581 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -94.74 108.42 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.778 178.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 4' ' ' VAL . 21.9 m -125.39 137.96 55.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.855 0.359 . . . . 0.0 110.975 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.89 -58.72 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.331 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -81.08 -16.58 52.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.084 0.469 . . . . 0.0 110.4 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.473 ' HB3' HG21 ' A' ' 34' ' ' THR . . . -68.15 -144.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.17 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.5 -163.35 1.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.785 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.9 13.75 29.42 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.544 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.37 -1.24 34.65 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.639 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.419 HG23 ' OG1' ' A' ' 34' ' ' THR . 3.1 p -74.75 -4.14 35.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.968 0.413 . . . . 0.0 110.205 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -54.96 -23.91 21.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.337 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.07 -25.6 58.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.159 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.48 -56.59 18.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.8 0.334 . . . . 0.0 110.244 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -58.97 -34.0 71.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.276 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.94 -51.02 69.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.307 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -18.23 63.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.263 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.836 HD11 HG21 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.65 -29.7 62.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.482 179.401 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -10.74 31.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.782 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.1 25.08 1.0 Allowed Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.836 HG21 HD11 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -73.32 -168.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.338 -0.431 . . . . 0.0 111.235 -179.04 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.416 ' H ' ' CG1' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -51.09 93.5 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.353 179.137 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.2 -26.32 61.23 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.018 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -87.99 -41.16 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.181 0.515 . . . . 0.0 110.186 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.549 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -95.9 87.97 4.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.122 178.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.545 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.81 135.74 38.0 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.263 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.786 HG22 HG22 ' A' ' 82' ' ' VAL . 1.7 mt -101.5 147.72 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.469 -176.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.567 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 7.2 tp10 -86.07 71.09 10.62 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 172.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.786 HG22 HG22 ' A' ' 80' ' ' ILE . 59.0 t -80.68 52.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.063 -174.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 m -132.8 4.57 3.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.402 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.676 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.2 m-20 -85.03 140.65 30.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.169 -178.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 p -148.15 157.67 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.221 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.45 ' O ' HD22 ' A' ' 88' ' ' LEU . 8.8 mtt180 -149.24 90.64 1.76 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.107 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.24 89.81 5.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.853 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.45 HD22 ' O ' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -81.38 89.65 6.12 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.629 179.545 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.425 ' OXT' ' HB3' ' A' ' 1' ' ' MET . 9.1 ptp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.964 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.873 0.368 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.23 -20.55 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -95.4 164.66 12.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.152 -0.524 . . . . 0.0 111.138 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.865 HG12 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -97.95 117.68 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.048 0.452 . . . . 0.0 110.17 177.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 40.8 t -109.71 120.36 60.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.492 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -95.03 167.91 11.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.669 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 11.4 m -141.65 131.37 24.18 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.6 0.714 . . . . 0.0 112.185 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.672 HG21 HG23 ' A' ' 80' ' ' ILE . 2.1 mm -120.56 105.01 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.688 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.727 ' C ' HG21 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -96.38 93.98 7.16 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.738 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.4 m -92.02 136.91 23.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.84 -177.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.784 ' HE3' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -147.32 119.26 4.67 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 121.131 0.491 . . . . 0.0 111.878 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 17.8 Cg_exo -70.96 122.22 8.59 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.49 2.794 . . . . 0.0 112.198 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.89 -30.3 65.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.388 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.8 148.32 75.73 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.012 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.491 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 36.8 Cg_endo -64.74 -6.56 12.65 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.399 2.066 . . . . 0.0 111.774 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -92.03 34.05 1.03 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.6 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.3 87.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.832 0.825 . . . . 0.0 110.124 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.604 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 74.2 m-20 -69.11 104.14 2.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.127 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.86 ' HG ' HD11 ' A' ' 51' ' ' LEU . 1.4 tt -61.05 -52.17 66.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.539 -178.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.688 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -70.5 -36.32 73.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.079 -177.812 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.2 -34.63 76.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.157 0.503 . . . . 0.0 109.758 177.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.604 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -65.68 -32.12 73.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.861 177.687 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.688 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -54.71 -47.65 73.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.505 179.01 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -66.6 -42.48 86.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.736 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -65.55 -29.3 69.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.185 0.516 . . . . 0.0 110.391 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.731 HG22 HD12 ' A' ' 39' ' ' ILE . 2.0 mt -61.83 -45.58 98.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.217 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -60.49 -35.86 76.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.717 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 17.5 mm-40 -74.17 -23.74 59.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.559 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.762 ' HD3' HD11 ' A' ' 74' ' ' ILE . 2.4 ptp180 -92.57 -14.54 28.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.842 -178.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.541 HG23 ' N ' ' A' ' 31' ' ' PRO . 15.2 mm -58.74 139.82 86.07 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.102 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.714 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.4 Cg_endo -50.82 112.16 0.71 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.838 2.359 . . . . 0.0 112.348 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 0.6 0.11 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.341 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.08 -40.01 9.62 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.042 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.36 -137.8 0.21 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.647 0.223 . . . . 0.0 110.882 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -136.63 166.9 22.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 111.048 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.484 ' HB3' HD11 ' A' ' 30' ' ' ILE . 0.2 OUTLIER -76.01 -175.45 3.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.269 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.551 ' ND1' HG22 ' A' ' 56' ' ' VAL . 82.4 t60 -130.73 -74.97 0.53 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.315 0.578 . . . . 0.0 110.829 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.577 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -164.22 132.6 3.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.998 -178.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.743 HD12 HG22 ' A' ' 53' ' ' VAL . 2.8 mt -94.39 158.38 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.683 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.1 t0 -123.88 128.55 49.63 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.381 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.474 ' HG2' HD22 ' A' ' 19' ' ' LEU . 13.4 mt-10 -90.8 69.06 6.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.228 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.526 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -100.92 148.03 34.51 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.264 -178.437 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.735 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 21.2 Cg_endo -91.7 159.75 3.48 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.043 2.495 . . . . 0.0 113.362 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.446 ' HB ' ' H ' ' A' ' 45' ' ' ALA . 5.0 mm -127.95 -83.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.248 -178.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.449 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.34 -151.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.031 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -72.11 -28.76 63.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.73 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.2 3.98 0.41 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.126 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.784 HD13 ' HE3' ' A' ' 11' ' ' MET . 6.9 mt -91.21 106.09 18.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.892 0.377 . . . . 0.0 110.777 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.735 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 40.7 t -92.95 132.06 38.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.694 -178.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.526 ' C ' HD13 ' A' ' 51' ' ' LEU . . . -96.27 164.09 12.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.093 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.86 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.3 mp -120.64 116.0 24.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.28 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.629 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.1 m120 -89.86 91.93 8.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.315 0.579 . . . . 0.0 110.378 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.743 HG22 HD12 ' A' ' 39' ' ' ILE . 4.6 t -86.8 105.21 14.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.536 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.544 ' HG3' HG21 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.6 164.61 18.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.169 178.836 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.1 m -139.24 141.06 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 111.572 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.551 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.9 t -93.07 100.4 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.668 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.865 HG23 HG12 ' A' ' 4' ' ' VAL . 27.2 m -130.15 140.35 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.046 0.45 . . . . 0.0 111.544 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.32 -61.67 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.51 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -81.34 -7.68 59.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.038 0.446 . . . . 0.0 110.625 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.77 -139.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.132 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -147.01 -166.27 2.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.77 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.58 12.88 31.79 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.638 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.15 -9.54 63.87 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.512 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.426 HG22 HG12 ' A' ' 57' ' ' VAL . 1.1 p -74.48 -5.99 45.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.857 0.361 . . . . 0.0 110.42 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -54.72 -23.79 19.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.056 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.93 -28.59 57.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.952 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.714 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.09 -57.59 11.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.401 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -59.53 -33.59 71.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.451 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.85 -51.42 68.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.238 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.404 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.3 t -63.48 -18.03 63.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.139 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.662 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.23 -29.91 63.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.478 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -12.86 44.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.709 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.26 27.41 0.99 Allowed Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.642 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.762 HD11 ' HD3' ' A' ' 29' ' ' ARG . 1.3 tt -73.17 -162.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.411 . . . . 0.0 111.187 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.534 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 1.7 mm-40 -50.89 94.13 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.141 0.496 . . . . 0.0 110.792 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.06 -32.42 62.8 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.692 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.552 HG11 ' N ' ' A' ' 78' ' ' SER . 0.4 OUTLIER -87.44 -36.82 10.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 0.0 110.364 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.552 ' N ' HG11 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -96.0 89.01 5.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.206 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.569 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -75.88 133.87 40.44 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.369 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.738 HG12 ' HB ' ' A' ' 10' ' ' VAL . 6.2 mt -101.12 144.82 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.068 -175.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.561 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 19.4 tp10 -85.34 69.96 10.77 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.595 HG23 ' HB ' ' A' ' 80' ' ' ILE . 49.1 t -80.8 48.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.035 -174.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 m -132.34 8.14 4.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.23 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.669 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.3 m-20 -84.11 150.37 25.59 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.88 0.371 . . . . 0.0 110.928 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.5 p -148.31 154.56 10.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.534 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.513 ' O ' HD22 ' A' ' 88' ' ' LEU . 6.9 mtt180 -150.52 84.8 1.37 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.227 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.52 85.67 5.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.62 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.513 HD22 ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -83.76 98.09 9.5 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.262 177.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.434 ' HE3' ' HB2' ' A' ' 89' ' ' MET . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.85 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.828 0.347 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.87 7.87 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.786 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.502 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 3.7 m-20 -88.63 147.74 24.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.811 0.339 . . . . 0.0 111.268 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -106.92 107.84 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.0 178.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.542 ' HB ' ' HG2' ' A' ' 86' ' ' ARG . 2.6 t -107.59 113.53 43.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.657 0.265 . . . . 0.0 111.369 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -94.68 167.17 11.63 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.257 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.783 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 7.5 m -143.15 131.19 21.76 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.537 0.684 . . . . 0.0 112.312 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.692 HG22 HG23 ' A' ' 80' ' ' ILE . 3.5 mm -125.01 108.29 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.763 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.648 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -96.15 95.05 7.88 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.553 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.4 m -93.89 138.49 20.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.632 ' O ' ' HG3' ' A' ' 11' ' ' MET . 1.2 ptm -145.49 125.37 7.03 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.353 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.623 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.1 Cg_exo -71.47 121.92 8.16 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.155 2.57 . . . . 0.0 112.077 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.32 -32.36 66.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.345 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.25 152.57 79.09 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.078 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.576 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 41.1 Cg_endo -67.31 -3.36 9.81 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.388 2.059 . . . . 0.0 112.204 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -90.87 43.89 1.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.927 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.628 HG21 HD22 ' A' ' 48' ' ' LEU . 93.1 t -65.59 75.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.37 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.568 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 81.9 m-20 -70.49 95.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.915 177.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.514 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -64.1 -43.63 94.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.5 -178.351 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.514 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 5.3 tp10 -68.36 -38.16 81.17 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.744 0.307 . . . . 0.0 110.412 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.431 ' O ' ' HG2' ' A' ' 24' ' ' LYS . . . -69.62 -39.82 76.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.372 0.606 . . . . 0.0 109.815 177.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.568 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -67.62 -30.66 70.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.035 177.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -46.75 81.7 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.775 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.519 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -69.26 -40.45 77.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.571 179.531 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.519 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 1.3 mt-10 -65.24 -28.04 69.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.117 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.787 HG23 HE21 ' A' ' 27' ' ' GLN . 0.5 OUTLIER -62.44 -47.12 94.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.354 179.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.787 HE21 HG23 ' A' ' 26' ' ' ILE . 6.2 mm-40 -62.68 -31.61 72.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.829 0.347 . . . . 0.0 110.721 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 17.7 mm-40 -74.72 -24.84 58.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.007 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.654 HH11 HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.46 -14.52 37.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.333 -179.128 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.815 HG13 HD11 ' A' ' 36' ' ' LEU . 24.8 mm -57.61 137.29 82.37 Favored Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.716 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.497 ' N ' HG21 ' A' ' 30' ' ' ILE . 4.5 Cg_endo -45.66 122.01 4.57 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.885 2.39 . . . . 0.0 112.169 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.37 -4.82 0.25 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.046 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.03 -41.4 8.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.73 -179.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.43 -146.54 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.674 0.273 . . . . 0.0 111.198 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -138.62 177.58 7.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.242 0.544 . . . . 0.0 111.185 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.815 HD11 HG13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -74.96 -178.24 3.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.434 -179.183 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.57 ' ND1' HG12 ' A' ' 56' ' ' VAL . 72.4 t60 -131.13 -71.24 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.66 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 7.2 mmtm -161.64 125.16 3.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.081 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.81 HD11 HG23 ' A' ' 53' ' ' VAL . 2.8 mt -92.1 160.49 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.781 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.644 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -129.17 125.0 36.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.726 -178.311 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -85.43 72.03 10.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.841 0.353 . . . . 0.0 110.548 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -98.09 134.73 21.82 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.621 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.749 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 56.8 Cg_endo -86.53 155.0 9.11 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.577 2.185 . . . . 0.0 112.782 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.2 mm -123.87 -82.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.403 -177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.21 -153.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.054 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -71.81 -27.99 63.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.805 0.336 . . . . 0.0 110.593 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.62 5.12 0.51 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.951 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.628 HD22 HG21 ' A' ' 17' ' ' VAL . 5.8 mt -92.22 101.36 13.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.784 0.326 . . . . 0.0 110.839 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.749 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 90.4 t -93.38 129.36 43.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.783 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.568 ' HB1' ' HB3' ' A' ' 11' ' ' MET . . . -95.24 162.94 13.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.022 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.644 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.2 mp -120.53 120.27 35.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.435 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.539 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.3 m120 -89.66 91.71 8.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.271 0.558 . . . . 0.0 109.813 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.81 HG23 HD11 ' A' ' 39' ' ' ILE . 12.4 t -86.82 106.35 15.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.793 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 6.2 mtt -85.63 165.23 17.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.031 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.1 m -140.3 134.35 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.903 0.383 . . . . 0.0 111.245 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.57 HG12 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.55 113.21 30.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.06 179.284 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 m -130.35 144.8 36.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.885 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.07 -63.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.25 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -81.09 -7.9 59.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 110.402 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.27 -147.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.992 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.56 -162.02 1.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.343 . . . . 0.0 110.782 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.62 11.91 37.16 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.38 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.43 -3.01 45.72 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.585 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 p -74.03 -5.49 41.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.934 0.397 . . . . 0.0 110.358 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -55.13 -24.36 25.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.193 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.2 -25.45 59.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.105 -179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.77 -57.26 13.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.164 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.37 -33.63 71.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.325 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -61.11 -52.13 66.21 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.501 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.78 -19.86 65.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.621 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.701 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.63 -28.08 62.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.69 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -15.1 57.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.731 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.39 29.33 0.96 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.701 ' HB ' ' HA ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -73.08 -165.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.253 -0.474 . . . . 0.0 111.279 -178.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.776 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 3.0 pm0 -51.63 89.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.658 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 74' ' ' ILE . . . -59.46 -26.99 62.75 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.937 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 78' ' ' SER . 2.7 p -86.06 -34.76 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.254 0.549 . . . . 0.0 110.2 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.776 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -95.71 89.07 5.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.626 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.403 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -74.68 128.86 36.58 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.206 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.786 HG23 HG22 ' A' ' 82' ' ' VAL . 1.9 mp -101.11 148.88 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.576 -175.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.648 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.1 tp10 -85.78 71.44 10.67 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 172.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.786 HG22 HG23 ' A' ' 80' ' ' ILE . 62.5 t -80.06 50.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.036 -173.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -132.93 7.12 4.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.176 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.783 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 26.8 t0 -85.82 133.31 33.98 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.934 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -147.25 147.44 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.131 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.542 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -145.45 81.56 1.62 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.878 0.847 . . . . 0.0 109.242 179.19 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.447 ' HB3' ' SD ' ' A' ' 89' ' ' MET . 0.9 OUTLIER -81.04 107.6 14.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.873 -177.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -86.12 86.67 7.35 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.438 177.145 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.447 ' SD ' ' HB3' ' A' ' 87' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.022 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.484 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 9.7 ttp . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.96 0.409 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.51 -8.4 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -94.8 169.44 10.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.279 -0.461 . . . . 0.0 111.62 179.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.869 HG11 HG22 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -105.22 116.38 48.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.891 177.333 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.699 ' HB ' ' HB2' ' A' ' 86' ' ' ARG . 4.8 t -106.96 117.26 52.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 121.046 -0.261 . . . . 0.0 111.66 -178.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -92.68 162.27 14.22 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.043 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.782 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 11.3 m -143.16 131.06 21.58 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.592 0.71 . . . . 0.0 112.309 -178.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.746 HG21 HG22 ' A' ' 80' ' ' ILE . 2.7 mm -120.22 106.05 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.628 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.666 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -93.62 92.35 7.49 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.326 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.478 HG22 ' O ' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -92.42 138.13 20.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.117 -177.019 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.78 ' HE3' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -145.73 119.05 5.29 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.074 179.312 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.525 ' HB2' HG23 ' A' ' 17' ' ' VAL . 14.9 Cg_exo -69.23 120.25 7.14 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.252 2.635 . . . . 0.0 112.137 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -57.42 -30.33 64.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.475 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.79 151.62 79.73 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.078 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.536 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 40.8 Cg_endo -66.81 -4.28 10.93 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.41 2.074 . . . . 0.0 112.001 179.65 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -91.84 42.35 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.321 179.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.686 HG22 HD21 ' A' ' 48' ' ' LEU . 90.9 t -65.14 78.17 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.166 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.575 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -67.82 100.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.134 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.749 HD12 HD22 ' A' ' 51' ' ' LEU . 1.3 tp -61.54 -51.87 66.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.488 -178.125 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.762 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 8.6 pt-20 -71.54 -34.55 70.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.261 -177.33 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -67.82 -36.21 79.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -64.86 -34.74 79.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.363 176.557 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.762 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -55.59 -48.11 75.38 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.296 178.649 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 3.6 mtmt -65.25 -44.18 88.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.967 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -66.32 -28.72 68.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.172 0.51 . . . . 0.0 110.444 -179.199 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.719 HG21 HD12 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -61.39 -47.46 93.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.495 -179.62 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.557 ' NE2' HD23 ' A' ' 36' ' ' LEU . 7.0 mm100 -63.53 -33.29 75.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.829 0.347 . . . . 0.0 110.798 -178.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 15.4 mt-10 -75.19 -23.56 57.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.925 179.216 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 26' ' ' ILE . 3.2 ptp180 -91.83 -14.66 29.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.414 -179.122 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.669 HD13 HG11 ' A' ' 53' ' ' VAL . 11.0 mm -59.35 141.25 87.7 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.025 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.562 ' N ' HG23 ' A' ' 30' ' ' ILE . 9.2 Cg_endo -51.25 113.55 1.16 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.844 2.363 . . . . 0.0 112.431 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.2 -1.61 0.21 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.328 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.11 -36.89 13.62 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.066 -178.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.54 -140.31 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.725 0.263 . . . . 0.0 111.077 -179.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -136.67 166.11 24.33 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.852 0.358 . . . . 0.0 110.892 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.557 HD23 ' NE2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -76.09 -175.03 2.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.355 -179.262 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.59 ' ND1' HG22 ' A' ' 56' ' ' VAL . 79.8 t60 -131.29 -76.78 0.52 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.278 0.561 . . . . 0.0 110.937 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.499 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -165.27 132.7 3.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.048 -178.793 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.767 HD12 HG23 ' A' ' 53' ' ' VAL . 2.6 mt -93.77 156.18 3.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.065 0.46 . . . . 0.0 112.197 -177.361 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.643 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 74.8 m-20 -122.72 119.2 29.97 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.465 -178.577 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -83.21 73.42 10.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.032 0.444 . . . . 0.0 110.608 178.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 50' ' ' ALA . 0.8 OUTLIER -97.33 132.95 24.48 Favored Pre-proline 0 C--O 1.225 -0.224 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.628 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.75 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 44.2 Cg_endo -85.33 155.21 10.81 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.449 2.099 . . . . 0.0 112.875 -178.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.4 mm -124.03 -83.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.411 -177.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.16 -154.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.018 179.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.97 -26.54 62.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.579 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.65 1.78 0.36 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.23 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.78 HD12 ' HE3' ' A' ' 11' ' ' MET . 5.6 mt -92.44 102.41 14.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.851 0.358 . . . . 0.0 110.875 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.75 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 73.4 t -93.34 132.15 38.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.035 -178.126 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.526 ' HB1' ' HB2' ' A' ' 11' ' ' MET . . . -95.93 153.77 17.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.816 177.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.749 HD22 HD12 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -117.39 120.8 39.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.518 179.377 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.602 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.3 m120 -89.73 93.89 9.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.109 -179.231 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.767 HG23 HD12 ' A' ' 39' ' ' ILE . 17.3 t -85.95 105.58 14.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.558 -177.851 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.556 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 44.2 mtt -86.52 160.51 18.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.35 178.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.483 HG22 HG13 ' A' ' 57' ' ' VAL . 2.8 m -139.05 140.7 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.101 -178.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.59 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.1 t -92.49 100.09 10.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.764 179.111 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.869 HG22 HG11 ' A' ' 4' ' ' VAL . 27.3 m -130.48 139.08 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.988 0.423 . . . . 0.0 111.473 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.73 -61.67 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.557 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.96 -5.4 58.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 110.575 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.41 -139.52 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.125 179.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -146.83 -165.92 2.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.762 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.32 11.09 39.4 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.691 179.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.2 -11.32 67.23 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.526 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -4.45 36.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 0.0 110.319 179.441 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -54.56 -23.9 18.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.387 0.613 . . . . 0.0 109.869 177.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.04 -28.17 56.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.94 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.406 ' HB1' ' HD3' ' A' ' 31' ' ' PRO . . . -60.96 -57.61 11.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.425 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -58.94 -34.06 71.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.455 178.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.96 -52.18 66.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.267 178.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -20.38 65.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.508 179.034 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.828 HD21 HD13 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.84 -26.1 61.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.659 -179.653 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.61 -17.02 63.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.556 178.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.48 31.74 0.93 Allowed Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.704 179.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.828 HD13 HD21 ' A' ' 71' ' ' LEU . 0.8 OUTLIER -73.08 -161.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.278 -0.461 . . . . 0.0 111.24 -178.431 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.687 ' HG3' ' O ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -51.55 88.13 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.219 0.533 . . . . 0.0 110.437 178.935 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 74' ' ' ILE . . . -60.26 -26.63 64.16 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.308 -177.658 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 p -85.44 -34.7 8.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.412 0.625 . . . . 0.0 110.177 179.502 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.687 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -95.57 90.02 5.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.588 -179.314 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.583 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -73.49 128.38 35.34 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.153 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.767 HG22 HG21 ' A' ' 82' ' ' VAL . 2.1 mp -101.16 149.31 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.648 -174.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.666 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 5.8 tp10 -85.65 71.91 10.65 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.767 HG21 HG22 ' A' ' 80' ' ' ILE . 75.7 t -79.73 48.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.93 -173.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -133.1 7.26 3.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.93 178.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.782 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 22.0 t0 -85.64 137.4 32.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.977 -178.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 2.9 p -148.18 167.91 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.112 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.699 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -147.13 107.64 4.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.169 0.509 . . . . 0.0 111.329 -179.036 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -82.76 79.77 9.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.985 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.484 ' HB3' ' N ' ' A' ' 1' ' ' MET . 8.2 mp -81.6 86.35 6.39 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.721 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.883 179.932 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.361 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.61 -4.56 0.03 OUTLIER Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.254 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -90.39 162.09 15.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.962 0.41 . . . . 0.0 111.375 -179.882 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.861 HG11 HG21 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -104.27 134.82 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.958 179.614 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.756 ' HB ' ' HG2' ' A' ' 86' ' ' ARG . 57.5 t -124.06 120.18 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.746 0.308 . . . . 0.0 111.605 179.233 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -98.05 166.44 11.43 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.689 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 14.2 m -140.52 136.48 32.94 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.6 0.714 . . . . 0.0 112.267 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.786 HG22 HG21 ' A' ' 80' ' ' ILE . 2.3 mm -125.71 106.94 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.573 -178.055 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.555 ' C ' HG23 ' A' ' 80' ' ' ILE . 1.6 mmmt -95.79 93.83 7.31 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.816 0.341 . . . . 0.0 111.892 -178.075 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.488 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 1.9 m -93.71 135.4 28.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -176.521 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.524 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -145.36 124.88 6.91 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.038 178.363 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.65 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.7 Cg_exo -71.79 117.3 5.08 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.147 2.565 . . . . 0.0 111.747 179.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -30.25 59.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.95 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.43 ' O ' HG23 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -77.96 155.1 80.39 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.72 179.454 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.561 ' HA ' HD23 ' A' ' 48' ' ' LEU . 3.8 Cg_exo -72.3 -0.96 9.42 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.562 2.175 . . . . 0.0 111.683 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -92.29 42.97 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.049 178.261 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.65 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 88.4 t -64.85 78.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.089 -178.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.576 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 2.3 m-20 -68.56 101.84 1.35 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.322 178.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.78 HD13 HD11 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -61.58 -53.43 56.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.68 -179.004 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.537 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 23.5 tt0 -69.76 -35.33 74.85 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 -176.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 25' ' ' GLU . . . -68.57 -36.81 79.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.57 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.576 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.1 OUTLIER -64.74 -34.11 77.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.469 177.071 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -57.41 -47.22 82.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.571 179.008 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 7.4 mttt -65.64 -41.92 92.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.649 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 21' ' ' ALA . 33.8 mt-10 -65.74 -31.49 72.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.197 0.523 . . . . 0.0 110.477 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.671 HG22 HD13 ' A' ' 39' ' ' ILE . 6.9 mt -61.38 -44.71 98.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.053 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -61.48 -38.41 87.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.951 0.405 . . . . 0.0 110.772 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 4.7 mm-40 -76.09 -21.94 56.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.689 -178.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.622 ' NH2' ' HB ' ' A' ' 8' ' ' ILE . 22.1 ptt85 -90.35 -13.59 34.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.643 -177.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.658 HG12 ' O ' ' A' ' 26' ' ' ILE . 29.4 mm -59.73 138.6 90.03 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.176 -179.438 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.558 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.1 Cg_endo -51.89 123.77 13.14 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.726 2.284 . . . . 0.0 112.496 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -62.25 2.92 0.21 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.262 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.36 -64.51 1.64 Allowed Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.01 -178.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.6 -131.43 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.348 0.118 . . . . 0.0 110.913 -179.17 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -139.21 166.63 24.03 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.947 0.404 . . . . 0.0 111.013 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -75.9 -172.41 1.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.971 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.501 ' HB2' HG21 ' A' ' 56' ' ' VAL . 84.0 t60 -130.36 -78.85 0.54 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.27 0.557 . . . . 0.0 111.481 -178.15 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.417 ' HB3' ' CD2' ' A' ' 37' ' ' HIS . 1.5 tptp -164.49 130.89 2.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.843 -178.322 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.702 HD13 HG23 ' A' ' 53' ' ' VAL . 2.6 mt -92.0 159.62 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -176.715 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.632 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -127.48 117.08 21.42 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.247 -179.39 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -81.87 72.6 8.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.991 0.424 . . . . 0.0 110.396 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.51 ' O ' HG11 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -97.0 134.86 22.39 Favored Pre-proline 0 C--O 1.225 -0.222 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.69 -179.595 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.75 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 53.7 Cg_endo -85.43 155.4 10.69 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.39 2.06 . . . . 0.0 112.837 -178.73 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.464 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.6 mm -124.88 -83.42 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.269 -177.505 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -66.74 -155.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.764 179.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -72.47 -22.93 60.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.72 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.62 0.93 0.26 Allowed Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.443 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 15' ' ' PRO . 5.6 mt -92.83 103.59 15.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.072 0.436 . . . . 0.0 111.138 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.75 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 72.8 t -93.5 129.14 44.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.891 -179.015 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.576 ' C ' HD23 ' A' ' 51' ' ' LEU . . . -96.1 151.8 19.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.943 178.168 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.78 HD11 HD13 ' A' ' 19' ' ' LEU . 0.2 OUTLIER -115.14 121.27 42.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.538 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.478 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.7 m120 -90.51 92.33 8.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.363 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.702 HG23 HD13 ' A' ' 39' ' ' ILE . 5.9 t -87.49 103.27 13.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.375 -178.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.482 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.7 mpt? -84.41 164.89 18.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.268 178.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.2 m -137.73 136.89 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.365 -178.002 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.501 HG21 ' HB2' ' A' ' 37' ' ' HIS . 1.7 t -94.33 99.13 8.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.744 178.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.861 HG21 HG11 ' A' ' 4' ' ' VAL . 33.3 m -130.47 139.89 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.213 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.86 -57.8 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.595 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -80.85 -11.04 59.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.513 179.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.62 -138.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.109 179.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.401 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 1.6 pt-20 -146.79 -164.38 1.98 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.757 -179.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -80.36 13.07 29.5 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.738 179.358 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.44 -11.49 68.27 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.609 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -74.46 -4.1 34.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.802 0.335 . . . . 0.0 110.422 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -55.19 -23.86 23.97 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.399 0.618 . . . . 0.0 110.055 177.433 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.11 -25.09 58.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.174 -179.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.558 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.54 -57.03 13.71 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.327 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -58.77 -34.06 71.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.218 178.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -62.17 -51.57 67.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.43 178.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.69 -18.95 64.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.401 178.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.611 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.19 -29.53 62.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.512 179.835 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -13.47 51.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.74 179.162 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.27 28.73 0.98 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.672 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.613 HD12 ' HD2' ' A' ' 29' ' ' ARG . 1.2 tt -73.19 -164.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.445 -0.377 . . . . 0.0 110.854 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.629 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -51.96 95.3 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.089 0.471 . . . . 0.0 110.648 179.61 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.74 -30.84 69.98 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.452 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.2 t -85.16 -35.12 9.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.921 0.391 . . . . 0.0 110.38 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.629 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 8.0 m -95.7 88.87 5.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.683 -179.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.57 129.97 38.06 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.491 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.786 HG21 HG22 ' A' ' 8' ' ' ILE . 3.2 mp -101.3 150.05 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.748 -175.269 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.5 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 52.4 tt0 -85.91 70.75 10.67 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 173.016 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.764 HG22 HG21 ' A' ' 80' ' ' ILE . 62.0 t -80.94 50.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.083 -174.53 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 m -132.9 10.5 4.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.891 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.689 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.3 m-20 -83.23 148.49 27.38 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.162 0.506 . . . . 0.0 111.227 -178.447 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.676 HG12 ' HD2' ' A' ' 87' ' ' ARG . 1.0 OUTLIER -147.83 139.15 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.214 -177.92 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.756 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -150.62 87.0 1.41 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.445 0.64 . . . . 0.0 110.609 -178.894 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.676 ' HD2' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -82.52 107.89 15.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.074 -179.278 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.427 HD11 ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -84.8 86.73 7.32 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.336 176.765 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.98 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.764 0.316 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.77 -4.32 0.03 OUTLIER Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.23 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 13.0 p-10 -92.16 146.96 23.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.765 0.317 . . . . 0.0 111.44 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -96.71 113.37 30.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.708 177.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 53.7 t -109.57 120.64 61.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.596 -178.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -96.39 166.0 11.91 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.087 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.785 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.1 m -143.04 130.09 20.69 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.57 0.7 . . . . 0.0 112.361 -179.196 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.76 HG22 HG22 ' A' ' 80' ' ' ILE . 6.7 mm -121.61 107.08 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.554 -179.11 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.54 ' O ' HG21 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -95.6 94.15 7.57 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.933 0.396 . . . . 0.0 111.946 -177.87 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.488 ' HB ' ' CG1' ' A' ' 80' ' ' ILE . 1.7 m -93.54 136.54 24.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -176.502 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.641 ' O ' ' HG3' ' A' ' 11' ' ' MET . 1.2 ptm -144.72 126.15 7.84 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.303 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.623 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 10.4 Cg_exo -73.46 124.53 9.45 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.399 2.732 . . . . 0.0 112.37 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.99 -33.82 69.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.357 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.406 ' O ' HG23 ' A' ' 17' ' ' VAL . 4.4 m -78.28 154.41 79.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.213 -179.289 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.579 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 52.9 Cg_endo -69.66 -3.41 11.88 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.428 2.085 . . . . 0.0 112.146 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.76 44.03 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.826 178.378 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.648 HG22 HD22 ' A' ' 48' ' ' LEU . 81.0 t -64.98 76.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.558 -178.418 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.57 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 6.3 m-20 -71.61 92.44 1.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.57 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.626 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -63.97 -42.08 97.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.303 -178.478 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.615 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 26.7 tt0 -68.3 -39.11 82.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.794 0.331 . . . . 0.0 110.253 -178.506 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.501 ' HB1' ' HB3' ' A' ' 18' ' ' ASP . . . -71.55 -36.75 71.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.053 0.454 . . . . 0.0 110.384 177.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.57 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -67.79 -28.75 67.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.976 178.026 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -42.48 87.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.321 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -43.82 86.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.246 178.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 2.2 mm-40 -65.79 -30.38 71.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.342 0.592 . . . . 0.0 110.207 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.788 HG21 HG23 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -60.66 -47.14 94.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.073 179.724 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.624 HE22 HD13 ' A' ' 36' ' ' LEU . 7.2 mm-40 -64.71 -35.24 80.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.193 -178.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.545 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 8.4 pt-20 -77.0 -20.79 55.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.907 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.788 ' HD3' HD11 ' A' ' 74' ' ' ILE . 4.2 ptp180 -90.51 -13.55 34.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.045 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 26' ' ' ILE . 14.2 mm -59.82 138.67 90.31 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.92 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.526 ' N ' HG22 ' A' ' 30' ' ' ILE . 9.6 Cg_endo -50.81 119.3 5.07 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.708 2.272 . . . . 0.0 112.112 178.884 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -59.23 -1.27 0.18 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.24 -179.597 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -81.49 -39.64 12.1 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.968 -178.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER -130.54 -147.41 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.668 0.271 . . . . 0.0 111.118 -179.714 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -131.9 170.06 15.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.998 0.428 . . . . 0.0 110.927 -179.309 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.624 HD13 HE22 ' A' ' 27' ' ' GLN . 0.5 OUTLIER -75.12 -177.2 3.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.123 -179.331 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.509 ' HB2' HG22 ' A' ' 56' ' ' VAL . 82.1 t60 -130.91 -76.38 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.294 0.569 . . . . 0.0 111.085 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.471 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 2.0 tptt -164.64 130.34 2.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.996 -178.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.645 HG23 HG22 ' A' ' 53' ' ' VAL . 2.2 mt -94.13 160.99 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -127.35 122.54 33.99 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.485 -179.182 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -84.83 74.06 10.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.602 178.311 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -101.23 136.16 19.74 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.969 -179.6 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.773 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 61.4 Cg_endo -86.43 155.49 9.29 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.793 2.328 . . . . 0.0 112.724 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.423 HD13 ' HB3' ' A' ' 50' ' ' ALA . 3.0 mm -124.55 -83.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.614 -177.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.589 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . . . -67.42 -148.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.355 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -70.45 -33.54 71.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.61 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.39 8.22 0.64 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.606 179.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.648 HD22 HG22 ' A' ' 17' ' ' VAL . 4.1 mt -91.41 102.02 14.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.876 0.369 . . . . 0.0 110.748 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 87.3 t -93.23 128.89 44.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.94 -178.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.598 ' HB1' ' HB3' ' A' ' 11' ' ' MET . . . -95.19 161.01 14.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.071 178.719 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.626 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.2 mp -120.27 119.96 34.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.405 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.533 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 2.0 m120 -89.74 91.4 8.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.305 0.574 . . . . 0.0 110.066 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.788 HG23 HG21 ' A' ' 26' ' ' ILE . 6.1 t -87.5 104.67 14.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.736 -177.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.488 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 27.8 mtt -86.54 164.38 16.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.277 178.458 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.2 m -139.26 136.15 41.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.845 0.355 . . . . 0.0 111.354 -178.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -95.69 114.94 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.311 179.733 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.41 ' O ' HG21 ' A' ' 57' ' ' VAL . 3.6 m -130.24 148.59 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.694 178.579 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.92 -67.65 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.356 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -80.71 -7.43 59.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.094 0.473 . . . . 0.0 110.64 179.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.66 -147.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.107 179.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.5 -165.33 2.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.875 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.13 14.04 29.47 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.523 178.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.9 -2.84 40.32 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.483 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 p -74.08 -3.66 30.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.359 . . . . 0.0 110.265 179.306 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -23.91 27.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.326 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.97 -25.7 58.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.262 -179.223 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.68 -49.3 78.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.635 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.682 ' HG3' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -61.72 -42.05 98.43 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.67 0.748 . . . . 0.0 109.53 176.996 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.682 ' N ' ' HG3' ' A' ' 68' ' ' GLU . 2.3 tm-20 -55.25 -46.62 76.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.821 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.2 p -68.42 -24.32 64.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.231 177.184 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.754 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.53 -30.23 62.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.608 179.901 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 p -63.41 -11.46 23.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.776 179.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.24 26.66 0.99 Allowed Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.788 HD11 ' HD3' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -73.33 -166.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.224 -0.488 . . . . 0.0 111.408 -178.606 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -50.75 92.17 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.096 179.0 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.55 -26.16 64.19 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.476 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.07 -37.88 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.142 0.496 . . . . 0.0 110.114 178.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.582 ' HB2' ' HB3' ' A' ' 75' ' ' GLU . 1.5 m -96.15 89.92 5.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.531 179.708 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.48 130.0 37.33 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.465 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.76 HG22 HG22 ' A' ' 8' ' ' ILE . 3.4 mp -101.35 149.55 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.539 -175.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.508 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.1 tt0 -85.75 71.15 10.72 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.762 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.744 HG21 HG22 ' A' ' 80' ' ' ILE . 58.3 t -80.26 50.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.031 -174.269 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.87 5.74 3.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.285 178.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.785 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 35.4 t0 -85.56 139.66 31.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.985 0.421 . . . . 0.0 111.008 -178.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.57 161.32 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.36 -179.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.8 mtt-85 -149.82 87.39 1.48 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.703 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.02 87.92 4.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.128 -179.514 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.591 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 11.1 mp -81.11 82.31 7.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.372 178.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.459 ' HB2' ' HE2' ' A' ' 89' ' ' MET . 7.1 tpp . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.916 -179.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.655 ' HB3' HD13 ' A' ' 88' ' ' LEU . 14.4 tpt . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.884 0.373 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.5 -16.46 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.432 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 12.1 m-20 -95.24 157.4 15.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.193 -0.503 . . . . 0.0 111.321 179.043 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.502 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 1.9 t -106.67 112.31 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 177.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.638 ' HB ' ' HG2' ' A' ' 86' ' ' ARG . 1.0 OUTLIER -109.43 117.05 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.688 0.28 . . . . 0.0 111.754 -178.995 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.473 ' HB1' HG21 ' A' ' 55' ' ' VAL . . . -98.54 165.69 11.7 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.314 178.055 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.671 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 6.0 m -143.24 132.96 23.81 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.632 0.729 . . . . 0.0 112.407 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.693 HG23 HG23 ' A' ' 80' ' ' ILE . 7.1 mm -126.28 108.12 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.499 -178.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.541 ' O ' HG22 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.25 95.0 7.81 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.011 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 10' ' ' VAL . 1.5 m -92.56 136.83 23.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.116 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.771 ' HE2' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -146.3 118.48 4.97 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 121.07 0.462 . . . . 0.0 111.717 179.896 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 21.1 Cg_exo -68.29 121.58 8.56 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.36 2.707 . . . . 0.0 111.822 178.529 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.89 -29.16 64.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.325 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.84 150.37 78.42 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.545 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 37.7 Cg_endo -65.88 -7.85 18.02 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.463 2.109 . . . . 0.0 112.075 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -91.81 35.97 0.96 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.502 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.657 HG13 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -68.17 82.58 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.814 0.816 . . . . 0.0 110.532 -179.378 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.5 m-20 -73.74 99.31 3.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.805 178.038 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.811 ' HB2' HD12 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -63.33 -44.11 95.83 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.025 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.784 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 4.4 tp10 -70.03 -36.15 74.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.868 0.366 . . . . 0.0 110.342 -178.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.16 -37.96 78.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.381 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.8 OUTLIER -67.72 -26.67 66.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.971 177.23 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.784 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -56.13 -46.13 79.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.235 179.13 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -41.22 85.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.705 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.71 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 52.9 mt-10 -66.74 -28.63 68.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.426 0.631 . . . . 0.0 110.151 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.823 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.2 mt -63.29 -39.2 84.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.163 178.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.557 ' NE2' HG21 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -60.66 -41.72 95.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.075 -179.85 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.71 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -77.62 -21.32 52.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.937 -178.101 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.823 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.01 -12.43 44.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.061 -179.001 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.684 HG12 ' O ' ' A' ' 26' ' ' ILE . 22.6 mm -60.46 137.53 92.31 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.872 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.482 ' N ' HG22 ' A' ' 30' ' ' ILE . 7.0 Cg_endo -47.45 121.5 5.56 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.748 2.298 . . . . 0.0 112.256 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.15 0.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.238 -179.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.0 -62.96 1.78 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.866 -179.023 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.476 ' OG1' HG13 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -111.77 -142.01 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.682 0.277 . . . . 0.0 111.183 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -133.39 172.98 11.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.974 0.416 . . . . 0.0 111.069 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.654 HD22 HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -75.39 -177.65 3.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.329 -178.958 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.514 ' ND1' HG11 ' A' ' 56' ' ' VAL . 80.0 t60 -131.02 -76.29 0.53 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.062 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 20.2 mmtt -160.21 129.25 4.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.089 -178.732 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.776 HD12 HG22 ' A' ' 53' ' ' VAL . 1.6 mt -92.0 160.93 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 111.616 -178.679 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.632 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -129.06 124.47 34.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.64 -178.606 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -85.85 71.93 10.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 0.0 110.653 178.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -99.22 136.21 20.55 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.593 179.936 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.769 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 59.7 Cg_endo -86.99 158.02 8.62 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.565 2.176 . . . . 0.0 112.785 -178.661 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mm -126.16 -82.69 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.421 -177.607 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.488 ' HB1' ' HG ' ' A' ' 48' ' ' LEU . . . -67.41 -151.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.167 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -71.35 -30.22 65.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.668 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.55 5.2 0.51 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.899 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.771 HD12 ' HE2' ' A' ' 11' ' ' MET . 5.1 mt -91.78 103.13 15.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.938 0.399 . . . . 0.0 110.708 179.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.769 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 76.0 t -92.92 131.76 39.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.88 -178.381 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' A' ' 11' ' ' MET . . . -96.03 162.29 13.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.831 178.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.811 HD12 ' HB2' ' A' ' 19' ' ' LEU . 11.2 mp -120.66 119.7 33.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.333 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.486 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.3 m120 -89.88 91.83 8.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.255 0.55 . . . . 0.0 110.134 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.776 HG22 HD12 ' A' ' 39' ' ' ILE . 12.4 t -86.5 102.3 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.583 -177.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.564 ' HG2' ' HG1' ' A' ' 7' ' ' THR . 24.8 mtt -84.59 164.46 18.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.169 178.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.473 HG21 ' HB1' ' A' ' 6' ' ' ALA . 3.0 m -139.35 135.86 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.456 -178.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.514 HG11 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -98.61 115.98 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.211 178.932 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.502 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 2.8 m -130.67 148.14 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.702 178.861 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.6 -68.06 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.578 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -80.42 -8.51 59.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.059 0.457 . . . . 0.0 110.607 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.86 -144.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.057 179.21 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.52 -167.34 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.815 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.86 16.35 15.8 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.562 178.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.5 -1.36 36.32 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.491 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 p -74.81 -4.23 36.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.874 0.368 . . . . 0.0 110.246 179.228 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -55.05 -23.37 19.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.182 177.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.29 -26.29 60.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.134 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.92 -55.94 27.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.338 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -58.33 -35.91 72.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.561 178.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -51.55 68.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.427 178.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.603 ' HG ' HD13 ' A' ' 74' ' ' ILE . 12.2 p -63.98 -20.81 66.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.487 179.023 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.537 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.22 -25.94 61.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.602 -179.802 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.01 -17.73 63.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.638 179.124 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.77 30.67 0.92 Allowed Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.05 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.762 HD11 ' HD2' ' A' ' 29' ' ' ARG . 4.3 tt -72.99 -160.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.571 -0.314 . . . . 0.0 111.01 -178.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.651 ' HG2' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -51.61 94.96 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.035 0.445 . . . . 0.0 110.63 179.77 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.16 -30.85 71.5 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.485 -177.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.5 t -85.02 -33.9 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.943 0.401 . . . . 0.0 110.578 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.603 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 28.1 t -95.77 91.53 6.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.937 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.5 128.84 36.2 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.012 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.786 HG23 HG23 ' A' ' 82' ' ' VAL . 3.4 mp -101.01 149.31 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.423 -174.949 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.536 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.7 tt0 -85.66 70.41 10.72 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 173.07 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.786 HG23 HG23 ' A' ' 80' ' ' ILE . 59.9 t -79.92 50.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.881 -174.393 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.66 6.54 4.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.351 179.272 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.671 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.5 m-20 -85.3 131.15 34.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.913 -178.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.9 p -146.25 146.4 19.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.143 -179.123 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.727 ' HG3' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -148.98 81.58 1.43 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.758 0.789 . . . . 0.0 109.325 -179.224 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.01 99.82 11.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.274 -177.147 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.727 HD23 ' HG3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -86.44 88.68 7.68 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.141 176.37 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.411 ' HB3' ' HE2' ' A' ' 89' ' ' MET . 12.7 ptp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.914 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.649 0.262 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.47 -2.33 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.291 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 4.6 m-20 -91.49 158.9 16.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.781 0.324 . . . . 0.0 111.371 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.28 121.87 50.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.609 177.567 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 78.9 t -119.85 122.52 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.49 -179.063 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -95.37 168.39 10.75 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.75 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 5.7 m -143.17 133.6 24.8 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.595 0.712 . . . . 0.0 112.235 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.788 HG22 HG23 ' A' ' 80' ' ' ILE . 3.8 mm -126.52 106.51 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.24 -178.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.524 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 2.5 mmmt -96.21 96.02 8.52 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -176.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.56 HG23 ' HG ' ' A' ' 78' ' ' SER . 0.9 OUTLIER -94.23 135.71 27.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -177.537 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.702 ' HE3' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -147.77 117.97 4.35 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 120.993 0.425 . . . . 0.0 111.414 178.97 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.598 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.3 Cg_exo -69.72 120.44 7.23 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.253 2.636 . . . . 0.0 111.964 178.515 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -57.61 -29.06 64.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.068 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.55 150.57 79.52 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.882 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 38.4 Cg_endo -66.34 -8.29 20.14 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.432 2.088 . . . . 0.0 112.063 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.92 36.51 0.97 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.634 179.313 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.644 HG11 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.8 86.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.811 0.815 . . . . 0.0 110.196 -179.87 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.582 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 55.9 m-20 -69.43 104.92 2.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.213 179.259 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.747 ' HG ' HD21 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -60.74 -52.52 64.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.548 -178.341 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.792 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 9.9 pt-20 -71.03 -34.51 71.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.257 -177.716 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.0 -35.7 78.76 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.622 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -66.03 -33.61 76.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.423 176.463 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.792 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -55.91 -46.38 78.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.112 178.529 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -66.14 -43.65 86.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.72 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.754 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 5.1 mm-40 -66.12 -28.06 68.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.404 0.621 . . . . 0.0 110.576 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.65 ' O ' HG12 ' A' ' 30' ' ' ILE . 1.1 mt -61.8 -46.54 96.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.267 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.568 ' NE2' HD23 ' A' ' 36' ' ' LEU . 5.9 mm100 -63.9 -35.32 80.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.297 -178.053 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.754 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.6 OUTLIER -76.63 -21.55 55.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.821 179.953 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.671 ' NH2' HG13 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -90.25 -15.12 31.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.793 179.249 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.65 HG12 ' O ' ' A' ' 26' ' ' ILE . 15.8 mm -58.93 138.28 87.37 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.97 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.508 ' N ' HG21 ' A' ' 30' ' ' ILE . 10.3 Cg_endo -50.27 117.23 3.0 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.884 2.389 . . . . 0.0 112.309 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -58.84 -2.07 0.21 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.182 -179.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.79 -57.52 2.54 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.794 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.76 -142.62 0.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.694 0.283 . . . . 0.0 111.064 -179.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -135.65 170.0 16.65 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.929 0.395 . . . . 0.0 110.761 -179.411 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.568 HD23 ' NE2' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -75.3 -178.31 3.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.062 -179.333 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.509 ' HB2' HG23 ' A' ' 56' ' ' VAL . 84.5 t60 -130.85 -77.01 0.53 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.41 0.624 . . . . 0.0 110.926 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -164.83 130.87 2.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.791 -178.893 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.75 HD13 HG21 ' A' ' 53' ' ' VAL . 2.7 mt -92.67 157.92 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.039 0.447 . . . . 0.0 112.098 -177.097 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.62 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -124.75 117.32 23.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.379 -179.106 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.544 ' HG2' HD21 ' A' ' 19' ' ' LEU . 1.4 mt-10 -82.8 70.91 9.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.952 0.406 . . . . 0.0 110.514 178.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.481 ' O ' HG12 ' A' ' 49' ' ' VAL . 1.7 mt-10 -95.66 135.84 22.77 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.356 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.747 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 56.7 Cg_endo -86.21 156.73 9.68 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.433 2.089 . . . . 0.0 112.933 -178.039 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.416 HD12 ' HB3' ' A' ' 50' ' ' ALA . 2.8 mm -125.53 -82.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.451 -177.168 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.593 ' HB1' ' HG ' ' A' ' 48' ' ' LEU . . . -67.22 -150.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.006 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -72.04 -30.52 65.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.848 0.356 . . . . 0.0 110.69 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.28 4.97 0.53 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.804 179.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.702 HD12 ' HE3' ' A' ' 11' ' ' MET . 4.5 mt -91.31 102.88 15.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.893 0.377 . . . . 0.0 110.732 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.747 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 75.7 t -93.3 131.29 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.059 -177.829 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.507 ' HB1' ' HB2' ' A' ' 11' ' ' MET . . . -96.08 150.72 20.18 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.719 177.785 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.747 HD21 ' HG ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -113.84 117.91 32.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.358 179.6 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.45 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 6.8 m-20 -89.87 92.83 9.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.223 -178.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.75 HG21 HD13 ' A' ' 39' ' ' ILE . 5.1 t -86.85 102.11 11.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.624 -177.757 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.605 ' HG3' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.54 163.59 19.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.054 178.253 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.5 m -138.21 136.9 44.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.765 0.317 . . . . 0.0 111.367 -178.373 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.509 HG23 ' HB2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -94.63 116.38 35.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.086 179.559 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.2 m -130.27 148.36 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.966 179.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.64 -72.79 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.419 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.66 -2.7 51.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 110.789 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.31 -150.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.303 179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.58 -165.19 2.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.792 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.16 14.72 26.25 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.619 178.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.12 -3.33 44.56 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.495 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -74.42 -3.2 29.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.941 0.401 . . . . 0.0 110.274 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -25.04 24.66 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.691 177.663 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.43 -25.16 59.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.953 -179.307 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.405 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . . . -62.4 -55.25 29.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 110.073 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 71' ' ' LEU . 58.5 mt-10 -58.6 -33.55 70.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.286 178.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -62.51 -52.59 62.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.256 178.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.65 -16.62 61.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.117 178.308 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.742 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 1.3 mt -73.38 -33.11 64.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.49 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.75 -10.29 18.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.792 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.08 28.6 1.0 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 178.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.742 ' HB ' ' HA ' ' A' ' 71' ' ' LEU . 7.3 tt -73.56 -166.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.834 -0.683 . . . . 0.0 111.269 -178.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.645 ' H ' HG12 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -52.01 101.39 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.986 0.422 . . . . 0.0 111.042 -179.658 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.52 -32.42 83.27 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.812 -179.004 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -86.44 -36.38 10.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.421 . . . . 0.0 110.242 179.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.627 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 10.3 t -95.67 92.39 6.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.462 179.332 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.566 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.32 130.74 37.56 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.325 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.792 HG23 HG23 ' A' ' 82' ' ' VAL . 2.7 mp -101.4 148.73 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.413 -175.655 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.524 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.2 tp10 -85.65 70.25 10.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 173.105 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.792 HG23 HG23 ' A' ' 80' ' ' ILE . 55.2 t -79.7 44.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.055 -174.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -132.32 9.84 4.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.522 177.762 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.75 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 34.5 t0 -85.97 143.96 27.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.828 0.346 . . . . 0.0 110.869 -178.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.19 164.68 5.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.179 -178.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.19 93.44 2.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.462 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.476 ' O ' ' HE1' ' A' ' 89' ' ' MET . 4.6 mmt180 -77.92 90.12 4.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.801 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.559 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 11.2 mp -81.49 81.47 7.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.603 179.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.476 ' HE1' ' O ' ' A' ' 87' ' ' ARG . 6.4 mtm . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.163 -0.923 . . . . 0.0 110.99 -179.738 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 121.009 0.433 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.71 13.48 0.23 Allowed Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.548 -179.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.476 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 0.7 OUTLIER -88.74 158.35 18.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.879 0.371 . . . . 0.0 111.301 -179.541 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.53 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -107.11 120.77 59.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.381 178.665 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.685 ' HB ' ' HG2' ' A' ' 86' ' ' ARG . 84.8 t -113.43 114.16 46.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.271 179.218 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -93.1 168.23 11.26 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.731 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.756 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 11.2 m -142.56 132.42 24.21 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.585 0.707 . . . . 0.0 112.505 -179.231 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.787 HG22 HG22 ' A' ' 80' ' ' ILE . 3.8 mm -120.61 105.24 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.276 -179.426 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.511 ' O ' HG21 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -93.56 93.82 8.29 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.941 0.401 . . . . 0.0 112.009 -177.657 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 22' ' ' LEU . 1.2 m -92.96 136.28 25.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.036 -177.211 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.672 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.6 OUTLIER -147.7 119.27 4.54 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 121.265 0.555 . . . . 0.0 111.508 178.712 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.818 ' HG3' HD12 ' A' ' 22' ' ' LEU . 19.1 Cg_exo -68.38 120.86 7.79 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.13 2.553 . . . . 0.0 111.622 178.688 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.93 -29.11 62.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.271 -179.222 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.3 p -77.78 153.25 80.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.127 -179.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 51.3 Cg_endo -68.54 -7.21 19.68 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.178 1.919 . . . . 0.0 111.31 178.144 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.47 34.49 0.88 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.282 178.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.711 HG11 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -68.24 81.78 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.889 0.852 . . . . 0.0 110.523 -179.363 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.485 ' HB3' ' HB1' ' A' ' 21' ' ' ALA . 1.1 m-20 -74.05 97.96 2.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.897 177.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.726 ' HB2' HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -64.53 -38.49 91.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.398 -178.473 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.655 ' H ' HD11 ' A' ' 19' ' ' LEU . 2.7 tp10 -69.11 -38.69 79.05 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.485 ' HB1' ' HB3' ' A' ' 18' ' ' ASP . . . -70.59 -38.24 73.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.414 0.626 . . . . 0.0 109.713 176.931 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.818 HD12 ' HG3' ' A' ' 12' ' ' PRO . 1.1 mt -68.08 -28.98 67.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.082 178.095 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.463 ' HA ' HD13 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -56.67 -46.66 80.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.032 -179.59 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.435 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -68.94 -40.91 78.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.186 0.517 . . . . 0.0 110.387 179.319 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.435 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 6.1 mm-40 -65.32 -28.05 69.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.359 179.524 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.716 HG22 HD13 ' A' ' 39' ' ' ILE . 2.1 mt -62.65 -45.66 98.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.106 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -34.67 72.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.654 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -75.02 -22.47 58.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.466 -179.378 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.731 ' HD3' HD11 ' A' ' 74' ' ' ILE . 1.9 ptp180 -88.55 -15.21 35.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.504 -178.697 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 26' ' ' ILE . 43.5 mm -58.07 137.57 84.07 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.568 179.132 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HB3' ' N ' ' A' ' 67' ' ' ALA . 18.6 Cg_endo -58.05 130.71 39.46 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.506 2.137 . . . . 0.0 112.837 -179.501 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.32 0.12 0.31 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.0 179.49 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -81.98 -60.88 2.1 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.566 -178.987 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER -113.96 -143.69 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.707 0.289 . . . . 0.0 111.08 -179.867 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -135.73 167.63 20.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.775 -179.671 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.532 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.8 pt? -75.16 -176.16 2.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.04 -179.469 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.572 ' ND1' HG21 ' A' ' 56' ' ' VAL . 84.8 t60 -130.64 -77.43 0.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.374 0.606 . . . . 0.0 111.4 -178.195 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.539 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER -163.98 129.42 2.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.656 -178.417 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.786 HD13 HG22 ' A' ' 53' ' ' VAL . 2.5 mt -91.15 155.66 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.07 0.462 . . . . 0.0 112.145 -176.632 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.644 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -121.9 118.77 29.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.367 -179.025 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -82.19 71.71 9.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.055 0.455 . . . . 0.0 110.183 178.187 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.499 ' O ' HG12 ' A' ' 49' ' ' VAL . 1.2 mt-10 -96.46 135.06 22.63 Favored Pre-proline 0 C--O 1.224 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.607 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.754 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 52.8 Cg_endo -86.07 156.24 9.84 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.513 2.142 . . . . 0.0 112.796 -178.925 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 44' ' ' ILE . 2.7 mm -125.83 -83.32 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.543 -177.447 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.517 ' HB1' ' HG ' ' A' ' 48' ' ' LEU . . . -67.37 -151.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 -179.861 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -71.91 -29.49 64.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.606 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.63 4.79 0.49 Allowed Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.932 179.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.711 ' HA ' HG11 ' A' ' 17' ' ' VAL . 4.1 mt -91.72 102.54 15.16 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.856 0.36 . . . . 0.0 110.787 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 69.6 t -93.7 129.62 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.913 -178.462 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.594 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.64 150.04 20.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.025 178.116 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.726 HD21 ' HB2' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -113.09 119.38 37.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.245 179.054 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 1.5 m120 -89.81 94.43 9.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.522 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.786 HG22 HD13 ' A' ' 39' ' ' ILE . 5.5 t -86.21 102.93 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.342 -178.663 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.529 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.69 167.73 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.455 179.208 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.537 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 4.2 m -139.28 135.01 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.449 -178.251 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.572 HG21 ' ND1' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -95.7 113.89 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.824 178.843 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 4' ' ' VAL . 2.9 m -129.52 154.98 40.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.841 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.43 -68.07 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.195 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.63 -6.35 58.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.108 0.48 . . . . 0.0 110.366 179.027 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.426 ' HB1' HG21 ' A' ' 34' ' ' THR . . . -67.82 -151.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.125 179.443 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.27 -159.12 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.856 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.41 12.47 32.87 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.44 178.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.96 -8.0 60.36 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.43 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.27 -3.36 29.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.983 0.42 . . . . 0.0 110.087 179.006 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -54.71 -24.07 20.42 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.99 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.25 -27.26 61.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.897 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.462 ' N ' ' HB3' ' A' ' 31' ' ' PRO . . . -60.23 -56.92 15.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.364 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -58.89 -34.97 72.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.405 178.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -51.23 70.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.383 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 t -63.7 -19.77 65.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.48 178.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.743 HD13 HG23 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -72.83 -28.39 62.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.651 179.957 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.82 -14.23 51.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.766 179.157 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.26 28.69 0.98 Allowed Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.743 HG23 HD13 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -73.41 -163.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.293 -0.453 . . . . 0.0 111.282 -178.698 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.635 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.7 OUTLIER -50.21 98.67 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.943 0.401 . . . . 0.0 110.918 179.513 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.62 -32.46 84.27 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.21 -178.302 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -85.66 -36.48 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.055 0.455 . . . . 0.0 110.205 179.606 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.635 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 42.4 t -95.64 90.08 5.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.455 179.225 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.557 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.17 133.34 38.97 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.1 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.787 HG22 HG22 ' A' ' 8' ' ' ILE . 2.2 mt -101.65 149.3 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.863 -175.485 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.504 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 5.3 tp10 -86.1 71.52 10.55 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 172.406 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.77 HG22 HG22 ' A' ' 80' ' ' ILE . 62.2 t -80.35 50.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.104 -174.216 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.92 5.96 3.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.349 178.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.756 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 46.9 t0 -86.03 139.01 31.54 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.984 0.421 . . . . 0.0 111.3 -178.147 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.0 p -147.99 152.36 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.923 -179.62 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.685 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -150.55 98.22 2.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.201 0.524 . . . . 0.0 110.47 -178.715 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.41 ' HD3' ' CG1' ' A' ' 4' ' ' VAL . 1.6 mmt85 -84.4 110.17 18.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.325 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -82.9 86.71 6.9 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.501 178.045 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.9 ttm . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.964 179.934 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ttt . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 121.143 0.497 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 89' ' ' MET . . . 173.42 4.02 0.03 OUTLIER Glycine 0 C--N 1.33 0.232 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.538 -179.344 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -93.25 164.87 13.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.943 0.401 . . . . 0.0 111.608 -179.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.46 136.98 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.615 177.842 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.451 ' CG2' HD12 ' A' ' 88' ' ' LEU . 2.1 t -128.48 116.41 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.73 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -96.37 166.3 11.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.28 178.897 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.67 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 25.6 m -142.05 132.6 25.31 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.569 0.7 . . . . 0.0 111.779 179.768 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.752 HG21 HG23 ' A' ' 80' ' ' ILE . 1.8 mm -120.46 106.46 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.615 -178.375 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.754 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -95.24 93.36 7.25 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -177.573 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 10' ' ' VAL . 1.0 OUTLIER -92.38 135.93 26.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.729 -177.667 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.733 ' O ' ' HG3' ' A' ' 11' ' ' MET . 1.0 OUTLIER -147.5 114.79 4.14 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 121.389 0.614 . . . . 0.0 111.974 179.801 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.502 ' HD2' ' CG2' ' A' ' 17' ' ' VAL . 35.5 Cg_exo -63.39 124.64 14.14 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.153 2.569 . . . . 0.0 112.055 178.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -57.52 -30.78 65.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.378 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.32 150.81 77.49 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.205 -179.304 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.563 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 40.9 Cg_endo -66.67 -6.29 15.09 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.38 2.053 . . . . 0.0 111.89 179.211 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -92.01 32.7 1.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.586 179.211 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -66.82 85.82 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.65 0.738 . . . . 0.0 110.064 179.929 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.554 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 12.1 m-20 -70.76 104.21 2.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.278 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.599 HD13 HD13 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -61.67 -49.56 76.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.237 -178.666 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.664 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 2.5 tp10 -70.11 -35.48 74.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.111 -178.163 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.606 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -69.06 -35.93 77.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.294 0.569 . . . . 0.0 109.809 177.548 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.554 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -66.54 -27.56 67.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.038 177.831 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.664 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -56.33 -46.72 79.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.44 179.051 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.606 ' HE2' ' HA ' ' A' ' 21' ' ' ALA . 1.2 mtmm -65.64 -41.86 92.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.847 179.731 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.697 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 33.3 mt-10 -66.71 -31.14 71.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.431 0.634 . . . . 0.0 110.356 179.526 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.791 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 3.2 mt -62.91 -41.62 93.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.93 179.757 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -62.64 -39.13 92.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.158 -179.222 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.697 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -78.0 -21.02 51.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.669 -178.499 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.791 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.51 -12.11 43.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.273 -178.955 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.685 HG13 HD22 ' A' ' 36' ' ' LEU . 28.5 mm -61.0 138.09 94.09 Favored Pre-proline 0 N--CA 1.463 0.2 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.089 179.626 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.671 ' HB3' ' HB1' ' A' ' 67' ' ' ALA . 9.5 Cg_endo -51.19 125.26 15.9 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.744 2.296 . . . . 0.0 112.478 179.211 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -60.72 -2.86 0.6 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.039 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.22 -62.34 1.82 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.896 -178.82 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.499 ' HG1' HG23 ' A' ' 64' ' ' THR . 0.2 OUTLIER -111.01 -143.67 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.692 0.282 . . . . 0.0 111.152 -179.462 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -133.93 172.57 12.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.941 0.401 . . . . 0.0 110.823 -179.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.685 HD22 HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -74.43 -177.05 2.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.667 -179.811 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.456 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 66.5 t60 -131.3 -73.58 0.53 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.146 0.498 . . . . 0.0 111.059 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 29.1 mmtm -161.46 127.55 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.417 -178.733 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.728 HD12 HG22 ' A' ' 53' ' ' VAL . 2.9 mt -93.55 154.34 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.817 -178.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.633 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.2 m-20 -119.36 124.22 46.07 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.317 -178.769 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -89.17 66.5 7.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.96 0.41 . . . . 0.0 110.083 177.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.562 ' O ' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.96 147.86 34.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.702 -178.035 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.747 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 35.1 Cg_endo -91.79 158.43 3.44 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.016 2.477 . . . . 0.0 112.861 -178.32 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.401 ' HB ' ' H ' ' A' ' 45' ' ' ALA . 4.0 mm -127.59 -82.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.334 -178.177 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' H ' ' HB ' ' A' ' 44' ' ' ILE . . . -67.15 -150.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.988 179.728 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -71.88 -27.46 62.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.737 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.28 7.89 0.3 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.157 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.563 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.0 mt -92.39 105.41 17.6 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.784 0.326 . . . . 0.0 110.885 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.747 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 25.6 t -92.92 128.07 44.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.886 -178.477 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.07 148.94 21.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.275 179.163 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.653 HD23 ' HD2' ' A' ' 23' ' ' LYS . 11.1 mp -106.48 114.74 29.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.019 177.706 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.615 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 3.9 m-20 -89.28 92.31 9.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.231 0.539 . . . . 0.0 109.938 -179.422 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.728 HG22 HD12 ' A' ' 39' ' ' ILE . 11.3 t -85.79 106.35 15.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.625 -177.292 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.533 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 37.4 mtt -85.24 164.15 18.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.078 178.499 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 m -140.71 136.77 35.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.31 -178.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.46 111.95 26.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.715 178.738 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.3 m -130.21 143.58 40.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.095 179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.42 -64.51 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.314 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.75 -8.29 59.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 110.495 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.59 -146.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.248 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -147.69 -163.12 1.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.783 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.419 ' O ' ' HG2' ' A' ' 65' ' ' GLU . . . -80.45 12.2 34.51 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.559 178.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.11 -9.05 62.83 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.507 179.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.499 HG23 ' HG1' ' A' ' 34' ' ' THR . 1.2 p -74.57 -5.15 41.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.861 0.362 . . . . 0.0 110.29 179.244 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 3.7 pt-20 -54.94 -24.09 22.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.405 0.621 . . . . 0.0 110.11 177.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.04 -28.21 62.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.969 -179.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.671 ' HB1' ' HB3' ' A' ' 31' ' ' PRO . . . -60.67 -56.4 21.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.271 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -59.37 -35.02 73.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.469 178.447 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -50.91 70.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.415 178.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.442 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 5.1 t -64.65 -20.32 66.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.56 178.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.6 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -72.69 -28.31 62.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.71 -179.678 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -15.61 58.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.793 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.37 29.2 0.97 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.791 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.6 ' HB ' ' HA ' ' A' ' 71' ' ' LEU . 0.7 OUTLIER -73.5 -161.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.451 -0.374 . . . . 0.0 111.142 -178.933 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 2.7 pm0 -51.6 91.45 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 121.063 0.459 . . . . 0.0 110.749 179.358 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.17 -24.05 62.75 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.833 -0.621 . . . . 0.0 113.04 -178.334 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.58 -36.64 10.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.234 0.54 . . . . 0.0 110.381 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.569 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 4.2 t -95.88 93.01 6.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.592 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.582 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -75.94 131.0 39.34 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.438 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.782 HG23 HG23 ' A' ' 82' ' ' VAL . 3.5 mp -101.19 148.1 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.559 -174.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.754 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -85.87 71.4 10.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 173.256 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.782 HG23 HG23 ' A' ' 80' ' ' ILE . 58.6 t -80.71 52.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.076 -174.302 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 m -133.32 5.73 3.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.902 179.426 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.67 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.1 m-20 -84.68 131.69 34.55 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.379 -177.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.4 p -149.97 139.72 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.659 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.55 ' HD2' ' N ' ' A' ' 86' ' ' ARG . 1.0 OUTLIER -134.46 104.83 6.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.242 -178.392 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -82.0 88.98 6.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.023 179.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.451 HD12 ' CG2' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -81.55 89.96 6.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.673 179.445 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.535 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 1.5 ttm . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.476 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.738 0.304 . . . . 0.0 111.345 . . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.55 -14.01 0.04 OUTLIER Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.475 179.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.662 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 4.3 m-20 -94.6 128.7 41.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.81 0.338 . . . . 0.0 111.893 -179.273 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.553 ' HB ' HG21 ' A' ' 57' ' ' VAL . 2.9 t -94.96 107.53 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.531 177.498 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.644 ' HB ' ' HB2' ' A' ' 86' ' ' ARG . 84.7 t -104.8 107.58 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.268 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.561 ' HB1' HG21 ' A' ' 55' ' ' VAL . . . -97.12 141.04 30.74 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 177.753 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.769 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 16.2 m -122.49 133.03 54.6 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.749 0.785 . . . . 0.0 112.251 -178.229 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.73 ' HB ' HH22 ' A' ' 29' ' ' ARG . 5.6 mm -123.99 109.17 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.677 -178.173 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.528 ' HD2' ' HB3' ' A' ' 52' ' ' ASN . 2.1 mmmt -99.57 95.61 7.1 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -177.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.417 ' HB ' HG13 ' A' ' 80' ' ' ILE . 1.4 m -93.32 136.73 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.533 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.691 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.4 OUTLIER -147.78 120.57 4.7 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 121.17 0.509 . . . . 0.0 111.72 178.751 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.545 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 20.6 Cg_exo -69.78 121.75 8.43 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.366 2.711 . . . . 0.0 112.143 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -30.58 64.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.207 -179.674 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.9 m -77.97 148.94 76.18 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.999 -179.732 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.628 ' HA ' HD23 ' A' ' 48' ' ' LEU . 38.1 Cg_endo -65.57 -6.79 14.5 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.416 2.077 . . . . 0.0 111.881 179.423 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -91.59 35.42 0.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.518 179.111 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.558 HG11 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -67.46 87.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.817 0.818 . . . . 0.0 110.184 -179.797 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.555 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -67.69 105.28 1.86 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.926 178.824 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.772 HD23 HG13 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -60.65 -54.25 47.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.748 -177.96 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.647 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -70.85 -34.23 71.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.133 -177.43 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.536 ' N ' ' HG2' ' A' ' 20' ' ' GLU . . . -68.74 -35.6 77.31 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.305 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.555 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -64.96 -35.53 81.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.138 176.524 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.647 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -55.44 -49.08 73.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.252 178.201 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -39.34 85.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.092 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.68 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 2.9 mt-10 -66.51 -32.34 73.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.383 0.611 . . . . 0.0 110.166 179.099 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.73 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -63.55 -38.47 82.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.925 178.565 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -43.27 92.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.108 -179.72 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.68 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -78.06 -21.37 50.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.755 -178.575 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.73 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 18.9 ptt85 -89.06 -8.65 53.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.411 -178.488 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.709 HD13 ' HB3' ' A' ' 36' ' ' LEU . 19.8 mm -60.11 137.55 91.21 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.966 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.505 ' N ' HG22 ' A' ' 30' ' ' ILE . 9.1 Cg_endo -48.75 117.65 2.87 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.897 2.398 . . . . 0.0 112.206 178.929 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.47 1.09 0.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.391 -179.395 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.459 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.51 -63.95 1.73 Allowed Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.752 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.648 HG21 ' HB1' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -110.24 -134.05 0.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.628 0.251 . . . . 0.0 111.086 -179.531 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -138.62 171.06 14.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.931 0.396 . . . . 0.0 110.669 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.709 ' HB3' HD13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -74.85 -177.57 3.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.018 -179.447 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.513 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 86.3 t60 -131.01 -73.31 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.322 0.582 . . . . 0.0 111.081 -179.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.499 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -163.46 126.64 2.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.046 -178.433 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.766 HD11 HG21 ' A' ' 53' ' ' VAL . 2.9 mt -94.13 157.04 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.161 -177.342 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.628 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 77.4 m-20 -122.62 124.17 42.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.384 -179.206 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.94 66.3 6.86 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.364 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -98.23 147.12 32.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.538 -177.539 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.761 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.6 Cg_endo -89.63 159.5 5.27 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.12 2.547 . . . . 0.0 113.211 -177.718 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.432 HG22 HD11 ' A' ' 44' ' ' ILE . 3.9 mm -129.03 -82.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.169 -178.121 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.556 ' HB1' ' HG ' ' A' ' 48' ' ' LEU . . . -67.07 -153.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.844 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -72.04 -24.65 61.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.51 3.74 0.25 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.285 179.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.628 HD23 ' HA ' ' A' ' 15' ' ' PRO . 5.3 mt -92.32 106.95 18.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.021 0.41 . . . . 0.0 111.045 -179.798 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.772 HG13 HD23 ' A' ' 19' ' ' LEU . 52.8 t -94.28 130.37 43.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.95 -178.314 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.572 ' HB3' ' HB3' ' A' ' 11' ' ' MET . . . -95.46 162.01 13.83 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.567 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.628 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.4 OUTLIER -116.05 113.77 23.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.283 179.501 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.56 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.6 m120 -90.04 90.32 8.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.286 0.565 . . . . 0.0 110.011 178.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.766 HG21 HD11 ' A' ' 39' ' ' ILE . 5.5 t -88.63 102.17 12.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.809 -177.716 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 14.3 mtt -86.36 163.57 17.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.066 178.183 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.561 HG21 ' HB1' ' A' ' 6' ' ' ALA . 4.2 m -137.01 127.44 39.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.923 0.392 . . . . 0.0 111.216 -178.88 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.513 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 1.1 p -98.15 111.86 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 179.603 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.553 HG21 ' HB ' ' A' ' 4' ' ' VAL . 1.2 m -127.4 169.9 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.965 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.89 -69.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.467 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -80.92 0.24 36.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.969 0.414 . . . . 0.0 110.6 179.585 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.648 ' HB1' HG21 ' A' ' 34' ' ' THR . . . -67.5 -154.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.272 179.722 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.65 -161.29 1.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.865 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.87 13.56 30.2 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.477 178.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.52 -9.1 61.02 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.541 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -74.23 -4.0 33.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.04 0.448 . . . . 0.0 110.157 179.12 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -55.39 -23.37 24.24 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.072 177.676 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.86 -27.04 49.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.919 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.5 -56.32 21.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.401 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -58.42 -34.58 70.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.541 178.595 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.25 -51.76 66.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.397 178.471 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.416 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -63.42 -17.85 63.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.318 179.013 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.634 HD12 HG21 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.39 -30.56 63.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.652 179.71 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -11.47 35.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.93 179.452 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.38 26.13 0.97 Allowed Glycine 0 N--CA 1.453 -0.198 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.711 HD11 ' HD2' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -73.28 -164.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.459 -0.371 . . . . 0.0 111.012 -179.27 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.8 OUTLIER -51.73 96.81 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.775 0.322 . . . . 0.0 111.106 179.586 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.33 -23.07 61.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.079 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.409 HG13 ' N ' ' A' ' 78' ' ' SER . 4.6 p -89.42 -40.0 12.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.036 0.446 . . . . 0.0 110.648 179.323 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 8.5 t -95.51 92.19 6.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.519 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.544 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -76.82 132.53 39.25 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.311 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.772 HG22 HG23 ' A' ' 82' ' ' VAL . 3.6 mp -101.15 149.68 6.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.447 -175.333 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.458 ' N ' HG21 ' A' ' 80' ' ' ILE . 6.8 tt0 -85.78 69.56 10.6 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.331 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.772 HG23 HG22 ' A' ' 80' ' ' ILE . 54.5 t -80.87 55.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.805 -175.096 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -132.51 -1.37 3.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.61 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.769 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 11.4 t0 -86.36 131.8 34.12 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.738 -178.771 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.752 HG22 ' HD2' ' A' ' 87' ' ' ARG . 2.0 p -151.41 160.6 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.37 -179.305 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.644 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 6.0 mmt180 -146.35 76.86 1.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.355 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.752 ' HD2' HG22 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -75.2 75.22 2.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.799 0.333 . . . . 0.0 111.341 -179.36 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.662 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 9.9 mp -81.88 82.81 7.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.269 179.009 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.457 ' OXT' ' HG3' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.012 -179.536 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.949 0.404 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.76 -5.29 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.802 179.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -94.65 164.43 12.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.105 0.479 . . . . 0.0 111.612 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.844 HG12 HG21 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -102.06 119.5 50.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.093 177.77 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 22.3 t -109.17 119.12 58.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.705 0.288 . . . . 0.0 111.484 -178.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.552 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.02 145.36 25.0 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.463 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.76 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 10.0 m -122.73 133.72 54.48 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.608 0.718 . . . . 0.0 112.427 -177.566 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.574 ' CG2' HG22 ' A' ' 80' ' ' ILE . 4.5 mm -123.01 104.68 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.386 -179.475 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.78 ' HB2' ' HG3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -95.94 98.18 10.2 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -177.217 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.783 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.5 m -96.18 138.4 21.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.82 -177.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.689 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 2.1 ptm -147.25 121.22 5.01 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-O 121.182 0.515 . . . . 0.0 111.878 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' O ' HD23 ' A' ' 48' ' ' LEU . 22.8 Cg_exo -68.02 126.93 15.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.362 2.708 . . . . 0.0 112.173 179.116 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -32.2 68.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.454 -179.882 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.7 m -77.42 146.88 74.68 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.625 ' HA ' HD13 ' A' ' 48' ' ' LEU . 35.2 Cg_endo -64.53 -6.93 13.02 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.402 2.068 . . . . 0.0 111.801 179.207 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -92.3 38.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.073 178.556 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.795 HG12 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -68.03 85.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 122.013 0.911 . . . . 0.0 110.712 -178.52 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 17.1 m-20 -73.07 96.63 2.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.056 177.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.836 ' HB2' HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -63.77 -41.36 97.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.637 -178.362 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.876 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 5.5 tp10 -69.8 -36.23 75.5 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.872 0.368 . . . . 0.0 110.371 -179.058 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.81 -37.43 76.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.452 0.644 . . . . 0.0 109.309 176.272 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -68.18 -25.81 65.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.064 177.164 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.876 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -56.31 -44.14 79.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.193 179.627 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -44.81 83.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.451 178.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.569 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 40.8 mt-10 -65.09 -28.18 69.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.466 0.65 . . . . 0.0 110.44 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.758 HG23 HD11 ' A' ' 39' ' ' ILE . 1.7 mt -60.21 -49.62 83.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.403 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.583 ' NE2' HD21 ' A' ' 36' ' ' LEU . 6.9 mm-40 -64.92 -32.95 74.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.476 -178.233 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 11.5 pt-20 -76.74 -21.27 55.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 110.751 179.617 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.794 ' HB2' HD12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.55 -12.06 38.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.013 179.914 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.59 HD13 HG11 ' A' ' 53' ' ' VAL . 27.2 mm -58.94 138.42 87.42 Favored Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.256 179.684 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.513 ' N ' HG22 ' A' ' 30' ' ' ILE . 11.0 Cg_endo -52.82 118.23 4.54 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.898 2.399 . . . . 0.0 112.433 178.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -59.67 1.21 0.1 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.321 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.04 -43.73 7.43 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.181 -178.441 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.32 -139.75 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.621 0.248 . . . . 0.0 111.192 -178.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -133.55 168.58 18.4 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.947 0.403 . . . . 0.0 111.255 -178.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.583 HD21 ' NE2' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -75.91 -178.79 4.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.274 -179.299 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.454 ' HD2' ' HB2' ' A' ' 38' ' ' LYS . 59.1 t60 -131.4 -77.47 0.52 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.176 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.454 ' HB2' ' HD2' ' A' ' 37' ' ' HIS . 30.7 mmtm -162.0 133.02 5.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.205 -179.035 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.758 HD11 HG23 ' A' ' 26' ' ' ILE . 2.7 mt -93.97 158.25 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.021 0.439 . . . . 0.0 112.108 -178.009 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.704 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 2.6 m-20 -122.77 120.77 34.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.122 -179.498 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.45 67.77 10.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.866 0.365 . . . . 0.0 110.057 178.698 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.556 ' O ' HG12 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.2 148.81 35.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.671 -177.889 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.751 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 50.4 Cg_endo -94.34 159.12 2.03 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.117 2.545 . . . . 0.0 113.347 -177.553 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.435 HD12 ' HB2' ' A' ' 50' ' ' ALA . 3.0 mm -128.9 -81.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.997 -178.707 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -67.73 -149.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.196 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -72.23 -30.14 64.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.875 0.369 . . . . 0.0 110.615 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.7 6.26 0.54 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.621 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.795 ' HA ' HG12 ' A' ' 17' ' ' VAL . 9.6 mp -89.25 101.07 13.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.912 0.387 . . . . 0.0 110.854 -179.271 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.751 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 11.3 t -91.97 127.83 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.129 -177.659 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.689 ' HB3' ' HB3' ' A' ' 11' ' ' MET . . . -95.35 144.35 25.97 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.829 177.695 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.836 HD22 ' HB2' ' A' ' 19' ' ' LEU . 0.7 OUTLIER -106.07 116.9 32.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.419 178.836 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.619 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -89.58 93.42 9.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.178 -178.893 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.758 HG23 HD11 ' A' ' 39' ' ' ILE . 5.7 t -85.98 106.19 15.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.527 -178.187 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.457 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 34.9 mtt -84.53 162.92 19.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.136 178.836 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.552 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.9 m -140.13 141.24 33.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.087 -178.789 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.04 101.51 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.491 179.096 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.844 HG21 HG12 ' A' ' 4' ' ' VAL . 29.7 m -129.99 140.9 47.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.068 0.461 . . . . 0.0 111.597 -179.14 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.42 -60.66 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.334 178.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -81.73 -7.56 59.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 0.0 110.429 179.099 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.4 -143.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.163 179.52 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -147.29 -165.27 2.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.803 -179.848 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.61 12.87 32.0 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.653 179.041 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.85 -6.84 57.53 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.44 179.621 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -74.44 -3.89 33.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 110.228 179.248 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -54.63 -24.08 19.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.114 177.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.79 -29.24 62.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.103 -179.465 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.472 ' HB3' ' HB3' ' A' ' 31' ' ' PRO . . . -61.61 -55.14 33.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.381 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.1 -34.95 72.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.357 178.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.86 -50.36 72.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.336 178.559 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 t -62.94 -18.28 62.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.349 178.608 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.715 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.37 -29.37 61.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.487 179.505 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -11.62 36.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.598 178.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.1 27.57 1.0 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.429 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.794 HD12 ' HB2' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -72.78 -166.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.366 -0.417 . . . . 0.0 111.099 -179.008 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.646 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 2.3 mm-40 -50.96 97.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.941 0.401 . . . . 0.0 110.81 179.222 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.71 -27.06 61.02 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.369 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.443 HG13 ' OE1' ' A' ' 75' ' ' GLU . 1.2 p -89.22 -38.21 10.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.977 0.418 . . . . 0.0 110.741 179.579 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.646 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 30.7 t -96.14 93.05 6.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.814 -179.712 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.431 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -76.52 130.88 38.55 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.161 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.783 HG12 ' HB ' ' A' ' 10' ' ' VAL . 5.2 mt -100.23 140.9 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.666 -176.094 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.78 ' HG3' ' HB2' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -84.86 74.04 10.55 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 174.648 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.606 HG22 ' HB ' ' A' ' 80' ' ' ILE . 86.5 t -81.55 51.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.187 -173.341 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.8 6.99 4.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.505 179.264 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.76 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 38.3 t0 -85.56 141.19 30.03 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.807 0.337 . . . . 0.0 111.082 -178.732 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.3 p -148.4 162.27 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.119 -179.412 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.842 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -147.14 110.33 4.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.057 0.456 . . . . 0.0 111.708 -178.445 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 mmt85 -89.13 79.58 7.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.845 179.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.842 HD21 ' HB3' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -84.29 88.48 7.24 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.513 178.187 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 mtm . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.941 179.858 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.501 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.83 0.348 . . . . 0.0 111.27 . . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.57 0.59 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.871 -179.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 37.5 m-20 -89.99 158.68 17.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.713 0.292 . . . . 0.0 111.348 -179.796 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 t -106.75 115.3 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.823 177.477 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.746 ' HB ' ' HG2' ' A' ' 86' ' ' ARG . 14.2 t -106.15 108.76 25.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.053 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.554 ' HB2' HG23 ' A' ' 55' ' ' VAL . . . -95.01 165.12 12.6 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.013 177.898 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.667 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 7.8 m -142.14 129.04 20.65 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.762 0.792 . . . . 0.0 112.276 179.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.794 HG23 HG23 ' A' ' 80' ' ' ILE . 3.1 mm -120.72 105.61 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.249 -179.445 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.579 ' HB3' ' ND2' ' A' ' 52' ' ' ASN . 1.0 OUTLIER -94.12 93.64 7.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -177.218 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 m -93.63 138.85 19.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.839 -177.258 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.707 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 2.6 ptm -146.19 123.27 5.97 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.27 179.374 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.52 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 18.6 Cg_exo -67.68 125.96 14.03 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.064 2.509 . . . . 0.0 112.217 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.35 -32.48 66.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.276 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.5 m -77.71 150.13 78.5 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.03 -179.55 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.544 ' HA ' HD11 ' A' ' 48' ' ' LEU . 50.1 Cg_endo -67.97 -4.62 12.81 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.486 2.124 . . . . 0.0 111.774 178.933 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -91.6 45.91 1.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.747 178.32 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.577 HG23 ' HG ' ' A' ' 48' ' ' LEU . 69.8 t -63.96 78.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.505 -178.189 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.52 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 0.2 OUTLIER -71.32 93.87 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.263 177.957 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.623 ' HB2' HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -64.35 -41.53 96.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.622 0.249 . . . . 0.0 111.134 -179.333 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.544 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 4.6 tp10 -68.05 -38.17 82.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.22 -178.404 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.567 ' HA ' ' HZ1' ' A' ' 24' ' ' LYS . . . -70.92 -38.51 72.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.285 0.564 . . . . 0.0 110.112 177.541 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.953 HD21 ' HG2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -65.86 -28.07 68.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.213 178.411 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -58.89 -46.57 87.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.922 -179.718 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.567 ' HZ1' ' HA ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -63.92 -41.02 97.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.683 -179.598 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.953 ' HG2' HD21 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.07 -38.35 90.5 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.731 0.776 . . . . 0.0 110.012 179.756 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.829 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 4.2 mt -58.84 -40.88 81.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.838 -176.809 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -62.6 -37.02 84.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.461 . . . . 0.0 110.178 178.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 3.2 mm-40 -76.05 -23.72 55.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.628 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.829 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.73 -11.92 43.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.663 -178.198 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.48 HG21 ' N ' ' A' ' 31' ' ' PRO . 24.8 mm -58.11 136.6 84.35 Favored Pre-proline 0 C--N 1.333 -0.138 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.48 ' N ' HG21 ' A' ' 30' ' ' ILE . 1.3 Cg_endo -45.13 122.59 4.53 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.88 2.387 . . . . 0.0 112.134 179.186 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.96 -6.0 0.3 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.131 -178.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.55 -58.02 2.48 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.575 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.45 HG21 ' HB2' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -115.44 -146.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.666 0.27 . . . . 0.0 111.001 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -136.78 175.82 9.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 110.881 -179.714 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.29 -175.47 2.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.423 -178.798 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.538 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 85.0 t60 -130.94 -72.12 0.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.755 -179.544 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.514 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -163.83 128.54 2.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.986 -178.92 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.769 HD11 HG23 ' A' ' 53' ' ' VAL . 2.9 mt -93.56 155.13 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.17 -177.104 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.691 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.2 t0 -119.43 121.6 39.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.046 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -86.28 67.77 10.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.931 0.396 . . . . 0.0 110.174 178.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.522 ' O ' HG11 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -98.34 148.89 35.14 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.621 -177.887 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.754 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 31.6 Cg_endo -93.47 157.86 2.46 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.052 2.501 . . . . 0.0 113.443 -177.269 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.453 HD12 ' HB3' ' A' ' 50' ' ' ALA . 3.5 mm -128.42 -82.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.024 -178.973 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -67.64 -149.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -71.47 -31.85 67.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.609 179.646 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.34 7.39 0.62 Allowed Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.413 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.614 ' HB3' ' HE2' ' A' ' 11' ' ' MET . 8.8 mp -90.17 100.08 12.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.985 0.421 . . . . 0.0 110.799 -179.626 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.754 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 17.7 t -91.43 127.88 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.928 -177.765 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.707 ' HB1' ' HB3' ' A' ' 11' ' ' MET . . . -95.16 143.85 26.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.135 178.415 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.691 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.6 OUTLIER -104.92 117.69 34.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.201 178.507 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.579 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.7 m120 -89.41 93.0 9.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.141 -178.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.769 HG23 HD11 ' A' ' 39' ' ' ILE . 10.9 t -85.9 102.63 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.67 -177.721 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.618 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.1 OUTLIER -84.76 166.1 17.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.18 178.517 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.554 HG23 ' HB2' ' A' ' 6' ' ' ALA . 3.9 m -138.89 126.53 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.055 0.455 . . . . 0.0 111.231 -179.059 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.538 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -97.72 107.49 20.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.836 179.363 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.6 m -123.66 171.79 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.568 179.835 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.04 -73.45 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.839 179.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -80.35 2.49 24.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.9 0.381 . . . . 0.0 110.795 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.45 ' HB2' HG21 ' A' ' 34' ' ' THR . . . -67.14 -151.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.97 179.339 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.56 -161.9 1.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.807 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.58 12.32 34.76 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.488 178.839 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.07 -7.64 60.0 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.362 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 p -74.3 -5.35 41.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 110.239 179.313 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -23.91 22.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.227 177.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.97 -26.37 59.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.136 -179.401 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 31' ' ' PRO . . . -60.91 -56.63 18.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.267 179.49 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.92 -34.63 71.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.573 178.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -51.55 68.43 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.444 178.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.459 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 7.6 p -64.17 -20.42 65.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.649 179.005 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.61 HD22 HD12 ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.34 -27.11 62.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.623 -179.727 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.1 -16.23 61.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.805 179.435 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.53 29.34 0.95 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.728 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.802 HD11 ' HD2' ' A' ' 29' ' ' ARG . 1.7 tt -73.38 -162.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.524 -0.338 . . . . 0.0 111.213 -178.704 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.633 ' HG2' HG21 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -51.39 90.21 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.084 0.468 . . . . 0.0 110.745 179.257 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.32 -24.71 67.72 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.927 -178.282 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -85.69 -35.92 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.408 0.623 . . . . 0.0 109.985 179.1 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.632 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 1.4 m -96.0 90.52 5.6 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.405 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.583 HD21 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -74.8 129.85 38.42 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.692 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.794 HG23 HG23 ' A' ' 8' ' ' ILE . 1.8 mp -101.12 148.81 6.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.47 -175.319 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.565 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 2.8 tt0 -85.8 70.14 10.65 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 173.129 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.745 HG23 HG23 ' A' ' 80' ' ' ILE . 57.7 t -80.0 53.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.999 -174.411 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.92 2.29 3.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.454 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.667 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.0 OUTLIER -85.61 132.44 34.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.313 -178.218 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.9 p -148.08 145.61 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.795 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.746 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -149.72 95.54 2.34 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.335 0.588 . . . . 0.0 110.346 -178.677 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.02 110.39 17.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.542 -178.778 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 6.9 mp -82.06 79.06 8.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.347 177.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.3 mtm . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.998 -179.699 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.58 0.228 . . . . 0.0 110.591 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 55.2 t -111.95 122.91 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.752 0.311 . . . . 0.0 111.745 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.516 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -97.41 167.49 10.97 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.631 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 5.3 m -141.94 127.55 19.07 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.596 0.712 . . . . 0.0 112.164 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.991 HG22 HG21 ' A' ' 80' ' ' ILE . 4.3 mm -122.08 108.45 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.578 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.8 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -98.31 96.71 8.24 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.354 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.461 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.4 m -91.39 135.5 26.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.841 0.353 . . . . 0.0 111.519 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.841 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.3 ptm -145.05 125.36 7.27 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 121.109 0.48 . . . . 0.0 111.648 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.628 ' CD ' HG13 ' A' ' 17' ' ' VAL . 14.6 Cg_exo -71.45 128.4 14.45 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.487 2.791 . . . . 0.0 112.404 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -35.51 71.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.347 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.74 154.87 78.41 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.346 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.605 ' HA ' HD22 ' A' ' 48' ' ' LEU . 56.1 Cg_endo -69.95 -3.24 11.74 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.554 2.17 . . . . 0.0 111.961 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -90.93 44.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.738 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.628 HG13 ' CD ' ' A' ' 12' ' ' PRO . 98.1 t -63.8 78.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.321 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.574 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -69.91 95.13 0.9 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.12 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.683 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -62.98 -43.75 97.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.394 -178.265 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.771 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 10.1 tt0 -70.6 -35.63 73.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 0.0 110.762 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.574 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -68.55 -37.23 79.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.507 ' CD2' ' HG3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -65.95 -28.73 69.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.011 177.507 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.771 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -55.93 -46.88 78.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.596 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -65.1 -42.86 93.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.421 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.559 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 2.4 mt-10 -66.4 -31.54 72.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.285 0.564 . . . . 0.0 110.598 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.805 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 9.5 mt -61.88 -42.94 96.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.709 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -62.29 -39.32 92.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.939 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 9.2 pt-20 -77.41 -20.97 53.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.59 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.811 ' HD2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.14 -11.94 39.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.194 -178.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.683 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.1 mm -60.26 137.87 91.71 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.326 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.658 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.9 Cg_endo -52.34 114.85 1.84 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.686 2.257 . . . . 0.0 112.113 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.52 3.01 0.05 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.362 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.51 -43.94 7.63 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.88 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.619 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.61 -135.47 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.718 0.259 . . . . 0.0 111.136 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -135.01 169.47 17.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.635 HD23 HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -76.15 -176.13 3.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.964 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.502 ' ND1' HG22 ' A' ' 56' ' ' VAL . 83.8 t60 -130.79 -77.51 0.53 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.251 0.548 . . . . 0.0 111.102 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.627 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -165.07 129.94 2.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.829 -178.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.648 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -92.66 158.23 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.724 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 2.0 t0 -123.7 131.47 53.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.632 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -91.1 71.36 6.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.354 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.6 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -103.68 146.78 33.14 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.64 -178.253 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.788 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.0 Cg_endo -88.91 157.45 5.95 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.123 2.549 . . . . 0.0 112.974 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.753 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.7 mm -127.15 -83.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.458 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.768 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.34 -150.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -71.89 -28.45 63.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.846 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.62 5.93 0.45 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.646 -0.787 . . . . 0.0 113.099 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.768 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.4 mt -93.03 106.29 18.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 111.108 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.788 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 60.3 t -93.7 127.55 45.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.72 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.841 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -94.6 166.63 11.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.391 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.724 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.1 mp -120.38 118.28 29.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.099 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.549 ' ND2' ' HB3' ' A' ' 40' ' ' ASP . 1.6 m-20 -89.61 92.09 8.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.333 0.587 . . . . 0.0 110.32 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.648 HG22 HD13 ' A' ' 39' ' ' ILE . 4.6 t -86.83 101.85 11.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.543 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.618 ' HG3' HG23 ' A' ' 7' ' ' THR . 2.6 mtt -84.6 165.18 18.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.34 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.516 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.0 m -139.43 135.14 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.394 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.502 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.48 116.91 39.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.022 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 4' ' ' VAL . 10.6 m -130.21 148.26 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.084 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -167.22 -69.56 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.297 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -81.44 -5.68 58.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.989 0.423 . . . . 0.0 110.579 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.619 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.67 -149.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.318 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.57 -165.53 2.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.793 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.22 15.06 24.87 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.639 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.49 -3.94 49.95 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.574 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p -74.28 -3.74 31.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.91 0.386 . . . . 0.0 110.142 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.15 -23.93 23.82 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.353 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.53 -25.77 52.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.164 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.658 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.44 -55.9 26.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.351 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -58.64 -34.6 71.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.44 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.29 -51.81 67.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.347 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.449 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.7 p -63.8 -20.13 65.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.424 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.607 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.87 -28.24 62.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.551 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.54 -13.26 51.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.957 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.31 26.1 0.98 Allowed Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.742 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.811 HD11 ' HD2' ' A' ' 29' ' ' ARG . 2.6 tt -73.38 -163.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.449 -0.376 . . . . 0.0 111.127 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.589 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -51.29 94.2 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.843 0.354 . . . . 0.0 111.009 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.13 -26.91 68.16 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.233 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 p -88.6 -38.3 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.188 0.518 . . . . 0.0 110.232 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -96.69 89.94 5.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.324 179.399 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -77.2 136.87 38.59 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.991 HG21 HG22 ' A' ' 8' ' ' ILE . 2.3 mp -101.91 147.91 8.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.397 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.646 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 3.8 tt0 -86.05 70.73 10.62 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 173.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.646 HG23 ' HB ' ' A' ' 80' ' ' ILE . 60.6 t -80.54 51.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.009 -174.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.78 3.84 3.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.328 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.631 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 4.1 m-20 . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 111.247 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.431 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.3 t . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.644 0.259 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 86.9 t -119.5 116.67 51.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.067 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.679 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -92.35 166.93 12.33 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.808 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 9.0 m -142.2 130.7 22.5 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.535 0.684 . . . . 0.0 112.129 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.944 HG22 HG21 ' A' ' 80' ' ' ILE . 9.8 mm -121.75 106.64 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.512 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.706 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.4 OUTLIER -96.83 96.13 8.34 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.841 0.353 . . . . 0.0 111.866 -177.798 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.823 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.5 m -93.65 137.3 23.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.939 -177.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.613 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -146.05 123.82 6.21 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 121.249 0.547 . . . . 0.0 111.412 178.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.629 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 11.5 Cg_exo -73.2 120.92 6.84 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.591 2.861 . . . . 0.0 111.979 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -56.44 -31.57 64.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 p -78.28 154.85 79.58 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.202 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.577 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 53.8 Cg_endo -69.31 -2.55 10.05 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.301 2.001 . . . . 0.0 111.695 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.43 41.15 1.04 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.237 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.629 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 91.1 t -65.93 77.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.493 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.63 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -69.49 95.04 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.495 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.671 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -63.82 -44.24 93.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.175 -178.469 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.671 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 5.1 tp10 -68.47 -40.05 81.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.613 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.767 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -70.85 -35.81 72.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.128 0.49 . . . . 0.0 110.504 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.586 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -66.13 -31.71 72.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.803 178.257 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -56.27 -45.21 80.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.68 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.767 ' HE2' ' HA ' ' A' ' 21' ' ' ALA . 1.9 mtmm -67.09 -43.57 82.22 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.518 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 21' ' ' ALA . 26.1 mt-10 -65.95 -27.14 67.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.634 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.778 HG12 HG21 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -61.81 -46.58 96.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.412 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.543 HE22 HD11 ' A' ' 39' ' ' ILE . 25.3 mm-40 -63.06 -31.89 73.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 0.0 110.969 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 5.6 mm-40 -73.25 -22.42 60.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.137 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.914 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.15 -18.6 25.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.381 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.457 HG23 ' HD2' ' A' ' 31' ' ' PRO . 27.6 mm -57.18 137.46 80.62 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.205 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.457 ' HD2' HG23 ' A' ' 30' ' ' ILE . 8.7 Cg_endo -48.9 118.75 3.69 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.902 2.401 . . . . 0.0 112.191 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -4.61 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.137 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.66 -35.01 17.64 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.152 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.596 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.61 -148.66 0.37 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 111.215 -179.324 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -136.71 171.33 14.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.93 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.686 ' H ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -75.35 -176.17 3.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.427 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.716 ' ND1' HG22 ' A' ' 56' ' ' VAL . 71.7 t60 -130.84 -74.85 0.53 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.796 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 mmtm -161.68 129.38 4.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.051 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.674 HG12 HG13 ' A' ' 53' ' ' VAL . 2.7 mt -92.33 160.75 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.985 0.421 . . . . 0.0 111.803 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -128.42 123.2 33.16 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.511 -178.699 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -85.06 72.12 10.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.783 0.325 . . . . 0.0 110.502 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.509 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -99.28 134.5 21.24 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.83 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.792 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 73.3 Cg_endo -88.1 156.94 7.05 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.553 2.168 . . . . 0.0 112.757 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.0 mm -124.64 -82.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.323 -177.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.671 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.52 -152.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.86 -28.6 63.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.595 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.77 5.44 0.5 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.979 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.671 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.7 mt -91.73 101.84 14.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.911 0.386 . . . . 0.0 110.76 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.792 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 89.2 t -93.75 128.45 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.853 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.716 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.64 153.33 17.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.923 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.626 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.1 mp -113.34 119.86 39.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.507 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.554 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.6 m120 -90.44 91.26 8.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.187 0.518 . . . . 0.0 110.207 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.778 HG21 HG12 ' A' ' 26' ' ' ILE . 6.0 t -87.45 106.29 16.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.547 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.566 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.64 165.5 17.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.283 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.679 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.2 m -139.98 137.97 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 111.446 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.716 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.5 OUTLIER -94.68 110.77 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.853 179.052 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.562 HG12 HG21 ' A' ' 34' ' ' THR . 13.1 m -130.13 148.01 33.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.949 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.73 -68.12 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.383 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -81.73 -3.07 52.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.934 0.397 . . . . 0.0 110.579 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.596 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.22 -146.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.119 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -147.34 -163.19 1.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.776 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.79 12.49 35.14 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.604 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.67 -6.16 58.34 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.617 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 p -74.94 -7.26 53.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.609 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -54.89 -24.39 23.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.274 0.559 . . . . 0.0 110.226 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.32 -27.75 62.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.229 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.498 ' HB1' HH22 ' A' ' 29' ' ' ARG . . . -60.77 -55.68 30.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.384 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.69 -35.09 73.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.455 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -49.92 75.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.28 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 p -64.17 -18.97 64.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.454 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.725 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -74.04 -28.96 61.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.605 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -14.42 54.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.46 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.28 32.96 0.93 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.448 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.914 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -72.68 -163.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.215 -0.492 . . . . 0.0 111.075 -178.577 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.5 OUTLIER -50.91 98.65 0.02 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.913 0.387 . . . . 0.0 110.968 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.35 -33.88 66.79 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.797 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.1 t -87.12 -39.63 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.984 0.421 . . . . 0.0 110.524 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 40.5 t -96.23 92.3 6.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.796 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -77.63 134.2 38.24 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.944 HG21 HG22 ' A' ' 8' ' ' ILE . 15.6 mt -101.41 147.05 8.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.584 -175.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -85.64 71.08 10.77 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 173.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.707 HG23 ' HB ' ' A' ' 80' ' ' ILE . 58.2 t -81.02 52.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.241 -174.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.94 4.34 3.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.458 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.808 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 39.5 t0 . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.899 0.38 . . . . 0.0 111.405 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.764 HG12 HG23 ' A' ' 57' ' ' VAL . 1.1 t . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 42.1 t -110.83 112.86 42.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.716 0.293 . . . . 0.0 111.242 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.612 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.67 142.5 27.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.227 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.685 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 7.8 m -122.53 129.25 51.76 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.621 0.724 . . . . 0.0 112.032 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.054 HG22 HG21 ' A' ' 80' ' ' ILE . 1.4 mm -120.44 108.3 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.713 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.814 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -95.29 93.72 7.44 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.748 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.471 HG12 HG12 ' A' ' 80' ' ' ILE . 1.4 m -92.49 136.02 25.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.791 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.828 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.7 ptm -144.4 124.73 7.51 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 121.058 0.456 . . . . 0.0 111.349 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.61 ' CD ' HG13 ' A' ' 17' ' ' VAL . 12.3 Cg_exo -70.9 125.1 11.21 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.246 2.631 . . . . 0.0 112.075 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.07 -33.85 69.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.639 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.8 m -78.01 153.4 80.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.582 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 42.4 Cg_endo -67.59 -3.47 10.28 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.402 2.068 . . . . 0.0 111.955 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.79 43.52 1.15 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.755 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.61 HG13 ' CD ' ' A' ' 12' ' ' PRO . 87.2 t -65.52 75.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.385 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -71.48 88.11 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.948 177.454 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.746 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -63.81 -39.18 93.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.065 -178.83 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.544 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -68.16 -39.13 82.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.971 -178.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -72.05 -36.06 69.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.134 0.493 . . . . 0.0 110.282 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -67.37 -28.22 67.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.979 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -57.73 -43.75 85.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.325 179.204 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -66.53 -43.34 85.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.528 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -66.31 -28.07 68.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.169 0.509 . . . . 0.0 110.531 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.794 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.6 mt -61.86 -44.7 99.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.008 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.88 -36.88 77.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.939 0.399 . . . . 0.0 110.417 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -75.35 -24.09 57.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.747 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.794 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.95 -14.17 37.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.713 0.292 . . . . 0.0 111.291 -178.732 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.2 mm -59.79 139.0 90.21 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.26 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.657 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.4 Cg_endo -51.54 111.69 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.769 2.312 . . . . 0.0 112.076 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.43 2.88 0.05 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.494 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.71 -41.08 9.11 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.821 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.6 ' CB ' HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.19 -133.56 0.21 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.435 0.16 . . . . 0.0 110.794 -179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -140.0 162.92 34.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.826 0.346 . . . . 0.0 110.978 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.6 pt? -76.47 -173.23 2.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.583 ' ND1' HG22 ' A' ' 56' ' ' VAL . 76.7 t60 -130.83 -77.62 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 111.334 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 3.0 mmtp -160.07 132.08 6.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.333 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.656 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -93.57 160.01 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.608 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.653 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -128.17 125.12 38.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.647 -178.648 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -85.74 74.16 10.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.835 0.35 . . . . 0.0 110.438 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.534 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -100.45 134.88 20.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.785 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.8 Cg_endo -84.97 156.01 11.41 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.589 2.193 . . . . 0.0 112.556 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.1 mm -124.76 -82.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.163 -178.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.633 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.27 -153.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.994 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -71.97 -26.59 62.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.663 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.73 3.07 0.41 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.122 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.633 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.1 mt -91.65 103.22 15.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.785 0.326 . . . . 0.0 110.786 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.785 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 93.6 t -94.1 129.06 44.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.746 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.828 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.22 162.71 13.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.906 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.746 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.0 mp -120.4 120.23 35.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.398 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.519 ' ND2' ' HB3' ' A' ' 40' ' ' ASP . 1.8 m-20 -89.66 91.5 8.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.216 0.532 . . . . 0.0 109.792 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.702 HG21 HG12 ' A' ' 26' ' ' ILE . 14.1 t -86.32 105.84 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.434 -177.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.56 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 13.0 mtt -84.94 160.58 20.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.14 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.612 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.0 m -139.09 137.87 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.212 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.583 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.7 t -93.0 98.16 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.883 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.764 HG23 HG12 ' A' ' 4' ' ' VAL . 34.9 m -130.4 138.21 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.124 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.33 -59.66 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.49 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.14 -8.19 59.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.994 0.426 . . . . 0.0 110.503 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.431 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.56 -139.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.122 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.11 -162.38 1.53 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.783 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.2 11.49 36.51 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.702 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.43 -12.21 69.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.474 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 p -74.31 -4.25 35.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.03 0.443 . . . . 0.0 110.278 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -24.32 22.18 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.072 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.63 -27.92 52.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.02 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.657 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.83 -57.89 10.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.372 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -58.45 -34.37 70.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.522 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.77 -52.33 64.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.058 0.456 . . . . 0.0 110.371 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.429 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -64.05 -20.75 66.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.475 178.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.592 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.99 -28.05 62.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.675 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.59 -16.6 61.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.767 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.53 31.0 0.94 Allowed Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.834 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.778 HD11 ' HB2' ' A' ' 29' ' ' ARG . 2.9 tt -73.21 -161.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.511 -0.344 . . . . 0.0 111.11 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.622 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -51.82 90.69 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.121 0.486 . . . . 0.0 110.714 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.53 -24.93 62.43 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.107 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 p -86.95 -34.67 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.352 0.596 . . . . 0.0 110.307 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.62 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 29.0 t -96.71 92.3 6.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.697 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -76.23 132.2 39.76 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.054 HG21 HG22 ' A' ' 8' ' ' ILE . 2.1 mt -101.03 148.16 7.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.493 -175.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.588 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 2.4 tp10 -85.86 71.11 10.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 172.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.705 HG23 ' HB ' ' A' ' 80' ' ' ILE . 68.4 t -79.95 55.89 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.947 -174.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -133.05 1.87 3.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.81 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.685 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.0 m-20 . . . . . 0 N--CA 1.454 -0.242 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.256 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.521 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.5 t . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.685 0.279 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 53.5 t -105.1 112.02 36.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.51 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.613 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.84 142.6 27.91 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.3 m -122.75 129.4 51.71 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.72 0.771 . . . . 0.0 112.563 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.978 HG22 HG21 ' A' ' 80' ' ' ILE . 3.2 mm -121.12 108.71 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.731 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.781 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.96 96.22 8.02 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -177.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.464 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.3 m -93.21 136.67 24.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.581 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -146.26 124.97 6.43 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.296 178.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.2 Cg_exo -71.38 120.35 6.9 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.137 2.558 . . . . 0.0 111.694 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.74 -31.34 64.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.285 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.5 p -77.88 154.21 80.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.985 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.554 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 54.5 Cg_endo -69.01 -1.14 7.31 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.223 1.949 . . . . 0.0 111.493 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.18 41.98 1.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.116 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.634 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 84.8 t -65.8 79.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.368 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 67.3 m-20 -68.11 101.12 1.09 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.16 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.62 HD12 ' HE2' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -61.41 -53.2 59.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.773 -178.623 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.669 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 13.6 pt-20 -71.06 -34.47 71.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.214 -176.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -68.17 -36.45 79.64 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.59 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -65.17 -34.0 77.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.389 176.645 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.669 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -57.14 -47.38 81.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.407 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 21' ' ' ALA . 2.5 mtmt -64.47 -42.91 95.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.61 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.622 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 2.1 mt-10 -66.55 -32.91 74.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.204 0.526 . . . . 0.0 110.811 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.659 ' O ' HG12 ' A' ' 30' ' ' ILE . 3.0 mt -61.78 -43.04 96.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.008 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -62.53 -40.41 96.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.683 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 9.0 pt-20 -78.49 -19.22 53.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.832 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.84 HH22 ' HB ' ' A' ' 8' ' ' ILE . 26.8 ptt85 -89.9 -11.44 41.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.255 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.659 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.9 mm -59.91 138.85 90.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.742 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 8.5 Cg_endo -49.13 117.07 2.57 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.872 2.381 . . . . 0.0 112.256 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -59.71 2.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.433 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.03 -46.18 6.33 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.122 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.643 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -130.07 -134.74 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.624 0.25 . . . . 0.0 110.998 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -137.1 166.41 23.77 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.812 0.339 . . . . 0.0 110.73 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -76.4 -171.91 1.95 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.241 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.458 ' ND1' HG22 ' A' ' 56' ' ' VAL . 85.7 t60 -130.55 -77.69 0.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.376 0.608 . . . . 0.0 111.101 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 2.0 tptp -164.47 129.83 2.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.668 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.622 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -91.78 160.88 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -176.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.616 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -126.4 120.71 30.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.383 -179.271 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -84.32 72.59 10.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.917 0.389 . . . . 0.0 110.465 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.507 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -99.13 135.35 20.83 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.951 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.783 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 62.2 Cg_endo -86.47 157.22 9.33 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.596 2.197 . . . . 0.0 112.515 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.5 mm -126.63 -83.19 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.532 -177.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.668 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.62 -149.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.188 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -70.5 -32.12 69.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.361 . . . . 0.0 110.549 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.69 7.63 0.59 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.658 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.668 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.9 mt -91.25 101.71 14.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.81 0.338 . . . . 0.0 110.793 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 73.9 t -92.53 129.54 42.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.739 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.716 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.03 160.28 14.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.675 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.616 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.1 mp -120.45 119.54 33.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.5 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.436 ' ND2' ' HB3' ' A' ' 40' ' ' ASP . 3.1 m-20 -89.73 90.74 8.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.268 0.556 . . . . 0.0 110.024 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.622 HG22 HD13 ' A' ' 39' ' ' ILE . 10.0 t -87.89 104.74 14.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.478 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.62 ' HG3' HG23 ' A' ' 7' ' ' THR . 2.0 mtt -85.39 163.82 18.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.35 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.613 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.4 m -140.24 136.04 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.984 0.421 . . . . 0.0 111.394 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.458 HG22 ' ND1' ' A' ' 37' ' ' HIS . 1.9 t -95.35 112.08 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.017 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 4' ' ' VAL . 21.4 m -130.17 139.11 52.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.897 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.78 -61.06 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.551 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -81.4 -14.43 57.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.014 0.435 . . . . 0.0 110.718 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.643 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.56 -139.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.092 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.9 -168.82 3.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.525 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.84 13.55 30.05 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.553 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.44 -1.73 38.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.663 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -74.29 -3.92 33.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.857 0.36 . . . . 0.0 110.374 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -55.18 -23.68 23.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.233 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.2 -24.59 42.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.155 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.742 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.39 -56.13 23.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.263 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.3 -34.75 70.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.342 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.53 -52.33 64.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.442 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.436 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.5 p -64.21 -19.11 65.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.629 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.59 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.52 -29.91 62.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.749 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.81 -12.06 43.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.9 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.21 26.02 0.99 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.862 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' A' ' 29' ' ' ARG . 2.7 tt -73.1 -163.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.774 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 0.0 OUTLIER -51.68 96.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.036 0.446 . . . . 0.0 110.665 179.351 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.97 -30.77 76.33 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.367 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 t -85.49 -33.32 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.885 0.374 . . . . 0.0 110.505 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.649 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 11.6 t -95.42 91.23 6.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.717 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -75.43 132.78 41.08 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.978 HG21 HG22 ' A' ' 8' ' ' ILE . 3.2 mp -101.09 148.85 6.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.607 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.585 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 38.7 tt0 -85.85 69.49 10.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 173.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.691 HG23 ' HB ' ' A' ' 80' ' ' ILE . 61.8 t -79.97 54.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.732 -175.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.89 0.57 3.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.567 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.791 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 10.2 t0 . . . . . 0 N--CA 1.452 -0.366 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.859 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.52 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.5 t . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.618 0.247 . . . . 0.0 110.703 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.5 t -109.96 119.97 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.699 0.285 . . . . 0.0 111.555 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.784 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -98.72 166.65 11.22 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.706 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 14.7 m -143.23 137.49 28.98 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.644 0.735 . . . . 0.0 112.43 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.058 HG22 HG21 ' A' ' 80' ' ' ILE . 4.2 mm -127.11 106.35 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.274 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.769 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.58 96.19 8.49 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -176.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.558 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.5 m -93.37 134.13 32.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.909 0.385 . . . . 0.0 111.822 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.679 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -146.3 124.91 6.4 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 121.094 0.473 . . . . 0.0 111.24 179.04 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.631 ' CD ' HG13 ' A' ' 17' ' ' VAL . 12.5 Cg_exo -72.51 122.67 8.47 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.467 2.778 . . . . 0.0 112.026 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -56.76 -32.13 65.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.235 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.91 153.58 80.37 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.037 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.6 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 53.6 Cg_endo -69.46 -2.86 10.69 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.403 2.068 . . . . 0.0 112.305 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.61 45.74 1.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.996 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.631 HG13 ' CD ' ' A' ' 12' ' ' PRO . 92.7 t -64.96 76.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.708 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -71.12 89.71 0.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.563 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.877 HD13 ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -63.53 -37.17 86.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.541 -178.17 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.877 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -70.61 -35.58 73.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.992 0.425 . . . . 0.0 110.077 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -69.05 -37.52 78.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.508 ' CD2' ' HG3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -65.92 -30.07 70.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.014 177.359 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.794 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -55.22 -46.71 75.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.663 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -65.84 -43.59 88.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.537 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.721 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 1.3 mm-40 -66.05 -29.32 69.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.266 0.555 . . . . 0.0 110.56 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.718 HG12 HG21 ' A' ' 53' ' ' VAL . 3.8 mt -60.94 -46.4 96.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.932 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -62.37 -38.74 90.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.208 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.721 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -78.33 -20.55 51.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.546 -178.543 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.911 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -89.05 -10.58 46.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.141 -179.222 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.65 HG12 ' O ' ' A' ' 26' ' ' ILE . 33.3 mm -60.89 138.12 93.74 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.265 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.511 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.3 Cg_endo -51.59 114.54 1.62 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.668 2.246 . . . . 0.0 112.126 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.17 -2.58 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.225 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.27 -39.25 10.08 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.875 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.581 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.51 -145.21 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.634 0.254 . . . . 0.0 110.977 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -133.25 164.82 26.23 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.892 0.377 . . . . 0.0 110.795 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.479 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.1 pt? -76.31 -175.09 3.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.389 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.543 ' ND1' HG22 ' A' ' 56' ' ' VAL . 85.3 t60 -130.7 -76.95 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.308 0.575 . . . . 0.0 111.345 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.443 ' HB3' ' CD2' ' A' ' 37' ' ' HIS . 1.1 tptt -163.54 132.66 3.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.959 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.708 HG12 HG13 ' A' ' 53' ' ' VAL . 2.6 mt -92.65 159.35 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.108 0.48 . . . . 0.0 112.172 -176.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.655 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -126.73 117.2 22.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.545 -178.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -82.7 69.9 9.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.941 0.4 . . . . 0.0 110.376 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.544 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -97.23 138.21 21.21 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.887 -179.347 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.775 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 71.1 Cg_endo -85.43 156.27 10.76 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.535 2.156 . . . . 0.0 112.632 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.1 mm -125.76 -83.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.505 -177.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.67 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.42 -147.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.218 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -70.98 -33.87 70.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.403 . . . . 0.0 110.752 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.48 8.4 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.738 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.67 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.3 mt -91.04 102.31 15.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.902 0.382 . . . . 0.0 110.791 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.775 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 70.7 t -92.78 127.5 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.882 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.744 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.56 150.49 20.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.045 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.655 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -112.2 116.23 30.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.158 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 4.6 m-20 -89.76 94.11 9.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.654 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.718 HG21 HG12 ' A' ' 26' ' ' ILE . 3.7 t -86.45 104.19 13.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.277 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 3.8 mtt -84.52 167.52 16.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.207 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.784 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.1 m -139.93 138.05 38.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.56 -178.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.543 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -95.35 111.09 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.736 178.775 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.581 HG12 HG21 ' A' ' 34' ' ' THR . 12.8 m -130.05 148.07 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.001 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.29 -72.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.451 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -81.39 -0.3 40.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.917 0.389 . . . . 0.0 110.553 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.529 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.21 -152.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.234 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.55 -162.69 1.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.729 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.94 14.49 26.09 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.565 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.35 -7.22 60.0 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.498 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.415 HG22 ' OG1' ' A' ' 34' ' ' THR . 1.4 p -74.12 -4.63 36.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.978 0.418 . . . . 0.0 110.261 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -54.83 -23.87 20.37 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.289 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.89 -29.21 62.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.031 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -62.09 -55.15 31.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.812 0.339 . . . . 0.0 110.212 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -58.99 -34.31 71.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.213 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.18 -51.24 68.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.127 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.8 p -63.78 -17.27 62.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.221 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.714 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.58 -29.85 62.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.368 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.07 -12.09 35.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.658 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.24 28.87 0.98 Allowed Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.463 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.911 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -72.59 -164.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.338 -0.431 . . . . 0.0 111.062 -178.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.637 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.5 OUTLIER -51.15 99.7 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.938 0.399 . . . . 0.0 110.81 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.93 -33.44 73.84 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.924 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.7 t -87.16 -38.61 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.984 0.421 . . . . 0.0 110.594 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.637 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 40.8 t -96.13 92.31 6.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.875 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -78.2 135.38 37.6 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.058 HG21 HG22 ' A' ' 8' ' ' ILE . 2.9 mt -101.57 148.63 7.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.514 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.662 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 15.8 tp10 -86.02 69.43 10.52 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 173.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.677 HG22 HG23 ' A' ' 8' ' ' ILE . 55.1 t -80.93 51.62 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.024 -174.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -133.03 9.25 4.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.919 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.706 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.1 m-20 . . . . . 0 N--CA 1.452 -0.365 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.297 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.4 ' HB ' HG23 ' A' ' 57' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.526 0.055 0 CA-C-O 120.58 0.228 . . . . 0.0 111.181 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 56' ' ' VAL . 4.7 t -132.75 127.04 55.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.758 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.578 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.13 168.92 10.63 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.802 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 6.2 m -142.81 129.76 20.64 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.466 0.65 . . . . 0.0 112.164 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.998 HG22 HG21 ' A' ' 80' ' ' ILE . 5.7 mm -121.21 108.03 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.677 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.687 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.54 96.18 8.13 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -177.484 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.83 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.9 m -94.8 137.37 23.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.769 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -147.67 121.65 4.94 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 121.205 0.526 . . . . 0.0 111.999 179.179 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 17.0 Cg_exo -71.34 121.15 7.51 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.417 2.745 . . . . 0.0 111.973 178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.66 -30.56 63.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.317 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -78.0 153.93 80.18 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.965 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.551 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 7.3 Cg_exo -70.39 -6.13 18.21 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.536 2.157 . . . . 0.0 111.719 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -91.17 33.62 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.284 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.638 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.29 85.68 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.738 0.78 . . . . 0.0 109.98 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 24.9 m-20 -69.96 106.13 3.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.352 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.409 ' HG ' HD21 ' A' ' 51' ' ' LEU . 1.5 tt -62.12 -48.91 78.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.17 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 12.6 tp10 -68.48 -37.95 80.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.513 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -70.94 -34.57 71.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.0 0.429 . . . . 0.0 110.591 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -65.28 -32.25 73.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.655 178.164 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -57.8 -45.21 86.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.554 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -42.21 88.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.593 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.604 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 10.3 mt-10 -66.49 -30.23 70.52 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.321 0.581 . . . . 0.0 110.477 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.685 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 3.4 mt -62.06 -43.57 97.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.766 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -60.89 -38.48 85.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.109 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 10.2 pt-20 -77.49 -21.69 52.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.306 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.792 ' HB2' HD11 ' A' ' 74' ' ' ILE . 21.1 ptt85 -91.1 -9.92 43.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.253 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.675 HG12 ' O ' ' A' ' 26' ' ' ILE . 31.5 mm -59.24 137.78 88.48 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.136 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.522 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.8 Cg_endo -51.54 115.02 1.83 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.743 2.296 . . . . 0.0 112.151 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.07 0.55 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.357 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.99 -53.55 3.46 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.858 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.596 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -117.02 -137.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.664 0.232 . . . . 0.0 111.116 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 3.8 pt-20 -137.48 169.14 18.3 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.915 0.388 . . . . 0.0 110.992 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -75.17 177.86 6.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.977 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.673 ' ND1' HG22 ' A' ' 56' ' ' VAL . 71.0 t60 -131.21 -76.28 0.52 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.047 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -161.37 131.78 5.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.402 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.657 HG12 HG13 ' A' ' 53' ' ' VAL . 2.8 mt -93.57 159.23 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.905 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.653 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -129.59 119.31 23.41 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.474 -178.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -82.75 75.52 9.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.91 0.386 . . . . 0.0 110.731 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.529 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -98.56 134.5 21.7 Favored Pre-proline 0 C--O 1.225 -0.205 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.777 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 57.3 Cg_endo -86.53 156.87 9.23 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.499 2.133 . . . . 0.0 112.815 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.711 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.5 mm -124.92 -83.52 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.24 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.772 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.85 -152.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.118 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -71.94 -28.38 63.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.726 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.61 4.31 0.47 Allowed Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.046 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.772 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.5 mt -91.67 101.94 14.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.825 0.345 . . . . 0.0 110.764 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.777 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 87.6 t -94.39 129.61 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.975 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.769 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.43 157.11 16.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.457 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.661 HD23 ' C ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -120.23 121.17 38.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.634 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.505 ' ND2' ' HB3' ' A' ' 40' ' ' ASP . 1.9 m-20 -89.89 92.79 9.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.257 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.657 HG13 HG12 ' A' ' 39' ' ' ILE . 10.3 t -86.03 104.73 13.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.212 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.584 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.8 mtt -84.58 164.52 18.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.234 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.578 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.0 m -139.27 139.52 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.164 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.673 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -92.18 112.15 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.794 0.33 . . . . 0.0 110.887 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.478 HG12 HG21 ' A' ' 34' ' ' THR . 28.3 m -128.34 140.52 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.999 0.428 . . . . 0.0 111.176 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.43 -69.8 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.235 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.75 -4.96 58.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.409 . . . . 0.0 110.509 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.596 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.06 -152.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.302 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.65 -162.96 1.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.803 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.09 14.24 28.23 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.557 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.27 -5.9 51.13 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.247 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 p -74.6 -3.18 29.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.102 0.477 . . . . 0.0 109.97 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.24 -23.71 23.93 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.161 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.33 -28.28 58.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.74 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.44 -56.78 16.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.156 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -58.49 -34.48 70.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.387 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.68 -52.2 65.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.305 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.414 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 3.1 p -64.08 -17.83 63.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.302 178.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.628 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.64 -28.56 62.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.356 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -12.96 49.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.18 26.02 0.99 Allowed Glycine 0 N--CA 1.453 -0.207 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.805 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' A' ' 29' ' ' ARG . 1.1 tt -73.47 -162.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.535 -0.332 . . . . 0.0 110.865 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.62 ' N ' HG23 ' A' ' 74' ' ' ILE . 1.4 mp0 -50.41 93.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.831 0.348 . . . . 0.0 110.932 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.57 -26.35 56.93 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.952 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.43 -39.81 12.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.113 0.482 . . . . 0.0 110.493 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -96.47 91.0 5.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.698 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -78.2 136.53 37.83 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.998 HG21 HG22 ' A' ' 8' ' ' ILE . 14.9 mt -101.48 145.87 10.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.604 -176.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -85.85 71.47 10.65 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.269 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.703 HG23 ' HB ' ' A' ' 80' ' ' ILE . 64.3 t -80.09 50.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.207 -173.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -132.99 6.39 3.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.18 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.802 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 31.4 t0 . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.037 0.446 . . . . 0.0 110.999 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.666 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.071 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 43.4 t -104.85 122.98 58.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.887 0.375 . . . . 0.0 111.806 -178.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -97.96 163.2 12.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.735 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.716 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 5.6 m -139.7 123.12 17.15 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.642 0.734 . . . . 0.0 111.625 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.951 HG22 HG21 ' A' ' 80' ' ' ILE . 17.6 mt -122.13 107.62 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.734 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.814 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.89 95.99 8.23 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -176.643 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.475 ' N ' HG23 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -91.43 136.3 24.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.875 0.369 . . . . 0.0 111.738 -177.765 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.817 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 2.2 ptm -144.14 124.97 7.79 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 121.036 0.446 . . . . 0.0 111.485 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.601 ' CD ' HG13 ' A' ' 17' ' ' VAL . 14.2 Cg_exo -69.7 124.54 11.21 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.173 2.582 . . . . 0.0 112.099 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -57.9 -32.6 67.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.457 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.6 p -77.34 152.94 81.76 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.119 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.56 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 46.8 Cg_endo -68.19 -3.11 10.13 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.216 1.944 . . . . 0.0 111.572 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.74 43.63 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.835 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.601 HG13 ' CD ' ' A' ' 12' ' ' PRO . 90.0 t -65.8 75.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.65 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.59 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -71.74 92.94 1.23 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.027 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.728 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -63.24 -42.06 99.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.596 -178.035 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.887 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 10.8 tt0 -69.96 -36.5 75.3 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.955 0.407 . . . . 0.0 110.292 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.59 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -69.21 -37.75 78.23 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -67.11 -27.01 66.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.004 177.483 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.887 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -56.2 -46.8 79.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.371 179.554 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 2.0 mtmt -66.86 -39.86 87.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.766 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -65.5 -33.8 76.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.213 0.53 . . . . 0.0 110.095 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.647 ' O ' HG12 ' A' ' 30' ' ' ILE . 1.8 mt -62.75 -39.01 83.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.935 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -42.35 91.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.639 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 13.3 mt-10 -76.01 -20.92 57.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.814 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.766 HH22 ' HB ' ' A' ' 8' ' ' ILE . 20.8 ptt85 -88.76 -15.63 34.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.484 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 26' ' ' ILE . 22.4 mm -59.4 137.48 89.0 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.917 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.561 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 8.0 Cg_endo -50.18 124.85 13.63 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.824 2.349 . . . . 0.0 112.521 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -60.79 -3.68 0.8 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.893 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.24 -61.7 1.88 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.991 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.626 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -110.24 -145.56 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.835 0.35 . . . . 0.0 111.296 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -132.05 172.01 12.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.614 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -74.97 -173.67 1.99 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.007 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.541 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.5 t60 -130.58 -74.81 0.54 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.426 0.631 . . . . 0.0 110.782 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -165.03 125.9 1.99 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.796 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.659 HD13 HG22 ' A' ' 53' ' ' VAL . 2.7 mt -92.4 154.35 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.848 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.716 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.8 t0 -121.25 129.2 53.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.488 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -89.69 69.76 7.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.86 0.362 . . . . 0.0 110.202 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.672 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -100.15 148.26 34.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.595 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.751 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.0 Cg_endo -91.07 156.19 3.88 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.026 2.484 . . . . 0.0 113.209 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.6 mm -125.89 -82.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.063 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.567 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.41 -151.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -72.07 -28.55 63.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.755 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.54 4.79 0.5 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.942 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.567 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.2 mt -91.43 103.44 16.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 110.968 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.751 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 36.7 t -92.3 128.58 43.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.694 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.817 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.0 165.68 12.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.094 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.728 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.0 mp -120.26 119.93 34.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.234 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 1.6 m-20 -89.52 90.96 8.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.225 0.536 . . . . 0.0 109.915 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.659 HG22 HD13 ' A' ' 39' ' ' ILE . 10.0 t -86.91 98.86 7.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.705 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 35.7 mtt -84.54 162.56 19.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.096 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.7 m -138.92 134.71 42.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.536 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.541 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.66 113.55 31.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.127 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 4' ' ' VAL . 4.4 m -129.63 143.63 40.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.934 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.57 -65.98 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.454 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -80.96 -8.21 59.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.996 0.427 . . . . 0.0 110.648 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.626 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.84 -146.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.21 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.62 -164.18 1.94 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.749 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.89 13.6 30.08 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.545 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.08 -5.62 53.89 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.54 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.58 -5.22 41.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.957 0.408 . . . . 0.0 110.338 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -54.9 -23.15 17.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.148 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.89 -29.08 62.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.968 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.65 -52.65 63.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.403 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.66 -37.27 75.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.309 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -50.21 74.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.312 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.425 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.1 p -64.0 -21.04 66.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.685 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.561 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.54 -29.36 62.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.827 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -13.74 53.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.888 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.36 28.57 0.97 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.871 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.683 HD11 ' HD2' ' A' ' 29' ' ' ARG . 3.6 tt -73.28 -163.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.61 -0.295 . . . . 0.0 111.067 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.762 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 1.2 pm0 -51.55 91.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.975 0.416 . . . . 0.0 110.877 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.83 -25.58 67.83 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.756 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.27 -34.67 8.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.289 0.566 . . . . 0.0 110.132 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.762 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -95.83 90.36 5.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.569 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -74.5 131.09 40.72 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.951 HG21 HG22 ' A' ' 8' ' ' ILE . 3.0 mp -100.83 149.21 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.524 -175.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.668 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 31.5 tp10 -85.79 70.33 10.67 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.686 HG23 ' HB ' ' A' ' 80' ' ' ILE . 52.8 t -81.06 54.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.857 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 m -132.65 1.97 3.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.689 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.716 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 2.2 m-20 . . . . . 0 N--CA 1.452 -0.339 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.753 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.827 HG12 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 121.023 0.44 . . . . 0.0 110.136 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 3.9 t -105.31 120.41 55.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.072 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.735 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.09 157.22 16.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.788 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 4.5 m -138.24 125.52 21.7 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.702 0.763 . . . . 0.0 111.979 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.976 HG22 HG21 ' A' ' 80' ' ' ILE . 6.7 mm -120.55 108.31 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.943 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.743 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.31 95.57 8.17 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.014 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.675 ' HB ' HG12 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -92.66 135.95 26.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.787 -178.101 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.757 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -145.75 127.0 7.5 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 120.964 0.411 . . . . 0.0 111.361 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 8.7 Cg_exo -73.4 120.19 6.38 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.252 2.635 . . . . 0.0 112.127 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -56.76 -32.19 65.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.303 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 p -78.45 154.01 79.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.012 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.567 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 56.1 Cg_endo -68.9 -2.09 8.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.213 1.942 . . . . 0.0 111.508 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.88 42.52 1.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.121 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.631 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 96.2 t -64.88 77.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.125 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.725 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.1 m-20 -68.35 98.6 0.85 Allowed 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.416 ' CD2' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -61.49 -51.35 69.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.659 -178.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -68.06 -37.95 81.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.619 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.667 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . . . -70.52 -38.32 74.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.063 0.459 . . . . 0.0 110.6 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -66.8 -30.14 70.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.189 178.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -44.6 93.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.43 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.667 ' HE3' ' HA ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -65.94 -41.94 90.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.587 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -64.76 -32.42 74.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.074 0.464 . . . . 0.0 110.635 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.919 HG12 HG21 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -62.14 -44.89 99.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.473 -179.448 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.477 ' OE1' HG22 ' A' ' 26' ' ' ILE . 7.2 mm100 -63.35 -33.41 75.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.82 0.343 . . . . 0.0 110.737 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.584 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 27.6 mt-10 -74.44 -23.2 58.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.088 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.75 ' HD2' HD11 ' A' ' 74' ' ' ILE . 28.7 ptt85 -89.26 -15.79 32.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.552 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.548 HG12 ' O ' ' A' ' 26' ' ' ILE . 24.2 mm -57.97 136.74 83.84 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.456 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 18.4 Cg_endo -56.81 116.73 3.41 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.274 1.983 . . . . 0.0 112.073 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.81 0.64 0.08 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.405 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.446 ' HA3' ' C ' ' A' ' 63' ' ' GLY . . . -82.46 -37.03 15.23 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.575 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.557 HG21 HG12 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -130.28 -144.06 0.26 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.647 0.26 . . . . 0.0 110.871 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -136.74 167.8 20.74 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.881 0.372 . . . . 0.0 111.031 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -75.26 -177.23 3.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.007 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.744 ' ND1' HG22 ' A' ' 56' ' ' VAL . 73.0 t60 -131.49 -75.64 0.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.205 0.526 . . . . 0.0 111.047 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 11.9 mmtt -161.25 129.37 4.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.222 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.628 HG12 HG13 ' A' ' 53' ' ' VAL . 3.2 mt -94.42 158.51 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.073 0.463 . . . . 0.0 111.989 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.699 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -126.49 118.69 25.44 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.98 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -85.7 71.24 10.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.905 0.383 . . . . 0.0 110.261 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.661 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -100.73 149.54 36.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.628 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.763 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 29.6 Cg_endo -91.92 158.88 3.35 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.074 2.516 . . . . 0.0 113.331 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.772 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.3 mm -128.89 -83.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.348 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.694 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.79 -148.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.184 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -71.17 -32.61 69.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.81 0.338 . . . . 0.0 110.808 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.67 8.85 0.64 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.493 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.694 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.3 mt -91.39 103.1 15.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.82 0.343 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.763 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 38.1 t -92.7 127.53 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.898 -178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.772 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.13 159.03 15.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.69 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.818 HD12 HD13 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -118.82 119.56 34.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.494 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.432 ' ND2' ' HB3' ' A' ' 40' ' ' ASP . 2.2 m-20 -89.49 90.26 8.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.709 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.919 HG21 HG12 ' A' ' 26' ' ' ILE . 14.6 t -86.52 104.23 13.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.529 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.633 ' HG3' HG23 ' A' ' 7' ' ' THR . 2.8 mtt -84.57 160.64 20.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.16 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.735 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.8 m -139.53 140.93 36.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.178 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.744 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.4 OUTLIER -92.11 101.8 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.836 179.342 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.827 HG23 HG12 ' A' ' 4' ' ' VAL . 31.8 m -130.72 137.2 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.499 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.62 -59.37 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.423 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -81.7 -7.78 59.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.038 0.447 . . . . 0.0 110.444 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.522 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.5 -140.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.178 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.428 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 1.0 OUTLIER -147.17 -162.35 1.52 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.814 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.428 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -80.23 11.71 35.62 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.741 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.446 ' C ' ' HA3' ' A' ' 33' ' ' GLY . . . -70.02 -11.4 66.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.615 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.469 ' HA ' ' HB2' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -73.68 -2.41 23.06 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.966 0.412 . . . . 0.0 110.103 179.335 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -54.5 -23.8 17.83 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.926 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.07 -31.38 63.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.891 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -59.72 -56.32 23.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.449 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.45 -35.98 75.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.547 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -48.97 79.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.347 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.66 -22.88 67.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.566 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.584 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -72.9 -27.42 61.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.681 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -18.25 64.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.519 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.47 35.88 0.87 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.688 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.75 HD11 ' HD2' ' A' ' 29' ' ' ARG . 0.6 OUTLIER -72.88 -164.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.493 -0.354 . . . . 0.0 111.047 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.7 OUTLIER -50.95 101.52 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.964 0.411 . . . . 0.0 111.154 -179.094 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.09 -33.33 79.07 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.51 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.4 t -86.98 -39.15 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 0.0 110.501 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.631 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 22.0 t -95.5 90.93 5.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.609 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -76.9 136.79 38.84 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.976 HG21 HG22 ' A' ' 8' ' ' ILE . 17.7 mt -101.45 146.91 8.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.743 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -85.84 71.72 10.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.695 HG23 ' HB ' ' A' ' 80' ' ' ILE . 73.6 t -79.96 54.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.08 -174.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -133.08 2.73 3.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.418 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.788 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 20.6 t0 . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 120.8 0.333 . . . . 0.0 110.961 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.486 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.634 0.254 . . . . 0.0 110.756 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -114.87 113.21 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.973 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.817 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.55 165.99 12.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.332 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.784 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 7.4 m -143.41 130.71 20.91 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.658 0.742 . . . . 0.0 112.187 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.083 HG22 HG21 ' A' ' 80' ' ' ILE . 5.7 mm -122.15 107.38 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.728 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.769 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.19 95.34 8.06 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.511 HG11 ' HE ' ' A' ' 29' ' ' ARG . 1.9 m -94.27 137.85 22.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.899 0.381 . . . . 0.0 111.841 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.741 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.1 ptm -147.43 127.61 6.76 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 121.177 0.513 . . . . 0.0 111.455 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.631 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 13.3 Cg_exo -72.37 124.74 10.14 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.525 2.817 . . . . 0.0 112.141 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.91 -33.54 67.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.274 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.94 151.9 79.48 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.992 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.95 -2.54 8.91 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.407 2.071 . . . . 0.0 111.978 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.39 44.23 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.025 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.631 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 74.3 t -64.86 77.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.625 -178.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 19.3 m-20 -70.86 91.44 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.916 177.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.886 HD13 ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.67 -36.08 83.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.353 -178.235 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.886 ' H ' HD13 ' A' ' 19' ' ' LEU . 8.7 pt-20 -69.91 -38.83 76.38 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.91 0.386 . . . . 0.0 110.177 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.658 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . . . -71.82 -33.9 68.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.341 0.591 . . . . 0.0 109.526 177.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.1 OUTLIER -66.04 -32.93 74.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.305 177.272 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.579 ' HA ' HD12 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -57.14 -45.53 83.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.419 178.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.658 ' HE3' ' HA ' ' A' ' 21' ' ' ALA . 2.0 mtmt -65.85 -43.25 89.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.582 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -65.54 -30.06 70.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.474 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.646 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 5.7 mt -60.83 -45.85 97.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.957 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.487 ' OE1' HD21 ' A' ' 36' ' ' LEU . 5.9 mm-40 -61.07 -38.0 84.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.947 0.403 . . . . 0.0 110.688 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -75.55 -23.07 56.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.333 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.767 HH22 ' HB ' ' A' ' 8' ' ' ILE . 23.6 ptt85 -90.99 -11.84 37.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.116 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 26' ' ' ILE . 27.6 mm -60.02 137.33 90.92 Favored Pre-proline 0 N--CA 1.463 0.21 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.019 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HD2' HG23 ' A' ' 30' ' ' ILE . 4.1 Cg_endo -46.89 120.82 4.41 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.853 2.368 . . . . 0.0 112.296 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -55.95 -11.02 0.91 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.832 -179.094 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.7 -41.84 10.58 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.901 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.539 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.38 -148.45 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.69 0.281 . . . . 0.0 110.995 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -137.23 175.02 9.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.836 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.487 HD21 ' OE1' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -74.69 -176.07 2.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.237 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.648 ' ND1' HG22 ' A' ' 56' ' ' VAL . 79.5 t60 -131.04 -69.78 0.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.662 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -161.31 127.13 3.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.1 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.669 HG12 HG13 ' A' ' 53' ' ' VAL . 2.9 mt -91.78 158.01 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.626 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.647 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -128.78 119.23 24.15 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.461 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -82.46 72.01 9.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.985 0.421 . . . . 0.0 110.401 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.542 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -97.05 132.85 24.98 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.816 -179.45 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.771 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 58.9 Cg_endo -87.68 155.83 7.58 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.527 2.151 . . . . 0.0 112.8 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.699 HD11 ' HB3' ' A' ' 50' ' ' ALA . 1.8 mm -124.43 -82.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.098 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -67.66 -153.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.951 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -71.98 -27.88 63.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 110.709 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.64 5.83 0.53 Allowed Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.581 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.623 ' HA ' HG21 ' A' ' 17' ' ' VAL . 8.2 mp -91.1 97.5 11.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.791 0.329 . . . . 0.0 110.645 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 95.4 t -93.97 127.36 46.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.085 0.469 . . . . 0.0 112.163 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.741 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.82 142.4 28.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.795 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.647 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -105.98 120.72 42.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.377 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.491 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 2.2 m-20 -89.61 91.85 8.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.374 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.669 HG13 HG12 ' A' ' 39' ' ' ILE . 9.4 t -86.41 107.46 16.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.264 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.567 ' HG3' HG23 ' A' ' 7' ' ' THR . 12.5 mtt -84.46 168.28 15.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.168 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.817 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.8 m -141.48 136.04 31.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.922 0.391 . . . . 0.0 111.312 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.648 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -96.12 112.76 28.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.769 178.631 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.539 HG12 HG21 ' A' ' 34' ' ' THR . 19.9 m -130.46 138.06 54.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.897 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.66 -60.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.322 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.89 -13.9 58.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.021 0.439 . . . . 0.0 110.376 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.527 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.91 -146.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.029 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.61 -160.37 1.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.717 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.66 13.21 30.61 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.36 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.21 -1.92 37.51 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.54 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.474 HG22 ' OG1' ' A' ' 34' ' ' THR . 1.8 p -75.34 -6.41 49.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.975 0.417 . . . . 0.0 110.264 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.83 -23.48 18.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.341 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.02 -27.5 61.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.996 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.41 -55.59 29.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.31 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -58.99 -34.85 72.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.573 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.58 -50.44 71.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.343 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.413 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 14.5 p -63.39 -18.86 64.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.211 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.605 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -72.9 -30.71 64.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.559 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -12.14 33.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.72 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.26 26.44 0.99 Allowed Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.829 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.682 HD11 ' HD2' ' A' ' 29' ' ' ARG . 2.4 tt -73.21 -160.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.671 -0.264 . . . . 0.0 110.873 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.606 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -51.01 99.9 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.842 0.353 . . . . 0.0 110.98 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.52 -32.58 78.42 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.596 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.2 t -88.25 -38.39 11.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.939 0.399 . . . . 0.0 110.543 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.588 ' HB2' ' HB3' ' A' ' 75' ' ' GLU . 6.1 m -95.81 90.65 5.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.76 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -79.43 137.75 37.37 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.083 HG21 HG22 ' A' ' 8' ' ' ILE . 1.7 mt -101.74 147.24 8.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.575 -176.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -86.01 72.02 10.51 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 172.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.686 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.9 t -80.79 56.66 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.124 -174.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -133.05 0.34 3.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.762 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.784 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 40.2 t0 . . . . . 0 N--CA 1.455 -0.213 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.229 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.575 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.062 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 41.1 t -109.96 118.41 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 0.0 111.755 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.691 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.04 161.76 14.16 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.646 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 6.2 m -140.97 131.41 25.24 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.682 0.753 . . . . 0.0 112.687 -178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.041 HG22 HG21 ' A' ' 80' ' ' ILE . 3.8 mm -121.03 105.78 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.367 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.808 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -93.69 93.4 8.0 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -177.794 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.483 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.9 m -92.44 136.0 25.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.826 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.722 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -146.55 123.94 5.98 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-O 121.235 0.54 . . . . 0.0 111.444 179.288 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.64 ' CD ' HG13 ' A' ' 17' ' ' VAL . 14.1 Cg_exo -70.4 120.99 7.57 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.305 2.67 . . . . 0.0 111.854 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -56.69 -31.2 64.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.62 153.19 81.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.983 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.593 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 46.4 Cg_endo -68.58 -2.9 10.08 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.446 2.097 . . . . 0.0 112.366 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -91.71 43.12 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.248 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.64 HG13 ' CD ' ' A' ' 12' ' ' PRO . 97.0 t -65.64 76.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.408 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 3.7 m-20 -70.03 97.65 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.619 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -63.23 -45.74 90.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.816 -177.576 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.78 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 28.3 tt0 -70.7 -35.62 72.85 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.759 0.314 . . . . 0.0 110.678 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -67.52 -39.2 85.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -66.57 -31.5 72.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.836 177.02 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.78 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -55.46 -48.61 74.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.115 -179.398 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -68.16 -40.76 82.26 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.522 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.589 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 29.8 mm-40 -64.75 -30.02 71.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.07 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.765 HG12 HG21 ' A' ' 53' ' ' VAL . 1.2 mt -62.61 -46.4 96.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.988 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -60.94 -36.19 78.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.413 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 9.9 pt-20 -77.16 -22.36 52.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.433 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.812 ' HD3' HD11 ' A' ' 74' ' ' ILE . 8.6 ptp180 -89.55 -9.19 50.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.253 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.553 HD11 HG11 ' A' ' 53' ' ' VAL . 34.6 mm -57.82 138.89 82.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.466 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.762 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.2 Cg_endo -50.91 117.23 3.17 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.711 2.274 . . . . 0.0 111.972 178.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -59.12 1.76 0.06 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.12 -62.54 1.81 Allowed Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.83 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.53 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -109.43 -139.26 0.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.591 0.234 . . . . 0.0 110.844 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -134.9 166.16 23.65 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.868 0.366 . . . . 0.0 110.839 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -75.56 -175.97 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.093 -179.369 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.546 ' ND1' HG22 ' A' ' 56' ' ' VAL . 73.7 t60 -131.25 -79.08 0.52 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 10.1 mmtt -161.69 137.81 7.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.687 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.641 HD12 HG22 ' A' ' 53' ' ' VAL . 2.4 mm -92.11 166.63 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.452 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -130.03 123.22 30.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.165 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -84.88 67.67 10.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.875 0.369 . . . . 0.0 110.518 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.535 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -95.44 133.9 25.16 Favored Pre-proline 0 C--O 1.225 -0.205 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.579 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.773 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 60.6 Cg_endo -87.12 155.65 8.32 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.62 2.213 . . . . 0.0 112.686 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.712 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.8 mm -124.81 -82.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.378 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.664 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.4 -150.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -71.87 -29.95 64.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.587 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.71 6.36 0.54 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.736 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.664 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.8 mt -91.45 100.91 13.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.975 0.417 . . . . 0.0 110.835 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 78.3 t -92.96 128.52 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.72 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.722 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.35 143.0 27.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.103 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 10.9 mp -101.53 119.46 38.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.251 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.585 ' ND2' ' HB3' ' A' ' 40' ' ' ASP . 4.7 m-20 -91.66 96.19 10.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.312 0.577 . . . . 0.0 111.011 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.765 HG21 HG12 ' A' ' 26' ' ' ILE . 39.6 t -84.51 103.12 11.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.15 -177.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.577 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 18.5 mtt -86.3 161.63 18.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.101 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.3 m -139.32 135.12 40.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 111.193 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.546 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -95.04 115.78 34.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.006 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 4' ' ' VAL . 13.8 m -130.35 151.1 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.983 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.53 -74.22 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.534 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -81.38 -3.01 51.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 0.0 110.713 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.53 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.21 -147.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.366 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -147.57 -166.08 2.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.855 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.69 15.62 24.35 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.668 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.82 -5.19 50.85 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.528 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.72 -3.76 33.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.94 0.4 . . . . 0.0 110.296 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -55.19 -23.11 20.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.142 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.19 -27.34 61.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.121 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.762 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.16 -55.09 36.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.482 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -58.21 -36.11 72.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.458 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.36 -51.03 70.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.345 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.518 ' OG ' HD12 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -63.5 -19.16 64.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.443 178.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.679 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.34 -29.55 62.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.602 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.68 -12.07 31.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.772 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.15 25.82 1.0 Allowed Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.619 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.812 HD11 ' HD3' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -73.48 -164.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.476 -0.362 . . . . 0.0 111.187 -178.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.645 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.6 OUTLIER -50.37 100.78 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.006 0.431 . . . . 0.0 111.114 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.28 -31.54 79.37 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.873 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.3 t -85.84 -35.79 9.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.006 0.432 . . . . 0.0 110.307 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.645 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 43.8 t -95.77 90.5 5.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.614 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -77.24 133.2 38.93 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.041 HG21 HG22 ' A' ' 8' ' ' ILE . 3.2 mp -101.56 148.76 7.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.686 -175.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.455 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -85.81 71.36 10.67 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 172.616 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.682 HG23 ' HB ' ' A' ' 80' ' ' ILE . 57.9 t -79.82 50.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.079 -174.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -133.13 7.18 3.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.359 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.646 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.5 m-20 . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.994 0.426 . . . . 0.0 111.207 -178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.545 ' O ' HG22 ' A' ' 57' ' ' VAL . 2.5 t . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.764 0.316 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 53.1 t -105.3 114.78 45.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.588 -178.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.695 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -97.01 165.74 11.93 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.765 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 13.4 m -143.25 128.84 19.15 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.542 0.687 . . . . 0.0 111.859 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.037 HG22 HG21 ' A' ' 80' ' ' ILE . 3.4 mm -120.54 107.7 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.759 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.793 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.58 95.46 7.63 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.669 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.535 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.8 m -93.28 135.86 26.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.854 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -147.59 119.31 4.58 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 121.279 0.561 . . . . 0.0 111.97 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.671 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.1 Cg_exo -69.99 119.14 6.13 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.197 2.598 . . . . 0.0 112.034 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -56.91 -29.13 62.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.172 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.43 148.98 74.75 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.046 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.53 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 35.9 Cg_endo -64.69 -7.38 14.52 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.303 2.002 . . . . 0.0 111.804 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.63 34.78 0.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.6 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.612 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.4 87.25 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.776 0.798 . . . . 0.0 109.892 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.605 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 55.3 m-20 -67.9 104.59 1.75 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.139 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.553 ' O ' ' HD3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -60.93 -53.47 56.94 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.445 -178.636 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.512 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 35.7 tt0 -69.75 -36.5 75.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.046 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.572 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -68.61 -35.16 76.96 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.779 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.605 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -65.36 -33.36 75.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.518 177.237 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HD3' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -55.98 -46.74 78.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.471 178.768 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -66.12 -42.81 88.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.41 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.734 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 51.0 mm-40 -65.34 -30.23 71.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.37 0.605 . . . . 0.0 110.438 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.679 ' O ' HG12 ' A' ' 30' ' ' ILE . 3.4 mt -60.69 -47.05 94.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.597 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.78 -38.11 89.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.387 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.734 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -77.32 -21.08 54.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.48 -178.568 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.658 ' HB2' HD11 ' A' ' 74' ' ' ILE . 3.3 ptp85 -89.15 -13.45 38.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.077 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 26' ' ' ILE . 34.4 mm -61.08 136.92 93.99 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.618 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 15.7 Cg_endo -55.88 129.49 35.24 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.334 2.023 . . . . 0.0 112.614 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.6 0.1 0.22 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.125 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.58 -56.69 2.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.977 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.593 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -119.11 -144.74 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.321 . . . . 0.0 111.416 -179.396 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -133.83 170.1 16.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.957 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -75.32 -173.83 2.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.217 -179.134 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.533 ' ND1' HG22 ' A' ' 56' ' ' VAL . 85.3 t60 -130.9 -75.48 0.53 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.423 0.63 . . . . 0.0 110.944 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.488 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER -164.45 129.37 2.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.788 -178.761 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.645 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -92.59 158.23 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.166 0.508 . . . . 0.0 112.362 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.608 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 5.1 m-20 -123.41 124.72 43.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.517 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -86.78 72.58 10.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.782 0.325 . . . . 0.0 110.624 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.559 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -100.05 136.0 20.25 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.93 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.76 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 64.2 Cg_endo -86.25 158.08 9.71 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.71 2.274 . . . . 0.0 112.629 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.725 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.9 mm -127.28 -83.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.657 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.756 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.83 -148.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.283 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -71.58 -32.81 68.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.826 0.346 . . . . 0.0 110.591 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.65 7.23 0.58 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.638 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.756 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.3 mt -91.41 102.33 15.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.905 0.383 . . . . 0.0 110.814 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.76 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 75.3 t -92.64 130.03 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.848 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -94.94 159.27 15.11 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.814 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.608 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 10.5 mp -117.93 119.12 33.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.397 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 4.1 m-20 -89.66 91.13 8.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.35 0.595 . . . . 0.0 110.159 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.674 HG21 HG12 ' A' ' 26' ' ' ILE . 5.9 t -87.04 103.24 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.418 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 15.1 mtt -84.63 166.13 17.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.237 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.695 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.6 m -140.0 135.21 37.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.868 0.366 . . . . 0.0 111.616 -178.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.533 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.79 110.62 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.759 178.483 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 4' ' ' VAL . 11.3 m -130.3 144.71 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.043 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.24 -64.14 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.417 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -80.94 -6.92 59.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.882 0.372 . . . . 0.0 110.635 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.593 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.88 -147.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.058 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -147.69 -161.65 1.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.78 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.56 13.08 30.6 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.579 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.26 -7.65 60.59 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.511 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -4.5 36.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.892 0.377 . . . . 0.0 110.216 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.64 -23.69 18.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.03 177.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.88 -28.83 62.34 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.038 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -59.87 -56.5 21.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.577 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -58.58 -35.51 72.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.492 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -61.33 -51.11 70.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.438 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.1 p -64.01 -17.9 63.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.533 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.74 HD22 HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.25 -31.13 62.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.533 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.93 -10.24 27.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.687 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.02 26.76 1.01 Allowed Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.74 HD13 HD22 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -73.2 -169.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.291 -0.455 . . . . 0.0 111.087 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -50.58 97.93 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 111.193 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.99 -31.68 81.51 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.778 -0.647 . . . . 0.0 112.927 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.59 -37.27 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.137 0.494 . . . . 0.0 109.982 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.671 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 1.5 m -95.37 87.8 4.91 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.039 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -76.45 135.62 39.4 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.037 HG21 HG22 ' A' ' 8' ' ' ILE . 2.6 mt -101.45 148.58 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.566 -175.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.682 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 33.6 tp10 -85.95 69.89 10.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.701 HG23 ' HB ' ' A' ' 80' ' ' ILE . 61.7 t -80.69 57.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.679 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -132.76 -2.56 3.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.874 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.765 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 2.6 m-20 . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.267 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.519 0.199 . . . . 0.0 111.32 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 83.2 t -129.54 115.25 33.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.055 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.537 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.56 165.98 12.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.76 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.775 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.9 m -141.99 127.01 18.36 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.588 0.709 . . . . 0.0 111.898 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.006 HG22 HG21 ' A' ' 80' ' ' ILE . 8.3 mm -120.57 108.85 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.925 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.817 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.77 96.85 8.52 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.613 ' CB ' HG12 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -92.85 139.98 17.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -176.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.643 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -146.14 122.57 5.82 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.249 179.328 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.598 ' HG2' HG13 ' A' ' 17' ' ' VAL . 11.6 Cg_exo -72.9 120.86 6.89 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.462 2.775 . . . . 0.0 112.383 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.57 -31.21 65.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.338 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.58 151.02 79.95 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.039 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.591 ' HA ' HD21 ' A' ' 48' ' ' LEU . 41.9 Cg_endo -66.86 -3.32 9.27 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.421 2.081 . . . . 0.0 112.003 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.16 42.69 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.353 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.598 HG13 ' HG2' ' A' ' 12' ' ' PRO . 95.7 t -65.02 77.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.068 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 62.7 m-20 -68.93 100.86 1.26 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.165 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.76 ' HG ' HD11 ' A' ' 51' ' ' LEU . 3.1 tt -62.96 -49.21 75.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.481 -178.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -68.15 -38.26 81.94 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.739 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -69.78 -37.13 76.25 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.011 177.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -65.42 -34.12 77.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.697 177.921 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -47.26 85.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.088 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.487 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -69.32 -37.15 77.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.188 0.518 . . . . 0.0 110.388 179.146 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 12.5 mt-10 -66.26 -31.02 71.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.017 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.708 HG12 HG21 ' A' ' 53' ' ' VAL . 2.1 mt -62.38 -42.69 96.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.444 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -57.72 -39.66 77.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.443 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -74.83 -24.24 58.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.708 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.792 ' HB2' HD11 ' A' ' 74' ' ' ILE . 2.4 ptp180 -88.56 -12.84 41.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.758 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.42 HG23 ' HD2' ' A' ' 31' ' ' PRO . 22.7 mm -57.65 135.44 82.58 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.577 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.626 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.5 Cg_endo -53.07 126.63 22.11 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.509 2.139 . . . . 0.0 112.335 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -58.05 -2.01 0.15 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.401 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -81.83 -46.36 6.77 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.515 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.472 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.55 -142.51 0.24 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.672 0.272 . . . . 0.0 110.993 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -139.44 173.09 11.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.022 0.439 . . . . 0.0 110.855 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -74.44 -176.75 2.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.236 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.52 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 83.4 t60 -131.73 -71.92 0.55 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.475 0.655 . . . . 0.0 111.167 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.531 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -162.72 128.62 3.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.992 -177.865 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.683 HD13 HG22 ' A' ' 53' ' ' VAL . 2.5 mt -94.77 160.1 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.118 -177.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.662 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.1 t0 -127.38 128.79 46.44 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.633 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -87.34 73.38 9.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.789 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.511 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -98.88 133.43 22.33 Favored Pre-proline 0 C--O 1.225 -0.22 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.309 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.794 ' HB3' HG22 ' A' ' 49' ' ' VAL . 62.6 Cg_endo -87.56 157.03 7.79 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.519 2.146 . . . . 0.0 113.086 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.712 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.3 mm -124.74 -83.01 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.245 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.457 ' H ' ' HB ' ' A' ' 44' ' ' ILE . . . -67.3 -156.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.034 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -71.94 -25.1 61.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.625 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.51 0.98 0.33 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.119 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 15' ' ' PRO . 6.0 mt -92.01 100.24 12.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.887 0.375 . . . . 0.0 110.765 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.794 HG22 ' HB3' ' A' ' 43' ' ' PRO . 70.0 t -92.52 132.8 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.646 -178.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.712 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.86 162.0 13.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.006 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.76 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.2 mp -120.63 121.15 37.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.546 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.551 HD22 ' HB3' ' A' ' 9' ' ' LYS . 1.2 m120 -90.11 91.66 8.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.207 0.527 . . . . 0.0 110.042 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.708 HG21 HG12 ' A' ' 26' ' ' ILE . 11.3 t -86.73 104.34 13.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.531 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.718 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -85.01 162.89 19.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.905 178.186 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' A' ' 6' ' ' ALA . 4.6 m -136.86 127.02 39.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.949 0.404 . . . . 0.0 111.116 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.52 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 0.4 OUTLIER -94.36 109.86 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.938 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 4' ' ' VAL . 2.3 m -128.24 146.63 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.664 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.28 -61.94 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.536 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -80.21 -11.26 59.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.092 0.472 . . . . 0.0 110.239 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.472 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.89 -144.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.935 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.45 -166.52 2.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.813 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.86 15.16 22.28 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.534 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.08 -0.54 28.56 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.521 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.44 HG22 ' OG1' ' A' ' 34' ' ' THR . 1.3 p -73.45 -3.45 27.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.944 0.402 . . . . 0.0 110.355 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.92 -23.72 20.22 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.163 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.17 -27.53 61.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.074 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -59.58 -56.28 23.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.488 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -57.88 -36.88 73.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.612 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.93 -51.86 67.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.552 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.422 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 54.7 p -64.59 -20.29 66.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.85 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.634 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -73.09 -27.96 62.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.834 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -14.38 55.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.707 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.35 28.16 0.97 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.819 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' A' ' 29' ' ' ARG . 1.2 tt -72.97 -160.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.497 -0.351 . . . . 0.0 110.933 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.703 ' HB2' HH12 ' A' ' 29' ' ' ARG . 0.1 OUTLIER -50.07 91.15 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.993 0.425 . . . . 0.0 111.011 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.3 -26.54 66.28 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.337 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.8 p -86.62 -39.59 13.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.282 0.563 . . . . 0.0 110.09 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.617 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 11.9 t -95.96 90.35 5.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.331 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.77 132.29 40.35 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.006 HG21 HG22 ' A' ' 8' ' ' ILE . 12.5 mt -101.08 147.3 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.479 -175.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.689 ' HG2' ' HB2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -85.62 73.69 10.4 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.106 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.739 HG23 ' HB ' ' A' ' 80' ' ' ILE . 90.5 t -80.97 55.55 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.743 -174.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.68 2.91 3.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.403 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.775 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 30.3 t0 . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.778 0.323 . . . . 0.0 110.854 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.59 ' O ' HG22 ' A' ' 57' ' ' VAL . 15.8 t . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.709 0.29 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 38.8 t -104.76 115.19 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.343 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.776 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -93.07 166.19 12.47 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.71 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 10.1 m -142.12 136.52 30.16 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.542 0.687 . . . . 0.0 112.44 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.975 HG22 HG21 ' A' ' 80' ' ' ILE . 8.3 mm -125.53 105.55 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.991 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.756 ' C ' HG23 ' A' ' 80' ' ' ILE . 2.2 mmmt -97.38 96.97 8.73 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -176.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.467 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.5 m -94.02 136.15 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.875 0.369 . . . . 0.0 111.931 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.63 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -146.9 123.16 5.58 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.314 179.306 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.64 ' CD ' HG13 ' A' ' 17' ' ' VAL . 10.2 Cg_exo -73.86 122.25 7.58 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.562 2.841 . . . . 0.0 112.077 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -57.47 -32.04 66.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.448 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.35 152.32 81.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.032 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.552 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 42.2 Cg_endo -67.55 -3.23 9.79 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.417 2.078 . . . . 0.0 112.154 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.8 43.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.103 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.64 HG13 ' CD ' ' A' ' 12' ' ' PRO . 93.7 t -65.29 75.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.389 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 3.8 m-20 -70.33 88.88 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.879 HD13 ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.18 -38.43 91.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.825 -177.187 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.94 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 1.4 tt0 -70.67 -36.23 73.23 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.05 0.452 . . . . 0.0 110.086 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.61 -37.54 76.92 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.52 ' CD2' ' HG3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -66.45 -30.19 70.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.909 177.441 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.94 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -54.53 -46.41 73.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.437 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 7.2 mtmt -67.14 -44.53 79.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.513 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -65.19 -25.96 67.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.566 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.741 HG12 HG21 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -60.47 -49.65 83.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.361 -179.368 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.478 ' OE1' HD22 ' A' ' 36' ' ' LEU . 6.1 mm-40 -62.97 -32.48 73.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.155 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 15.3 mt-10 -74.62 -24.08 58.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.024 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.734 ' HB2' HD11 ' A' ' 74' ' ' ILE . 1.2 ptp85 -91.95 -13.51 31.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.362 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 26' ' ' ILE . 10.1 mm -59.49 140.16 88.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.911 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.587 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.4 Cg_endo -51.44 112.7 0.87 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.744 2.296 . . . . 0.0 112.119 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.77 -0.87 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.253 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.03 -35.95 16.76 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.956 -178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.5 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.3 -142.96 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.694 0.247 . . . . 0.0 110.96 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 8.1 mt-10 -135.12 167.01 21.75 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.883 0.373 . . . . 0.0 111.116 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.497 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -75.32 -179.89 4.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.384 -179.033 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.653 ' ND1' HG22 ' A' ' 56' ' ' VAL . 79.4 t60 -130.77 -75.81 0.53 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.96 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.615 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -165.43 131.84 2.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.744 -178.51 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.713 HG12 HG13 ' A' ' 53' ' ' VAL . 2.5 mt -91.41 155.93 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 112.362 -176.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.601 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 61.0 m-20 -120.42 126.68 51.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.692 -178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.39 71.38 9.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.819 0.343 . . . . 0.0 110.304 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.521 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.81 134.25 21.14 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.796 -179.619 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.791 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 73.7 Cg_endo -87.07 157.69 8.5 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.575 2.184 . . . . 0.0 112.608 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.5 mm -125.65 -82.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.36 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.537 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.05 -153.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -71.74 -28.22 63.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.637 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.45 4.58 0.5 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.97 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.552 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.7 mt -92.34 102.61 15.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.859 0.361 . . . . 0.0 110.975 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.791 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 76.6 t -93.0 130.47 42.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.792 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.727 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.21 153.31 17.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.916 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.601 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 10.5 mp -111.53 117.18 32.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.33 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.607 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.2 m120 -89.79 92.48 9.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.208 0.528 . . . . 0.0 110.379 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.741 HG21 HG12 ' A' ' 26' ' ' ILE . 4.0 t -86.81 105.82 15.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.274 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.486 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.1 OUTLIER -84.62 166.56 17.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.432 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.776 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.9 m -138.99 139.3 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.223 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.653 HG22 ' ND1' ' A' ' 37' ' ' HIS . 1.9 t -93.57 106.61 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.137 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.617 HG13 HG23 ' A' ' 55' ' ' VAL . 2.8 m -127.82 155.61 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.793 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.79 -73.41 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.087 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.67 0.89 36.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.994 0.426 . . . . 0.0 110.494 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.492 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.02 -146.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.019 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.82 -165.35 2.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.936 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.3 13.34 33.97 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.433 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.01 -4.23 47.75 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.536 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.6 p -75.04 -3.92 35.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.966 0.412 . . . . 0.0 110.105 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -55.43 -23.55 25.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.258 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.11 -29.63 60.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.874 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.587 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.78 -56.29 21.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.337 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.681 ' HA ' HD12 ' A' ' 71' ' ' LEU . 3.3 mt-10 -58.57 -33.92 70.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.431 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -51.85 65.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.261 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.58 -16.83 61.93 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.028 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.02 HD11 HG11 ' A' ' 82' ' ' VAL . 2.1 mt -72.3 -33.52 67.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.374 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -9.7 15.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.0 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.08 26.73 1.0 Allowed Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.734 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.9 OUTLIER -73.3 -166.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.153 -0.523 . . . . 0.0 111.407 -178.437 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 2.7 mm-40 -51.61 101.65 0.04 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.878 0.371 . . . . 0.0 110.901 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.75 -33.95 88.33 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.776 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -86.02 -39.45 13.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 0.0 110.346 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 48.3 t -96.06 91.22 5.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.782 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -77.79 134.02 38.11 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.975 HG21 HG22 ' A' ' 8' ' ' ILE . 2.9 mp -101.38 148.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.379 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.532 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.3 tp10 -86.02 69.32 10.51 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 1.02 HG11 HD11 ' A' ' 71' ' ' LEU . 47.7 t -81.12 51.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.18 -174.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.82 6.64 4.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.542 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.71 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 2.3 m-20 . . . . . 0 N--CA 1.454 -0.243 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.441 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.444 ' HB ' HG23 ' A' ' 57' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.107 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 42.1 t -128.62 128.09 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.701 0.286 . . . . 0.0 111.652 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.698 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -99.4 167.04 10.88 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.829 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.4 m -142.83 133.2 24.79 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.594 0.712 . . . . 0.0 112.386 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.977 HG22 HG21 ' A' ' 80' ' ' ILE . 5.9 mm -125.89 108.43 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.777 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.721 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -98.7 96.69 8.09 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.376 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.802 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.9 m -94.0 138.02 21.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.659 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.76 119.57 4.57 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 121.157 0.503 . . . . 0.0 111.806 179.41 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 21.1 Cg_exo -69.71 123.64 10.32 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.464 2.776 . . . . 0.0 112.007 178.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.17 -30.52 64.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.508 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 m -77.6 148.52 76.74 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.053 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.64 -6.6 14.21 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.419 2.079 . . . . 0.0 111.779 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -93.44 36.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.605 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.623 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.72 88.49 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.78 0.8 . . . . 0.0 110.134 -179.569 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.568 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 32.9 m-20 -68.25 104.27 1.79 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.034 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.792 ' HG ' HD11 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -61.24 -52.2 65.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.707 -178.146 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.743 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -71.2 -34.37 70.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.277 -177.782 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -68.28 -35.93 78.61 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.568 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -66.16 -33.53 75.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.384 176.456 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.743 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -55.92 -46.61 78.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.132 178.65 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -43.31 90.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.798 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.541 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 11.3 mt-10 -66.55 -30.73 71.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.257 0.551 . . . . 0.0 110.722 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.751 HG12 HG21 ' A' ' 53' ' ' VAL . 1.6 mt -61.75 -43.92 97.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.816 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.21 -38.8 90.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.063 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 10.6 pt-20 -77.84 -21.16 51.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.553 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.8 ' HB2' HD11 ' A' ' 74' ' ' ILE . 20.0 ptt85 -89.86 -9.57 48.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.19 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 26' ' ' ILE . 32.6 mm -59.7 138.16 89.92 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.281 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.639 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.2 Cg_endo -50.83 118.86 4.56 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.868 2.378 . . . . 0.0 112.279 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -59.13 -1.2 0.16 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.116 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.26 -42.82 8.39 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.918 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.688 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.49 -144.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.685 0.279 . . . . 0.0 110.951 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -133.35 167.08 21.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.874 0.368 . . . . 0.0 110.807 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.538 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.8 pt? -75.92 -176.01 3.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.23 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.58 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.8 t60 -130.85 -76.46 0.53 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.369 0.604 . . . . 0.0 111.195 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 2.2 tptt -164.53 133.52 3.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.794 -178.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.695 HG23 HG22 ' A' ' 53' ' ' VAL . 1.7 mt -93.09 158.2 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -123.79 125.51 44.83 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.318 -178.635 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.454 ' H ' ' HG3' ' A' ' 41' ' ' GLU . 0.9 OUTLIER -86.12 73.84 10.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.93 0.395 . . . . 0.0 110.508 178.216 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.493 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -98.94 131.02 26.27 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.295 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.82 ' HB3' HG22 ' A' ' 49' ' ' VAL . 59.0 Cg_endo -87.53 157.57 7.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.485 2.123 . . . . 0.0 112.949 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.705 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.4 mm -124.34 -82.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.107 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -67.25 -157.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.84 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -72.28 -22.82 61.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.666 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.57 -1.18 0.25 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.039 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 8.8 mp -90.7 100.99 13.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.81 0.305 . . . . 0.0 110.966 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.82 HG22 ' HB3' ' A' ' 43' ' ' PRO . 93.4 t -94.57 132.94 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.971 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.705 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.38 162.9 13.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.847 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.792 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.2 mp -121.12 120.36 35.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.716 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.2 m120 -90.92 91.18 8.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.281 0.562 . . . . 0.0 110.027 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.751 HG21 HG12 ' A' ' 26' ' ' ILE . 5.0 t -87.48 104.11 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.32 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.709 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.3 OUTLIER -84.69 165.28 18.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.339 179.187 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.698 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.5 m -138.41 137.47 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.451 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.58 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -94.35 118.19 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.911 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.688 HG12 HG21 ' A' ' 34' ' ' THR . 35.4 m -130.2 142.4 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.95 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.4 -70.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.455 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -81.41 -5.76 58.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 0.0 110.5 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.547 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.67 -152.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.196 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.413 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -148.01 -162.35 1.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.803 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -81.07 14.07 28.93 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.276 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.0 -3.73 45.42 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.36 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -74.67 -3.39 31.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.016 0.436 . . . . 0.0 110.097 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.99 -23.47 19.44 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.045 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.0 -26.87 60.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.11 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.639 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.6 -52.79 62.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.107 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -59.21 -37.32 77.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.308 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -49.05 78.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.137 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -63.85 -19.78 65.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.327 178.656 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.599 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.0 -30.7 62.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.422 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 p -64.51 -9.52 19.43 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.739 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.14 22.05 0.98 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.108 -0.567 . . . . 0.0 111.968 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.8 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -72.82 -164.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 122.3 0.24 . . . . 0.0 110.666 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.589 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -50.81 100.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.929 0.395 . . . . 0.0 110.981 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.4 -27.03 68.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.048 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.4 p -90.15 -36.83 8.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.094 0.473 . . . . 0.0 110.824 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 1.6 m -95.6 89.26 5.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.602 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -76.32 132.1 39.59 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.977 HG21 HG22 ' A' ' 8' ' ' ILE . 15.7 mt -101.18 147.16 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.469 -175.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.634 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 16.3 tp10 -85.53 69.93 10.71 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 173.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.706 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.0 t -80.17 48.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.001 -174.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.85 9.29 4.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.291 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.829 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 8.6 t70 . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.856 0.36 . . . . 0.0 111.082 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.627 ' HB ' HG22 ' A' ' 57' ' ' VAL . 1.7 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.671 0.272 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 9.7 t -104.88 110.78 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.12 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.619 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -101.2 166.86 10.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.338 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.754 HG23 ' HG3' ' A' ' 54' ' ' MET . 8.5 m -143.33 129.16 19.41 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.699 0.762 . . . . 0.0 112.251 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.008 HG22 HG21 ' A' ' 80' ' ' ILE . 6.3 mm -121.91 107.97 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.523 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.772 ' C ' HG23 ' A' ' 80' ' ' ILE . 2.8 mmmt -97.28 94.56 7.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.503 ' N ' HG23 ' A' ' 80' ' ' ILE . 2.0 m -93.37 137.84 21.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.741 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -147.31 119.53 4.72 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 121.306 0.574 . . . . 0.0 111.915 178.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 22.2 Cg_exo -68.51 121.89 8.85 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.372 2.715 . . . . 0.0 111.982 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -56.25 -29.61 61.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.269 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.424 ' O ' HG12 ' A' ' 17' ' ' VAL . 1.3 p -76.97 151.16 81.81 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.173 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 48.4 Cg_endo -67.85 -6.47 17.0 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.165 1.91 . . . . 0.0 111.387 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -92.6 33.92 1.1 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.565 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.635 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.05 87.15 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.8 0.809 . . . . 0.0 110.015 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 15.6 m-20 -70.08 106.99 3.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.47 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.924 ' HG ' HD11 ' A' ' 51' ' ' LEU . 2.2 tt -62.16 -49.58 75.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.226 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -68.67 -37.55 79.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.864 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -70.95 -34.0 71.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.58 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -65.34 -32.62 74.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.574 177.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.644 ' HA ' HD12 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -58.37 -44.49 88.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.604 178.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.5 -42.49 92.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.337 178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.63 -32.12 73.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.179 0.514 . . . . 0.0 110.337 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.662 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 9.7 mt -60.94 -44.35 97.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.745 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -59.96 -39.65 86.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.542 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -74.73 -24.31 58.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.379 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.847 HH22 ' HB ' ' A' ' 8' ' ' ILE . 24.7 ptt85 -91.06 -14.02 32.08 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.629 HD11 HG11 ' A' ' 53' ' ' VAL . 12.1 mm -58.16 137.78 84.38 Favored Pre-proline 0 C--N 1.332 -0.186 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.481 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.492 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 5.2 Cg_endo -45.3 119.03 2.34 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.807 2.338 . . . . 0.0 112.231 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -57.3 -4.55 0.23 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.076 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.95 -45.15 6.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.516 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.43 -142.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.765 0.316 . . . . 0.0 111.135 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -138.7 175.55 9.47 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.968 0.413 . . . . 0.0 110.748 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -74.69 -175.69 2.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.342 -178.862 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.563 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 85.5 t60 -131.35 -68.87 0.64 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.095 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -159.34 121.27 3.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.257 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.675 HD13 HG22 ' A' ' 53' ' ' VAL . 2.5 mt -91.72 157.5 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.513 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.647 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.64 123.66 36.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.804 -178.164 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.496 ' HB3' HD11 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -85.22 70.71 10.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.927 0.394 . . . . 0.0 110.426 177.826 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.547 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -97.41 135.73 21.65 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.767 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.782 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 64.3 Cg_endo -86.62 157.73 9.16 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.609 2.206 . . . . 0.0 112.739 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.706 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.8 mm -126.56 -83.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.444 -177.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.741 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.52 -149.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -70.75 -32.85 70.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.638 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.56 7.76 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.631 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.741 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.7 mt -90.9 101.56 14.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 110.685 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.782 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 73.8 t -93.0 128.99 44.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.923 -178.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.741 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.64 156.6 16.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.853 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.924 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.1 mp -115.76 119.97 37.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.461 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.514 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 3.7 m-20 -89.82 91.0 8.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.337 0.589 . . . . 0.0 110.016 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.675 HG22 HD13 ' A' ' 39' ' ' ILE . 14.2 t -87.37 102.35 12.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.539 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.754 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.1 OUTLIER -84.61 166.93 16.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.852 178.102 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.619 HG22 ' HB3' ' A' ' 6' ' ' ALA . 4.4 m -138.72 126.4 27.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.089 0.471 . . . . 0.0 111.431 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.563 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 1.3 p -99.06 106.85 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.696 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.627 HG22 ' HB ' ' A' ' 4' ' ' VAL . 1.3 m -124.99 166.6 20.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.649 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.25 -64.93 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.729 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.41 -5.8 57.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.943 0.401 . . . . 0.0 110.58 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.66 -147.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.037 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.62 -162.56 1.57 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.764 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.8 14.11 27.11 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.429 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.83 -4.28 46.7 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.46 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -74.31 -7.3 52.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.923 0.392 . . . . 0.0 110.26 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.93 -23.38 31.52 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.984 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.3 -24.52 55.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.847 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.11 -55.93 26.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.137 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.25 -34.96 72.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.408 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -60.9 -50.97 71.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.387 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.462 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 5.0 p -64.0 -20.92 66.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.544 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.594 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.11 -27.44 62.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.565 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -14.37 58.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.749 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.41 26.34 0.97 Allowed Glycine 0 N--CA 1.451 -0.3 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.897 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 29' ' ' ARG . 2.8 tt -73.24 -163.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.55 -0.325 . . . . 0.0 110.906 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.702 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -52.16 90.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.989 0.423 . . . . 0.0 110.862 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.08 -24.86 59.01 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.844 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.96 -35.76 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.174 0.511 . . . . 0.0 110.251 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.702 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -95.63 90.39 5.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.771 -179.498 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -75.06 130.25 38.99 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.008 HG21 HG22 ' A' ' 8' ' ' ILE . 3.0 mp -100.93 149.12 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.38 -175.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.478 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 28.4 tt0 -85.69 68.99 10.58 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 173.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.709 HG23 ' HB ' ' A' ' 80' ' ' ILE . 48.7 t -80.47 58.34 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.728 -175.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.36 -3.9 3.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.879 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.693 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 8.3 m-20 . . . . . 0 N--CA 1.453 -0.294 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.03 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.512 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 1.8 t . . . . . 0 C--O 1.231 0.103 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 14.5 t -104.31 115.05 45.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.874 0.368 . . . . 0.0 111.752 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.587 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -97.31 165.05 12.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.687 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 8.5 m -140.67 131.45 25.81 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.643 0.735 . . . . 0.0 112.019 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.035 HG22 HG21 ' A' ' 80' ' ' ILE . 2.6 mm -124.32 106.0 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.667 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.584 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.55 95.26 7.86 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.634 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.772 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.4 m -92.89 136.05 26.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.804 0.335 . . . . 0.0 111.897 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.656 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -146.41 120.1 5.18 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 121.142 0.496 . . . . 0.0 111.81 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.4 Cg_exo -69.34 122.88 9.67 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.419 2.746 . . . . 0.0 111.9 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.57 -29.63 64.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.291 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.472 ' O ' HG12 ' A' ' 17' ' ' VAL . 1.5 p -76.34 151.09 83.19 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.143 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 46.5 Cg_endo -67.41 -6.77 17.26 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.237 1.958 . . . . 0.0 111.457 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.17 35.63 0.99 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.435 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.656 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -68.12 83.8 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.93 0.871 . . . . 0.0 110.588 -179.046 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.556 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 19.4 m-20 -73.08 98.38 2.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.902 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.793 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -63.66 -43.81 95.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.589 -178.068 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.884 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 4.1 tp10 -69.23 -37.0 77.8 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.85 0.357 . . . . 0.0 110.321 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.572 ' O ' ' HD3' ' A' ' 24' ' ' LYS . . . -68.8 -38.12 79.72 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -68.12 -24.82 65.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.2 177.218 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.884 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -58.59 -44.9 89.99 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.24 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.572 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -68.62 -40.01 80.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.762 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.731 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 4.9 mm-40 -67.8 -29.4 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.336 0.588 . . . . 0.0 110.302 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.729 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.2 mt -63.92 -38.38 82.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.036 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.85 -40.95 94.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.221 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.731 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -77.77 -20.8 52.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.514 -178.728 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.792 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.23 -11.95 45.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.342 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.639 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.4 mm -60.11 138.28 91.26 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.239 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.608 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.2 Cg_endo -50.68 114.71 1.59 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.793 2.328 . . . . 0.0 112.062 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.33 2.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.47 -45.73 6.78 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.789 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.588 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -130.36 -133.35 0.21 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.664 0.232 . . . . 0.0 111.175 -179.515 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -136.63 170.08 16.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.905 0.383 . . . . 0.0 110.941 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.538 HD22 HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -75.59 -174.09 2.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.108 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.506 ' ND1' HG22 ' A' ' 56' ' ' VAL . 85.2 t60 -130.45 -76.03 0.53 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.328 0.585 . . . . 0.0 110.939 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.546 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -164.91 126.67 2.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.868 -178.594 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.633 HD13 HG22 ' A' ' 53' ' ' VAL . 2.8 mt -90.8 159.82 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.986 0.422 . . . . 0.0 111.865 -177.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.634 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.12 124.75 39.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.946 -178.147 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.67 68.82 10.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.914 0.388 . . . . 0.0 110.216 177.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.55 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -97.11 137.41 21.24 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.616 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.797 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 73.7 Cg_endo -86.03 156.72 9.93 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.486 2.124 . . . . 0.0 112.738 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.742 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.1 mm -124.56 -82.23 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.3 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.526 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.02 -152.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.992 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -71.8 -28.12 63.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.707 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.92 4.62 0.46 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.101 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.556 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.5 mt -92.43 104.24 16.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.842 0.353 . . . . 0.0 110.966 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.797 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 76.3 t -93.12 131.35 40.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.858 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.25 164.19 12.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.072 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.3 mp -120.63 117.69 28.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.211 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.562 ' ND2' ' HB3' ' A' ' 40' ' ' ASP . 2.0 m-20 -90.47 92.05 8.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.254 0.55 . . . . 0.0 110.422 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.684 HG21 HG12 ' A' ' 26' ' ' ILE . 4.3 t -87.31 101.96 11.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.583 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.488 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 33.4 mtt -84.71 165.91 17.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.218 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.1 m -139.63 133.76 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.38 . . . . 0.0 111.678 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.506 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -98.36 113.47 33.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 178.474 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.512 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 7.7 m -130.49 142.54 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.979 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.38 -62.12 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.583 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.92 -12.19 59.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.002 0.43 . . . . 0.0 110.706 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.588 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -68.07 -144.53 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.106 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.29 -166.82 2.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.72 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.71 15.28 20.7 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.682 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.67 -0.51 32.69 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.602 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 p -74.16 -2.21 23.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.972 0.415 . . . . 0.0 110.148 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -55.07 -24.41 25.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.348 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.78 -27.27 59.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.08 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.608 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.51 -56.12 23.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.809 0.338 . . . . 0.0 110.362 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -58.75 -34.22 71.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.362 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.53 -51.45 68.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.325 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.7 p -63.19 -19.05 64.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.561 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.854 HD22 HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.59 -28.79 61.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.59 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -13.51 47.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.531 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.9 30.92 1.0 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.392 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.854 HD13 HD22 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -72.85 -166.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.165 -0.517 . . . . 0.0 111.173 -178.615 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.681 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 1.4 mp0 -51.05 100.33 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.888 0.375 . . . . 0.0 111.007 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.15 -30.83 71.41 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.794 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 t -87.92 -37.27 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.803 0.335 . . . . 0.0 110.744 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.681 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 32.2 t -95.77 92.42 6.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.844 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -76.58 132.26 39.37 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.035 HG21 HG22 ' A' ' 8' ' ' ILE . 8.0 mt -100.58 144.7 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.088 -175.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.518 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.3 tt0 -85.24 69.56 10.76 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.711 HG23 ' HB ' ' A' ' 80' ' ' ILE . 48.0 t -81.43 56.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 113.92 -1.491 . . . . 0.0 111.249 -174.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -132.44 -0.12 3.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.929 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.687 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 5.5 m-20 . . . . . 0 N--CA 1.455 -0.208 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.251 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.416 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 2.7 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.672 0.272 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 21.7 t -113.92 109.74 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.427 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.666 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.66 165.41 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 177.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.803 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.6 m -141.9 132.63 25.62 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.715 0.769 . . . . 0.0 112.273 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.027 HG22 HG21 ' A' ' 80' ' ' ILE . 4.3 mm -123.77 106.79 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.457 -178.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.766 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.62 96.45 8.65 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.221 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.491 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.6 m -94.62 137.62 22.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.904 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.673 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.2 OUTLIER -147.39 121.72 5.06 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 121.264 0.554 . . . . 0.0 111.984 179.251 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 18.7 Cg_exo -71.02 124.11 10.28 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.599 2.866 . . . . 0.0 112.15 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -57.9 -31.42 66.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.444 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.2 m -77.64 150.64 79.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.04 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.571 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 40.1 Cg_endo -66.66 -6.51 15.6 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.379 2.052 . . . . 0.0 111.942 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.53 34.0 0.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.405 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.662 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.52 84.54 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 121.774 0.797 . . . . 0.0 110.111 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 11.5 m-20 -71.64 108.73 5.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.197 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.605 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -63.45 -43.62 96.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.793 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.605 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 20.6 tp10 -68.95 -39.19 79.68 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.655 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.519 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -69.92 -36.54 75.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.44 0.638 . . . . 0.0 109.93 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -66.48 -33.89 76.71 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.48 177.383 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -45.65 89.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.079 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -68.88 -39.85 79.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.138 0.494 . . . . 0.0 110.385 179.121 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.521 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 31.9 mm-40 -66.01 -29.34 69.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.254 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.714 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 2.1 mt -62.22 -44.42 99.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.964 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.72 -36.72 77.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.985 0.421 . . . . 0.0 110.539 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -75.37 -23.93 57.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.687 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.762 ' HD2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.05 -14.27 39.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.524 -178.573 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 26' ' ' ILE . 39.1 mm -58.55 136.82 86.04 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.461 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.607 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 17.7 Cg_endo -58.89 131.24 40.72 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.372 2.048 . . . . 0.0 112.534 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -61.0 0.53 0.22 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.962 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.52 -59.03 2.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.708 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.569 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -117.9 -143.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.668 0.27 . . . . 0.0 110.885 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -136.41 167.8 20.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.87 0.367 . . . . 0.0 110.711 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.403 ' H ' ' CD2' ' A' ' 36' ' ' LEU . 1.6 pt? -75.08 -175.71 2.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.108 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.522 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 81.4 t60 -131.52 -75.88 0.52 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.315 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -159.37 132.08 6.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.048 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.664 HG23 HG22 ' A' ' 53' ' ' VAL . 1.7 mt -93.37 161.23 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.013 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.76 123.52 35.5 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.593 -178.639 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -85.56 71.16 10.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.897 0.38 . . . . 0.0 110.674 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.547 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.5 mt-10 -98.65 136.28 20.8 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.739 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.777 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 61.5 Cg_endo -87.64 157.26 7.69 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.662 2.241 . . . . 0.0 112.877 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.717 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.2 mm -125.41 -82.75 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.428 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.723 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.26 -150.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.16 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -71.36 -31.49 67.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.592 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.43 6.73 0.58 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.771 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.723 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.9 mt -91.11 102.26 15.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.822 0.344 . . . . 0.0 110.771 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.777 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 70.2 t -93.32 129.65 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.966 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.717 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.42 155.96 16.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.889 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.625 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.3 mp -114.45 118.09 32.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.392 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.52 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.9 m-20 -89.9 92.56 9.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.245 0.545 . . . . 0.0 110.09 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.698 HG21 HG12 ' A' ' 26' ' ' ILE . 6.3 t -86.54 105.77 15.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.445 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 50.6 mtt -84.46 166.67 17.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.409 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.666 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.5 m -138.78 127.57 29.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.237 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.522 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 0.7 OUTLIER -95.68 108.25 20.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.598 179.254 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.569 HG12 HG21 ' A' ' 34' ' ' THR . 3.3 m -125.41 167.03 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.817 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.73 -75.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.842 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -81.3 2.57 27.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 0.0 110.99 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.453 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.78 -147.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.116 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.74 -166.48 2.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.683 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.91 15.16 22.54 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.591 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.39 -5.56 55.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.549 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.43 ' HA ' ' HB2' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -74.08 -4.6 36.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.908 0.385 . . . . 0.0 110.383 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.02 -23.65 20.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.044 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.18 -27.78 62.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.937 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.607 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.54 -56.54 20.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.353 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -58.74 -34.83 71.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.447 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -60.71 -51.96 67.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.471 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.418 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -64.04 -19.33 65.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.572 178.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.614 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -72.92 -28.76 62.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.559 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -11.88 43.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.954 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.2 25.29 0.99 Allowed Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.75 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.762 HD11 ' HD2' ' A' ' 29' ' ' ARG . 2.6 tt -73.32 -163.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.47 -0.365 . . . . 0.0 111.059 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.605 ' N ' HG23 ' A' ' 74' ' ' ILE . 1.8 mp0 -51.01 96.51 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.81 0.338 . . . . 0.0 111.003 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.43 -27.34 69.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.281 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -88.27 -37.94 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.173 0.511 . . . . 0.0 110.435 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -96.23 90.0 5.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.424 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -77.57 134.77 38.18 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.027 HG21 HG22 ' A' ' 8' ' ' ILE . 1.7 mt -101.54 147.42 8.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.563 -176.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.534 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 9.7 tp10 -86.02 70.39 10.6 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 173.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.706 HG23 ' HB ' ' A' ' 80' ' ' ILE . 58.2 t -80.46 52.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.999 -174.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -133.0 3.61 3.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.575 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.803 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 18.8 t0 . . . . . 0 N--CA 1.453 -0.291 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.052 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.108 0 CA-C-O 120.575 0.226 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 13.1 t -125.54 118.34 52.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.039 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.581 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.74 169.76 9.93 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.69 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 10.0 m -143.04 131.85 22.71 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.587 0.708 . . . . 0.0 112.011 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.091 HG22 HG21 ' A' ' 80' ' ' ILE . 7.3 mm -122.98 107.52 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.896 -177.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.779 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.28 95.28 7.6 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -177.7 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.596 HG11 ' NH1' ' A' ' 29' ' ' ARG . 2.0 m -94.64 136.71 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.659 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.53 121.11 4.88 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 121.036 0.446 . . . . 0.0 111.76 179.475 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 17.2 Cg_exo -71.82 118.64 5.74 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.522 2.815 . . . . 0.0 111.946 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -56.21 -28.36 58.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.133 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.38 149.21 78.49 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.106 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 37.9 Cg_endo -66.03 -7.68 17.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.401 2.068 . . . . 0.0 111.92 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.1 36.06 1.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.698 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.624 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.16 87.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.79 0.805 . . . . 0.0 110.09 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 28.0 m-20 -68.32 107.19 2.74 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.336 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.732 HD12 ' NZ ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -60.45 -54.81 41.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.66 -178.619 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.527 ' HG2' ' N ' ' A' ' 21' ' ' ALA . 7.6 pm0 -71.29 -34.46 70.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.279 -177.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.642 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . . . -67.92 -35.71 78.92 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -65.77 -35.25 80.19 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.234 176.159 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.732 ' NZ ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -55.93 -46.83 78.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.034 178.541 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.642 ' HE3' ' HA ' ' A' ' 21' ' ' ALA . 2.6 mtmt -66.41 -43.8 84.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.815 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.737 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 52.9 mt-10 -67.58 -27.0 66.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.247 0.546 . . . . 0.0 110.969 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.652 HG12 HG21 ' A' ' 53' ' ' VAL . 1.1 mt -63.06 -43.14 98.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.951 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -62.56 -37.57 86.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.26 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.737 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 1.4 pp20? -77.21 -22.67 51.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.405 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.846 ' HB2' HD11 ' A' ' 74' ' ' ILE . 4.3 ptp85 -90.6 -11.95 38.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.088 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.646 HG12 ' O ' ' A' ' 26' ' ' ILE . 10.9 mm -61.57 139.29 95.13 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.87 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.667 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 7.3 Cg_endo -47.88 115.87 1.67 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.854 2.37 . . . . 0.0 112.445 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -59.38 0.74 0.1 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.105 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.92 -43.15 7.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.003 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.573 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.15 -139.01 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.712 0.292 . . . . 0.0 111.246 -179.45 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -135.64 169.9 16.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.881 0.372 . . . . 0.0 110.932 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.702 ' H ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -76.38 -175.91 3.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.229 -179.532 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.645 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.3 t60 -131.01 -74.74 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.412 0.625 . . . . 0.0 110.952 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HB3' ' CD2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -163.88 129.27 2.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.667 -178.926 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.696 HG12 HG13 ' A' ' 53' ' ' VAL . 2.8 mt -93.08 155.85 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -176.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.637 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.7 m-20 -117.97 123.0 44.69 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.971 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -88.34 67.68 8.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.96 0.409 . . . . 0.0 110.142 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.688 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.98 148.54 34.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.368 -178.459 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.772 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 30.6 Cg_endo -92.49 160.53 2.97 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.996 2.464 . . . . 0.0 113.266 -177.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.2 mm -128.85 -82.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.248 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.56 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -66.91 -151.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.924 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -72.27 -28.55 63.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.67 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.07 4.99 0.46 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.1 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.9 mt -92.1 106.1 18.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.89 0.345 . . . . 0.0 110.906 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 24.2 t -92.59 132.22 37.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.814 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.75 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.18 163.29 13.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.85 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.637 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.0 mp -120.57 116.17 24.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.513 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 3.8 m-20 -89.65 91.0 8.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.379 0.609 . . . . 0.0 110.046 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.696 HG13 HG12 ' A' ' 39' ' ' ILE . 3.8 t -87.16 105.65 15.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.576 -177.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 62.8 mtt -84.71 165.31 17.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.937 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.3 m -138.69 136.77 43.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.886 0.374 . . . . 0.0 111.581 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.645 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.3 OUTLIER -94.74 108.42 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.778 178.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.434 HG12 ' CB ' ' A' ' 34' ' ' THR . 21.9 m -125.39 137.96 55.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.855 0.359 . . . . 0.0 110.975 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.89 -58.72 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.331 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -81.08 -16.58 52.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.084 0.469 . . . . 0.0 110.4 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.573 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -68.15 -144.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.17 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.5 -163.35 1.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.785 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.9 13.75 29.42 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.544 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.37 -1.24 34.65 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.639 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -74.75 -4.14 35.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.968 0.413 . . . . 0.0 110.205 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -54.96 -23.91 21.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.337 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.07 -25.6 58.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.159 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.667 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.48 -56.59 18.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.8 0.334 . . . . 0.0 110.244 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -58.97 -34.0 71.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.276 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.94 -51.02 69.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.307 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -18.23 63.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.263 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.702 HD22 HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.65 -29.7 62.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.482 179.401 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -10.74 31.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.782 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.1 25.08 1.0 Allowed Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.846 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -73.32 -168.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.338 -0.431 . . . . 0.0 111.235 -179.04 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.558 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -51.09 93.5 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.353 179.137 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.2 -26.32 61.23 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.018 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -87.99 -41.16 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.181 0.515 . . . . 0.0 110.186 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -95.9 87.97 4.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.122 178.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -77.81 135.74 38.0 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.091 HG21 HG22 ' A' ' 8' ' ' ILE . 1.7 mt -101.5 147.72 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.469 -176.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.586 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 7.2 tp10 -86.07 71.09 10.62 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 172.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.688 HG23 ' HB ' ' A' ' 80' ' ' ILE . 59.0 t -80.68 52.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.063 -174.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 m -132.8 4.57 3.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.402 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.69 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.2 m-20 . . . . . 0 N--CA 1.452 -0.358 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.169 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.823 HG12 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 121.048 0.452 . . . . 0.0 110.17 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 40.8 t -109.71 120.36 60.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.492 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.627 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.03 167.91 11.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.682 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 11.4 m -141.65 131.37 24.18 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.6 0.714 . . . . 0.0 112.185 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.069 HG22 HG21 ' A' ' 80' ' ' ILE . 2.1 mm -120.56 105.01 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.688 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.636 ' HD2' ' HB3' ' A' ' 52' ' ' ASN . 0.9 OUTLIER -96.38 93.98 7.16 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.738 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.745 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.4 m -92.02 136.91 23.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.84 -177.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.675 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.32 119.26 4.67 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 121.131 0.491 . . . . 0.0 111.878 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 17.8 Cg_exo -70.96 122.22 8.59 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.49 2.794 . . . . 0.0 112.198 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.89 -30.3 65.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.388 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.8 148.32 75.73 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.012 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 36.8 Cg_endo -64.74 -6.56 12.65 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.399 2.066 . . . . 0.0 111.774 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -92.03 34.05 1.03 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.6 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.63 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.3 87.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.832 0.825 . . . . 0.0 110.124 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 74.2 m-20 -69.11 104.14 2.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.127 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.871 ' HG ' HD11 ' A' ' 51' ' ' LEU . 1.4 tt -61.05 -52.17 66.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.539 -178.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.705 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -70.5 -36.32 73.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.079 -177.812 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' HB3' ' CB ' ' A' ' 18' ' ' ASP . . . -68.2 -34.63 76.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.157 0.503 . . . . 0.0 109.758 177.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -65.68 -32.12 73.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.861 177.687 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.705 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -54.71 -47.65 73.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.505 179.01 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -66.6 -42.48 86.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.736 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -65.55 -29.3 69.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.185 0.516 . . . . 0.0 110.391 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.695 HG12 HG21 ' A' ' 53' ' ' VAL . 2.0 mt -61.83 -45.58 98.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.217 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -60.49 -35.86 76.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.717 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 17.5 mm-40 -74.17 -23.74 59.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.559 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.819 ' HB2' HD11 ' A' ' 74' ' ' ILE . 2.4 ptp180 -92.57 -14.54 28.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.842 -178.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.552 HD11 HG11 ' A' ' 53' ' ' VAL . 15.2 mm -58.74 139.82 86.07 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.102 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.664 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.4 Cg_endo -50.82 112.16 0.71 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.838 2.359 . . . . 0.0 112.348 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 0.6 0.11 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.341 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.08 -40.01 9.62 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.042 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.539 ' CB ' HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.36 -137.8 0.21 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.647 0.223 . . . . 0.0 110.882 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -136.63 166.9 22.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 111.048 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -76.01 -175.45 3.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.269 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.603 ' ND1' HG22 ' A' ' 56' ' ' VAL . 82.4 t60 -130.73 -74.97 0.53 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.315 0.578 . . . . 0.0 110.829 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.584 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -164.22 132.6 3.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.998 -178.698 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.664 HG12 HG13 ' A' ' 53' ' ' VAL . 2.8 mt -94.39 158.38 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.691 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.1 t0 -123.88 128.55 49.63 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.381 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.445 ' HG2' HD21 ' A' ' 19' ' ' LEU . 13.4 mt-10 -90.8 69.06 6.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.228 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.666 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -100.92 148.03 34.51 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.264 -178.437 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.783 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 21.2 Cg_endo -91.7 159.75 3.48 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.043 2.495 . . . . 0.0 113.362 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' A' ' 50' ' ' ALA . 5.0 mm -127.95 -83.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.248 -178.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.474 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.34 -151.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.031 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -72.11 -28.76 63.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.73 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.2 3.98 0.41 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.126 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.504 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 6.9 mt -91.21 106.09 18.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.892 0.377 . . . . 0.0 110.777 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 40.7 t -92.95 132.06 38.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.694 -178.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.704 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.27 164.09 12.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.093 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.871 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.3 mp -120.64 116.0 24.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.28 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.636 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.1 m120 -89.86 91.93 8.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.315 0.579 . . . . 0.0 110.378 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.695 HG21 HG12 ' A' ' 26' ' ' ILE . 4.6 t -86.8 105.21 14.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.536 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.679 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.6 164.61 18.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.169 178.836 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.627 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.1 m -139.24 141.06 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 111.572 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.603 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.9 t -93.07 100.4 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.668 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.823 HG23 HG12 ' A' ' 4' ' ' VAL . 27.2 m -130.15 140.35 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.046 0.45 . . . . 0.0 111.544 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.32 -61.67 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.51 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -81.34 -7.68 59.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.038 0.446 . . . . 0.0 110.625 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.535 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.77 -139.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.132 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -147.01 -166.27 2.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.77 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.58 12.88 31.79 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.638 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.15 -9.54 63.87 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.512 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -74.48 -5.99 45.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.857 0.361 . . . . 0.0 110.42 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -54.72 -23.79 19.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.056 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.93 -28.59 57.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.952 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.664 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.09 -57.59 11.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.401 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -59.53 -33.59 71.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.451 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.85 -51.42 68.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.238 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.409 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.3 t -63.48 -18.03 63.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.139 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.678 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.23 -29.91 63.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.478 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -12.86 44.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.709 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.26 27.41 0.99 Allowed Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.642 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.819 HD11 ' HB2' ' A' ' 29' ' ' ARG . 1.3 tt -73.17 -162.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.411 . . . . 0.0 111.187 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.633 ' OE1' HG12 ' A' ' 77' ' ' VAL . 1.7 mm-40 -50.89 94.13 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.141 0.496 . . . . 0.0 110.792 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.06 -32.42 62.8 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.692 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.633 HG12 ' OE1' ' A' ' 75' ' ' GLU . 0.4 OUTLIER -87.44 -36.82 10.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 0.0 110.364 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -96.0 89.01 5.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.206 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -75.88 133.87 40.44 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.069 HG21 HG22 ' A' ' 8' ' ' ILE . 6.2 mt -101.12 144.82 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.068 -175.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.596 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 19.4 tp10 -85.34 69.96 10.77 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.693 HG23 ' HB ' ' A' ' 80' ' ' ILE . 49.1 t -80.8 48.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.035 -174.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 m -132.34 8.14 4.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.23 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.682 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.3 m-20 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.88 0.371 . . . . 0.0 110.928 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.618 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.6 0.238 . . . . 0.0 111.0 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 2.6 t -107.59 113.53 43.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.657 0.265 . . . . 0.0 111.369 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.556 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.68 167.17 11.63 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.257 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.812 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 7.5 m -143.15 131.19 21.76 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.537 0.684 . . . . 0.0 112.312 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.0 HG22 HG21 ' A' ' 80' ' ' ILE . 3.5 mm -125.01 108.29 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.763 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.81 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.15 95.05 7.88 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.553 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.462 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.4 m -93.89 138.49 20.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.769 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.2 ptm -145.49 125.37 7.03 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.353 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.601 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.1 Cg_exo -71.47 121.92 8.16 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.155 2.57 . . . . 0.0 112.077 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.32 -32.36 66.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.345 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.25 152.57 79.09 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.078 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.584 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 41.1 Cg_endo -67.31 -3.36 9.81 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.388 2.059 . . . . 0.0 112.204 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -90.87 43.89 1.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.927 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.601 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 93.1 t -65.59 75.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.37 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 81.9 m-20 -70.49 95.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.915 177.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.527 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -64.1 -43.63 94.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.5 -178.351 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.527 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 5.3 tp10 -68.36 -38.16 81.17 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.744 0.307 . . . . 0.0 110.412 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -69.62 -39.82 76.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.372 0.606 . . . . 0.0 109.815 177.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -67.62 -30.66 70.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.035 177.883 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -46.75 81.7 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.775 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -69.26 -40.45 77.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.571 179.531 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.527 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 1.3 mt-10 -65.24 -28.04 69.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.117 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.847 HG12 HG21 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -62.44 -47.12 94.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.354 179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.406 HE22 ' HG ' ' A' ' 36' ' ' LEU . 8.1 mm100 -62.68 -31.61 72.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.829 0.347 . . . . 0.0 110.721 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 17.7 mm-40 -74.72 -24.84 58.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.007 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.978 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.46 -14.52 37.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.333 -179.128 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.432 HG13 HD12 ' A' ' 36' ' ' LEU . 24.8 mm -57.61 137.29 82.37 Favored Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.716 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 4.5 Cg_endo -45.66 122.01 4.57 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.885 2.39 . . . . 0.0 112.169 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.37 -4.82 0.25 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.046 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.03 -41.4 8.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.73 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.511 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.43 -146.54 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.674 0.273 . . . . 0.0 111.198 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -138.62 177.58 7.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.242 0.544 . . . . 0.0 111.185 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.715 ' H ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -74.96 -178.24 3.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.434 -179.183 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.535 ' ND1' HG22 ' A' ' 56' ' ' VAL . 72.4 t60 -131.13 -71.24 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.66 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 7.2 mmtm -161.64 125.16 3.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.081 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.651 HD13 HG22 ' A' ' 53' ' ' VAL . 2.8 mt -92.1 160.49 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.781 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.65 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -129.17 125.0 36.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.726 -178.311 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -85.43 72.03 10.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.841 0.353 . . . . 0.0 110.548 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.524 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.4 mt-10 -98.09 134.73 21.82 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.621 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.771 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 56.8 Cg_endo -86.53 155.0 9.11 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.577 2.185 . . . . 0.0 112.782 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.687 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.2 mm -123.87 -82.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.403 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.606 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.21 -153.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.054 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -71.81 -27.99 63.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.805 0.336 . . . . 0.0 110.593 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.62 5.12 0.51 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.951 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.606 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.8 mt -92.22 101.36 13.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.784 0.326 . . . . 0.0 110.839 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 90.4 t -93.38 129.36 43.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.783 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.769 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.24 162.94 13.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.022 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.65 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.2 mp -120.53 120.27 35.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.435 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.523 ' ND2' ' HB3' ' A' ' 40' ' ' ASP . 2.3 m-20 -89.66 91.71 8.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.271 0.558 . . . . 0.0 109.813 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.847 HG21 HG12 ' A' ' 26' ' ' ILE . 12.4 t -86.82 106.35 15.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.793 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.574 ' HG3' HG23 ' A' ' 7' ' ' THR . 6.2 mtt -85.63 165.23 17.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.031 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.556 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.1 m -140.3 134.35 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.903 0.383 . . . . 0.0 111.245 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.535 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.55 113.21 30.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.06 179.284 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 4' ' ' VAL . 3.5 m -130.35 144.8 36.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.885 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.07 -63.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.25 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -81.09 -7.9 59.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 110.402 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.511 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.27 -147.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.992 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.56 -162.02 1.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.343 . . . . 0.0 110.782 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.62 11.91 37.16 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.38 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.43 -3.01 45.72 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.585 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 p -74.03 -5.49 41.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.934 0.397 . . . . 0.0 110.358 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -55.13 -24.36 25.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.193 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . . . -57.2 -25.45 59.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.105 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.77 -57.26 13.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.164 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.37 -33.63 71.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.325 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 1.8 mm-40 -61.11 -52.13 66.21 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.501 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.78 -19.86 65.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.621 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.724 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.63 -28.08 62.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.69 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -15.1 57.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.731 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.39 29.33 0.96 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.978 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -73.08 -165.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.253 -0.474 . . . . 0.0 111.279 -178.589 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.771 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 3.0 pm0 -51.63 89.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.658 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 74' ' ' ILE . . . -59.46 -26.99 62.75 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.937 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.06 -34.76 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.254 0.549 . . . . 0.0 110.2 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.771 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -95.71 89.07 5.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.626 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -74.68 128.86 36.58 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.0 HG21 HG22 ' A' ' 8' ' ' ILE . 1.9 mp -101.11 148.88 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.576 -175.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.662 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.1 tp10 -85.78 71.44 10.67 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 172.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.705 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.5 t -80.06 50.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.036 -173.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -132.93 7.12 4.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.176 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.812 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 26.8 t0 . . . . . 0 N--CA 1.451 -0.381 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.934 -178.632 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.78 HG12 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 4.8 t -106.96 117.26 52.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 121.046 -0.261 . . . . 0.0 111.66 -178.379 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.696 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -92.68 162.27 14.22 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.043 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.81 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 11.3 m -143.16 131.06 21.58 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.592 0.71 . . . . 0.0 112.309 -178.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.021 HG22 HG21 ' A' ' 80' ' ' ILE . 2.7 mm -120.22 106.05 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.628 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.834 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -93.62 92.35 7.49 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.326 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.609 HG12 HG12 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -92.42 138.13 20.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.117 -177.019 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.64 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.73 119.05 5.29 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.074 179.312 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.613 ' CD ' HG13 ' A' ' 17' ' ' VAL . 14.9 Cg_exo -69.23 120.25 7.14 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.252 2.635 . . . . 0.0 112.137 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -57.42 -30.33 64.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.475 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.79 151.62 79.73 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.078 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 40.8 Cg_endo -66.81 -4.28 10.93 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.41 2.074 . . . . 0.0 112.001 179.65 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -91.84 42.35 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.321 179.162 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.613 HG13 ' CD ' ' A' ' 12' ' ' PRO . 90.9 t -65.14 78.17 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.166 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.669 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -67.82 100.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.134 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.618 HD11 ' HE2' ' A' ' 23' ' ' LYS . 1.3 tp -61.54 -51.87 66.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.488 -178.125 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.782 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 8.6 pt-20 -71.54 -34.55 70.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.261 -177.33 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -67.82 -36.21 79.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.195 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -64.86 -34.74 79.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.363 176.557 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.782 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -55.59 -48.11 75.38 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.296 178.649 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 3.6 mtmt -65.25 -44.18 88.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.967 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -66.32 -28.72 68.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.172 0.51 . . . . 0.0 110.444 -179.199 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.838 HG12 HG21 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -61.39 -47.46 93.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.495 -179.62 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.539 ' OE1' HD22 ' A' ' 36' ' ' LEU . 7.0 mm100 -63.53 -33.29 75.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.829 0.347 . . . . 0.0 110.798 -178.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 15.4 mt-10 -75.19 -23.56 57.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.925 179.216 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.755 ' HB2' HD11 ' A' ' 74' ' ' ILE . 3.2 ptp180 -91.83 -14.66 29.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.414 -179.122 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.59 HG12 ' O ' ' A' ' 26' ' ' ILE . 11.0 mm -59.35 141.25 87.7 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.025 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.716 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.2 Cg_endo -51.25 113.55 1.16 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.844 2.363 . . . . 0.0 112.431 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.2 -1.61 0.21 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.328 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.11 -36.89 13.62 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.066 -178.525 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.542 ' CB ' HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.54 -140.31 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.725 0.263 . . . . 0.0 111.077 -179.32 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -136.67 166.11 24.33 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.852 0.358 . . . . 0.0 110.892 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.539 HD22 ' OE1' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -76.09 -175.03 2.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.355 -179.262 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.6 ' ND1' HG22 ' A' ' 56' ' ' VAL . 79.8 t60 -131.29 -76.78 0.52 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.278 0.561 . . . . 0.0 110.937 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -165.27 132.7 3.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.048 -178.793 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.742 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -93.77 156.18 3.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.065 0.46 . . . . 0.0 112.197 -177.361 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.649 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 74.8 m-20 -122.72 119.2 29.97 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.465 -178.577 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -83.21 73.42 10.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.032 0.444 . . . . 0.0 110.608 178.675 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.559 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -97.33 132.95 24.48 Favored Pre-proline 0 C--O 1.225 -0.224 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.628 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.779 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 44.2 Cg_endo -85.33 155.21 10.81 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.449 2.099 . . . . 0.0 112.875 -178.594 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.749 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.4 mm -124.03 -83.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.411 -177.502 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.459 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.16 -154.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.018 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.97 -26.54 62.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.579 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.65 1.78 0.36 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.23 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.543 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.6 mt -92.44 102.41 14.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.851 0.358 . . . . 0.0 110.875 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.779 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 73.4 t -93.34 132.15 38.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.035 -178.126 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.749 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.93 153.77 17.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.816 177.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.649 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -117.39 120.8 39.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.518 179.377 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.575 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 2.1 m-20 -89.73 93.89 9.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.109 -179.231 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.838 HG21 HG12 ' A' ' 26' ' ' ILE . 17.3 t -85.95 105.58 14.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.558 -177.851 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 44.2 mtt -86.52 160.51 18.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.35 178.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.696 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.8 m -139.05 140.7 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.101 -178.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.6 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.1 t -92.49 100.09 10.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.764 179.111 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.78 HG23 HG12 ' A' ' 4' ' ' VAL . 27.3 m -130.48 139.08 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.988 0.423 . . . . 0.0 111.473 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.73 -61.67 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.557 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.96 -5.4 58.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 110.575 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.51 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.41 -139.52 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.125 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -146.83 -165.92 2.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.762 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.32 11.09 39.4 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.691 179.345 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.2 -11.32 67.23 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.526 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -4.45 36.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 0.0 110.319 179.441 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -54.56 -23.9 18.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.387 0.613 . . . . 0.0 109.869 177.428 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.04 -28.17 56.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.94 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.716 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.96 -57.61 11.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.425 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -58.94 -34.06 71.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.455 178.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.96 -52.18 66.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.267 178.713 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -20.38 65.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.508 179.034 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.72 HD22 HD13 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.84 -26.1 61.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.659 -179.653 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.61 -17.02 63.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.556 178.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.48 31.74 0.93 Allowed Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.704 179.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.755 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -73.08 -161.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.278 -0.461 . . . . 0.0 111.24 -178.431 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.705 ' HG3' ' O ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -51.55 88.13 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.219 0.533 . . . . 0.0 110.437 178.935 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 74' ' ' ILE . . . -60.26 -26.63 64.16 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.308 -177.658 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 p -85.44 -34.7 8.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.412 0.625 . . . . 0.0 110.177 179.502 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.705 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -95.57 90.02 5.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.588 -179.314 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -73.49 128.38 35.34 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.153 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.021 HG21 HG22 ' A' ' 8' ' ' ILE . 2.1 mp -101.16 149.31 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.648 -174.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.68 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 5.8 tp10 -85.65 71.91 10.65 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.737 HG23 ' HB ' ' A' ' 80' ' ' ILE . 75.7 t -79.73 48.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.93 -173.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -133.1 7.26 3.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.93 178.422 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.81 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 22.0 t0 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.977 -178.51 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.627 HG12 HG23 ' A' ' 57' ' ' VAL . 1.0 OUTLIER . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 120.56 0.219 . . . . 0.0 110.958 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 57.5 t -124.06 120.18 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.746 0.308 . . . . 0.0 111.605 179.233 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.55 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -98.05 166.44 11.43 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.706 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 14.2 m -140.52 136.48 32.94 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.6 0.714 . . . . 0.0 112.267 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.077 HG22 HG21 ' A' ' 80' ' ' ILE . 2.3 mm -125.71 106.94 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.573 -178.055 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.822 ' C ' HG23 ' A' ' 80' ' ' ILE . 1.6 mmmt -95.79 93.83 7.31 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.816 0.341 . . . . 0.0 111.892 -178.075 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.493 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.9 m -93.71 135.4 28.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -176.521 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.648 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.36 124.88 6.91 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.038 178.363 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.643 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.7 Cg_exo -71.79 117.3 5.08 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.147 2.565 . . . . 0.0 111.747 179.285 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -30.25 59.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.95 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.96 155.1 80.39 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.72 179.454 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 3.8 Cg_exo -72.3 -0.96 9.42 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.562 2.175 . . . . 0.0 111.683 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -92.29 42.97 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.049 178.261 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.643 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 88.4 t -64.85 78.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.089 -178.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.659 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 2.3 m-20 -68.56 101.84 1.35 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.322 178.881 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.58 -53.43 56.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.68 -179.004 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 23.5 tt0 -69.76 -35.33 74.85 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 -176.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -68.57 -36.81 79.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.57 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.584 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.1 OUTLIER -64.74 -34.11 77.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.469 177.071 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -57.41 -47.22 82.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.571 179.008 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 7.4 mttt -65.64 -41.92 92.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.649 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 21' ' ' ALA . 33.8 mt-10 -65.74 -31.49 72.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.197 0.523 . . . . 0.0 110.477 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.685 HD11 HD12 ' A' ' 51' ' ' LEU . 6.9 mt -61.38 -44.71 98.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.053 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -61.48 -38.41 87.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.951 0.405 . . . . 0.0 110.772 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 4.7 mm-40 -76.09 -21.94 56.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.689 -178.691 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.632 HH22 ' HB ' ' A' ' 8' ' ' ILE . 22.1 ptt85 -90.35 -13.59 34.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.643 -177.919 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 26' ' ' ILE . 29.4 mm -59.73 138.6 90.03 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.176 -179.438 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.595 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.1 Cg_endo -51.89 123.77 13.14 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.726 2.284 . . . . 0.0 112.496 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -62.25 2.92 0.21 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.262 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.36 -64.51 1.64 Allowed Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.01 -178.618 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.624 ' CB ' HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -112.6 -131.43 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.348 0.118 . . . . 0.0 110.913 -179.17 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -139.21 166.63 24.03 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.947 0.404 . . . . 0.0 111.013 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.2 pt? -75.9 -172.41 1.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.971 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.575 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.0 t60 -130.36 -78.85 0.54 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.27 0.557 . . . . 0.0 111.481 -178.15 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HB3' ' CD2' ' A' ' 37' ' ' HIS . 1.5 tptp -164.49 130.89 2.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.843 -178.322 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.672 HD13 HD13 ' A' ' 26' ' ' ILE . 2.6 mt -92.0 159.62 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -176.715 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.643 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -127.48 117.08 21.42 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.247 -179.39 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -81.87 72.6 8.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.991 0.424 . . . . 0.0 110.396 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.539 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -97.0 134.86 22.39 Favored Pre-proline 0 C--O 1.225 -0.222 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.69 -179.595 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.776 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 53.7 Cg_endo -85.43 155.4 10.69 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.39 2.06 . . . . 0.0 112.837 -178.73 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.777 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.6 mm -124.88 -83.42 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.269 -177.505 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.493 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -66.74 -155.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.764 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -72.47 -22.93 60.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.72 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.62 0.93 0.26 Allowed Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.443 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.52 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.6 mt -92.83 103.59 15.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.072 0.436 . . . . 0.0 111.138 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.776 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 72.8 t -93.5 129.14 44.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.891 -179.015 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.777 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.1 151.8 19.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.943 178.168 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.685 HD12 HD11 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -115.14 121.27 42.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.538 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 1.7 m120 -90.51 92.33 8.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.363 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.647 HG22 HD13 ' A' ' 39' ' ' ILE . 5.9 t -87.49 103.27 13.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.375 -178.62 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.581 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.7 mpt? -84.41 164.89 18.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.268 178.939 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.55 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.2 m -137.73 136.89 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.365 -178.002 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.575 HG22 ' ND1' ' A' ' 37' ' ' HIS . 1.7 t -94.33 99.13 8.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.744 178.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.627 HG23 HG12 ' A' ' 4' ' ' VAL . 33.3 m -130.47 139.89 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.213 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.86 -57.8 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.595 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -80.85 -11.04 59.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.513 179.524 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.431 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.62 -138.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.109 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -146.79 -164.38 1.98 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.757 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.36 13.07 29.5 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.738 179.358 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.44 -11.49 68.27 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.609 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -74.46 -4.1 34.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.802 0.335 . . . . 0.0 110.422 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -55.19 -23.86 23.97 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.399 0.618 . . . . 0.0 110.055 177.433 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.413 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . . . -57.11 -25.09 58.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.174 -179.427 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.54 -57.03 13.71 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.327 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -58.77 -34.06 71.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.218 178.041 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 2.5 mt-10 -62.17 -51.57 67.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.43 178.778 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.69 -18.95 64.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.401 178.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.63 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.19 -29.53 62.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.512 179.835 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -13.47 51.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.74 179.162 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.27 28.73 0.98 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.672 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.63 ' HB ' ' HA ' ' A' ' 71' ' ' LEU . 1.2 tt -73.19 -164.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.445 -0.377 . . . . 0.0 110.854 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.64 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -51.96 95.3 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.089 0.471 . . . . 0.0 110.648 179.61 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.74 -30.84 69.98 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.452 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.2 t -85.16 -35.12 9.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.921 0.391 . . . . 0.0 110.38 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.64 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 8.0 m -95.7 88.87 5.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.683 -179.514 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -75.57 129.97 38.06 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.491 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.077 HG21 HG22 ' A' ' 8' ' ' ILE . 3.2 mp -101.3 150.05 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.748 -175.269 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.527 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 52.4 tt0 -85.91 70.75 10.67 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 173.016 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.68 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.0 t -80.94 50.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.083 -174.53 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 m -132.9 10.5 4.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.891 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.706 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.3 m-20 . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 121.162 0.506 . . . . 0.0 111.227 -178.447 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.649 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.461 0.078 0 CA-C-O 120.71 0.29 . . . . 0.0 110.708 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 53.7 t -109.57 120.64 61.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.596 -178.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.576 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -96.39 166.0 11.91 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.087 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.816 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.1 m -143.04 130.09 20.69 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.57 0.7 . . . . 0.0 112.361 -179.196 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.025 HG22 HG21 ' A' ' 80' ' ' ILE . 6.7 mm -121.61 107.08 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.554 -179.11 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.813 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -95.6 94.15 7.57 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.933 0.396 . . . . 0.0 111.946 -177.87 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.518 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.7 m -93.54 136.54 24.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -176.502 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.772 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.2 ptm -144.72 126.15 7.84 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.303 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.611 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 10.4 Cg_exo -73.46 124.53 9.45 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.399 2.732 . . . . 0.0 112.37 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.99 -33.82 69.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.357 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.4 m -78.28 154.41 79.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.213 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.582 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 52.9 Cg_endo -69.66 -3.41 11.88 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.428 2.085 . . . . 0.0 112.146 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.76 44.03 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.826 178.378 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.611 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 81.0 t -64.98 76.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.558 -178.418 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 6.3 m-20 -71.61 92.44 1.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.57 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.65 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -63.97 -42.08 97.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.303 -178.478 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.628 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 26.7 tt0 -68.3 -39.11 82.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.794 0.331 . . . . 0.0 110.253 -178.506 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -71.55 -36.75 71.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.053 0.454 . . . . 0.0 110.384 177.861 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -67.79 -28.75 67.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.976 178.026 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -42.48 87.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.321 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -43.82 86.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.246 178.71 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.57 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 2.2 mm-40 -65.79 -30.38 71.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.342 0.592 . . . . 0.0 110.207 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.782 HG12 HG21 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -60.66 -47.14 94.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.073 179.724 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.423 ' OE1' HD22 ' A' ' 36' ' ' LEU . 7.2 mm-40 -64.71 -35.24 80.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.193 -178.829 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 8.4 pt-20 -77.0 -20.79 55.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.907 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.832 ' HB2' HD11 ' A' ' 74' ' ' ILE . 4.2 ptp180 -90.51 -13.55 34.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.045 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 26' ' ' ILE . 14.2 mm -59.82 138.67 90.31 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.92 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 30' ' ' ILE . 9.6 Cg_endo -50.81 119.3 5.07 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.708 2.272 . . . . 0.0 112.112 178.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -59.23 -1.27 0.18 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.24 -179.597 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -81.49 -39.64 12.1 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.968 -178.855 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.538 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.54 -147.41 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.668 0.271 . . . . 0.0 111.118 -179.714 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -131.9 170.06 15.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.998 0.428 . . . . 0.0 110.927 -179.309 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.518 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -75.12 -177.2 3.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.123 -179.331 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.568 ' ND1' HG22 ' A' ' 56' ' ' VAL . 82.1 t60 -130.91 -76.38 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.294 0.569 . . . . 0.0 111.085 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 2.0 tptt -164.64 130.34 2.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.996 -178.717 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.65 HD13 HG22 ' A' ' 53' ' ' VAL . 2.2 mt -94.13 160.99 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.634 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -127.35 122.54 33.99 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.485 -179.182 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -84.83 74.06 10.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.602 178.311 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.557 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.0 OUTLIER -101.23 136.16 19.74 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.969 -179.6 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.774 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 61.4 Cg_endo -86.43 155.49 9.29 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.793 2.328 . . . . 0.0 112.724 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.735 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.0 mm -124.55 -83.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.614 -177.78 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.72 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.42 -148.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.355 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -70.45 -33.54 71.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.61 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.39 8.22 0.64 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.606 179.713 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.72 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mt -91.41 102.02 14.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.876 0.369 . . . . 0.0 110.748 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 87.3 t -93.23 128.89 44.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.94 -178.435 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.772 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.19 161.01 14.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.071 178.719 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.2 mp -120.27 119.96 34.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.405 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 4.7 m-20 -89.74 91.4 8.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.305 0.574 . . . . 0.0 110.066 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.782 HG21 HG12 ' A' ' 26' ' ' ILE . 6.1 t -87.5 104.67 14.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.736 -177.586 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 27.8 mtt -86.54 164.38 16.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.277 178.458 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.576 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.2 m -139.26 136.15 41.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.845 0.355 . . . . 0.0 111.354 -178.818 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.568 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -95.69 114.94 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.311 179.733 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 4' ' ' VAL . 3.6 m -130.24 148.59 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.694 178.579 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.92 -67.65 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.356 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -80.71 -7.43 59.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.094 0.473 . . . . 0.0 110.64 179.442 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.455 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.66 -147.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.107 179.339 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.5 -165.33 2.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.875 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.13 14.04 29.47 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.523 178.546 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.9 -2.84 40.32 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.483 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 p -74.08 -3.66 30.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.359 . . . . 0.0 110.265 179.306 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -23.91 27.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.326 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.97 -25.7 58.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.262 -179.223 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.68 -49.3 78.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.635 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.686 ' HG3' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -61.72 -42.05 98.43 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.67 0.748 . . . . 0.0 109.53 176.996 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.686 ' N ' ' HG3' ' A' ' 68' ' ' GLU . 2.3 tm-20 -55.25 -46.62 76.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.821 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.2 p -68.42 -24.32 64.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.231 177.184 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.773 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.53 -30.23 62.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.608 179.901 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 p -63.41 -11.46 23.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.776 179.168 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.24 26.66 0.99 Allowed Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.832 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -73.33 -166.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.224 -0.488 . . . . 0.0 111.408 -178.606 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.585 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -50.75 92.17 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.096 179.0 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.55 -26.16 64.19 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.476 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.07 -37.88 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.142 0.496 . . . . 0.0 110.114 178.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.58 ' HB2' ' HB3' ' A' ' 75' ' ' GLU . 1.5 m -96.15 89.92 5.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.531 179.708 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -76.48 130.0 37.33 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.465 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.025 HG21 HG22 ' A' ' 8' ' ' ILE . 3.4 mp -101.35 149.55 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.539 -175.483 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.525 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.1 tt0 -85.75 71.15 10.72 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.762 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.694 HG23 ' HB ' ' A' ' 80' ' ' ILE . 58.3 t -80.26 50.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.031 -174.269 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.87 5.74 3.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.285 178.892 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.816 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 35.4 t0 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.985 0.421 . . . . 0.0 111.008 -178.451 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.514 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 1.9 t . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 120.575 0.226 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.43 117.05 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.688 0.28 . . . . 0.0 111.754 -178.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.624 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -98.54 165.69 11.7 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.314 178.055 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.682 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 6.0 m -143.24 132.96 23.81 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.632 0.729 . . . . 0.0 112.407 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.972 HG22 HG21 ' A' ' 80' ' ' ILE . 7.1 mm -126.28 108.12 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.499 -178.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.81 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.25 95.0 7.81 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.011 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.49 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.5 m -92.56 136.83 23.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.116 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.663 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -146.3 118.48 4.97 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 121.07 0.462 . . . . 0.0 111.717 179.896 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 21.1 Cg_exo -68.29 121.58 8.56 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.36 2.707 . . . . 0.0 111.822 178.529 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.89 -29.16 64.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.325 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.84 150.37 78.42 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 37.7 Cg_endo -65.88 -7.85 18.02 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.463 2.109 . . . . 0.0 112.075 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -91.81 35.97 0.96 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.502 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.677 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -68.17 82.58 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.814 0.816 . . . . 0.0 110.532 -179.378 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.5 m-20 -73.74 99.31 3.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.805 178.038 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.851 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -63.33 -44.11 95.83 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.025 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.806 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 4.4 tp10 -70.03 -36.15 74.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.868 0.366 . . . . 0.0 110.342 -178.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -69.16 -37.96 78.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.381 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.56 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.8 OUTLIER -67.72 -26.67 66.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.971 177.23 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.806 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -56.13 -46.13 79.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.235 179.13 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -41.22 85.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.705 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.725 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 52.9 mt-10 -66.74 -28.63 68.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.426 0.631 . . . . 0.0 110.151 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.831 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.2 mt -63.29 -39.2 84.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.163 178.76 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -60.66 -41.72 95.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.075 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.725 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -77.62 -21.32 52.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.937 -178.101 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.831 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.01 -12.43 44.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.061 -179.001 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.697 HG12 ' O ' ' A' ' 26' ' ' ILE . 22.6 mm -60.46 137.53 92.31 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.872 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.619 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 7.0 Cg_endo -47.45 121.5 5.56 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.748 2.298 . . . . 0.0 112.256 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.15 0.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.238 -179.306 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.0 -62.96 1.78 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.866 -179.023 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.481 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -111.77 -142.01 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.682 0.277 . . . . 0.0 111.183 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -133.39 172.98 11.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.974 0.416 . . . . 0.0 111.069 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.39 -177.65 3.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.329 -178.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.502 ' ND1' HG22 ' A' ' 56' ' ' VAL . 80.0 t60 -131.02 -76.29 0.53 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.062 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 20.2 mmtt -160.21 129.25 4.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.089 -178.732 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.725 HD13 HG22 ' A' ' 53' ' ' VAL . 1.6 mt -92.0 160.93 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 111.616 -178.679 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.64 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -129.06 124.47 34.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.64 -178.606 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -85.85 71.93 10.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 0.0 110.653 178.239 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.533 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -99.22 136.21 20.55 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.593 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.787 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 59.7 Cg_endo -86.99 158.02 8.62 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.565 2.176 . . . . 0.0 112.785 -178.661 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.687 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.3 mm -126.16 -82.69 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.421 -177.607 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.566 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.41 -151.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.167 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -71.35 -30.22 65.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.668 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.55 5.2 0.51 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.899 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.566 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.1 mt -91.78 103.13 15.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.938 0.399 . . . . 0.0 110.708 179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.787 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 76.0 t -92.92 131.76 39.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.88 -178.381 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.687 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.03 162.29 13.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.831 178.47 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.851 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.2 mp -120.66 119.7 33.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.333 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.504 ' ND2' ' HB3' ' A' ' 40' ' ' ASP . 2.3 m-20 -89.88 91.83 8.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.255 0.55 . . . . 0.0 110.134 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.754 HG21 HG12 ' A' ' 26' ' ' ILE . 12.4 t -86.5 102.3 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.583 -177.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.511 ' HG3' HG23 ' A' ' 7' ' ' THR . 24.8 mtt -84.59 164.46 18.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.169 178.795 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.624 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.0 m -139.35 135.86 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.456 -178.628 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.502 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -98.61 115.98 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.211 178.932 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.514 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 2.8 m -130.67 148.14 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.702 178.861 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.6 -68.06 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.578 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -80.42 -8.51 59.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.059 0.457 . . . . 0.0 110.607 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.481 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.86 -144.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.057 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.52 -167.34 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.815 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.86 16.35 15.8 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.562 178.674 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.5 -1.36 36.32 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.491 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 p -74.81 -4.23 36.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.874 0.368 . . . . 0.0 110.246 179.228 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -55.05 -23.37 19.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.182 177.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.29 -26.29 60.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.134 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.619 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.92 -55.94 27.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.338 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -58.33 -35.91 72.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.561 178.462 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -51.55 68.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.427 178.824 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 12.2 p -63.98 -20.81 66.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.487 179.023 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.549 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.22 -25.94 61.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.602 -179.802 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.01 -17.73 63.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.638 179.124 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.77 30.67 0.92 Allowed Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.05 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.764 HD11 ' HD2' ' A' ' 29' ' ' ARG . 4.3 tt -72.99 -160.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.571 -0.314 . . . . 0.0 111.01 -178.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.642 ' H ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -51.61 94.96 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.035 0.445 . . . . 0.0 110.63 179.77 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.16 -30.85 71.5 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.485 -177.732 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.5 t -85.02 -33.9 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.943 0.401 . . . . 0.0 110.578 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.617 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 28.1 t -95.77 91.53 6.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.937 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -75.5 128.84 36.2 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.972 HG21 HG22 ' A' ' 8' ' ' ILE . 3.4 mp -101.01 149.31 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.423 -174.949 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.563 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.7 tt0 -85.66 70.41 10.72 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 173.07 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.698 HG23 ' HB ' ' A' ' 80' ' ' ILE . 59.9 t -79.92 50.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.881 -174.393 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.66 6.54 4.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.351 179.272 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.682 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.5 m-20 . . . . . 0 N--CA 1.452 -0.361 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.913 -178.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.562 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.646 0.26 . . . . 0.0 110.609 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 78.9 t -119.85 122.52 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.49 -179.063 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.589 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.37 168.39 10.75 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.825 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.777 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 5.7 m -143.17 133.6 24.8 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.595 0.712 . . . . 0.0 112.235 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.989 HG22 HG21 ' A' ' 80' ' ' ILE . 3.8 mm -126.52 106.51 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.24 -178.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.813 ' C ' HG23 ' A' ' 80' ' ' ILE . 2.5 mmmt -96.21 96.02 8.52 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -176.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.499 HG12 HG12 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -94.23 135.71 27.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -177.537 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.671 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.77 117.97 4.35 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 120.993 0.425 . . . . 0.0 111.414 178.97 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.3 Cg_exo -69.72 120.44 7.23 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.253 2.636 . . . . 0.0 111.964 178.515 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -57.61 -29.06 64.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.068 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.55 150.57 79.52 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.882 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 38.4 Cg_endo -66.34 -8.29 20.14 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.432 2.088 . . . . 0.0 112.063 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.92 36.51 0.97 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.634 179.313 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.626 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.8 86.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.811 0.815 . . . . 0.0 110.196 -179.87 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 55.9 m-20 -69.43 104.92 2.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.213 179.259 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.589 HD21 ' HG2' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -60.74 -52.52 64.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.548 -178.341 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.794 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 9.9 pt-20 -71.03 -34.51 71.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.257 -177.716 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.528 ' HB3' ' CB ' ' A' ' 18' ' ' ASP . . . -68.0 -35.7 78.76 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.443 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.592 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.3 OUTLIER -66.03 -33.61 76.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.423 176.463 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.794 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -55.91 -46.38 78.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.112 178.529 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -66.14 -43.65 86.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.72 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.772 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 5.1 mm-40 -66.12 -28.06 68.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.404 0.621 . . . . 0.0 110.576 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.878 HG12 HG21 ' A' ' 53' ' ' VAL . 1.1 mt -61.8 -46.54 96.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.267 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.59 ' OE1' HD22 ' A' ' 36' ' ' LEU . 26.7 mm-40 -63.9 -35.32 80.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.297 -178.053 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.772 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.6 OUTLIER -76.63 -21.55 55.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.821 179.953 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.978 ' HD2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.25 -15.12 31.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.793 179.249 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 26' ' ' ILE . 15.8 mm -58.93 138.28 87.37 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.97 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.511 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.3 Cg_endo -50.27 117.23 3.0 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.884 2.389 . . . . 0.0 112.309 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -58.84 -2.07 0.21 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.182 -179.651 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.79 -57.52 2.54 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.794 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.59 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -109.76 -142.62 0.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.694 0.283 . . . . 0.0 111.064 -179.588 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -135.65 170.0 16.65 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.929 0.395 . . . . 0.0 110.761 -179.411 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.59 HD22 ' OE1' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -75.3 -178.31 3.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.062 -179.333 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.544 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.5 t60 -130.85 -77.01 0.53 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.41 0.624 . . . . 0.0 110.926 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -164.83 130.87 2.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.791 -178.893 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.686 HG12 HG13 ' A' ' 53' ' ' VAL . 2.7 mt -92.67 157.92 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.039 0.447 . . . . 0.0 112.098 -177.097 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.631 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -124.75 117.32 23.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.379 -179.106 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.589 ' HG2' HD21 ' A' ' 19' ' ' LEU . 1.4 mt-10 -82.8 70.91 9.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.952 0.406 . . . . 0.0 110.514 178.556 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.545 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.7 mt-10 -95.66 135.84 22.77 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.356 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.772 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 56.7 Cg_endo -86.21 156.73 9.68 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.433 2.089 . . . . 0.0 112.933 -178.039 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.753 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.8 mm -125.53 -82.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.451 -177.168 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.603 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.22 -150.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.006 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -72.04 -30.52 65.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.848 0.356 . . . . 0.0 110.69 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.28 4.97 0.53 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.804 179.739 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.603 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.5 mt -91.31 102.88 15.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.893 0.377 . . . . 0.0 110.732 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 75.7 t -93.3 131.29 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.059 -177.829 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.753 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.08 150.72 20.18 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.719 177.785 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -113.84 117.91 32.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.358 179.6 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.45 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 6.8 m-20 -89.87 92.83 9.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.223 -178.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.878 HG21 HG12 ' A' ' 26' ' ' ILE . 5.1 t -86.85 102.11 11.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.624 -177.757 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.742 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.54 163.59 19.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.054 178.253 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.5 m -138.21 136.9 44.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.765 0.317 . . . . 0.0 111.367 -178.373 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.544 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -94.63 116.38 35.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.086 179.559 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.59 HG12 HG21 ' A' ' 34' ' ' THR . 6.2 m -130.27 148.36 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.966 179.272 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.64 -72.79 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.419 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.66 -2.7 51.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 110.789 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.547 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.31 -150.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.303 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.58 -165.19 2.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.792 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.16 14.72 26.25 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.619 178.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.12 -3.33 44.56 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.495 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -74.42 -3.2 29.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.941 0.401 . . . . 0.0 110.274 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -25.04 24.66 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.691 177.663 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.43 -25.16 59.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.953 -179.307 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -62.4 -55.25 29.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 110.073 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.55 ' HA ' HD12 ' A' ' 71' ' ' LEU . 58.5 mt-10 -58.6 -33.55 70.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.286 178.457 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -62.51 -52.59 62.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.256 178.216 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.65 -16.62 61.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.117 178.308 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.028 HD11 HG11 ' A' ' 82' ' ' VAL . 1.3 mt -73.38 -33.11 64.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.49 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.75 -10.29 18.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.792 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.08 28.6 1.0 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 178.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.978 HD11 ' HD2' ' A' ' 29' ' ' ARG . 7.3 tt -73.56 -166.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.834 -0.683 . . . . 0.0 111.269 -178.426 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.681 ' H ' HG12 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -52.01 101.39 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.986 0.422 . . . . 0.0 111.042 -179.658 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.52 -32.42 83.27 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.812 -179.004 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -86.44 -36.38 10.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.421 . . . . 0.0 110.242 179.377 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.636 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 10.3 t -95.67 92.39 6.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.462 179.332 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -77.32 130.74 37.56 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.325 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.989 HG21 HG22 ' A' ' 8' ' ' ILE . 2.7 mp -101.4 148.73 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.413 -175.655 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.559 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.2 tp10 -85.65 70.25 10.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 173.105 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 1.028 HG11 HD11 ' A' ' 71' ' ' LEU . 55.2 t -79.7 44.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.055 -174.081 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -132.32 9.84 4.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.522 177.762 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.777 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 34.5 t0 . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.828 0.346 . . . . 0.0 110.869 -178.886 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.579 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.659 0.266 . . . . 0.0 111.381 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 84.8 t -113.43 114.16 46.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.271 179.218 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.596 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -93.1 168.23 11.26 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.731 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.78 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 11.2 m -142.56 132.42 24.21 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.585 0.707 . . . . 0.0 112.505 -179.231 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.074 HG22 HG21 ' A' ' 80' ' ' ILE . 3.8 mm -120.61 105.24 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.276 -179.426 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.823 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -93.56 93.82 8.29 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.941 0.401 . . . . 0.0 112.009 -177.657 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.558 HG12 HG12 ' A' ' 80' ' ' ILE . 1.2 m -92.96 136.28 25.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.036 -177.211 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.728 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -147.7 119.27 4.54 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 121.265 0.555 . . . . 0.0 111.508 178.712 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.1 Cg_exo -68.38 120.86 7.79 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.13 2.553 . . . . 0.0 111.622 178.688 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.93 -29.11 62.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.271 -179.222 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.476 ' O ' HG12 ' A' ' 17' ' ' VAL . 1.3 p -77.78 153.25 80.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.127 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.549 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 51.3 Cg_endo -68.54 -7.21 19.68 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.178 1.919 . . . . 0.0 111.31 178.144 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.47 34.49 0.88 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.282 178.898 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.673 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -68.24 81.78 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.889 0.852 . . . . 0.0 110.523 -179.363 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -74.05 97.96 2.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.897 177.726 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.884 HD13 ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.53 -38.49 91.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.398 -178.473 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.884 ' H ' HD13 ' A' ' 19' ' ' LEU . 2.7 tp10 -69.11 -38.69 79.05 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -70.59 -38.24 73.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.414 0.626 . . . . 0.0 109.713 176.931 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.1 mt -68.08 -28.98 67.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.082 178.095 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -46.66 80.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.032 -179.59 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -68.94 -40.91 78.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.186 0.517 . . . . 0.0 110.387 179.319 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.44 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 6.1 mm-40 -65.32 -28.05 69.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.359 179.524 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.538 HG12 HG21 ' A' ' 53' ' ' VAL . 2.1 mt -62.65 -45.66 98.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.106 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -34.67 72.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.654 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -75.02 -22.47 58.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.466 -179.378 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.806 ' HB2' HD11 ' A' ' 74' ' ' ILE . 1.9 ptp180 -88.55 -15.21 35.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.504 -178.697 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.466 HG23 ' HD2' ' A' ' 31' ' ' PRO . 43.5 mm -58.07 137.57 84.07 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.568 179.132 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.587 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 18.6 Cg_endo -58.05 130.71 39.46 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.506 2.137 . . . . 0.0 112.837 -179.501 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.32 0.12 0.31 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.0 179.49 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -81.98 -60.88 2.1 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.566 -178.987 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.496 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -113.96 -143.69 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.707 0.289 . . . . 0.0 111.08 -179.867 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -135.73 167.63 20.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.775 -179.671 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.8 pt? -75.16 -176.16 2.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.04 -179.469 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.579 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.8 t60 -130.64 -77.43 0.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.374 0.606 . . . . 0.0 111.4 -178.195 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.54 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER -163.98 129.42 2.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.656 -178.417 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.687 HD13 HG22 ' A' ' 53' ' ' VAL . 2.5 mt -91.15 155.66 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.07 0.462 . . . . 0.0 112.145 -176.632 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.658 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -121.9 118.77 29.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.367 -179.025 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -82.19 71.71 9.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.055 0.455 . . . . 0.0 110.183 178.187 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.544 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.2 mt-10 -96.46 135.06 22.63 Favored Pre-proline 0 C--O 1.224 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.607 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.785 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 52.8 Cg_endo -86.07 156.24 9.84 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.513 2.142 . . . . 0.0 112.796 -178.925 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.7 mm -125.83 -83.32 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.543 -177.447 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.684 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.37 -151.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 -179.861 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -71.91 -29.49 64.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.606 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.63 4.79 0.49 Allowed Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.932 179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.684 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mt -91.72 102.54 15.16 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.856 0.36 . . . . 0.0 110.787 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.785 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 69.6 t -93.7 129.62 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.913 -178.462 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.758 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.64 150.04 20.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.025 178.116 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.658 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -113.09 119.38 37.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.245 179.054 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 2.8 m-20 -89.81 94.43 9.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.522 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.687 HG22 HD13 ' A' ' 39' ' ' ILE . 5.5 t -86.21 102.93 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.342 -178.663 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.677 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.69 167.73 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.455 179.208 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 6' ' ' ALA . 4.2 m -139.28 135.01 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.449 -178.251 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.579 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -95.7 113.89 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.824 178.843 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 4' ' ' VAL . 2.9 m -129.52 154.98 40.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.841 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.43 -68.07 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.195 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.63 -6.35 58.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.108 0.48 . . . . 0.0 110.366 179.027 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.496 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.82 -151.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.125 179.443 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.421 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -150.27 -159.12 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.856 -179.956 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.421 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -80.41 12.47 32.87 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.44 178.637 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.96 -8.0 60.36 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.43 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.27 -3.36 29.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.983 0.42 . . . . 0.0 110.087 179.006 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -54.71 -24.07 20.42 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.99 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.25 -27.26 61.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.897 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.587 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.23 -56.92 15.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.364 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -58.89 -34.97 72.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.405 178.838 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -51.23 70.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.383 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 t -63.7 -19.77 65.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.48 178.796 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.762 HD22 HD13 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -72.83 -28.39 62.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.651 179.957 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.82 -14.23 51.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.766 179.157 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.26 28.69 0.98 Allowed Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -73.41 -163.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.293 -0.453 . . . . 0.0 111.282 -178.698 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.7 OUTLIER -50.21 98.67 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.943 0.401 . . . . 0.0 110.918 179.513 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.62 -32.46 84.27 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.21 -178.302 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -85.66 -36.48 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.055 0.455 . . . . 0.0 110.205 179.606 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 42.4 t -95.64 90.08 5.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.455 179.225 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -77.17 133.34 38.97 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.1 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.074 HG21 HG22 ' A' ' 8' ' ' ILE . 2.2 mt -101.65 149.3 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.863 -175.485 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.531 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 5.3 tp10 -86.1 71.52 10.55 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 172.406 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.69 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.2 t -80.35 50.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.104 -174.216 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.92 5.96 3.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.349 178.897 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.78 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 46.9 t0 . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.984 0.421 . . . . 0.0 111.3 -178.147 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.624 0.25 . . . . 0.0 110.615 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.48 116.41 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.73 179.787 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.44 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -96.37 166.3 11.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.28 178.897 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.683 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 25.6 m -142.05 132.6 25.31 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.569 0.7 . . . . 0.0 111.779 179.768 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.06 HG22 HG21 ' A' ' 80' ' ' ILE . 1.8 mm -120.46 106.46 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.615 -178.375 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.816 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -95.24 93.36 7.25 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -177.573 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.458 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -92.38 135.93 26.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.729 -177.667 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.823 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -147.5 114.79 4.14 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 121.389 0.614 . . . . 0.0 111.974 179.801 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 35.5 Cg_exo -63.39 124.64 14.14 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.153 2.569 . . . . 0.0 112.055 178.995 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -57.52 -30.78 65.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.378 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.32 150.81 77.49 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.205 -179.304 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.565 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 40.9 Cg_endo -66.67 -6.29 15.09 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.38 2.053 . . . . 0.0 111.89 179.211 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -92.01 32.7 1.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.586 179.211 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.636 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -66.82 85.82 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.65 0.738 . . . . 0.0 110.064 179.929 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.572 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 12.1 m-20 -70.76 104.21 2.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.278 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.906 HD12 HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -61.67 -49.56 76.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.237 -178.666 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.662 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 2.5 tp10 -70.11 -35.48 74.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.111 -178.163 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.629 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -69.06 -35.93 77.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.294 0.569 . . . . 0.0 109.809 177.548 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -66.54 -27.56 67.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.038 177.831 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.662 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -56.33 -46.72 79.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.44 179.051 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.629 ' HE2' ' HA ' ' A' ' 21' ' ' ALA . 1.2 mtmm -65.64 -41.86 92.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.847 179.731 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.716 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 33.3 mt-10 -66.71 -31.14 71.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.431 0.634 . . . . 0.0 110.356 179.526 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.815 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 3.2 mt -62.91 -41.62 93.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.93 179.757 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -62.64 -39.13 92.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.158 -179.222 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.716 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -78.0 -21.02 51.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.669 -178.499 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.943 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.51 -12.11 43.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.273 -178.955 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.708 HG13 HD23 ' A' ' 36' ' ' LEU . 28.5 mm -61.0 138.09 94.09 Favored Pre-proline 0 N--CA 1.463 0.2 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.089 179.626 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.546 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.5 Cg_endo -51.19 125.26 15.9 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.744 2.296 . . . . 0.0 112.478 179.211 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -60.72 -2.86 0.6 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.039 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.22 -62.34 1.82 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.896 -178.82 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.675 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -111.01 -143.67 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.692 0.282 . . . . 0.0 111.152 -179.462 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -133.93 172.57 12.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.941 0.401 . . . . 0.0 110.823 -179.566 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.708 HD23 HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -74.43 -177.05 2.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.667 -179.811 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.627 ' ND1' HG22 ' A' ' 56' ' ' VAL . 66.5 t60 -131.3 -73.58 0.53 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.146 0.498 . . . . 0.0 111.059 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 29.1 mmtm -161.46 127.55 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.417 -178.733 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.67 HD13 HG22 ' A' ' 53' ' ' VAL . 2.9 mt -93.55 154.34 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.817 -178.439 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.643 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.2 m-20 -119.36 124.22 46.07 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.317 -178.769 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -89.17 66.5 7.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.96 0.41 . . . . 0.0 110.083 177.981 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.659 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.96 147.86 34.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.702 -178.035 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.77 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 35.1 Cg_endo -91.79 158.43 3.44 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.016 2.477 . . . . 0.0 112.861 -178.32 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.734 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.0 mm -127.59 -82.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.334 -178.177 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.689 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.15 -150.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.988 179.728 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -71.88 -27.46 62.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.737 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.28 7.89 0.3 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.157 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.689 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.0 mt -92.39 105.41 17.6 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.784 0.326 . . . . 0.0 110.885 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.77 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 25.6 t -92.92 128.07 44.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.886 -178.477 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.823 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.07 148.94 21.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.275 179.163 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.906 HD21 HD12 ' A' ' 19' ' ' LEU . 11.1 mp -106.48 114.74 29.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.019 177.706 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.598 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 3.9 m-20 -89.28 92.31 9.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.231 0.539 . . . . 0.0 109.938 -179.422 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.678 HG21 HG12 ' A' ' 26' ' ' ILE . 11.3 t -85.79 106.35 15.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.625 -177.292 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.552 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 37.4 mtt -85.24 164.15 18.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.078 178.499 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.6 m -140.71 136.77 35.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.31 -178.684 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.627 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -94.46 111.95 26.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.715 178.738 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.437 HG12 ' OG1' ' A' ' 34' ' ' THR . 34.3 m -130.21 143.58 40.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.095 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.42 -64.51 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.314 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.75 -8.29 59.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 110.495 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.675 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.59 -146.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.248 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -147.69 -163.12 1.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.783 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 65' ' ' GLU . . . -80.45 12.2 34.51 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.559 178.916 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.11 -9.05 62.83 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.507 179.714 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -74.57 -5.15 41.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.861 0.362 . . . . 0.0 110.29 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 3.7 pt-20 -54.94 -24.09 22.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.405 0.621 . . . . 0.0 110.11 177.671 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.04 -28.21 62.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.969 -179.489 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.546 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.67 -56.4 21.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.271 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -59.37 -35.02 73.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.469 178.447 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -50.91 70.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.415 178.92 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.447 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 5.1 t -64.65 -20.32 66.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.56 178.962 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.616 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -72.69 -28.31 62.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.71 -179.678 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -15.61 58.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.793 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.37 29.2 0.97 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.791 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.943 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -73.5 -161.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.451 -0.374 . . . . 0.0 111.142 -178.933 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.604 ' N ' HG23 ' A' ' 74' ' ' ILE . 2.7 pm0 -51.6 91.45 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 121.063 0.459 . . . . 0.0 110.749 179.358 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.17 -24.05 62.75 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.833 -0.621 . . . . 0.0 113.04 -178.334 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.58 -36.64 10.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.234 0.54 . . . . 0.0 110.381 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.575 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 4.2 t -95.88 93.01 6.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.592 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -75.94 131.0 39.34 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.438 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.06 HG21 HG22 ' A' ' 8' ' ' ILE . 3.5 mp -101.19 148.1 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.559 -174.965 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.773 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -85.87 71.4 10.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 173.256 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.7 HG23 ' HB ' ' A' ' 80' ' ' ILE . 58.6 t -80.71 52.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.076 -174.302 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 m -133.32 5.73 3.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.902 179.426 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.683 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.1 m-20 . . . . . 0 N--CA 1.456 -0.158 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.379 -177.915 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.713 ' HB ' HG22 ' A' ' 57' ' ' VAL . 2.9 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.561 0.22 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 84.7 t -104.8 107.58 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.268 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.514 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -97.12 141.04 30.74 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 177.753 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.805 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 16.2 m -122.49 133.03 54.6 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.749 0.785 . . . . 0.0 112.251 -178.229 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.05 HG22 HG21 ' A' ' 80' ' ' ILE . 5.6 mm -123.99 109.17 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.677 -178.173 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.801 ' C ' HG23 ' A' ' 80' ' ' ILE . 2.1 mmmt -99.57 95.61 7.1 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -177.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.642 HG11 ' HE ' ' A' ' 29' ' ' ARG . 1.4 m -93.32 136.73 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.533 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.699 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.4 OUTLIER -147.78 120.57 4.7 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 121.17 0.509 . . . . 0.0 111.72 178.751 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 20.6 Cg_exo -69.78 121.75 8.43 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.366 2.711 . . . . 0.0 112.143 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -30.58 64.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.207 -179.674 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.9 m -77.97 148.94 76.18 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.999 -179.732 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 38.1 Cg_endo -65.57 -6.79 14.5 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.416 2.077 . . . . 0.0 111.881 179.423 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -91.59 35.42 0.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.518 179.111 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.623 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.46 87.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.817 0.818 . . . . 0.0 110.184 -179.797 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.653 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -67.69 105.28 1.86 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.926 178.824 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.662 HD12 ' HE2' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -60.65 -54.25 47.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.748 -177.96 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.658 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -70.85 -34.23 71.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.133 -177.43 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -68.74 -35.6 77.31 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.305 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.562 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -64.96 -35.53 81.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.138 176.524 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.662 ' HE2' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -55.44 -49.08 73.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.252 178.201 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -39.34 85.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.092 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.695 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 2.9 mt-10 -66.51 -32.34 73.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.383 0.611 . . . . 0.0 110.166 179.099 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.743 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -63.55 -38.47 82.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.925 178.565 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -43.27 92.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.108 -179.72 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.695 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -78.06 -21.37 50.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.755 -178.575 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.753 HH22 ' HB ' ' A' ' 8' ' ' ILE . 18.9 ptt85 -89.06 -8.65 53.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.411 -178.488 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 26' ' ' ILE . 19.8 mm -60.11 137.55 91.21 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.966 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.635 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.1 Cg_endo -48.75 117.65 2.87 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.897 2.398 . . . . 0.0 112.206 178.929 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.47 1.09 0.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.391 -179.395 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.51 -63.95 1.73 Allowed Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.752 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.411 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -110.24 -134.05 0.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.628 0.251 . . . . 0.0 111.086 -179.531 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -138.62 171.06 14.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.931 0.396 . . . . 0.0 110.669 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -177.57 3.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.018 -179.447 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.517 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 86.3 t60 -131.01 -73.31 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.322 0.582 . . . . 0.0 111.081 -179.58 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.509 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -163.46 126.64 2.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.046 -178.433 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.723 HG23 HG22 ' A' ' 53' ' ' VAL . 2.9 mt -94.13 157.04 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.161 -177.342 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.631 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 77.4 m-20 -122.62 124.17 42.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.384 -179.206 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.94 66.3 6.86 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.364 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.651 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -98.23 147.12 32.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.538 -177.539 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.766 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.6 Cg_endo -89.63 159.5 5.27 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.12 2.547 . . . . 0.0 113.211 -177.718 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.746 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.9 mm -129.03 -82.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.169 -178.121 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.577 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.07 -153.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.844 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -72.04 -24.65 61.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.51 3.74 0.25 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.285 179.891 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.577 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.3 mt -92.32 106.95 18.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.021 0.41 . . . . 0.0 111.045 -179.798 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.766 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 52.8 t -94.28 130.37 43.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.95 -178.314 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.746 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.46 162.01 13.83 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.567 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.4 OUTLIER -116.05 113.77 23.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.283 179.501 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.6 m120 -90.04 90.32 8.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.286 0.565 . . . . 0.0 110.011 178.958 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.723 HG22 HG23 ' A' ' 39' ' ' ILE . 5.5 t -88.63 102.17 12.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.809 -177.716 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.495 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 14.3 mtt -86.36 163.57 17.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.066 178.183 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 4.2 m -137.01 127.44 39.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.923 0.392 . . . . 0.0 111.216 -178.88 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.517 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 1.1 p -98.15 111.86 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 179.603 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.713 HG22 ' HB ' ' A' ' 4' ' ' VAL . 1.2 m -127.4 169.9 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.965 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.89 -69.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.467 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -80.92 0.24 36.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.969 0.414 . . . . 0.0 110.6 179.585 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.411 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.5 -154.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.272 179.722 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.65 -161.29 1.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.865 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.87 13.56 30.2 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.477 178.613 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.52 -9.1 61.02 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.541 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -74.23 -4.0 33.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.04 0.448 . . . . 0.0 110.157 179.12 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -55.39 -23.37 24.24 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.072 177.676 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.86 -27.04 49.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.919 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.635 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.5 -56.32 21.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.401 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -58.42 -34.58 70.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.541 178.595 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.25 -51.76 66.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.397 178.471 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.423 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -63.42 -17.85 63.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.318 179.013 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.586 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.39 -30.56 63.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.652 179.71 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -11.47 35.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.93 179.452 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.38 26.13 0.97 Allowed Glycine 0 N--CA 1.453 -0.198 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.724 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -73.28 -164.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.459 -0.371 . . . . 0.0 111.012 -179.27 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.639 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.8 OUTLIER -51.73 96.81 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.775 0.322 . . . . 0.0 111.106 179.586 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.33 -23.07 61.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.079 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.6 p -89.42 -40.0 12.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.036 0.446 . . . . 0.0 110.648 179.323 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.639 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 8.5 t -95.51 92.19 6.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.519 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -76.82 132.53 39.25 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.311 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.05 HG21 HG22 ' A' ' 8' ' ' ILE . 3.6 mp -101.15 149.68 6.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.447 -175.333 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.432 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 6.8 tt0 -85.78 69.56 10.6 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.331 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.694 HG23 ' HB ' ' A' ' 80' ' ' ILE . 54.5 t -80.87 55.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.805 -175.096 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -132.51 -1.37 3.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.61 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.805 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 11.4 t0 . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.738 -178.771 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.847 HG12 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 22.3 t -109.17 119.12 58.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.705 0.288 . . . . 0.0 111.484 -178.998 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.529 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.02 145.36 25.0 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.463 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.799 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 10.0 m -122.73 133.72 54.48 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.608 0.718 . . . . 0.0 112.427 -177.566 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.987 HG22 HG21 ' A' ' 80' ' ' ILE . 4.5 mm -123.01 104.68 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.386 -179.475 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.77 ' HB2' ' HG3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -95.94 98.18 10.2 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -177.217 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.79 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.5 m -96.18 138.4 21.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.82 -177.875 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.793 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 2.1 ptm -147.25 121.22 5.01 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-O 121.182 0.515 . . . . 0.0 111.878 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 22.8 Cg_exo -68.02 126.93 15.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.362 2.708 . . . . 0.0 112.173 179.116 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -32.2 68.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.454 -179.882 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.7 m -77.42 146.88 74.68 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.701 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.53 -6.93 13.02 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.402 2.068 . . . . 0.0 111.801 179.207 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -92.3 38.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.073 178.556 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.724 HG11 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -68.03 85.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 122.013 0.911 . . . . 0.0 110.712 -178.52 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.579 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 17.1 m-20 -73.07 96.63 2.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.056 177.959 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -63.77 -41.36 97.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.637 -178.362 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.899 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 5.5 tp10 -69.8 -36.23 75.5 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.872 0.368 . . . . 0.0 110.371 -179.058 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -69.81 -37.43 76.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.452 0.644 . . . . 0.0 109.309 176.272 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -68.18 -25.81 65.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.064 177.164 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.899 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -56.31 -44.14 79.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.193 179.627 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -44.81 83.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.451 178.908 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.594 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 40.8 mt-10 -65.09 -28.18 69.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.466 0.65 . . . . 0.0 110.44 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.812 HG12 HG21 ' A' ' 53' ' ' VAL . 1.7 mt -60.21 -49.62 83.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.403 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.525 ' OE1' HD22 ' A' ' 36' ' ' LEU . 6.9 mm-40 -64.92 -32.95 74.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.476 -178.233 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 11.5 pt-20 -76.74 -21.27 55.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 110.751 179.617 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.95 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.55 -12.06 38.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.013 179.914 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.582 HG12 ' O ' ' A' ' 26' ' ' ILE . 27.2 mm -58.94 138.42 87.42 Favored Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.256 179.684 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.62 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 11.0 Cg_endo -52.82 118.23 4.54 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.898 2.399 . . . . 0.0 112.433 178.764 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -59.67 1.21 0.1 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.321 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.04 -43.73 7.43 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.181 -178.441 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.574 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.32 -139.75 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.621 0.248 . . . . 0.0 111.192 -178.868 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -133.55 168.58 18.4 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.947 0.403 . . . . 0.0 111.255 -178.988 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.525 HD22 ' OE1' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -75.91 -178.79 4.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.274 -179.299 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.693 ' ND1' HG22 ' A' ' 56' ' ' VAL . 59.1 t60 -131.4 -77.47 0.52 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.176 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.452 ' HB2' ' HD2' ' A' ' 37' ' ' HIS . 30.7 mmtm -162.0 133.02 5.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.205 -179.035 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.631 HG12 HG13 ' A' ' 53' ' ' VAL . 2.7 mt -93.97 158.25 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.021 0.439 . . . . 0.0 112.108 -178.009 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.713 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 2.6 m-20 -122.77 120.77 34.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.122 -179.498 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.45 67.77 10.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.866 0.365 . . . . 0.0 110.057 178.698 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.673 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.2 148.81 35.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.671 -177.889 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.769 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 50.4 Cg_endo -94.34 159.12 2.03 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.117 2.545 . . . . 0.0 113.347 -177.553 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.757 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.0 mm -128.9 -81.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.997 -178.707 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -67.73 -149.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.196 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -72.23 -30.14 64.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.875 0.369 . . . . 0.0 110.615 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.7 6.26 0.54 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.621 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.724 ' HA ' HG11 ' A' ' 17' ' ' VAL . 9.6 mp -89.25 101.07 13.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.912 0.387 . . . . 0.0 110.854 -179.271 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.769 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 11.3 t -91.97 127.83 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.129 -177.659 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.793 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.35 144.35 25.97 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.829 177.695 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.713 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -106.07 116.9 32.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.419 178.836 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.586 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.5 m-20 -89.58 93.42 9.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.178 -178.893 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.812 HG21 HG12 ' A' ' 26' ' ' ILE . 5.7 t -85.98 106.19 15.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.527 -178.187 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.468 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 34.9 mtt -84.53 162.92 19.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.136 178.836 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.9 m -140.13 141.24 33.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.087 -178.789 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.693 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.3 t -91.04 101.51 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.491 179.096 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.847 HG23 HG12 ' A' ' 4' ' ' VAL . 29.7 m -129.99 140.9 47.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.068 0.461 . . . . 0.0 111.597 -179.14 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.42 -60.66 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.334 178.895 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -81.73 -7.56 59.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 0.0 110.429 179.099 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.574 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.4 -143.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.163 179.52 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -147.29 -165.27 2.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.803 -179.848 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.61 12.87 32.0 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.653 179.041 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.85 -6.84 57.53 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.44 179.621 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -74.44 -3.89 33.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 110.228 179.248 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -54.63 -24.08 19.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.114 177.713 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.79 -29.24 62.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.103 -179.465 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.61 -55.14 33.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.381 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.1 -34.95 72.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.357 178.297 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.86 -50.36 72.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.336 178.559 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 t -62.94 -18.28 62.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.349 178.608 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.726 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.37 -29.37 61.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.487 179.505 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -11.62 36.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.598 178.868 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.1 27.57 1.0 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.429 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.95 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -72.78 -166.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.366 -0.417 . . . . 0.0 111.099 -179.008 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.674 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 2.3 mm-40 -50.96 97.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.941 0.401 . . . . 0.0 110.81 179.222 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.71 -27.06 61.02 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.369 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.564 HG12 ' OE1' ' A' ' 75' ' ' GLU . 1.2 p -89.22 -38.21 10.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.977 0.418 . . . . 0.0 110.741 179.579 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.674 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 30.7 t -96.14 93.05 6.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.814 -179.712 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -76.52 130.88 38.55 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.161 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.987 HG21 HG22 ' A' ' 8' ' ' ILE . 5.2 mt -100.23 140.9 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.666 -176.094 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.77 ' HG3' ' HB2' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -84.86 74.04 10.55 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 174.648 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.728 HG23 ' HB ' ' A' ' 80' ' ' ILE . 86.5 t -81.55 51.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.187 -173.341 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.8 6.99 4.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.505 179.264 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.799 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 38.3 t0 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.807 0.337 . . . . 0.0 111.082 -178.732 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.525 ' HB ' HG22 ' A' ' 57' ' ' VAL . 2.6 t . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.566 0.222 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 14.2 t -106.15 108.76 25.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.053 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.659 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.01 165.12 12.6 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.013 177.898 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.739 HG23 ' HG3' ' A' ' 54' ' ' MET . 7.8 m -142.14 129.04 20.65 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.762 0.792 . . . . 0.0 112.276 179.814 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 1.035 HG22 HG21 ' A' ' 80' ' ' ILE . 3.1 mm -120.72 105.61 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.249 -179.445 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.797 ' C ' HG23 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -94.12 93.64 7.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -177.218 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.49 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.7 m -93.63 138.85 19.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.839 -177.258 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.8 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 2.6 ptm -146.19 123.27 5.97 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.27 179.374 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.566 ' CD ' HG13 ' A' ' 17' ' ' VAL . 18.6 Cg_exo -67.68 125.96 14.03 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.064 2.509 . . . . 0.0 112.217 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.35 -32.48 66.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.276 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.5 m -77.71 150.13 78.5 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.03 -179.55 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -67.97 -4.62 12.81 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.486 2.124 . . . . 0.0 111.774 178.933 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -91.6 45.91 1.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.747 178.32 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.566 HG13 ' CD ' ' A' ' 12' ' ' PRO . 69.8 t -63.96 78.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.505 -178.189 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.567 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -71.32 93.87 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.263 177.957 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.557 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -64.35 -41.53 96.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.622 0.249 . . . . 0.0 111.134 -179.333 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.557 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 4.6 tp10 -68.05 -38.17 82.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.22 -178.404 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.572 ' O ' ' HE2' ' A' ' 24' ' ' LYS . . . -70.92 -38.51 72.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.285 0.564 . . . . 0.0 110.112 177.541 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.972 HD23 ' HG2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -65.86 -28.07 68.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.213 178.411 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -58.89 -46.57 87.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.922 -179.718 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.572 ' HE2' ' O ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -63.92 -41.02 97.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.683 -179.598 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.972 ' HG2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.07 -38.35 90.5 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.731 0.776 . . . . 0.0 110.012 179.756 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.854 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 4.2 mt -58.84 -40.88 81.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.838 -176.809 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -62.6 -37.02 84.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.461 . . . . 0.0 110.178 178.931 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 3.2 mm-40 -76.05 -23.72 55.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.628 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.854 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.73 -11.92 43.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.663 -178.198 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 26' ' ' ILE . 24.8 mm -58.11 136.6 84.35 Favored Pre-proline 0 C--N 1.333 -0.138 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.503 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 1.3 Cg_endo -45.13 122.59 4.53 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.88 2.387 . . . . 0.0 112.134 179.186 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.448 ' H ' ' HB3' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -56.96 -6.0 0.3 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.131 -178.936 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.55 -58.02 2.48 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.575 -179.589 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.44 -146.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.666 0.27 . . . . 0.0 111.001 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -136.78 175.82 9.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 110.881 -179.714 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.29 -175.47 2.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.423 -178.798 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.541 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 85.0 t60 -130.94 -72.12 0.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.755 -179.544 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.518 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -163.83 128.54 2.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.986 -178.92 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.705 HD13 HG22 ' A' ' 53' ' ' VAL . 2.9 mt -93.56 155.13 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.17 -177.104 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.699 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.2 t0 -119.43 121.6 39.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.046 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -86.28 67.77 10.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.931 0.396 . . . . 0.0 110.174 178.835 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.694 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -98.34 148.89 35.14 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.621 -177.887 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.76 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 31.6 Cg_endo -93.47 157.86 2.46 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.052 2.501 . . . . 0.0 113.443 -177.269 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.745 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.5 mm -128.42 -82.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.024 -178.973 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -67.64 -149.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -71.47 -31.85 67.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.609 179.646 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.34 7.39 0.62 Allowed Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.413 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 8.8 mp -90.17 100.08 12.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.985 0.421 . . . . 0.0 110.799 -179.626 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.76 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 17.7 t -91.43 127.88 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.928 -177.765 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.8 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.16 143.85 26.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.135 178.415 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.699 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.6 OUTLIER -104.92 117.69 34.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.201 178.507 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.578 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.7 m120 -89.41 93.0 9.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.141 -178.894 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.705 HG22 HD13 ' A' ' 39' ' ' ILE . 10.9 t -85.9 102.63 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.67 -177.721 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.739 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.1 OUTLIER -84.76 166.1 17.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.18 178.517 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.659 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.9 m -138.89 126.53 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.055 0.455 . . . . 0.0 111.231 -179.059 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.541 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -97.72 107.49 20.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.836 179.363 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.525 HG22 ' HB ' ' A' ' 4' ' ' VAL . 1.6 m -123.66 171.79 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.568 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.04 -73.45 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.839 179.541 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -80.35 2.49 24.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.9 0.381 . . . . 0.0 110.795 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.14 -151.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.97 179.339 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.56 -161.9 1.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.807 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.58 12.32 34.76 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.488 178.839 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.07 -7.64 60.0 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.362 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 p -74.3 -5.35 41.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 110.239 179.313 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -23.91 22.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.227 177.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.448 ' HB3' ' H ' ' A' ' 32' ' ' GLU . . . -56.97 -26.37 59.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.136 -179.401 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.91 -56.63 18.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.267 179.49 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.92 -34.63 71.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.573 178.536 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -51.55 68.43 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.444 178.888 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.465 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 7.6 p -64.17 -20.42 65.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.649 179.005 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.6 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.34 -27.11 62.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.623 -179.727 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.1 -16.23 61.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.805 179.435 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.53 29.34 0.95 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.728 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.821 HD11 ' HD2' ' A' ' 29' ' ' ARG . 1.7 tt -73.38 -162.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.524 -0.338 . . . . 0.0 111.213 -178.704 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.629 ' HG3' ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -51.39 90.21 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.084 0.468 . . . . 0.0 110.745 179.257 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.32 -24.71 67.72 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.927 -178.282 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -85.69 -35.92 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.408 0.623 . . . . 0.0 109.985 179.1 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.629 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 1.4 m -96.0 90.52 5.6 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.405 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -74.8 129.85 38.42 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.692 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 1.035 HG21 HG22 ' A' ' 8' ' ' ILE . 1.8 mp -101.12 148.81 6.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.47 -175.319 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.586 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 2.8 tt0 -85.8 70.14 10.65 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 173.129 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.723 HG23 ' HB ' ' A' ' 80' ' ' ILE . 57.7 t -80.0 53.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.999 -174.411 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.92 2.29 3.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.454 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.674 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.453 -0.294 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.313 -178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.878 0.37 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.5 -8.64 0.03 OUTLIER Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.197 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.606 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 11.1 p-10 -90.03 145.69 24.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.795 0.331 . . . . 0.0 111.423 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -97.16 112.58 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.591 177.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 55.2 t -111.95 122.91 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.752 0.311 . . . . 0.0 111.745 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.516 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -97.41 167.49 10.97 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.631 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 5.3 m -141.94 127.55 19.07 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.596 0.712 . . . . 0.0 112.164 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.991 HG22 HG21 ' A' ' 80' ' ' ILE . 4.3 mm -122.08 108.45 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.578 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.8 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -98.31 96.71 8.24 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.354 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.461 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.4 m -91.39 135.5 26.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.841 0.353 . . . . 0.0 111.519 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.841 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.3 ptm -145.05 125.36 7.27 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 121.109 0.48 . . . . 0.0 111.648 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.628 ' CD ' HG13 ' A' ' 17' ' ' VAL . 14.6 Cg_exo -71.45 128.4 14.45 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.487 2.791 . . . . 0.0 112.404 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -35.51 71.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.347 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.74 154.87 78.41 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.346 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.605 ' HA ' HD22 ' A' ' 48' ' ' LEU . 56.1 Cg_endo -69.95 -3.24 11.74 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.554 2.17 . . . . 0.0 111.961 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -90.93 44.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.738 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.628 HG13 ' CD ' ' A' ' 12' ' ' PRO . 98.1 t -63.8 78.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.321 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.574 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -69.91 95.13 0.9 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.12 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.683 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -62.98 -43.75 97.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.394 -178.265 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.771 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 10.1 tt0 -70.6 -35.63 73.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 0.0 110.762 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.574 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -68.55 -37.23 79.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.507 ' CD2' ' HG3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -65.95 -28.73 69.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.011 177.507 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.771 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -55.93 -46.88 78.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.596 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -65.1 -42.86 93.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.421 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.559 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 2.4 mt-10 -66.4 -31.54 72.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.285 0.564 . . . . 0.0 110.598 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.805 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 9.5 mt -61.88 -42.94 96.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.709 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -62.29 -39.32 92.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.939 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 9.2 pt-20 -77.41 -20.97 53.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.59 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.811 ' HD2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.14 -11.94 39.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.194 -178.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.683 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.1 mm -60.26 137.87 91.71 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.326 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.658 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.9 Cg_endo -52.34 114.85 1.84 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.686 2.257 . . . . 0.0 112.113 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.52 3.01 0.05 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.362 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.51 -43.94 7.63 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.88 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.619 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.61 -135.47 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.718 0.259 . . . . 0.0 111.136 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -135.01 169.47 17.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.635 HD23 HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -76.15 -176.13 3.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.964 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.502 ' ND1' HG22 ' A' ' 56' ' ' VAL . 83.8 t60 -130.79 -77.51 0.53 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.251 0.548 . . . . 0.0 111.102 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.627 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -165.07 129.94 2.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.829 -178.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.648 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -92.66 158.23 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.724 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 2.0 t0 -123.7 131.47 53.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.632 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -91.1 71.36 6.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.354 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.6 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -103.68 146.78 33.14 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.64 -178.253 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.788 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.0 Cg_endo -88.91 157.45 5.95 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.123 2.549 . . . . 0.0 112.974 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.753 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.7 mm -127.15 -83.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.458 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.768 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.34 -150.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -71.89 -28.45 63.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.846 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.62 5.93 0.45 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.646 -0.787 . . . . 0.0 113.099 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.768 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.4 mt -93.03 106.29 18.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 111.108 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.788 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 60.3 t -93.7 127.55 45.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.72 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.841 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -94.6 166.63 11.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.391 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.724 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.1 mp -120.38 118.28 29.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.099 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.549 ' ND2' ' HB3' ' A' ' 40' ' ' ASP . 1.6 m-20 -89.61 92.09 8.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.333 0.587 . . . . 0.0 110.32 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.648 HG22 HD13 ' A' ' 39' ' ' ILE . 4.6 t -86.83 101.85 11.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.543 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.618 ' HG3' HG23 ' A' ' 7' ' ' THR . 2.6 mtt -84.6 165.18 18.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.34 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.516 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.0 m -139.43 135.14 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.394 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.502 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.48 116.91 39.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.022 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 4' ' ' VAL . 10.6 m -130.21 148.26 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.084 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -167.22 -69.56 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.297 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -81.44 -5.68 58.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.989 0.423 . . . . 0.0 110.579 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.619 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.67 -149.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.318 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.57 -165.53 2.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.793 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.22 15.06 24.87 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.639 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.49 -3.94 49.95 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.574 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p -74.28 -3.74 31.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.91 0.386 . . . . 0.0 110.142 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.15 -23.93 23.82 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.353 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.53 -25.77 52.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.164 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.658 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.44 -55.9 26.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.351 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -58.64 -34.6 71.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.44 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.29 -51.81 67.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.347 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.449 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.7 p -63.8 -20.13 65.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.424 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.607 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.87 -28.24 62.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.551 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.54 -13.26 51.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.957 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.31 26.1 0.98 Allowed Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.742 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.811 HD11 ' HD2' ' A' ' 29' ' ' ARG . 2.6 tt -73.38 -163.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.449 -0.376 . . . . 0.0 111.127 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.589 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -51.29 94.2 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.843 0.354 . . . . 0.0 111.009 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.13 -26.91 68.16 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.233 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 p -88.6 -38.3 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.188 0.518 . . . . 0.0 110.232 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -96.69 89.94 5.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.324 179.399 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -77.2 136.87 38.59 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.991 HG21 HG22 ' A' ' 8' ' ' ILE . 2.3 mp -101.91 147.91 8.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.397 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.646 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 3.8 tt0 -86.05 70.73 10.62 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 173.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.646 HG23 ' HB ' ' A' ' 80' ' ' ILE . 60.6 t -80.54 51.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.009 -174.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.78 3.84 3.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.328 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.631 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 4.1 m-20 -85.48 143.28 28.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 111.247 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 p -148.26 158.12 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.408 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 86' ' ' ARG . 10.4 mtt-85 -148.84 84.92 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.471 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.37 89.04 4.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.175 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 11.1 mp -81.53 82.3 7.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.555 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 5.9 mtp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.088 -179.599 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 121.048 0.452 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.97 6.96 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.673 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.549 ' HB2' HD12 ' A' ' 88' ' ' LEU . 6.7 m-20 -91.6 162.74 14.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 111.421 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.587 HG13 ' HG3' ' A' ' 87' ' ' ARG . 1.3 t -107.28 128.88 61.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.222 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.576 HG23 HD11 ' A' ' 88' ' ' LEU . 86.9 t -119.5 116.67 51.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.067 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.679 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -92.35 166.93 12.33 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.808 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 9.0 m -142.2 130.7 22.5 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.535 0.684 . . . . 0.0 112.129 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.944 HG22 HG21 ' A' ' 80' ' ' ILE . 9.8 mm -121.75 106.64 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.512 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.706 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.4 OUTLIER -96.83 96.13 8.34 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.841 0.353 . . . . 0.0 111.866 -177.798 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.823 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.5 m -93.65 137.3 23.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.939 -177.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.613 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -146.05 123.82 6.21 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 121.249 0.547 . . . . 0.0 111.412 178.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.629 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 11.5 Cg_exo -73.2 120.92 6.84 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.591 2.861 . . . . 0.0 111.979 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -56.44 -31.57 64.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 p -78.28 154.85 79.58 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.202 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.577 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 53.8 Cg_endo -69.31 -2.55 10.05 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.301 2.001 . . . . 0.0 111.695 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.43 41.15 1.04 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.237 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.629 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 91.1 t -65.93 77.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.493 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.63 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -69.49 95.04 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.495 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.671 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -63.82 -44.24 93.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.175 -178.469 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.671 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 5.1 tp10 -68.47 -40.05 81.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.613 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.767 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -70.85 -35.81 72.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.128 0.49 . . . . 0.0 110.504 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.586 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -66.13 -31.71 72.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.803 178.257 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -56.27 -45.21 80.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.68 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.767 ' HE2' ' HA ' ' A' ' 21' ' ' ALA . 1.9 mtmm -67.09 -43.57 82.22 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.518 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 21' ' ' ALA . 26.1 mt-10 -65.95 -27.14 67.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.634 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.778 HG12 HG21 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -61.81 -46.58 96.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.412 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.543 HE22 HD11 ' A' ' 39' ' ' ILE . 25.3 mm-40 -63.06 -31.89 73.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 0.0 110.969 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 5.6 mm-40 -73.25 -22.42 60.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.137 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.914 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.15 -18.6 25.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.381 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.457 HG23 ' HD2' ' A' ' 31' ' ' PRO . 27.6 mm -57.18 137.46 80.62 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.205 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.457 ' HD2' HG23 ' A' ' 30' ' ' ILE . 8.7 Cg_endo -48.9 118.75 3.69 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.902 2.401 . . . . 0.0 112.191 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -4.61 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.137 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.66 -35.01 17.64 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.152 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.596 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.61 -148.66 0.37 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 111.215 -179.324 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -136.71 171.33 14.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.93 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.686 ' H ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -75.35 -176.17 3.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.427 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.716 ' ND1' HG22 ' A' ' 56' ' ' VAL . 71.7 t60 -130.84 -74.85 0.53 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.796 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 mmtm -161.68 129.38 4.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.051 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.674 HG12 HG13 ' A' ' 53' ' ' VAL . 2.7 mt -92.33 160.75 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.985 0.421 . . . . 0.0 111.803 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -128.42 123.2 33.16 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.511 -178.699 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -85.06 72.12 10.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.783 0.325 . . . . 0.0 110.502 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.509 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -99.28 134.5 21.24 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.83 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.792 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 73.3 Cg_endo -88.1 156.94 7.05 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.553 2.168 . . . . 0.0 112.757 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.0 mm -124.64 -82.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.323 -177.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.671 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.52 -152.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.86 -28.6 63.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.595 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.77 5.44 0.5 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.979 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.671 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.7 mt -91.73 101.84 14.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.911 0.386 . . . . 0.0 110.76 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.792 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 89.2 t -93.75 128.45 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.853 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.716 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.64 153.33 17.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.923 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.626 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.1 mp -113.34 119.86 39.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.507 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.554 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.6 m120 -90.44 91.26 8.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.187 0.518 . . . . 0.0 110.207 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.778 HG21 HG12 ' A' ' 26' ' ' ILE . 6.0 t -87.45 106.29 16.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.547 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.566 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.64 165.5 17.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.283 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.679 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.2 m -139.98 137.97 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 111.446 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.716 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.5 OUTLIER -94.68 110.77 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.853 179.052 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.562 HG12 HG21 ' A' ' 34' ' ' THR . 13.1 m -130.13 148.01 33.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.949 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.73 -68.12 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.383 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -81.73 -3.07 52.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.934 0.397 . . . . 0.0 110.579 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.596 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.22 -146.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.119 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -147.34 -163.19 1.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.776 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.79 12.49 35.14 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.604 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.67 -6.16 58.34 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.617 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 p -74.94 -7.26 53.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.609 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -54.89 -24.39 23.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.274 0.559 . . . . 0.0 110.226 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.32 -27.75 62.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.229 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.498 ' HB1' HH22 ' A' ' 29' ' ' ARG . . . -60.77 -55.68 30.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.384 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.69 -35.09 73.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.455 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -49.92 75.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.28 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 p -64.17 -18.97 64.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.454 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.725 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -74.04 -28.96 61.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.605 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -14.42 54.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.46 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.28 32.96 0.93 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.448 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.914 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -72.68 -163.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.215 -0.492 . . . . 0.0 111.075 -178.577 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.5 OUTLIER -50.91 98.65 0.02 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.913 0.387 . . . . 0.0 110.968 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.35 -33.88 66.79 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.797 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.1 t -87.12 -39.63 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.984 0.421 . . . . 0.0 110.524 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 40.5 t -96.23 92.3 6.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.796 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -77.63 134.2 38.24 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.944 HG21 HG22 ' A' ' 8' ' ' ILE . 15.6 mt -101.41 147.05 8.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.584 -175.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -85.64 71.08 10.77 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 173.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.707 HG23 ' HB ' ' A' ' 80' ' ' ILE . 58.2 t -81.02 52.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.241 -174.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.94 4.34 3.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.458 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.808 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 39.5 t0 -85.68 136.72 33.25 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.899 0.38 . . . . 0.0 111.405 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 p -148.42 152.97 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.964 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.52 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -149.53 97.83 2.69 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.134 0.493 . . . . 0.0 110.552 -178.488 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.587 ' HG3' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -82.64 109.73 17.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.424 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.576 HD11 HG23 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -82.21 90.26 6.59 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.551 178.159 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 30.0 mmt . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.935 179.696 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.814 0.34 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.406 ' H ' ' H ' ' A' ' 3' ' ' ASP . . . 173.39 0.23 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.161 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.406 ' H ' ' H ' ' A' ' 2' ' ' GLY . 11.0 m-20 -89.04 154.93 19.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 111.423 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.764 HG12 HG23 ' A' ' 57' ' ' VAL . 1.1 t -106.39 121.7 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.045 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 42.1 t -110.83 112.86 42.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.716 0.293 . . . . 0.0 111.242 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.612 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.67 142.5 27.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.227 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.685 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 7.8 m -122.53 129.25 51.76 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.621 0.724 . . . . 0.0 112.032 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.054 HG22 HG21 ' A' ' 80' ' ' ILE . 1.4 mm -120.44 108.3 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.713 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.814 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -95.29 93.72 7.44 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.748 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.471 HG12 HG12 ' A' ' 80' ' ' ILE . 1.4 m -92.49 136.02 25.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.791 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.828 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.7 ptm -144.4 124.73 7.51 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 121.058 0.456 . . . . 0.0 111.349 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.61 ' CD ' HG13 ' A' ' 17' ' ' VAL . 12.3 Cg_exo -70.9 125.1 11.21 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.246 2.631 . . . . 0.0 112.075 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.07 -33.85 69.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.639 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.8 m -78.01 153.4 80.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.582 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 42.4 Cg_endo -67.59 -3.47 10.28 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.402 2.068 . . . . 0.0 111.955 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.79 43.52 1.15 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.755 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.61 HG13 ' CD ' ' A' ' 12' ' ' PRO . 87.2 t -65.52 75.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.385 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -71.48 88.11 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.948 177.454 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.746 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -63.81 -39.18 93.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.065 -178.83 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.544 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -68.16 -39.13 82.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.971 -178.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -72.05 -36.06 69.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.134 0.493 . . . . 0.0 110.282 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -67.37 -28.22 67.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.979 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -57.73 -43.75 85.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.325 179.204 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -66.53 -43.34 85.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.528 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -66.31 -28.07 68.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.169 0.509 . . . . 0.0 110.531 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.794 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.6 mt -61.86 -44.7 99.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.008 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.88 -36.88 77.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.939 0.399 . . . . 0.0 110.417 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -75.35 -24.09 57.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.747 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.794 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.95 -14.17 37.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.713 0.292 . . . . 0.0 111.291 -178.732 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.2 mm -59.79 139.0 90.21 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.26 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.657 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.4 Cg_endo -51.54 111.69 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.769 2.312 . . . . 0.0 112.076 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.43 2.88 0.05 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.494 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.71 -41.08 9.11 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.821 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.6 ' CB ' HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.19 -133.56 0.21 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.435 0.16 . . . . 0.0 110.794 -179.787 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -140.0 162.92 34.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.826 0.346 . . . . 0.0 110.978 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.6 pt? -76.47 -173.23 2.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.583 ' ND1' HG22 ' A' ' 56' ' ' VAL . 76.7 t60 -130.83 -77.62 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 111.334 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 3.0 mmtp -160.07 132.08 6.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.333 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.656 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -93.57 160.01 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.608 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.653 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -128.17 125.12 38.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.647 -178.648 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -85.74 74.16 10.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.835 0.35 . . . . 0.0 110.438 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.534 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -100.45 134.88 20.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.785 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.8 Cg_endo -84.97 156.01 11.41 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.589 2.193 . . . . 0.0 112.556 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.1 mm -124.76 -82.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.163 -178.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.633 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.27 -153.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.994 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -71.97 -26.59 62.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.663 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.73 3.07 0.41 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.122 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.633 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.1 mt -91.65 103.22 15.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.785 0.326 . . . . 0.0 110.786 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.785 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 93.6 t -94.1 129.06 44.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.746 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.828 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.22 162.71 13.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.906 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.746 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.0 mp -120.4 120.23 35.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.398 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.519 ' ND2' ' HB3' ' A' ' 40' ' ' ASP . 1.8 m-20 -89.66 91.5 8.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.216 0.532 . . . . 0.0 109.792 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.702 HG21 HG12 ' A' ' 26' ' ' ILE . 14.1 t -86.32 105.84 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.434 -177.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.56 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 13.0 mtt -84.94 160.58 20.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.14 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.612 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.0 m -139.09 137.87 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.212 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.583 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.7 t -93.0 98.16 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.883 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.764 HG23 HG12 ' A' ' 4' ' ' VAL . 34.9 m -130.4 138.21 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.124 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.33 -59.66 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.49 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.14 -8.19 59.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.994 0.426 . . . . 0.0 110.503 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.431 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.56 -139.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.122 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.11 -162.38 1.53 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.783 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.2 11.49 36.51 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.702 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.43 -12.21 69.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.474 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 p -74.31 -4.25 35.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.03 0.443 . . . . 0.0 110.278 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -24.32 22.18 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.072 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.63 -27.92 52.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.02 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.657 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.83 -57.89 10.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.372 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -58.45 -34.37 70.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.522 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.77 -52.33 64.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.058 0.456 . . . . 0.0 110.371 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.429 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -64.05 -20.75 66.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.475 178.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.592 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.99 -28.05 62.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.675 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.59 -16.6 61.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.767 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.53 31.0 0.94 Allowed Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.834 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.778 HD11 ' HB2' ' A' ' 29' ' ' ARG . 2.9 tt -73.21 -161.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.511 -0.344 . . . . 0.0 111.11 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.622 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -51.82 90.69 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.121 0.486 . . . . 0.0 110.714 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.53 -24.93 62.43 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.107 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 p -86.95 -34.67 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.352 0.596 . . . . 0.0 110.307 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.62 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 29.0 t -96.71 92.3 6.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.697 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -76.23 132.2 39.76 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.054 HG21 HG22 ' A' ' 8' ' ' ILE . 2.1 mt -101.03 148.16 7.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.493 -175.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.588 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 2.4 tp10 -85.86 71.11 10.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 172.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.705 HG23 ' HB ' ' A' ' 80' ' ' ILE . 68.4 t -79.95 55.89 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.947 -174.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -133.05 1.87 3.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.81 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.685 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.0 m-20 -85.06 138.82 32.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.256 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.2 p -148.96 155.92 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.192 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.5 mtt85 -148.93 85.37 1.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.018 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -79.28 88.7 4.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.215 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.403 ' HG ' ' H ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -82.21 91.89 6.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.585 179.112 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 6.4 mtm . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.976 179.885 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.961 0.41 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.59 -14.08 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.849 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -92.35 147.8 22.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 111.556 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.521 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.5 t -100.07 113.17 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.869 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.711 ' HB ' ' HB2' ' A' ' 86' ' ' ARG . 53.5 t -105.1 112.02 36.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.51 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.613 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.84 142.6 27.91 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.3 m -122.75 129.4 51.71 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.72 0.771 . . . . 0.0 112.563 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.978 HG22 HG21 ' A' ' 80' ' ' ILE . 3.2 mm -121.12 108.71 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.731 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.781 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.96 96.22 8.02 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -177.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.464 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.3 m -93.21 136.67 24.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.581 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -146.26 124.97 6.43 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.296 178.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.2 Cg_exo -71.38 120.35 6.9 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.137 2.558 . . . . 0.0 111.694 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.74 -31.34 64.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.285 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.5 p -77.88 154.21 80.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.985 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.554 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 54.5 Cg_endo -69.01 -1.14 7.31 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.223 1.949 . . . . 0.0 111.493 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.18 41.98 1.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.116 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.634 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 84.8 t -65.8 79.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.368 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 67.3 m-20 -68.11 101.12 1.09 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.16 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.62 HD12 ' HE2' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -61.41 -53.2 59.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.773 -178.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.669 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 13.6 pt-20 -71.06 -34.47 71.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.214 -176.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -68.17 -36.45 79.64 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.59 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -65.17 -34.0 77.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.389 176.645 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.669 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -57.14 -47.38 81.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.407 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 21' ' ' ALA . 2.5 mtmt -64.47 -42.91 95.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.61 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.622 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 2.1 mt-10 -66.55 -32.91 74.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.204 0.526 . . . . 0.0 110.811 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.659 ' O ' HG12 ' A' ' 30' ' ' ILE . 3.0 mt -61.78 -43.04 96.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.008 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -62.53 -40.41 96.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.683 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 9.0 pt-20 -78.49 -19.22 53.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.832 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.84 HH22 ' HB ' ' A' ' 8' ' ' ILE . 26.8 ptt85 -89.9 -11.44 41.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.255 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.659 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.9 mm -59.91 138.85 90.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.742 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 8.5 Cg_endo -49.13 117.07 2.57 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.872 2.381 . . . . 0.0 112.256 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -59.71 2.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.433 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.03 -46.18 6.33 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.122 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.643 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -130.07 -134.74 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.624 0.25 . . . . 0.0 110.998 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -137.1 166.41 23.77 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.812 0.339 . . . . 0.0 110.73 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -76.4 -171.91 1.95 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.241 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.458 ' ND1' HG22 ' A' ' 56' ' ' VAL . 85.7 t60 -130.55 -77.69 0.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.376 0.608 . . . . 0.0 111.101 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 2.0 tptp -164.47 129.83 2.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.668 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.622 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -91.78 160.88 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -176.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.616 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -126.4 120.71 30.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.383 -179.271 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -84.32 72.59 10.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.917 0.389 . . . . 0.0 110.465 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.507 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -99.13 135.35 20.83 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.951 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.783 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 62.2 Cg_endo -86.47 157.22 9.33 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.596 2.197 . . . . 0.0 112.515 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.5 mm -126.63 -83.19 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.532 -177.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.668 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.62 -149.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.188 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -70.5 -32.12 69.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.361 . . . . 0.0 110.549 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.69 7.63 0.59 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.658 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.668 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.9 mt -91.25 101.71 14.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.81 0.338 . . . . 0.0 110.793 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 73.9 t -92.53 129.54 42.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.739 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.716 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.03 160.28 14.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.675 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.616 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.1 mp -120.45 119.54 33.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.5 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.436 ' ND2' ' HB3' ' A' ' 40' ' ' ASP . 3.1 m-20 -89.73 90.74 8.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.268 0.556 . . . . 0.0 110.024 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.622 HG22 HD13 ' A' ' 39' ' ' ILE . 10.0 t -87.89 104.74 14.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.478 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.62 ' HG3' HG23 ' A' ' 7' ' ' THR . 2.0 mtt -85.39 163.82 18.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.35 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.613 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.4 m -140.24 136.04 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.984 0.421 . . . . 0.0 111.394 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.458 HG22 ' ND1' ' A' ' 37' ' ' HIS . 1.9 t -95.35 112.08 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.017 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 4' ' ' VAL . 21.4 m -130.17 139.11 52.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.897 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.78 -61.06 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.551 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -81.4 -14.43 57.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.014 0.435 . . . . 0.0 110.718 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.643 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.56 -139.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.092 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.9 -168.82 3.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.525 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.84 13.55 30.05 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.553 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.44 -1.73 38.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.663 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -74.29 -3.92 33.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.857 0.36 . . . . 0.0 110.374 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -55.18 -23.68 23.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.233 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.2 -24.59 42.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.155 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.742 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.39 -56.13 23.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.263 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.3 -34.75 70.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.342 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.53 -52.33 64.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.442 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.436 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.5 p -64.21 -19.11 65.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.629 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.59 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.52 -29.91 62.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.749 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.81 -12.06 43.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.9 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.21 26.02 0.99 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.862 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' A' ' 29' ' ' ARG . 2.7 tt -73.1 -163.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.774 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 0.0 OUTLIER -51.68 96.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.036 0.446 . . . . 0.0 110.665 179.351 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.97 -30.77 76.33 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.367 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 t -85.49 -33.32 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.885 0.374 . . . . 0.0 110.505 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.649 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 11.6 t -95.42 91.23 6.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.717 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -75.43 132.78 41.08 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.978 HG21 HG22 ' A' ' 8' ' ' ILE . 3.2 mp -101.09 148.85 6.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.607 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.585 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 38.7 tt0 -85.85 69.49 10.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 173.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.691 HG23 ' HB ' ' A' ' 80' ' ' ILE . 61.8 t -79.97 54.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.732 -175.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.89 0.57 3.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.567 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.791 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 10.2 t0 -85.66 136.72 33.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.859 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.526 ' C ' ' HG2' ' A' ' 86' ' ' ARG . 4.4 p -148.38 158.0 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.333 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.711 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -145.53 81.35 1.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.224 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.51 76.96 6.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.373 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -82.66 91.91 7.07 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 121.056 -0.257 . . . . 0.0 110.527 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.947 0.403 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 3' ' ' ASP . . . -171.56 -6.63 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.205 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.696 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.411 ' H ' ' H ' ' A' ' 2' ' ' GLY . 3.6 m-20 -92.72 149.63 21.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.552 -0.324 . . . . 0.0 111.396 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.52 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.5 t -97.91 115.53 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.703 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 55.5 t -109.96 119.97 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.699 0.285 . . . . 0.0 111.555 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.784 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -98.72 166.65 11.22 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.706 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 14.7 m -143.23 137.49 28.98 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.644 0.735 . . . . 0.0 112.43 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.058 HG22 HG21 ' A' ' 80' ' ' ILE . 4.2 mm -127.11 106.35 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.274 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.769 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.58 96.19 8.49 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -176.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.558 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.5 m -93.37 134.13 32.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.909 0.385 . . . . 0.0 111.822 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.679 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -146.3 124.91 6.4 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 121.094 0.473 . . . . 0.0 111.24 179.04 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.631 ' CD ' HG13 ' A' ' 17' ' ' VAL . 12.5 Cg_exo -72.51 122.67 8.47 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.467 2.778 . . . . 0.0 112.026 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -56.76 -32.13 65.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.235 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.91 153.58 80.37 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.037 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.6 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 53.6 Cg_endo -69.46 -2.86 10.69 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.403 2.068 . . . . 0.0 112.305 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.61 45.74 1.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.996 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.631 HG13 ' CD ' ' A' ' 12' ' ' PRO . 92.7 t -64.96 76.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.708 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -71.12 89.71 0.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.563 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.877 HD13 ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -63.53 -37.17 86.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.541 -178.17 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.877 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -70.61 -35.58 73.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.992 0.425 . . . . 0.0 110.077 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -69.05 -37.52 78.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.508 ' CD2' ' HG3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -65.92 -30.07 70.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.014 177.359 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.794 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -55.22 -46.71 75.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.663 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -65.84 -43.59 88.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.537 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.721 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 1.3 mm-40 -66.05 -29.32 69.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.266 0.555 . . . . 0.0 110.56 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.718 HG12 HG21 ' A' ' 53' ' ' VAL . 3.8 mt -60.94 -46.4 96.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.932 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -62.37 -38.74 90.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.208 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.721 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -78.33 -20.55 51.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.546 -178.543 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.911 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -89.05 -10.58 46.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.141 -179.222 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.65 HG12 ' O ' ' A' ' 26' ' ' ILE . 33.3 mm -60.89 138.12 93.74 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.265 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.511 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.3 Cg_endo -51.59 114.54 1.62 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.668 2.246 . . . . 0.0 112.126 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.17 -2.58 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.225 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.27 -39.25 10.08 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.875 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.581 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.51 -145.21 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.634 0.254 . . . . 0.0 110.977 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -133.25 164.82 26.23 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.892 0.377 . . . . 0.0 110.795 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.479 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.1 pt? -76.31 -175.09 3.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.389 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.543 ' ND1' HG22 ' A' ' 56' ' ' VAL . 85.3 t60 -130.7 -76.95 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.308 0.575 . . . . 0.0 111.345 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.443 ' HB3' ' CD2' ' A' ' 37' ' ' HIS . 1.1 tptt -163.54 132.66 3.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.959 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.708 HG12 HG13 ' A' ' 53' ' ' VAL . 2.6 mt -92.65 159.35 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.108 0.48 . . . . 0.0 112.172 -176.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.655 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -126.73 117.2 22.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.545 -178.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -82.7 69.9 9.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.941 0.4 . . . . 0.0 110.376 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.544 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -97.23 138.21 21.21 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.887 -179.347 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.775 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 71.1 Cg_endo -85.43 156.27 10.76 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.535 2.156 . . . . 0.0 112.632 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.1 mm -125.76 -83.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.505 -177.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.67 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.42 -147.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.218 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -70.98 -33.87 70.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.403 . . . . 0.0 110.752 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.48 8.4 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.738 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.67 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.3 mt -91.04 102.31 15.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.902 0.382 . . . . 0.0 110.791 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.775 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 70.7 t -92.78 127.5 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.882 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.744 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.56 150.49 20.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.045 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.655 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -112.2 116.23 30.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.158 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 4.6 m-20 -89.76 94.11 9.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.654 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.718 HG21 HG12 ' A' ' 26' ' ' ILE . 3.7 t -86.45 104.19 13.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.277 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 3.8 mtt -84.52 167.52 16.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.207 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.784 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.1 m -139.93 138.05 38.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.56 -178.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.543 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -95.35 111.09 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.736 178.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.581 HG12 HG21 ' A' ' 34' ' ' THR . 12.8 m -130.05 148.07 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.001 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.29 -72.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.451 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -81.39 -0.3 40.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.917 0.389 . . . . 0.0 110.553 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.529 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.21 -152.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.234 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.55 -162.69 1.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.729 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.94 14.49 26.09 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.565 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.35 -7.22 60.0 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.498 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.415 HG22 ' OG1' ' A' ' 34' ' ' THR . 1.4 p -74.12 -4.63 36.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.978 0.418 . . . . 0.0 110.261 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -54.83 -23.87 20.37 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.289 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.89 -29.21 62.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.031 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -62.09 -55.15 31.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.812 0.339 . . . . 0.0 110.212 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -58.99 -34.31 71.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.213 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.18 -51.24 68.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.127 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.8 p -63.78 -17.27 62.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.221 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.714 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.58 -29.85 62.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.368 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.07 -12.09 35.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.658 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.24 28.87 0.98 Allowed Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.463 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.911 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -72.59 -164.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.338 -0.431 . . . . 0.0 111.062 -178.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.637 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.5 OUTLIER -51.15 99.7 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.938 0.399 . . . . 0.0 110.81 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.93 -33.44 73.84 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.924 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.7 t -87.16 -38.61 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.984 0.421 . . . . 0.0 110.594 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.637 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 40.8 t -96.13 92.31 6.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.875 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -78.2 135.38 37.6 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.058 HG21 HG22 ' A' ' 8' ' ' ILE . 2.9 mt -101.57 148.63 7.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.514 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.662 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 15.8 tp10 -86.02 69.43 10.52 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 173.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.677 HG22 HG23 ' A' ' 8' ' ' ILE . 55.1 t -80.93 51.62 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.024 -174.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -133.03 9.25 4.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.919 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.706 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.1 m-20 -83.2 146.66 28.48 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.297 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.6 t -148.9 144.18 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.866 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 9.7 mtt180 -146.4 79.52 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.622 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.68 84.91 4.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.026 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -81.45 91.99 6.39 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.461 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.971 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.447 ' SD ' ' HB3' ' A' ' 88' ' ' LEU . 2.7 mtm . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.989 0.423 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 89' ' ' MET . . . 173.82 -0.68 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.581 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.481 ' OD1' HD12 ' A' ' 88' ' ' LEU . 2.4 p-10 -92.68 164.65 13.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.581 -0.31 . . . . 0.0 111.154 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.4 ' HB ' HG23 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -99.57 136.87 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.181 178.709 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.578 ' CG2' HD11 ' A' ' 88' ' ' LEU . 4.7 t -132.75 127.04 55.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.758 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.578 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.13 168.92 10.63 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.802 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 6.2 m -142.81 129.76 20.64 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.466 0.65 . . . . 0.0 112.164 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.998 HG22 HG21 ' A' ' 80' ' ' ILE . 5.7 mm -121.21 108.03 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.677 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.687 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.54 96.18 8.13 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -177.484 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.83 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.9 m -94.8 137.37 23.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.769 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -147.67 121.65 4.94 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 121.205 0.526 . . . . 0.0 111.999 179.179 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 17.0 Cg_exo -71.34 121.15 7.51 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.417 2.745 . . . . 0.0 111.973 178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.66 -30.56 63.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.317 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -78.0 153.93 80.18 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.965 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.551 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 7.3 Cg_exo -70.39 -6.13 18.21 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.536 2.157 . . . . 0.0 111.719 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -91.17 33.62 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.284 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.638 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.29 85.68 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.738 0.78 . . . . 0.0 109.98 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 24.9 m-20 -69.96 106.13 3.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.352 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.409 ' HG ' HD21 ' A' ' 51' ' ' LEU . 1.5 tt -62.12 -48.91 78.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.17 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 12.6 tp10 -68.48 -37.95 80.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.513 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -70.94 -34.57 71.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.0 0.429 . . . . 0.0 110.591 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -65.28 -32.25 73.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.655 178.164 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -57.8 -45.21 86.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.554 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -42.21 88.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.593 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.604 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 10.3 mt-10 -66.49 -30.23 70.52 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.321 0.581 . . . . 0.0 110.477 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.685 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 3.4 mt -62.06 -43.57 97.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.766 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -60.89 -38.48 85.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.109 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 10.2 pt-20 -77.49 -21.69 52.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.306 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.792 ' HB2' HD11 ' A' ' 74' ' ' ILE . 21.1 ptt85 -91.1 -9.92 43.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.253 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.675 HG12 ' O ' ' A' ' 26' ' ' ILE . 31.5 mm -59.24 137.78 88.48 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.136 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.522 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.8 Cg_endo -51.54 115.02 1.83 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.743 2.296 . . . . 0.0 112.151 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.07 0.55 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.357 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.99 -53.55 3.46 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.858 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.596 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -117.02 -137.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.664 0.232 . . . . 0.0 111.116 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 3.8 pt-20 -137.48 169.14 18.3 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.915 0.388 . . . . 0.0 110.992 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -75.17 177.86 6.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.977 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.673 ' ND1' HG22 ' A' ' 56' ' ' VAL . 71.0 t60 -131.21 -76.28 0.52 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.047 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -161.37 131.78 5.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.402 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.657 HG12 HG13 ' A' ' 53' ' ' VAL . 2.8 mt -93.57 159.23 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.905 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.653 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -129.59 119.31 23.41 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.474 -178.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -82.75 75.52 9.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.91 0.386 . . . . 0.0 110.731 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.529 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -98.56 134.5 21.7 Favored Pre-proline 0 C--O 1.225 -0.205 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.777 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 57.3 Cg_endo -86.53 156.87 9.23 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.499 2.133 . . . . 0.0 112.815 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.711 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.5 mm -124.92 -83.52 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.24 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.772 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.85 -152.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.118 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -71.94 -28.38 63.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.726 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.61 4.31 0.47 Allowed Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.046 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.772 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.5 mt -91.67 101.94 14.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.825 0.345 . . . . 0.0 110.764 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.777 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 87.6 t -94.39 129.61 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.975 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.769 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.43 157.11 16.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.457 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.661 HD23 ' C ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -120.23 121.17 38.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.634 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.505 ' ND2' ' HB3' ' A' ' 40' ' ' ASP . 1.9 m-20 -89.89 92.79 9.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.257 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.657 HG13 HG12 ' A' ' 39' ' ' ILE . 10.3 t -86.03 104.73 13.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.212 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.584 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.8 mtt -84.58 164.52 18.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.234 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.578 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.0 m -139.27 139.52 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.164 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.673 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -92.18 112.15 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.794 0.33 . . . . 0.0 110.887 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.478 HG12 HG21 ' A' ' 34' ' ' THR . 28.3 m -128.34 140.52 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.999 0.428 . . . . 0.0 111.176 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.43 -69.8 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.235 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.75 -4.96 58.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.409 . . . . 0.0 110.509 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.596 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.06 -152.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.302 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.65 -162.96 1.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.803 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.09 14.24 28.23 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.557 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.27 -5.9 51.13 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.247 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 p -74.6 -3.18 29.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.102 0.477 . . . . 0.0 109.97 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.24 -23.71 23.93 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.161 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.33 -28.28 58.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.74 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.44 -56.78 16.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.156 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -58.49 -34.48 70.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.387 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.68 -52.2 65.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.305 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.414 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 3.1 p -64.08 -17.83 63.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.302 178.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.628 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.64 -28.56 62.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.356 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -12.96 49.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.18 26.02 0.99 Allowed Glycine 0 N--CA 1.453 -0.207 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.805 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' A' ' 29' ' ' ARG . 1.1 tt -73.47 -162.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.535 -0.332 . . . . 0.0 110.865 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.62 ' N ' HG23 ' A' ' 74' ' ' ILE . 1.4 mp0 -50.41 93.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.831 0.348 . . . . 0.0 110.932 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.57 -26.35 56.93 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.952 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.43 -39.81 12.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.113 0.482 . . . . 0.0 110.493 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -96.47 91.0 5.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.698 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -78.2 136.53 37.83 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.998 HG21 HG22 ' A' ' 8' ' ' ILE . 14.9 mt -101.48 145.87 10.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.604 -176.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -85.85 71.47 10.65 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.269 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.703 HG23 ' HB ' ' A' ' 80' ' ' ILE . 64.3 t -80.09 50.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.207 -173.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -132.99 6.39 3.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.18 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.802 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 31.4 t0 -85.32 144.65 27.94 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.037 0.446 . . . . 0.0 110.999 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 86' ' ' ARG . 2.9 p -147.29 164.91 6.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.01 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' H ' HG22 ' A' ' 85' ' ' VAL . 4.4 mtt180 -149.92 95.58 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.289 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 87' ' ' ARG . 3.7 mmt85 -81.69 88.5 6.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.942 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.578 HD11 ' CG2' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -81.91 92.92 6.81 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.786 179.66 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.469 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.003 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ptp . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.935 0.397 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.72 -2.65 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.125 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.632 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 4.7 m-20 -91.63 130.47 37.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.743 0.306 . . . . 0.0 111.522 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.666 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -93.15 101.81 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.321 177.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 43.4 t -104.85 122.98 58.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.887 0.375 . . . . 0.0 111.806 -178.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -97.96 163.2 12.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.735 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.716 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 5.6 m -139.7 123.12 17.15 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.642 0.734 . . . . 0.0 111.625 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.951 HG22 HG21 ' A' ' 80' ' ' ILE . 17.6 mt -122.13 107.62 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.734 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.814 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.89 95.99 8.23 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -176.643 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.475 ' N ' HG23 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -91.43 136.3 24.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.875 0.369 . . . . 0.0 111.738 -177.765 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.817 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 2.2 ptm -144.14 124.97 7.79 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 121.036 0.446 . . . . 0.0 111.485 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.601 ' CD ' HG13 ' A' ' 17' ' ' VAL . 14.2 Cg_exo -69.7 124.54 11.21 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.173 2.582 . . . . 0.0 112.099 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -57.9 -32.6 67.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.457 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.6 p -77.34 152.94 81.76 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.119 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.56 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 46.8 Cg_endo -68.19 -3.11 10.13 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.216 1.944 . . . . 0.0 111.572 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.74 43.63 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.835 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.601 HG13 ' CD ' ' A' ' 12' ' ' PRO . 90.0 t -65.8 75.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.65 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.59 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -71.74 92.94 1.23 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.027 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.728 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -63.24 -42.06 99.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.596 -178.035 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.887 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 10.8 tt0 -69.96 -36.5 75.3 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.955 0.407 . . . . 0.0 110.292 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.59 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -69.21 -37.75 78.23 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -67.11 -27.01 66.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.004 177.483 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.887 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -56.2 -46.8 79.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.371 179.554 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 2.0 mtmt -66.86 -39.86 87.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.766 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -65.5 -33.8 76.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.213 0.53 . . . . 0.0 110.095 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.647 ' O ' HG12 ' A' ' 30' ' ' ILE . 1.8 mt -62.75 -39.01 83.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.935 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -42.35 91.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.639 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 13.3 mt-10 -76.01 -20.92 57.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.814 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.766 HH22 ' HB ' ' A' ' 8' ' ' ILE . 20.8 ptt85 -88.76 -15.63 34.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.484 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 26' ' ' ILE . 22.4 mm -59.4 137.48 89.0 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.917 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.561 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 8.0 Cg_endo -50.18 124.85 13.63 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.824 2.349 . . . . 0.0 112.521 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -60.79 -3.68 0.8 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.893 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.24 -61.7 1.88 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.991 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.626 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -110.24 -145.56 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.835 0.35 . . . . 0.0 111.296 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -132.05 172.01 12.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.614 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -74.97 -173.67 1.99 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.007 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.541 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.5 t60 -130.58 -74.81 0.54 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.426 0.631 . . . . 0.0 110.782 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -165.03 125.9 1.99 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.796 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.659 HD13 HG22 ' A' ' 53' ' ' VAL . 2.7 mt -92.4 154.35 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.848 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.716 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.8 t0 -121.25 129.2 53.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.488 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -89.69 69.76 7.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.86 0.362 . . . . 0.0 110.202 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.672 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -100.15 148.26 34.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.595 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.751 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.0 Cg_endo -91.07 156.19 3.88 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.026 2.484 . . . . 0.0 113.209 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.6 mm -125.89 -82.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.063 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.567 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.41 -151.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -72.07 -28.55 63.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.755 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.54 4.79 0.5 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.942 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.567 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.2 mt -91.43 103.44 16.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 110.968 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.751 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 36.7 t -92.3 128.58 43.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.694 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.817 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.0 165.68 12.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.094 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.728 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.0 mp -120.26 119.93 34.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.234 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 1.6 m-20 -89.52 90.96 8.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.225 0.536 . . . . 0.0 109.915 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.659 HG22 HD13 ' A' ' 39' ' ' ILE . 10.0 t -86.91 98.86 7.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.705 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 35.7 mtt -84.54 162.56 19.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.096 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.7 m -138.92 134.71 42.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.536 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.541 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.66 113.55 31.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.127 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 4' ' ' VAL . 4.4 m -129.63 143.63 40.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.934 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.57 -65.98 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.454 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -80.96 -8.21 59.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.996 0.427 . . . . 0.0 110.648 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.626 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.84 -146.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.21 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.62 -164.18 1.94 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.749 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.89 13.6 30.08 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.545 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.08 -5.62 53.89 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.54 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.58 -5.22 41.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.957 0.408 . . . . 0.0 110.338 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -54.9 -23.15 17.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.148 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.89 -29.08 62.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.968 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.65 -52.65 63.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.403 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.66 -37.27 75.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.309 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -50.21 74.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.312 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.425 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.1 p -64.0 -21.04 66.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.685 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.561 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.54 -29.36 62.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.827 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -13.74 53.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.888 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.36 28.57 0.97 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.871 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.683 HD11 ' HD2' ' A' ' 29' ' ' ARG . 3.6 tt -73.28 -163.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.61 -0.295 . . . . 0.0 111.067 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.762 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 1.2 pm0 -51.55 91.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.975 0.416 . . . . 0.0 110.877 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.83 -25.58 67.83 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.756 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.27 -34.67 8.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.289 0.566 . . . . 0.0 110.132 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.762 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -95.83 90.36 5.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.569 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -74.5 131.09 40.72 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.951 HG21 HG22 ' A' ' 8' ' ' ILE . 3.0 mp -100.83 149.21 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.524 -175.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.668 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 31.5 tp10 -85.79 70.33 10.67 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.686 HG23 ' HB ' ' A' ' 80' ' ' ILE . 52.8 t -81.06 54.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.857 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 m -132.65 1.97 3.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.689 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.716 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 2.2 m-20 -84.62 141.63 30.52 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.753 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -147.58 149.98 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.002 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 5.5 mtt180 -145.46 73.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.502 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.28 87.0 3.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.09 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.632 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 11.0 mp -82.16 82.35 7.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.626 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.9 ptp . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.979 -179.8 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.812 0.339 . . . . 0.0 111.41 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.406 ' H ' ' H ' ' A' ' 3' ' ' ASP . . . -165.66 -6.15 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.733 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.406 ' H ' ' H ' ' A' ' 2' ' ' GLY . 0.8 OUTLIER -94.44 159.67 15.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.006 0.431 . . . . 0.0 111.279 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.827 HG12 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -99.16 116.54 42.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.136 177.724 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 86' ' ' ARG . 3.9 t -105.31 120.41 55.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.072 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.735 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.09 157.22 16.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.788 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 4.5 m -138.24 125.52 21.7 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.702 0.763 . . . . 0.0 111.979 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.976 HG22 HG21 ' A' ' 80' ' ' ILE . 6.7 mm -120.55 108.31 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.943 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.743 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.31 95.57 8.17 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.014 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.675 ' HB ' HG12 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -92.66 135.95 26.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.787 -178.101 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.757 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -145.75 127.0 7.5 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 120.964 0.411 . . . . 0.0 111.361 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 8.7 Cg_exo -73.4 120.19 6.38 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.252 2.635 . . . . 0.0 112.127 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -56.76 -32.19 65.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.303 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 p -78.45 154.01 79.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.012 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.567 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 56.1 Cg_endo -68.9 -2.09 8.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.213 1.942 . . . . 0.0 111.508 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.88 42.52 1.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.121 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.631 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 96.2 t -64.88 77.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.125 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.725 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.1 m-20 -68.35 98.6 0.85 Allowed 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.416 ' CD2' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -61.49 -51.35 69.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.659 -178.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -68.06 -37.95 81.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.619 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.667 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . . . -70.52 -38.32 74.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.063 0.459 . . . . 0.0 110.6 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -66.8 -30.14 70.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.189 178.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -44.6 93.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.43 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.667 ' HE3' ' HA ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -65.94 -41.94 90.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.587 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -64.76 -32.42 74.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.074 0.464 . . . . 0.0 110.635 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.919 HG12 HG21 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -62.14 -44.89 99.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.473 -179.448 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.477 ' OE1' HG22 ' A' ' 26' ' ' ILE . 7.2 mm100 -63.35 -33.41 75.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.82 0.343 . . . . 0.0 110.737 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.584 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 27.6 mt-10 -74.44 -23.2 58.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.088 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.75 ' HD2' HD11 ' A' ' 74' ' ' ILE . 28.7 ptt85 -89.26 -15.79 32.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.552 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.548 HG12 ' O ' ' A' ' 26' ' ' ILE . 24.2 mm -57.97 136.74 83.84 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.456 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 18.4 Cg_endo -56.81 116.73 3.41 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.274 1.983 . . . . 0.0 112.073 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.81 0.64 0.08 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.405 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.446 ' HA3' ' C ' ' A' ' 63' ' ' GLY . . . -82.46 -37.03 15.23 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.575 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.557 HG21 HG12 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -130.28 -144.06 0.26 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.647 0.26 . . . . 0.0 110.871 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -136.74 167.8 20.74 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.881 0.372 . . . . 0.0 111.031 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -75.26 -177.23 3.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.007 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.744 ' ND1' HG22 ' A' ' 56' ' ' VAL . 73.0 t60 -131.49 -75.64 0.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.205 0.526 . . . . 0.0 111.047 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 11.9 mmtt -161.25 129.37 4.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.222 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.628 HG12 HG13 ' A' ' 53' ' ' VAL . 3.2 mt -94.42 158.51 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.073 0.463 . . . . 0.0 111.989 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.699 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -126.49 118.69 25.44 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.98 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -85.7 71.24 10.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.905 0.383 . . . . 0.0 110.261 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.661 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -100.73 149.54 36.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.628 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.763 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 29.6 Cg_endo -91.92 158.88 3.35 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.074 2.516 . . . . 0.0 113.331 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.772 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.3 mm -128.89 -83.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.348 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.694 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.79 -148.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.184 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -71.17 -32.61 69.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.81 0.338 . . . . 0.0 110.808 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.67 8.85 0.64 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.493 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.694 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.3 mt -91.39 103.1 15.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.82 0.343 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.763 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 38.1 t -92.7 127.53 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.898 -178.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.772 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.13 159.03 15.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.69 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.818 HD12 HD13 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -118.82 119.56 34.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.494 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.432 ' ND2' ' HB3' ' A' ' 40' ' ' ASP . 2.2 m-20 -89.49 90.26 8.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.709 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.919 HG21 HG12 ' A' ' 26' ' ' ILE . 14.6 t -86.52 104.23 13.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.529 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.633 ' HG3' HG23 ' A' ' 7' ' ' THR . 2.8 mtt -84.57 160.64 20.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.16 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.735 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.8 m -139.53 140.93 36.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.178 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.744 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.4 OUTLIER -92.11 101.8 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.836 179.342 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.827 HG23 HG12 ' A' ' 4' ' ' VAL . 31.8 m -130.72 137.2 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.499 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.62 -59.37 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.423 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -81.7 -7.78 59.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.038 0.447 . . . . 0.0 110.444 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.522 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.5 -140.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.178 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.428 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 1.0 OUTLIER -147.17 -162.35 1.52 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.814 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.428 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -80.23 11.71 35.62 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.741 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.446 ' C ' ' HA3' ' A' ' 33' ' ' GLY . . . -70.02 -11.4 66.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.615 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.469 ' HA ' ' HB2' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -73.68 -2.41 23.06 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.966 0.412 . . . . 0.0 110.103 179.335 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -54.5 -23.8 17.83 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.926 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.07 -31.38 63.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.891 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -59.72 -56.32 23.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.449 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.45 -35.98 75.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.547 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -48.97 79.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.347 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.66 -22.88 67.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.566 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.584 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -72.9 -27.42 61.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.681 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -18.25 64.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.519 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.47 35.88 0.87 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.688 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.75 HD11 ' HD2' ' A' ' 29' ' ' ARG . 0.6 OUTLIER -72.88 -164.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.493 -0.354 . . . . 0.0 111.047 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.7 OUTLIER -50.95 101.52 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.964 0.411 . . . . 0.0 111.154 -179.094 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.09 -33.33 79.07 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.51 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.4 t -86.98 -39.15 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 0.0 110.501 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.631 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 22.0 t -95.5 90.93 5.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.609 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -76.9 136.79 38.84 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.976 HG21 HG22 ' A' ' 8' ' ' ILE . 17.7 mt -101.45 146.91 8.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.743 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -85.84 71.72 10.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.695 HG23 ' HB ' ' A' ' 80' ' ' ILE . 73.6 t -79.96 54.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.08 -174.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -133.08 2.73 3.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.418 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.788 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 20.6 t0 -85.3 140.11 31.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.8 0.333 . . . . 0.0 110.961 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.505 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 4.7 p -147.82 163.75 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.385 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.508 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 4.1 mtt180 -148.62 87.45 1.57 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.614 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.64 81.79 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.704 -0.226 . . . . 0.0 111.587 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.29 89.19 7.31 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.775 178.687 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.2 mtm . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.961 179.953 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.554 ' HG2' ' HB3' ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.925 0.393 . . . . 0.0 111.252 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.417 ' H ' ' H ' ' A' ' 3' ' ' ASP . . . -173.07 3.0 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.748 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.417 ' H ' ' H ' ' A' ' 2' ' ' GLY . 0.1 OUTLIER -94.4 160.89 14.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.851 0.358 . . . . 0.0 111.481 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.492 HG13 ' HD3' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -102.52 119.11 50.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.756 177.785 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -114.87 113.21 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.973 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.817 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.55 165.99 12.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.332 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.784 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 7.4 m -143.41 130.71 20.91 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.658 0.742 . . . . 0.0 112.187 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.083 HG22 HG21 ' A' ' 80' ' ' ILE . 5.7 mm -122.15 107.38 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.728 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.769 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.19 95.34 8.06 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.511 HG11 ' HE ' ' A' ' 29' ' ' ARG . 1.9 m -94.27 137.85 22.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.899 0.381 . . . . 0.0 111.841 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.741 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.1 ptm -147.43 127.61 6.76 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 121.177 0.513 . . . . 0.0 111.455 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.631 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 13.3 Cg_exo -72.37 124.74 10.14 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.525 2.817 . . . . 0.0 112.141 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.91 -33.54 67.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.274 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.94 151.9 79.48 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.992 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.95 -2.54 8.91 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.407 2.071 . . . . 0.0 111.978 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.39 44.23 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.025 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.631 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 74.3 t -64.86 77.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.625 -178.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 19.3 m-20 -70.86 91.44 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.916 177.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.886 HD13 ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.67 -36.08 83.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.353 -178.235 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.886 ' H ' HD13 ' A' ' 19' ' ' LEU . 8.7 pt-20 -69.91 -38.83 76.38 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.91 0.386 . . . . 0.0 110.177 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.658 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . . . -71.82 -33.9 68.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.341 0.591 . . . . 0.0 109.526 177.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.1 OUTLIER -66.04 -32.93 74.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.305 177.272 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.579 ' HA ' HD12 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -57.14 -45.53 83.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.419 178.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.658 ' HE3' ' HA ' ' A' ' 21' ' ' ALA . 2.0 mtmt -65.85 -43.25 89.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.582 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -65.54 -30.06 70.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.474 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.646 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 5.7 mt -60.83 -45.85 97.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.957 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.487 ' OE1' HD21 ' A' ' 36' ' ' LEU . 5.9 mm-40 -61.07 -38.0 84.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.947 0.403 . . . . 0.0 110.688 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -75.55 -23.07 56.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.333 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.767 HH22 ' HB ' ' A' ' 8' ' ' ILE . 23.6 ptt85 -90.99 -11.84 37.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.116 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 26' ' ' ILE . 27.6 mm -60.02 137.33 90.92 Favored Pre-proline 0 N--CA 1.463 0.21 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.019 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HD2' HG23 ' A' ' 30' ' ' ILE . 4.1 Cg_endo -46.89 120.82 4.41 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.853 2.368 . . . . 0.0 112.296 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -55.95 -11.02 0.91 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.832 -179.094 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.7 -41.84 10.58 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.901 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.539 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.38 -148.45 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.69 0.281 . . . . 0.0 110.995 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -137.23 175.02 9.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.836 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.487 HD21 ' OE1' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -74.69 -176.07 2.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.237 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.648 ' ND1' HG22 ' A' ' 56' ' ' VAL . 79.5 t60 -131.04 -69.78 0.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.662 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -161.31 127.13 3.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.1 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.669 HG12 HG13 ' A' ' 53' ' ' VAL . 2.9 mt -91.78 158.01 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.626 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.647 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -128.78 119.23 24.15 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.461 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -82.46 72.01 9.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.985 0.421 . . . . 0.0 110.401 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.542 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -97.05 132.85 24.98 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.816 -179.45 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.771 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 58.9 Cg_endo -87.68 155.83 7.58 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.527 2.151 . . . . 0.0 112.8 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.699 HD11 ' HB3' ' A' ' 50' ' ' ALA . 1.8 mm -124.43 -82.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.098 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -67.66 -153.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.951 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -71.98 -27.88 63.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 110.709 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.64 5.83 0.53 Allowed Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.581 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.623 ' HA ' HG21 ' A' ' 17' ' ' VAL . 8.2 mp -91.1 97.5 11.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.791 0.329 . . . . 0.0 110.645 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 95.4 t -93.97 127.36 46.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.085 0.469 . . . . 0.0 112.163 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.741 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.82 142.4 28.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.795 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.647 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -105.98 120.72 42.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.377 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.491 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 2.2 m-20 -89.61 91.85 8.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.374 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.669 HG13 HG12 ' A' ' 39' ' ' ILE . 9.4 t -86.41 107.46 16.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.264 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.567 ' HG3' HG23 ' A' ' 7' ' ' THR . 12.5 mtt -84.46 168.28 15.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.168 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.817 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.8 m -141.48 136.04 31.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.922 0.391 . . . . 0.0 111.312 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.648 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -96.12 112.76 28.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.769 178.631 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.539 HG12 HG21 ' A' ' 34' ' ' THR . 19.9 m -130.46 138.06 54.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.897 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.66 -60.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.322 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.89 -13.9 58.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.021 0.439 . . . . 0.0 110.376 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.527 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.91 -146.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.029 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.61 -160.37 1.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.717 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.66 13.21 30.61 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.36 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.21 -1.92 37.51 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.54 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.474 HG22 ' OG1' ' A' ' 34' ' ' THR . 1.8 p -75.34 -6.41 49.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.975 0.417 . . . . 0.0 110.264 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.83 -23.48 18.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.341 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.02 -27.5 61.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.996 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.41 -55.59 29.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.31 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -58.99 -34.85 72.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.573 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.58 -50.44 71.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.343 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.413 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 14.5 p -63.39 -18.86 64.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.211 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.605 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -72.9 -30.71 64.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.559 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -12.14 33.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.72 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.26 26.44 0.99 Allowed Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.829 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.682 HD11 ' HD2' ' A' ' 29' ' ' ARG . 2.4 tt -73.21 -160.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.671 -0.264 . . . . 0.0 110.873 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.606 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -51.01 99.9 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.842 0.353 . . . . 0.0 110.98 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.52 -32.58 78.42 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.596 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.2 t -88.25 -38.39 11.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.939 0.399 . . . . 0.0 110.543 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.588 ' HB2' ' HB3' ' A' ' 75' ' ' GLU . 6.1 m -95.81 90.65 5.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.76 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -79.43 137.75 37.37 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.083 HG21 HG22 ' A' ' 8' ' ' ILE . 1.7 mt -101.74 147.24 8.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.575 -176.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -86.01 72.02 10.51 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 172.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.686 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.9 t -80.79 56.66 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.124 -174.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -133.05 0.34 3.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.762 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.784 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 40.2 t0 -86.09 127.21 34.64 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.229 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.3 p -151.9 147.45 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 121.033 0.444 . . . . 0.0 111.792 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.73 100.82 4.89 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.216 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.492 ' HD3' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -82.01 83.46 7.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.964 178.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.554 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 0.0 OUTLIER -81.11 92.17 6.22 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.686 179.6 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.5 ptp . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.989 179.712 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttm . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.957 0.408 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.54 -12.72 0.03 OUTLIER Glycine 0 CA--C 1.516 0.126 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.158 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.519 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 2.9 m-20 -94.08 161.51 14.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.933 0.397 . . . . 0.0 111.59 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.575 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -98.62 118.15 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.364 177.4 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 41.1 t -109.96 118.41 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 0.0 111.755 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.691 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.04 161.76 14.16 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.646 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 6.2 m -140.97 131.41 25.24 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.682 0.753 . . . . 0.0 112.687 -178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.041 HG22 HG21 ' A' ' 80' ' ' ILE . 3.8 mm -121.03 105.78 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.367 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.808 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -93.69 93.4 8.0 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -177.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.483 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.9 m -92.44 136.0 25.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.826 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.722 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -146.55 123.94 5.98 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-O 121.235 0.54 . . . . 0.0 111.444 179.288 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.64 ' CD ' HG13 ' A' ' 17' ' ' VAL . 14.1 Cg_exo -70.4 120.99 7.57 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.305 2.67 . . . . 0.0 111.854 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -56.69 -31.2 64.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.62 153.19 81.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.983 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.593 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 46.4 Cg_endo -68.58 -2.9 10.08 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.446 2.097 . . . . 0.0 112.366 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -91.71 43.12 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.248 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.64 HG13 ' CD ' ' A' ' 12' ' ' PRO . 97.0 t -65.64 76.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.408 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 3.7 m-20 -70.03 97.65 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.619 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -63.23 -45.74 90.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.816 -177.576 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.78 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 28.3 tt0 -70.7 -35.62 72.85 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.759 0.314 . . . . 0.0 110.678 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -67.52 -39.2 85.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -66.57 -31.5 72.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.836 177.02 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.78 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -55.46 -48.61 74.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.115 -179.398 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -68.16 -40.76 82.26 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.522 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.589 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 29.8 mm-40 -64.75 -30.02 71.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.07 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.765 HG12 HG21 ' A' ' 53' ' ' VAL . 1.2 mt -62.61 -46.4 96.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.988 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -60.94 -36.19 78.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.413 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 9.9 pt-20 -77.16 -22.36 52.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.433 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.812 ' HD3' HD11 ' A' ' 74' ' ' ILE . 8.6 ptp180 -89.55 -9.19 50.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.253 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.553 HD11 HG11 ' A' ' 53' ' ' VAL . 34.6 mm -57.82 138.89 82.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.466 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.762 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.2 Cg_endo -50.91 117.23 3.17 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.711 2.274 . . . . 0.0 111.972 178.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -59.12 1.76 0.06 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.12 -62.54 1.81 Allowed Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.83 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.53 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -109.43 -139.26 0.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.591 0.234 . . . . 0.0 110.844 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -134.9 166.16 23.65 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.868 0.366 . . . . 0.0 110.839 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -75.56 -175.97 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.093 -179.369 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.546 ' ND1' HG22 ' A' ' 56' ' ' VAL . 73.7 t60 -131.25 -79.08 0.52 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 10.1 mmtt -161.69 137.81 7.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.687 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.641 HD12 HG22 ' A' ' 53' ' ' VAL . 2.4 mm -92.11 166.63 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.452 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -130.03 123.22 30.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.165 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -84.88 67.67 10.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.875 0.369 . . . . 0.0 110.518 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.535 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -95.44 133.9 25.16 Favored Pre-proline 0 C--O 1.225 -0.205 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.579 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.773 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 60.6 Cg_endo -87.12 155.65 8.32 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.62 2.213 . . . . 0.0 112.686 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.712 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.8 mm -124.81 -82.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.378 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.664 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.4 -150.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -71.87 -29.95 64.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.587 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.71 6.36 0.54 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.736 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.664 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.8 mt -91.45 100.91 13.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.975 0.417 . . . . 0.0 110.835 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 78.3 t -92.96 128.52 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.72 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.722 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.35 143.0 27.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.103 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 10.9 mp -101.53 119.46 38.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.251 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.585 ' ND2' ' HB3' ' A' ' 40' ' ' ASP . 4.7 m-20 -91.66 96.19 10.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.312 0.577 . . . . 0.0 111.011 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.765 HG21 HG12 ' A' ' 26' ' ' ILE . 39.6 t -84.51 103.12 11.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.15 -177.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.577 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 18.5 mtt -86.3 161.63 18.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.101 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.3 m -139.32 135.12 40.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 111.193 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.546 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -95.04 115.78 34.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.006 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 4' ' ' VAL . 13.8 m -130.35 151.1 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.983 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.53 -74.22 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.534 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -81.38 -3.01 51.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 0.0 110.713 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.53 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.21 -147.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.366 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -147.57 -166.08 2.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.855 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.69 15.62 24.35 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.668 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.82 -5.19 50.85 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.528 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.72 -3.76 33.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.94 0.4 . . . . 0.0 110.296 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -55.19 -23.11 20.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.142 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.19 -27.34 61.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.121 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.762 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.16 -55.09 36.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.482 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -58.21 -36.11 72.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.458 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.36 -51.03 70.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.345 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.518 ' OG ' HD12 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -63.5 -19.16 64.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.443 178.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.679 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.34 -29.55 62.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.602 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.68 -12.07 31.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.772 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.15 25.82 1.0 Allowed Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.619 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.812 HD11 ' HD3' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -73.48 -164.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.476 -0.362 . . . . 0.0 111.187 -178.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.645 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.6 OUTLIER -50.37 100.78 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.006 0.431 . . . . 0.0 111.114 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.28 -31.54 79.37 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.873 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.3 t -85.84 -35.79 9.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.006 0.432 . . . . 0.0 110.307 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.645 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 43.8 t -95.77 90.5 5.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.614 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -77.24 133.2 38.93 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.041 HG21 HG22 ' A' ' 8' ' ' ILE . 3.2 mp -101.56 148.76 7.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.686 -175.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.455 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -85.81 71.36 10.67 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 172.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.682 HG23 ' HB ' ' A' ' 80' ' ' ILE . 57.9 t -79.82 50.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.079 -174.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -133.13 7.18 3.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.359 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.646 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.5 m-20 -84.33 142.55 30.11 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.994 0.426 . . . . 0.0 111.207 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.7 p -147.51 157.03 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.057 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -145.32 105.09 4.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.41 -178.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.7 83.56 7.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.921 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 10.5 mp -81.21 85.26 6.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.516 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.942 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttm . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.976 0.417 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.38 -2.42 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.375 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.674 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 2.1 m-20 -93.6 127.24 39.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.733 0.301 . . . . 0.0 111.712 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.545 ' O ' HG22 ' A' ' 57' ' ' VAL . 2.5 t -97.43 104.03 15.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.764 0.316 . . . . 0.0 110.565 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.497 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 53.1 t -105.3 114.78 45.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.588 -178.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.695 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -97.01 165.74 11.93 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.765 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 13.4 m -143.25 128.84 19.15 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.542 0.687 . . . . 0.0 111.859 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.037 HG22 HG21 ' A' ' 80' ' ' ILE . 3.4 mm -120.54 107.7 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.759 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.793 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.58 95.46 7.63 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.669 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.535 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.8 m -93.28 135.86 26.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.854 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -147.59 119.31 4.58 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 121.279 0.561 . . . . 0.0 111.97 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.671 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.1 Cg_exo -69.99 119.14 6.13 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.197 2.598 . . . . 0.0 112.034 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -56.91 -29.13 62.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.172 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.43 148.98 74.75 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.046 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.53 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 35.9 Cg_endo -64.69 -7.38 14.52 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.303 2.002 . . . . 0.0 111.804 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.63 34.78 0.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.6 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.612 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.4 87.25 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.776 0.798 . . . . 0.0 109.892 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.605 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 55.3 m-20 -67.9 104.59 1.75 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.139 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.553 ' O ' ' HD3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -60.93 -53.47 56.94 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.445 -178.636 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.512 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 35.7 tt0 -69.75 -36.5 75.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.046 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.572 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -68.61 -35.16 76.96 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.779 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.605 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -65.36 -33.36 75.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.518 177.237 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HD3' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -55.98 -46.74 78.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.471 178.768 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -66.12 -42.81 88.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.41 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.734 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 51.0 mm-40 -65.34 -30.23 71.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.37 0.605 . . . . 0.0 110.438 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.679 ' O ' HG12 ' A' ' 30' ' ' ILE . 3.4 mt -60.69 -47.05 94.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.597 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.78 -38.11 89.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.387 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.734 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -77.32 -21.08 54.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.48 -178.568 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.658 ' HB2' HD11 ' A' ' 74' ' ' ILE . 3.3 ptp85 -89.15 -13.45 38.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.077 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 26' ' ' ILE . 34.4 mm -61.08 136.92 93.99 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.618 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 15.7 Cg_endo -55.88 129.49 35.24 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.334 2.023 . . . . 0.0 112.614 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.6 0.1 0.22 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.125 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.58 -56.69 2.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.977 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.593 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -119.11 -144.74 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.321 . . . . 0.0 111.416 -179.396 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -133.83 170.1 16.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.957 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -75.32 -173.83 2.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.217 -179.134 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.533 ' ND1' HG22 ' A' ' 56' ' ' VAL . 85.3 t60 -130.9 -75.48 0.53 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.423 0.63 . . . . 0.0 110.944 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.488 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER -164.45 129.37 2.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.788 -178.761 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.645 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -92.59 158.23 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.166 0.508 . . . . 0.0 112.362 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.608 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 5.1 m-20 -123.41 124.72 43.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.517 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -86.78 72.58 10.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.782 0.325 . . . . 0.0 110.624 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.559 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -100.05 136.0 20.25 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.93 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.76 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 64.2 Cg_endo -86.25 158.08 9.71 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.71 2.274 . . . . 0.0 112.629 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.725 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.9 mm -127.28 -83.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.657 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.756 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.83 -148.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.283 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -71.58 -32.81 68.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.826 0.346 . . . . 0.0 110.591 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.65 7.23 0.58 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.638 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.756 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.3 mt -91.41 102.33 15.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.905 0.383 . . . . 0.0 110.814 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.76 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 75.3 t -92.64 130.03 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.848 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -94.94 159.27 15.11 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.814 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.608 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 10.5 mp -117.93 119.12 33.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.397 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 4.1 m-20 -89.66 91.13 8.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.35 0.595 . . . . 0.0 110.159 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.674 HG21 HG12 ' A' ' 26' ' ' ILE . 5.9 t -87.04 103.24 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.418 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 15.1 mtt -84.63 166.13 17.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.237 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.695 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.6 m -140.0 135.21 37.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.868 0.366 . . . . 0.0 111.616 -178.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.533 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.79 110.62 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.759 178.483 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 4' ' ' VAL . 11.3 m -130.3 144.71 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.043 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.24 -64.14 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.417 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -80.94 -6.92 59.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.882 0.372 . . . . 0.0 110.635 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.593 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.88 -147.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.058 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -147.69 -161.65 1.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.78 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.56 13.08 30.6 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.579 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.26 -7.65 60.59 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.511 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -4.5 36.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.892 0.377 . . . . 0.0 110.216 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.64 -23.69 18.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.03 177.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.88 -28.83 62.34 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.038 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -59.87 -56.5 21.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.577 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -58.58 -35.51 72.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.492 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -61.33 -51.11 70.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.438 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.1 p -64.01 -17.9 63.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.533 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.74 HD22 HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.25 -31.13 62.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.533 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.93 -10.24 27.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.687 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.02 26.76 1.01 Allowed Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.74 HD13 HD22 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -73.2 -169.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.291 -0.455 . . . . 0.0 111.087 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -50.58 97.93 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 111.193 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.99 -31.68 81.51 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.778 -0.647 . . . . 0.0 112.927 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.59 -37.27 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.137 0.494 . . . . 0.0 109.982 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.671 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 1.5 m -95.37 87.8 4.91 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.039 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -76.45 135.62 39.4 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.037 HG21 HG22 ' A' ' 8' ' ' ILE . 2.6 mt -101.45 148.58 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.566 -175.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.682 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 33.6 tp10 -85.95 69.89 10.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.701 HG23 ' HB ' ' A' ' 80' ' ' ILE . 61.7 t -80.69 57.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.679 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -132.76 -2.56 3.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.874 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.765 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 2.6 m-20 -85.3 131.51 34.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.267 -178.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.479 HG22 ' HD2' ' A' ' 87' ' ' ARG . 2.6 p -150.74 158.04 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.017 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 4.9 mtt180 -148.27 81.79 1.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.013 0.435 . . . . 0.0 111.06 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.479 ' HD2' HG22 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -78.16 82.28 4.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.132 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.674 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 10.3 mp -80.7 84.11 6.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.294 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.926 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.625 ' HG2' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.986 0.422 . . . . 0.0 111.311 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.405 ' H ' ' H ' ' A' ' 3' ' ' ASP . . . -173.54 10.97 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.581 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.679 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -89.76 160.93 16.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.908 0.385 . . . . 0.0 111.49 -179.427 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -107.87 128.65 62.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.32 177.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 83.2 t -129.54 115.25 33.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.055 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.537 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.56 165.98 12.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.76 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.775 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.9 m -141.99 127.01 18.36 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.588 0.709 . . . . 0.0 111.898 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.006 HG22 HG21 ' A' ' 80' ' ' ILE . 8.3 mm -120.57 108.85 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.925 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.817 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.77 96.85 8.52 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.613 ' CB ' HG12 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -92.85 139.98 17.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -176.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.643 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -146.14 122.57 5.82 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.249 179.328 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.598 ' HG2' HG13 ' A' ' 17' ' ' VAL . 11.6 Cg_exo -72.9 120.86 6.89 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.462 2.775 . . . . 0.0 112.383 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.57 -31.21 65.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.338 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.58 151.02 79.95 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.039 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.591 ' HA ' HD21 ' A' ' 48' ' ' LEU . 41.9 Cg_endo -66.86 -3.32 9.27 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.421 2.081 . . . . 0.0 112.003 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.16 42.69 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.353 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.598 HG13 ' HG2' ' A' ' 12' ' ' PRO . 95.7 t -65.02 77.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.068 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 62.7 m-20 -68.93 100.86 1.26 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.165 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.76 ' HG ' HD11 ' A' ' 51' ' ' LEU . 3.1 tt -62.96 -49.21 75.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.481 -178.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -68.15 -38.26 81.94 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.739 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -69.78 -37.13 76.25 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.011 177.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -65.42 -34.12 77.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.697 177.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -47.26 85.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.088 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.487 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -69.32 -37.15 77.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.188 0.518 . . . . 0.0 110.388 179.146 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 12.5 mt-10 -66.26 -31.02 71.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.017 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.708 HG12 HG21 ' A' ' 53' ' ' VAL . 2.1 mt -62.38 -42.69 96.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.444 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -57.72 -39.66 77.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.443 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -74.83 -24.24 58.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.708 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.792 ' HB2' HD11 ' A' ' 74' ' ' ILE . 2.4 ptp180 -88.56 -12.84 41.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.758 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.42 HG23 ' HD2' ' A' ' 31' ' ' PRO . 22.7 mm -57.65 135.44 82.58 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.577 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.626 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.5 Cg_endo -53.07 126.63 22.11 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.509 2.139 . . . . 0.0 112.335 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -58.05 -2.01 0.15 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.401 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -81.83 -46.36 6.77 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.515 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.472 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.55 -142.51 0.24 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.672 0.272 . . . . 0.0 110.993 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -139.44 173.09 11.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.022 0.439 . . . . 0.0 110.855 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -74.44 -176.75 2.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.236 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.52 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 83.4 t60 -131.73 -71.92 0.55 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.475 0.655 . . . . 0.0 111.167 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.531 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -162.72 128.62 3.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.992 -177.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.683 HD13 HG22 ' A' ' 53' ' ' VAL . 2.5 mt -94.77 160.1 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.118 -177.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.662 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.1 t0 -127.38 128.79 46.44 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.633 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -87.34 73.38 9.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.789 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.511 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -98.88 133.43 22.33 Favored Pre-proline 0 C--O 1.225 -0.22 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.309 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.794 ' HB3' HG22 ' A' ' 49' ' ' VAL . 62.6 Cg_endo -87.56 157.03 7.79 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.519 2.146 . . . . 0.0 113.086 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.712 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.3 mm -124.74 -83.01 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.245 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.457 ' H ' ' HB ' ' A' ' 44' ' ' ILE . . . -67.3 -156.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.034 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -71.94 -25.1 61.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.625 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.51 0.98 0.33 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.119 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 15' ' ' PRO . 6.0 mt -92.01 100.24 12.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.887 0.375 . . . . 0.0 110.765 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.794 HG22 ' HB3' ' A' ' 43' ' ' PRO . 70.0 t -92.52 132.8 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.646 -178.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.712 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.86 162.0 13.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.006 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.76 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.2 mp -120.63 121.15 37.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.546 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.551 HD22 ' HB3' ' A' ' 9' ' ' LYS . 1.2 m120 -90.11 91.66 8.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.207 0.527 . . . . 0.0 110.042 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.708 HG21 HG12 ' A' ' 26' ' ' ILE . 11.3 t -86.73 104.34 13.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.531 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.718 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -85.01 162.89 19.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.905 178.186 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' A' ' 6' ' ' ALA . 4.6 m -136.86 127.02 39.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.949 0.404 . . . . 0.0 111.116 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.52 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 0.4 OUTLIER -94.36 109.86 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.938 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 4' ' ' VAL . 2.3 m -128.24 146.63 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.664 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.28 -61.94 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.536 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -80.21 -11.26 59.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.092 0.472 . . . . 0.0 110.239 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.472 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.89 -144.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.935 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.45 -166.52 2.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.813 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.86 15.16 22.28 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.534 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.08 -0.54 28.56 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.521 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.44 HG22 ' OG1' ' A' ' 34' ' ' THR . 1.3 p -73.45 -3.45 27.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.944 0.402 . . . . 0.0 110.355 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.92 -23.72 20.22 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.163 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.17 -27.53 61.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.074 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -59.58 -56.28 23.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.488 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -57.88 -36.88 73.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.612 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.93 -51.86 67.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.552 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.422 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 54.7 p -64.59 -20.29 66.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.85 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.634 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -73.09 -27.96 62.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.834 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -14.38 55.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.707 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.35 28.16 0.97 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.819 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' A' ' 29' ' ' ARG . 1.2 tt -72.97 -160.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.497 -0.351 . . . . 0.0 110.933 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.703 ' HB2' HH12 ' A' ' 29' ' ' ARG . 0.1 OUTLIER -50.07 91.15 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.993 0.425 . . . . 0.0 111.011 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.3 -26.54 66.28 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.337 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.8 p -86.62 -39.59 13.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.282 0.563 . . . . 0.0 110.09 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.617 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 11.9 t -95.96 90.35 5.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.331 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -75.77 132.29 40.35 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.006 HG21 HG22 ' A' ' 8' ' ' ILE . 12.5 mt -101.08 147.3 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.479 -175.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.689 ' HG2' ' HB2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -85.62 73.69 10.4 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.106 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.739 HG23 ' HB ' ' A' ' 80' ' ' ILE . 90.5 t -80.97 55.55 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.743 -174.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.68 2.91 3.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.403 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.775 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 30.3 t0 -85.5 137.4 32.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.778 0.323 . . . . 0.0 110.854 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 p -146.66 160.6 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.1 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.5 mtt-85 -148.92 89.29 1.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.839 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -78.8 109.42 13.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.723 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.679 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 10.2 mp -81.83 77.8 8.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.81 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 17.1 ptp . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.859 179.736 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.593 ' HG2' ' H ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 121.078 0.466 . . . . 0.0 111.027 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.593 ' H ' ' HG2' ' A' ' 1' ' ' MET . . . -161.17 -9.6 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.192 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -95.19 154.09 17.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.209 -0.495 . . . . 0.0 111.421 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.648 HG13 ' HA ' ' A' ' 87' ' ' ARG . 15.8 t -98.48 114.0 34.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.798 177.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 38.8 t -104.76 115.19 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.343 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.776 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -93.07 166.19 12.47 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.71 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 10.1 m -142.12 136.52 30.16 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.542 0.687 . . . . 0.0 112.44 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.975 HG22 HG21 ' A' ' 80' ' ' ILE . 8.3 mm -125.53 105.55 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.991 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.756 ' C ' HG23 ' A' ' 80' ' ' ILE . 2.2 mmmt -97.38 96.97 8.73 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -176.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.467 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.5 m -94.02 136.15 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.875 0.369 . . . . 0.0 111.931 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.63 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -146.9 123.16 5.58 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.314 179.306 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.64 ' CD ' HG13 ' A' ' 17' ' ' VAL . 10.2 Cg_exo -73.86 122.25 7.58 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.562 2.841 . . . . 0.0 112.077 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -57.47 -32.04 66.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.448 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.35 152.32 81.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.032 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.552 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 42.2 Cg_endo -67.55 -3.23 9.79 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.417 2.078 . . . . 0.0 112.154 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.8 43.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.103 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.64 HG13 ' CD ' ' A' ' 12' ' ' PRO . 93.7 t -65.29 75.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.389 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 3.8 m-20 -70.33 88.88 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.879 HD13 ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.18 -38.43 91.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.825 -177.187 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.94 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 1.4 tt0 -70.67 -36.23 73.23 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.05 0.452 . . . . 0.0 110.086 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.61 -37.54 76.92 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.52 ' CD2' ' HG3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -66.45 -30.19 70.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.909 177.441 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.94 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -54.53 -46.41 73.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.437 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 7.2 mtmt -67.14 -44.53 79.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.513 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -65.19 -25.96 67.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.566 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.741 HG12 HG21 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -60.47 -49.65 83.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.361 -179.368 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.478 ' OE1' HD22 ' A' ' 36' ' ' LEU . 6.1 mm-40 -62.97 -32.48 73.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.155 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 15.3 mt-10 -74.62 -24.08 58.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.024 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.734 ' HB2' HD11 ' A' ' 74' ' ' ILE . 1.2 ptp85 -91.95 -13.51 31.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.362 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 26' ' ' ILE . 10.1 mm -59.49 140.16 88.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.911 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.587 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.4 Cg_endo -51.44 112.7 0.87 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.744 2.296 . . . . 0.0 112.119 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.77 -0.87 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.253 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.03 -35.95 16.76 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.956 -178.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.5 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.3 -142.96 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.694 0.247 . . . . 0.0 110.96 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 8.1 mt-10 -135.12 167.01 21.75 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.883 0.373 . . . . 0.0 111.116 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.497 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -75.32 -179.89 4.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.384 -179.033 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.653 ' ND1' HG22 ' A' ' 56' ' ' VAL . 79.4 t60 -130.77 -75.81 0.53 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.96 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.615 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -165.43 131.84 2.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.744 -178.51 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.713 HG12 HG13 ' A' ' 53' ' ' VAL . 2.5 mt -91.41 155.93 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 112.362 -176.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.601 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 61.0 m-20 -120.42 126.68 51.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.692 -178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.39 71.38 9.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.819 0.343 . . . . 0.0 110.304 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.521 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.81 134.25 21.14 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.796 -179.619 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.791 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 73.7 Cg_endo -87.07 157.69 8.5 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.575 2.184 . . . . 0.0 112.608 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.5 mm -125.65 -82.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.36 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.537 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.05 -153.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -71.74 -28.22 63.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.637 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.45 4.58 0.5 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.97 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.552 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.7 mt -92.34 102.61 15.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.859 0.361 . . . . 0.0 110.975 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.791 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 76.6 t -93.0 130.47 42.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.792 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.727 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.21 153.31 17.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.916 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.601 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 10.5 mp -111.53 117.18 32.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.33 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.607 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.2 m120 -89.79 92.48 9.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.208 0.528 . . . . 0.0 110.379 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.741 HG21 HG12 ' A' ' 26' ' ' ILE . 4.0 t -86.81 105.82 15.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.274 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.486 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.1 OUTLIER -84.62 166.56 17.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.432 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.776 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.9 m -138.99 139.3 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.223 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.653 HG22 ' ND1' ' A' ' 37' ' ' HIS . 1.9 t -93.57 106.61 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.137 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.617 HG13 HG23 ' A' ' 55' ' ' VAL . 2.8 m -127.82 155.61 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.793 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.79 -73.41 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.087 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.67 0.89 36.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.994 0.426 . . . . 0.0 110.494 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.492 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.02 -146.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.019 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.82 -165.35 2.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.936 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.3 13.34 33.97 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.433 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.01 -4.23 47.75 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.536 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.6 p -75.04 -3.92 35.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.966 0.412 . . . . 0.0 110.105 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -55.43 -23.55 25.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.258 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.11 -29.63 60.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.874 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.587 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.78 -56.29 21.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.337 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.681 ' HA ' HD12 ' A' ' 71' ' ' LEU . 3.3 mt-10 -58.57 -33.92 70.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.431 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -51.85 65.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.261 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.58 -16.83 61.93 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.028 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.02 HD11 HG11 ' A' ' 82' ' ' VAL . 2.1 mt -72.3 -33.52 67.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.374 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -9.7 15.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.0 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.08 26.73 1.0 Allowed Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.734 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.9 OUTLIER -73.3 -166.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.153 -0.523 . . . . 0.0 111.407 -178.437 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 2.7 mm-40 -51.61 101.65 0.04 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.878 0.371 . . . . 0.0 110.901 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.75 -33.95 88.33 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.776 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -86.02 -39.45 13.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 0.0 110.346 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 48.3 t -96.06 91.22 5.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.782 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -77.79 134.02 38.11 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.975 HG21 HG22 ' A' ' 8' ' ' ILE . 2.9 mp -101.38 148.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.379 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.532 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.3 tp10 -86.02 69.32 10.51 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 1.02 HG11 HD11 ' A' ' 71' ' ' LEU . 47.7 t -81.12 51.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.18 -174.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.82 6.64 4.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.542 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.71 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 2.3 m-20 -85.29 138.2 32.47 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.441 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.45 151.63 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.151 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.577 ' HB3' HD21 ' A' ' 88' ' ' LEU . 5.8 mtt180 -149.53 78.2 1.36 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.018 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.648 ' HA ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -79.63 79.67 6.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.52 -179.708 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.577 HD21 ' HB3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -81.06 93.82 6.47 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.369 178.734 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.3 mtm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.245 -0.884 . . . . 0.0 111.005 -179.924 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 121.424 0.63 . . . . 0.0 112.115 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.76 -13.19 0.04 OUTLIER Glycine 0 C--N 1.331 0.261 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.409 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 1.6 m-20 -94.72 174.98 6.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.182 0.515 . . . . 0.0 111.943 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.444 ' HB ' HG23 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -103.17 132.22 49.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.361 177.262 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 86' ' ' ARG . 42.1 t -128.62 128.09 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.701 0.286 . . . . 0.0 111.652 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.698 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -99.4 167.04 10.88 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.829 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.4 m -142.83 133.2 24.79 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.594 0.712 . . . . 0.0 112.386 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.977 HG22 HG21 ' A' ' 80' ' ' ILE . 5.9 mm -125.89 108.43 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.777 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.721 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -98.7 96.69 8.09 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.376 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.802 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.9 m -94.0 138.02 21.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.659 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.76 119.57 4.57 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 121.157 0.503 . . . . 0.0 111.806 179.41 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 21.1 Cg_exo -69.71 123.64 10.32 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.464 2.776 . . . . 0.0 112.007 178.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.17 -30.52 64.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.508 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 m -77.6 148.52 76.74 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.053 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.64 -6.6 14.21 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.419 2.079 . . . . 0.0 111.779 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -93.44 36.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.605 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.623 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.72 88.49 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.78 0.8 . . . . 0.0 110.134 -179.569 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.568 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 32.9 m-20 -68.25 104.27 1.79 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.034 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.792 ' HG ' HD11 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -61.24 -52.2 65.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.707 -178.146 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.743 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -71.2 -34.37 70.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.277 -177.782 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -68.28 -35.93 78.61 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.568 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -66.16 -33.53 75.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.384 176.456 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.743 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -55.92 -46.61 78.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.132 178.65 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -43.31 90.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.798 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.541 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 11.3 mt-10 -66.55 -30.73 71.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.257 0.551 . . . . 0.0 110.722 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.751 HG12 HG21 ' A' ' 53' ' ' VAL . 1.6 mt -61.75 -43.92 97.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.816 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.21 -38.8 90.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.063 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 10.6 pt-20 -77.84 -21.16 51.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.553 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.8 ' HB2' HD11 ' A' ' 74' ' ' ILE . 20.0 ptt85 -89.86 -9.57 48.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.19 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 26' ' ' ILE . 32.6 mm -59.7 138.16 89.92 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.281 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.639 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.2 Cg_endo -50.83 118.86 4.56 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.868 2.378 . . . . 0.0 112.279 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -59.13 -1.2 0.16 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.116 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.26 -42.82 8.39 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.918 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.688 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.49 -144.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.685 0.279 . . . . 0.0 110.951 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -133.35 167.08 21.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.874 0.368 . . . . 0.0 110.807 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.538 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.8 pt? -75.92 -176.01 3.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.23 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.58 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.8 t60 -130.85 -76.46 0.53 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.369 0.604 . . . . 0.0 111.195 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 2.2 tptt -164.53 133.52 3.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.794 -178.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.695 HG23 HG22 ' A' ' 53' ' ' VAL . 1.7 mt -93.09 158.2 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -123.79 125.51 44.83 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.318 -178.635 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.454 ' H ' ' HG3' ' A' ' 41' ' ' GLU . 0.9 OUTLIER -86.12 73.84 10.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.93 0.395 . . . . 0.0 110.508 178.216 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.493 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -98.94 131.02 26.27 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.295 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.82 ' HB3' HG22 ' A' ' 49' ' ' VAL . 59.0 Cg_endo -87.53 157.57 7.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.485 2.123 . . . . 0.0 112.949 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.705 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.4 mm -124.34 -82.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.107 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -67.25 -157.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.84 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -72.28 -22.82 61.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.666 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.57 -1.18 0.25 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.039 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 8.8 mp -90.7 100.99 13.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.81 0.305 . . . . 0.0 110.966 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.82 HG22 ' HB3' ' A' ' 43' ' ' PRO . 93.4 t -94.57 132.94 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.971 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.705 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.38 162.9 13.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.847 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.792 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.2 mp -121.12 120.36 35.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.716 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.2 m120 -90.92 91.18 8.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.281 0.562 . . . . 0.0 110.027 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.751 HG21 HG12 ' A' ' 26' ' ' ILE . 5.0 t -87.48 104.11 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.32 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.709 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.3 OUTLIER -84.69 165.28 18.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.339 179.187 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.698 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.5 m -138.41 137.47 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.451 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.58 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -94.35 118.19 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.911 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.688 HG12 HG21 ' A' ' 34' ' ' THR . 35.4 m -130.2 142.4 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.95 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.4 -70.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.455 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -81.41 -5.76 58.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 0.0 110.5 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.547 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.67 -152.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.196 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.413 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -148.01 -162.35 1.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.803 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -81.07 14.07 28.93 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.276 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.0 -3.73 45.42 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.36 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -74.67 -3.39 31.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.016 0.436 . . . . 0.0 110.097 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.99 -23.47 19.44 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.045 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.0 -26.87 60.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.11 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.639 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.6 -52.79 62.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.107 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -59.21 -37.32 77.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.308 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -49.05 78.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.137 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -63.85 -19.78 65.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.327 178.656 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.599 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.0 -30.7 62.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.422 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 p -64.51 -9.52 19.43 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.739 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.14 22.05 0.98 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.108 -0.567 . . . . 0.0 111.968 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.8 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -72.82 -164.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 122.3 0.24 . . . . 0.0 110.666 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.589 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -50.81 100.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.929 0.395 . . . . 0.0 110.981 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.4 -27.03 68.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.048 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.4 p -90.15 -36.83 8.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.094 0.473 . . . . 0.0 110.824 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 1.6 m -95.6 89.26 5.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.602 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -76.32 132.1 39.59 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.977 HG21 HG22 ' A' ' 8' ' ' ILE . 15.7 mt -101.18 147.16 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.469 -175.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.634 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 16.3 tp10 -85.53 69.93 10.71 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 173.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.706 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.0 t -80.17 48.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.001 -174.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.85 9.29 4.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.291 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.829 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 8.6 t70 -85.92 151.42 23.78 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.856 0.36 . . . . 0.0 111.082 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.48 ' C ' ' HG2' ' A' ' 86' ' ' ARG . 3.1 p -147.82 160.04 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.17 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.635 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -146.32 95.24 2.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.048 -179.498 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -79.1 86.97 4.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.335 178.446 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.477 HD13 ' HB ' ' A' ' 5' ' ' VAL . 11.2 mp -81.96 76.78 8.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.86 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.1 mmt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.946 179.906 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.786 0.327 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 89' ' ' MET . . . 173.42 -10.09 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.38 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.422 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 11.6 p-10 -88.92 140.78 29.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 111.382 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.627 ' HB ' HG22 ' A' ' 57' ' ' VAL . 1.7 t -96.83 107.0 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.724 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 9.7 t -104.88 110.78 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.12 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.619 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -101.2 166.86 10.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.338 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.754 HG23 ' HG3' ' A' ' 54' ' ' MET . 8.5 m -143.33 129.16 19.41 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.699 0.762 . . . . 0.0 112.251 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.008 HG22 HG21 ' A' ' 80' ' ' ILE . 6.3 mm -121.91 107.97 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.523 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.772 ' C ' HG23 ' A' ' 80' ' ' ILE . 2.8 mmmt -97.28 94.56 7.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.503 ' N ' HG23 ' A' ' 80' ' ' ILE . 2.0 m -93.37 137.84 21.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.741 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -147.31 119.53 4.72 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 121.306 0.574 . . . . 0.0 111.915 178.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 22.2 Cg_exo -68.51 121.89 8.85 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.372 2.715 . . . . 0.0 111.982 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -56.25 -29.61 61.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.269 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.424 ' O ' HG12 ' A' ' 17' ' ' VAL . 1.3 p -76.97 151.16 81.81 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.173 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 48.4 Cg_endo -67.85 -6.47 17.0 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.165 1.91 . . . . 0.0 111.387 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -92.6 33.92 1.1 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.565 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.635 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.05 87.15 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.8 0.809 . . . . 0.0 110.015 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 15.6 m-20 -70.08 106.99 3.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.47 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.924 ' HG ' HD11 ' A' ' 51' ' ' LEU . 2.2 tt -62.16 -49.58 75.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.226 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -68.67 -37.55 79.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.864 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -70.95 -34.0 71.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.58 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -65.34 -32.62 74.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.574 177.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.644 ' HA ' HD12 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -58.37 -44.49 88.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.604 178.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.5 -42.49 92.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.337 178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.63 -32.12 73.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.179 0.514 . . . . 0.0 110.337 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.662 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 9.7 mt -60.94 -44.35 97.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.745 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -59.96 -39.65 86.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.542 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -74.73 -24.31 58.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.379 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.847 HH22 ' HB ' ' A' ' 8' ' ' ILE . 24.7 ptt85 -91.06 -14.02 32.08 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.629 HD11 HG11 ' A' ' 53' ' ' VAL . 12.1 mm -58.16 137.78 84.38 Favored Pre-proline 0 C--N 1.332 -0.186 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.481 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.492 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 5.2 Cg_endo -45.3 119.03 2.34 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.807 2.338 . . . . 0.0 112.231 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -57.3 -4.55 0.23 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.076 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.95 -45.15 6.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.516 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.43 -142.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.765 0.316 . . . . 0.0 111.135 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -138.7 175.55 9.47 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.968 0.413 . . . . 0.0 110.748 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.493 HD23 ' H ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -74.69 -175.69 2.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.342 -178.862 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.563 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 85.5 t60 -131.35 -68.87 0.64 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.095 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -159.34 121.27 3.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.257 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.675 HD13 HG22 ' A' ' 53' ' ' VAL . 2.5 mt -91.72 157.5 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.513 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.647 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.64 123.66 36.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.804 -178.164 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.496 ' HB3' HD11 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -85.22 70.71 10.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.927 0.394 . . . . 0.0 110.426 177.826 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.547 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -97.41 135.73 21.65 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.767 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.782 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 64.3 Cg_endo -86.62 157.73 9.16 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.609 2.206 . . . . 0.0 112.739 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.706 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.8 mm -126.56 -83.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.444 -177.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.741 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.52 -149.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -70.75 -32.85 70.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.638 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.56 7.76 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.631 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.741 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.7 mt -90.9 101.56 14.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 110.685 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.782 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 73.8 t -93.0 128.99 44.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.923 -178.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.741 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.64 156.6 16.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.853 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.924 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.1 mp -115.76 119.97 37.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.461 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.514 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 3.7 m-20 -89.82 91.0 8.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.337 0.589 . . . . 0.0 110.016 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.675 HG22 HD13 ' A' ' 39' ' ' ILE . 14.2 t -87.37 102.35 12.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.539 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.754 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.1 OUTLIER -84.61 166.93 16.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.852 178.102 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.619 HG22 ' HB3' ' A' ' 6' ' ' ALA . 4.4 m -138.72 126.4 27.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.089 0.471 . . . . 0.0 111.431 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.563 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 1.3 p -99.06 106.85 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.696 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.627 HG22 ' HB ' ' A' ' 4' ' ' VAL . 1.3 m -124.99 166.6 20.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.649 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.25 -64.93 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.729 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.41 -5.8 57.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.943 0.401 . . . . 0.0 110.58 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.66 -147.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.037 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.62 -162.56 1.57 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.764 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.8 14.11 27.11 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.429 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.83 -4.28 46.7 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.46 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -74.31 -7.3 52.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.923 0.392 . . . . 0.0 110.26 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.93 -23.38 31.52 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.984 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.3 -24.52 55.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.847 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.11 -55.93 26.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.137 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.25 -34.96 72.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.408 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -60.9 -50.97 71.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.387 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.462 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 5.0 p -64.0 -20.92 66.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.544 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.594 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.11 -27.44 62.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.565 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -14.37 58.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.749 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.41 26.34 0.97 Allowed Glycine 0 N--CA 1.451 -0.3 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.897 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 29' ' ' ARG . 2.8 tt -73.24 -163.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.55 -0.325 . . . . 0.0 110.906 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.702 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -52.16 90.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.989 0.423 . . . . 0.0 110.862 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.08 -24.86 59.01 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.844 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.96 -35.76 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.174 0.511 . . . . 0.0 110.251 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.702 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -95.63 90.39 5.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.771 -179.498 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -75.06 130.25 38.99 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.008 HG21 HG22 ' A' ' 8' ' ' ILE . 3.0 mp -100.93 149.12 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.38 -175.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.478 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 28.4 tt0 -85.69 68.99 10.58 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 173.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.709 HG23 ' HB ' ' A' ' 80' ' ' ILE . 48.7 t -80.47 58.34 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.728 -175.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.36 -3.9 3.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.879 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.693 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 8.3 m-20 -85.15 124.3 31.66 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.03 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.2 p -148.83 136.58 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.241 0.543 . . . . 0.0 111.653 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.56 HH21 ' HB3' ' A' ' 84' ' ' ASP . 1.1 mpt_? -134.52 87.42 2.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.919 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.42 82.2 7.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.301 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -82.93 90.46 6.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.663 179.26 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.447 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.449 ' N ' ' HB2' ' A' ' 88' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 3' ' ' ASP . . . -159.93 -3.27 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.646 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.532 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 3.5 p30 -94.85 142.89 26.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.329 -0.435 . . . . 0.0 111.46 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.512 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 1.8 t -98.14 103.01 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.329 177.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.531 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 14.5 t -104.31 115.05 45.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.874 0.368 . . . . 0.0 111.752 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.587 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -97.31 165.05 12.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.687 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 8.5 m -140.67 131.45 25.81 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.643 0.735 . . . . 0.0 112.019 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.035 HG22 HG21 ' A' ' 80' ' ' ILE . 2.6 mm -124.32 106.0 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.667 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.584 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.55 95.26 7.86 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.634 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.772 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.4 m -92.89 136.05 26.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.804 0.335 . . . . 0.0 111.897 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.656 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -146.41 120.1 5.18 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 121.142 0.496 . . . . 0.0 111.81 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.4 Cg_exo -69.34 122.88 9.67 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.419 2.746 . . . . 0.0 111.9 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.57 -29.63 64.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.291 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.472 ' O ' HG12 ' A' ' 17' ' ' VAL . 1.5 p -76.34 151.09 83.19 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.143 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 46.5 Cg_endo -67.41 -6.77 17.26 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.237 1.958 . . . . 0.0 111.457 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.17 35.63 0.99 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.435 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.656 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -68.12 83.8 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.93 0.871 . . . . 0.0 110.588 -179.046 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.556 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 19.4 m-20 -73.08 98.38 2.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.902 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.793 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -63.66 -43.81 95.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.589 -178.068 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.884 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 4.1 tp10 -69.23 -37.0 77.8 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.85 0.357 . . . . 0.0 110.321 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.572 ' O ' ' HD3' ' A' ' 24' ' ' LYS . . . -68.8 -38.12 79.72 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -68.12 -24.82 65.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.2 177.218 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.884 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -58.59 -44.9 89.99 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.24 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.572 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -68.62 -40.01 80.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.762 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.731 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 4.9 mm-40 -67.8 -29.4 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.336 0.588 . . . . 0.0 110.302 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.729 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.2 mt -63.92 -38.38 82.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.036 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.85 -40.95 94.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.221 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.731 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -77.77 -20.8 52.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.514 -178.728 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.792 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.23 -11.95 45.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.342 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.639 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.4 mm -60.11 138.28 91.26 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.239 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.608 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.2 Cg_endo -50.68 114.71 1.59 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.793 2.328 . . . . 0.0 112.062 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.33 2.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.47 -45.73 6.78 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.789 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.588 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -130.36 -133.35 0.21 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.664 0.232 . . . . 0.0 111.175 -179.515 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -136.63 170.08 16.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.905 0.383 . . . . 0.0 110.941 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.538 HD22 HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -75.59 -174.09 2.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.108 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.506 ' ND1' HG22 ' A' ' 56' ' ' VAL . 85.2 t60 -130.45 -76.03 0.53 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.328 0.585 . . . . 0.0 110.939 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.546 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -164.91 126.67 2.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.868 -178.594 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.633 HD13 HG22 ' A' ' 53' ' ' VAL . 2.8 mt -90.8 159.82 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.986 0.422 . . . . 0.0 111.865 -177.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.634 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.12 124.75 39.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.946 -178.147 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.67 68.82 10.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.914 0.388 . . . . 0.0 110.216 177.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.55 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -97.11 137.41 21.24 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.616 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.797 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 73.7 Cg_endo -86.03 156.72 9.93 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.486 2.124 . . . . 0.0 112.738 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.742 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.1 mm -124.56 -82.23 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.3 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.526 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.02 -152.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.992 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -71.8 -28.12 63.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.707 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.92 4.62 0.46 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.101 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.556 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.5 mt -92.43 104.24 16.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.842 0.353 . . . . 0.0 110.966 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.797 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 76.3 t -93.12 131.35 40.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.858 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.25 164.19 12.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.072 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.3 mp -120.63 117.69 28.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.211 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.562 ' ND2' ' HB3' ' A' ' 40' ' ' ASP . 2.0 m-20 -90.47 92.05 8.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.254 0.55 . . . . 0.0 110.422 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.684 HG21 HG12 ' A' ' 26' ' ' ILE . 4.3 t -87.31 101.96 11.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.583 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.488 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 33.4 mtt -84.71 165.91 17.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.218 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.1 m -139.63 133.76 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.38 . . . . 0.0 111.678 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.506 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -98.36 113.47 33.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 178.474 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.512 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 7.7 m -130.49 142.54 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.979 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.38 -62.12 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.583 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.92 -12.19 59.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.002 0.43 . . . . 0.0 110.706 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.588 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -68.07 -144.53 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.106 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.29 -166.82 2.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.72 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.71 15.28 20.7 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.682 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.67 -0.51 32.69 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.602 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 p -74.16 -2.21 23.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.972 0.415 . . . . 0.0 110.148 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -55.07 -24.41 25.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.348 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.78 -27.27 59.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.08 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.608 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.51 -56.12 23.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.809 0.338 . . . . 0.0 110.362 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -58.75 -34.22 71.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.362 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.53 -51.45 68.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.325 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.7 p -63.19 -19.05 64.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.561 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.854 HD22 HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.59 -28.79 61.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.59 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -13.51 47.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.531 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.9 30.92 1.0 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.392 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.854 HD13 HD22 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -72.85 -166.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.165 -0.517 . . . . 0.0 111.173 -178.615 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.681 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 1.4 mp0 -51.05 100.33 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.888 0.375 . . . . 0.0 111.007 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.15 -30.83 71.41 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.794 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 t -87.92 -37.27 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.803 0.335 . . . . 0.0 110.744 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.681 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 32.2 t -95.77 92.42 6.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.844 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -76.58 132.26 39.37 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.035 HG21 HG22 ' A' ' 8' ' ' ILE . 8.0 mt -100.58 144.7 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.088 -175.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.518 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.3 tt0 -85.24 69.56 10.76 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.711 HG23 ' HB ' ' A' ' 80' ' ' ILE . 48.0 t -81.43 56.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 113.92 -1.491 . . . . 0.0 111.249 -174.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -132.44 -0.12 3.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.929 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.687 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 5.5 m-20 -85.45 135.82 33.7 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.251 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' A' ' 87' ' ' ARG . 5.3 p -149.57 152.1 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.554 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.593 ' HB3' HD21 ' A' ' 88' ' ' LEU . 6.8 mtt180 -149.41 75.2 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.264 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.475 ' HA ' HG13 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -81.48 78.27 8.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.557 -178.847 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.593 HD21 ' HB3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -82.8 102.62 11.71 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.417 178.53 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.969 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ttm . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.663 0.268 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.57 -10.04 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.49 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.613 ' OD1' HD12 ' A' ' 88' ' ' LEU . 12.4 p-10 -90.17 147.12 23.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 111.26 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.62 HG13 ' HG3' ' A' ' 87' ' ' ARG . 2.7 t -98.18 125.88 51.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.35 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 21.7 t -113.92 109.74 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.427 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.666 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.66 165.41 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 177.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.803 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.6 m -141.9 132.63 25.62 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.715 0.769 . . . . 0.0 112.273 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.027 HG22 HG21 ' A' ' 80' ' ' ILE . 4.3 mm -123.77 106.79 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.457 -178.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.766 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.62 96.45 8.65 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.221 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.491 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.6 m -94.62 137.62 22.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.904 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.673 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.2 OUTLIER -147.39 121.72 5.06 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 121.264 0.554 . . . . 0.0 111.984 179.251 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 18.7 Cg_exo -71.02 124.11 10.28 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.599 2.866 . . . . 0.0 112.15 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -57.9 -31.42 66.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.444 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.2 m -77.64 150.64 79.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.04 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.571 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 40.1 Cg_endo -66.66 -6.51 15.6 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.379 2.052 . . . . 0.0 111.942 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.53 34.0 0.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.405 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.662 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.52 84.54 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 121.774 0.797 . . . . 0.0 110.111 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 11.5 m-20 -71.64 108.73 5.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.197 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.605 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -63.45 -43.62 96.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.793 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.605 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 20.6 tp10 -68.95 -39.19 79.68 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.655 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.519 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -69.92 -36.54 75.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.44 0.638 . . . . 0.0 109.93 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -66.48 -33.89 76.71 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.48 177.383 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -45.65 89.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.079 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -68.88 -39.85 79.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.138 0.494 . . . . 0.0 110.385 179.121 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.521 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 31.9 mm-40 -66.01 -29.34 69.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.254 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.714 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 2.1 mt -62.22 -44.42 99.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.964 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.72 -36.72 77.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.985 0.421 . . . . 0.0 110.539 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -75.37 -23.93 57.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.687 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.762 ' HD2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.05 -14.27 39.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.524 -178.573 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 26' ' ' ILE . 39.1 mm -58.55 136.82 86.04 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.461 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.607 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 17.7 Cg_endo -58.89 131.24 40.72 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.372 2.048 . . . . 0.0 112.534 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -61.0 0.53 0.22 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.962 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.52 -59.03 2.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.708 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.569 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -117.9 -143.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.668 0.27 . . . . 0.0 110.885 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -136.41 167.8 20.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.87 0.367 . . . . 0.0 110.711 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.403 ' H ' ' CD2' ' A' ' 36' ' ' LEU . 1.6 pt? -75.08 -175.71 2.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.108 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.522 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 81.4 t60 -131.52 -75.88 0.52 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.315 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -159.37 132.08 6.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.048 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.664 HG23 HG22 ' A' ' 53' ' ' VAL . 1.7 mt -93.37 161.23 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.013 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.76 123.52 35.5 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.593 -178.639 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -85.56 71.16 10.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.897 0.38 . . . . 0.0 110.674 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.547 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.5 mt-10 -98.65 136.28 20.8 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.739 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.777 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 61.5 Cg_endo -87.64 157.26 7.69 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.662 2.241 . . . . 0.0 112.877 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.717 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.2 mm -125.41 -82.75 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.428 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.723 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.26 -150.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.16 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -71.36 -31.49 67.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.592 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.43 6.73 0.58 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.771 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.723 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.9 mt -91.11 102.26 15.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.822 0.344 . . . . 0.0 110.771 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.777 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 70.2 t -93.32 129.65 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.966 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.717 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.42 155.96 16.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.889 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.625 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.3 mp -114.45 118.09 32.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.392 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.52 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.9 m-20 -89.9 92.56 9.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.245 0.545 . . . . 0.0 110.09 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.698 HG21 HG12 ' A' ' 26' ' ' ILE . 6.3 t -86.54 105.77 15.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.445 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 50.6 mtt -84.46 166.67 17.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.409 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.666 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.5 m -138.78 127.57 29.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.237 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.522 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 0.7 OUTLIER -95.68 108.25 20.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.598 179.254 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.569 HG12 HG21 ' A' ' 34' ' ' THR . 3.3 m -125.41 167.03 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.817 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.73 -75.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.842 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -81.3 2.57 27.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 0.0 110.99 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.453 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.78 -147.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.116 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.74 -166.48 2.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.683 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.91 15.16 22.54 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.591 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.39 -5.56 55.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.549 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.43 ' HA ' ' HB2' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -74.08 -4.6 36.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.908 0.385 . . . . 0.0 110.383 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.02 -23.65 20.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.044 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.18 -27.78 62.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.937 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.607 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.54 -56.54 20.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.353 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -58.74 -34.83 71.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.447 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -60.71 -51.96 67.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.471 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.418 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -64.04 -19.33 65.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.572 178.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.614 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -72.92 -28.76 62.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.559 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -11.88 43.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.954 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.2 25.29 0.99 Allowed Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.75 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.762 HD11 ' HD2' ' A' ' 29' ' ' ARG . 2.6 tt -73.32 -163.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.47 -0.365 . . . . 0.0 111.059 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.605 ' N ' HG23 ' A' ' 74' ' ' ILE . 1.8 mp0 -51.01 96.51 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.81 0.338 . . . . 0.0 111.003 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.43 -27.34 69.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.281 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -88.27 -37.94 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.173 0.511 . . . . 0.0 110.435 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -96.23 90.0 5.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.424 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -77.57 134.77 38.18 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.027 HG21 HG22 ' A' ' 8' ' ' ILE . 1.7 mt -101.54 147.42 8.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.563 -176.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.534 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 9.7 tp10 -86.02 70.39 10.6 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 173.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.706 HG23 ' HB ' ' A' ' 80' ' ' ILE . 58.2 t -80.46 52.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.999 -174.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -133.0 3.61 3.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.575 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.803 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 18.8 t0 -85.4 130.64 34.54 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.052 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.517 HG22 ' HD2' ' A' ' 87' ' ' ARG . 4.7 p -148.08 146.04 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.022 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -149.26 95.15 2.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.149 0.5 . . . . 0.0 109.967 -178.644 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.62 ' HG3' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -85.13 106.15 16.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.399 -177.316 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.613 HD12 ' OD1' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -86.7 89.17 7.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.172 176.171 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.6 ttm . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.026 179.984 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.428 ' HB3' ' OXT' ' A' ' 89' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.862 0.363 . . . . 0.0 111.298 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 89' ' ' MET . . . 173.72 -0.59 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.153 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.692 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -90.19 156.8 18.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 111.464 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.88 128.69 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.741 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 13.1 t -125.54 118.34 52.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.039 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.581 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.74 169.76 9.93 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.69 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 10.0 m -143.04 131.85 22.71 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.587 0.708 . . . . 0.0 112.011 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.091 HG22 HG21 ' A' ' 80' ' ' ILE . 7.3 mm -122.98 107.52 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.896 -177.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.779 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.28 95.28 7.6 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -177.7 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.596 HG11 ' NH1' ' A' ' 29' ' ' ARG . 2.0 m -94.64 136.71 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.659 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.53 121.11 4.88 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 121.036 0.446 . . . . 0.0 111.76 179.475 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 17.2 Cg_exo -71.82 118.64 5.74 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.522 2.815 . . . . 0.0 111.946 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -56.21 -28.36 58.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.133 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.38 149.21 78.49 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.106 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 37.9 Cg_endo -66.03 -7.68 17.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.401 2.068 . . . . 0.0 111.92 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.1 36.06 1.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.698 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.624 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.16 87.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.79 0.805 . . . . 0.0 110.09 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 28.0 m-20 -68.32 107.19 2.74 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.336 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.732 HD12 ' NZ ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -60.45 -54.81 41.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.66 -178.619 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.527 ' HG2' ' N ' ' A' ' 21' ' ' ALA . 7.6 pm0 -71.29 -34.46 70.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.279 -177.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.642 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . . . -67.92 -35.71 78.92 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -65.77 -35.25 80.19 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.234 176.159 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.732 ' NZ ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -55.93 -46.83 78.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.034 178.541 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.642 ' HE3' ' HA ' ' A' ' 21' ' ' ALA . 2.6 mtmt -66.41 -43.8 84.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.815 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.737 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 52.9 mt-10 -67.58 -27.0 66.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.247 0.546 . . . . 0.0 110.969 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.652 HG12 HG21 ' A' ' 53' ' ' VAL . 1.1 mt -63.06 -43.14 98.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.951 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -62.56 -37.57 86.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.26 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.737 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 1.4 pp20? -77.21 -22.67 51.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.405 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.846 ' HB2' HD11 ' A' ' 74' ' ' ILE . 4.3 ptp85 -90.6 -11.95 38.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.088 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.646 HG12 ' O ' ' A' ' 26' ' ' ILE . 10.9 mm -61.57 139.29 95.13 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.87 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.667 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 7.3 Cg_endo -47.88 115.87 1.67 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.854 2.37 . . . . 0.0 112.445 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -59.38 0.74 0.1 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.105 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.92 -43.15 7.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.003 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.573 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.15 -139.01 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.712 0.292 . . . . 0.0 111.246 -179.45 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -135.64 169.9 16.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.881 0.372 . . . . 0.0 110.932 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.702 ' H ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -76.38 -175.91 3.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.229 -179.532 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.645 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.3 t60 -131.01 -74.74 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.412 0.625 . . . . 0.0 110.952 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HB3' ' CD2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -163.88 129.27 2.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.667 -178.926 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.696 HG12 HG13 ' A' ' 53' ' ' VAL . 2.8 mt -93.08 155.85 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -176.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.637 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.7 m-20 -117.97 123.0 44.69 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.971 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -88.34 67.68 8.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.96 0.409 . . . . 0.0 110.142 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.688 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.98 148.54 34.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.368 -178.459 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.772 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 30.6 Cg_endo -92.49 160.53 2.97 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.996 2.464 . . . . 0.0 113.266 -177.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.2 mm -128.85 -82.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.248 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.56 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -66.91 -151.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.924 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -72.27 -28.55 63.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.67 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.07 4.99 0.46 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.1 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.9 mt -92.1 106.1 18.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.89 0.345 . . . . 0.0 110.906 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 24.2 t -92.59 132.22 37.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.814 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.75 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.18 163.29 13.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.85 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.637 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.0 mp -120.57 116.17 24.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.513 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 3.8 m-20 -89.65 91.0 8.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.379 0.609 . . . . 0.0 110.046 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.696 HG13 HG12 ' A' ' 39' ' ' ILE . 3.8 t -87.16 105.65 15.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.576 -177.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 62.8 mtt -84.71 165.31 17.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.937 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.3 m -138.69 136.77 43.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.886 0.374 . . . . 0.0 111.581 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.645 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.3 OUTLIER -94.74 108.42 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.778 178.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.434 HG12 ' CB ' ' A' ' 34' ' ' THR . 21.9 m -125.39 137.96 55.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.855 0.359 . . . . 0.0 110.975 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.89 -58.72 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.331 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -81.08 -16.58 52.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.084 0.469 . . . . 0.0 110.4 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.573 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -68.15 -144.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.17 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.5 -163.35 1.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.785 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.9 13.75 29.42 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.544 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.37 -1.24 34.65 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.639 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -74.75 -4.14 35.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.968 0.413 . . . . 0.0 110.205 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -54.96 -23.91 21.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.337 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.07 -25.6 58.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.159 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.667 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.48 -56.59 18.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.8 0.334 . . . . 0.0 110.244 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -58.97 -34.0 71.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.276 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.94 -51.02 69.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.307 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -18.23 63.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.263 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.702 HD22 HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.65 -29.7 62.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.482 179.401 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -10.74 31.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.782 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.1 25.08 1.0 Allowed Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.846 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -73.32 -168.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.338 -0.431 . . . . 0.0 111.235 -179.04 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.558 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -51.09 93.5 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.353 179.137 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.2 -26.32 61.23 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.018 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -87.99 -41.16 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.181 0.515 . . . . 0.0 110.186 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -95.9 87.97 4.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.122 178.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -77.81 135.74 38.0 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.091 HG21 HG22 ' A' ' 8' ' ' ILE . 1.7 mt -101.5 147.72 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.469 -176.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.586 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 7.2 tp10 -86.07 71.09 10.62 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 172.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.688 HG23 ' HB ' ' A' ' 80' ' ' ILE . 59.0 t -80.68 52.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.063 -174.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 m -132.8 4.57 3.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.402 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.69 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.2 m-20 -85.03 140.65 30.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.169 -178.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 p -148.15 157.67 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.221 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 8.8 mtt180 -149.24 90.64 1.76 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.107 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.24 89.81 5.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.853 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.446 HD11 ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -81.38 89.65 6.12 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.629 179.545 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.428 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 9.1 ptp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.964 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.873 0.368 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.41 ' HA2' ' OXT' ' A' ' 89' ' ' MET . . . 173.23 -20.55 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -95.4 164.66 12.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.152 -0.524 . . . . 0.0 111.138 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.823 HG12 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -97.95 117.68 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.048 0.452 . . . . 0.0 110.17 177.483 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 40.8 t -109.71 120.36 60.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.492 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.627 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.03 167.91 11.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.682 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 11.4 m -141.65 131.37 24.18 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.6 0.714 . . . . 0.0 112.185 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.069 HG22 HG21 ' A' ' 80' ' ' ILE . 2.1 mm -120.56 105.01 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.688 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.636 ' HD2' ' HB3' ' A' ' 52' ' ' ASN . 0.9 OUTLIER -96.38 93.98 7.16 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.738 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.745 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.4 m -92.02 136.91 23.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.84 -177.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.675 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.32 119.26 4.67 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 121.131 0.491 . . . . 0.0 111.878 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 17.8 Cg_exo -70.96 122.22 8.59 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.49 2.794 . . . . 0.0 112.198 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.89 -30.3 65.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.388 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.8 148.32 75.73 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.012 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 36.8 Cg_endo -64.74 -6.56 12.65 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.399 2.066 . . . . 0.0 111.774 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -92.03 34.05 1.03 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.6 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.63 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.3 87.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.832 0.825 . . . . 0.0 110.124 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 74.2 m-20 -69.11 104.14 2.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.127 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.871 ' HG ' HD11 ' A' ' 51' ' ' LEU . 1.4 tt -61.05 -52.17 66.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.539 -178.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.705 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -70.5 -36.32 73.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.079 -177.812 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' HB3' ' CB ' ' A' ' 18' ' ' ASP . . . -68.2 -34.63 76.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.157 0.503 . . . . 0.0 109.758 177.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -65.68 -32.12 73.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.861 177.687 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.705 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -54.71 -47.65 73.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.505 179.01 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -66.6 -42.48 86.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.736 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -65.55 -29.3 69.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.185 0.516 . . . . 0.0 110.391 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.695 HG12 HG21 ' A' ' 53' ' ' VAL . 2.0 mt -61.83 -45.58 98.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.217 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -60.49 -35.86 76.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.717 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 17.5 mm-40 -74.17 -23.74 59.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.559 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.819 ' HB2' HD11 ' A' ' 74' ' ' ILE . 2.4 ptp180 -92.57 -14.54 28.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.842 -178.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.552 HD11 HG11 ' A' ' 53' ' ' VAL . 15.2 mm -58.74 139.82 86.07 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.102 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.664 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.4 Cg_endo -50.82 112.16 0.71 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.838 2.359 . . . . 0.0 112.348 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 0.6 0.11 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.341 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.08 -40.01 9.62 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.042 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.539 ' CB ' HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.36 -137.8 0.21 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.647 0.223 . . . . 0.0 110.882 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -136.63 166.9 22.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 111.048 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -76.01 -175.45 3.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.269 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.603 ' ND1' HG22 ' A' ' 56' ' ' VAL . 82.4 t60 -130.73 -74.97 0.53 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.315 0.578 . . . . 0.0 110.829 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.584 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -164.22 132.6 3.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.998 -178.698 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.664 HG12 HG13 ' A' ' 53' ' ' VAL . 2.8 mt -94.39 158.38 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.691 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.1 t0 -123.88 128.55 49.63 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.381 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.445 ' HG2' HD21 ' A' ' 19' ' ' LEU . 13.4 mt-10 -90.8 69.06 6.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.228 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.666 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -100.92 148.03 34.51 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.264 -178.437 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.783 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 21.2 Cg_endo -91.7 159.75 3.48 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.043 2.495 . . . . 0.0 113.362 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' A' ' 50' ' ' ALA . 5.0 mm -127.95 -83.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.248 -178.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.474 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.34 -151.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.031 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -72.11 -28.76 63.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.73 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.2 3.98 0.41 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.126 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.504 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 6.9 mt -91.21 106.09 18.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.892 0.377 . . . . 0.0 110.777 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 40.7 t -92.95 132.06 38.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.694 -178.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.704 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.27 164.09 12.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.093 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.871 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.3 mp -120.64 116.0 24.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.28 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.636 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.1 m120 -89.86 91.93 8.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.315 0.579 . . . . 0.0 110.378 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.695 HG21 HG12 ' A' ' 26' ' ' ILE . 4.6 t -86.8 105.21 14.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.536 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.679 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.6 164.61 18.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.169 178.836 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.627 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.1 m -139.24 141.06 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 111.572 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.603 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.9 t -93.07 100.4 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.668 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.823 HG23 HG12 ' A' ' 4' ' ' VAL . 27.2 m -130.15 140.35 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.046 0.45 . . . . 0.0 111.544 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.32 -61.67 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.51 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -81.34 -7.68 59.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.038 0.446 . . . . 0.0 110.625 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.535 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.77 -139.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.132 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -147.01 -166.27 2.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.77 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.58 12.88 31.79 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.638 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.15 -9.54 63.87 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.512 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -74.48 -5.99 45.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.857 0.361 . . . . 0.0 110.42 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -54.72 -23.79 19.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.056 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.93 -28.59 57.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.952 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.664 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.09 -57.59 11.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.401 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -59.53 -33.59 71.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.451 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.85 -51.42 68.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.238 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.409 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.3 t -63.48 -18.03 63.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.139 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.678 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.23 -29.91 63.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.478 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -12.86 44.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.709 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.26 27.41 0.99 Allowed Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.642 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.819 HD11 ' HB2' ' A' ' 29' ' ' ARG . 1.3 tt -73.17 -162.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.411 . . . . 0.0 111.187 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.633 ' OE1' HG12 ' A' ' 77' ' ' VAL . 1.7 mm-40 -50.89 94.13 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.141 0.496 . . . . 0.0 110.792 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.06 -32.42 62.8 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.692 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.633 HG12 ' OE1' ' A' ' 75' ' ' GLU . 0.4 OUTLIER -87.44 -36.82 10.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 0.0 110.364 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -96.0 89.01 5.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.206 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -75.88 133.87 40.44 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.069 HG21 HG22 ' A' ' 8' ' ' ILE . 6.2 mt -101.12 144.82 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.068 -175.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.596 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 19.4 tp10 -85.34 69.96 10.77 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.693 HG23 ' HB ' ' A' ' 80' ' ' ILE . 49.1 t -80.8 48.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.035 -174.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 m -132.34 8.14 4.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.23 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.682 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.3 m-20 -84.11 150.37 25.59 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.88 0.371 . . . . 0.0 110.928 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.5 p -148.31 154.56 10.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.534 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -150.52 84.8 1.37 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.227 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.52 85.67 5.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.62 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.445 HD23 ' N ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -83.76 98.09 9.5 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.262 177.848 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.41 ' OXT' ' HA2' ' A' ' 2' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.85 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.828 0.347 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.87 7.87 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.786 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.765 ' HB2' HD12 ' A' ' 88' ' ' LEU . 3.7 m-20 -88.63 147.74 24.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.811 0.339 . . . . 0.0 111.268 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.618 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -106.92 107.84 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.0 178.183 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.57 ' HB ' ' HG2' ' A' ' 86' ' ' ARG . 2.6 t -107.59 113.53 43.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.657 0.265 . . . . 0.0 111.369 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.556 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.68 167.17 11.63 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.257 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.812 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 7.5 m -143.15 131.19 21.76 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.537 0.684 . . . . 0.0 112.312 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.0 HG22 HG21 ' A' ' 80' ' ' ILE . 3.5 mm -125.01 108.29 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.763 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.81 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.15 95.05 7.88 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.553 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.462 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.4 m -93.89 138.49 20.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.769 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.2 ptm -145.49 125.37 7.03 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.353 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.601 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.1 Cg_exo -71.47 121.92 8.16 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.155 2.57 . . . . 0.0 112.077 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.32 -32.36 66.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.345 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.25 152.57 79.09 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.078 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.584 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 41.1 Cg_endo -67.31 -3.36 9.81 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.388 2.059 . . . . 0.0 112.204 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -90.87 43.89 1.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.927 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.601 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 93.1 t -65.59 75.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.37 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 81.9 m-20 -70.49 95.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.915 177.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.527 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -64.1 -43.63 94.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.5 -178.351 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.527 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 5.3 tp10 -68.36 -38.16 81.17 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.744 0.307 . . . . 0.0 110.412 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -69.62 -39.82 76.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.372 0.606 . . . . 0.0 109.815 177.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -67.62 -30.66 70.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.035 177.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -46.75 81.7 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.775 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -69.26 -40.45 77.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.571 179.531 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.527 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 1.3 mt-10 -65.24 -28.04 69.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.117 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.847 HG12 HG21 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -62.44 -47.12 94.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.354 179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.406 HE22 ' HG ' ' A' ' 36' ' ' LEU . 8.1 mm100 -62.68 -31.61 72.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.829 0.347 . . . . 0.0 110.721 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 17.7 mm-40 -74.72 -24.84 58.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.007 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.978 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.46 -14.52 37.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.333 -179.128 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.432 HG13 HD12 ' A' ' 36' ' ' LEU . 24.8 mm -57.61 137.29 82.37 Favored Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.716 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 4.5 Cg_endo -45.66 122.01 4.57 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.885 2.39 . . . . 0.0 112.169 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.37 -4.82 0.25 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.046 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.03 -41.4 8.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.73 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.511 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.43 -146.54 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.674 0.273 . . . . 0.0 111.198 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -138.62 177.58 7.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.242 0.544 . . . . 0.0 111.185 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.715 ' H ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -74.96 -178.24 3.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.434 -179.183 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.535 ' ND1' HG22 ' A' ' 56' ' ' VAL . 72.4 t60 -131.13 -71.24 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.66 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 7.2 mmtm -161.64 125.16 3.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.081 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.651 HD13 HG22 ' A' ' 53' ' ' VAL . 2.8 mt -92.1 160.49 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.781 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.65 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -129.17 125.0 36.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.726 -178.311 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -85.43 72.03 10.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.841 0.353 . . . . 0.0 110.548 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.524 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.4 mt-10 -98.09 134.73 21.82 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.621 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.771 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 56.8 Cg_endo -86.53 155.0 9.11 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.577 2.185 . . . . 0.0 112.782 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.687 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.2 mm -123.87 -82.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.403 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.606 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.21 -153.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.054 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -71.81 -27.99 63.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.805 0.336 . . . . 0.0 110.593 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.62 5.12 0.51 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.951 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.606 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.8 mt -92.22 101.36 13.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.784 0.326 . . . . 0.0 110.839 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 90.4 t -93.38 129.36 43.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.783 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.769 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.24 162.94 13.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.022 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.65 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.2 mp -120.53 120.27 35.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.435 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.523 ' ND2' ' HB3' ' A' ' 40' ' ' ASP . 2.3 m-20 -89.66 91.71 8.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.271 0.558 . . . . 0.0 109.813 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.847 HG21 HG12 ' A' ' 26' ' ' ILE . 12.4 t -86.82 106.35 15.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.793 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.574 ' HG3' HG23 ' A' ' 7' ' ' THR . 6.2 mtt -85.63 165.23 17.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.031 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.556 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.1 m -140.3 134.35 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.903 0.383 . . . . 0.0 111.245 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.535 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.55 113.21 30.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.06 179.284 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 4' ' ' VAL . 3.5 m -130.35 144.8 36.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.885 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.07 -63.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.25 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -81.09 -7.9 59.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 110.402 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.511 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.27 -147.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.992 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.56 -162.02 1.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.343 . . . . 0.0 110.782 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.62 11.91 37.16 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.38 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.43 -3.01 45.72 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.585 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 p -74.03 -5.49 41.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.934 0.397 . . . . 0.0 110.358 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -55.13 -24.36 25.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.193 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . . . -57.2 -25.45 59.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.105 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.77 -57.26 13.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.164 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.37 -33.63 71.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.325 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 1.8 mm-40 -61.11 -52.13 66.21 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.501 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.78 -19.86 65.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.621 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.724 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.63 -28.08 62.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.69 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -15.1 57.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.731 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.39 29.33 0.96 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.978 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -73.08 -165.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.253 -0.474 . . . . 0.0 111.279 -178.589 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.771 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 3.0 pm0 -51.63 89.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.658 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 74' ' ' ILE . . . -59.46 -26.99 62.75 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.937 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.06 -34.76 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.254 0.549 . . . . 0.0 110.2 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.771 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -95.71 89.07 5.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.626 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -74.68 128.86 36.58 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.0 HG21 HG22 ' A' ' 8' ' ' ILE . 1.9 mp -101.11 148.88 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.576 -175.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.662 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.1 tp10 -85.78 71.44 10.67 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 172.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.705 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.5 t -80.06 50.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.036 -173.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -132.93 7.12 4.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.176 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.812 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 26.8 t0 -85.82 133.31 33.98 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.934 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -147.25 147.44 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.131 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.57 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -145.45 81.56 1.62 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.878 0.847 . . . . 0.0 109.242 179.19 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.464 ' HB3' ' SD ' ' A' ' 89' ' ' MET . 0.9 OUTLIER -81.04 107.6 14.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.873 -177.788 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.765 HD12 ' HB2' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -86.12 86.67 7.35 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.438 177.145 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.464 ' SD ' ' HB3' ' A' ' 87' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.022 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.483 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 9.7 ttp . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.96 0.409 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.51 -8.4 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 3.5 m-20 -94.8 169.44 10.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.279 -0.461 . . . . 0.0 111.62 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.78 HG12 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -105.22 116.38 48.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.891 177.333 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.73 ' HB ' ' HB2' ' A' ' 86' ' ' ARG . 4.8 t -106.96 117.26 52.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 121.046 -0.261 . . . . 0.0 111.66 -178.379 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.696 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -92.68 162.27 14.22 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.043 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.81 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 11.3 m -143.16 131.06 21.58 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.592 0.71 . . . . 0.0 112.309 -178.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.021 HG22 HG21 ' A' ' 80' ' ' ILE . 2.7 mm -120.22 106.05 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.628 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.834 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -93.62 92.35 7.49 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.326 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.609 HG12 HG12 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -92.42 138.13 20.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.117 -177.019 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.64 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.73 119.05 5.29 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.074 179.312 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.613 ' CD ' HG13 ' A' ' 17' ' ' VAL . 14.9 Cg_exo -69.23 120.25 7.14 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.252 2.635 . . . . 0.0 112.137 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -57.42 -30.33 64.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.475 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.79 151.62 79.73 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.078 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 40.8 Cg_endo -66.81 -4.28 10.93 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.41 2.074 . . . . 0.0 112.001 179.65 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -91.84 42.35 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.321 179.162 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.613 HG13 ' CD ' ' A' ' 12' ' ' PRO . 90.9 t -65.14 78.17 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.166 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.669 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -67.82 100.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.134 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.618 HD11 ' HE2' ' A' ' 23' ' ' LYS . 1.3 tp -61.54 -51.87 66.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.488 -178.125 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.782 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 8.6 pt-20 -71.54 -34.55 70.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.261 -177.33 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -67.82 -36.21 79.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.195 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -64.86 -34.74 79.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.363 176.557 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.782 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -55.59 -48.11 75.38 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.296 178.649 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 3.6 mtmt -65.25 -44.18 88.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.967 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -66.32 -28.72 68.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.172 0.51 . . . . 0.0 110.444 -179.199 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.838 HG12 HG21 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -61.39 -47.46 93.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.495 -179.62 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.539 ' OE1' HD22 ' A' ' 36' ' ' LEU . 7.0 mm100 -63.53 -33.29 75.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.829 0.347 . . . . 0.0 110.798 -178.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 15.4 mt-10 -75.19 -23.56 57.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.925 179.216 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.755 ' HB2' HD11 ' A' ' 74' ' ' ILE . 3.2 ptp180 -91.83 -14.66 29.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.414 -179.122 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.59 HG12 ' O ' ' A' ' 26' ' ' ILE . 11.0 mm -59.35 141.25 87.7 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.025 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.716 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.2 Cg_endo -51.25 113.55 1.16 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.844 2.363 . . . . 0.0 112.431 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.2 -1.61 0.21 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.328 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.11 -36.89 13.62 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.066 -178.525 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.542 ' CB ' HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.54 -140.31 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.725 0.263 . . . . 0.0 111.077 -179.32 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -136.67 166.11 24.33 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.852 0.358 . . . . 0.0 110.892 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.539 HD22 ' OE1' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -76.09 -175.03 2.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.355 -179.262 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.6 ' ND1' HG22 ' A' ' 56' ' ' VAL . 79.8 t60 -131.29 -76.78 0.52 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.278 0.561 . . . . 0.0 110.937 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -165.27 132.7 3.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.048 -178.793 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.742 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -93.77 156.18 3.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.065 0.46 . . . . 0.0 112.197 -177.361 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.649 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 74.8 m-20 -122.72 119.2 29.97 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.465 -178.577 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -83.21 73.42 10.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.032 0.444 . . . . 0.0 110.608 178.675 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.559 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -97.33 132.95 24.48 Favored Pre-proline 0 C--O 1.225 -0.224 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.628 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.779 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 44.2 Cg_endo -85.33 155.21 10.81 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.449 2.099 . . . . 0.0 112.875 -178.594 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.749 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.4 mm -124.03 -83.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.411 -177.502 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.459 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.16 -154.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.018 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.97 -26.54 62.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.579 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.65 1.78 0.36 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.23 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.543 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.6 mt -92.44 102.41 14.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.851 0.358 . . . . 0.0 110.875 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.779 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 73.4 t -93.34 132.15 38.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.035 -178.126 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.749 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.93 153.77 17.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.816 177.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.649 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -117.39 120.8 39.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.518 179.377 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.575 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 2.1 m-20 -89.73 93.89 9.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.109 -179.231 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.838 HG21 HG12 ' A' ' 26' ' ' ILE . 17.3 t -85.95 105.58 14.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.558 -177.851 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 44.2 mtt -86.52 160.51 18.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.35 178.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.696 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.8 m -139.05 140.7 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.101 -178.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.6 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.1 t -92.49 100.09 10.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.764 179.111 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.78 HG23 HG12 ' A' ' 4' ' ' VAL . 27.3 m -130.48 139.08 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.988 0.423 . . . . 0.0 111.473 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.73 -61.67 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.557 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.96 -5.4 58.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 110.575 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.51 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.41 -139.52 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.125 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -146.83 -165.92 2.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.762 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.32 11.09 39.4 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.691 179.345 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.2 -11.32 67.23 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.526 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -4.45 36.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 0.0 110.319 179.441 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -54.56 -23.9 18.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.387 0.613 . . . . 0.0 109.869 177.428 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.04 -28.17 56.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.94 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.716 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.96 -57.61 11.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.425 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -58.94 -34.06 71.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.455 178.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.96 -52.18 66.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.267 178.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -20.38 65.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.508 179.034 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.72 HD22 HD13 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.84 -26.1 61.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.659 -179.653 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.61 -17.02 63.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.556 178.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.48 31.74 0.93 Allowed Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.704 179.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.755 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -73.08 -161.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.278 -0.461 . . . . 0.0 111.24 -178.431 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.705 ' HG3' ' O ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -51.55 88.13 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.219 0.533 . . . . 0.0 110.437 178.935 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 74' ' ' ILE . . . -60.26 -26.63 64.16 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.308 -177.658 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 p -85.44 -34.7 8.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.412 0.625 . . . . 0.0 110.177 179.502 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.705 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -95.57 90.02 5.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.588 -179.314 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -73.49 128.38 35.34 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.153 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.021 HG21 HG22 ' A' ' 8' ' ' ILE . 2.1 mp -101.16 149.31 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.648 -174.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.68 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 5.8 tp10 -85.65 71.91 10.65 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.737 HG23 ' HB ' ' A' ' 80' ' ' ILE . 75.7 t -79.73 48.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.93 -173.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -133.1 7.26 3.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.93 178.422 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.81 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 22.0 t0 -85.64 137.4 32.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.977 -178.51 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 86' ' ' ARG . 2.9 p -148.18 167.91 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.112 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.73 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -147.13 107.64 4.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.169 0.509 . . . . 0.0 111.329 -179.036 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -82.76 79.77 9.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.985 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.483 ' HB3' ' N ' ' A' ' 1' ' ' MET . 8.2 mp -81.6 86.35 6.39 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.721 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.883 179.932 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.361 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.61 -4.56 0.03 OUTLIER Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.254 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.562 ' OD1' HD12 ' A' ' 88' ' ' LEU . 13.2 p-10 -90.39 162.09 15.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.962 0.41 . . . . 0.0 111.375 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.778 HG22 ' HG3' ' A' ' 87' ' ' ARG . 1.0 OUTLIER -104.27 134.82 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.958 179.614 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.779 ' HB ' ' HG2' ' A' ' 86' ' ' ARG . 57.5 t -124.06 120.18 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.746 0.308 . . . . 0.0 111.605 179.233 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.55 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -98.05 166.44 11.43 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.706 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 14.2 m -140.52 136.48 32.94 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.6 0.714 . . . . 0.0 112.267 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.077 HG22 HG21 ' A' ' 80' ' ' ILE . 2.3 mm -125.71 106.94 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.573 -178.055 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.822 ' C ' HG23 ' A' ' 80' ' ' ILE . 1.6 mmmt -95.79 93.83 7.31 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.816 0.341 . . . . 0.0 111.892 -178.075 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.493 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.9 m -93.71 135.4 28.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -176.521 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.648 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.36 124.88 6.91 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.038 178.363 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.643 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.7 Cg_exo -71.79 117.3 5.08 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.147 2.565 . . . . 0.0 111.747 179.285 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -30.25 59.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.95 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.96 155.1 80.39 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.72 179.454 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 3.8 Cg_exo -72.3 -0.96 9.42 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.562 2.175 . . . . 0.0 111.683 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -92.29 42.97 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.049 178.261 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.643 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 88.4 t -64.85 78.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.089 -178.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.659 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 2.3 m-20 -68.56 101.84 1.35 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.322 178.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.58 -53.43 56.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.68 -179.004 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 23.5 tt0 -69.76 -35.33 74.85 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 -176.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -68.57 -36.81 79.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.57 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.584 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.1 OUTLIER -64.74 -34.11 77.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.469 177.071 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -57.41 -47.22 82.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.571 179.008 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 7.4 mttt -65.64 -41.92 92.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.649 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 21' ' ' ALA . 33.8 mt-10 -65.74 -31.49 72.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.197 0.523 . . . . 0.0 110.477 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.685 HD11 HD12 ' A' ' 51' ' ' LEU . 6.9 mt -61.38 -44.71 98.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.053 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -61.48 -38.41 87.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.951 0.405 . . . . 0.0 110.772 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 4.7 mm-40 -76.09 -21.94 56.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.689 -178.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.632 HH22 ' HB ' ' A' ' 8' ' ' ILE . 22.1 ptt85 -90.35 -13.59 34.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.643 -177.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 26' ' ' ILE . 29.4 mm -59.73 138.6 90.03 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.176 -179.438 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.1 Cg_endo -51.89 123.77 13.14 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.726 2.284 . . . . 0.0 112.496 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -62.25 2.92 0.21 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.262 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.36 -64.51 1.64 Allowed Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.01 -178.618 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.624 ' CB ' HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -112.6 -131.43 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.348 0.118 . . . . 0.0 110.913 -179.17 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -139.21 166.63 24.03 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.947 0.404 . . . . 0.0 111.013 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.2 pt? -75.9 -172.41 1.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.971 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.575 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.0 t60 -130.36 -78.85 0.54 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.27 0.557 . . . . 0.0 111.481 -178.15 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HB3' ' CD2' ' A' ' 37' ' ' HIS . 1.5 tptp -164.49 130.89 2.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.843 -178.322 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.672 HD13 HD13 ' A' ' 26' ' ' ILE . 2.6 mt -92.0 159.62 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -176.715 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.643 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -127.48 117.08 21.42 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.247 -179.39 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -81.87 72.6 8.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.991 0.424 . . . . 0.0 110.396 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.539 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -97.0 134.86 22.39 Favored Pre-proline 0 C--O 1.225 -0.222 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.69 -179.595 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.776 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 53.7 Cg_endo -85.43 155.4 10.69 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.39 2.06 . . . . 0.0 112.837 -178.73 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.777 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.6 mm -124.88 -83.42 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.269 -177.505 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.493 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -66.74 -155.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.764 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -72.47 -22.93 60.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.72 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.62 0.93 0.26 Allowed Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.443 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.52 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.6 mt -92.83 103.59 15.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.072 0.436 . . . . 0.0 111.138 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.776 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 72.8 t -93.5 129.14 44.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.891 -179.015 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.777 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.1 151.8 19.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.943 178.168 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.685 HD12 HD11 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -115.14 121.27 42.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.538 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 1.7 m120 -90.51 92.33 8.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.363 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.647 HG22 HD13 ' A' ' 39' ' ' ILE . 5.9 t -87.49 103.27 13.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.375 -178.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.581 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.7 mpt? -84.41 164.89 18.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.268 178.939 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.55 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.2 m -137.73 136.89 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.365 -178.002 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.575 HG22 ' ND1' ' A' ' 37' ' ' HIS . 1.7 t -94.33 99.13 8.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.744 178.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.627 HG23 HG12 ' A' ' 4' ' ' VAL . 33.3 m -130.47 139.89 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.213 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.86 -57.8 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.595 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -80.85 -11.04 59.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.513 179.524 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.431 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.62 -138.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.109 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -146.79 -164.38 1.98 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.757 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.36 13.07 29.5 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.738 179.358 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.44 -11.49 68.27 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.609 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -74.46 -4.1 34.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.802 0.335 . . . . 0.0 110.422 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -55.19 -23.86 23.97 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.399 0.618 . . . . 0.0 110.055 177.433 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.413 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . . . -57.11 -25.09 58.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.174 -179.427 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.54 -57.03 13.71 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.327 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -58.77 -34.06 71.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.218 178.041 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 2.5 mt-10 -62.17 -51.57 67.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.43 178.778 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.69 -18.95 64.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.401 178.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.63 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.19 -29.53 62.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.512 179.835 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -13.47 51.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.74 179.162 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.27 28.73 0.98 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.672 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.63 ' HB ' ' HA ' ' A' ' 71' ' ' LEU . 1.2 tt -73.19 -164.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.445 -0.377 . . . . 0.0 110.854 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.64 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -51.96 95.3 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.089 0.471 . . . . 0.0 110.648 179.61 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.74 -30.84 69.98 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.452 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.2 t -85.16 -35.12 9.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.921 0.391 . . . . 0.0 110.38 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.64 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 8.0 m -95.7 88.87 5.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.683 -179.514 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -75.57 129.97 38.06 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.077 HG21 HG22 ' A' ' 8' ' ' ILE . 3.2 mp -101.3 150.05 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.748 -175.269 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.527 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 52.4 tt0 -85.91 70.75 10.67 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 173.016 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.68 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.0 t -80.94 50.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.083 -174.53 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 m -132.9 10.5 4.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.891 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.706 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.3 m-20 -83.23 148.49 27.38 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.162 0.506 . . . . 0.0 111.227 -178.447 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.704 HG13 ' HD2' ' A' ' 87' ' ' ARG . 1.0 OUTLIER -147.83 139.15 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.214 -177.92 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.779 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -150.62 87.0 1.41 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.445 0.64 . . . . 0.0 110.609 -178.894 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.778 ' HG3' HG22 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -82.52 107.89 15.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.074 -179.278 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.562 HD12 ' OD1' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -84.8 86.73 7.32 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.336 176.765 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.98 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.764 0.316 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 3' ' ' ASP . . . 173.77 -4.32 0.03 OUTLIER Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.23 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.606 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 13.0 p-10 -92.16 146.96 23.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.765 0.317 . . . . 0.0 111.44 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.649 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -96.71 113.37 30.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.708 177.949 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 53.7 t -109.57 120.64 61.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.596 -178.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.576 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -96.39 166.0 11.91 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.087 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.816 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.1 m -143.04 130.09 20.69 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.57 0.7 . . . . 0.0 112.361 -179.196 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.025 HG22 HG21 ' A' ' 80' ' ' ILE . 6.7 mm -121.61 107.08 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.554 -179.11 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.813 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -95.6 94.15 7.57 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.933 0.396 . . . . 0.0 111.946 -177.87 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.518 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.7 m -93.54 136.54 24.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -176.502 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.772 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.2 ptm -144.72 126.15 7.84 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.303 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.611 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 10.4 Cg_exo -73.46 124.53 9.45 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.399 2.732 . . . . 0.0 112.37 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.99 -33.82 69.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.357 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.4 m -78.28 154.41 79.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.213 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.582 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 52.9 Cg_endo -69.66 -3.41 11.88 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.428 2.085 . . . . 0.0 112.146 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.76 44.03 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.826 178.378 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.611 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 81.0 t -64.98 76.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.558 -178.418 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 6.3 m-20 -71.61 92.44 1.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.57 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.65 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -63.97 -42.08 97.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.303 -178.478 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.628 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 26.7 tt0 -68.3 -39.11 82.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.794 0.331 . . . . 0.0 110.253 -178.506 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -71.55 -36.75 71.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.053 0.454 . . . . 0.0 110.384 177.861 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -67.79 -28.75 67.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.976 178.026 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -42.48 87.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.321 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -43.82 86.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.246 178.71 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.57 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 2.2 mm-40 -65.79 -30.38 71.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.342 0.592 . . . . 0.0 110.207 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.782 HG12 HG21 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -60.66 -47.14 94.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.073 179.724 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.423 ' OE1' HD22 ' A' ' 36' ' ' LEU . 7.2 mm-40 -64.71 -35.24 80.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.193 -178.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 8.4 pt-20 -77.0 -20.79 55.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.907 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.832 ' HB2' HD11 ' A' ' 74' ' ' ILE . 4.2 ptp180 -90.51 -13.55 34.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.045 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 26' ' ' ILE . 14.2 mm -59.82 138.67 90.31 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.92 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 30' ' ' ILE . 9.6 Cg_endo -50.81 119.3 5.07 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.708 2.272 . . . . 0.0 112.112 178.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -59.23 -1.27 0.18 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.24 -179.597 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -81.49 -39.64 12.1 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.968 -178.855 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.538 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.54 -147.41 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.668 0.271 . . . . 0.0 111.118 -179.714 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -131.9 170.06 15.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.998 0.428 . . . . 0.0 110.927 -179.309 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.518 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -75.12 -177.2 3.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.123 -179.331 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.568 ' ND1' HG22 ' A' ' 56' ' ' VAL . 82.1 t60 -130.91 -76.38 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.294 0.569 . . . . 0.0 111.085 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 2.0 tptt -164.64 130.34 2.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.996 -178.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.65 HD13 HG22 ' A' ' 53' ' ' VAL . 2.2 mt -94.13 160.99 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.634 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -127.35 122.54 33.99 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.485 -179.182 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -84.83 74.06 10.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.602 178.311 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.557 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.0 OUTLIER -101.23 136.16 19.74 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.969 -179.6 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.774 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 61.4 Cg_endo -86.43 155.49 9.29 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.793 2.328 . . . . 0.0 112.724 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.735 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.0 mm -124.55 -83.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.614 -177.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.72 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.42 -148.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.355 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -70.45 -33.54 71.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.61 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.39 8.22 0.64 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.606 179.713 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.72 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mt -91.41 102.02 14.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.876 0.369 . . . . 0.0 110.748 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 87.3 t -93.23 128.89 44.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.94 -178.435 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.772 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.19 161.01 14.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.071 178.719 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.2 mp -120.27 119.96 34.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.405 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 4.7 m-20 -89.74 91.4 8.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.305 0.574 . . . . 0.0 110.066 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.782 HG21 HG12 ' A' ' 26' ' ' ILE . 6.1 t -87.5 104.67 14.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.736 -177.586 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 27.8 mtt -86.54 164.38 16.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.277 178.458 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.576 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.2 m -139.26 136.15 41.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.845 0.355 . . . . 0.0 111.354 -178.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.568 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -95.69 114.94 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.311 179.733 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 4' ' ' VAL . 3.6 m -130.24 148.59 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.694 178.579 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.92 -67.65 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.356 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -80.71 -7.43 59.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.094 0.473 . . . . 0.0 110.64 179.442 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.455 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.66 -147.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.107 179.339 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.5 -165.33 2.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.875 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.13 14.04 29.47 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.523 178.546 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.9 -2.84 40.32 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.483 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 p -74.08 -3.66 30.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.359 . . . . 0.0 110.265 179.306 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -23.91 27.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.326 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.97 -25.7 58.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.262 -179.223 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.68 -49.3 78.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.635 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.686 ' HG3' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -61.72 -42.05 98.43 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.67 0.748 . . . . 0.0 109.53 176.996 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.686 ' N ' ' HG3' ' A' ' 68' ' ' GLU . 2.3 tm-20 -55.25 -46.62 76.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.821 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.2 p -68.42 -24.32 64.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.231 177.184 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.773 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.53 -30.23 62.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.608 179.901 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 p -63.41 -11.46 23.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.776 179.168 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.24 26.66 0.99 Allowed Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.832 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -73.33 -166.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.224 -0.488 . . . . 0.0 111.408 -178.606 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.585 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -50.75 92.17 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.096 179.0 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.55 -26.16 64.19 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.476 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.07 -37.88 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.142 0.496 . . . . 0.0 110.114 178.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.58 ' HB2' ' HB3' ' A' ' 75' ' ' GLU . 1.5 m -96.15 89.92 5.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.531 179.708 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -76.48 130.0 37.33 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.465 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.025 HG21 HG22 ' A' ' 8' ' ' ILE . 3.4 mp -101.35 149.55 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.539 -175.483 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.525 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.1 tt0 -85.75 71.15 10.72 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.762 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.694 HG23 ' HB ' ' A' ' 80' ' ' ILE . 58.3 t -80.26 50.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.031 -174.269 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.87 5.74 3.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.285 178.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.816 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 35.4 t0 -85.56 139.66 31.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.985 0.421 . . . . 0.0 111.008 -178.451 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.57 161.32 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.36 -179.127 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.8 mtt-85 -149.82 87.39 1.48 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.703 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.02 87.92 4.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.128 -179.514 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 11.1 mp -81.11 82.31 7.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.372 178.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.1 tpp . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.916 -179.283 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.5 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . 14.4 tpt . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.884 0.373 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.5 -16.46 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 12.1 m-20 -95.24 157.4 15.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.193 -0.503 . . . . 0.0 111.321 179.043 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.514 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 1.9 t -106.67 112.31 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 177.558 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.659 ' HB ' ' HG2' ' A' ' 86' ' ' ARG . 1.0 OUTLIER -109.43 117.05 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.688 0.28 . . . . 0.0 111.754 -178.995 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.624 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -98.54 165.69 11.7 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.314 178.055 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.682 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 6.0 m -143.24 132.96 23.81 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.632 0.729 . . . . 0.0 112.407 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.972 HG22 HG21 ' A' ' 80' ' ' ILE . 7.1 mm -126.28 108.12 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.499 -178.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.81 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.25 95.0 7.81 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.011 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.49 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.5 m -92.56 136.83 23.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.116 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.663 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -146.3 118.48 4.97 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 121.07 0.462 . . . . 0.0 111.717 179.896 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 21.1 Cg_exo -68.29 121.58 8.56 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.36 2.707 . . . . 0.0 111.822 178.529 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.89 -29.16 64.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.325 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.84 150.37 78.42 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 37.7 Cg_endo -65.88 -7.85 18.02 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.463 2.109 . . . . 0.0 112.075 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -91.81 35.97 0.96 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.502 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.677 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -68.17 82.58 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.814 0.816 . . . . 0.0 110.532 -179.378 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.5 m-20 -73.74 99.31 3.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.805 178.038 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.851 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -63.33 -44.11 95.83 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.025 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.806 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 4.4 tp10 -70.03 -36.15 74.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.868 0.366 . . . . 0.0 110.342 -178.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -69.16 -37.96 78.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.381 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.56 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.8 OUTLIER -67.72 -26.67 66.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.971 177.23 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.806 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -56.13 -46.13 79.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.235 179.13 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -41.22 85.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.705 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.725 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 52.9 mt-10 -66.74 -28.63 68.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.426 0.631 . . . . 0.0 110.151 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.831 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.2 mt -63.29 -39.2 84.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.163 178.76 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -60.66 -41.72 95.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.075 -179.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.725 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -77.62 -21.32 52.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.937 -178.101 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.831 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.01 -12.43 44.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.061 -179.001 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.697 HG12 ' O ' ' A' ' 26' ' ' ILE . 22.6 mm -60.46 137.53 92.31 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.872 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.619 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 7.0 Cg_endo -47.45 121.5 5.56 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.748 2.298 . . . . 0.0 112.256 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.15 0.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.238 -179.306 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.0 -62.96 1.78 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.866 -179.023 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.481 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -111.77 -142.01 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.682 0.277 . . . . 0.0 111.183 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -133.39 172.98 11.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.974 0.416 . . . . 0.0 111.069 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.39 -177.65 3.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.329 -178.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.502 ' ND1' HG22 ' A' ' 56' ' ' VAL . 80.0 t60 -131.02 -76.29 0.53 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.062 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 20.2 mmtt -160.21 129.25 4.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.089 -178.732 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.725 HD13 HG22 ' A' ' 53' ' ' VAL . 1.6 mt -92.0 160.93 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 111.616 -178.679 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.64 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -129.06 124.47 34.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.64 -178.606 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -85.85 71.93 10.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 0.0 110.653 178.239 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.533 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -99.22 136.21 20.55 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.593 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.787 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 59.7 Cg_endo -86.99 158.02 8.62 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.565 2.176 . . . . 0.0 112.785 -178.661 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.687 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.3 mm -126.16 -82.69 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.421 -177.607 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.566 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.41 -151.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.167 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -71.35 -30.22 65.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.668 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.55 5.2 0.51 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.899 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.566 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.1 mt -91.78 103.13 15.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.938 0.399 . . . . 0.0 110.708 179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.787 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 76.0 t -92.92 131.76 39.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.88 -178.381 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.687 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.03 162.29 13.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.831 178.47 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.851 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.2 mp -120.66 119.7 33.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.333 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.504 ' ND2' ' HB3' ' A' ' 40' ' ' ASP . 2.3 m-20 -89.88 91.83 8.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.255 0.55 . . . . 0.0 110.134 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.754 HG21 HG12 ' A' ' 26' ' ' ILE . 12.4 t -86.5 102.3 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.583 -177.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.511 ' HG3' HG23 ' A' ' 7' ' ' THR . 24.8 mtt -84.59 164.46 18.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.169 178.795 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.624 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.0 m -139.35 135.86 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.456 -178.628 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.502 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -98.61 115.98 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.211 178.932 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.514 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 2.8 m -130.67 148.14 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.702 178.861 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.6 -68.06 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.578 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -80.42 -8.51 59.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.059 0.457 . . . . 0.0 110.607 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.481 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.86 -144.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.057 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.52 -167.34 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.815 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.86 16.35 15.8 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.562 178.674 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.5 -1.36 36.32 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.491 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 p -74.81 -4.23 36.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.874 0.368 . . . . 0.0 110.246 179.228 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -55.05 -23.37 19.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.182 177.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.29 -26.29 60.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.134 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.619 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.92 -55.94 27.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.338 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -58.33 -35.91 72.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.561 178.462 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -51.55 68.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.427 178.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 12.2 p -63.98 -20.81 66.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.487 179.023 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.549 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.22 -25.94 61.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.602 -179.802 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.01 -17.73 63.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.638 179.124 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.77 30.67 0.92 Allowed Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.05 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.764 HD11 ' HD2' ' A' ' 29' ' ' ARG . 4.3 tt -72.99 -160.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.571 -0.314 . . . . 0.0 111.01 -178.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.642 ' H ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -51.61 94.96 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.035 0.445 . . . . 0.0 110.63 179.77 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.16 -30.85 71.5 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.485 -177.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.5 t -85.02 -33.9 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.943 0.401 . . . . 0.0 110.578 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.617 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 28.1 t -95.77 91.53 6.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.937 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -75.5 128.84 36.2 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.012 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.972 HG21 HG22 ' A' ' 8' ' ' ILE . 3.4 mp -101.01 149.31 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.423 -174.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.563 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.7 tt0 -85.66 70.41 10.72 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 173.07 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.698 HG23 ' HB ' ' A' ' 80' ' ' ILE . 59.9 t -79.92 50.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.881 -174.393 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.66 6.54 4.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.351 179.272 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.682 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.5 m-20 -85.3 131.15 34.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.913 -178.895 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.9 p -146.25 146.4 19.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.143 -179.123 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.659 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -148.98 81.58 1.43 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.758 0.789 . . . . 0.0 109.325 -179.224 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.01 99.82 11.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.274 -177.147 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.541 ' CD2' ' HG3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -86.44 88.68 7.68 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.141 176.37 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.7 ptp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.914 -179.956 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.649 0.262 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.47 -2.33 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.291 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 4.6 m-20 -91.49 158.9 16.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.781 0.324 . . . . 0.0 111.371 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.562 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -99.28 121.87 50.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.609 177.567 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 78.9 t -119.85 122.52 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.49 -179.063 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.589 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.37 168.39 10.75 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.825 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.777 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 5.7 m -143.17 133.6 24.8 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.595 0.712 . . . . 0.0 112.235 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.989 HG22 HG21 ' A' ' 80' ' ' ILE . 3.8 mm -126.52 106.51 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.24 -178.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.813 ' C ' HG23 ' A' ' 80' ' ' ILE . 2.5 mmmt -96.21 96.02 8.52 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -176.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.499 HG12 HG12 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -94.23 135.71 27.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -177.537 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.671 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.77 117.97 4.35 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 120.993 0.425 . . . . 0.0 111.414 178.97 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.3 Cg_exo -69.72 120.44 7.23 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.253 2.636 . . . . 0.0 111.964 178.515 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -57.61 -29.06 64.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.068 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.55 150.57 79.52 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.882 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 38.4 Cg_endo -66.34 -8.29 20.14 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.432 2.088 . . . . 0.0 112.063 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.92 36.51 0.97 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.634 179.313 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.626 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.8 86.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.811 0.815 . . . . 0.0 110.196 -179.87 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 55.9 m-20 -69.43 104.92 2.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.213 179.259 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.589 HD21 ' HG2' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -60.74 -52.52 64.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.548 -178.341 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.794 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 9.9 pt-20 -71.03 -34.51 71.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.257 -177.716 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.528 ' HB3' ' CB ' ' A' ' 18' ' ' ASP . . . -68.0 -35.7 78.76 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.443 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.592 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.3 OUTLIER -66.03 -33.61 76.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.423 176.463 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.794 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -55.91 -46.38 78.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.112 178.529 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -66.14 -43.65 86.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.72 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.772 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 5.1 mm-40 -66.12 -28.06 68.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.404 0.621 . . . . 0.0 110.576 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.878 HG12 HG21 ' A' ' 53' ' ' VAL . 1.1 mt -61.8 -46.54 96.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.267 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.59 ' OE1' HD22 ' A' ' 36' ' ' LEU . 26.7 mm-40 -63.9 -35.32 80.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.297 -178.053 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.772 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.6 OUTLIER -76.63 -21.55 55.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.821 179.953 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.978 ' HD2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.25 -15.12 31.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.793 179.249 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 26' ' ' ILE . 15.8 mm -58.93 138.28 87.37 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.97 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.511 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.3 Cg_endo -50.27 117.23 3.0 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.884 2.389 . . . . 0.0 112.309 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -58.84 -2.07 0.21 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.182 -179.651 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.79 -57.52 2.54 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.794 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.59 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -109.76 -142.62 0.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.694 0.283 . . . . 0.0 111.064 -179.588 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -135.65 170.0 16.65 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.929 0.395 . . . . 0.0 110.761 -179.411 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.59 HD22 ' OE1' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -75.3 -178.31 3.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.062 -179.333 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.544 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.5 t60 -130.85 -77.01 0.53 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.41 0.624 . . . . 0.0 110.926 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -164.83 130.87 2.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.791 -178.893 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.686 HG12 HG13 ' A' ' 53' ' ' VAL . 2.7 mt -92.67 157.92 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.039 0.447 . . . . 0.0 112.098 -177.097 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.631 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -124.75 117.32 23.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.379 -179.106 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.589 ' HG2' HD21 ' A' ' 19' ' ' LEU . 1.4 mt-10 -82.8 70.91 9.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.952 0.406 . . . . 0.0 110.514 178.556 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.545 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.7 mt-10 -95.66 135.84 22.77 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.356 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.772 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 56.7 Cg_endo -86.21 156.73 9.68 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.433 2.089 . . . . 0.0 112.933 -178.039 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.753 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.8 mm -125.53 -82.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.451 -177.168 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.603 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.22 -150.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.006 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -72.04 -30.52 65.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.848 0.356 . . . . 0.0 110.69 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.28 4.97 0.53 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.804 179.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.603 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.5 mt -91.31 102.88 15.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.893 0.377 . . . . 0.0 110.732 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 75.7 t -93.3 131.29 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.059 -177.829 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.753 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.08 150.72 20.18 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.719 177.785 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -113.84 117.91 32.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.358 179.6 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.45 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 6.8 m-20 -89.87 92.83 9.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.223 -178.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.878 HG21 HG12 ' A' ' 26' ' ' ILE . 5.1 t -86.85 102.11 11.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.624 -177.757 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.742 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.54 163.59 19.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.054 178.253 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.5 m -138.21 136.9 44.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.765 0.317 . . . . 0.0 111.367 -178.373 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.544 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -94.63 116.38 35.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.086 179.559 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.59 HG12 HG21 ' A' ' 34' ' ' THR . 6.2 m -130.27 148.36 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.966 179.272 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.64 -72.79 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.419 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.66 -2.7 51.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 110.789 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.547 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.31 -150.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.303 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.58 -165.19 2.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.792 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.16 14.72 26.25 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.619 178.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.12 -3.33 44.56 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.495 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -74.42 -3.2 29.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.941 0.401 . . . . 0.0 110.274 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -25.04 24.66 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.691 177.663 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.43 -25.16 59.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.953 -179.307 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -62.4 -55.25 29.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 110.073 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.55 ' HA ' HD12 ' A' ' 71' ' ' LEU . 58.5 mt-10 -58.6 -33.55 70.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.286 178.457 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -62.51 -52.59 62.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.256 178.216 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.65 -16.62 61.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.117 178.308 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.028 HD11 HG11 ' A' ' 82' ' ' VAL . 1.3 mt -73.38 -33.11 64.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.49 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.75 -10.29 18.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.792 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.08 28.6 1.0 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 178.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.978 HD11 ' HD2' ' A' ' 29' ' ' ARG . 7.3 tt -73.56 -166.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.834 -0.683 . . . . 0.0 111.269 -178.426 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.681 ' H ' HG12 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -52.01 101.39 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.986 0.422 . . . . 0.0 111.042 -179.658 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.52 -32.42 83.27 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.812 -179.004 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -86.44 -36.38 10.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.421 . . . . 0.0 110.242 179.377 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.636 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 10.3 t -95.67 92.39 6.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.462 179.332 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -77.32 130.74 37.56 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.325 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.989 HG21 HG22 ' A' ' 8' ' ' ILE . 2.7 mp -101.4 148.73 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.413 -175.655 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.559 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.2 tp10 -85.65 70.25 10.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 173.105 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 1.028 HG11 HD11 ' A' ' 71' ' ' LEU . 55.2 t -79.7 44.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.055 -174.081 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -132.32 9.84 4.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.522 177.762 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.777 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 34.5 t0 -85.97 143.96 27.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.828 0.346 . . . . 0.0 110.869 -178.886 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 86' ' ' ARG . 3.7 p -148.19 164.68 5.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.179 -178.984 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.421 ' H ' HG22 ' A' ' 85' ' ' VAL . 0.7 OUTLIER -149.19 93.44 2.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.462 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -77.92 90.12 4.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.801 -179.802 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 11.2 mp -81.49 81.47 7.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.603 179.488 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 6.4 mtm . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.163 -0.923 . . . . 0.0 110.99 -179.738 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 121.009 0.433 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.71 13.48 0.23 Allowed Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.548 -179.814 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.546 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -88.74 158.35 18.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.879 0.371 . . . . 0.0 111.301 -179.541 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.579 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -107.11 120.77 59.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.381 178.665 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.709 ' HB ' ' HG2' ' A' ' 86' ' ' ARG . 84.8 t -113.43 114.16 46.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.271 179.218 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.596 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -93.1 168.23 11.26 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.731 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.78 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 11.2 m -142.56 132.42 24.21 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.585 0.707 . . . . 0.0 112.505 -179.231 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.074 HG22 HG21 ' A' ' 80' ' ' ILE . 3.8 mm -120.61 105.24 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.276 -179.426 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.823 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -93.56 93.82 8.29 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.941 0.401 . . . . 0.0 112.009 -177.657 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.558 HG12 HG12 ' A' ' 80' ' ' ILE . 1.2 m -92.96 136.28 25.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.036 -177.211 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.728 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -147.7 119.27 4.54 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 121.265 0.555 . . . . 0.0 111.508 178.712 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.1 Cg_exo -68.38 120.86 7.79 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.13 2.553 . . . . 0.0 111.622 178.688 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.93 -29.11 62.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.271 -179.222 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.476 ' O ' HG12 ' A' ' 17' ' ' VAL . 1.3 p -77.78 153.25 80.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.127 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.549 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 51.3 Cg_endo -68.54 -7.21 19.68 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.178 1.919 . . . . 0.0 111.31 178.144 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.47 34.49 0.88 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.282 178.898 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.673 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -68.24 81.78 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.889 0.852 . . . . 0.0 110.523 -179.363 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -74.05 97.96 2.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.897 177.726 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.884 HD13 ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.53 -38.49 91.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.398 -178.473 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.884 ' H ' HD13 ' A' ' 19' ' ' LEU . 2.7 tp10 -69.11 -38.69 79.05 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -70.59 -38.24 73.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.414 0.626 . . . . 0.0 109.713 176.931 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.1 mt -68.08 -28.98 67.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.082 178.095 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -46.66 80.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.032 -179.59 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -68.94 -40.91 78.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.186 0.517 . . . . 0.0 110.387 179.319 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.44 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 6.1 mm-40 -65.32 -28.05 69.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.359 179.524 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.538 HG12 HG21 ' A' ' 53' ' ' VAL . 2.1 mt -62.65 -45.66 98.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.106 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -34.67 72.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.654 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -75.02 -22.47 58.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.466 -179.378 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.806 ' HB2' HD11 ' A' ' 74' ' ' ILE . 1.9 ptp180 -88.55 -15.21 35.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.504 -178.697 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.466 HG23 ' HD2' ' A' ' 31' ' ' PRO . 43.5 mm -58.07 137.57 84.07 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.568 179.132 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.587 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 18.6 Cg_endo -58.05 130.71 39.46 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.506 2.137 . . . . 0.0 112.837 -179.501 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.32 0.12 0.31 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.0 179.49 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -81.98 -60.88 2.1 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.566 -178.987 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.496 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -113.96 -143.69 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.707 0.289 . . . . 0.0 111.08 -179.867 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -135.73 167.63 20.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.775 -179.671 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.8 pt? -75.16 -176.16 2.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.04 -179.469 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.579 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.8 t60 -130.64 -77.43 0.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.374 0.606 . . . . 0.0 111.4 -178.195 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.54 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER -163.98 129.42 2.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.656 -178.417 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.687 HD13 HG22 ' A' ' 53' ' ' VAL . 2.5 mt -91.15 155.66 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.07 0.462 . . . . 0.0 112.145 -176.632 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.658 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -121.9 118.77 29.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.367 -179.025 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -82.19 71.71 9.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.055 0.455 . . . . 0.0 110.183 178.187 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.544 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.2 mt-10 -96.46 135.06 22.63 Favored Pre-proline 0 C--O 1.224 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.607 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.785 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 52.8 Cg_endo -86.07 156.24 9.84 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.513 2.142 . . . . 0.0 112.796 -178.925 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.7 mm -125.83 -83.32 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.543 -177.447 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.684 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.37 -151.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 -179.861 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -71.91 -29.49 64.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.606 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.63 4.79 0.49 Allowed Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.932 179.944 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.684 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mt -91.72 102.54 15.16 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.856 0.36 . . . . 0.0 110.787 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.785 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 69.6 t -93.7 129.62 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.913 -178.462 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.758 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.64 150.04 20.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.025 178.116 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.658 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -113.09 119.38 37.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.245 179.054 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 2.8 m-20 -89.81 94.43 9.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.522 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.687 HG22 HD13 ' A' ' 39' ' ' ILE . 5.5 t -86.21 102.93 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.342 -178.663 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.677 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.69 167.73 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.455 179.208 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 6' ' ' ALA . 4.2 m -139.28 135.01 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.449 -178.251 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.579 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -95.7 113.89 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.824 178.843 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 4' ' ' VAL . 2.9 m -129.52 154.98 40.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.841 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.43 -68.07 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.195 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.63 -6.35 58.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.108 0.48 . . . . 0.0 110.366 179.027 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.496 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.82 -151.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.125 179.443 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.421 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -150.27 -159.12 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.856 -179.956 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.421 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -80.41 12.47 32.87 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.44 178.637 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.96 -8.0 60.36 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.43 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.27 -3.36 29.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.983 0.42 . . . . 0.0 110.087 179.006 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -54.71 -24.07 20.42 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.99 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.25 -27.26 61.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.897 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.587 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.23 -56.92 15.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.364 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -58.89 -34.97 72.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.405 178.838 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -51.23 70.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.383 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 t -63.7 -19.77 65.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.48 178.796 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.762 HD22 HD13 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -72.83 -28.39 62.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.651 179.957 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.82 -14.23 51.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.766 179.157 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.26 28.69 0.98 Allowed Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -73.41 -163.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.293 -0.453 . . . . 0.0 111.282 -178.698 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.7 OUTLIER -50.21 98.67 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.943 0.401 . . . . 0.0 110.918 179.513 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.62 -32.46 84.27 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.21 -178.302 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -85.66 -36.48 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.055 0.455 . . . . 0.0 110.205 179.606 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 42.4 t -95.64 90.08 5.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.455 179.225 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -77.17 133.34 38.97 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.1 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.074 HG21 HG22 ' A' ' 8' ' ' ILE . 2.2 mt -101.65 149.3 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.863 -175.485 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.531 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 5.3 tp10 -86.1 71.52 10.55 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 172.406 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.69 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.2 t -80.35 50.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.104 -174.216 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.92 5.96 3.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.349 178.897 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.78 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 46.9 t0 -86.03 139.01 31.54 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.984 0.421 . . . . 0.0 111.3 -178.147 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.0 p -147.99 152.36 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.923 -179.62 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.709 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -150.55 98.22 2.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.201 0.524 . . . . 0.0 110.47 -178.715 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.476 ' HD3' HG13 ' A' ' 4' ' ' VAL . 1.6 mmt85 -84.4 110.17 18.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.325 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.586 HD11 HG23 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -82.9 86.71 6.9 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.501 178.045 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.9 ttm . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.964 179.934 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ttt . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 121.143 0.497 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 89' ' ' MET . . . 173.42 4.02 0.03 OUTLIER Glycine 0 C--N 1.33 0.232 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.538 -179.344 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.43 ' H ' ' H ' ' A' ' 2' ' ' GLY . 3.0 m-20 -93.25 164.87 13.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.943 0.401 . . . . 0.0 111.608 -179.695 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.46 136.98 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.615 177.842 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.542 ' CG2' HD11 ' A' ' 88' ' ' LEU . 2.1 t -128.48 116.41 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.73 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.44 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -96.37 166.3 11.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.28 178.897 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.683 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 25.6 m -142.05 132.6 25.31 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.569 0.7 . . . . 0.0 111.779 179.768 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.06 HG22 HG21 ' A' ' 80' ' ' ILE . 1.8 mm -120.46 106.46 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.615 -178.375 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.816 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -95.24 93.36 7.25 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -177.573 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.458 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -92.38 135.93 26.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.729 -177.667 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.823 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -147.5 114.79 4.14 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 121.389 0.614 . . . . 0.0 111.974 179.801 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 35.5 Cg_exo -63.39 124.64 14.14 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.153 2.569 . . . . 0.0 112.055 178.995 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -57.52 -30.78 65.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.378 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.32 150.81 77.49 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.205 -179.304 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.565 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 40.9 Cg_endo -66.67 -6.29 15.09 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.38 2.053 . . . . 0.0 111.89 179.211 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -92.01 32.7 1.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.586 179.211 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.636 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -66.82 85.82 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.65 0.738 . . . . 0.0 110.064 179.929 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.572 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 12.1 m-20 -70.76 104.21 2.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.278 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.906 HD12 HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -61.67 -49.56 76.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.237 -178.666 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.662 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 2.5 tp10 -70.11 -35.48 74.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.111 -178.163 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.629 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -69.06 -35.93 77.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.294 0.569 . . . . 0.0 109.809 177.548 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -66.54 -27.56 67.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.038 177.831 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.662 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -56.33 -46.72 79.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.44 179.051 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.629 ' HE2' ' HA ' ' A' ' 21' ' ' ALA . 1.2 mtmm -65.64 -41.86 92.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.847 179.731 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.716 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 33.3 mt-10 -66.71 -31.14 71.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.431 0.634 . . . . 0.0 110.356 179.526 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.815 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 3.2 mt -62.91 -41.62 93.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.93 179.757 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -62.64 -39.13 92.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.158 -179.222 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.716 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -78.0 -21.02 51.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.669 -178.499 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.943 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.51 -12.11 43.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.273 -178.955 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.708 HG13 HD23 ' A' ' 36' ' ' LEU . 28.5 mm -61.0 138.09 94.09 Favored Pre-proline 0 N--CA 1.463 0.2 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.089 179.626 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.546 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.5 Cg_endo -51.19 125.26 15.9 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.744 2.296 . . . . 0.0 112.478 179.211 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -60.72 -2.86 0.6 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.039 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.22 -62.34 1.82 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.896 -178.82 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.675 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -111.01 -143.67 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.692 0.282 . . . . 0.0 111.152 -179.462 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -133.93 172.57 12.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.941 0.401 . . . . 0.0 110.823 -179.566 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.708 HD23 HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -74.43 -177.05 2.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.667 -179.811 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.627 ' ND1' HG22 ' A' ' 56' ' ' VAL . 66.5 t60 -131.3 -73.58 0.53 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.146 0.498 . . . . 0.0 111.059 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 29.1 mmtm -161.46 127.55 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.417 -178.733 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.67 HD13 HG22 ' A' ' 53' ' ' VAL . 2.9 mt -93.55 154.34 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.817 -178.439 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.643 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.2 m-20 -119.36 124.22 46.07 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.317 -178.769 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -89.17 66.5 7.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.96 0.41 . . . . 0.0 110.083 177.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.659 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.96 147.86 34.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.702 -178.035 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.77 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 35.1 Cg_endo -91.79 158.43 3.44 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.016 2.477 . . . . 0.0 112.861 -178.32 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.734 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.0 mm -127.59 -82.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.334 -178.177 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.689 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.15 -150.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.988 179.728 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -71.88 -27.46 62.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.737 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.28 7.89 0.3 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.157 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.689 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.0 mt -92.39 105.41 17.6 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.784 0.326 . . . . 0.0 110.885 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.77 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 25.6 t -92.92 128.07 44.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.886 -178.477 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.823 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.07 148.94 21.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.275 179.163 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.906 HD21 HD12 ' A' ' 19' ' ' LEU . 11.1 mp -106.48 114.74 29.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.019 177.706 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.598 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 3.9 m-20 -89.28 92.31 9.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.231 0.539 . . . . 0.0 109.938 -179.422 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.678 HG21 HG12 ' A' ' 26' ' ' ILE . 11.3 t -85.79 106.35 15.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.625 -177.292 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.552 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 37.4 mtt -85.24 164.15 18.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.078 178.499 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.6 m -140.71 136.77 35.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.31 -178.684 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.627 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -94.46 111.95 26.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.715 178.738 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.437 HG12 ' OG1' ' A' ' 34' ' ' THR . 34.3 m -130.21 143.58 40.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.095 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.42 -64.51 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.314 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.75 -8.29 59.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 110.495 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.675 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.59 -146.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.248 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -147.69 -163.12 1.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.783 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 65' ' ' GLU . . . -80.45 12.2 34.51 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.559 178.916 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.11 -9.05 62.83 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.507 179.714 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -74.57 -5.15 41.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.861 0.362 . . . . 0.0 110.29 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 3.7 pt-20 -54.94 -24.09 22.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.405 0.621 . . . . 0.0 110.11 177.671 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.04 -28.21 62.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.969 -179.489 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.546 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.67 -56.4 21.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.271 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -59.37 -35.02 73.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.469 178.447 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -50.91 70.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.415 178.92 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.447 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 5.1 t -64.65 -20.32 66.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.56 178.962 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.616 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -72.69 -28.31 62.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.71 -179.678 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -15.61 58.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.793 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.37 29.2 0.97 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.791 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.943 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -73.5 -161.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.451 -0.374 . . . . 0.0 111.142 -178.933 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.604 ' N ' HG23 ' A' ' 74' ' ' ILE . 2.7 pm0 -51.6 91.45 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 121.063 0.459 . . . . 0.0 110.749 179.358 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.17 -24.05 62.75 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.833 -0.621 . . . . 0.0 113.04 -178.334 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.58 -36.64 10.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.234 0.54 . . . . 0.0 110.381 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.575 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 4.2 t -95.88 93.01 6.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.592 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -75.94 131.0 39.34 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.438 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.06 HG21 HG22 ' A' ' 8' ' ' ILE . 3.5 mp -101.19 148.1 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.559 -174.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.773 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -85.87 71.4 10.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 173.256 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.7 HG23 ' HB ' ' A' ' 80' ' ' ILE . 58.6 t -80.71 52.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.076 -174.302 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 m -133.32 5.73 3.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.902 179.426 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.683 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.1 m-20 -84.68 131.69 34.55 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.379 -177.915 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.4 p -149.97 139.72 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.659 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.546 ' HD2' ' N ' ' A' ' 86' ' ' ARG . 1.0 OUTLIER -134.46 104.83 6.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.242 -178.392 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -82.0 88.98 6.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.023 179.28 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.542 HD11 ' CG2' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -81.55 89.96 6.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.673 179.445 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.545 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 1.5 ttm . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.497 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.738 0.304 . . . . 0.0 111.345 . . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.55 -14.01 0.04 OUTLIER Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.475 179.17 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.675 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 4.3 m-20 -94.6 128.7 41.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.81 0.338 . . . . 0.0 111.893 -179.273 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.713 ' HB ' HG22 ' A' ' 57' ' ' VAL . 2.9 t -94.96 107.53 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.531 177.498 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.661 ' HB ' ' HB2' ' A' ' 86' ' ' ARG . 84.7 t -104.8 107.58 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.268 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.514 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -97.12 141.04 30.74 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 177.753 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.805 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 16.2 m -122.49 133.03 54.6 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.749 0.785 . . . . 0.0 112.251 -178.229 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.05 HG22 HG21 ' A' ' 80' ' ' ILE . 5.6 mm -123.99 109.17 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.677 -178.173 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.801 ' C ' HG23 ' A' ' 80' ' ' ILE . 2.1 mmmt -99.57 95.61 7.1 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -177.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.642 HG11 ' HE ' ' A' ' 29' ' ' ARG . 1.4 m -93.32 136.73 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.533 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.699 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.4 OUTLIER -147.78 120.57 4.7 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 121.17 0.509 . . . . 0.0 111.72 178.751 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 20.6 Cg_exo -69.78 121.75 8.43 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.366 2.711 . . . . 0.0 112.143 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -30.58 64.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.207 -179.674 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.9 m -77.97 148.94 76.18 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.999 -179.732 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 38.1 Cg_endo -65.57 -6.79 14.5 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.416 2.077 . . . . 0.0 111.881 179.423 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -91.59 35.42 0.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.518 179.111 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.623 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.46 87.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.817 0.818 . . . . 0.0 110.184 -179.797 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.653 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -67.69 105.28 1.86 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.926 178.824 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.662 HD12 ' HE2' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -60.65 -54.25 47.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.748 -177.96 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.658 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -70.85 -34.23 71.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.133 -177.43 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -68.74 -35.6 77.31 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.305 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.562 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -64.96 -35.53 81.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.138 176.524 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.662 ' HE2' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -55.44 -49.08 73.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.252 178.201 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -39.34 85.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.092 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.695 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 2.9 mt-10 -66.51 -32.34 73.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.383 0.611 . . . . 0.0 110.166 179.099 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.743 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -63.55 -38.47 82.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.925 178.565 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -43.27 92.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.108 -179.72 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.695 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -78.06 -21.37 50.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.755 -178.575 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.753 HH22 ' HB ' ' A' ' 8' ' ' ILE . 18.9 ptt85 -89.06 -8.65 53.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.411 -178.488 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 26' ' ' ILE . 19.8 mm -60.11 137.55 91.21 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.966 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.635 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.1 Cg_endo -48.75 117.65 2.87 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.897 2.398 . . . . 0.0 112.206 178.929 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.47 1.09 0.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.391 -179.395 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.51 -63.95 1.73 Allowed Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.752 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.411 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -110.24 -134.05 0.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.628 0.251 . . . . 0.0 111.086 -179.531 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -138.62 171.06 14.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.931 0.396 . . . . 0.0 110.669 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -177.57 3.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.018 -179.447 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.517 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 86.3 t60 -131.01 -73.31 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.322 0.582 . . . . 0.0 111.081 -179.58 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.509 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -163.46 126.64 2.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.046 -178.433 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.723 HG23 HG22 ' A' ' 53' ' ' VAL . 2.9 mt -94.13 157.04 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.161 -177.342 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.631 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 77.4 m-20 -122.62 124.17 42.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.384 -179.206 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.94 66.3 6.86 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.364 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.651 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -98.23 147.12 32.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.538 -177.539 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.766 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.6 Cg_endo -89.63 159.5 5.27 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.12 2.547 . . . . 0.0 113.211 -177.718 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.746 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.9 mm -129.03 -82.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.169 -178.121 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.577 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.07 -153.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.844 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -72.04 -24.65 61.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.51 3.74 0.25 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.285 179.891 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.577 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.3 mt -92.32 106.95 18.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.021 0.41 . . . . 0.0 111.045 -179.798 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.766 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 52.8 t -94.28 130.37 43.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.95 -178.314 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.746 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.46 162.01 13.83 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.567 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.4 OUTLIER -116.05 113.77 23.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.283 179.501 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.6 m120 -90.04 90.32 8.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.286 0.565 . . . . 0.0 110.011 178.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.723 HG22 HG23 ' A' ' 39' ' ' ILE . 5.5 t -88.63 102.17 12.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.809 -177.716 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.495 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 14.3 mtt -86.36 163.57 17.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.066 178.183 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 4.2 m -137.01 127.44 39.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.923 0.392 . . . . 0.0 111.216 -178.88 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.517 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 1.1 p -98.15 111.86 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 179.603 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.713 HG22 ' HB ' ' A' ' 4' ' ' VAL . 1.2 m -127.4 169.9 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.965 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.89 -69.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.467 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -80.92 0.24 36.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.969 0.414 . . . . 0.0 110.6 179.585 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.411 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.5 -154.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.272 179.722 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.65 -161.29 1.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.865 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.87 13.56 30.2 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.477 178.613 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.52 -9.1 61.02 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.541 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -74.23 -4.0 33.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.04 0.448 . . . . 0.0 110.157 179.12 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -55.39 -23.37 24.24 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.072 177.676 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.86 -27.04 49.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.919 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.635 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.5 -56.32 21.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.401 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -58.42 -34.58 70.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.541 178.595 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.25 -51.76 66.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.397 178.471 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.423 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -63.42 -17.85 63.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.318 179.013 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.586 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.39 -30.56 63.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.652 179.71 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -11.47 35.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.93 179.452 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.38 26.13 0.97 Allowed Glycine 0 N--CA 1.453 -0.198 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.724 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -73.28 -164.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.459 -0.371 . . . . 0.0 111.012 -179.27 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.639 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.8 OUTLIER -51.73 96.81 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.775 0.322 . . . . 0.0 111.106 179.586 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.33 -23.07 61.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.079 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.6 p -89.42 -40.0 12.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.036 0.446 . . . . 0.0 110.648 179.323 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.639 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 8.5 t -95.51 92.19 6.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.519 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -76.82 132.53 39.25 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.311 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.05 HG21 HG22 ' A' ' 8' ' ' ILE . 3.6 mp -101.15 149.68 6.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.447 -175.333 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.432 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 6.8 tt0 -85.78 69.56 10.6 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.331 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.694 HG23 ' HB ' ' A' ' 80' ' ' ILE . 54.5 t -80.87 55.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.805 -175.096 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -132.51 -1.37 3.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.61 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.805 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 11.4 t0 -86.36 131.8 34.12 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.738 -178.771 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.508 ' C ' ' HG2' ' A' ' 86' ' ' ARG . 2.0 p -151.41 160.6 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.37 -179.305 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.661 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 6.0 mmt180 -146.35 76.86 1.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.355 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.477 ' HA ' HG13 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -75.2 75.22 2.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.799 0.333 . . . . 0.0 111.341 -179.36 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.675 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 9.9 mp -81.88 82.81 7.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.269 179.009 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.471 ' OXT' ' HG3' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.012 -179.536 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.949 0.404 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.76 -5.29 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.802 179.919 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -94.65 164.43 12.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.105 0.479 . . . . 0.0 111.612 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.847 HG12 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -102.06 119.5 50.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.093 177.77 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.541 ' CG2' HD11 ' A' ' 88' ' ' LEU . 22.3 t -109.17 119.12 58.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.705 0.288 . . . . 0.0 111.484 -178.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.529 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.02 145.36 25.0 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.463 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.799 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 10.0 m -122.73 133.72 54.48 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.608 0.718 . . . . 0.0 112.427 -177.566 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.987 HG22 HG21 ' A' ' 80' ' ' ILE . 4.5 mm -123.01 104.68 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.386 -179.475 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.77 ' HB2' ' HG3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -95.94 98.18 10.2 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -177.217 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.79 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.5 m -96.18 138.4 21.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.82 -177.875 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.793 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 2.1 ptm -147.25 121.22 5.01 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-O 121.182 0.515 . . . . 0.0 111.878 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 22.8 Cg_exo -68.02 126.93 15.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.362 2.708 . . . . 0.0 112.173 179.116 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -32.2 68.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.454 -179.882 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.7 m -77.42 146.88 74.68 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.701 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.53 -6.93 13.02 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.402 2.068 . . . . 0.0 111.801 179.207 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -92.3 38.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.073 178.556 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.724 HG11 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -68.03 85.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 122.013 0.911 . . . . 0.0 110.712 -178.52 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.579 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 17.1 m-20 -73.07 96.63 2.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.056 177.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -63.77 -41.36 97.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.637 -178.362 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.899 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 5.5 tp10 -69.8 -36.23 75.5 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.872 0.368 . . . . 0.0 110.371 -179.058 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -69.81 -37.43 76.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.452 0.644 . . . . 0.0 109.309 176.272 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -68.18 -25.81 65.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.064 177.164 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.899 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -56.31 -44.14 79.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.193 179.627 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -44.81 83.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.451 178.908 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.594 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 40.8 mt-10 -65.09 -28.18 69.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.466 0.65 . . . . 0.0 110.44 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.812 HG12 HG21 ' A' ' 53' ' ' VAL . 1.7 mt -60.21 -49.62 83.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.403 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.525 ' OE1' HD22 ' A' ' 36' ' ' LEU . 6.9 mm-40 -64.92 -32.95 74.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.476 -178.233 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 11.5 pt-20 -76.74 -21.27 55.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 110.751 179.617 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.95 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.55 -12.06 38.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.013 179.914 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.582 HG12 ' O ' ' A' ' 26' ' ' ILE . 27.2 mm -58.94 138.42 87.42 Favored Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.256 179.684 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.62 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 11.0 Cg_endo -52.82 118.23 4.54 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.898 2.399 . . . . 0.0 112.433 178.764 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -59.67 1.21 0.1 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.321 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.04 -43.73 7.43 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.181 -178.441 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.574 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.32 -139.75 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.621 0.248 . . . . 0.0 111.192 -178.868 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -133.55 168.58 18.4 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.947 0.403 . . . . 0.0 111.255 -178.988 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.525 HD22 ' OE1' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -75.91 -178.79 4.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.274 -179.299 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.693 ' ND1' HG22 ' A' ' 56' ' ' VAL . 59.1 t60 -131.4 -77.47 0.52 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.176 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.452 ' HB2' ' HD2' ' A' ' 37' ' ' HIS . 30.7 mmtm -162.0 133.02 5.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.205 -179.035 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.631 HG12 HG13 ' A' ' 53' ' ' VAL . 2.7 mt -93.97 158.25 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.021 0.439 . . . . 0.0 112.108 -178.009 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.713 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 2.6 m-20 -122.77 120.77 34.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.122 -179.498 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.45 67.77 10.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.866 0.365 . . . . 0.0 110.057 178.698 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.673 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.2 148.81 35.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.671 -177.889 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.769 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 50.4 Cg_endo -94.34 159.12 2.03 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.117 2.545 . . . . 0.0 113.347 -177.553 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.757 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.0 mm -128.9 -81.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.997 -178.707 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -67.73 -149.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.196 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -72.23 -30.14 64.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.875 0.369 . . . . 0.0 110.615 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.7 6.26 0.54 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.621 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.724 ' HA ' HG11 ' A' ' 17' ' ' VAL . 9.6 mp -89.25 101.07 13.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.912 0.387 . . . . 0.0 110.854 -179.271 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.769 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 11.3 t -91.97 127.83 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.129 -177.659 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.793 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.35 144.35 25.97 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.829 177.695 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.713 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -106.07 116.9 32.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.419 178.836 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.586 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.5 m-20 -89.58 93.42 9.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.178 -178.893 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.812 HG21 HG12 ' A' ' 26' ' ' ILE . 5.7 t -85.98 106.19 15.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.527 -178.187 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.468 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 34.9 mtt -84.53 162.92 19.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.136 178.836 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.9 m -140.13 141.24 33.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.087 -178.789 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.693 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.3 t -91.04 101.51 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.491 179.096 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.847 HG23 HG12 ' A' ' 4' ' ' VAL . 29.7 m -129.99 140.9 47.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.068 0.461 . . . . 0.0 111.597 -179.14 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.42 -60.66 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.334 178.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -81.73 -7.56 59.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 0.0 110.429 179.099 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.574 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.4 -143.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.163 179.52 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -147.29 -165.27 2.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.803 -179.848 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.61 12.87 32.0 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.653 179.041 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.85 -6.84 57.53 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.44 179.621 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -74.44 -3.89 33.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 110.228 179.248 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -54.63 -24.08 19.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.114 177.713 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.79 -29.24 62.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.103 -179.465 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.61 -55.14 33.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.381 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.1 -34.95 72.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.357 178.297 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.86 -50.36 72.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.336 178.559 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 t -62.94 -18.28 62.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.349 178.608 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.726 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.37 -29.37 61.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.487 179.505 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -11.62 36.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.598 178.868 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.1 27.57 1.0 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.429 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.95 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -72.78 -166.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.366 -0.417 . . . . 0.0 111.099 -179.008 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.674 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 2.3 mm-40 -50.96 97.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.941 0.401 . . . . 0.0 110.81 179.222 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.71 -27.06 61.02 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.369 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.564 HG12 ' OE1' ' A' ' 75' ' ' GLU . 1.2 p -89.22 -38.21 10.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.977 0.418 . . . . 0.0 110.741 179.579 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.674 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 30.7 t -96.14 93.05 6.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.814 -179.712 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -76.52 130.88 38.55 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.161 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.987 HG21 HG22 ' A' ' 8' ' ' ILE . 5.2 mt -100.23 140.9 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.666 -176.094 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.77 ' HG3' ' HB2' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -84.86 74.04 10.55 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 174.648 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.728 HG23 ' HB ' ' A' ' 80' ' ' ILE . 86.5 t -81.55 51.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.187 -173.341 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.8 6.99 4.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.505 179.264 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.799 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 38.3 t0 -85.56 141.19 30.03 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.807 0.337 . . . . 0.0 111.082 -178.732 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.3 p -148.4 162.27 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.119 -179.412 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.667 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -147.14 110.33 4.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.057 0.456 . . . . 0.0 111.708 -178.445 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 mmt85 -89.13 79.58 7.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.845 179.545 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.667 HD21 ' HB3' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -84.29 88.48 7.24 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.513 178.187 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 mtm . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.941 179.858 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.511 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.83 0.348 . . . . 0.0 111.27 . . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.435 ' H ' ' H ' ' A' ' 3' ' ' ASP . . . 173.57 0.59 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.871 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 37.5 m-20 -89.99 158.68 17.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.713 0.292 . . . . 0.0 111.348 -179.796 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.525 ' HB ' HG22 ' A' ' 57' ' ' VAL . 2.6 t -106.75 115.3 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.823 177.477 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.768 ' HB ' ' HG2' ' A' ' 86' ' ' ARG . 14.2 t -106.15 108.76 25.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.053 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.659 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.01 165.12 12.6 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.013 177.898 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.739 HG23 ' HG3' ' A' ' 54' ' ' MET . 7.8 m -142.14 129.04 20.65 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.762 0.792 . . . . 0.0 112.276 179.814 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.035 HG22 HG21 ' A' ' 80' ' ' ILE . 3.1 mm -120.72 105.61 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.249 -179.445 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.797 ' C ' HG23 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -94.12 93.64 7.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -177.218 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.49 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.7 m -93.63 138.85 19.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.839 -177.258 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.8 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 2.6 ptm -146.19 123.27 5.97 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.27 179.374 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.566 ' CD ' HG13 ' A' ' 17' ' ' VAL . 18.6 Cg_exo -67.68 125.96 14.03 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.064 2.509 . . . . 0.0 112.217 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.35 -32.48 66.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.276 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.5 m -77.71 150.13 78.5 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.03 -179.55 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -67.97 -4.62 12.81 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.486 2.124 . . . . 0.0 111.774 178.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -91.6 45.91 1.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.747 178.32 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.566 HG13 ' CD ' ' A' ' 12' ' ' PRO . 69.8 t -63.96 78.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.505 -178.189 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.567 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -71.32 93.87 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.263 177.957 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.557 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -64.35 -41.53 96.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.622 0.249 . . . . 0.0 111.134 -179.333 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.557 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 4.6 tp10 -68.05 -38.17 82.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.22 -178.404 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.572 ' O ' ' HE2' ' A' ' 24' ' ' LYS . . . -70.92 -38.51 72.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.285 0.564 . . . . 0.0 110.112 177.541 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.972 HD23 ' HG2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -65.86 -28.07 68.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.213 178.411 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -58.89 -46.57 87.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.922 -179.718 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.572 ' HE2' ' O ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -63.92 -41.02 97.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.683 -179.598 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.972 ' HG2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.07 -38.35 90.5 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.731 0.776 . . . . 0.0 110.012 179.756 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.854 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 4.2 mt -58.84 -40.88 81.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.838 -176.809 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -62.6 -37.02 84.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.461 . . . . 0.0 110.178 178.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 3.2 mm-40 -76.05 -23.72 55.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.628 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.854 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.73 -11.92 43.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.663 -178.198 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 26' ' ' ILE . 24.8 mm -58.11 136.6 84.35 Favored Pre-proline 0 C--N 1.333 -0.138 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.503 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 1.3 Cg_endo -45.13 122.59 4.53 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.88 2.387 . . . . 0.0 112.134 179.186 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.448 ' H ' ' HB3' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -56.96 -6.0 0.3 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.131 -178.936 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.55 -58.02 2.48 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.575 -179.589 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.44 -146.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.666 0.27 . . . . 0.0 111.001 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -136.78 175.82 9.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 110.881 -179.714 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.29 -175.47 2.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.423 -178.798 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.541 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 85.0 t60 -130.94 -72.12 0.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.755 -179.544 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.518 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -163.83 128.54 2.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.986 -178.92 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.705 HD13 HG22 ' A' ' 53' ' ' VAL . 2.9 mt -93.56 155.13 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.17 -177.104 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.699 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.2 t0 -119.43 121.6 39.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.046 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -86.28 67.77 10.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.931 0.396 . . . . 0.0 110.174 178.835 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.694 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -98.34 148.89 35.14 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.621 -177.887 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.76 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 31.6 Cg_endo -93.47 157.86 2.46 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.052 2.501 . . . . 0.0 113.443 -177.269 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.745 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.5 mm -128.42 -82.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.024 -178.973 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -67.64 -149.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -71.47 -31.85 67.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.609 179.646 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.34 7.39 0.62 Allowed Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.413 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 8.8 mp -90.17 100.08 12.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.985 0.421 . . . . 0.0 110.799 -179.626 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.76 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 17.7 t -91.43 127.88 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.928 -177.765 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.8 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.16 143.85 26.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.135 178.415 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.699 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.6 OUTLIER -104.92 117.69 34.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.201 178.507 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.578 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.7 m120 -89.41 93.0 9.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.141 -178.894 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.705 HG22 HD13 ' A' ' 39' ' ' ILE . 10.9 t -85.9 102.63 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.67 -177.721 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.739 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.1 OUTLIER -84.76 166.1 17.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.18 178.517 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.659 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.9 m -138.89 126.53 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.055 0.455 . . . . 0.0 111.231 -179.059 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.541 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -97.72 107.49 20.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.836 179.363 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.525 HG22 ' HB ' ' A' ' 4' ' ' VAL . 1.6 m -123.66 171.79 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.568 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.04 -73.45 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.839 179.541 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -80.35 2.49 24.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.9 0.381 . . . . 0.0 110.795 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.14 -151.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.97 179.339 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.56 -161.9 1.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.807 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.58 12.32 34.76 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.488 178.839 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.07 -7.64 60.0 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.362 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 p -74.3 -5.35 41.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 110.239 179.313 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -23.91 22.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.227 177.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.448 ' HB3' ' H ' ' A' ' 32' ' ' GLU . . . -56.97 -26.37 59.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.136 -179.401 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.91 -56.63 18.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.267 179.49 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.92 -34.63 71.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.573 178.536 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -51.55 68.43 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.444 178.888 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.465 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 7.6 p -64.17 -20.42 65.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.649 179.005 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.6 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.34 -27.11 62.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.623 -179.727 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.1 -16.23 61.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.805 179.435 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.53 29.34 0.95 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.728 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.821 HD11 ' HD2' ' A' ' 29' ' ' ARG . 1.7 tt -73.38 -162.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.524 -0.338 . . . . 0.0 111.213 -178.704 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.629 ' HG3' ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -51.39 90.21 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.084 0.468 . . . . 0.0 110.745 179.257 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.32 -24.71 67.72 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.927 -178.282 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -85.69 -35.92 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.408 0.623 . . . . 0.0 109.985 179.1 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.629 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 1.4 m -96.0 90.52 5.6 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.405 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -74.8 129.85 38.42 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.692 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.035 HG21 HG22 ' A' ' 8' ' ' ILE . 1.8 mp -101.12 148.81 6.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.47 -175.319 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.586 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 2.8 tt0 -85.8 70.14 10.65 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 173.129 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.723 HG23 ' HB ' ' A' ' 80' ' ' ILE . 57.7 t -80.0 53.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.999 -174.411 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.92 2.29 3.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.454 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.674 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.0 OUTLIER -85.61 132.44 34.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.313 -178.218 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.9 p -148.08 145.61 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.795 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.768 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -149.72 95.54 2.34 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.335 0.588 . . . . 0.0 110.346 -178.677 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' HG3' HG13 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -82.02 110.39 17.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.542 -178.778 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.585 HD11 ' NE ' ' A' ' 86' ' ' ARG . 6.9 mp -82.06 79.06 8.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.347 177.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.3 mtm . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.998 -179.699 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.58 0.228 . . . . 0.0 110.591 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 55.2 t -111.95 122.91 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.752 0.311 . . . . 0.0 111.745 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.516 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -97.41 167.49 10.97 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.631 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 5.3 m -141.94 127.55 19.07 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.596 0.712 . . . . 0.0 112.164 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.991 HG22 HG21 ' A' ' 80' ' ' ILE . 4.3 mm -122.08 108.45 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.578 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.8 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -98.31 96.71 8.24 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.461 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.4 m -91.39 135.5 26.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.841 0.353 . . . . 0.0 111.519 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.841 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.3 ptm -145.05 125.36 7.27 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 121.109 0.48 . . . . 0.0 111.648 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.628 ' CD ' HG13 ' A' ' 17' ' ' VAL . 14.6 Cg_exo -71.45 128.4 14.45 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.487 2.791 . . . . 0.0 112.404 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -35.51 71.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.347 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.74 154.87 78.41 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.346 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.605 ' HA ' HD22 ' A' ' 48' ' ' LEU . 56.1 Cg_endo -69.95 -3.24 11.74 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.554 2.17 . . . . 0.0 111.961 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -90.93 44.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.738 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.628 HG13 ' CD ' ' A' ' 12' ' ' PRO . 98.1 t -63.8 78.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.321 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.574 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -69.91 95.13 0.9 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.12 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.683 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -62.98 -43.75 97.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.394 -178.265 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.771 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 10.1 tt0 -70.6 -35.63 73.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 0.0 110.762 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.574 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -68.55 -37.23 79.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.507 ' CD2' ' HG3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -65.95 -28.73 69.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.011 177.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.771 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -55.93 -46.88 78.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.596 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -65.1 -42.86 93.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.421 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.559 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 2.4 mt-10 -66.4 -31.54 72.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.285 0.564 . . . . 0.0 110.598 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.805 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 9.5 mt -61.88 -42.94 96.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.709 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -62.29 -39.32 92.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.939 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 9.2 pt-20 -77.41 -20.97 53.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.59 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.811 ' HD2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.14 -11.94 39.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.194 -178.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.683 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.1 mm -60.26 137.87 91.71 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.326 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.658 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.9 Cg_endo -52.34 114.85 1.84 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.686 2.257 . . . . 0.0 112.113 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.52 3.01 0.05 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.362 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.51 -43.94 7.63 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.88 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.619 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.61 -135.47 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.718 0.259 . . . . 0.0 111.136 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -135.01 169.47 17.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.635 HD23 HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -76.15 -176.13 3.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.964 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.502 ' ND1' HG22 ' A' ' 56' ' ' VAL . 83.8 t60 -130.79 -77.51 0.53 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.251 0.548 . . . . 0.0 111.102 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.627 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -165.07 129.94 2.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.829 -178.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.648 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -92.66 158.23 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.724 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 2.0 t0 -123.7 131.47 53.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.632 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -91.1 71.36 6.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.354 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.6 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -103.68 146.78 33.14 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.64 -178.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.788 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.0 Cg_endo -88.91 157.45 5.95 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.123 2.549 . . . . 0.0 112.974 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.753 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.7 mm -127.15 -83.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.458 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.768 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.34 -150.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -71.89 -28.45 63.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.846 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.62 5.93 0.45 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.646 -0.787 . . . . 0.0 113.099 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.768 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.4 mt -93.03 106.29 18.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 111.108 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.788 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 60.3 t -93.7 127.55 45.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.72 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.841 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -94.6 166.63 11.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.391 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.724 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.1 mp -120.38 118.28 29.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.099 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -89.61 92.09 8.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.333 0.587 . . . . 0.0 110.32 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.648 HG22 HD13 ' A' ' 39' ' ' ILE . 4.6 t -86.83 101.85 11.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.543 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.618 ' HG3' HG23 ' A' ' 7' ' ' THR . 2.6 mtt -84.6 165.18 18.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.34 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.516 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.0 m -139.43 135.14 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.394 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.502 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.48 116.91 39.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.022 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 4' ' ' VAL . 10.6 m -130.21 148.26 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.084 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -167.22 -69.56 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.297 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -81.44 -5.68 58.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.989 0.423 . . . . 0.0 110.579 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.619 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.67 -149.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.318 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.57 -165.53 2.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.793 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.22 15.06 24.87 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.639 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.49 -3.94 49.95 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.574 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p -74.28 -3.74 31.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.91 0.386 . . . . 0.0 110.142 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.15 -23.93 23.82 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.353 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.53 -25.77 52.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.164 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.658 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.44 -55.9 26.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.351 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -58.64 -34.6 71.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.44 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.29 -51.81 67.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.347 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.449 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.7 p -63.8 -20.13 65.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.424 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.607 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.87 -28.24 62.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.551 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.54 -13.26 51.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.957 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.31 26.1 0.98 Allowed Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.742 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.811 HD11 ' HD2' ' A' ' 29' ' ' ARG . 2.6 tt -73.38 -163.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.449 -0.376 . . . . 0.0 111.127 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.589 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -51.29 94.2 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.843 0.354 . . . . 0.0 111.009 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.13 -26.91 68.16 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.233 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 p -88.6 -38.3 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.188 0.518 . . . . 0.0 110.232 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -96.69 89.94 5.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.324 179.399 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.544 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.2 136.87 38.59 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.991 HG21 HG22 ' A' ' 8' ' ' ILE . 2.3 mp -101.91 147.91 8.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.397 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.646 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 3.8 tt0 -86.05 70.73 10.62 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 173.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.646 HG23 ' HB ' ' A' ' 80' ' ' ILE . 60.6 t -80.54 51.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.009 -174.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.78 3.84 3.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.328 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.631 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 4.1 m-20 . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 111.247 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.431 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.3 t . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.644 0.259 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 86.9 t -119.5 116.67 51.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.067 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.679 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -92.35 166.93 12.33 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.808 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 9.0 m -142.2 130.7 22.5 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.535 0.684 . . . . 0.0 112.129 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.944 HG22 HG21 ' A' ' 80' ' ' ILE . 9.8 mm -121.75 106.64 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.512 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.706 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.4 OUTLIER -96.83 96.13 8.34 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.841 0.353 . . . . 0.0 111.866 -177.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.823 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.5 m -93.65 137.3 23.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.939 -177.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.613 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -146.05 123.82 6.21 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 121.249 0.547 . . . . 0.0 111.412 178.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.629 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 11.5 Cg_exo -73.2 120.92 6.84 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.591 2.861 . . . . 0.0 111.979 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -56.44 -31.57 64.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 p -78.28 154.85 79.58 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.202 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.577 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 53.8 Cg_endo -69.31 -2.55 10.05 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.301 2.001 . . . . 0.0 111.695 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.43 41.15 1.04 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.237 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.629 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 91.1 t -65.93 77.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.493 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.63 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -69.49 95.04 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.671 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -63.82 -44.24 93.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.175 -178.469 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.671 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 5.1 tp10 -68.47 -40.05 81.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.613 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.767 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -70.85 -35.81 72.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.128 0.49 . . . . 0.0 110.504 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.586 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -66.13 -31.71 72.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.803 178.257 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -56.27 -45.21 80.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.68 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.767 ' HE2' ' HA ' ' A' ' 21' ' ' ALA . 1.9 mtmm -67.09 -43.57 82.22 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.518 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 21' ' ' ALA . 26.1 mt-10 -65.95 -27.14 67.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.634 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.778 HG12 HG21 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -61.81 -46.58 96.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.412 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.543 HE22 HD11 ' A' ' 39' ' ' ILE . 25.3 mm-40 -63.06 -31.89 73.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 0.0 110.969 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 5.6 mm-40 -73.25 -22.42 60.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.137 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.914 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.15 -18.6 25.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.381 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.457 HG23 ' HD2' ' A' ' 31' ' ' PRO . 27.6 mm -57.18 137.46 80.62 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.205 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.457 ' HD2' HG23 ' A' ' 30' ' ' ILE . 8.7 Cg_endo -48.9 118.75 3.69 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.902 2.401 . . . . 0.0 112.191 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -4.61 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.137 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.66 -35.01 17.64 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.152 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.596 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.61 -148.66 0.37 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 111.215 -179.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -136.71 171.33 14.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.93 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.686 HD13 ' H ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -75.35 -176.17 3.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.427 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.716 ' ND1' HG22 ' A' ' 56' ' ' VAL . 71.7 t60 -130.84 -74.85 0.53 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.796 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 mmtm -161.68 129.38 4.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.051 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.674 HG12 HG13 ' A' ' 53' ' ' VAL . 2.7 mt -92.33 160.75 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.985 0.421 . . . . 0.0 111.803 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -128.42 123.2 33.16 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.511 -178.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -85.06 72.12 10.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.783 0.325 . . . . 0.0 110.502 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.509 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -99.28 134.5 21.24 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.83 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.792 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 73.3 Cg_endo -88.1 156.94 7.05 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.553 2.168 . . . . 0.0 112.757 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.0 mm -124.64 -82.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.323 -177.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.671 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.52 -152.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.86 -28.6 63.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.595 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.77 5.44 0.5 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.979 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.671 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.7 mt -91.73 101.84 14.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.911 0.386 . . . . 0.0 110.76 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.792 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 89.2 t -93.75 128.45 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.853 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.716 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.64 153.33 17.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.923 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.626 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.1 mp -113.34 119.86 39.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.507 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.554 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.6 m120 -90.44 91.26 8.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.187 0.518 . . . . 0.0 110.207 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.778 HG21 HG12 ' A' ' 26' ' ' ILE . 6.0 t -87.45 106.29 16.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.547 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.566 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.64 165.5 17.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.283 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.679 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.2 m -139.98 137.97 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 111.446 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.716 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.5 OUTLIER -94.68 110.77 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.853 179.052 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.562 HG12 HG21 ' A' ' 34' ' ' THR . 13.1 m -130.13 148.01 33.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.949 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.73 -68.12 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.383 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -81.73 -3.07 52.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.934 0.397 . . . . 0.0 110.579 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.596 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.22 -146.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.119 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -147.34 -163.19 1.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.776 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.79 12.49 35.14 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.604 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.67 -6.16 58.34 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.617 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 p -74.94 -7.26 53.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.609 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -54.89 -24.39 23.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.274 0.559 . . . . 0.0 110.226 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.32 -27.75 62.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.229 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.498 ' HB1' HH22 ' A' ' 29' ' ' ARG . . . -60.77 -55.68 30.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.384 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.69 -35.09 73.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.455 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -49.92 75.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.28 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 p -64.17 -18.97 64.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.454 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.725 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -74.04 -28.96 61.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.605 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -14.42 54.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.46 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.28 32.96 0.93 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.448 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.914 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -72.68 -163.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.215 -0.492 . . . . 0.0 111.075 -178.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.5 OUTLIER -50.91 98.65 0.02 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.913 0.387 . . . . 0.0 110.968 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.35 -33.88 66.79 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.797 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.1 t -87.12 -39.63 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.984 0.421 . . . . 0.0 110.524 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 40.5 t -96.23 92.3 6.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.796 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.604 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.63 134.2 38.24 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.944 HG21 HG22 ' A' ' 8' ' ' ILE . 15.6 mt -101.41 147.05 8.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.584 -175.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -85.64 71.08 10.77 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 173.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.707 HG23 ' HB ' ' A' ' 80' ' ' ILE . 58.2 t -81.02 52.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.241 -174.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.94 4.34 3.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.458 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.808 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 39.5 t0 . . . . . 0 N--CA 1.452 -0.332 0 CA-C-O 120.899 0.38 . . . . 0.0 111.405 -178.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.764 HG12 HG23 ' A' ' 57' ' ' VAL . 1.1 t . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 42.1 t -110.83 112.86 42.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.716 0.293 . . . . 0.0 111.242 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.612 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.67 142.5 27.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.227 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.685 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 7.8 m -122.53 129.25 51.76 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.621 0.724 . . . . 0.0 112.032 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.054 HG22 HG21 ' A' ' 80' ' ' ILE . 1.4 mm -120.44 108.3 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.713 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.814 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -95.29 93.72 7.44 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.471 HG12 HG12 ' A' ' 80' ' ' ILE . 1.4 m -92.49 136.02 25.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.791 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.828 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.7 ptm -144.4 124.73 7.51 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 121.058 0.456 . . . . 0.0 111.349 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.61 ' CD ' HG13 ' A' ' 17' ' ' VAL . 12.3 Cg_exo -70.9 125.1 11.21 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.246 2.631 . . . . 0.0 112.075 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.07 -33.85 69.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.639 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.8 m -78.01 153.4 80.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.582 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 42.4 Cg_endo -67.59 -3.47 10.28 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.402 2.068 . . . . 0.0 111.955 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.79 43.52 1.15 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.755 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.61 HG13 ' CD ' ' A' ' 12' ' ' PRO . 87.2 t -65.52 75.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.385 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -71.48 88.11 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.948 177.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.746 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -63.81 -39.18 93.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.065 -178.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.544 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -68.16 -39.13 82.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.971 -178.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -72.05 -36.06 69.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.134 0.493 . . . . 0.0 110.282 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -67.37 -28.22 67.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.979 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -57.73 -43.75 85.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.325 179.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -66.53 -43.34 85.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.528 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -66.31 -28.07 68.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.169 0.509 . . . . 0.0 110.531 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.794 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.6 mt -61.86 -44.7 99.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.008 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.88 -36.88 77.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.939 0.399 . . . . 0.0 110.417 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -75.35 -24.09 57.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.747 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.794 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.95 -14.17 37.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.713 0.292 . . . . 0.0 111.291 -178.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.2 mm -59.79 139.0 90.21 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.26 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.657 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.4 Cg_endo -51.54 111.69 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.769 2.312 . . . . 0.0 112.076 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.43 2.88 0.05 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.494 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.71 -41.08 9.11 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.821 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.6 ' CB ' HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.19 -133.56 0.21 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.435 0.16 . . . . 0.0 110.794 -179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -140.0 162.92 34.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.826 0.346 . . . . 0.0 110.978 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.6 pt? -76.47 -173.23 2.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.583 ' ND1' HG22 ' A' ' 56' ' ' VAL . 76.7 t60 -130.83 -77.62 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 111.334 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 3.0 mmtp -160.07 132.08 6.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.333 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.656 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -93.57 160.01 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.608 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.653 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -128.17 125.12 38.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.647 -178.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -85.74 74.16 10.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.835 0.35 . . . . 0.0 110.438 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.534 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -100.45 134.88 20.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.785 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.8 Cg_endo -84.97 156.01 11.41 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.589 2.193 . . . . 0.0 112.556 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.1 mm -124.76 -82.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.163 -178.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.633 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.27 -153.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.994 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -71.97 -26.59 62.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.663 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.73 3.07 0.41 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.122 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.633 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.1 mt -91.65 103.22 15.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.785 0.326 . . . . 0.0 110.786 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.785 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 93.6 t -94.1 129.06 44.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.746 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.828 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.22 162.71 13.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.906 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.746 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.0 mp -120.4 120.23 35.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.398 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 1.1 m120 -89.66 91.5 8.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.216 0.532 . . . . 0.0 109.792 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.702 HG21 HG12 ' A' ' 26' ' ' ILE . 14.1 t -86.32 105.84 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.434 -177.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.56 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 13.0 mtt -84.94 160.58 20.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.14 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.612 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.0 m -139.09 137.87 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.212 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.583 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.7 t -93.0 98.16 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.883 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.764 HG23 HG12 ' A' ' 4' ' ' VAL . 34.9 m -130.4 138.21 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.124 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.33 -59.66 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.49 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.14 -8.19 59.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.994 0.426 . . . . 0.0 110.503 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.431 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.56 -139.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.122 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.11 -162.38 1.53 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.783 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.2 11.49 36.51 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.702 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.43 -12.21 69.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.474 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 p -74.31 -4.25 35.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.03 0.443 . . . . 0.0 110.278 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -24.32 22.18 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.072 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.63 -27.92 52.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.02 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.657 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.83 -57.89 10.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.372 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -58.45 -34.37 70.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.522 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.77 -52.33 64.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.058 0.456 . . . . 0.0 110.371 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.429 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -64.05 -20.75 66.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.475 178.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.592 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.99 -28.05 62.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.675 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.59 -16.6 61.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.767 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.53 31.0 0.94 Allowed Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.834 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.778 HD11 ' HB2' ' A' ' 29' ' ' ARG . 2.9 tt -73.21 -161.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.511 -0.344 . . . . 0.0 111.11 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.622 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -51.82 90.69 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.121 0.486 . . . . 0.0 110.714 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.53 -24.93 62.43 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.107 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 p -86.95 -34.67 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.352 0.596 . . . . 0.0 110.307 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.62 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 29.0 t -96.71 92.3 6.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.697 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.592 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -76.23 132.2 39.76 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.146 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.054 HG21 HG22 ' A' ' 8' ' ' ILE . 2.1 mt -101.03 148.16 7.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.493 -175.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.588 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 2.4 tp10 -85.86 71.11 10.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 172.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.705 HG23 ' HB ' ' A' ' 80' ' ' ILE . 68.4 t -79.95 55.89 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.947 -174.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -133.05 1.87 3.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.81 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.685 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.0 m-20 . . . . . 0 N--CA 1.454 -0.242 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.256 -178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.521 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.5 t . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.685 0.279 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 53.5 t -105.1 112.02 36.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.51 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.613 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.84 142.6 27.91 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.3 m -122.75 129.4 51.71 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.72 0.771 . . . . 0.0 112.563 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.978 HG22 HG21 ' A' ' 80' ' ' ILE . 3.2 mm -121.12 108.71 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.731 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.781 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.96 96.22 8.02 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -177.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.464 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.3 m -93.21 136.67 24.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.581 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -146.26 124.97 6.43 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.296 178.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.634 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.2 Cg_exo -71.38 120.35 6.9 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.137 2.558 . . . . 0.0 111.694 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.74 -31.34 64.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.285 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.5 p -77.88 154.21 80.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.985 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.554 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 54.5 Cg_endo -69.01 -1.14 7.31 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.223 1.949 . . . . 0.0 111.493 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.18 41.98 1.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.116 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.634 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 84.8 t -65.8 79.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.368 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 67.3 m-20 -68.11 101.12 1.09 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.16 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.62 HD12 ' HE2' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -61.41 -53.2 59.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.773 -178.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.669 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 13.6 pt-20 -71.06 -34.47 71.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.214 -176.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -68.17 -36.45 79.64 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.59 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -65.17 -34.0 77.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.389 176.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.669 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -57.14 -47.38 81.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.407 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 21' ' ' ALA . 2.5 mtmt -64.47 -42.91 95.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.61 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.622 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 2.1 mt-10 -66.55 -32.91 74.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.204 0.526 . . . . 0.0 110.811 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.659 ' O ' HG12 ' A' ' 30' ' ' ILE . 3.0 mt -61.78 -43.04 96.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.008 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -62.53 -40.41 96.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.683 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 9.0 pt-20 -78.49 -19.22 53.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.832 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.84 HH22 ' HB ' ' A' ' 8' ' ' ILE . 26.8 ptt85 -89.9 -11.44 41.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.255 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.659 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.9 mm -59.91 138.85 90.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.742 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 8.5 Cg_endo -49.13 117.07 2.57 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.872 2.381 . . . . 0.0 112.256 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -59.71 2.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.433 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.03 -46.18 6.33 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.122 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.643 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -130.07 -134.74 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.624 0.25 . . . . 0.0 110.998 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -137.1 166.41 23.77 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.812 0.339 . . . . 0.0 110.73 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -76.4 -171.91 1.95 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.241 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.458 ' ND1' HG22 ' A' ' 56' ' ' VAL . 85.7 t60 -130.55 -77.69 0.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.376 0.608 . . . . 0.0 111.101 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 2.0 tptp -164.47 129.83 2.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.668 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.622 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -91.78 160.88 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -176.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.616 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -126.4 120.71 30.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.383 -179.271 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -84.32 72.59 10.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.917 0.389 . . . . 0.0 110.465 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.507 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -99.13 135.35 20.83 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.951 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.783 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 62.2 Cg_endo -86.47 157.22 9.33 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.596 2.197 . . . . 0.0 112.515 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.5 mm -126.63 -83.19 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.532 -177.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.668 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.62 -149.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.188 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -70.5 -32.12 69.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.361 . . . . 0.0 110.549 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.69 7.63 0.59 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.658 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.668 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.9 mt -91.25 101.71 14.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.81 0.338 . . . . 0.0 110.793 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 73.9 t -92.53 129.54 42.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.739 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.716 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.03 160.28 14.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.675 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.616 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.1 mp -120.45 119.54 33.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.5 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.531 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.4 m120 -89.73 90.74 8.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.268 0.556 . . . . 0.0 110.024 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.622 HG22 HD13 ' A' ' 39' ' ' ILE . 10.0 t -87.89 104.74 14.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.478 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.62 ' HG3' HG23 ' A' ' 7' ' ' THR . 2.0 mtt -85.39 163.82 18.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.35 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.613 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.4 m -140.24 136.04 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.984 0.421 . . . . 0.0 111.394 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.458 HG22 ' ND1' ' A' ' 37' ' ' HIS . 1.9 t -95.35 112.08 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.017 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 4' ' ' VAL . 21.4 m -130.17 139.11 52.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.897 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.78 -61.06 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.551 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -81.4 -14.43 57.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.014 0.435 . . . . 0.0 110.718 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.643 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.56 -139.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.092 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.9 -168.82 3.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.525 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.84 13.55 30.05 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.553 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.44 -1.73 38.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.663 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -74.29 -3.92 33.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.857 0.36 . . . . 0.0 110.374 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -55.18 -23.68 23.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.233 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.2 -24.59 42.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.155 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.742 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.39 -56.13 23.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.263 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.3 -34.75 70.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.342 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.53 -52.33 64.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.442 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.436 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.5 p -64.21 -19.11 65.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.629 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.59 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.52 -29.91 62.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.749 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.81 -12.06 43.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.9 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.21 26.02 0.99 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.862 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' A' ' 29' ' ' ARG . 2.7 tt -73.1 -163.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.774 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 0.0 OUTLIER -51.68 96.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.036 0.446 . . . . 0.0 110.665 179.351 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.97 -30.77 76.33 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.367 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 t -85.49 -33.32 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.885 0.374 . . . . 0.0 110.505 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.649 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 11.6 t -95.42 91.23 6.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.717 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.584 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -75.43 132.78 41.08 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.978 HG21 HG22 ' A' ' 8' ' ' ILE . 3.2 mp -101.09 148.85 6.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.607 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.585 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 38.7 tt0 -85.85 69.49 10.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 173.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.691 HG23 ' HB ' ' A' ' 80' ' ' ILE . 61.8 t -79.97 54.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.732 -175.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.89 0.57 3.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.567 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.791 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 10.2 t0 . . . . . 0 N--CA 1.452 -0.366 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.859 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.52 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.5 t . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.618 0.247 . . . . 0.0 110.703 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.5 t -109.96 119.97 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.699 0.285 . . . . 0.0 111.555 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.784 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -98.72 166.65 11.22 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.706 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 14.7 m -143.23 137.49 28.98 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.644 0.735 . . . . 0.0 112.43 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.058 HG22 HG21 ' A' ' 80' ' ' ILE . 4.2 mm -127.11 106.35 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.274 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.769 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.58 96.19 8.49 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -176.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.558 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.5 m -93.37 134.13 32.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.909 0.385 . . . . 0.0 111.822 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.679 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -146.3 124.91 6.4 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 121.094 0.473 . . . . 0.0 111.24 179.04 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.631 ' CD ' HG13 ' A' ' 17' ' ' VAL . 12.5 Cg_exo -72.51 122.67 8.47 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.467 2.778 . . . . 0.0 112.026 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -56.76 -32.13 65.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.235 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.91 153.58 80.37 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.037 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.6 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 53.6 Cg_endo -69.46 -2.86 10.69 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.403 2.068 . . . . 0.0 112.305 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.61 45.74 1.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.996 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.631 HG13 ' CD ' ' A' ' 12' ' ' PRO . 92.7 t -64.96 76.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.708 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -71.12 89.71 0.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.877 HD13 ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -63.53 -37.17 86.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.541 -178.17 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.877 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -70.61 -35.58 73.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.992 0.425 . . . . 0.0 110.077 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -69.05 -37.52 78.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.508 ' CD2' ' HG3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -65.92 -30.07 70.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.014 177.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.794 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -55.22 -46.71 75.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.663 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -65.84 -43.59 88.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.537 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.721 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 1.3 mm-40 -66.05 -29.32 69.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.266 0.555 . . . . 0.0 110.56 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.718 HG12 HG21 ' A' ' 53' ' ' VAL . 3.8 mt -60.94 -46.4 96.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.932 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -62.37 -38.74 90.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.208 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.721 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -78.33 -20.55 51.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.546 -178.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.911 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -89.05 -10.58 46.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.141 -179.222 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.65 HG12 ' O ' ' A' ' 26' ' ' ILE . 33.3 mm -60.89 138.12 93.74 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.265 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.511 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.3 Cg_endo -51.59 114.54 1.62 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.668 2.246 . . . . 0.0 112.126 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.17 -2.58 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.225 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.27 -39.25 10.08 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.875 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.581 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.51 -145.21 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.634 0.254 . . . . 0.0 110.977 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -133.25 164.82 26.23 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.892 0.377 . . . . 0.0 110.795 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.479 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.1 pt? -76.31 -175.09 3.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.389 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.543 ' ND1' HG22 ' A' ' 56' ' ' VAL . 85.3 t60 -130.7 -76.95 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.308 0.575 . . . . 0.0 111.345 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.443 ' HB3' ' CD2' ' A' ' 37' ' ' HIS . 1.1 tptt -163.54 132.66 3.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.959 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.708 HG12 HG13 ' A' ' 53' ' ' VAL . 2.6 mt -92.65 159.35 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.108 0.48 . . . . 0.0 112.172 -176.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.655 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -126.73 117.2 22.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.545 -178.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -82.7 69.9 9.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.941 0.4 . . . . 0.0 110.376 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.544 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -97.23 138.21 21.21 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.887 -179.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.775 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 71.1 Cg_endo -85.43 156.27 10.76 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.535 2.156 . . . . 0.0 112.632 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.1 mm -125.76 -83.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.505 -177.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.67 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.42 -147.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.218 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -70.98 -33.87 70.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.403 . . . . 0.0 110.752 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.48 8.4 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.738 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.67 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.3 mt -91.04 102.31 15.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.902 0.382 . . . . 0.0 110.791 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.775 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 70.7 t -92.78 127.5 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.882 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.744 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.56 150.49 20.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.045 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.655 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -112.2 116.23 30.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.158 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 4.6 m-20 -89.76 94.11 9.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.654 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.718 HG21 HG12 ' A' ' 26' ' ' ILE . 3.7 t -86.45 104.19 13.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.277 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 3.8 mtt -84.52 167.52 16.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.207 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.784 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.1 m -139.93 138.05 38.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.56 -178.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.543 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -95.35 111.09 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.736 178.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.581 HG12 HG21 ' A' ' 34' ' ' THR . 12.8 m -130.05 148.07 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.001 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.29 -72.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.451 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -81.39 -0.3 40.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.917 0.389 . . . . 0.0 110.553 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.529 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.21 -152.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.234 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.55 -162.69 1.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.729 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.94 14.49 26.09 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.565 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.35 -7.22 60.0 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.498 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.415 HG22 ' OG1' ' A' ' 34' ' ' THR . 1.4 p -74.12 -4.63 36.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.978 0.418 . . . . 0.0 110.261 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -54.83 -23.87 20.37 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.289 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.89 -29.21 62.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.031 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -62.09 -55.15 31.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.812 0.339 . . . . 0.0 110.212 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -58.99 -34.31 71.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.213 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.18 -51.24 68.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.127 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.8 p -63.78 -17.27 62.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.221 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.714 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.58 -29.85 62.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.368 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.07 -12.09 35.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.658 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.24 28.87 0.98 Allowed Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.463 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.911 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -72.59 -164.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.338 -0.431 . . . . 0.0 111.062 -178.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.637 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.5 OUTLIER -51.15 99.7 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.938 0.399 . . . . 0.0 110.81 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.93 -33.44 73.84 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.924 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.7 t -87.16 -38.61 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.984 0.421 . . . . 0.0 110.594 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.637 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 40.8 t -96.13 92.31 6.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.875 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.573 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -78.2 135.38 37.6 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.442 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.058 HG21 HG22 ' A' ' 8' ' ' ILE . 2.9 mt -101.57 148.63 7.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.514 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.662 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 15.8 tp10 -86.02 69.43 10.52 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 173.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.677 HG22 HG23 ' A' ' 8' ' ' ILE . 55.1 t -80.93 51.62 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.024 -174.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -133.03 9.25 4.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.919 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.706 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.1 m-20 . . . . . 0 N--CA 1.452 -0.365 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.297 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.4 ' HB ' HG23 ' A' ' 57' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.526 0.055 0 CA-C-O 120.58 0.228 . . . . 0.0 111.181 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.47 HG22 ' HA ' ' A' ' 56' ' ' VAL . 4.7 t -132.75 127.04 55.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.758 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.578 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.13 168.92 10.63 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.802 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 6.2 m -142.81 129.76 20.64 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.466 0.65 . . . . 0.0 112.164 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.998 HG22 HG21 ' A' ' 80' ' ' ILE . 5.7 mm -121.21 108.03 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.677 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.687 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.54 96.18 8.13 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -177.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.83 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.9 m -94.8 137.37 23.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.769 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -147.67 121.65 4.94 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 121.205 0.526 . . . . 0.0 111.999 179.179 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 17.0 Cg_exo -71.34 121.15 7.51 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.417 2.745 . . . . 0.0 111.973 178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.66 -30.56 63.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.317 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -78.0 153.93 80.18 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.965 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.551 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 7.3 Cg_exo -70.39 -6.13 18.21 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.536 2.157 . . . . 0.0 111.719 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -91.17 33.62 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.284 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.29 85.68 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.738 0.78 . . . . 0.0 109.98 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 24.9 m-20 -69.96 106.13 3.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.352 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.409 ' HG ' HD21 ' A' ' 51' ' ' LEU . 1.5 tt -62.12 -48.91 78.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.17 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 12.6 tp10 -68.48 -37.95 80.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.513 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -70.94 -34.57 71.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.0 0.429 . . . . 0.0 110.591 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -65.28 -32.25 73.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.655 178.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -57.8 -45.21 86.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.554 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -42.21 88.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.593 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.604 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 10.3 mt-10 -66.49 -30.23 70.52 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.321 0.581 . . . . 0.0 110.477 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.685 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 3.4 mt -62.06 -43.57 97.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.766 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -60.89 -38.48 85.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.109 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 10.2 pt-20 -77.49 -21.69 52.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.306 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.792 ' HB2' HD11 ' A' ' 74' ' ' ILE . 21.1 ptt85 -91.1 -9.92 43.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.253 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.675 HG12 ' O ' ' A' ' 26' ' ' ILE . 31.5 mm -59.24 137.78 88.48 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.136 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.522 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.8 Cg_endo -51.54 115.02 1.83 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.743 2.296 . . . . 0.0 112.151 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.07 0.55 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.357 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.99 -53.55 3.46 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.858 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.596 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -117.02 -137.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.664 0.232 . . . . 0.0 111.116 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 3.8 pt-20 -137.48 169.14 18.3 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.915 0.388 . . . . 0.0 110.992 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -75.17 177.86 6.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.977 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.673 ' ND1' HG22 ' A' ' 56' ' ' VAL . 71.0 t60 -131.21 -76.28 0.52 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.047 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -161.37 131.78 5.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.402 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.657 HG12 HG13 ' A' ' 53' ' ' VAL . 2.8 mt -93.57 159.23 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.905 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.653 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -129.59 119.31 23.41 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.474 -178.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -82.75 75.52 9.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.91 0.386 . . . . 0.0 110.731 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.529 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -98.56 134.5 21.7 Favored Pre-proline 0 C--O 1.225 -0.205 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.777 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 57.3 Cg_endo -86.53 156.87 9.23 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.499 2.133 . . . . 0.0 112.815 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.711 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.5 mm -124.92 -83.52 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.24 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.772 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.85 -152.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.118 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -71.94 -28.38 63.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.726 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.61 4.31 0.47 Allowed Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.046 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.772 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.5 mt -91.67 101.94 14.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.825 0.345 . . . . 0.0 110.764 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.777 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 87.6 t -94.39 129.61 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.975 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.769 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.43 157.11 16.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.457 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.661 HD23 ' C ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -120.23 121.17 38.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.634 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.486 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.2 m120 -89.89 92.79 9.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.257 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.657 HG13 HG12 ' A' ' 39' ' ' ILE . 10.3 t -86.03 104.73 13.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.212 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.584 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.8 mtt -84.58 164.52 18.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.234 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.578 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.0 m -139.27 139.52 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.164 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.673 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -92.18 112.15 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.794 0.33 . . . . 0.0 110.887 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.478 HG12 HG21 ' A' ' 34' ' ' THR . 28.3 m -128.34 140.52 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.999 0.428 . . . . 0.0 111.176 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.43 -69.8 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.235 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.75 -4.96 58.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.409 . . . . 0.0 110.509 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.596 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.06 -152.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.302 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.65 -162.96 1.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.803 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.09 14.24 28.23 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.557 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.27 -5.9 51.13 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.247 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 p -74.6 -3.18 29.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.102 0.477 . . . . 0.0 109.97 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.24 -23.71 23.93 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.161 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.33 -28.28 58.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.74 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.44 -56.78 16.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.156 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -58.49 -34.48 70.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.387 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.68 -52.2 65.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.305 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.414 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 3.1 p -64.08 -17.83 63.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.302 178.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.628 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.64 -28.56 62.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.356 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -12.96 49.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.18 26.02 0.99 Allowed Glycine 0 N--CA 1.453 -0.207 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.805 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' A' ' 29' ' ' ARG . 1.1 tt -73.47 -162.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.535 -0.332 . . . . 0.0 110.865 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.62 ' N ' HG23 ' A' ' 74' ' ' ILE . 1.4 mp0 -50.41 93.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.831 0.348 . . . . 0.0 110.932 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.57 -26.35 56.93 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.952 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.43 -39.81 12.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.113 0.482 . . . . 0.0 110.493 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -96.47 91.0 5.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.698 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.594 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -78.2 136.53 37.83 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.998 HG21 HG22 ' A' ' 8' ' ' ILE . 14.9 mt -101.48 145.87 10.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.604 -176.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -85.85 71.47 10.65 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.703 HG23 ' HB ' ' A' ' 80' ' ' ILE . 64.3 t -80.09 50.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.207 -173.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -132.99 6.39 3.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.18 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.802 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 31.4 t0 . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.037 0.446 . . . . 0.0 110.999 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.666 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.5 OUTLIER . . . . . 0 CA--C 1.527 0.071 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 43.4 t -104.85 122.98 58.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.887 0.375 . . . . 0.0 111.806 -178.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -97.96 163.2 12.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.735 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.716 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 5.6 m -139.7 123.12 17.15 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.642 0.734 . . . . 0.0 111.625 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.951 HG22 HG21 ' A' ' 80' ' ' ILE . 17.6 mt -122.13 107.62 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.734 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.814 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.89 95.99 8.23 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -176.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.475 ' N ' HG23 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -91.43 136.3 24.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.875 0.369 . . . . 0.0 111.738 -177.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.817 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 2.2 ptm -144.14 124.97 7.79 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 121.036 0.446 . . . . 0.0 111.485 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.601 ' CD ' HG13 ' A' ' 17' ' ' VAL . 14.2 Cg_exo -69.7 124.54 11.21 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.173 2.582 . . . . 0.0 112.099 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -57.9 -32.6 67.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.457 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.6 p -77.34 152.94 81.76 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.119 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.56 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 46.8 Cg_endo -68.19 -3.11 10.13 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.216 1.944 . . . . 0.0 111.572 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.74 43.63 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.835 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.601 HG13 ' CD ' ' A' ' 12' ' ' PRO . 90.0 t -65.8 75.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.65 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.59 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -71.74 92.94 1.23 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.027 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.728 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -63.24 -42.06 99.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.596 -178.035 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.887 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 10.8 tt0 -69.96 -36.5 75.3 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.955 0.407 . . . . 0.0 110.292 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.59 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -69.21 -37.75 78.23 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -67.11 -27.01 66.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.004 177.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.887 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -56.2 -46.8 79.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.371 179.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 2.0 mtmt -66.86 -39.86 87.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.766 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -65.5 -33.8 76.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.213 0.53 . . . . 0.0 110.095 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.647 ' O ' HG12 ' A' ' 30' ' ' ILE . 1.8 mt -62.75 -39.01 83.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.935 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -42.35 91.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.639 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 13.3 mt-10 -76.01 -20.92 57.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.814 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.766 HH22 ' HB ' ' A' ' 8' ' ' ILE . 20.8 ptt85 -88.76 -15.63 34.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.484 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 26' ' ' ILE . 22.4 mm -59.4 137.48 89.0 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.917 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.561 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 8.0 Cg_endo -50.18 124.85 13.63 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.824 2.349 . . . . 0.0 112.521 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -60.79 -3.68 0.8 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.893 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.24 -61.7 1.88 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.991 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.626 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -110.24 -145.56 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.835 0.35 . . . . 0.0 111.296 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -132.05 172.01 12.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.614 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.466 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -74.97 -173.67 1.99 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.007 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.541 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.5 t60 -130.58 -74.81 0.54 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.426 0.631 . . . . 0.0 110.782 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -165.03 125.9 1.99 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.796 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.659 HD13 HG22 ' A' ' 53' ' ' VAL . 2.7 mt -92.4 154.35 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.848 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.716 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.8 t0 -121.25 129.2 53.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.488 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -89.69 69.76 7.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.86 0.362 . . . . 0.0 110.202 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.672 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -100.15 148.26 34.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.595 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.751 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.0 Cg_endo -91.07 156.19 3.88 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.026 2.484 . . . . 0.0 113.209 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.6 mm -125.89 -82.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.063 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.567 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.41 -151.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -72.07 -28.55 63.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.755 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.54 4.79 0.5 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.942 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.567 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.2 mt -91.43 103.44 16.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 110.968 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.751 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 36.7 t -92.3 128.58 43.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.694 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.817 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.0 165.68 12.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.094 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.728 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.0 mp -120.26 119.93 34.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.234 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -89.52 90.96 8.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.225 0.536 . . . . 0.0 109.915 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.659 HG22 HD13 ' A' ' 39' ' ' ILE . 10.0 t -86.91 98.86 7.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.705 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 35.7 mtt -84.54 162.56 19.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.096 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.7 m -138.92 134.71 42.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.536 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.541 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.66 113.55 31.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.127 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 4' ' ' VAL . 4.4 m -129.63 143.63 40.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.934 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.57 -65.98 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.454 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -80.96 -8.21 59.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.996 0.427 . . . . 0.0 110.648 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.626 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.84 -146.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.21 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.62 -164.18 1.94 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.749 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.89 13.6 30.08 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.545 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.08 -5.62 53.89 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.54 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.58 -5.22 41.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.957 0.408 . . . . 0.0 110.338 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -54.9 -23.15 17.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.148 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.89 -29.08 62.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.968 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.65 -52.65 63.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.403 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.66 -37.27 75.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.309 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -50.21 74.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.312 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.425 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.1 p -64.0 -21.04 66.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.685 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.561 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.54 -29.36 62.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.827 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -13.74 53.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.888 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.36 28.57 0.97 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.871 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.683 HD11 ' HD2' ' A' ' 29' ' ' ARG . 3.6 tt -73.28 -163.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.61 -0.295 . . . . 0.0 111.067 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.762 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 1.2 pm0 -51.55 91.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.975 0.416 . . . . 0.0 110.877 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.83 -25.58 67.83 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.756 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.27 -34.67 8.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.289 0.566 . . . . 0.0 110.132 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.762 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -95.83 90.36 5.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.569 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.408 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -74.5 131.09 40.72 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.951 HG21 HG22 ' A' ' 8' ' ' ILE . 3.0 mp -100.83 149.21 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.524 -175.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.668 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 31.5 tp10 -85.79 70.33 10.67 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.686 HG23 ' HB ' ' A' ' 80' ' ' ILE . 52.8 t -81.06 54.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.857 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 m -132.65 1.97 3.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.689 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.716 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 2.2 m-20 . . . . . 0 N--CA 1.452 -0.339 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.753 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.827 HG12 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 121.023 0.44 . . . . 0.0 110.136 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 3.9 t -105.31 120.41 55.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.072 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.735 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.09 157.22 16.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.788 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 4.5 m -138.24 125.52 21.7 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.702 0.763 . . . . 0.0 111.979 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.976 HG22 HG21 ' A' ' 80' ' ' ILE . 6.7 mm -120.55 108.31 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.943 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.743 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.31 95.57 8.17 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.014 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.675 ' HB ' HG12 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -92.66 135.95 26.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.787 -178.101 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.757 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -145.75 127.0 7.5 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 120.964 0.411 . . . . 0.0 111.361 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 8.7 Cg_exo -73.4 120.19 6.38 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.252 2.635 . . . . 0.0 112.127 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -56.76 -32.19 65.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.303 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 p -78.45 154.01 79.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.012 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.567 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 56.1 Cg_endo -68.9 -2.09 8.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.213 1.942 . . . . 0.0 111.508 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.88 42.52 1.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.121 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.631 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 96.2 t -64.88 77.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.125 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.725 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.1 m-20 -68.35 98.6 0.85 Allowed 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.416 ' CD2' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -61.49 -51.35 69.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.659 -178.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -68.06 -37.95 81.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.619 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.667 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . . . -70.52 -38.32 74.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.063 0.459 . . . . 0.0 110.6 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -66.8 -30.14 70.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.189 178.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -44.6 93.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.43 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.667 ' HE3' ' HA ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -65.94 -41.94 90.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.587 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -64.76 -32.42 74.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.074 0.464 . . . . 0.0 110.635 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.919 HG12 HG21 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -62.14 -44.89 99.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.473 -179.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.477 ' OE1' HG22 ' A' ' 26' ' ' ILE . 7.2 mm100 -63.35 -33.41 75.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.82 0.343 . . . . 0.0 110.737 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.584 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 27.6 mt-10 -74.44 -23.2 58.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.088 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.75 ' HD2' HD11 ' A' ' 74' ' ' ILE . 28.7 ptt85 -89.26 -15.79 32.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.552 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.548 HG12 ' O ' ' A' ' 26' ' ' ILE . 24.2 mm -57.97 136.74 83.84 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.456 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 18.4 Cg_endo -56.81 116.73 3.41 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.274 1.983 . . . . 0.0 112.073 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.81 0.64 0.08 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.405 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.446 ' HA3' ' C ' ' A' ' 63' ' ' GLY . . . -82.46 -37.03 15.23 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.575 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.557 HG21 HG12 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -130.28 -144.06 0.26 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.647 0.26 . . . . 0.0 110.871 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -136.74 167.8 20.74 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.881 0.372 . . . . 0.0 111.031 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -75.26 -177.23 3.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.007 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.744 ' ND1' HG22 ' A' ' 56' ' ' VAL . 73.0 t60 -131.49 -75.64 0.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.205 0.526 . . . . 0.0 111.047 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 11.9 mmtt -161.25 129.37 4.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.222 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.628 HG12 HG13 ' A' ' 53' ' ' VAL . 3.2 mt -94.42 158.51 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.073 0.463 . . . . 0.0 111.989 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.699 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -126.49 118.69 25.44 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.98 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -85.7 71.24 10.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.905 0.383 . . . . 0.0 110.261 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.661 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -100.73 149.54 36.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.628 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.763 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 29.6 Cg_endo -91.92 158.88 3.35 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.074 2.516 . . . . 0.0 113.331 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.772 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.3 mm -128.89 -83.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.348 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.694 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.79 -148.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.184 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -71.17 -32.61 69.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.81 0.338 . . . . 0.0 110.808 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.67 8.85 0.64 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.493 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.694 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.3 mt -91.39 103.1 15.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.82 0.343 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.763 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 38.1 t -92.7 127.53 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.898 -178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.772 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.13 159.03 15.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.69 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.818 HD12 HD13 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -118.82 119.56 34.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.494 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.483 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.2 m120 -89.49 90.26 8.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.709 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.919 HG21 HG12 ' A' ' 26' ' ' ILE . 14.6 t -86.52 104.23 13.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.529 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.633 ' HG3' HG23 ' A' ' 7' ' ' THR . 2.8 mtt -84.57 160.64 20.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.16 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.735 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.8 m -139.53 140.93 36.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.178 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.744 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.4 OUTLIER -92.11 101.8 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.836 179.342 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.827 HG23 HG12 ' A' ' 4' ' ' VAL . 31.8 m -130.72 137.2 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.499 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.62 -59.37 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.423 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -81.7 -7.78 59.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.038 0.447 . . . . 0.0 110.444 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.522 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.5 -140.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.178 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.428 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 1.0 OUTLIER -147.17 -162.35 1.52 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.814 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.428 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -80.23 11.71 35.62 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.741 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.446 ' C ' ' HA3' ' A' ' 33' ' ' GLY . . . -70.02 -11.4 66.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.615 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.469 ' HA ' ' HB2' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -73.68 -2.41 23.06 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.966 0.412 . . . . 0.0 110.103 179.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -54.5 -23.8 17.83 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.926 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.07 -31.38 63.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.891 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -59.72 -56.32 23.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.449 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.45 -35.98 75.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.547 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -48.97 79.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.347 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.66 -22.88 67.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.566 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.584 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -72.9 -27.42 61.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.681 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -18.25 64.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.519 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.47 35.88 0.87 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.688 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.75 HD11 ' HD2' ' A' ' 29' ' ' ARG . 0.6 OUTLIER -72.88 -164.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.493 -0.354 . . . . 0.0 111.047 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.7 OUTLIER -50.95 101.52 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.964 0.411 . . . . 0.0 111.154 -179.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.09 -33.33 79.07 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.51 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.4 t -86.98 -39.15 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 0.0 110.501 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.631 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 22.0 t -95.5 90.93 5.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.609 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.588 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -76.9 136.79 38.84 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.098 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.976 HG21 HG22 ' A' ' 8' ' ' ILE . 17.7 mt -101.45 146.91 8.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.743 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -85.84 71.72 10.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.695 HG23 ' HB ' ' A' ' 80' ' ' ILE . 73.6 t -79.96 54.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.08 -174.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -133.08 2.73 3.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.418 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.788 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 20.6 t0 . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 120.8 0.333 . . . . 0.0 110.961 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.486 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.634 0.254 . . . . 0.0 110.756 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -114.87 113.21 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.973 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.817 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.55 165.99 12.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.332 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.784 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 7.4 m -143.41 130.71 20.91 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.658 0.742 . . . . 0.0 112.187 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.083 HG22 HG21 ' A' ' 80' ' ' ILE . 5.7 mm -122.15 107.38 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.728 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.769 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.19 95.34 8.06 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.511 HG11 ' HE ' ' A' ' 29' ' ' ARG . 1.9 m -94.27 137.85 22.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.899 0.381 . . . . 0.0 111.841 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.741 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.1 ptm -147.43 127.61 6.76 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 121.177 0.513 . . . . 0.0 111.455 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.631 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 13.3 Cg_exo -72.37 124.74 10.14 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.525 2.817 . . . . 0.0 112.141 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.91 -33.54 67.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.274 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.94 151.9 79.48 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.992 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.95 -2.54 8.91 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.407 2.071 . . . . 0.0 111.978 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.39 44.23 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.025 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.631 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 74.3 t -64.86 77.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.625 -178.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 19.3 m-20 -70.86 91.44 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.916 177.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.886 HD13 ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.67 -36.08 83.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.353 -178.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.886 ' H ' HD13 ' A' ' 19' ' ' LEU . 8.7 pt-20 -69.91 -38.83 76.38 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.91 0.386 . . . . 0.0 110.177 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.658 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . . . -71.82 -33.9 68.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.341 0.591 . . . . 0.0 109.526 177.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.1 OUTLIER -66.04 -32.93 74.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.305 177.272 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.579 ' HA ' HD12 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -57.14 -45.53 83.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.419 178.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.658 ' HE3' ' HA ' ' A' ' 21' ' ' ALA . 2.0 mtmt -65.85 -43.25 89.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.582 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -65.54 -30.06 70.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.474 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.646 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 5.7 mt -60.83 -45.85 97.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.957 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.637 ' NE2' HD21 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -61.07 -38.0 84.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.947 0.403 . . . . 0.0 110.688 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -75.55 -23.07 56.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.333 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.767 HH22 ' HB ' ' A' ' 8' ' ' ILE . 23.6 ptt85 -90.99 -11.84 37.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.116 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 26' ' ' ILE . 27.6 mm -60.02 137.33 90.92 Favored Pre-proline 0 N--CA 1.463 0.21 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.019 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HD2' HG23 ' A' ' 30' ' ' ILE . 4.1 Cg_endo -46.89 120.82 4.41 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.853 2.368 . . . . 0.0 112.296 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -55.95 -11.02 0.91 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.832 -179.094 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.7 -41.84 10.58 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.901 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.539 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.38 -148.45 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.69 0.281 . . . . 0.0 110.995 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -137.23 175.02 9.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.836 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.637 HD21 ' NE2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -74.69 -176.07 2.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.237 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.648 ' ND1' HG22 ' A' ' 56' ' ' VAL . 79.5 t60 -131.04 -69.78 0.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.662 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -161.31 127.13 3.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.1 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.669 HG12 HG13 ' A' ' 53' ' ' VAL . 2.9 mt -91.78 158.01 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.626 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.647 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -128.78 119.23 24.15 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.461 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -82.46 72.01 9.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.985 0.421 . . . . 0.0 110.401 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.542 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -97.05 132.85 24.98 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.816 -179.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.771 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 58.9 Cg_endo -87.68 155.83 7.58 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.527 2.151 . . . . 0.0 112.8 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.699 HD11 ' HB3' ' A' ' 50' ' ' ALA . 1.8 mm -124.43 -82.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.098 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -67.66 -153.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.951 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -71.98 -27.88 63.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 110.709 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.64 5.83 0.53 Allowed Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.581 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.623 ' HA ' HG21 ' A' ' 17' ' ' VAL . 8.2 mp -91.1 97.5 11.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.791 0.329 . . . . 0.0 110.645 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 95.4 t -93.97 127.36 46.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.085 0.469 . . . . 0.0 112.163 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.741 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.82 142.4 28.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.795 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.647 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -105.98 120.72 42.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.377 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.497 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.3 m120 -89.61 91.85 8.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.374 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.669 HG13 HG12 ' A' ' 39' ' ' ILE . 9.4 t -86.41 107.46 16.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.264 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.567 ' HG3' HG23 ' A' ' 7' ' ' THR . 12.5 mtt -84.46 168.28 15.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.168 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.817 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.8 m -141.48 136.04 31.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.922 0.391 . . . . 0.0 111.312 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.648 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -96.12 112.76 28.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.769 178.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.539 HG12 HG21 ' A' ' 34' ' ' THR . 19.9 m -130.46 138.06 54.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.897 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.66 -60.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.322 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.89 -13.9 58.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.021 0.439 . . . . 0.0 110.376 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.527 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.91 -146.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.029 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.61 -160.37 1.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.717 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.66 13.21 30.61 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.36 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.21 -1.92 37.51 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.54 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.474 HG22 ' OG1' ' A' ' 34' ' ' THR . 1.8 p -75.34 -6.41 49.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.975 0.417 . . . . 0.0 110.264 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.83 -23.48 18.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.341 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.02 -27.5 61.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.996 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.41 -55.59 29.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.31 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -58.99 -34.85 72.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.573 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.58 -50.44 71.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.343 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.413 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 14.5 p -63.39 -18.86 64.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.211 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.605 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -72.9 -30.71 64.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.559 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -12.14 33.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.72 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.26 26.44 0.99 Allowed Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.829 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.682 HD11 ' HD2' ' A' ' 29' ' ' ARG . 2.4 tt -73.21 -160.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.671 -0.264 . . . . 0.0 110.873 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.606 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -51.01 99.9 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.842 0.353 . . . . 0.0 110.98 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.52 -32.58 78.42 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.596 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.2 t -88.25 -38.39 11.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.939 0.399 . . . . 0.0 110.543 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.588 ' HB2' ' HB3' ' A' ' 75' ' ' GLU . 6.1 m -95.81 90.65 5.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.76 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.568 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -79.43 137.75 37.37 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.083 HG21 HG22 ' A' ' 8' ' ' ILE . 1.7 mt -101.74 147.24 8.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.575 -176.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -86.01 72.02 10.51 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 172.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.686 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.9 t -80.79 56.66 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.124 -174.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -133.05 0.34 3.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.762 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.784 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 40.2 t0 . . . . . 0 N--CA 1.455 -0.213 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.229 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.575 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.062 0 N-CA-C 110.364 -0.236 . . . . 0.0 110.364 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 41.1 t -109.96 118.41 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 0.0 111.755 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.691 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.04 161.76 14.16 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.646 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 6.2 m -140.97 131.41 25.24 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.682 0.753 . . . . 0.0 112.687 -178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.041 HG22 HG21 ' A' ' 80' ' ' ILE . 3.8 mm -121.03 105.78 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.367 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.808 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -93.69 93.4 8.0 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -177.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.483 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.9 m -92.44 136.0 25.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.826 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.722 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -146.55 123.94 5.98 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-O 121.235 0.54 . . . . 0.0 111.444 179.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.64 ' CD ' HG13 ' A' ' 17' ' ' VAL . 14.1 Cg_exo -70.4 120.99 7.57 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.305 2.67 . . . . 0.0 111.854 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -56.69 -31.2 64.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.62 153.19 81.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.983 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.593 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 46.4 Cg_endo -68.58 -2.9 10.08 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.446 2.097 . . . . 0.0 112.366 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -91.71 43.12 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.248 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.64 HG13 ' CD ' ' A' ' 12' ' ' PRO . 97.0 t -65.64 76.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.408 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 3.7 m-20 -70.03 97.65 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.619 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -63.23 -45.74 90.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.816 -177.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.78 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 28.3 tt0 -70.7 -35.62 72.85 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.759 0.314 . . . . 0.0 110.678 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -67.52 -39.2 85.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -66.57 -31.5 72.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.836 177.02 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.78 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -55.46 -48.61 74.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.115 -179.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -68.16 -40.76 82.26 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.522 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.589 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 29.8 mm-40 -64.75 -30.02 71.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.07 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.765 HG12 HG21 ' A' ' 53' ' ' VAL . 1.2 mt -62.61 -46.4 96.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.988 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -60.94 -36.19 78.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.413 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 9.9 pt-20 -77.16 -22.36 52.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.433 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.812 ' HD3' HD11 ' A' ' 74' ' ' ILE . 8.6 ptp180 -89.55 -9.19 50.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.253 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.553 HD11 HG11 ' A' ' 53' ' ' VAL . 34.6 mm -57.82 138.89 82.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.466 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.762 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.2 Cg_endo -50.91 117.23 3.17 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.711 2.274 . . . . 0.0 111.972 178.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -59.12 1.76 0.06 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.12 -62.54 1.81 Allowed Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.83 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.53 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -109.43 -139.26 0.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.591 0.234 . . . . 0.0 110.844 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -134.9 166.16 23.65 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.868 0.366 . . . . 0.0 110.839 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -75.56 -175.97 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.093 -179.369 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.546 ' ND1' HG22 ' A' ' 56' ' ' VAL . 73.7 t60 -131.25 -79.08 0.52 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 10.1 mmtt -161.69 137.81 7.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.687 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.641 HD12 HG22 ' A' ' 53' ' ' VAL . 2.4 mm -92.11 166.63 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.452 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -130.03 123.22 30.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.165 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -84.88 67.67 10.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.875 0.369 . . . . 0.0 110.518 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.535 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -95.44 133.9 25.16 Favored Pre-proline 0 C--O 1.225 -0.205 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.579 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.773 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 60.6 Cg_endo -87.12 155.65 8.32 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.62 2.213 . . . . 0.0 112.686 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.712 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.8 mm -124.81 -82.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.378 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.664 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.4 -150.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -71.87 -29.95 64.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.587 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.71 6.36 0.54 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.736 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.664 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.8 mt -91.45 100.91 13.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.975 0.417 . . . . 0.0 110.835 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 78.3 t -92.96 128.52 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.72 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.722 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.35 143.0 27.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.103 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 10.9 mp -101.53 119.46 38.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.251 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.8 m120 -91.66 96.19 10.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.312 0.577 . . . . 0.0 111.011 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.765 HG21 HG12 ' A' ' 26' ' ' ILE . 39.6 t -84.51 103.12 11.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.15 -177.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.577 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 18.5 mtt -86.3 161.63 18.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.101 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.3 m -139.32 135.12 40.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 111.193 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.546 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -95.04 115.78 34.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.006 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 4' ' ' VAL . 13.8 m -130.35 151.1 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.983 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.53 -74.22 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.534 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -81.38 -3.01 51.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 0.0 110.713 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.53 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.21 -147.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.366 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -147.57 -166.08 2.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.855 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.69 15.62 24.35 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.668 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.82 -5.19 50.85 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.528 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.72 -3.76 33.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.94 0.4 . . . . 0.0 110.296 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -55.19 -23.11 20.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.142 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.19 -27.34 61.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.121 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.762 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.16 -55.09 36.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.482 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -58.21 -36.11 72.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.458 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.36 -51.03 70.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.345 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.518 ' OG ' HD12 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -63.5 -19.16 64.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.443 178.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.679 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.34 -29.55 62.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.602 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.68 -12.07 31.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.772 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.15 25.82 1.0 Allowed Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.619 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.812 HD11 ' HD3' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -73.48 -164.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.476 -0.362 . . . . 0.0 111.187 -178.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.645 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.6 OUTLIER -50.37 100.78 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.006 0.431 . . . . 0.0 111.114 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.28 -31.54 79.37 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.873 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.3 t -85.84 -35.79 9.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.006 0.432 . . . . 0.0 110.307 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.645 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 43.8 t -95.77 90.5 5.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.614 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.584 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.24 133.2 38.93 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.041 HG21 HG22 ' A' ' 8' ' ' ILE . 3.2 mp -101.56 148.76 7.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.686 -175.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.455 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -85.81 71.36 10.67 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 172.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.682 HG23 ' HB ' ' A' ' 80' ' ' ILE . 57.9 t -79.82 50.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.079 -174.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -133.13 7.18 3.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.359 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.646 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.5 m-20 . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.994 0.426 . . . . 0.0 111.207 -178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.545 ' O ' HG22 ' A' ' 57' ' ' VAL . 2.5 t . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.764 0.316 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 53.1 t -105.3 114.78 45.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.588 -178.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.695 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -97.01 165.74 11.93 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.765 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 13.4 m -143.25 128.84 19.15 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.542 0.687 . . . . 0.0 111.859 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.037 HG22 HG21 ' A' ' 80' ' ' ILE . 3.4 mm -120.54 107.7 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.759 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.793 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.58 95.46 7.63 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.535 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.8 m -93.28 135.86 26.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.854 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -147.59 119.31 4.58 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 121.279 0.561 . . . . 0.0 111.97 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.671 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.1 Cg_exo -69.99 119.14 6.13 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.197 2.598 . . . . 0.0 112.034 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -56.91 -29.13 62.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.172 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.43 148.98 74.75 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.046 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.53 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 35.9 Cg_endo -64.69 -7.38 14.52 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.303 2.002 . . . . 0.0 111.804 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.63 34.78 0.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.6 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.4 87.25 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.776 0.798 . . . . 0.0 109.892 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.605 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 55.3 m-20 -67.9 104.59 1.75 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.139 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.553 ' O ' ' HD3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -60.93 -53.47 56.94 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.445 -178.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.512 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 35.7 tt0 -69.75 -36.5 75.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.046 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.572 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -68.61 -35.16 76.96 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.779 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.605 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -65.36 -33.36 75.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.518 177.237 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HD3' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -55.98 -46.74 78.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.471 178.768 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -66.12 -42.81 88.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.41 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.734 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 51.0 mm-40 -65.34 -30.23 71.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.37 0.605 . . . . 0.0 110.438 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.679 ' O ' HG12 ' A' ' 30' ' ' ILE . 3.4 mt -60.69 -47.05 94.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.597 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.78 -38.11 89.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.387 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.734 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -77.32 -21.08 54.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.48 -178.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.658 ' HB2' HD11 ' A' ' 74' ' ' ILE . 3.3 ptp85 -89.15 -13.45 38.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.077 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 26' ' ' ILE . 34.4 mm -61.08 136.92 93.99 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.618 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 15.7 Cg_endo -55.88 129.49 35.24 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.334 2.023 . . . . 0.0 112.614 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.6 0.1 0.22 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.125 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.58 -56.69 2.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.977 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.593 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -119.11 -144.74 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.321 . . . . 0.0 111.416 -179.396 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -133.83 170.1 16.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.957 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -75.32 -173.83 2.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.217 -179.134 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.533 ' ND1' HG22 ' A' ' 56' ' ' VAL . 85.3 t60 -130.9 -75.48 0.53 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.423 0.63 . . . . 0.0 110.944 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.488 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER -164.45 129.37 2.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.788 -178.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.645 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -92.59 158.23 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.166 0.508 . . . . 0.0 112.362 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.608 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 5.1 m-20 -123.41 124.72 43.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.517 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -86.78 72.58 10.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.782 0.325 . . . . 0.0 110.624 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.559 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -100.05 136.0 20.25 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.93 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.76 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 64.2 Cg_endo -86.25 158.08 9.71 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.71 2.274 . . . . 0.0 112.629 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.725 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.9 mm -127.28 -83.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.657 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.756 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.83 -148.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.283 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -71.58 -32.81 68.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.826 0.346 . . . . 0.0 110.591 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.65 7.23 0.58 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.638 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.756 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.3 mt -91.41 102.33 15.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.905 0.383 . . . . 0.0 110.814 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.76 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 75.3 t -92.64 130.03 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.848 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -94.94 159.27 15.11 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.814 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.608 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 10.5 mp -117.93 119.12 33.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.397 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.7 m120 -89.66 91.13 8.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.35 0.595 . . . . 0.0 110.159 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.674 HG21 HG12 ' A' ' 26' ' ' ILE . 5.9 t -87.04 103.24 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.418 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 15.1 mtt -84.63 166.13 17.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.237 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.695 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.6 m -140.0 135.21 37.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.868 0.366 . . . . 0.0 111.616 -178.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.533 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.79 110.62 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.759 178.483 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 4' ' ' VAL . 11.3 m -130.3 144.71 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.043 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.24 -64.14 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.417 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -80.94 -6.92 59.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.882 0.372 . . . . 0.0 110.635 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.593 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.88 -147.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.058 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -147.69 -161.65 1.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.78 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.56 13.08 30.6 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.579 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.26 -7.65 60.59 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.511 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -4.5 36.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.892 0.377 . . . . 0.0 110.216 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.64 -23.69 18.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.03 177.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.88 -28.83 62.34 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.038 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -59.87 -56.5 21.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.577 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -58.58 -35.51 72.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.492 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -61.33 -51.11 70.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.438 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.1 p -64.01 -17.9 63.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.533 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.74 HD22 HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.25 -31.13 62.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.533 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.93 -10.24 27.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.687 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.02 26.76 1.01 Allowed Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.74 HD13 HD22 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -73.2 -169.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.291 -0.455 . . . . 0.0 111.087 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -50.58 97.93 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 111.193 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.99 -31.68 81.51 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.778 -0.647 . . . . 0.0 112.927 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.59 -37.27 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.137 0.494 . . . . 0.0 109.982 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.671 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 1.5 m -95.37 87.8 4.91 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.039 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.561 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -76.45 135.62 39.4 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.103 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.037 HG21 HG22 ' A' ' 8' ' ' ILE . 2.6 mt -101.45 148.58 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.566 -175.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.682 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 33.6 tp10 -85.95 69.89 10.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.701 HG23 ' HB ' ' A' ' 80' ' ' ILE . 61.7 t -80.69 57.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.679 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -132.76 -2.56 3.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.874 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.765 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 2.6 m-20 . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.267 -178.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.519 0.199 . . . . 0.0 111.32 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 83.2 t -129.54 115.25 33.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.055 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.537 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.56 165.98 12.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.76 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.775 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.9 m -141.99 127.01 18.36 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.588 0.709 . . . . 0.0 111.898 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.006 HG22 HG21 ' A' ' 80' ' ' ILE . 8.3 mm -120.57 108.85 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.925 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.817 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.77 96.85 8.52 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.613 ' CB ' HG12 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -92.85 139.98 17.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -176.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.643 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -146.14 122.57 5.82 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.249 179.328 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.598 ' HG2' HG13 ' A' ' 17' ' ' VAL . 11.6 Cg_exo -72.9 120.86 6.89 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.462 2.775 . . . . 0.0 112.383 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.57 -31.21 65.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.338 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.58 151.02 79.95 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.039 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.591 ' HA ' HD21 ' A' ' 48' ' ' LEU . 41.9 Cg_endo -66.86 -3.32 9.27 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.421 2.081 . . . . 0.0 112.003 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.16 42.69 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.353 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.598 HG13 ' HG2' ' A' ' 12' ' ' PRO . 95.7 t -65.02 77.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.068 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 62.7 m-20 -68.93 100.86 1.26 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.165 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.76 ' HG ' HD11 ' A' ' 51' ' ' LEU . 3.1 tt -62.96 -49.21 75.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.481 -178.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -68.15 -38.26 81.94 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.739 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -69.78 -37.13 76.25 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.011 177.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -65.42 -34.12 77.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.697 177.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -47.26 85.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.088 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.487 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -69.32 -37.15 77.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.188 0.518 . . . . 0.0 110.388 179.146 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 12.5 mt-10 -66.26 -31.02 71.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.017 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.708 HG12 HG21 ' A' ' 53' ' ' VAL . 2.1 mt -62.38 -42.69 96.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.444 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.434 ' NE2' HG22 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -57.72 -39.66 77.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.443 179.343 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -74.83 -24.24 58.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.708 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.792 ' HB2' HD11 ' A' ' 74' ' ' ILE . 2.4 ptp180 -88.56 -12.84 41.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.758 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.42 HG23 ' HD2' ' A' ' 31' ' ' PRO . 22.7 mm -57.65 135.44 82.58 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.577 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.626 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.5 Cg_endo -53.07 126.63 22.11 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.509 2.139 . . . . 0.0 112.335 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -58.05 -2.01 0.15 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.401 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -81.83 -46.36 6.77 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.515 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.472 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.55 -142.51 0.24 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.672 0.272 . . . . 0.0 110.993 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -139.44 173.09 11.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.022 0.439 . . . . 0.0 110.855 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -74.44 -176.75 2.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.236 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.52 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 83.4 t60 -131.73 -71.92 0.55 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.475 0.655 . . . . 0.0 111.167 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.531 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -162.72 128.62 3.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.992 -177.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.683 HD13 HG22 ' A' ' 53' ' ' VAL . 2.5 mt -94.77 160.1 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.118 -177.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.662 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.1 t0 -127.38 128.79 46.44 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.633 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -87.34 73.38 9.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.789 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.511 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -98.88 133.43 22.33 Favored Pre-proline 0 C--O 1.225 -0.22 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.309 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.794 ' HB3' HG22 ' A' ' 49' ' ' VAL . 62.6 Cg_endo -87.56 157.03 7.79 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.519 2.146 . . . . 0.0 113.086 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.712 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.3 mm -124.74 -83.01 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.245 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.457 ' H ' ' HB ' ' A' ' 44' ' ' ILE . . . -67.3 -156.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.034 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -71.94 -25.1 61.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.625 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.51 0.98 0.33 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.119 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 15' ' ' PRO . 6.0 mt -92.01 100.24 12.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.887 0.375 . . . . 0.0 110.765 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.794 HG22 ' HB3' ' A' ' 43' ' ' PRO . 70.0 t -92.52 132.8 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.646 -178.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.712 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.86 162.0 13.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.006 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.76 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.2 mp -120.63 121.15 37.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.546 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.551 HD22 ' HB3' ' A' ' 9' ' ' LYS . 1.2 m120 -90.11 91.66 8.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.207 0.527 . . . . 0.0 110.042 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.708 HG21 HG12 ' A' ' 26' ' ' ILE . 11.3 t -86.73 104.34 13.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.531 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.718 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -85.01 162.89 19.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.905 178.186 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' A' ' 6' ' ' ALA . 4.6 m -136.86 127.02 39.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.949 0.404 . . . . 0.0 111.116 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.52 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 0.4 OUTLIER -94.36 109.86 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.938 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 4' ' ' VAL . 2.3 m -128.24 146.63 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.664 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.28 -61.94 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.536 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -80.21 -11.26 59.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.092 0.472 . . . . 0.0 110.239 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.472 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.89 -144.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.935 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.45 -166.52 2.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.813 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.86 15.16 22.28 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.534 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.08 -0.54 28.56 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.521 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.44 HG22 ' OG1' ' A' ' 34' ' ' THR . 1.3 p -73.45 -3.45 27.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.944 0.402 . . . . 0.0 110.355 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.92 -23.72 20.22 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.163 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.17 -27.53 61.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.074 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -59.58 -56.28 23.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.488 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -57.88 -36.88 73.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.612 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.93 -51.86 67.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.552 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.422 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 54.7 p -64.59 -20.29 66.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.85 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.634 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -73.09 -27.96 62.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.834 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -14.38 55.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.707 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.35 28.16 0.97 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.819 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' A' ' 29' ' ' ARG . 1.2 tt -72.97 -160.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.497 -0.351 . . . . 0.0 110.933 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.703 ' HB2' HH12 ' A' ' 29' ' ' ARG . 0.1 OUTLIER -50.07 91.15 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.993 0.425 . . . . 0.0 111.011 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.3 -26.54 66.28 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.337 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.8 p -86.62 -39.59 13.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.282 0.563 . . . . 0.0 110.09 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.617 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 11.9 t -95.96 90.35 5.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.331 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.6 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -75.77 132.29 40.35 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.006 HG21 HG22 ' A' ' 8' ' ' ILE . 12.5 mt -101.08 147.3 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.479 -175.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.689 ' HG2' ' HB2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -85.62 73.69 10.4 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.106 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.739 HG23 ' HB ' ' A' ' 80' ' ' ILE . 90.5 t -80.97 55.55 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.743 -174.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.68 2.91 3.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.403 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.775 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 30.3 t0 . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.778 0.323 . . . . 0.0 110.854 -178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.59 ' O ' HG22 ' A' ' 57' ' ' VAL . 15.8 t . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.709 0.29 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 38.8 t -104.76 115.19 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.343 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.776 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -93.07 166.19 12.47 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.71 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 10.1 m -142.12 136.52 30.16 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.542 0.687 . . . . 0.0 112.44 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.975 HG22 HG21 ' A' ' 80' ' ' ILE . 8.3 mm -125.53 105.55 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.991 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.756 ' C ' HG23 ' A' ' 80' ' ' ILE . 2.2 mmmt -97.38 96.97 8.73 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -176.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.467 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.5 m -94.02 136.15 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.875 0.369 . . . . 0.0 111.931 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.63 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -146.9 123.16 5.58 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.314 179.306 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.64 ' CD ' HG13 ' A' ' 17' ' ' VAL . 10.2 Cg_exo -73.86 122.25 7.58 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.562 2.841 . . . . 0.0 112.077 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -57.47 -32.04 66.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.448 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.35 152.32 81.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.032 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.552 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 42.2 Cg_endo -67.55 -3.23 9.79 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.417 2.078 . . . . 0.0 112.154 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.8 43.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.103 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.64 HG13 ' CD ' ' A' ' 12' ' ' PRO . 93.7 t -65.29 75.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.389 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 3.8 m-20 -70.33 88.88 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.879 HD13 ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.18 -38.43 91.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.825 -177.187 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.94 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 1.4 tt0 -70.67 -36.23 73.23 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.05 0.452 . . . . 0.0 110.086 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.61 -37.54 76.92 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.52 ' CD2' ' HG3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -66.45 -30.19 70.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.909 177.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.94 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -54.53 -46.41 73.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.437 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 7.2 mtmt -67.14 -44.53 79.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.513 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -65.19 -25.96 67.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.566 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.741 HG12 HG21 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -60.47 -49.65 83.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.361 -179.368 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.478 ' OE1' HD22 ' A' ' 36' ' ' LEU . 6.1 mm-40 -62.97 -32.48 73.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.155 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 15.3 mt-10 -74.62 -24.08 58.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.024 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.734 ' HB2' HD11 ' A' ' 74' ' ' ILE . 1.2 ptp85 -91.95 -13.51 31.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.362 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 26' ' ' ILE . 10.1 mm -59.49 140.16 88.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.911 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.587 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.4 Cg_endo -51.44 112.7 0.87 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.744 2.296 . . . . 0.0 112.119 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.77 -0.87 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.253 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.03 -35.95 16.76 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.956 -178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.5 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.3 -142.96 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.694 0.247 . . . . 0.0 110.96 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 8.1 mt-10 -135.12 167.01 21.75 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.883 0.373 . . . . 0.0 111.116 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.497 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -75.32 -179.89 4.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.384 -179.033 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.653 ' ND1' HG22 ' A' ' 56' ' ' VAL . 79.4 t60 -130.77 -75.81 0.53 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.96 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.615 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -165.43 131.84 2.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.744 -178.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.713 HG12 HG13 ' A' ' 53' ' ' VAL . 2.5 mt -91.41 155.93 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 112.362 -176.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.601 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 61.0 m-20 -120.42 126.68 51.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.692 -178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.39 71.38 9.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.819 0.343 . . . . 0.0 110.304 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.521 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.81 134.25 21.14 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.796 -179.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.791 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 73.7 Cg_endo -87.07 157.69 8.5 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.575 2.184 . . . . 0.0 112.608 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.5 mm -125.65 -82.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.36 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.537 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.05 -153.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -71.74 -28.22 63.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.637 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.45 4.58 0.5 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.97 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.552 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.7 mt -92.34 102.61 15.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.859 0.361 . . . . 0.0 110.975 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.791 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 76.6 t -93.0 130.47 42.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.792 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.727 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.21 153.31 17.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.916 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.601 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 10.5 mp -111.53 117.18 32.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.33 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.607 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.2 m120 -89.79 92.48 9.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.208 0.528 . . . . 0.0 110.379 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.741 HG21 HG12 ' A' ' 26' ' ' ILE . 4.0 t -86.81 105.82 15.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.274 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.486 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.1 OUTLIER -84.62 166.56 17.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.432 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.776 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.9 m -138.99 139.3 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.223 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.653 HG22 ' ND1' ' A' ' 37' ' ' HIS . 1.9 t -93.57 106.61 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.137 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.617 HG13 HG23 ' A' ' 55' ' ' VAL . 2.8 m -127.82 155.61 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.793 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.79 -73.41 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.087 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.67 0.89 36.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.994 0.426 . . . . 0.0 110.494 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.492 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.02 -146.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.019 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.82 -165.35 2.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.936 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.3 13.34 33.97 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.433 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.01 -4.23 47.75 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.536 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.6 p -75.04 -3.92 35.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.966 0.412 . . . . 0.0 110.105 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -55.43 -23.55 25.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.258 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.11 -29.63 60.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.874 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.587 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.78 -56.29 21.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.337 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.681 ' HA ' HD12 ' A' ' 71' ' ' LEU . 3.3 mt-10 -58.57 -33.92 70.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.431 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -51.85 65.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.261 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.58 -16.83 61.93 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.028 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.02 HD11 HG11 ' A' ' 82' ' ' VAL . 2.1 mt -72.3 -33.52 67.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.374 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -9.7 15.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.0 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.08 26.73 1.0 Allowed Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.734 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.9 OUTLIER -73.3 -166.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.153 -0.523 . . . . 0.0 111.407 -178.437 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 2.7 mm-40 -51.61 101.65 0.04 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.878 0.371 . . . . 0.0 110.901 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.75 -33.95 88.33 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.776 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -86.02 -39.45 13.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 0.0 110.346 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 48.3 t -96.06 91.22 5.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.782 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.596 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.79 134.02 38.11 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.975 HG21 HG22 ' A' ' 8' ' ' ILE . 2.9 mp -101.38 148.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.379 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.532 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.3 tp10 -86.02 69.32 10.51 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 1.02 HG11 HD11 ' A' ' 71' ' ' LEU . 47.7 t -81.12 51.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.18 -174.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.82 6.64 4.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.542 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.71 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 2.3 m-20 . . . . . 0 N--CA 1.454 -0.243 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.441 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.444 ' HB ' HG23 ' A' ' 57' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.107 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 42.1 t -128.62 128.09 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.701 0.286 . . . . 0.0 111.652 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.698 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -99.4 167.04 10.88 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.829 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.4 m -142.83 133.2 24.79 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.594 0.712 . . . . 0.0 112.386 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.977 HG22 HG21 ' A' ' 80' ' ' ILE . 5.9 mm -125.89 108.43 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.777 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.721 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -98.7 96.69 8.09 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.376 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.802 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.9 m -94.0 138.02 21.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.659 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.76 119.57 4.57 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 121.157 0.503 . . . . 0.0 111.806 179.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 21.1 Cg_exo -69.71 123.64 10.32 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.464 2.776 . . . . 0.0 112.007 178.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.17 -30.52 64.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.508 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 m -77.6 148.52 76.74 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.053 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.64 -6.6 14.21 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.419 2.079 . . . . 0.0 111.779 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -93.44 36.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.605 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.72 88.49 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.78 0.8 . . . . 0.0 110.134 -179.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.568 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 32.9 m-20 -68.25 104.27 1.79 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.034 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.792 ' HG ' HD11 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -61.24 -52.2 65.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.707 -178.146 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.743 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -71.2 -34.37 70.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.277 -177.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -68.28 -35.93 78.61 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.568 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -66.16 -33.53 75.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.384 176.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.743 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -55.92 -46.61 78.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.132 178.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -43.31 90.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.798 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.541 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 11.3 mt-10 -66.55 -30.73 71.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.257 0.551 . . . . 0.0 110.722 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.751 HG12 HG21 ' A' ' 53' ' ' VAL . 1.6 mt -61.75 -43.92 97.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.816 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.21 -38.8 90.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.063 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 10.6 pt-20 -77.84 -21.16 51.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.553 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.8 ' HB2' HD11 ' A' ' 74' ' ' ILE . 20.0 ptt85 -89.86 -9.57 48.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.19 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 26' ' ' ILE . 32.6 mm -59.7 138.16 89.92 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.281 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.639 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.2 Cg_endo -50.83 118.86 4.56 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.868 2.378 . . . . 0.0 112.279 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -59.13 -1.2 0.16 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.116 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.26 -42.82 8.39 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.918 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.688 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.49 -144.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.685 0.279 . . . . 0.0 110.951 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -133.35 167.08 21.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.874 0.368 . . . . 0.0 110.807 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.538 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.8 pt? -75.92 -176.01 3.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.23 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.58 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.8 t60 -130.85 -76.46 0.53 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.369 0.604 . . . . 0.0 111.195 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 2.2 tptt -164.53 133.52 3.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.794 -178.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.695 HG23 HG22 ' A' ' 53' ' ' VAL . 1.7 mt -93.09 158.2 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -123.79 125.51 44.83 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.318 -178.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.454 ' H ' ' HG3' ' A' ' 41' ' ' GLU . 0.9 OUTLIER -86.12 73.84 10.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.93 0.395 . . . . 0.0 110.508 178.216 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.493 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -98.94 131.02 26.27 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.295 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.82 ' HB3' HG22 ' A' ' 49' ' ' VAL . 59.0 Cg_endo -87.53 157.57 7.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.485 2.123 . . . . 0.0 112.949 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.705 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.4 mm -124.34 -82.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.107 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -67.25 -157.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.84 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -72.28 -22.82 61.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.666 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.57 -1.18 0.25 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.039 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 8.8 mp -90.7 100.99 13.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.81 0.305 . . . . 0.0 110.966 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.82 HG22 ' HB3' ' A' ' 43' ' ' PRO . 93.4 t -94.57 132.94 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.971 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.705 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.38 162.9 13.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.847 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.792 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.2 mp -121.12 120.36 35.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.716 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.2 m120 -90.92 91.18 8.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.281 0.562 . . . . 0.0 110.027 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.751 HG21 HG12 ' A' ' 26' ' ' ILE . 5.0 t -87.48 104.11 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.32 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.709 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.3 OUTLIER -84.69 165.28 18.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.339 179.187 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.698 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.5 m -138.41 137.47 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.451 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.58 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -94.35 118.19 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.911 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.688 HG12 HG21 ' A' ' 34' ' ' THR . 35.4 m -130.2 142.4 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.95 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.4 -70.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.455 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -81.41 -5.76 58.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 0.0 110.5 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.547 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.67 -152.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.196 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.413 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -148.01 -162.35 1.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.803 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -81.07 14.07 28.93 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.276 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.0 -3.73 45.42 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.36 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -74.67 -3.39 31.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.016 0.436 . . . . 0.0 110.097 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.99 -23.47 19.44 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.045 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.0 -26.87 60.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.11 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.639 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.6 -52.79 62.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.107 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -59.21 -37.32 77.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.308 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -49.05 78.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.137 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -63.85 -19.78 65.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.327 178.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.599 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.0 -30.7 62.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.422 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 p -64.51 -9.52 19.43 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.739 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.14 22.05 0.98 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.108 -0.567 . . . . 0.0 111.968 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.8 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -72.82 -164.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 122.3 0.24 . . . . 0.0 110.666 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.589 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -50.81 100.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.929 0.395 . . . . 0.0 110.981 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.4 -27.03 68.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.048 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.4 p -90.15 -36.83 8.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.094 0.473 . . . . 0.0 110.824 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 1.6 m -95.6 89.26 5.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.602 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.417 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -76.32 132.1 39.59 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.655 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.977 HG21 HG22 ' A' ' 8' ' ' ILE . 15.7 mt -101.18 147.16 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.469 -175.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.634 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 16.3 tp10 -85.53 69.93 10.71 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 173.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.706 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.0 t -80.17 48.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.001 -174.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.85 9.29 4.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.291 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.829 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 8.6 t70 . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.856 0.36 . . . . 0.0 111.082 -178.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.627 ' HB ' HG22 ' A' ' 57' ' ' VAL . 1.7 t . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.671 0.272 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 9.7 t -104.88 110.78 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.12 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.619 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -101.2 166.86 10.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.338 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.754 HG23 ' HG3' ' A' ' 54' ' ' MET . 8.5 m -143.33 129.16 19.41 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.699 0.762 . . . . 0.0 112.251 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.008 HG22 HG21 ' A' ' 80' ' ' ILE . 6.3 mm -121.91 107.97 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.523 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.772 ' C ' HG23 ' A' ' 80' ' ' ILE . 2.8 mmmt -97.28 94.56 7.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.503 ' N ' HG23 ' A' ' 80' ' ' ILE . 2.0 m -93.37 137.84 21.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.741 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -147.31 119.53 4.72 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 121.306 0.574 . . . . 0.0 111.915 178.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 22.2 Cg_exo -68.51 121.89 8.85 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.372 2.715 . . . . 0.0 111.982 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -56.25 -29.61 61.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.269 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.424 ' O ' HG12 ' A' ' 17' ' ' VAL . 1.3 p -76.97 151.16 81.81 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.173 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 48.4 Cg_endo -67.85 -6.47 17.0 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.165 1.91 . . . . 0.0 111.387 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -92.6 33.92 1.1 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.565 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.05 87.15 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.8 0.809 . . . . 0.0 110.015 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 15.6 m-20 -70.08 106.99 3.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.47 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.924 ' HG ' HD11 ' A' ' 51' ' ' LEU . 2.2 tt -62.16 -49.58 75.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.226 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -68.67 -37.55 79.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.864 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -70.95 -34.0 71.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.58 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -65.34 -32.62 74.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.574 177.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.644 ' HA ' HD12 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -58.37 -44.49 88.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.604 178.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.5 -42.49 92.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.337 178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.63 -32.12 73.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.179 0.514 . . . . 0.0 110.337 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.662 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 9.7 mt -60.94 -44.35 97.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.745 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.96 -39.65 86.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.542 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -74.73 -24.31 58.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.379 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.847 HH22 ' HB ' ' A' ' 8' ' ' ILE . 24.7 ptt85 -91.06 -14.02 32.08 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.629 HD11 HG11 ' A' ' 53' ' ' VAL . 12.1 mm -58.16 137.78 84.38 Favored Pre-proline 0 C--N 1.332 -0.186 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.481 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.492 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 5.2 Cg_endo -45.3 119.03 2.34 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.807 2.338 . . . . 0.0 112.231 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -57.3 -4.55 0.23 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.076 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.95 -45.15 6.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.516 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.43 -142.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.765 0.316 . . . . 0.0 111.135 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -138.7 175.55 9.47 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.968 0.413 . . . . 0.0 110.748 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.493 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -74.69 -175.69 2.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.342 -178.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.563 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 85.5 t60 -131.35 -68.87 0.64 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.095 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -159.34 121.27 3.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.257 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.675 HD13 HG22 ' A' ' 53' ' ' VAL . 2.5 mt -91.72 157.5 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.513 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.647 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.64 123.66 36.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.804 -178.164 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.496 ' HB3' HD11 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -85.22 70.71 10.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.927 0.394 . . . . 0.0 110.426 177.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.547 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -97.41 135.73 21.65 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.767 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.782 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 64.3 Cg_endo -86.62 157.73 9.16 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.609 2.206 . . . . 0.0 112.739 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.706 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.8 mm -126.56 -83.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.444 -177.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.741 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.52 -149.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -70.75 -32.85 70.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.638 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.56 7.76 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.631 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.741 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.7 mt -90.9 101.56 14.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 110.685 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.782 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 73.8 t -93.0 128.99 44.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.923 -178.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.741 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.64 156.6 16.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.853 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.924 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.1 mp -115.76 119.97 37.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.461 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.514 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.6 m120 -89.82 91.0 8.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.337 0.589 . . . . 0.0 110.016 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.675 HG22 HD13 ' A' ' 39' ' ' ILE . 14.2 t -87.37 102.35 12.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.539 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.754 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.1 OUTLIER -84.61 166.93 16.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.852 178.102 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.619 HG22 ' HB3' ' A' ' 6' ' ' ALA . 4.4 m -138.72 126.4 27.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.089 0.471 . . . . 0.0 111.431 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.563 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 1.3 p -99.06 106.85 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.696 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.627 HG22 ' HB ' ' A' ' 4' ' ' VAL . 1.3 m -124.99 166.6 20.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.649 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.25 -64.93 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.729 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.41 -5.8 57.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.943 0.401 . . . . 0.0 110.58 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.66 -147.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.037 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.62 -162.56 1.57 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.764 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.8 14.11 27.11 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.429 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.83 -4.28 46.7 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.46 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -74.31 -7.3 52.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.923 0.392 . . . . 0.0 110.26 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.93 -23.38 31.52 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.984 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.3 -24.52 55.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.847 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.11 -55.93 26.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.137 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.25 -34.96 72.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.408 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -60.9 -50.97 71.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.387 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.462 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 5.0 p -64.0 -20.92 66.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.544 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.594 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.11 -27.44 62.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.565 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -14.37 58.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.749 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.41 26.34 0.97 Allowed Glycine 0 N--CA 1.451 -0.3 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.897 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 29' ' ' ARG . 2.8 tt -73.24 -163.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.55 -0.325 . . . . 0.0 110.906 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.702 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -52.16 90.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.989 0.423 . . . . 0.0 110.862 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.08 -24.86 59.01 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.844 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.96 -35.76 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.174 0.511 . . . . 0.0 110.251 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.702 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -95.63 90.39 5.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.771 -179.498 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.406 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.7 OUTLIER -75.06 130.25 38.99 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.008 HG21 HG22 ' A' ' 8' ' ' ILE . 3.0 mp -100.93 149.12 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.38 -175.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.478 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 28.4 tt0 -85.69 68.99 10.58 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 173.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.709 HG23 ' HB ' ' A' ' 80' ' ' ILE . 48.7 t -80.47 58.34 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.728 -175.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.36 -3.9 3.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.879 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.693 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 8.3 m-20 . . . . . 0 N--CA 1.453 -0.294 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.03 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.512 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 1.8 t . . . . . 0 C--O 1.231 0.103 0 N-CA-C 110.329 -0.248 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 14.5 t -104.31 115.05 45.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.874 0.368 . . . . 0.0 111.752 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.587 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -97.31 165.05 12.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.687 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 8.5 m -140.67 131.45 25.81 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.643 0.735 . . . . 0.0 112.019 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.035 HG22 HG21 ' A' ' 80' ' ' ILE . 2.6 mm -124.32 106.0 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.667 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.584 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.55 95.26 7.86 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.772 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.4 m -92.89 136.05 26.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.804 0.335 . . . . 0.0 111.897 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.656 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -146.41 120.1 5.18 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 121.142 0.496 . . . . 0.0 111.81 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.4 Cg_exo -69.34 122.88 9.67 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.419 2.746 . . . . 0.0 111.9 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.57 -29.63 64.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.291 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.472 ' O ' HG12 ' A' ' 17' ' ' VAL . 1.5 p -76.34 151.09 83.19 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.143 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 46.5 Cg_endo -67.41 -6.77 17.26 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.237 1.958 . . . . 0.0 111.457 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.17 35.63 0.99 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.435 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -68.12 83.8 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.93 0.871 . . . . 0.0 110.588 -179.046 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.556 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 19.4 m-20 -73.08 98.38 2.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.902 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.793 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -63.66 -43.81 95.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.589 -178.068 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.884 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 4.1 tp10 -69.23 -37.0 77.8 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.85 0.357 . . . . 0.0 110.321 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.572 ' O ' ' HD3' ' A' ' 24' ' ' LYS . . . -68.8 -38.12 79.72 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -68.12 -24.82 65.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.2 177.218 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.884 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -58.59 -44.9 89.99 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.24 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.572 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -68.62 -40.01 80.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.762 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.731 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 4.9 mm-40 -67.8 -29.4 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.336 0.588 . . . . 0.0 110.302 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.729 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.2 mt -63.92 -38.38 82.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.036 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.421 ' NE2' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -60.85 -40.95 94.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.221 -179.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.731 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -77.77 -20.8 52.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.514 -178.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.792 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.23 -11.95 45.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.342 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.639 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.4 mm -60.11 138.28 91.26 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.239 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.608 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.2 Cg_endo -50.68 114.71 1.59 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.793 2.328 . . . . 0.0 112.062 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.33 2.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.47 -45.73 6.78 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.789 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.588 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -130.36 -133.35 0.21 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.664 0.232 . . . . 0.0 111.175 -179.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -136.63 170.08 16.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.905 0.383 . . . . 0.0 110.941 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.538 HD22 HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -75.59 -174.09 2.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.108 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.506 ' ND1' HG22 ' A' ' 56' ' ' VAL . 85.2 t60 -130.45 -76.03 0.53 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.328 0.585 . . . . 0.0 110.939 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.546 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -164.91 126.67 2.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.868 -178.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.633 HD13 HG22 ' A' ' 53' ' ' VAL . 2.8 mt -90.8 159.82 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.986 0.422 . . . . 0.0 111.865 -177.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.634 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.12 124.75 39.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.946 -178.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.67 68.82 10.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.914 0.388 . . . . 0.0 110.216 177.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.55 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -97.11 137.41 21.24 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.616 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.797 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 73.7 Cg_endo -86.03 156.72 9.93 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.486 2.124 . . . . 0.0 112.738 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.742 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.1 mm -124.56 -82.23 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.3 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.526 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.02 -152.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.992 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -71.8 -28.12 63.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.707 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.92 4.62 0.46 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.101 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.556 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.5 mt -92.43 104.24 16.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.842 0.353 . . . . 0.0 110.966 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.797 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 76.3 t -93.12 131.35 40.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.858 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.25 164.19 12.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.072 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.3 mp -120.63 117.69 28.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.211 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.2 m120 -90.47 92.05 8.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.254 0.55 . . . . 0.0 110.422 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.684 HG21 HG12 ' A' ' 26' ' ' ILE . 4.3 t -87.31 101.96 11.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.583 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.488 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 33.4 mtt -84.71 165.91 17.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.218 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.1 m -139.63 133.76 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.38 . . . . 0.0 111.678 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.506 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -98.36 113.47 33.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 178.474 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.512 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 7.7 m -130.49 142.54 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.979 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.38 -62.12 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.583 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.92 -12.19 59.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.002 0.43 . . . . 0.0 110.706 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.588 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -68.07 -144.53 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.106 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.29 -166.82 2.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.72 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.71 15.28 20.7 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.682 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.67 -0.51 32.69 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.602 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 p -74.16 -2.21 23.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.972 0.415 . . . . 0.0 110.148 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -55.07 -24.41 25.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.348 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.78 -27.27 59.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.08 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.608 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.51 -56.12 23.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.809 0.338 . . . . 0.0 110.362 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -58.75 -34.22 71.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.362 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.53 -51.45 68.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.325 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.7 p -63.19 -19.05 64.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.561 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.854 HD22 HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.59 -28.79 61.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.59 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -13.51 47.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.531 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.9 30.92 1.0 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.392 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.854 HD13 HD22 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -72.85 -166.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.165 -0.517 . . . . 0.0 111.173 -178.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.681 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 1.4 mp0 -51.05 100.33 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.888 0.375 . . . . 0.0 111.007 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.15 -30.83 71.41 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.794 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 t -87.92 -37.27 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.803 0.335 . . . . 0.0 110.744 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.681 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 32.2 t -95.77 92.42 6.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.844 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.427 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -76.58 132.26 39.37 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.306 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.035 HG21 HG22 ' A' ' 8' ' ' ILE . 8.0 mt -100.58 144.7 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.088 -175.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.518 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.3 tt0 -85.24 69.56 10.76 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.711 HG23 ' HB ' ' A' ' 80' ' ' ILE . 48.0 t -81.43 56.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 113.92 -1.491 . . . . 0.0 111.249 -174.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -132.44 -0.12 3.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.929 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.687 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 5.5 m-20 . . . . . 0 N--CA 1.455 -0.208 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.251 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.416 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 2.7 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.672 0.272 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 21.7 t -113.92 109.74 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.427 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.666 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.66 165.41 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 177.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.803 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.6 m -141.9 132.63 25.62 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.715 0.769 . . . . 0.0 112.273 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.027 HG22 HG21 ' A' ' 80' ' ' ILE . 4.3 mm -123.77 106.79 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.457 -178.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.766 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.62 96.45 8.65 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.221 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.491 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.6 m -94.62 137.62 22.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.904 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.673 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.2 OUTLIER -147.39 121.72 5.06 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 121.264 0.554 . . . . 0.0 111.984 179.251 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 18.7 Cg_exo -71.02 124.11 10.28 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.599 2.866 . . . . 0.0 112.15 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -57.9 -31.42 66.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.444 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.2 m -77.64 150.64 79.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.04 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.571 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 40.1 Cg_endo -66.66 -6.51 15.6 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.379 2.052 . . . . 0.0 111.942 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.53 34.0 0.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.405 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.52 84.54 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 121.774 0.797 . . . . 0.0 110.111 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 11.5 m-20 -71.64 108.73 5.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.197 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.605 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -63.45 -43.62 96.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.793 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.605 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 20.6 tp10 -68.95 -39.19 79.68 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.655 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.519 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -69.92 -36.54 75.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.44 0.638 . . . . 0.0 109.93 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -66.48 -33.89 76.71 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.48 177.383 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -45.65 89.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.079 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -68.88 -39.85 79.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.138 0.494 . . . . 0.0 110.385 179.121 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.521 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 31.9 mm-40 -66.01 -29.34 69.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.254 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.714 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 2.1 mt -62.22 -44.42 99.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.964 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.72 -36.72 77.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.985 0.421 . . . . 0.0 110.539 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -75.37 -23.93 57.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.687 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.762 ' HD2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.05 -14.27 39.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.524 -178.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 26' ' ' ILE . 39.1 mm -58.55 136.82 86.04 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.461 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.607 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 17.7 Cg_endo -58.89 131.24 40.72 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.372 2.048 . . . . 0.0 112.534 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -61.0 0.53 0.22 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.962 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.52 -59.03 2.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.708 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.569 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -117.9 -143.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.668 0.27 . . . . 0.0 110.885 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -136.41 167.8 20.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.87 0.367 . . . . 0.0 110.711 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.403 ' H ' ' CD2' ' A' ' 36' ' ' LEU . 1.6 pt? -75.08 -175.71 2.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.108 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.522 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 81.4 t60 -131.52 -75.88 0.52 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.315 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -159.37 132.08 6.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.048 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.664 HG23 HG22 ' A' ' 53' ' ' VAL . 1.7 mt -93.37 161.23 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.013 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.76 123.52 35.5 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.593 -178.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -85.56 71.16 10.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.897 0.38 . . . . 0.0 110.674 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.547 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.5 mt-10 -98.65 136.28 20.8 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.739 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.777 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 61.5 Cg_endo -87.64 157.26 7.69 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.662 2.241 . . . . 0.0 112.877 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.717 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.2 mm -125.41 -82.75 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.428 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.723 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.26 -150.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.16 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -71.36 -31.49 67.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.592 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.43 6.73 0.58 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.771 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.723 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.9 mt -91.11 102.26 15.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.822 0.344 . . . . 0.0 110.771 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.777 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 70.2 t -93.32 129.65 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.966 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.717 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.42 155.96 16.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.889 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.625 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.3 mp -114.45 118.09 32.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.392 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.52 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.2 m120 -89.9 92.56 9.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.245 0.545 . . . . 0.0 110.09 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.698 HG21 HG12 ' A' ' 26' ' ' ILE . 6.3 t -86.54 105.77 15.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.445 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 50.6 mtt -84.46 166.67 17.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.409 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.666 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.5 m -138.78 127.57 29.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.237 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.522 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 0.7 OUTLIER -95.68 108.25 20.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.598 179.254 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.569 HG12 HG21 ' A' ' 34' ' ' THR . 3.3 m -125.41 167.03 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.817 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.73 -75.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.842 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -81.3 2.57 27.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 0.0 110.99 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.453 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.78 -147.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.116 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.74 -166.48 2.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.683 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.91 15.16 22.54 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.591 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.39 -5.56 55.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.549 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.43 ' HA ' ' HB2' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -74.08 -4.6 36.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.908 0.385 . . . . 0.0 110.383 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.02 -23.65 20.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.044 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.18 -27.78 62.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.937 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.607 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.54 -56.54 20.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.353 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -58.74 -34.83 71.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.447 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -60.71 -51.96 67.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.471 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.418 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -64.04 -19.33 65.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.572 178.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.614 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -72.92 -28.76 62.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.559 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -11.88 43.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.954 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.2 25.29 0.99 Allowed Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.75 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.762 HD11 ' HD2' ' A' ' 29' ' ' ARG . 2.6 tt -73.32 -163.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.47 -0.365 . . . . 0.0 111.059 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.605 ' N ' HG23 ' A' ' 74' ' ' ILE . 1.8 mp0 -51.01 96.51 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.81 0.338 . . . . 0.0 111.003 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.43 -27.34 69.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.281 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -88.27 -37.94 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.173 0.511 . . . . 0.0 110.435 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -96.23 90.0 5.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.424 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.595 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.57 134.77 38.18 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.472 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.027 HG21 HG22 ' A' ' 8' ' ' ILE . 1.7 mt -101.54 147.42 8.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.563 -176.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.534 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 9.7 tp10 -86.02 70.39 10.6 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 173.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.706 HG23 ' HB ' ' A' ' 80' ' ' ILE . 58.2 t -80.46 52.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.999 -174.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -133.0 3.61 3.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.575 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.803 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 18.8 t0 . . . . . 0 N--CA 1.453 -0.291 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.052 -178.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.108 0 CA-C-O 120.575 0.226 . . . . 0.0 110.741 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 13.1 t -125.54 118.34 52.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.039 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.581 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.74 169.76 9.93 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.69 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 10.0 m -143.04 131.85 22.71 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.587 0.708 . . . . 0.0 112.011 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.091 HG22 HG21 ' A' ' 80' ' ' ILE . 7.3 mm -122.98 107.52 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.896 -177.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.779 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.28 95.28 7.6 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -177.7 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.596 HG11 ' NH1' ' A' ' 29' ' ' ARG . 2.0 m -94.64 136.71 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.659 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.53 121.11 4.88 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 121.036 0.446 . . . . 0.0 111.76 179.475 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 17.2 Cg_exo -71.82 118.64 5.74 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.522 2.815 . . . . 0.0 111.946 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -56.21 -28.36 58.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.133 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.38 149.21 78.49 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.106 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 37.9 Cg_endo -66.03 -7.68 17.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.401 2.068 . . . . 0.0 111.92 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.1 36.06 1.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.698 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.624 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.16 87.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.79 0.805 . . . . 0.0 110.09 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 28.0 m-20 -68.32 107.19 2.74 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.336 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.732 HD12 ' NZ ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -60.45 -54.81 41.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.66 -178.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.527 ' HG2' ' N ' ' A' ' 21' ' ' ALA . 7.6 pm0 -71.29 -34.46 70.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.279 -177.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.642 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . . . -67.92 -35.71 78.92 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -65.77 -35.25 80.19 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.234 176.159 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.732 ' NZ ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -55.93 -46.83 78.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.034 178.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.642 ' HE3' ' HA ' ' A' ' 21' ' ' ALA . 2.6 mtmt -66.41 -43.8 84.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.815 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.737 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 52.9 mt-10 -67.58 -27.0 66.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.247 0.546 . . . . 0.0 110.969 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.652 HG12 HG21 ' A' ' 53' ' ' VAL . 1.1 mt -63.06 -43.14 98.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.951 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -62.56 -37.57 86.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.26 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.737 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 1.4 pp20? -77.21 -22.67 51.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.405 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.846 ' HB2' HD11 ' A' ' 74' ' ' ILE . 4.3 ptp85 -90.6 -11.95 38.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.088 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.646 HG12 ' O ' ' A' ' 26' ' ' ILE . 10.9 mm -61.57 139.29 95.13 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.87 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.667 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 7.3 Cg_endo -47.88 115.87 1.67 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.854 2.37 . . . . 0.0 112.445 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -59.38 0.74 0.1 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.105 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.92 -43.15 7.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.003 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.573 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.15 -139.01 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.712 0.292 . . . . 0.0 111.246 -179.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -135.64 169.9 16.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.881 0.372 . . . . 0.0 110.932 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.702 HD13 ' H ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -76.38 -175.91 3.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.229 -179.532 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.645 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.3 t60 -131.01 -74.74 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.412 0.625 . . . . 0.0 110.952 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HB3' ' CD2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -163.88 129.27 2.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.667 -178.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.696 HG12 HG13 ' A' ' 53' ' ' VAL . 2.8 mt -93.08 155.85 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -176.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.637 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.7 m-20 -117.97 123.0 44.69 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.971 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -88.34 67.68 8.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.96 0.409 . . . . 0.0 110.142 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.688 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.98 148.54 34.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.368 -178.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.772 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 30.6 Cg_endo -92.49 160.53 2.97 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.996 2.464 . . . . 0.0 113.266 -177.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.2 mm -128.85 -82.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.248 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.56 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -66.91 -151.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.924 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -72.27 -28.55 63.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.67 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.07 4.99 0.46 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.1 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.9 mt -92.1 106.1 18.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.89 0.345 . . . . 0.0 110.906 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 24.2 t -92.59 132.22 37.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.814 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.75 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.18 163.29 13.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.85 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.637 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.0 mp -120.57 116.17 24.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.513 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.7 m120 -89.65 91.0 8.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.379 0.609 . . . . 0.0 110.046 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.696 HG13 HG12 ' A' ' 39' ' ' ILE . 3.8 t -87.16 105.65 15.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.576 -177.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 62.8 mtt -84.71 165.31 17.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.937 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.3 m -138.69 136.77 43.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.886 0.374 . . . . 0.0 111.581 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.645 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.3 OUTLIER -94.74 108.42 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.778 178.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.434 HG12 ' CB ' ' A' ' 34' ' ' THR . 21.9 m -125.39 137.96 55.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.855 0.359 . . . . 0.0 110.975 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.89 -58.72 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.331 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -81.08 -16.58 52.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.084 0.469 . . . . 0.0 110.4 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.573 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -68.15 -144.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.17 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.5 -163.35 1.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.785 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.9 13.75 29.42 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.544 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.37 -1.24 34.65 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.639 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -74.75 -4.14 35.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.968 0.413 . . . . 0.0 110.205 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -54.96 -23.91 21.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.337 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.07 -25.6 58.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.159 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.667 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.48 -56.59 18.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.8 0.334 . . . . 0.0 110.244 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -58.97 -34.0 71.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.276 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.94 -51.02 69.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.307 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -18.23 63.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.263 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.702 HD22 HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.65 -29.7 62.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.482 179.401 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -10.74 31.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.782 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.1 25.08 1.0 Allowed Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.846 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -73.32 -168.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.338 -0.431 . . . . 0.0 111.235 -179.04 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.558 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -51.09 93.5 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.353 179.137 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.2 -26.32 61.23 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.018 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -87.99 -41.16 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.181 0.515 . . . . 0.0 110.186 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -95.9 87.97 4.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.122 178.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.572 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.81 135.74 38.0 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.263 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.091 HG21 HG22 ' A' ' 8' ' ' ILE . 1.7 mt -101.5 147.72 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.469 -176.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.586 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 7.2 tp10 -86.07 71.09 10.62 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 172.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.688 HG23 ' HB ' ' A' ' 80' ' ' ILE . 59.0 t -80.68 52.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.063 -174.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 m -132.8 4.57 3.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.402 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.69 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.2 m-20 . . . . . 0 N--CA 1.452 -0.358 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.169 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.823 HG12 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 121.048 0.452 . . . . 0.0 110.17 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 40.8 t -109.71 120.36 60.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.492 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.627 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.03 167.91 11.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.682 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 11.4 m -141.65 131.37 24.18 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.6 0.714 . . . . 0.0 112.185 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.069 HG22 HG21 ' A' ' 80' ' ' ILE . 2.1 mm -120.56 105.01 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.688 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.636 ' HD2' ' HB3' ' A' ' 52' ' ' ASN . 0.9 OUTLIER -96.38 93.98 7.16 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.745 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.4 m -92.02 136.91 23.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.84 -177.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.675 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.32 119.26 4.67 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 121.131 0.491 . . . . 0.0 111.878 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 17.8 Cg_exo -70.96 122.22 8.59 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.49 2.794 . . . . 0.0 112.198 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.89 -30.3 65.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.388 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.8 148.32 75.73 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.012 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 36.8 Cg_endo -64.74 -6.56 12.65 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.399 2.066 . . . . 0.0 111.774 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -92.03 34.05 1.03 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.6 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.3 87.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.832 0.825 . . . . 0.0 110.124 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 74.2 m-20 -69.11 104.14 2.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.127 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.871 ' HG ' HD11 ' A' ' 51' ' ' LEU . 1.4 tt -61.05 -52.17 66.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.539 -178.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.705 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -70.5 -36.32 73.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.079 -177.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.55 ' HB3' ' CB ' ' A' ' 18' ' ' ASP . . . -68.2 -34.63 76.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.157 0.503 . . . . 0.0 109.758 177.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -65.68 -32.12 73.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.861 177.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.705 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -54.71 -47.65 73.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.505 179.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -66.6 -42.48 86.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.736 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -65.55 -29.3 69.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.185 0.516 . . . . 0.0 110.391 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.695 HG12 HG21 ' A' ' 53' ' ' VAL . 2.0 mt -61.83 -45.58 98.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.217 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -60.49 -35.86 76.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.717 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 17.5 mm-40 -74.17 -23.74 59.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.559 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.819 ' HB2' HD11 ' A' ' 74' ' ' ILE . 2.4 ptp180 -92.57 -14.54 28.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.842 -178.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.552 HD11 HG11 ' A' ' 53' ' ' VAL . 15.2 mm -58.74 139.82 86.07 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.102 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.664 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.4 Cg_endo -50.82 112.16 0.71 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.838 2.359 . . . . 0.0 112.348 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 0.6 0.11 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.341 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.08 -40.01 9.62 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.042 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.539 ' CB ' HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.36 -137.8 0.21 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.647 0.223 . . . . 0.0 110.882 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -136.63 166.9 22.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 111.048 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -76.01 -175.45 3.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.269 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.603 ' ND1' HG22 ' A' ' 56' ' ' VAL . 82.4 t60 -130.73 -74.97 0.53 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.315 0.578 . . . . 0.0 110.829 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.584 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -164.22 132.6 3.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.998 -178.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.664 HG12 HG13 ' A' ' 53' ' ' VAL . 2.8 mt -94.39 158.38 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.691 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.1 t0 -123.88 128.55 49.63 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.381 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.445 ' HG2' HD21 ' A' ' 19' ' ' LEU . 13.4 mt-10 -90.8 69.06 6.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.228 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.666 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -100.92 148.03 34.51 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.264 -178.437 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.783 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 21.2 Cg_endo -91.7 159.75 3.48 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.043 2.495 . . . . 0.0 113.362 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' A' ' 50' ' ' ALA . 5.0 mm -127.95 -83.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.248 -178.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.474 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.34 -151.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.031 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -72.11 -28.76 63.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.73 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.2 3.98 0.41 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.126 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.504 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 6.9 mt -91.21 106.09 18.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.892 0.377 . . . . 0.0 110.777 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 40.7 t -92.95 132.06 38.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.694 -178.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.704 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.27 164.09 12.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.093 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.871 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.3 mp -120.64 116.0 24.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.28 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.636 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.1 m120 -89.86 91.93 8.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.315 0.579 . . . . 0.0 110.378 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.695 HG21 HG12 ' A' ' 26' ' ' ILE . 4.6 t -86.8 105.21 14.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.536 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.679 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.6 164.61 18.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.169 178.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.627 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.1 m -139.24 141.06 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 111.572 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.603 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.9 t -93.07 100.4 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.668 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.823 HG23 HG12 ' A' ' 4' ' ' VAL . 27.2 m -130.15 140.35 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.046 0.45 . . . . 0.0 111.544 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.32 -61.67 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.51 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -81.34 -7.68 59.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.038 0.446 . . . . 0.0 110.625 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.535 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.77 -139.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.132 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -147.01 -166.27 2.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.77 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.58 12.88 31.79 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.638 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.15 -9.54 63.87 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.512 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -74.48 -5.99 45.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.857 0.361 . . . . 0.0 110.42 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -54.72 -23.79 19.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.056 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.93 -28.59 57.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.952 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.664 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.09 -57.59 11.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.401 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -59.53 -33.59 71.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.451 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.85 -51.42 68.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.238 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.409 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.3 t -63.48 -18.03 63.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.139 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.678 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.23 -29.91 63.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.478 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -12.86 44.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.709 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.26 27.41 0.99 Allowed Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.642 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.819 HD11 ' HB2' ' A' ' 29' ' ' ARG . 1.3 tt -73.17 -162.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.411 . . . . 0.0 111.187 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.633 ' OE1' HG12 ' A' ' 77' ' ' VAL . 1.7 mm-40 -50.89 94.13 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.141 0.496 . . . . 0.0 110.792 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.06 -32.42 62.8 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.692 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.633 HG12 ' OE1' ' A' ' 75' ' ' GLU . 0.4 OUTLIER -87.44 -36.82 10.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 0.0 110.364 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -96.0 89.01 5.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.206 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.597 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -75.88 133.87 40.44 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.369 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.069 HG21 HG22 ' A' ' 8' ' ' ILE . 6.2 mt -101.12 144.82 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.068 -175.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.596 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 19.4 tp10 -85.34 69.96 10.77 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.693 HG23 ' HB ' ' A' ' 80' ' ' ILE . 49.1 t -80.8 48.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.035 -174.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 m -132.34 8.14 4.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.23 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.682 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.3 m-20 . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.88 0.371 . . . . 0.0 110.928 -178.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.618 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.527 0.086 0 CA-C-O 120.6 0.238 . . . . 0.0 111.0 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 2.6 t -107.59 113.53 43.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.657 0.265 . . . . 0.0 111.369 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.556 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.68 167.17 11.63 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.257 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.812 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 7.5 m -143.15 131.19 21.76 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.537 0.684 . . . . 0.0 112.312 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.0 HG22 HG21 ' A' ' 80' ' ' ILE . 3.5 mm -125.01 108.29 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.763 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.81 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.15 95.05 7.88 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.553 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.462 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.4 m -93.89 138.49 20.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.769 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.2 ptm -145.49 125.37 7.03 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.353 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.601 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.1 Cg_exo -71.47 121.92 8.16 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.155 2.57 . . . . 0.0 112.077 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.32 -32.36 66.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.345 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.25 152.57 79.09 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.078 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.584 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 41.1 Cg_endo -67.31 -3.36 9.81 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.388 2.059 . . . . 0.0 112.204 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -90.87 43.89 1.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.927 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.601 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 93.1 t -65.59 75.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.37 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 81.9 m-20 -70.49 95.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.915 177.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.527 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -64.1 -43.63 94.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.5 -178.351 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.527 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 5.3 tp10 -68.36 -38.16 81.17 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.744 0.307 . . . . 0.0 110.412 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -69.62 -39.82 76.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.372 0.606 . . . . 0.0 109.815 177.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -67.62 -30.66 70.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.035 177.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -46.75 81.7 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.775 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -69.26 -40.45 77.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.571 179.531 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.527 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 1.3 mt-10 -65.24 -28.04 69.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.117 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.886 HG22 HE21 ' A' ' 27' ' ' GLN . 0.5 OUTLIER -62.44 -47.12 94.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.354 179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.886 HE21 HG22 ' A' ' 26' ' ' ILE . 6.2 mm-40 -62.68 -31.61 72.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.829 0.347 . . . . 0.0 110.721 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 17.7 mm-40 -74.72 -24.84 58.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.007 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.978 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.46 -14.52 37.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.333 -179.128 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.432 HG13 HD12 ' A' ' 36' ' ' LEU . 24.8 mm -57.61 137.29 82.37 Favored Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.716 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 4.5 Cg_endo -45.66 122.01 4.57 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.885 2.39 . . . . 0.0 112.169 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.37 -4.82 0.25 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.046 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.03 -41.4 8.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.73 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.511 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.43 -146.54 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.674 0.273 . . . . 0.0 111.198 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -138.62 177.58 7.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.242 0.544 . . . . 0.0 111.185 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.715 HD13 ' H ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -74.96 -178.24 3.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.434 -179.183 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.535 ' ND1' HG22 ' A' ' 56' ' ' VAL . 72.4 t60 -131.13 -71.24 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.66 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 7.2 mmtm -161.64 125.16 3.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.081 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.651 HD13 HG22 ' A' ' 53' ' ' VAL . 2.8 mt -92.1 160.49 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.781 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.65 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -129.17 125.0 36.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.726 -178.311 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -85.43 72.03 10.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.841 0.353 . . . . 0.0 110.548 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.524 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.4 mt-10 -98.09 134.73 21.82 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.621 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.771 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 56.8 Cg_endo -86.53 155.0 9.11 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.577 2.185 . . . . 0.0 112.782 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.687 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.2 mm -123.87 -82.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.403 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.606 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.21 -153.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.054 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -71.81 -27.99 63.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.805 0.336 . . . . 0.0 110.593 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.62 5.12 0.51 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.951 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.606 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.8 mt -92.22 101.36 13.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.784 0.326 . . . . 0.0 110.839 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 90.4 t -93.38 129.36 43.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.783 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.769 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.24 162.94 13.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.022 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.65 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.2 mp -120.53 120.27 35.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.435 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.538 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.3 m120 -89.66 91.71 8.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.271 0.558 . . . . 0.0 109.813 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.847 HG21 HG12 ' A' ' 26' ' ' ILE . 12.4 t -86.82 106.35 15.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.793 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.574 ' HG3' HG23 ' A' ' 7' ' ' THR . 6.2 mtt -85.63 165.23 17.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.031 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.556 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.1 m -140.3 134.35 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.903 0.383 . . . . 0.0 111.245 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.535 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.55 113.21 30.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.06 179.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 4' ' ' VAL . 3.5 m -130.35 144.8 36.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.885 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.07 -63.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.25 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -81.09 -7.9 59.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 110.402 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.511 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.27 -147.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.992 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.56 -162.02 1.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.343 . . . . 0.0 110.782 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.62 11.91 37.16 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.38 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.43 -3.01 45.72 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.585 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 p -74.03 -5.49 41.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.934 0.397 . . . . 0.0 110.358 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -55.13 -24.36 25.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.193 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . . . -57.2 -25.45 59.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.105 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.77 -57.26 13.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.164 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.37 -33.63 71.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.325 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 1.8 mm-40 -61.11 -52.13 66.21 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.501 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.78 -19.86 65.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.621 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.724 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.63 -28.08 62.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.69 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -15.1 57.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.731 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.39 29.33 0.96 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.978 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -73.08 -165.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.253 -0.474 . . . . 0.0 111.279 -178.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.771 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 3.0 pm0 -51.63 89.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.658 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 74' ' ' ILE . . . -59.46 -26.99 62.75 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.937 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.06 -34.76 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.254 0.549 . . . . 0.0 110.2 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.771 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -95.71 89.07 5.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.626 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.403 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -74.68 128.86 36.58 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.206 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.0 HG21 HG22 ' A' ' 8' ' ' ILE . 1.9 mp -101.11 148.88 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.576 -175.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.662 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.1 tp10 -85.78 71.44 10.67 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 172.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.705 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.5 t -80.06 50.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.036 -173.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -132.93 7.12 4.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.176 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.812 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 26.8 t0 . . . . . 0 N--CA 1.451 -0.381 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.934 -178.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.78 HG12 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 4.8 t -106.96 117.26 52.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 121.046 -0.261 . . . . 0.0 111.66 -178.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.696 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -92.68 162.27 14.22 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.81 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 11.3 m -143.16 131.06 21.58 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.592 0.71 . . . . 0.0 112.309 -178.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.021 HG22 HG21 ' A' ' 80' ' ' ILE . 2.7 mm -120.22 106.05 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.628 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.834 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -93.62 92.35 7.49 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.326 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.609 HG12 HG12 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -92.42 138.13 20.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.117 -177.019 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.64 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.73 119.05 5.29 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.074 179.312 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.613 ' CD ' HG13 ' A' ' 17' ' ' VAL . 14.9 Cg_exo -69.23 120.25 7.14 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.252 2.635 . . . . 0.0 112.137 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -57.42 -30.33 64.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.475 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.79 151.62 79.73 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.078 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 40.8 Cg_endo -66.81 -4.28 10.93 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.41 2.074 . . . . 0.0 112.001 179.65 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -91.84 42.35 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.321 179.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.613 HG13 ' CD ' ' A' ' 12' ' ' PRO . 90.9 t -65.14 78.17 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.166 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.669 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -67.82 100.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.134 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.618 HD11 ' HE2' ' A' ' 23' ' ' LYS . 1.3 tp -61.54 -51.87 66.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.488 -178.125 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.782 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 8.6 pt-20 -71.54 -34.55 70.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.261 -177.33 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -67.82 -36.21 79.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -64.86 -34.74 79.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.363 176.557 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.782 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -55.59 -48.11 75.38 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.296 178.649 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 3.6 mtmt -65.25 -44.18 88.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.967 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -66.32 -28.72 68.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.172 0.51 . . . . 0.0 110.444 -179.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.838 HG12 HG21 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -61.39 -47.46 93.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.495 -179.62 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.539 ' OE1' HD22 ' A' ' 36' ' ' LEU . 7.0 mm100 -63.53 -33.29 75.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.829 0.347 . . . . 0.0 110.798 -178.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 15.4 mt-10 -75.19 -23.56 57.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.925 179.216 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.755 ' HB2' HD11 ' A' ' 74' ' ' ILE . 3.2 ptp180 -91.83 -14.66 29.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.414 -179.122 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.59 HG12 ' O ' ' A' ' 26' ' ' ILE . 11.0 mm -59.35 141.25 87.7 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.025 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.716 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.2 Cg_endo -51.25 113.55 1.16 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.844 2.363 . . . . 0.0 112.431 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.2 -1.61 0.21 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.328 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.11 -36.89 13.62 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.066 -178.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.542 ' CB ' HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.54 -140.31 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.725 0.263 . . . . 0.0 111.077 -179.32 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -136.67 166.11 24.33 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.852 0.358 . . . . 0.0 110.892 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.539 HD22 ' OE1' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -76.09 -175.03 2.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.355 -179.262 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.6 ' ND1' HG22 ' A' ' 56' ' ' VAL . 79.8 t60 -131.29 -76.78 0.52 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.278 0.561 . . . . 0.0 110.937 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -165.27 132.7 3.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.048 -178.793 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.742 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -93.77 156.18 3.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.065 0.46 . . . . 0.0 112.197 -177.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.649 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 74.8 m-20 -122.72 119.2 29.97 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.465 -178.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -83.21 73.42 10.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.032 0.444 . . . . 0.0 110.608 178.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.559 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -97.33 132.95 24.48 Favored Pre-proline 0 C--O 1.225 -0.224 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.628 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.779 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 44.2 Cg_endo -85.33 155.21 10.81 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.449 2.099 . . . . 0.0 112.875 -178.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.749 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.4 mm -124.03 -83.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.411 -177.502 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.459 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.16 -154.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.018 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.97 -26.54 62.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.579 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.65 1.78 0.36 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.23 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.543 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.6 mt -92.44 102.41 14.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.851 0.358 . . . . 0.0 110.875 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.779 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 73.4 t -93.34 132.15 38.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.035 -178.126 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.749 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.93 153.77 17.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.816 177.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.649 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -117.39 120.8 39.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.518 179.377 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.575 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.3 m120 -89.73 93.89 9.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.109 -179.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.838 HG21 HG12 ' A' ' 26' ' ' ILE . 17.3 t -85.95 105.58 14.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.558 -177.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 44.2 mtt -86.52 160.51 18.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.35 178.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.696 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.8 m -139.05 140.7 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.101 -178.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.6 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.1 t -92.49 100.09 10.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.764 179.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.78 HG23 HG12 ' A' ' 4' ' ' VAL . 27.3 m -130.48 139.08 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.988 0.423 . . . . 0.0 111.473 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.73 -61.67 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.557 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.96 -5.4 58.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 110.575 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.51 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.41 -139.52 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.125 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -146.83 -165.92 2.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.762 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.32 11.09 39.4 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.691 179.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.2 -11.32 67.23 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.526 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -4.45 36.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 0.0 110.319 179.441 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -54.56 -23.9 18.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.387 0.613 . . . . 0.0 109.869 177.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.04 -28.17 56.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.94 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.716 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.96 -57.61 11.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.425 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -58.94 -34.06 71.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.455 178.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.96 -52.18 66.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.267 178.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -20.38 65.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.508 179.034 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.72 HD22 HD13 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.84 -26.1 61.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.659 -179.653 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.61 -17.02 63.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.556 178.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.48 31.74 0.93 Allowed Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.704 179.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.755 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -73.08 -161.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.278 -0.461 . . . . 0.0 111.24 -178.431 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.705 ' HG3' ' O ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -51.55 88.13 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.219 0.533 . . . . 0.0 110.437 178.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 74' ' ' ILE . . . -60.26 -26.63 64.16 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.308 -177.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 p -85.44 -34.7 8.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.412 0.625 . . . . 0.0 110.177 179.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.705 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -95.57 90.02 5.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.588 -179.314 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.611 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -73.49 128.38 35.34 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.153 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.021 HG21 HG22 ' A' ' 8' ' ' ILE . 2.1 mp -101.16 149.31 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.648 -174.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.68 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 5.8 tp10 -85.65 71.91 10.65 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.737 HG23 ' HB ' ' A' ' 80' ' ' ILE . 75.7 t -79.73 48.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.93 -173.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -133.1 7.26 3.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.93 178.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.81 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 22.0 t0 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.977 -178.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.627 HG12 HG23 ' A' ' 57' ' ' VAL . 1.0 OUTLIER . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 120.56 0.219 . . . . 0.0 110.958 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 57.5 t -124.06 120.18 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.746 0.308 . . . . 0.0 111.605 179.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.55 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -98.05 166.44 11.43 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.706 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 14.2 m -140.52 136.48 32.94 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.6 0.714 . . . . 0.0 112.267 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.077 HG22 HG21 ' A' ' 80' ' ' ILE . 2.3 mm -125.71 106.94 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.573 -178.055 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.822 ' C ' HG23 ' A' ' 80' ' ' ILE . 1.6 mmmt -95.79 93.83 7.31 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.816 0.341 . . . . 0.0 111.892 -178.075 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.493 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.9 m -93.71 135.4 28.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -176.521 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.648 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.36 124.88 6.91 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.038 178.363 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.643 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.7 Cg_exo -71.79 117.3 5.08 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.147 2.565 . . . . 0.0 111.747 179.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -30.25 59.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.95 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.96 155.1 80.39 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.72 179.454 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 3.8 Cg_exo -72.3 -0.96 9.42 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.562 2.175 . . . . 0.0 111.683 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -92.29 42.97 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.049 178.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.643 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 88.4 t -64.85 78.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.089 -178.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.659 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 2.3 m-20 -68.56 101.84 1.35 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.322 178.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.58 -53.43 56.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.68 -179.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 23.5 tt0 -69.76 -35.33 74.85 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 -176.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -68.57 -36.81 79.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.584 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.1 OUTLIER -64.74 -34.11 77.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.469 177.071 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -57.41 -47.22 82.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.571 179.008 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 7.4 mttt -65.64 -41.92 92.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.649 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 21' ' ' ALA . 33.8 mt-10 -65.74 -31.49 72.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.197 0.523 . . . . 0.0 110.477 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.685 HD11 HD12 ' A' ' 51' ' ' LEU . 6.9 mt -61.38 -44.71 98.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.053 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -61.48 -38.41 87.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.951 0.405 . . . . 0.0 110.772 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 4.7 mm-40 -76.09 -21.94 56.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.689 -178.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.632 HH22 ' HB ' ' A' ' 8' ' ' ILE . 22.1 ptt85 -90.35 -13.59 34.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.643 -177.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 26' ' ' ILE . 29.4 mm -59.73 138.6 90.03 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.176 -179.438 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.595 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.1 Cg_endo -51.89 123.77 13.14 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.726 2.284 . . . . 0.0 112.496 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -62.25 2.92 0.21 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.262 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.36 -64.51 1.64 Allowed Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.01 -178.618 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.624 ' CB ' HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -112.6 -131.43 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.348 0.118 . . . . 0.0 110.913 -179.17 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -139.21 166.63 24.03 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.947 0.404 . . . . 0.0 111.013 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.2 pt? -75.9 -172.41 1.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.971 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.575 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.0 t60 -130.36 -78.85 0.54 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.27 0.557 . . . . 0.0 111.481 -178.15 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HB3' ' CD2' ' A' ' 37' ' ' HIS . 1.5 tptp -164.49 130.89 2.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.843 -178.322 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.672 HD13 HD13 ' A' ' 26' ' ' ILE . 2.6 mt -92.0 159.62 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -176.715 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.643 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -127.48 117.08 21.42 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.247 -179.39 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -81.87 72.6 8.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.991 0.424 . . . . 0.0 110.396 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.539 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -97.0 134.86 22.39 Favored Pre-proline 0 C--O 1.225 -0.222 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.69 -179.595 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.776 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 53.7 Cg_endo -85.43 155.4 10.69 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.39 2.06 . . . . 0.0 112.837 -178.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.777 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.6 mm -124.88 -83.42 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.269 -177.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.493 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -66.74 -155.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.764 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -72.47 -22.93 60.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.72 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.62 0.93 0.26 Allowed Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.443 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.52 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.6 mt -92.83 103.59 15.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.072 0.436 . . . . 0.0 111.138 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.776 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 72.8 t -93.5 129.14 44.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.891 -179.015 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.777 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.1 151.8 19.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.943 178.168 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.685 HD12 HD11 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -115.14 121.27 42.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.538 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 1.7 m120 -90.51 92.33 8.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.363 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.647 HG22 HD13 ' A' ' 39' ' ' ILE . 5.9 t -87.49 103.27 13.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.375 -178.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.581 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.7 mpt? -84.41 164.89 18.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.268 178.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.55 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.2 m -137.73 136.89 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.365 -178.002 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.575 HG22 ' ND1' ' A' ' 37' ' ' HIS . 1.7 t -94.33 99.13 8.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.744 178.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.627 HG23 HG12 ' A' ' 4' ' ' VAL . 33.3 m -130.47 139.89 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.213 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.86 -57.8 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.595 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -80.85 -11.04 59.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.513 179.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.431 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.62 -138.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.109 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -146.79 -164.38 1.98 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.757 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.36 13.07 29.5 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.738 179.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.44 -11.49 68.27 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.609 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -74.46 -4.1 34.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.802 0.335 . . . . 0.0 110.422 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -55.19 -23.86 23.97 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.399 0.618 . . . . 0.0 110.055 177.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.413 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . . . -57.11 -25.09 58.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.174 -179.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.54 -57.03 13.71 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.327 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -58.77 -34.06 71.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.218 178.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 2.5 mt-10 -62.17 -51.57 67.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.43 178.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.69 -18.95 64.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.401 178.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.63 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.19 -29.53 62.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.512 179.835 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -13.47 51.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.74 179.162 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.27 28.73 0.98 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.672 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.63 ' HB ' ' HA ' ' A' ' 71' ' ' LEU . 1.2 tt -73.19 -164.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.445 -0.377 . . . . 0.0 110.854 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.64 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -51.96 95.3 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.089 0.471 . . . . 0.0 110.648 179.61 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.74 -30.84 69.98 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.452 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.2 t -85.16 -35.12 9.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.921 0.391 . . . . 0.0 110.38 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.64 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 8.0 m -95.7 88.87 5.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.683 -179.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.57 129.97 38.06 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.077 HG21 HG22 ' A' ' 8' ' ' ILE . 3.2 mp -101.3 150.05 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.748 -175.269 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.527 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 52.4 tt0 -85.91 70.75 10.67 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 173.016 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.68 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.0 t -80.94 50.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.083 -174.53 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 m -132.9 10.5 4.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.891 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.706 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.3 m-20 . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 121.162 0.506 . . . . 0.0 111.227 -178.447 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.649 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.461 0.078 0 CA-C-O 120.71 0.29 . . . . 0.0 110.708 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 53.7 t -109.57 120.64 61.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.596 -178.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.576 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -96.39 166.0 11.91 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.087 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.816 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.1 m -143.04 130.09 20.69 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.57 0.7 . . . . 0.0 112.361 -179.196 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.025 HG22 HG21 ' A' ' 80' ' ' ILE . 6.7 mm -121.61 107.08 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.554 -179.11 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.813 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -95.6 94.15 7.57 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.933 0.396 . . . . 0.0 111.946 -177.87 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.518 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.7 m -93.54 136.54 24.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -176.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.772 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.2 ptm -144.72 126.15 7.84 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.303 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.611 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 10.4 Cg_exo -73.46 124.53 9.45 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.399 2.732 . . . . 0.0 112.37 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.99 -33.82 69.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.357 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.4 m -78.28 154.41 79.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.213 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.582 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 52.9 Cg_endo -69.66 -3.41 11.88 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.428 2.085 . . . . 0.0 112.146 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.76 44.03 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.826 178.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.611 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 81.0 t -64.98 76.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.558 -178.418 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 6.3 m-20 -71.61 92.44 1.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.65 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -63.97 -42.08 97.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.303 -178.478 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.628 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 26.7 tt0 -68.3 -39.11 82.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.794 0.331 . . . . 0.0 110.253 -178.506 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -71.55 -36.75 71.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.053 0.454 . . . . 0.0 110.384 177.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -67.79 -28.75 67.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.976 178.026 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -42.48 87.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.321 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -43.82 86.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.246 178.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.57 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 2.2 mm-40 -65.79 -30.38 71.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.342 0.592 . . . . 0.0 110.207 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.782 HG12 HG21 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -60.66 -47.14 94.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.073 179.724 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.423 ' OE1' HD22 ' A' ' 36' ' ' LEU . 7.2 mm-40 -64.71 -35.24 80.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.193 -178.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 8.4 pt-20 -77.0 -20.79 55.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.907 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.832 ' HB2' HD11 ' A' ' 74' ' ' ILE . 4.2 ptp180 -90.51 -13.55 34.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.045 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 26' ' ' ILE . 14.2 mm -59.82 138.67 90.31 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.92 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 30' ' ' ILE . 9.6 Cg_endo -50.81 119.3 5.07 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.708 2.272 . . . . 0.0 112.112 178.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -59.23 -1.27 0.18 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.24 -179.597 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -81.49 -39.64 12.1 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.968 -178.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.538 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.54 -147.41 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.668 0.271 . . . . 0.0 111.118 -179.714 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -131.9 170.06 15.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.998 0.428 . . . . 0.0 110.927 -179.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.518 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -75.12 -177.2 3.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.123 -179.331 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.568 ' ND1' HG22 ' A' ' 56' ' ' VAL . 82.1 t60 -130.91 -76.38 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.294 0.569 . . . . 0.0 111.085 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 2.0 tptt -164.64 130.34 2.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.996 -178.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.65 HD13 HG22 ' A' ' 53' ' ' VAL . 2.2 mt -94.13 160.99 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.634 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -127.35 122.54 33.99 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.485 -179.182 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -84.83 74.06 10.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.602 178.311 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.557 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.0 OUTLIER -101.23 136.16 19.74 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.969 -179.6 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.774 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 61.4 Cg_endo -86.43 155.49 9.29 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.793 2.328 . . . . 0.0 112.724 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.735 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.0 mm -124.55 -83.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.614 -177.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.72 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.42 -148.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.355 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -70.45 -33.54 71.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.61 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.39 8.22 0.64 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.606 179.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.72 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mt -91.41 102.02 14.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.876 0.369 . . . . 0.0 110.748 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 87.3 t -93.23 128.89 44.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.94 -178.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.772 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.19 161.01 14.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.071 178.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.2 mp -120.27 119.96 34.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.405 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.535 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 2.0 m120 -89.74 91.4 8.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.305 0.574 . . . . 0.0 110.066 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.782 HG21 HG12 ' A' ' 26' ' ' ILE . 6.1 t -87.5 104.67 14.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.736 -177.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 27.8 mtt -86.54 164.38 16.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.277 178.458 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.576 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.2 m -139.26 136.15 41.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.845 0.355 . . . . 0.0 111.354 -178.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.568 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -95.69 114.94 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.311 179.733 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 4' ' ' VAL . 3.6 m -130.24 148.59 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.694 178.579 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.92 -67.65 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.356 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -80.71 -7.43 59.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.094 0.473 . . . . 0.0 110.64 179.442 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.455 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.66 -147.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.107 179.339 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.5 -165.33 2.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.875 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.13 14.04 29.47 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.523 178.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.9 -2.84 40.32 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.483 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 p -74.08 -3.66 30.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.359 . . . . 0.0 110.265 179.306 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -23.91 27.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.326 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.97 -25.7 58.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.262 -179.223 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.68 -49.3 78.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.635 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.686 ' HG3' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -61.72 -42.05 98.43 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.67 0.748 . . . . 0.0 109.53 176.996 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.686 ' N ' ' HG3' ' A' ' 68' ' ' GLU . 2.3 tm-20 -55.25 -46.62 76.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.821 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.2 p -68.42 -24.32 64.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.231 177.184 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.773 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.53 -30.23 62.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.608 179.901 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 p -63.41 -11.46 23.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.776 179.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.24 26.66 0.99 Allowed Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.832 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -73.33 -166.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.224 -0.488 . . . . 0.0 111.408 -178.606 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.585 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -50.75 92.17 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.096 179.0 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.55 -26.16 64.19 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.476 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.07 -37.88 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.142 0.496 . . . . 0.0 110.114 178.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.58 ' HB2' ' HB3' ' A' ' 75' ' ' GLU . 1.5 m -96.15 89.92 5.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.531 179.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.48 130.0 37.33 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.025 HG21 HG22 ' A' ' 8' ' ' ILE . 3.4 mp -101.35 149.55 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.539 -175.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.525 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.1 tt0 -85.75 71.15 10.72 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.694 HG23 ' HB ' ' A' ' 80' ' ' ILE . 58.3 t -80.26 50.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.031 -174.269 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.87 5.74 3.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.285 178.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.816 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 35.4 t0 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.985 0.421 . . . . 0.0 111.008 -178.451 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.514 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 1.9 t . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 120.575 0.226 . . . . 0.0 110.833 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.43 117.05 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.688 0.28 . . . . 0.0 111.754 -178.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.624 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -98.54 165.69 11.7 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.314 178.055 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.682 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 6.0 m -143.24 132.96 23.81 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.632 0.729 . . . . 0.0 112.407 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.972 HG22 HG21 ' A' ' 80' ' ' ILE . 7.1 mm -126.28 108.12 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.499 -178.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.81 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.25 95.0 7.81 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.011 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.49 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.5 m -92.56 136.83 23.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.663 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -146.3 118.48 4.97 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 121.07 0.462 . . . . 0.0 111.717 179.896 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 21.1 Cg_exo -68.29 121.58 8.56 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.36 2.707 . . . . 0.0 111.822 178.529 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.89 -29.16 64.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.325 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.84 150.37 78.42 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 37.7 Cg_endo -65.88 -7.85 18.02 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.463 2.109 . . . . 0.0 112.075 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -91.81 35.97 0.96 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.502 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -68.17 82.58 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.814 0.816 . . . . 0.0 110.532 -179.378 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.5 m-20 -73.74 99.31 3.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.805 178.038 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.851 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -63.33 -44.11 95.83 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.025 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.806 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 4.4 tp10 -70.03 -36.15 74.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.868 0.366 . . . . 0.0 110.342 -178.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -69.16 -37.96 78.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.381 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.56 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.8 OUTLIER -67.72 -26.67 66.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.971 177.23 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.806 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -56.13 -46.13 79.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.235 179.13 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -41.22 85.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.705 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.725 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 52.9 mt-10 -66.74 -28.63 68.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.426 0.631 . . . . 0.0 110.151 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.831 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.2 mt -63.29 -39.2 84.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.163 178.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.451 ' NE2' HG22 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -60.66 -41.72 95.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.075 -179.85 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.725 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -77.62 -21.32 52.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.937 -178.101 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.831 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.01 -12.43 44.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.061 -179.001 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.697 HG12 ' O ' ' A' ' 26' ' ' ILE . 22.6 mm -60.46 137.53 92.31 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.872 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.619 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 7.0 Cg_endo -47.45 121.5 5.56 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.748 2.298 . . . . 0.0 112.256 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.15 0.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.238 -179.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.0 -62.96 1.78 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.866 -179.023 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.481 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -111.77 -142.01 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.682 0.277 . . . . 0.0 111.183 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -133.39 172.98 11.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.974 0.416 . . . . 0.0 111.069 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.39 -177.65 3.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.329 -178.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.502 ' ND1' HG22 ' A' ' 56' ' ' VAL . 80.0 t60 -131.02 -76.29 0.53 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.062 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 20.2 mmtt -160.21 129.25 4.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.089 -178.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.725 HD13 HG22 ' A' ' 53' ' ' VAL . 1.6 mt -92.0 160.93 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 111.616 -178.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.64 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -129.06 124.47 34.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.64 -178.606 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -85.85 71.93 10.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 0.0 110.653 178.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.533 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -99.22 136.21 20.55 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.593 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.787 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 59.7 Cg_endo -86.99 158.02 8.62 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.565 2.176 . . . . 0.0 112.785 -178.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.687 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.3 mm -126.16 -82.69 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.421 -177.607 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.566 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.41 -151.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.167 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -71.35 -30.22 65.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.668 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.55 5.2 0.51 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.899 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.566 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.1 mt -91.78 103.13 15.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.938 0.399 . . . . 0.0 110.708 179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.787 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 76.0 t -92.92 131.76 39.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.88 -178.381 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.687 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.03 162.29 13.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.831 178.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.851 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.2 mp -120.66 119.7 33.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.333 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.488 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.3 m120 -89.88 91.83 8.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.255 0.55 . . . . 0.0 110.134 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.754 HG21 HG12 ' A' ' 26' ' ' ILE . 12.4 t -86.5 102.3 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.583 -177.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.511 ' HG3' HG23 ' A' ' 7' ' ' THR . 24.8 mtt -84.59 164.46 18.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.169 178.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.624 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.0 m -139.35 135.86 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.456 -178.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.502 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -98.61 115.98 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.211 178.932 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.514 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 2.8 m -130.67 148.14 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.702 178.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.6 -68.06 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.578 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -80.42 -8.51 59.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.059 0.457 . . . . 0.0 110.607 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.481 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.86 -144.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.057 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.52 -167.34 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.815 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.86 16.35 15.8 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.562 178.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.5 -1.36 36.32 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.491 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 p -74.81 -4.23 36.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.874 0.368 . . . . 0.0 110.246 179.228 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -55.05 -23.37 19.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.182 177.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.29 -26.29 60.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.134 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.619 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.92 -55.94 27.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.338 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -58.33 -35.91 72.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.561 178.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -51.55 68.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.427 178.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 12.2 p -63.98 -20.81 66.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.487 179.023 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.549 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.22 -25.94 61.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.602 -179.802 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.01 -17.73 63.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.638 179.124 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.77 30.67 0.92 Allowed Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.05 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.764 HD11 ' HD2' ' A' ' 29' ' ' ARG . 4.3 tt -72.99 -160.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.571 -0.314 . . . . 0.0 111.01 -178.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.642 ' H ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -51.61 94.96 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.035 0.445 . . . . 0.0 110.63 179.77 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.16 -30.85 71.5 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.485 -177.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.5 t -85.02 -33.9 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.943 0.401 . . . . 0.0 110.578 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.617 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 28.1 t -95.77 91.53 6.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.937 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.5 128.84 36.2 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.012 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.972 HG21 HG22 ' A' ' 8' ' ' ILE . 3.4 mp -101.01 149.31 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.423 -174.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.563 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.7 tt0 -85.66 70.41 10.72 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 173.07 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.698 HG23 ' HB ' ' A' ' 80' ' ' ILE . 59.9 t -79.92 50.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.881 -174.393 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.66 6.54 4.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.351 179.272 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.682 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.5 m-20 . . . . . 0 N--CA 1.452 -0.361 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.913 -178.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.562 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.646 0.26 . . . . 0.0 110.609 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 78.9 t -119.85 122.52 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.49 -179.063 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.589 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.37 168.39 10.75 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.777 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 5.7 m -143.17 133.6 24.8 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.595 0.712 . . . . 0.0 112.235 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.989 HG22 HG21 ' A' ' 80' ' ' ILE . 3.8 mm -126.52 106.51 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.24 -178.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.813 ' C ' HG23 ' A' ' 80' ' ' ILE . 2.5 mmmt -96.21 96.02 8.52 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -176.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.499 HG12 HG12 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -94.23 135.71 27.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -177.537 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.671 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.77 117.97 4.35 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 120.993 0.425 . . . . 0.0 111.414 178.97 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.3 Cg_exo -69.72 120.44 7.23 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.253 2.636 . . . . 0.0 111.964 178.515 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -57.61 -29.06 64.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.068 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.55 150.57 79.52 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.882 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 38.4 Cg_endo -66.34 -8.29 20.14 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.432 2.088 . . . . 0.0 112.063 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.92 36.51 0.97 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.634 179.313 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.8 86.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.811 0.815 . . . . 0.0 110.196 -179.87 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 55.9 m-20 -69.43 104.92 2.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.213 179.259 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.589 HD21 ' HG2' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -60.74 -52.52 64.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.548 -178.341 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.794 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 9.9 pt-20 -71.03 -34.51 71.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.257 -177.716 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.528 ' HB3' ' CB ' ' A' ' 18' ' ' ASP . . . -68.0 -35.7 78.76 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.443 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.592 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.3 OUTLIER -66.03 -33.61 76.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.423 176.463 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.794 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -55.91 -46.38 78.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.112 178.529 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -66.14 -43.65 86.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.72 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.772 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 5.1 mm-40 -66.12 -28.06 68.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.404 0.621 . . . . 0.0 110.576 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.878 HG12 HG21 ' A' ' 53' ' ' VAL . 1.1 mt -61.8 -46.54 96.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.267 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.739 ' NE2' HD22 ' A' ' 36' ' ' LEU . 5.9 mm100 -63.9 -35.32 80.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.297 -178.053 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.772 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.6 OUTLIER -76.63 -21.55 55.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.821 179.953 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.978 ' HD2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.25 -15.12 31.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.793 179.249 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 26' ' ' ILE . 15.8 mm -58.93 138.28 87.37 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.97 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.511 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.3 Cg_endo -50.27 117.23 3.0 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.884 2.389 . . . . 0.0 112.309 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -58.84 -2.07 0.21 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.182 -179.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.79 -57.52 2.54 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.794 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.59 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -109.76 -142.62 0.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.694 0.283 . . . . 0.0 111.064 -179.588 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -135.65 170.0 16.65 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.929 0.395 . . . . 0.0 110.761 -179.411 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.739 HD22 ' NE2' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -75.3 -178.31 3.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.062 -179.333 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.544 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.5 t60 -130.85 -77.01 0.53 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.41 0.624 . . . . 0.0 110.926 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -164.83 130.87 2.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.791 -178.893 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.686 HG12 HG13 ' A' ' 53' ' ' VAL . 2.7 mt -92.67 157.92 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.039 0.447 . . . . 0.0 112.098 -177.097 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.631 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -124.75 117.32 23.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.379 -179.106 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.589 ' HG2' HD21 ' A' ' 19' ' ' LEU . 1.4 mt-10 -82.8 70.91 9.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.952 0.406 . . . . 0.0 110.514 178.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.545 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.7 mt-10 -95.66 135.84 22.77 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.356 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.772 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 56.7 Cg_endo -86.21 156.73 9.68 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.433 2.089 . . . . 0.0 112.933 -178.039 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.753 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.8 mm -125.53 -82.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.451 -177.168 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.603 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.22 -150.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.006 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -72.04 -30.52 65.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.848 0.356 . . . . 0.0 110.69 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.28 4.97 0.53 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.804 179.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.603 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.5 mt -91.31 102.88 15.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.893 0.377 . . . . 0.0 110.732 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 75.7 t -93.3 131.29 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.059 -177.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.753 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.08 150.72 20.18 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.719 177.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -113.84 117.91 32.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.358 179.6 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.45 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 6.8 m-20 -89.87 92.83 9.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.223 -178.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.878 HG21 HG12 ' A' ' 26' ' ' ILE . 5.1 t -86.85 102.11 11.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.624 -177.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.742 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.54 163.59 19.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.054 178.253 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.5 m -138.21 136.9 44.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.765 0.317 . . . . 0.0 111.367 -178.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.544 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -94.63 116.38 35.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.086 179.559 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.59 HG12 HG21 ' A' ' 34' ' ' THR . 6.2 m -130.27 148.36 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.966 179.272 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.64 -72.79 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.419 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.66 -2.7 51.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 110.789 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.547 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.31 -150.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.303 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.58 -165.19 2.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.792 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.16 14.72 26.25 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.619 178.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.12 -3.33 44.56 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.495 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -74.42 -3.2 29.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.941 0.401 . . . . 0.0 110.274 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -25.04 24.66 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.691 177.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.43 -25.16 59.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.953 -179.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -62.4 -55.25 29.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 110.073 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.55 ' HA ' HD12 ' A' ' 71' ' ' LEU . 58.5 mt-10 -58.6 -33.55 70.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.286 178.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -62.51 -52.59 62.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.256 178.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.65 -16.62 61.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.117 178.308 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.028 HD11 HG11 ' A' ' 82' ' ' VAL . 1.3 mt -73.38 -33.11 64.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.49 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.75 -10.29 18.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.792 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.08 28.6 1.0 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 178.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.978 HD11 ' HD2' ' A' ' 29' ' ' ARG . 7.3 tt -73.56 -166.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.834 -0.683 . . . . 0.0 111.269 -178.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.681 ' H ' HG12 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -52.01 101.39 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.986 0.422 . . . . 0.0 111.042 -179.658 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.52 -32.42 83.27 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.812 -179.004 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -86.44 -36.38 10.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.421 . . . . 0.0 110.242 179.377 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.636 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 10.3 t -95.67 92.39 6.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.462 179.332 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.595 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.32 130.74 37.56 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.325 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.989 HG21 HG22 ' A' ' 8' ' ' ILE . 2.7 mp -101.4 148.73 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.413 -175.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.559 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.2 tp10 -85.65 70.25 10.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 173.105 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 1.028 HG11 HD11 ' A' ' 71' ' ' LEU . 55.2 t -79.7 44.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.055 -174.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -132.32 9.84 4.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.522 177.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.777 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 34.5 t0 . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.828 0.346 . . . . 0.0 110.869 -178.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.579 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.659 0.266 . . . . 0.0 111.381 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 84.8 t -113.43 114.16 46.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.271 179.218 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.596 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -93.1 168.23 11.26 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.731 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.78 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 11.2 m -142.56 132.42 24.21 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.585 0.707 . . . . 0.0 112.505 -179.231 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.074 HG22 HG21 ' A' ' 80' ' ' ILE . 3.8 mm -120.61 105.24 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.276 -179.426 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.823 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -93.56 93.82 8.29 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.941 0.401 . . . . 0.0 112.009 -177.657 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.558 HG12 HG12 ' A' ' 80' ' ' ILE . 1.2 m -92.96 136.28 25.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.036 -177.211 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.728 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -147.7 119.27 4.54 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 121.265 0.555 . . . . 0.0 111.508 178.712 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.1 Cg_exo -68.38 120.86 7.79 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.13 2.553 . . . . 0.0 111.622 178.688 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.93 -29.11 62.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.271 -179.222 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.476 ' O ' HG12 ' A' ' 17' ' ' VAL . 1.3 p -77.78 153.25 80.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.127 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.549 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 51.3 Cg_endo -68.54 -7.21 19.68 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.178 1.919 . . . . 0.0 111.31 178.144 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.47 34.49 0.88 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.282 178.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -68.24 81.78 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.889 0.852 . . . . 0.0 110.523 -179.363 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -74.05 97.96 2.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.897 177.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.884 HD13 ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.53 -38.49 91.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.398 -178.473 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.884 ' H ' HD13 ' A' ' 19' ' ' LEU . 2.7 tp10 -69.11 -38.69 79.05 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -70.59 -38.24 73.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.414 0.626 . . . . 0.0 109.713 176.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.1 mt -68.08 -28.98 67.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.082 178.095 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -46.66 80.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.032 -179.59 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -68.94 -40.91 78.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.186 0.517 . . . . 0.0 110.387 179.319 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.44 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 6.1 mm-40 -65.32 -28.05 69.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.359 179.524 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.538 HG12 HG21 ' A' ' 53' ' ' VAL . 2.1 mt -62.65 -45.66 98.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.106 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -34.67 72.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.654 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -75.02 -22.47 58.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.466 -179.378 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.806 ' HB2' HD11 ' A' ' 74' ' ' ILE . 1.9 ptp180 -88.55 -15.21 35.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.504 -178.697 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.466 HG23 ' HD2' ' A' ' 31' ' ' PRO . 43.5 mm -58.07 137.57 84.07 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.568 179.132 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.587 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 18.6 Cg_endo -58.05 130.71 39.46 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.506 2.137 . . . . 0.0 112.837 -179.501 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.32 0.12 0.31 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.0 179.49 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -81.98 -60.88 2.1 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.566 -178.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.496 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -113.96 -143.69 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.707 0.289 . . . . 0.0 111.08 -179.867 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -135.73 167.63 20.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.775 -179.671 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.8 pt? -75.16 -176.16 2.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.04 -179.469 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.579 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.8 t60 -130.64 -77.43 0.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.374 0.606 . . . . 0.0 111.4 -178.195 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.54 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER -163.98 129.42 2.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.656 -178.417 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.687 HD13 HG22 ' A' ' 53' ' ' VAL . 2.5 mt -91.15 155.66 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.07 0.462 . . . . 0.0 112.145 -176.632 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.658 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -121.9 118.77 29.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.367 -179.025 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -82.19 71.71 9.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.055 0.455 . . . . 0.0 110.183 178.187 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.544 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.2 mt-10 -96.46 135.06 22.63 Favored Pre-proline 0 C--O 1.224 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.607 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.785 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 52.8 Cg_endo -86.07 156.24 9.84 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.513 2.142 . . . . 0.0 112.796 -178.925 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.7 mm -125.83 -83.32 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.543 -177.447 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.684 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.37 -151.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 -179.861 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -71.91 -29.49 64.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.606 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.63 4.79 0.49 Allowed Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.932 179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.684 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mt -91.72 102.54 15.16 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.856 0.36 . . . . 0.0 110.787 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.785 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 69.6 t -93.7 129.62 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.913 -178.462 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.758 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.64 150.04 20.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.025 178.116 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.658 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -113.09 119.38 37.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.245 179.054 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 1.5 m120 -89.81 94.43 9.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.522 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.687 HG22 HD13 ' A' ' 39' ' ' ILE . 5.5 t -86.21 102.93 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.342 -178.663 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.677 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.69 167.73 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.455 179.208 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 6' ' ' ALA . 4.2 m -139.28 135.01 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.449 -178.251 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.579 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -95.7 113.89 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.824 178.843 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 4' ' ' VAL . 2.9 m -129.52 154.98 40.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.841 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.43 -68.07 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.195 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.63 -6.35 58.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.108 0.48 . . . . 0.0 110.366 179.027 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.496 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.82 -151.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.125 179.443 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.421 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -150.27 -159.12 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.856 -179.956 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.421 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -80.41 12.47 32.87 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.44 178.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.96 -8.0 60.36 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.43 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.27 -3.36 29.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.983 0.42 . . . . 0.0 110.087 179.006 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -54.71 -24.07 20.42 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.99 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.25 -27.26 61.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.897 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.587 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.23 -56.92 15.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.364 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -58.89 -34.97 72.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.405 178.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -51.23 70.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.383 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 t -63.7 -19.77 65.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.48 178.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.762 HD22 HD13 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -72.83 -28.39 62.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.651 179.957 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.82 -14.23 51.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.766 179.157 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.26 28.69 0.98 Allowed Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -73.41 -163.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.293 -0.453 . . . . 0.0 111.282 -178.698 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.7 OUTLIER -50.21 98.67 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.943 0.401 . . . . 0.0 110.918 179.513 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.62 -32.46 84.27 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.21 -178.302 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -85.66 -36.48 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.055 0.455 . . . . 0.0 110.205 179.606 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 42.4 t -95.64 90.08 5.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.455 179.225 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.586 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.17 133.34 38.97 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.1 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.074 HG21 HG22 ' A' ' 8' ' ' ILE . 2.2 mt -101.65 149.3 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.863 -175.485 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.531 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 5.3 tp10 -86.1 71.52 10.55 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 172.406 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.69 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.2 t -80.35 50.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.104 -174.216 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.92 5.96 3.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.349 178.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.78 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 46.9 t0 . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.984 0.421 . . . . 0.0 111.3 -178.147 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.624 0.25 . . . . 0.0 110.615 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.1 t -128.48 116.41 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.73 179.787 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.44 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -96.37 166.3 11.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.28 178.897 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.683 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 25.6 m -142.05 132.6 25.31 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.569 0.7 . . . . 0.0 111.779 179.768 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.06 HG22 HG21 ' A' ' 80' ' ' ILE . 1.8 mm -120.46 106.46 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.615 -178.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.816 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -95.24 93.36 7.25 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -177.573 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.458 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -92.38 135.93 26.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.729 -177.667 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.823 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -147.5 114.79 4.14 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 121.389 0.614 . . . . 0.0 111.974 179.801 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 35.5 Cg_exo -63.39 124.64 14.14 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.153 2.569 . . . . 0.0 112.055 178.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -57.52 -30.78 65.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.378 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.32 150.81 77.49 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.205 -179.304 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.565 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 40.9 Cg_endo -66.67 -6.29 15.09 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.38 2.053 . . . . 0.0 111.89 179.211 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -92.01 32.7 1.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.586 179.211 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -66.82 85.82 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.65 0.738 . . . . 0.0 110.064 179.929 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.572 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 12.1 m-20 -70.76 104.21 2.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.278 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.906 HD12 HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -61.67 -49.56 76.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.237 -178.666 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.662 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 2.5 tp10 -70.11 -35.48 74.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.111 -178.163 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.629 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -69.06 -35.93 77.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.294 0.569 . . . . 0.0 109.809 177.548 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -66.54 -27.56 67.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.038 177.831 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.662 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -56.33 -46.72 79.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.44 179.051 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.629 ' HE2' ' HA ' ' A' ' 21' ' ' ALA . 1.2 mtmm -65.64 -41.86 92.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.847 179.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.716 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 33.3 mt-10 -66.71 -31.14 71.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.431 0.634 . . . . 0.0 110.356 179.526 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.815 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 3.2 mt -62.91 -41.62 93.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.93 179.757 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -62.64 -39.13 92.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.158 -179.222 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.716 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -78.0 -21.02 51.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.669 -178.499 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.943 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.51 -12.11 43.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.273 -178.955 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.708 HG13 HD23 ' A' ' 36' ' ' LEU . 28.5 mm -61.0 138.09 94.09 Favored Pre-proline 0 N--CA 1.463 0.2 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.089 179.626 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.546 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.5 Cg_endo -51.19 125.26 15.9 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.744 2.296 . . . . 0.0 112.478 179.211 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -60.72 -2.86 0.6 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.039 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.22 -62.34 1.82 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.896 -178.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.675 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -111.01 -143.67 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.692 0.282 . . . . 0.0 111.152 -179.462 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -133.93 172.57 12.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.941 0.401 . . . . 0.0 110.823 -179.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.708 HD23 HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -74.43 -177.05 2.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.667 -179.811 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.627 ' ND1' HG22 ' A' ' 56' ' ' VAL . 66.5 t60 -131.3 -73.58 0.53 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.146 0.498 . . . . 0.0 111.059 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 29.1 mmtm -161.46 127.55 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.417 -178.733 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.67 HD13 HG22 ' A' ' 53' ' ' VAL . 2.9 mt -93.55 154.34 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.817 -178.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.643 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.2 m-20 -119.36 124.22 46.07 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.317 -178.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -89.17 66.5 7.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.96 0.41 . . . . 0.0 110.083 177.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.659 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.96 147.86 34.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.702 -178.035 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.77 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 35.1 Cg_endo -91.79 158.43 3.44 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.016 2.477 . . . . 0.0 112.861 -178.32 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.734 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.0 mm -127.59 -82.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.334 -178.177 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.689 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.15 -150.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.988 179.728 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -71.88 -27.46 62.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.737 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.28 7.89 0.3 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.157 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.689 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.0 mt -92.39 105.41 17.6 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.784 0.326 . . . . 0.0 110.885 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.77 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 25.6 t -92.92 128.07 44.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.886 -178.477 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.823 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.07 148.94 21.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.275 179.163 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.906 HD21 HD12 ' A' ' 19' ' ' LEU . 11.1 mp -106.48 114.74 29.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.019 177.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.598 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 3.9 m-20 -89.28 92.31 9.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.231 0.539 . . . . 0.0 109.938 -179.422 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.678 HG21 HG12 ' A' ' 26' ' ' ILE . 11.3 t -85.79 106.35 15.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.625 -177.292 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.552 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 37.4 mtt -85.24 164.15 18.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.078 178.499 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.6 m -140.71 136.77 35.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.31 -178.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.627 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -94.46 111.95 26.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.715 178.738 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.437 HG12 ' OG1' ' A' ' 34' ' ' THR . 34.3 m -130.21 143.58 40.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.095 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.42 -64.51 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.314 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.75 -8.29 59.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 110.495 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.675 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.59 -146.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.248 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -147.69 -163.12 1.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.783 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 65' ' ' GLU . . . -80.45 12.2 34.51 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.559 178.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.11 -9.05 62.83 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.507 179.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -74.57 -5.15 41.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.861 0.362 . . . . 0.0 110.29 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 3.7 pt-20 -54.94 -24.09 22.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.405 0.621 . . . . 0.0 110.11 177.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.04 -28.21 62.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.969 -179.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.546 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.67 -56.4 21.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.271 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -59.37 -35.02 73.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.469 178.447 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -50.91 70.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.415 178.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.447 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 5.1 t -64.65 -20.32 66.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.56 178.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.616 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -72.69 -28.31 62.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.71 -179.678 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -15.61 58.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.793 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.37 29.2 0.97 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.791 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.943 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -73.5 -161.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.451 -0.374 . . . . 0.0 111.142 -178.933 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.604 ' N ' HG23 ' A' ' 74' ' ' ILE . 2.7 pm0 -51.6 91.45 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 121.063 0.459 . . . . 0.0 110.749 179.358 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.17 -24.05 62.75 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.833 -0.621 . . . . 0.0 113.04 -178.334 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.58 -36.64 10.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.234 0.54 . . . . 0.0 110.381 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.575 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 4.2 t -95.88 93.01 6.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.592 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.61 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -75.94 131.0 39.34 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.438 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.06 HG21 HG22 ' A' ' 8' ' ' ILE . 3.5 mp -101.19 148.1 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.559 -174.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.773 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -85.87 71.4 10.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 173.256 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.7 HG23 ' HB ' ' A' ' 80' ' ' ILE . 58.6 t -80.71 52.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.076 -174.302 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 m -133.32 5.73 3.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.902 179.426 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.683 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.1 m-20 . . . . . 0 N--CA 1.456 -0.158 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.379 -177.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.713 ' HB ' HG22 ' A' ' 57' ' ' VAL . 2.9 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.561 0.22 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 84.7 t -104.8 107.58 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.268 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.514 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -97.12 141.04 30.74 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 177.753 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.805 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 16.2 m -122.49 133.03 54.6 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.749 0.785 . . . . 0.0 112.251 -178.229 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.05 HG22 HG21 ' A' ' 80' ' ' ILE . 5.6 mm -123.99 109.17 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.677 -178.173 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.801 ' C ' HG23 ' A' ' 80' ' ' ILE . 2.1 mmmt -99.57 95.61 7.1 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -177.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.642 HG11 ' HE ' ' A' ' 29' ' ' ARG . 1.4 m -93.32 136.73 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.533 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.699 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.4 OUTLIER -147.78 120.57 4.7 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 121.17 0.509 . . . . 0.0 111.72 178.751 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 20.6 Cg_exo -69.78 121.75 8.43 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.366 2.711 . . . . 0.0 112.143 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -30.58 64.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.207 -179.674 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.9 m -77.97 148.94 76.18 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.999 -179.732 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 38.1 Cg_endo -65.57 -6.79 14.5 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.416 2.077 . . . . 0.0 111.881 179.423 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -91.59 35.42 0.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.518 179.111 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.46 87.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.817 0.818 . . . . 0.0 110.184 -179.797 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.653 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -67.69 105.28 1.86 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.926 178.824 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.662 HD12 ' HE2' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -60.65 -54.25 47.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.748 -177.96 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.658 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -70.85 -34.23 71.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.133 -177.43 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -68.74 -35.6 77.31 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.305 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.562 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -64.96 -35.53 81.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.138 176.524 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.662 ' HE2' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -55.44 -49.08 73.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.252 178.201 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -39.34 85.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.092 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.695 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 2.9 mt-10 -66.51 -32.34 73.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.383 0.611 . . . . 0.0 110.166 179.099 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.743 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -63.55 -38.47 82.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.925 178.565 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -43.27 92.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.108 -179.72 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.695 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -78.06 -21.37 50.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.755 -178.575 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.753 HH22 ' HB ' ' A' ' 8' ' ' ILE . 18.9 ptt85 -89.06 -8.65 53.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.411 -178.488 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 26' ' ' ILE . 19.8 mm -60.11 137.55 91.21 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.966 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.635 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.1 Cg_endo -48.75 117.65 2.87 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.897 2.398 . . . . 0.0 112.206 178.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.47 1.09 0.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.391 -179.395 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.51 -63.95 1.73 Allowed Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.752 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.411 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -110.24 -134.05 0.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.628 0.251 . . . . 0.0 111.086 -179.531 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -138.62 171.06 14.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.931 0.396 . . . . 0.0 110.669 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -177.57 3.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.018 -179.447 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.517 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 86.3 t60 -131.01 -73.31 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.322 0.582 . . . . 0.0 111.081 -179.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.509 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -163.46 126.64 2.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.046 -178.433 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.723 HG23 HG22 ' A' ' 53' ' ' VAL . 2.9 mt -94.13 157.04 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.161 -177.342 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.631 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 77.4 m-20 -122.62 124.17 42.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.384 -179.206 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.94 66.3 6.86 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.364 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.651 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -98.23 147.12 32.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.538 -177.539 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.766 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.6 Cg_endo -89.63 159.5 5.27 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.12 2.547 . . . . 0.0 113.211 -177.718 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.746 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.9 mm -129.03 -82.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.169 -178.121 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.577 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.07 -153.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.844 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -72.04 -24.65 61.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.51 3.74 0.25 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.285 179.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.577 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.3 mt -92.32 106.95 18.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.021 0.41 . . . . 0.0 111.045 -179.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.766 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 52.8 t -94.28 130.37 43.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.95 -178.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.746 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.46 162.01 13.83 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.567 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.4 OUTLIER -116.05 113.77 23.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.283 179.501 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.6 m120 -90.04 90.32 8.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.286 0.565 . . . . 0.0 110.011 178.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.723 HG22 HG23 ' A' ' 39' ' ' ILE . 5.5 t -88.63 102.17 12.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.809 -177.716 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.495 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 14.3 mtt -86.36 163.57 17.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.066 178.183 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 4.2 m -137.01 127.44 39.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.923 0.392 . . . . 0.0 111.216 -178.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.517 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 1.1 p -98.15 111.86 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 179.603 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.713 HG22 ' HB ' ' A' ' 4' ' ' VAL . 1.2 m -127.4 169.9 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.965 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.89 -69.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.467 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -80.92 0.24 36.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.969 0.414 . . . . 0.0 110.6 179.585 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.411 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.5 -154.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.272 179.722 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.65 -161.29 1.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.865 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.87 13.56 30.2 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.477 178.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.52 -9.1 61.02 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.541 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -74.23 -4.0 33.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.04 0.448 . . . . 0.0 110.157 179.12 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -55.39 -23.37 24.24 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.072 177.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.86 -27.04 49.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.919 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.635 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.5 -56.32 21.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.401 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -58.42 -34.58 70.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.541 178.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.25 -51.76 66.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.397 178.471 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.423 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -63.42 -17.85 63.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.318 179.013 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.586 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.39 -30.56 63.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.652 179.71 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -11.47 35.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.93 179.452 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.38 26.13 0.97 Allowed Glycine 0 N--CA 1.453 -0.198 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.724 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -73.28 -164.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.459 -0.371 . . . . 0.0 111.012 -179.27 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.639 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.8 OUTLIER -51.73 96.81 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.775 0.322 . . . . 0.0 111.106 179.586 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.33 -23.07 61.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.079 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.6 p -89.42 -40.0 12.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.036 0.446 . . . . 0.0 110.648 179.323 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.639 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 8.5 t -95.51 92.19 6.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.519 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.575 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -76.82 132.53 39.25 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.311 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.05 HG21 HG22 ' A' ' 8' ' ' ILE . 3.6 mp -101.15 149.68 6.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.447 -175.333 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.432 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 6.8 tt0 -85.78 69.56 10.6 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.331 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.694 HG23 ' HB ' ' A' ' 80' ' ' ILE . 54.5 t -80.87 55.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.805 -175.096 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -132.51 -1.37 3.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.61 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.805 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 11.4 t0 . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.738 -178.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.847 HG12 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 22.3 t -109.17 119.12 58.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.705 0.288 . . . . 0.0 111.484 -178.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.529 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.02 145.36 25.0 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.463 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.799 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 10.0 m -122.73 133.72 54.48 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.608 0.718 . . . . 0.0 112.427 -177.566 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.987 HG22 HG21 ' A' ' 80' ' ' ILE . 4.5 mm -123.01 104.68 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.386 -179.475 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.77 ' HB2' ' HG3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -95.94 98.18 10.2 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -177.217 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.79 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.5 m -96.18 138.4 21.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.82 -177.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.793 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 2.1 ptm -147.25 121.22 5.01 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-O 121.182 0.515 . . . . 0.0 111.878 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 22.8 Cg_exo -68.02 126.93 15.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.362 2.708 . . . . 0.0 112.173 179.116 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -32.2 68.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.454 -179.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.7 m -77.42 146.88 74.68 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.53 -6.93 13.02 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.402 2.068 . . . . 0.0 111.801 179.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -92.3 38.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.073 178.556 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.724 HG11 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -68.03 85.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 122.013 0.911 . . . . 0.0 110.712 -178.52 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.579 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 17.1 m-20 -73.07 96.63 2.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.056 177.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -63.77 -41.36 97.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.637 -178.362 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.899 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 5.5 tp10 -69.8 -36.23 75.5 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.872 0.368 . . . . 0.0 110.371 -179.058 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -69.81 -37.43 76.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.452 0.644 . . . . 0.0 109.309 176.272 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -68.18 -25.81 65.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.064 177.164 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.899 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -56.31 -44.14 79.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.193 179.627 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -44.81 83.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.451 178.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.594 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 40.8 mt-10 -65.09 -28.18 69.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.466 0.65 . . . . 0.0 110.44 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.812 HG12 HG21 ' A' ' 53' ' ' VAL . 1.7 mt -60.21 -49.62 83.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.403 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.525 ' OE1' HD22 ' A' ' 36' ' ' LEU . 6.9 mm-40 -64.92 -32.95 74.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.476 -178.233 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 11.5 pt-20 -76.74 -21.27 55.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 110.751 179.617 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.95 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.55 -12.06 38.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.013 179.914 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.582 HG12 ' O ' ' A' ' 26' ' ' ILE . 27.2 mm -58.94 138.42 87.42 Favored Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.256 179.684 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.62 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 11.0 Cg_endo -52.82 118.23 4.54 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.898 2.399 . . . . 0.0 112.433 178.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -59.67 1.21 0.1 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.321 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.04 -43.73 7.43 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.181 -178.441 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.574 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.32 -139.75 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.621 0.248 . . . . 0.0 111.192 -178.868 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -133.55 168.58 18.4 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.947 0.403 . . . . 0.0 111.255 -178.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.525 HD22 ' OE1' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -75.91 -178.79 4.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.274 -179.299 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.693 ' ND1' HG22 ' A' ' 56' ' ' VAL . 59.1 t60 -131.4 -77.47 0.52 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.176 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.452 ' HB2' ' HD2' ' A' ' 37' ' ' HIS . 30.7 mmtm -162.0 133.02 5.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.205 -179.035 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.631 HG12 HG13 ' A' ' 53' ' ' VAL . 2.7 mt -93.97 158.25 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.021 0.439 . . . . 0.0 112.108 -178.009 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.713 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 2.6 m-20 -122.77 120.77 34.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.122 -179.498 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.45 67.77 10.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.866 0.365 . . . . 0.0 110.057 178.698 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.673 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.2 148.81 35.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.671 -177.889 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.769 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 50.4 Cg_endo -94.34 159.12 2.03 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.117 2.545 . . . . 0.0 113.347 -177.553 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.757 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.0 mm -128.9 -81.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.997 -178.707 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -67.73 -149.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.196 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -72.23 -30.14 64.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.875 0.369 . . . . 0.0 110.615 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.7 6.26 0.54 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.621 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.724 ' HA ' HG11 ' A' ' 17' ' ' VAL . 9.6 mp -89.25 101.07 13.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.912 0.387 . . . . 0.0 110.854 -179.271 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.769 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 11.3 t -91.97 127.83 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.129 -177.659 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.793 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.35 144.35 25.97 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.829 177.695 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.713 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -106.07 116.9 32.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.419 178.836 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.626 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -89.58 93.42 9.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.178 -178.893 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.812 HG21 HG12 ' A' ' 26' ' ' ILE . 5.7 t -85.98 106.19 15.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.527 -178.187 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.468 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 34.9 mtt -84.53 162.92 19.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.136 178.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.9 m -140.13 141.24 33.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.087 -178.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.693 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.3 t -91.04 101.51 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.491 179.096 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.847 HG23 HG12 ' A' ' 4' ' ' VAL . 29.7 m -129.99 140.9 47.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.068 0.461 . . . . 0.0 111.597 -179.14 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.42 -60.66 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.334 178.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -81.73 -7.56 59.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 0.0 110.429 179.099 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.574 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.4 -143.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.163 179.52 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -147.29 -165.27 2.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.803 -179.848 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.61 12.87 32.0 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.653 179.041 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.85 -6.84 57.53 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.44 179.621 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -74.44 -3.89 33.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 110.228 179.248 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -54.63 -24.08 19.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.114 177.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.79 -29.24 62.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.103 -179.465 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.61 -55.14 33.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.381 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.1 -34.95 72.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.357 178.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.86 -50.36 72.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.336 178.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 t -62.94 -18.28 62.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.349 178.608 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.726 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.37 -29.37 61.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.487 179.505 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -11.62 36.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.598 178.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.1 27.57 1.0 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.429 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.95 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -72.78 -166.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.366 -0.417 . . . . 0.0 111.099 -179.008 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.674 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 2.3 mm-40 -50.96 97.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.941 0.401 . . . . 0.0 110.81 179.222 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.71 -27.06 61.02 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.369 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.564 HG12 ' OE1' ' A' ' 75' ' ' GLU . 1.2 p -89.22 -38.21 10.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.977 0.418 . . . . 0.0 110.741 179.579 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.674 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 30.7 t -96.14 93.05 6.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.814 -179.712 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.437 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -76.52 130.88 38.55 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.161 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.987 HG21 HG22 ' A' ' 8' ' ' ILE . 5.2 mt -100.23 140.9 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.666 -176.094 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.77 ' HG3' ' HB2' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -84.86 74.04 10.55 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 174.648 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.728 HG23 ' HB ' ' A' ' 80' ' ' ILE . 86.5 t -81.55 51.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.187 -173.341 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.8 6.99 4.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.505 179.264 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.799 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 38.3 t0 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.807 0.337 . . . . 0.0 111.082 -178.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.525 ' HB ' HG22 ' A' ' 57' ' ' VAL . 2.6 t . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.566 0.222 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 14.2 t -106.15 108.76 25.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.053 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.659 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.01 165.12 12.6 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.013 177.898 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.739 HG23 ' HG3' ' A' ' 54' ' ' MET . 7.8 m -142.14 129.04 20.65 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.762 0.792 . . . . 0.0 112.276 179.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 1.035 HG22 HG21 ' A' ' 80' ' ' ILE . 3.1 mm -120.72 105.61 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.249 -179.445 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.797 ' C ' HG23 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -94.12 93.64 7.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -177.218 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.49 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.7 m -93.63 138.85 19.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.839 -177.258 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.8 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 2.6 ptm -146.19 123.27 5.97 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.27 179.374 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.566 ' CD ' HG13 ' A' ' 17' ' ' VAL . 18.6 Cg_exo -67.68 125.96 14.03 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.064 2.509 . . . . 0.0 112.217 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.35 -32.48 66.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.276 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.5 m -77.71 150.13 78.5 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.03 -179.55 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -67.97 -4.62 12.81 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.486 2.124 . . . . 0.0 111.774 178.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -91.6 45.91 1.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.747 178.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.566 HG13 ' CD ' ' A' ' 12' ' ' PRO . 69.8 t -63.96 78.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.505 -178.189 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.567 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -71.32 93.87 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.263 177.957 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.557 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -64.35 -41.53 96.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.622 0.249 . . . . 0.0 111.134 -179.333 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.557 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 4.6 tp10 -68.05 -38.17 82.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.22 -178.404 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.572 ' O ' ' HE2' ' A' ' 24' ' ' LYS . . . -70.92 -38.51 72.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.285 0.564 . . . . 0.0 110.112 177.541 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.972 HD23 ' HG2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -65.86 -28.07 68.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.213 178.411 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -58.89 -46.57 87.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.922 -179.718 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.572 ' HE2' ' O ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -63.92 -41.02 97.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.683 -179.598 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.972 ' HG2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.07 -38.35 90.5 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.731 0.776 . . . . 0.0 110.012 179.756 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.854 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 4.2 mt -58.84 -40.88 81.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.838 -176.809 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -62.6 -37.02 84.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.461 . . . . 0.0 110.178 178.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 3.2 mm-40 -76.05 -23.72 55.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.628 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.854 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.73 -11.92 43.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.663 -178.198 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 26' ' ' ILE . 24.8 mm -58.11 136.6 84.35 Favored Pre-proline 0 C--N 1.333 -0.138 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.503 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 1.3 Cg_endo -45.13 122.59 4.53 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.88 2.387 . . . . 0.0 112.134 179.186 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.448 ' H ' ' HB3' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -56.96 -6.0 0.3 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.131 -178.936 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.55 -58.02 2.48 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.575 -179.589 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.44 -146.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.666 0.27 . . . . 0.0 111.001 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -136.78 175.82 9.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 110.881 -179.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.29 -175.47 2.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.423 -178.798 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.541 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 85.0 t60 -130.94 -72.12 0.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.755 -179.544 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.518 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -163.83 128.54 2.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.986 -178.92 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.705 HD13 HG22 ' A' ' 53' ' ' VAL . 2.9 mt -93.56 155.13 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.17 -177.104 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.699 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.2 t0 -119.43 121.6 39.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.046 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -86.28 67.77 10.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.931 0.396 . . . . 0.0 110.174 178.835 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.694 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -98.34 148.89 35.14 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.621 -177.887 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.76 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 31.6 Cg_endo -93.47 157.86 2.46 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.052 2.501 . . . . 0.0 113.443 -177.269 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.745 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.5 mm -128.42 -82.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.024 -178.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -67.64 -149.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -71.47 -31.85 67.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.609 179.646 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.34 7.39 0.62 Allowed Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.413 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 8.8 mp -90.17 100.08 12.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.985 0.421 . . . . 0.0 110.799 -179.626 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.76 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 17.7 t -91.43 127.88 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.928 -177.765 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.8 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.16 143.85 26.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.135 178.415 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.699 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.6 OUTLIER -104.92 117.69 34.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.201 178.507 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.578 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.7 m120 -89.41 93.0 9.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.141 -178.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.705 HG22 HD13 ' A' ' 39' ' ' ILE . 10.9 t -85.9 102.63 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.67 -177.721 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.739 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.1 OUTLIER -84.76 166.1 17.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.18 178.517 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.659 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.9 m -138.89 126.53 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.055 0.455 . . . . 0.0 111.231 -179.059 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.541 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -97.72 107.49 20.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.836 179.363 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.525 HG22 ' HB ' ' A' ' 4' ' ' VAL . 1.6 m -123.66 171.79 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.568 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.04 -73.45 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.839 179.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -80.35 2.49 24.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.9 0.381 . . . . 0.0 110.795 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.14 -151.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.97 179.339 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.56 -161.9 1.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.807 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.58 12.32 34.76 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.488 178.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.07 -7.64 60.0 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.362 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 p -74.3 -5.35 41.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 110.239 179.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -23.91 22.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.227 177.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.448 ' HB3' ' H ' ' A' ' 32' ' ' GLU . . . -56.97 -26.37 59.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.136 -179.401 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.91 -56.63 18.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.267 179.49 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.92 -34.63 71.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.573 178.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -51.55 68.43 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.444 178.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.465 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 7.6 p -64.17 -20.42 65.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.649 179.005 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.6 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.34 -27.11 62.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.623 -179.727 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.1 -16.23 61.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.805 179.435 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.53 29.34 0.95 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.728 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.821 HD11 ' HD2' ' A' ' 29' ' ' ARG . 1.7 tt -73.38 -162.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.524 -0.338 . . . . 0.0 111.213 -178.704 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.629 ' HG3' ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -51.39 90.21 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.084 0.468 . . . . 0.0 110.745 179.257 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.32 -24.71 67.72 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.927 -178.282 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -85.69 -35.92 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.408 0.623 . . . . 0.0 109.985 179.1 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.629 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 1.4 m -96.0 90.52 5.6 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.405 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.611 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -74.8 129.85 38.42 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.692 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 1.035 HG21 HG22 ' A' ' 8' ' ' ILE . 1.8 mp -101.12 148.81 6.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.47 -175.319 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.586 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 2.8 tt0 -85.8 70.14 10.65 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 173.129 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.723 HG23 ' HB ' ' A' ' 80' ' ' ILE . 57.7 t -80.0 53.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.999 -174.411 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.92 2.29 3.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.454 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.674 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.453 -0.294 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.313 -178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.878 0.37 . . . . 0.0 111.266 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.5 -8.64 0.03 OUTLIER Glycine 0 C--N 1.33 0.195 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.197 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.606 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 11.1 p-10 -90.03 145.69 24.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.795 0.331 . . . . 0.0 111.423 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.4 OUTLIER -97.16 112.58 29.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.591 177.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 55.2 t -111.95 122.91 67.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.752 0.311 . . . . 0.0 111.745 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.516 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -97.41 167.49 10.97 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.631 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 5.3 m -141.94 127.55 19.07 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.596 0.712 . . . . 0.0 112.164 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.991 HG22 HG21 ' A' ' 80' ' ' ILE . 4.3 mm -122.08 108.45 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.578 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.8 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -98.31 96.71 8.24 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -177.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.461 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.4 m -91.39 135.5 26.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.841 0.353 . . . . 0.0 111.519 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.841 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.3 ptm -145.05 125.36 7.27 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 121.109 0.48 . . . . 0.0 111.648 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.628 ' CD ' HG13 ' A' ' 17' ' ' VAL . 14.6 Cg_exo -71.45 128.4 14.45 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.487 2.791 . . . . 0.0 112.404 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.14 -35.51 71.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.347 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -78.74 154.87 78.41 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.346 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.605 ' HA ' HD22 ' A' ' 48' ' ' LEU . 56.1 Cg_endo -69.95 -3.24 11.74 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.554 2.17 . . . . 0.0 111.961 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -90.93 44.88 1.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.738 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.628 HG13 ' CD ' ' A' ' 12' ' ' PRO . 98.1 t -63.8 78.35 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.246 -0.888 . . . . 0.0 111.321 -178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.574 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -69.91 95.13 0.9 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.12 178.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.683 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -62.98 -43.75 97.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.394 -178.265 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.771 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 10.1 tt0 -70.6 -35.63 73.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 0.0 110.762 -178.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.574 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -68.55 -37.23 79.75 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.507 ' CD2' ' HG3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -65.95 -28.73 69.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.011 177.507 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.771 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -55.93 -46.88 78.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.596 179.839 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.8 mtmt -65.1 -42.86 93.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.421 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.559 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 2.4 mt-10 -66.4 -31.54 72.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.285 0.564 . . . . 0.0 110.598 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.805 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 9.5 mt -61.88 -42.94 96.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.709 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -62.29 -39.32 92.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.939 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 9.2 pt-20 -77.41 -20.97 53.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.59 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.811 ' HD2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.14 -11.94 39.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.194 -178.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.683 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.1 mm -60.26 137.87 91.71 Favored Pre-proline 0 C--N 1.332 -0.167 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.326 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.658 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.9 Cg_endo -52.34 114.85 1.84 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.686 2.257 . . . . 0.0 112.113 178.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -59.52 3.01 0.05 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.0 -0.545 . . . . 0.0 112.362 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.51 -43.94 7.63 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.88 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.619 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.61 -135.47 0.21 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.718 0.259 . . . . 0.0 111.136 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -135.01 169.47 17.38 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.904 0.383 . . . . 0.0 110.841 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.635 HD23 HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -76.15 -176.13 3.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.964 -179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.502 ' ND1' HG22 ' A' ' 56' ' ' VAL . 83.8 t60 -130.79 -77.51 0.53 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.251 0.548 . . . . 0.0 111.102 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.627 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -165.07 129.94 2.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.829 -178.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.648 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -92.66 158.23 2.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.724 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 2.0 t0 -123.7 131.47 53.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.632 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -91.1 71.36 6.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.354 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.6 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -103.68 146.78 33.14 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.64 -178.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.788 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.0 Cg_endo -88.91 157.45 5.95 Favored 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.123 2.549 . . . . 0.0 112.974 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.753 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.7 mm -127.15 -83.69 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.458 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.768 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.34 -150.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -71.89 -28.45 63.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.846 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.62 5.93 0.45 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.646 -0.787 . . . . 0.0 113.099 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.768 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.4 mt -93.03 106.29 18.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.879 0.371 . . . . 0.0 111.108 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.788 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 60.3 t -93.7 127.55 45.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.72 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.841 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -94.6 166.63 11.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.391 179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.724 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.1 mp -120.38 118.28 29.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.099 178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 1.0 OUTLIER -89.61 92.09 8.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.333 0.587 . . . . 0.0 110.32 -179.304 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.648 HG22 HD13 ' A' ' 39' ' ' ILE . 4.6 t -86.83 101.85 11.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.543 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.618 ' HG3' HG23 ' A' ' 7' ' ' THR . 2.6 mtt -84.6 165.18 18.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.34 178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.516 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.0 m -139.43 135.14 40.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.394 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.502 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.48 116.91 39.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.022 179.291 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 4' ' ' VAL . 10.6 m -130.21 148.26 33.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.084 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -167.22 -69.56 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.297 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -81.44 -5.68 58.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.989 0.423 . . . . 0.0 110.579 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.619 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.67 -149.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.318 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.57 -165.53 2.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.793 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.22 15.06 24.87 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.639 178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.49 -3.94 49.95 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.961 -0.637 . . . . 0.0 112.574 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p -74.28 -3.74 31.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.91 0.386 . . . . 0.0 110.142 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.15 -23.93 23.82 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.353 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.53 -25.77 52.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.164 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.658 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.44 -55.9 26.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.351 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -58.64 -34.6 71.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.44 178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -61.29 -51.81 67.32 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.347 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.449 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.7 p -63.8 -20.13 65.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.424 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.607 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.87 -28.24 62.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.551 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.54 -13.26 51.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.957 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.31 26.1 0.98 Allowed Glycine 0 C--N 1.33 0.245 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.742 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.811 HD11 ' HD2' ' A' ' 29' ' ' ARG . 2.6 tt -73.38 -163.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.449 -0.376 . . . . 0.0 111.127 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.589 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.7 OUTLIER -51.29 94.2 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.843 0.354 . . . . 0.0 111.009 179.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.13 -26.91 68.16 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.233 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.5 p -88.6 -38.3 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.188 0.518 . . . . 0.0 110.232 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -96.69 89.94 5.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.324 179.399 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.544 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.2 136.87 38.59 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 178.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.991 HG21 HG22 ' A' ' 8' ' ' ILE . 2.3 mp -101.91 147.91 8.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.397 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.646 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 3.8 tt0 -86.05 70.73 10.62 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 173.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.646 HG23 ' HB ' ' A' ' 80' ' ' ILE . 60.6 t -80.54 51.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.459 -1.246 . . . . 0.0 111.009 -174.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.78 3.84 3.82 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.328 179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.631 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 4.1 m-20 -85.48 143.28 28.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.969 0.414 . . . . 0.0 111.247 -178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 p -148.26 158.12 7.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.408 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.455 HH11 ' HD3' ' A' ' 86' ' ' ARG . 10.4 mtt-85 -148.84 84.92 1.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.471 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.37 89.04 4.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.175 -179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 11.1 mp -81.53 82.3 7.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.555 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 5.9 mtp . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.088 -179.599 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 121.048 0.452 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.97 6.96 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.673 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.549 ' HB2' HD12 ' A' ' 88' ' ' LEU . 6.7 m-20 -91.6 162.74 14.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.83 0.348 . . . . 0.0 111.421 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.587 HG13 ' HG3' ' A' ' 87' ' ' ARG . 1.3 t -107.28 128.88 61.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.222 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.576 HG23 HD11 ' A' ' 88' ' ' LEU . 86.9 t -119.5 116.67 51.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.067 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.679 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -92.35 166.93 12.33 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.808 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 9.0 m -142.2 130.7 22.5 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.535 0.684 . . . . 0.0 112.129 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.944 HG22 HG21 ' A' ' 80' ' ' ILE . 9.8 mm -121.75 106.64 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.512 -178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.706 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.4 OUTLIER -96.83 96.13 8.34 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.841 0.353 . . . . 0.0 111.866 -177.798 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.823 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.5 m -93.65 137.3 23.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.939 -177.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.613 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -146.05 123.82 6.21 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 121.249 0.547 . . . . 0.0 111.412 178.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.629 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 11.5 Cg_exo -73.2 120.92 6.84 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.591 2.861 . . . . 0.0 111.979 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -56.44 -31.57 64.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.4 p -78.28 154.85 79.58 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.202 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.577 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 53.8 Cg_endo -69.31 -2.55 10.05 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.301 2.001 . . . . 0.0 111.695 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.43 41.15 1.04 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.237 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.629 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 91.1 t -65.93 77.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.493 -178.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.63 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -69.49 95.04 0.79 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.495 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.671 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -63.82 -44.24 93.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.175 -178.469 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.671 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 5.1 tp10 -68.47 -40.05 81.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.613 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.767 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -70.85 -35.81 72.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.128 0.49 . . . . 0.0 110.504 178.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.586 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -66.13 -31.71 72.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.803 178.257 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -56.27 -45.21 80.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.68 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.767 ' HE2' ' HA ' ' A' ' 21' ' ' ALA . 1.9 mtmm -67.09 -43.57 82.22 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.518 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 21' ' ' ALA . 26.1 mt-10 -65.95 -27.14 67.94 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.634 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.778 HG12 HG21 ' A' ' 53' ' ' VAL . 0.5 OUTLIER -61.81 -46.58 96.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.412 -179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.543 HE22 HD11 ' A' ' 39' ' ' ILE . 25.3 mm-40 -63.06 -31.89 73.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 0.0 110.969 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 5.6 mm-40 -73.25 -22.42 60.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.137 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.914 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.15 -18.6 25.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.381 -179.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.457 HG23 ' HD2' ' A' ' 31' ' ' PRO . 27.6 mm -57.18 137.46 80.62 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.205 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.457 ' HD2' HG23 ' A' ' 30' ' ' ILE . 8.7 Cg_endo -48.9 118.75 3.69 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.902 2.401 . . . . 0.0 112.191 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -4.61 0.31 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.137 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.66 -35.01 17.64 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.152 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.596 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.61 -148.66 0.37 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 111.215 -179.324 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -136.71 171.33 14.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.93 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.686 HD13 ' H ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -75.35 -176.17 3.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.427 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.716 ' ND1' HG22 ' A' ' 56' ' ' VAL . 71.7 t60 -130.84 -74.85 0.53 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.796 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 mmtm -161.68 129.38 4.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.051 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.674 HG12 HG13 ' A' ' 53' ' ' VAL . 2.7 mt -92.33 160.75 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.985 0.421 . . . . 0.0 111.803 -177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.626 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -128.42 123.2 33.16 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.511 -178.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -85.06 72.12 10.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.783 0.325 . . . . 0.0 110.502 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.509 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -99.28 134.5 21.24 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.83 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.792 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 73.3 Cg_endo -88.1 156.94 7.05 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.553 2.168 . . . . 0.0 112.757 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.0 mm -124.64 -82.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.323 -177.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.671 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.52 -152.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.142 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.86 -28.6 63.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.595 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.77 5.44 0.5 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.979 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.671 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.7 mt -91.73 101.84 14.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.911 0.386 . . . . 0.0 110.76 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.792 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 89.2 t -93.75 128.45 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.853 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.716 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.64 153.33 17.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.923 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.626 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.1 mp -113.34 119.86 39.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.507 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.554 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.6 m120 -90.44 91.26 8.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.187 0.518 . . . . 0.0 110.207 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.778 HG21 HG12 ' A' ' 26' ' ' ILE . 6.0 t -87.45 106.29 16.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.547 -177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.566 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.64 165.5 17.88 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.283 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.679 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.2 m -139.98 137.97 38.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.879 0.371 . . . . 0.0 111.446 -178.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.716 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.5 OUTLIER -94.68 110.77 24.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.853 179.052 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.562 HG12 HG21 ' A' ' 34' ' ' THR . 13.1 m -130.13 148.01 33.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.949 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.73 -68.12 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.383 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -81.73 -3.07 52.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.934 0.397 . . . . 0.0 110.579 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.596 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.22 -146.47 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.119 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -147.34 -163.19 1.71 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.776 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.79 12.49 35.14 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.604 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.67 -6.16 58.34 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.617 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 p -74.94 -7.26 53.06 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.609 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -54.89 -24.39 23.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.274 0.559 . . . . 0.0 110.226 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.32 -27.75 62.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.229 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.498 ' HB1' HH22 ' A' ' 29' ' ' ARG . . . -60.77 -55.68 30.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.384 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.69 -35.09 73.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.455 178.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -49.92 75.13 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.28 178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 p -64.17 -18.97 64.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.454 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.725 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -74.04 -28.96 61.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.605 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.0 -14.42 54.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.46 178.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.28 32.96 0.93 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.448 179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.914 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -72.68 -163.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.215 -0.492 . . . . 0.0 111.075 -178.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.5 OUTLIER -50.91 98.65 0.02 OUTLIER 'General case' 0 C--O 1.231 0.106 0 CA-C-O 120.913 0.387 . . . . 0.0 110.968 -179.643 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.35 -33.88 66.79 Favored Glycine 0 C--N 1.333 0.382 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.797 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.1 t -87.12 -39.63 13.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.984 0.421 . . . . 0.0 110.524 179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 40.5 t -96.23 92.3 6.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.796 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.604 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.63 134.2 38.24 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 176.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.944 HG21 HG22 ' A' ' 8' ' ' ILE . 15.6 mt -101.41 147.05 8.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.584 -175.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -85.64 71.08 10.77 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 173.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.707 HG23 ' HB ' ' A' ' 80' ' ' ILE . 58.2 t -81.02 52.9 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.241 -174.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.94 4.34 3.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.458 179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.808 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 39.5 t0 -85.68 136.72 33.25 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.899 0.38 . . . . 0.0 111.405 -178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.5 p -148.42 152.97 11.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.964 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.52 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -149.53 97.83 2.69 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 121.134 0.493 . . . . 0.0 110.552 -178.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.587 ' HG3' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -82.64 109.73 17.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.424 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.576 HD11 HG23 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -82.21 90.26 6.59 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.551 178.159 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 30.0 mmt . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.935 179.696 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.814 0.34 . . . . 0.0 111.461 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.406 ' H ' ' H ' ' A' ' 3' ' ' ASP . . . 173.39 0.23 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.161 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.406 ' H ' ' H ' ' A' ' 2' ' ' GLY . 11.0 m-20 -89.04 154.93 19.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.01 0.433 . . . . 0.0 111.423 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.764 HG12 HG23 ' A' ' 57' ' ' VAL . 1.1 t -106.39 121.7 59.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.045 177.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.483 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 42.1 t -110.83 112.86 42.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.716 0.293 . . . . 0.0 111.242 -178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.612 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.67 142.5 27.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.227 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.685 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 7.8 m -122.53 129.25 51.76 Favored 'General case' 0 C--O 1.241 0.607 0 CA-C-O 121.621 0.724 . . . . 0.0 112.032 -178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.054 HG22 HG21 ' A' ' 80' ' ' ILE . 1.4 mm -120.44 108.3 22.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.277 -1.329 . . . . 0.0 110.713 -178.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.814 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -95.29 93.72 7.44 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -177.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.471 HG12 HG12 ' A' ' 80' ' ' ILE . 1.4 m -92.49 136.02 25.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.791 -177.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.828 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.7 ptm -144.4 124.73 7.51 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-O 121.058 0.456 . . . . 0.0 111.349 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.61 ' CD ' HG13 ' A' ' 17' ' ' VAL . 12.3 Cg_exo -70.9 125.1 11.21 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.246 2.631 . . . . 0.0 112.075 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.07 -33.85 69.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.639 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 19.8 m -78.01 153.4 80.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.286 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.582 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 42.4 Cg_endo -67.59 -3.47 10.28 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.402 2.068 . . . . 0.0 111.955 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.79 43.52 1.15 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.755 178.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.61 HG13 ' CD ' ' A' ' 12' ' ' PRO . 87.2 t -65.52 75.49 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.385 -178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.0 OUTLIER -71.48 88.11 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.948 177.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.746 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -63.81 -39.18 93.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.065 -178.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.544 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -68.16 -39.13 82.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.971 -178.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.449 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -72.05 -36.06 69.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.134 0.493 . . . . 0.0 110.282 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -67.37 -28.22 67.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.979 178.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -57.73 -43.75 85.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.325 179.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -66.53 -43.34 85.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.528 178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -66.31 -28.07 68.4 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.169 0.509 . . . . 0.0 110.531 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.794 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.6 mt -61.86 -44.7 99.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.008 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.88 -36.88 77.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.939 0.399 . . . . 0.0 110.417 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -75.35 -24.09 57.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.747 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.794 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.95 -14.17 37.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.713 0.292 . . . . 0.0 111.291 -178.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.2 mm -59.79 139.0 90.21 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.26 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.657 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.4 Cg_endo -51.54 111.69 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.769 2.312 . . . . 0.0 112.076 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.43 2.88 0.05 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.494 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.456 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.71 -41.08 9.11 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.821 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.6 ' CB ' HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.19 -133.56 0.21 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.435 0.16 . . . . 0.0 110.794 -179.787 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -140.0 162.92 34.04 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.826 0.346 . . . . 0.0 110.978 -179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.6 pt? -76.47 -173.23 2.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.583 ' ND1' HG22 ' A' ' 56' ' ' VAL . 76.7 t60 -130.83 -77.62 0.53 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.014 0.435 . . . . 0.0 111.334 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 3.0 mmtp -160.07 132.08 6.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.333 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.656 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -93.57 160.01 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.608 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.653 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -128.17 125.12 38.45 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.647 -178.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -85.74 74.16 10.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.835 0.35 . . . . 0.0 110.438 178.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.534 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -100.45 134.88 20.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.785 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.8 Cg_endo -84.97 156.01 11.41 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.589 2.193 . . . . 0.0 112.556 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.1 mm -124.76 -82.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.163 -178.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.633 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.27 -153.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.994 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -71.97 -26.59 62.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.663 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.73 3.07 0.41 Allowed Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.122 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.633 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.1 mt -91.65 103.22 15.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.785 0.326 . . . . 0.0 110.786 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.785 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 93.6 t -94.1 129.06 44.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.746 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.828 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.22 162.71 13.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.906 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.746 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.0 mp -120.4 120.23 35.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.398 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 1.1 m120 -89.66 91.5 8.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.216 0.532 . . . . 0.0 109.792 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.702 HG21 HG12 ' A' ' 26' ' ' ILE . 14.1 t -86.32 105.84 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.434 -177.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.56 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 13.0 mtt -84.94 160.58 20.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.14 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.612 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.0 m -139.09 137.87 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.212 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.583 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.7 t -93.0 98.16 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.883 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.764 HG23 HG12 ' A' ' 4' ' ' VAL . 34.9 m -130.4 138.21 54.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.124 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.33 -59.66 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.49 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.14 -8.19 59.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.994 0.426 . . . . 0.0 110.503 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.431 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.56 -139.36 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.122 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.11 -162.38 1.53 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.783 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.2 11.49 36.51 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.595 -0.812 . . . . 0.0 111.702 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.43 -12.21 69.28 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.474 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 p -74.31 -4.25 35.12 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.03 0.443 . . . . 0.0 110.278 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.79 -24.32 22.18 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.072 177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.63 -27.92 52.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.02 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.657 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.83 -57.89 10.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.372 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -58.45 -34.37 70.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.522 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.77 -52.33 64.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.058 0.456 . . . . 0.0 110.371 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.429 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -64.05 -20.75 66.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.475 178.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.592 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.99 -28.05 62.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.675 -179.643 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.59 -16.6 61.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.767 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.53 31.0 0.94 Allowed Glycine 0 N--CA 1.453 -0.227 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.834 179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.778 HD11 ' HB2' ' A' ' 29' ' ' ARG . 2.9 tt -73.21 -161.02 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.511 -0.344 . . . . 0.0 111.11 -178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.622 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -51.82 90.69 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 121.121 0.486 . . . . 0.0 110.714 179.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.53 -24.93 62.43 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 115.726 -0.67 . . . . 0.0 113.107 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.8 p -86.95 -34.67 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.352 0.596 . . . . 0.0 110.307 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.62 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 29.0 t -96.71 92.3 6.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.697 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.592 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -76.23 132.2 39.76 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.146 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.054 HG21 HG22 ' A' ' 8' ' ' ILE . 2.1 mt -101.03 148.16 7.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.493 -175.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.588 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 2.4 tp10 -85.86 71.11 10.69 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 172.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.705 HG23 ' HB ' ' A' ' 80' ' ' ILE . 68.4 t -79.95 55.89 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 CA-C-N 114.174 -1.375 . . . . 0.0 110.947 -174.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -133.05 1.87 3.58 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.81 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.685 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.0 m-20 -85.06 138.82 32.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.256 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.2 p -148.96 155.92 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.192 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.5 mtt85 -148.93 85.37 1.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.018 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -79.28 88.7 4.93 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.215 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.403 ' HG ' ' H ' ' A' ' 88' ' ' LEU . 0.1 OUTLIER -82.21 91.89 6.81 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.585 179.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 6.4 mtm . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.976 179.885 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.961 0.41 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.59 -14.08 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.849 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -92.35 147.8 22.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 111.556 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.521 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.5 t -100.07 113.17 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.869 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.711 ' HB ' ' HB2' ' A' ' 86' ' ' ARG . 53.5 t -105.1 112.02 36.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.51 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.613 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.84 142.6 27.91 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 177.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.791 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.3 m -122.75 129.4 51.71 Favored 'General case' 0 C--O 1.242 0.699 0 CA-C-O 121.72 0.771 . . . . 0.0 112.563 -177.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.978 HG22 HG21 ' A' ' 80' ' ' ILE . 3.2 mm -121.12 108.71 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.731 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.781 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.96 96.22 8.02 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -177.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.464 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.3 m -93.21 136.67 24.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -177.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.581 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -146.26 124.97 6.43 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.296 178.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.634 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.2 Cg_exo -71.38 120.35 6.9 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.137 2.558 . . . . 0.0 111.694 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -56.74 -31.34 64.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.285 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.5 p -77.88 154.21 80.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.985 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.554 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 54.5 Cg_endo -69.01 -1.14 7.31 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.223 1.949 . . . . 0.0 111.493 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.18 41.98 1.09 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.116 178.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.634 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 84.8 t -65.8 79.55 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.368 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 67.3 m-20 -68.11 101.12 1.09 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.16 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.62 HD12 ' HE2' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -61.41 -53.2 59.61 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.773 -178.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.669 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 13.6 pt-20 -71.06 -34.47 71.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.214 -176.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.539 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -68.17 -36.45 79.64 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.59 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -65.17 -34.0 77.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.389 176.645 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.669 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -57.14 -47.38 81.28 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.407 178.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 21' ' ' ALA . 2.5 mtmt -64.47 -42.91 95.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.61 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.622 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 2.1 mt-10 -66.55 -32.91 74.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.204 0.526 . . . . 0.0 110.811 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.659 ' O ' HG12 ' A' ' 30' ' ' ILE . 3.0 mt -61.78 -43.04 96.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.008 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -62.53 -40.41 96.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.683 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 9.0 pt-20 -78.49 -19.22 53.5 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.832 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.84 HH22 ' HB ' ' A' ' 8' ' ' ILE . 26.8 ptt85 -89.9 -11.44 41.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.255 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.659 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.9 mm -59.91 138.85 90.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.742 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 8.5 Cg_endo -49.13 117.07 2.57 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.872 2.381 . . . . 0.0 112.256 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -59.71 2.2 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.433 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.03 -46.18 6.33 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.611 -0.804 . . . . 0.0 113.122 -178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.643 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -130.07 -134.74 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.624 0.25 . . . . 0.0 110.998 -179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -137.1 166.41 23.77 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.812 0.339 . . . . 0.0 110.73 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -76.4 -171.91 1.95 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.241 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.458 ' ND1' HG22 ' A' ' 56' ' ' VAL . 85.7 t60 -130.55 -77.69 0.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.376 0.608 . . . . 0.0 111.101 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.476 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 2.0 tptp -164.47 129.83 2.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.668 -178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.622 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -91.78 160.88 2.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -176.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.616 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -126.4 120.71 30.51 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.383 -179.271 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -84.32 72.59 10.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.917 0.389 . . . . 0.0 110.465 178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.507 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -99.13 135.35 20.83 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.951 -179.421 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.783 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 62.2 Cg_endo -86.47 157.22 9.33 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.596 2.197 . . . . 0.0 112.515 -179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.5 mm -126.63 -83.19 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.532 -177.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.668 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.62 -149.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.188 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -70.5 -32.12 69.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.857 0.361 . . . . 0.0 110.549 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.69 7.63 0.59 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.658 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.668 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.9 mt -91.25 101.71 14.42 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.81 0.338 . . . . 0.0 110.793 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 73.9 t -92.53 129.54 42.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.739 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.716 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.03 160.28 14.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.675 177.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.616 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.1 mp -120.45 119.54 33.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.5 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.531 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.4 m120 -89.73 90.74 8.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.268 0.556 . . . . 0.0 110.024 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.622 HG22 HD13 ' A' ' 39' ' ' ILE . 10.0 t -87.89 104.74 14.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.478 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.62 ' HG3' HG23 ' A' ' 7' ' ' THR . 2.0 mtt -85.39 163.82 18.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.35 178.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.613 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.4 m -140.24 136.04 36.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.984 0.421 . . . . 0.0 111.394 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.458 HG22 ' ND1' ' A' ' 37' ' ' HIS . 1.9 t -95.35 112.08 27.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.017 179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 4' ' ' VAL . 21.4 m -130.17 139.11 52.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.897 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.78 -61.06 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.551 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -81.4 -14.43 57.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.014 0.435 . . . . 0.0 110.718 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.643 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.56 -139.02 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.092 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.9 -168.82 3.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.525 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.84 13.55 30.05 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.451 -0.88 . . . . 0.0 111.553 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.44 -1.73 38.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.663 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -74.29 -3.92 33.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.857 0.36 . . . . 0.0 110.374 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -55.18 -23.68 23.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.233 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.2 -24.59 42.74 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.155 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.742 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.39 -56.13 23.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.263 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.3 -34.75 70.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.342 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.53 -52.33 64.92 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.442 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.436 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.5 p -64.21 -19.11 65.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.629 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.59 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.52 -29.91 62.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.749 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.81 -12.06 43.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.9 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.21 26.02 0.99 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.862 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' A' ' 29' ' ' ARG . 2.7 tt -73.1 -163.59 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.596 -0.302 . . . . 0.0 110.774 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.649 ' HB2' ' HB3' ' A' ' 78' ' ' SER . 0.0 OUTLIER -51.68 96.6 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.036 0.446 . . . . 0.0 110.665 179.351 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.97 -30.77 76.33 Favored Glycine 0 C--N 1.332 0.34 0 CA-C-N 115.818 -0.628 . . . . 0.0 113.367 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.2 t -85.49 -33.32 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.885 0.374 . . . . 0.0 110.505 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.649 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 11.6 t -95.42 91.23 6.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.717 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.584 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -75.43 132.78 41.08 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.978 HG21 HG22 ' A' ' 8' ' ' ILE . 3.2 mp -101.09 148.85 6.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.607 -175.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.585 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 38.7 tt0 -85.85 69.49 10.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 173.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.691 HG23 ' HB ' ' A' ' 80' ' ' ILE . 61.8 t -79.97 54.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 114.311 -1.313 . . . . 0.0 110.732 -175.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.89 0.57 3.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.567 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.791 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 10.2 t0 -85.66 136.72 33.25 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.859 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.526 ' C ' ' HG2' ' A' ' 86' ' ' ARG . 4.4 p -148.38 158.0 7.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.333 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.711 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -145.53 81.35 1.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.224 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -79.51 76.96 6.11 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.373 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.462 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -82.66 91.91 7.07 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 121.056 -0.257 . . . . 0.0 110.527 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.864 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.947 0.403 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.411 ' H ' ' H ' ' A' ' 3' ' ' ASP . . . -171.56 -6.63 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.205 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.696 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.411 ' H ' ' H ' ' A' ' 2' ' ' GLY . 3.6 m-20 -92.72 149.63 21.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.552 -0.324 . . . . 0.0 111.396 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.52 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.5 t -97.91 115.53 38.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.703 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 55.5 t -109.96 119.97 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.699 0.285 . . . . 0.0 111.555 -178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.784 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -98.72 166.65 11.22 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 177.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.706 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 14.7 m -143.23 137.49 28.98 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-O 121.644 0.735 . . . . 0.0 112.43 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.058 HG22 HG21 ' A' ' 80' ' ' ILE . 4.2 mm -127.11 106.35 15.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 114.283 -1.326 . . . . 0.0 110.274 -178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.769 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.58 96.19 8.49 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 -176.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.558 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.5 m -93.37 134.13 32.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 120.909 0.385 . . . . 0.0 111.822 -178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.679 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.3 OUTLIER -146.3 124.91 6.4 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-O 121.094 0.473 . . . . 0.0 111.24 179.04 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.631 ' CD ' HG13 ' A' ' 17' ' ' VAL . 12.5 Cg_exo -72.51 122.67 8.47 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.467 2.778 . . . . 0.0 112.026 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -56.76 -32.13 65.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.235 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.91 153.58 80.37 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.037 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.6 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 53.6 Cg_endo -69.46 -2.86 10.69 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.403 2.068 . . . . 0.0 112.305 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.61 45.74 1.21 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.996 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.631 HG13 ' CD ' ' A' ' 12' ' ' PRO . 92.7 t -64.96 76.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.708 -178.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.4 OUTLIER -71.12 89.71 0.84 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 177.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.877 HD13 ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -63.53 -37.17 86.29 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.541 -178.17 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.877 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -70.61 -35.58 73.06 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 120.992 0.425 . . . . 0.0 110.077 -179.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.48 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -69.05 -37.52 78.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.508 ' CD2' ' HG3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -65.92 -30.07 70.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.014 177.359 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.794 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -55.22 -46.71 75.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.663 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.1 mtmt -65.84 -43.59 88.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.537 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.721 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 1.3 mm-40 -66.05 -29.32 69.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.266 0.555 . . . . 0.0 110.56 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.718 HG12 HG21 ' A' ' 53' ' ' VAL . 3.8 mt -60.94 -46.4 96.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.932 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -62.37 -38.74 90.77 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.208 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.721 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -78.33 -20.55 51.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.546 -178.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.911 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -89.05 -10.58 46.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.141 -179.222 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.65 HG12 ' O ' ' A' ' 26' ' ' ILE . 33.3 mm -60.89 138.12 93.74 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.265 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.511 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.3 Cg_endo -51.59 114.54 1.62 Allowed 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.668 2.246 . . . . 0.0 112.126 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.17 -2.58 0.19 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.225 -179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.27 -39.25 10.08 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.875 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.581 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.51 -145.21 0.28 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.634 0.254 . . . . 0.0 110.977 -179.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -133.25 164.82 26.23 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.892 0.377 . . . . 0.0 110.795 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.479 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.1 pt? -76.31 -175.09 3.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.389 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.543 ' ND1' HG22 ' A' ' 56' ' ' VAL . 85.3 t60 -130.7 -76.95 0.53 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.308 0.575 . . . . 0.0 111.345 -178.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.443 ' HB3' ' CD2' ' A' ' 37' ' ' HIS . 1.1 tptt -163.54 132.66 3.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.959 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.708 HG12 HG13 ' A' ' 53' ' ' VAL . 2.6 mt -92.65 159.35 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.108 0.48 . . . . 0.0 112.172 -176.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.655 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -126.73 117.2 22.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.545 -178.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -82.7 69.9 9.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.941 0.4 . . . . 0.0 110.376 178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.544 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -97.23 138.21 21.21 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.887 -179.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.775 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 71.1 Cg_endo -85.43 156.27 10.76 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.535 2.156 . . . . 0.0 112.632 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.744 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.1 mm -125.76 -83.27 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.505 -177.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.67 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.42 -147.67 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.218 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -70.98 -33.87 70.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.947 0.403 . . . . 0.0 110.752 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.48 8.4 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.738 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.67 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.3 mt -91.04 102.31 15.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.902 0.382 . . . . 0.0 110.791 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.775 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 70.7 t -92.78 127.5 44.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.882 -178.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.744 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.56 150.49 20.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.045 178.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.655 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -112.2 116.23 30.11 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.158 179.145 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 4.6 m-20 -89.76 94.11 9.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.654 -178.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.718 HG21 HG12 ' A' ' 26' ' ' ILE . 3.7 t -86.45 104.19 13.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.221 -0.899 . . . . 0.0 111.277 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.435 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 3.8 mtt -84.52 167.52 16.27 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.207 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.784 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.1 m -139.93 138.05 38.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.942 0.401 . . . . 0.0 111.56 -178.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.543 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -95.35 111.09 25.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.736 178.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.581 HG12 HG21 ' A' ' 34' ' ' THR . 12.8 m -130.05 148.07 33.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.001 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.29 -72.15 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.451 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -81.39 -0.3 40.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.917 0.389 . . . . 0.0 110.553 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.529 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.21 -152.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.234 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -147.55 -162.69 1.6 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.729 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.94 14.49 26.09 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.565 178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.35 -7.22 60.0 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.498 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.415 HG22 ' OG1' ' A' ' 34' ' ' THR . 1.4 p -74.12 -4.63 36.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.978 0.418 . . . . 0.0 110.261 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -54.83 -23.87 20.37 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.289 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.89 -29.21 62.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.031 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -62.09 -55.15 31.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.812 0.339 . . . . 0.0 110.212 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -58.99 -34.31 71.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.213 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -62.18 -51.24 68.62 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.127 178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 7.8 p -63.78 -17.27 62.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.221 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.714 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.58 -29.85 62.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.368 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.07 -12.09 35.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.658 178.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.24 28.87 0.98 Allowed Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.463 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.911 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -72.59 -164.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.338 -0.431 . . . . 0.0 111.062 -178.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.637 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.5 OUTLIER -51.15 99.7 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.938 0.399 . . . . 0.0 110.81 179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.93 -33.44 73.84 Favored Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.892 -0.594 . . . . 0.0 112.924 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 15.7 t -87.16 -38.61 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.984 0.421 . . . . 0.0 110.594 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.637 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 40.8 t -96.13 92.31 6.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.875 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.573 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -78.2 135.38 37.6 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 177.442 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.058 HG21 HG22 ' A' ' 8' ' ' ILE . 2.9 mt -101.57 148.63 7.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.514 -176.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.662 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 15.8 tp10 -86.02 69.43 10.52 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 173.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.677 HG22 HG23 ' A' ' 8' ' ' ILE . 55.1 t -80.93 51.62 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 114.481 -1.236 . . . . 0.0 111.024 -174.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -133.03 9.25 4.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.919 179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.706 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.1 m-20 -83.2 146.66 28.48 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.423 -0.511 . . . . 0.0 111.297 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.6 t -148.9 144.18 18.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.866 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 9.7 mtt180 -146.4 79.52 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.622 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.68 84.91 4.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.026 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -81.45 91.99 6.39 Favored 'General case' 0 CA--C 1.52 -0.177 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.461 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.971 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.447 ' SD ' ' HB3' ' A' ' 88' ' ' LEU . 2.7 mtm . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 120.989 0.423 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 89' ' ' MET . . . 173.82 -0.68 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.234 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.581 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.481 ' OD1' HD12 ' A' ' 88' ' ' LEU . 2.4 p-10 -92.68 164.65 13.31 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.581 -0.31 . . . . 0.0 111.154 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.4 ' HB ' HG23 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -99.57 136.87 28.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.181 178.709 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.578 ' CG2' HD11 ' A' ' 88' ' ' LEU . 4.7 t -132.75 127.04 55.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.758 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.578 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.13 168.92 10.63 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.224 -0.287 . . . . 0.0 110.224 178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.802 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 6.2 m -142.81 129.76 20.64 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.466 0.65 . . . . 0.0 112.164 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.998 HG22 HG21 ' A' ' 80' ' ' ILE . 5.7 mm -121.21 108.03 21.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.677 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.687 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.54 96.18 8.13 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -177.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.83 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.9 m -94.8 137.37 23.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -177.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.769 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -147.67 121.65 4.94 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-O 121.205 0.526 . . . . 0.0 111.999 179.179 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 17.0 Cg_exo -71.34 121.15 7.51 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.417 2.745 . . . . 0.0 111.973 178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.66 -30.56 63.49 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.317 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 1.2 m -78.0 153.93 80.18 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.965 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.551 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 7.3 Cg_exo -70.39 -6.13 18.21 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.536 2.157 . . . . 0.0 111.719 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -91.17 33.62 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.284 178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.29 85.68 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.738 0.78 . . . . 0.0 109.98 -179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 24.9 m-20 -69.96 106.13 3.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.352 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.409 ' HG ' HD21 ' A' ' 51' ' ' LEU . 1.5 tt -62.12 -48.91 78.06 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.17 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 12.6 tp10 -68.48 -37.95 80.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.827 -178.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.513 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -70.94 -34.57 71.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.0 0.429 . . . . 0.0 110.591 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -65.28 -32.25 73.82 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.655 178.164 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -57.8 -45.21 86.4 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.554 179.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -42.21 88.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.593 179.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.604 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 10.3 mt-10 -66.49 -30.23 70.52 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.321 0.581 . . . . 0.0 110.477 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.685 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 3.4 mt -62.06 -43.57 97.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.766 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -60.89 -38.48 85.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.109 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 10.2 pt-20 -77.49 -21.69 52.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.306 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.792 ' HB2' HD11 ' A' ' 74' ' ' ILE . 21.1 ptt85 -91.1 -9.92 43.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.253 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.675 HG12 ' O ' ' A' ' 26' ' ' ILE . 31.5 mm -59.24 137.78 88.48 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.136 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.522 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.8 Cg_endo -51.54 115.02 1.83 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.743 2.296 . . . . 0.0 112.151 178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.07 0.55 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.357 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.99 -53.55 3.46 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.858 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.596 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -117.02 -137.52 0.36 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.664 0.232 . . . . 0.0 111.116 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 3.8 pt-20 -137.48 169.14 18.3 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.915 0.388 . . . . 0.0 110.992 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.57 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -75.17 177.86 6.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.977 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.673 ' ND1' HG22 ' A' ' 56' ' ' VAL . 71.0 t60 -131.21 -76.28 0.52 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.047 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -161.37 131.78 5.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.402 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.657 HG12 HG13 ' A' ' 53' ' ' VAL . 2.8 mt -93.57 159.23 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.905 -178.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.653 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -129.59 119.31 23.41 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.474 -178.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -82.75 75.52 9.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.91 0.386 . . . . 0.0 110.731 178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.529 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -98.56 134.5 21.7 Favored Pre-proline 0 C--O 1.225 -0.205 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.591 179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.777 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 57.3 Cg_endo -86.53 156.87 9.23 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.499 2.133 . . . . 0.0 112.815 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.711 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.5 mm -124.92 -83.52 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.24 -177.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.772 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.85 -152.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.118 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -71.94 -28.38 63.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.726 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.61 4.31 0.47 Allowed Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.046 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.772 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.5 mt -91.67 101.94 14.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.825 0.345 . . . . 0.0 110.764 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.777 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 87.6 t -94.39 129.61 44.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.975 -178.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.769 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.43 157.11 16.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.457 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.661 HD23 ' C ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -120.23 121.17 38.13 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.634 179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.486 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.2 m120 -89.89 92.79 9.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.257 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.657 HG13 HG12 ' A' ' 39' ' ' ILE . 10.3 t -86.03 104.73 13.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.212 -178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.584 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.8 mtt -84.58 164.52 18.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.234 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.578 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.0 m -139.27 139.52 39.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.164 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.673 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -92.18 112.15 25.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.794 0.33 . . . . 0.0 110.887 179.525 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.478 HG12 HG21 ' A' ' 34' ' ' THR . 28.3 m -128.34 140.52 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.999 0.428 . . . . 0.0 111.176 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.43 -69.8 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.235 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.75 -4.96 58.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.409 . . . . 0.0 110.509 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.596 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.06 -152.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.302 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.65 -162.96 1.66 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.803 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.09 14.24 28.23 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.557 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.27 -5.9 51.13 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.247 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.5 p -74.6 -3.18 29.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.102 0.477 . . . . 0.0 109.97 178.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -55.24 -23.71 23.93 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.161 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.33 -28.28 58.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.74 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.44 -56.78 16.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.156 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -58.49 -34.48 70.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.387 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.68 -52.2 65.3 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.305 178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.414 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 3.1 p -64.08 -17.83 63.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.302 178.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.628 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.64 -28.56 62.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.356 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.5 -12.96 49.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.18 26.02 0.99 Allowed Glycine 0 N--CA 1.453 -0.207 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.805 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' A' ' 29' ' ' ARG . 1.1 tt -73.47 -162.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.535 -0.332 . . . . 0.0 110.865 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.62 ' N ' HG23 ' A' ' 74' ' ' ILE . 1.4 mp0 -50.41 93.74 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.831 0.348 . . . . 0.0 110.932 179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.57 -26.35 56.93 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.952 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.43 -39.81 12.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.113 0.482 . . . . 0.0 110.493 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -96.47 91.0 5.58 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.698 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.594 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -78.2 136.53 37.83 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.998 HG21 HG22 ' A' ' 8' ' ' ILE . 14.9 mt -101.48 145.87 10.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.604 -176.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.479 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -85.85 71.47 10.65 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 173.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.703 HG23 ' HB ' ' A' ' 80' ' ' ILE . 64.3 t -80.09 50.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 114.383 -1.28 . . . . 0.0 111.207 -173.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -132.99 6.39 3.93 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.18 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.802 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 31.4 t0 -85.32 144.65 27.94 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.037 0.446 . . . . 0.0 110.999 -178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.43 HG22 ' H ' ' A' ' 86' ' ' ARG . 2.9 p -147.29 164.91 6.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.01 -179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' H ' HG22 ' A' ' 85' ' ' VAL . 4.4 mtt180 -149.92 95.58 2.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.289 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 87' ' ' ARG . 3.7 mmt85 -81.69 88.5 6.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.942 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.578 HD11 ' CG2' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -81.91 92.92 6.81 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.786 179.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.469 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.311 -0.852 . . . . 0.0 111.003 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 ptp . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.935 0.397 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.72 -2.65 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.125 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.632 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 4.7 m-20 -91.63 130.47 37.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.743 0.306 . . . . 0.0 111.522 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.666 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -93.15 101.81 13.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.321 177.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 43.4 t -104.85 122.98 58.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.887 0.375 . . . . 0.0 111.806 -178.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 54' ' ' MET . . . -97.96 163.2 12.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.735 177.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.716 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 5.6 m -139.7 123.12 17.15 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.642 0.734 . . . . 0.0 111.625 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.951 HG22 HG21 ' A' ' 80' ' ' ILE . 17.6 mt -122.13 107.62 20.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.734 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.814 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.89 95.99 8.23 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -176.643 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.475 ' N ' HG23 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -91.43 136.3 24.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.875 0.369 . . . . 0.0 111.738 -177.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.817 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 2.2 ptm -144.14 124.97 7.79 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-O 121.036 0.446 . . . . 0.0 111.485 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.601 ' CD ' HG13 ' A' ' 17' ' ' VAL . 14.2 Cg_exo -69.7 124.54 11.21 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.173 2.582 . . . . 0.0 112.099 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -57.9 -32.6 67.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.457 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.6 p -77.34 152.94 81.76 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.119 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.56 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 46.8 Cg_endo -68.19 -3.11 10.13 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.216 1.944 . . . . 0.0 111.572 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.74 43.63 1.16 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.835 178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.601 HG13 ' CD ' ' A' ' 12' ' ' PRO . 90.0 t -65.8 75.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.65 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.59 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.6 OUTLIER -71.74 92.94 1.23 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 177.027 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.728 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -63.24 -42.06 99.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.596 -178.035 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.887 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 10.8 tt0 -69.96 -36.5 75.3 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 120.955 0.407 . . . . 0.0 110.292 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.59 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -69.21 -37.75 78.23 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.486 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -67.11 -27.01 66.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.004 177.483 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.887 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -56.2 -46.8 79.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.371 179.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 2.0 mtmt -66.86 -39.86 87.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.766 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -65.5 -33.8 76.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.213 0.53 . . . . 0.0 110.095 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.647 ' O ' HG12 ' A' ' 30' ' ' ILE . 1.8 mt -62.75 -39.01 83.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.935 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.39 -42.35 91.51 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.639 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 13.3 mt-10 -76.01 -20.92 57.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.814 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.766 HH22 ' HB ' ' A' ' 8' ' ' ILE . 20.8 ptt85 -88.76 -15.63 34.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.484 -178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 26' ' ' ILE . 22.4 mm -59.4 137.48 89.0 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.705 -0.225 . . . . 0.0 110.917 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.561 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 8.0 Cg_endo -50.18 124.85 13.63 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.824 2.349 . . . . 0.0 112.521 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -60.79 -3.68 0.8 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.893 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.24 -61.7 1.88 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.991 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.626 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -110.24 -145.56 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.835 0.35 . . . . 0.0 111.296 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -132.05 172.01 12.9 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.614 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.466 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -74.97 -173.67 1.99 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.007 -179.268 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.541 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.5 t60 -130.58 -74.81 0.54 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.426 0.631 . . . . 0.0 110.782 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -165.03 125.9 1.99 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.796 -179.391 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.659 HD13 HG22 ' A' ' 53' ' ' VAL . 2.7 mt -92.4 154.35 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.848 -177.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.716 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.8 t0 -121.25 129.2 53.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.488 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -89.69 69.76 7.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.86 0.362 . . . . 0.0 110.202 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.672 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -100.15 148.26 34.63 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.595 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.751 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.0 Cg_endo -91.07 156.19 3.88 Favored 'Trans proline' 0 N--CA 1.455 -0.794 0 C-N-CA 123.026 2.484 . . . . 0.0 113.209 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.6 mm -125.89 -82.48 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.063 -178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.567 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.41 -151.8 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.943 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -72.07 -28.55 63.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.755 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.54 4.79 0.5 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.942 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.567 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.2 mt -91.43 103.44 16.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 110.968 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.751 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 36.7 t -92.3 128.58 43.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.694 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.817 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.0 165.68 12.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.094 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.728 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.0 mp -120.26 119.93 34.63 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.234 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER -89.52 90.96 8.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.225 0.536 . . . . 0.0 109.915 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.659 HG22 HD13 ' A' ' 39' ' ' ILE . 10.0 t -86.91 98.86 7.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.705 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 35.7 mtt -84.54 162.56 19.8 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.096 178.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.7 m -138.92 134.71 42.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.536 -178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.541 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.66 113.55 31.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.127 179.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 4' ' ' VAL . 4.4 m -129.63 143.63 40.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.934 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.57 -65.98 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.454 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -80.96 -8.21 59.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.996 0.427 . . . . 0.0 110.648 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.626 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.84 -146.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.21 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.62 -164.18 1.94 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.749 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.89 13.6 30.08 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.544 -0.836 . . . . 0.0 111.545 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.08 -5.62 53.89 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.54 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.58 -5.22 41.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.957 0.408 . . . . 0.0 110.338 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -54.9 -23.15 17.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.148 177.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.89 -29.08 62.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.968 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.561 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.65 -52.65 63.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.403 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.66 -37.27 75.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.309 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -50.21 74.39 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.312 178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.425 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.1 p -64.0 -21.04 66.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.685 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.561 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.54 -29.36 62.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.827 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -13.74 53.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.888 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.36 28.57 0.97 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.871 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.683 HD11 ' HD2' ' A' ' 29' ' ' ARG . 3.6 tt -73.28 -163.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.61 -0.295 . . . . 0.0 111.067 -179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.762 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 1.2 pm0 -51.55 91.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.975 0.416 . . . . 0.0 110.877 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.83 -25.58 67.83 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.756 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.27 -34.67 8.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.289 0.566 . . . . 0.0 110.132 179.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.762 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.9 OUTLIER -95.83 90.36 5.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.569 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.408 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -74.5 131.09 40.72 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.951 HG21 HG22 ' A' ' 8' ' ' ILE . 3.0 mp -100.83 149.21 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.524 -175.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.668 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 31.5 tp10 -85.79 70.33 10.67 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.686 HG23 ' HB ' ' A' ' 80' ' ' ILE . 52.8 t -81.06 54.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.857 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 m -132.65 1.97 3.72 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.689 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.716 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 2.2 m-20 -84.62 141.63 30.52 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.753 -178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.0 t -147.58 149.98 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.002 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 5.5 mtt180 -145.46 73.85 1.37 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.502 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.28 87.0 3.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.09 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.632 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 11.0 mp -82.16 82.35 7.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.626 179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.9 ptp . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.979 -179.8 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.812 0.339 . . . . 0.0 111.41 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.406 ' H ' ' H ' ' A' ' 3' ' ' ASP . . . -165.66 -6.15 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 121.044 -0.598 . . . . 0.0 111.733 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.406 ' H ' ' H ' ' A' ' 2' ' ' GLY . 0.8 OUTLIER -94.44 159.67 15.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.006 0.431 . . . . 0.0 111.279 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.827 HG12 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -99.16 116.54 42.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.136 177.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 86' ' ' ARG . 3.9 t -105.31 120.41 55.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.072 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.735 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.09 157.22 16.18 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 177.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.788 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 4.5 m -138.24 125.52 21.7 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.702 0.763 . . . . 0.0 111.979 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.976 HG22 HG21 ' A' ' 80' ' ' ILE . 6.7 mm -120.55 108.31 22.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.943 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.743 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.31 95.57 8.17 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -178.014 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.675 ' HB ' HG12 ' A' ' 80' ' ' ILE . 0.8 OUTLIER -92.66 135.95 26.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.787 -178.101 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.757 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -145.75 127.0 7.5 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-O 120.964 0.411 . . . . 0.0 111.361 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 8.7 Cg_exo -73.4 120.19 6.38 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.252 2.635 . . . . 0.0 112.127 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -56.76 -32.19 65.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.303 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.8 p -78.45 154.01 79.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.012 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.567 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 56.1 Cg_endo -68.9 -2.09 8.93 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.213 1.942 . . . . 0.0 111.508 178.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.88 42.52 1.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.121 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.631 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 96.2 t -64.88 77.95 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.125 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.725 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.1 m-20 -68.35 98.6 0.85 Allowed 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.416 ' CD2' HD21 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -61.49 -51.35 69.03 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.659 -178.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -68.06 -37.95 81.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.619 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.667 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . . . -70.52 -38.32 74.24 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.063 0.459 . . . . 0.0 110.6 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.725 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -66.8 -30.14 70.27 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.189 178.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.51 -44.6 93.09 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.43 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.667 ' HE3' ' HA ' ' A' ' 21' ' ' ALA . 0.5 OUTLIER -65.94 -41.94 90.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.587 179.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -64.76 -32.42 74.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.074 0.464 . . . . 0.0 110.635 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.919 HG12 HG21 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -62.14 -44.89 99.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.473 -179.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.477 ' OE1' HG22 ' A' ' 26' ' ' ILE . 7.2 mm100 -63.35 -33.41 75.48 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.82 0.343 . . . . 0.0 110.737 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.584 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 27.6 mt-10 -74.44 -23.2 58.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.088 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.75 ' HD2' HD11 ' A' ' 74' ' ' ILE . 28.7 ptt85 -89.26 -15.79 32.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.552 -178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.548 HG12 ' O ' ' A' ' 26' ' ' ILE . 24.2 mm -57.97 136.74 83.84 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.456 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.53 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 18.4 Cg_endo -56.81 116.73 3.41 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.274 1.983 . . . . 0.0 112.073 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.81 0.64 0.08 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.405 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.446 ' HA3' ' C ' ' A' ' 63' ' ' GLY . . . -82.46 -37.03 15.23 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.575 -179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.557 HG21 HG12 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -130.28 -144.06 0.26 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.647 0.26 . . . . 0.0 110.871 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -136.74 167.8 20.74 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.881 0.372 . . . . 0.0 111.031 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -75.26 -177.23 3.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.007 -179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.744 ' ND1' HG22 ' A' ' 56' ' ' VAL . 73.0 t60 -131.49 -75.64 0.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.205 0.526 . . . . 0.0 111.047 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 11.9 mmtt -161.25 129.37 4.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.222 -178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.628 HG12 HG13 ' A' ' 53' ' ' VAL . 3.2 mt -94.42 158.51 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.073 0.463 . . . . 0.0 111.989 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.699 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -126.49 118.69 25.44 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.98 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -85.7 71.24 10.73 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.905 0.383 . . . . 0.0 110.261 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.661 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -100.73 149.54 36.25 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.628 -178.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.763 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 29.6 Cg_endo -91.92 158.88 3.35 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.074 2.516 . . . . 0.0 113.331 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.772 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.3 mm -128.89 -83.37 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.348 -178.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.694 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.79 -148.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.184 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -71.17 -32.61 69.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.81 0.338 . . . . 0.0 110.808 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.67 8.85 0.64 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.493 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.694 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.3 mt -91.39 103.1 15.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.82 0.343 . . . . 0.0 110.889 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.763 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 38.1 t -92.7 127.53 44.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.898 -178.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.772 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.13 159.03 15.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.69 178.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.818 HD12 HD13 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -118.82 119.56 34.75 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.494 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.483 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.2 m120 -89.49 90.26 8.21 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.709 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.919 HG21 HG12 ' A' ' 26' ' ' ILE . 14.6 t -86.52 104.23 13.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.529 -177.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.633 ' HG3' HG23 ' A' ' 7' ' ' THR . 2.8 mtt -84.57 160.64 20.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.16 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.735 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.8 m -139.53 140.93 36.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.178 -178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.744 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.4 OUTLIER -92.11 101.8 12.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.836 179.342 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.827 HG23 HG12 ' A' ' 4' ' ' VAL . 31.8 m -130.72 137.2 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.499 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.62 -59.37 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.423 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -81.7 -7.78 59.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.038 0.447 . . . . 0.0 110.444 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.522 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.5 -140.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.178 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.428 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 1.0 OUTLIER -147.17 -162.35 1.52 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.814 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.428 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -80.23 11.71 35.62 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.741 179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.446 ' C ' ' HA3' ' A' ' 33' ' ' GLY . . . -70.02 -11.4 66.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.615 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.469 ' HA ' ' HB2' ' A' ' 31' ' ' PRO . 0.4 OUTLIER -73.68 -2.41 23.06 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.966 0.412 . . . . 0.0 110.103 179.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -54.5 -23.8 17.83 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.926 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.07 -31.38 63.15 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.891 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -59.72 -56.32 23.25 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.449 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -59.45 -35.98 75.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.547 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.67 -48.97 79.4 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.347 178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.66 -22.88 67.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.566 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.584 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -72.9 -27.42 61.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.681 -179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.65 -18.25 64.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.519 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.47 35.88 0.87 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.688 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.75 HD11 ' HD2' ' A' ' 29' ' ' ARG . 0.6 OUTLIER -72.88 -164.57 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.493 -0.354 . . . . 0.0 111.047 -178.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.624 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.7 OUTLIER -50.95 101.52 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.964 0.411 . . . . 0.0 111.154 -179.094 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.09 -33.33 79.07 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.51 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.4 t -86.98 -39.15 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.841 0.353 . . . . 0.0 110.501 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.631 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 22.0 t -95.5 90.93 5.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.609 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.588 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -76.9 136.79 38.84 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 177.098 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.976 HG21 HG22 ' A' ' 8' ' ' ILE . 17.7 mt -101.45 146.91 8.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.743 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -85.84 71.72 10.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.695 HG23 ' HB ' ' A' ' 80' ' ' ILE . 73.6 t -79.96 54.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.08 -174.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -133.08 2.73 3.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.418 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.788 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 20.6 t0 -85.3 140.11 31.07 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 120.8 0.333 . . . . 0.0 110.961 -178.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.505 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 4.7 p -147.82 163.75 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.385 -178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.508 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 4.1 mtt180 -148.62 87.45 1.57 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.614 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.64 81.79 5.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.704 -0.226 . . . . 0.0 111.587 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -84.29 89.19 7.31 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.775 178.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.2 mtm . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.961 179.953 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.554 ' HG2' ' HB3' ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.925 0.393 . . . . 0.0 111.252 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.417 ' H ' ' H ' ' A' ' 3' ' ' ASP . . . -173.07 3.0 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.748 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.417 ' H ' ' H ' ' A' ' 2' ' ' GLY . 0.1 OUTLIER -94.4 160.89 14.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.851 0.358 . . . . 0.0 111.481 179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.492 HG13 ' HD3' ' A' ' 87' ' ' ARG . 0.2 OUTLIER -102.52 119.11 50.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.756 177.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 t -114.87 113.21 42.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.973 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.817 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.55 165.99 12.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.332 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.784 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 7.4 m -143.41 130.71 20.91 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.658 0.742 . . . . 0.0 112.187 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.083 HG22 HG21 ' A' ' 80' ' ' ILE . 5.7 mm -122.15 107.38 19.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.728 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.769 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.19 95.34 8.06 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.511 HG11 ' HE ' ' A' ' 29' ' ' ARG . 1.9 m -94.27 137.85 22.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.899 0.381 . . . . 0.0 111.841 -177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.741 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.1 ptm -147.43 127.61 6.76 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 121.177 0.513 . . . . 0.0 111.455 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.631 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 13.3 Cg_exo -72.37 124.74 10.14 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.525 2.817 . . . . 0.0 112.141 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -56.91 -33.54 67.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.274 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.94 151.9 79.48 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.992 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -67.95 -2.54 8.91 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.407 2.071 . . . . 0.0 111.978 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.39 44.23 1.18 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.025 178.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.631 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 74.3 t -64.86 77.99 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.625 -178.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.42 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 19.3 m-20 -70.86 91.44 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.916 177.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.886 HD13 ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.67 -36.08 83.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.353 -178.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.886 ' H ' HD13 ' A' ' 19' ' ' LEU . 8.7 pt-20 -69.91 -38.83 76.38 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 120.91 0.386 . . . . 0.0 110.177 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.658 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . . . -71.82 -33.9 68.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.341 0.591 . . . . 0.0 109.526 177.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.1 OUTLIER -66.04 -32.93 74.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.305 177.272 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.579 ' HA ' HD12 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -57.14 -45.53 83.45 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.95 -1.023 . . . . 0.0 110.419 178.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.658 ' HE3' ' HA ' ' A' ' 21' ' ' ALA . 2.0 mtmt -65.85 -43.25 89.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.582 179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -65.54 -30.06 70.77 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.474 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.646 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 5.7 mt -60.83 -45.85 97.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.957 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.637 ' NE2' HD21 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -61.07 -38.0 84.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.947 0.403 . . . . 0.0 110.688 -179.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -75.55 -23.07 56.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.333 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.767 HH22 ' HB ' ' A' ' 8' ' ' ILE . 23.6 ptt85 -90.99 -11.84 37.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.116 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 26' ' ' ILE . 27.6 mm -60.02 137.33 90.92 Favored Pre-proline 0 N--CA 1.463 0.21 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.019 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HD2' HG23 ' A' ' 30' ' ' ILE . 4.1 Cg_endo -46.89 120.82 4.41 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.853 2.368 . . . . 0.0 112.296 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -55.95 -11.02 0.91 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.832 -179.094 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.7 -41.84 10.58 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.407 -0.901 . . . . 0.0 112.901 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.539 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.38 -148.45 0.36 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.69 0.281 . . . . 0.0 110.995 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -137.23 175.02 9.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.836 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.637 HD21 ' NE2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -74.69 -176.07 2.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.237 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.648 ' ND1' HG22 ' A' ' 56' ' ' VAL . 79.5 t60 -131.04 -69.78 0.62 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.662 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -161.31 127.13 3.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.1 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.669 HG12 HG13 ' A' ' 53' ' ' VAL . 2.9 mt -91.78 158.01 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.626 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.647 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -128.78 119.23 24.15 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.461 -178.859 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -82.46 72.01 9.52 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.985 0.421 . . . . 0.0 110.401 178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.542 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -97.05 132.85 24.98 Favored Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.816 -179.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.771 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 58.9 Cg_endo -87.68 155.83 7.58 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.527 2.151 . . . . 0.0 112.8 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.699 HD11 ' HB3' ' A' ' 50' ' ' ALA . 1.8 mm -124.43 -82.03 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.098 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -67.66 -153.19 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.951 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -71.98 -27.88 63.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 110.709 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.64 5.83 0.53 Allowed Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.581 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.623 ' HA ' HG21 ' A' ' 17' ' ' VAL . 8.2 mp -91.1 97.5 11.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.791 0.329 . . . . 0.0 110.645 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 95.4 t -93.97 127.36 46.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.085 0.469 . . . . 0.0 112.163 -177.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.741 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.82 142.4 28.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.795 177.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.647 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -105.98 120.72 42.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.377 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.497 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.3 m120 -89.61 91.85 8.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.374 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.669 HG13 HG12 ' A' ' 39' ' ' ILE . 9.4 t -86.41 107.46 16.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.264 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.567 ' HG3' HG23 ' A' ' 7' ' ' THR . 12.5 mtt -84.46 168.28 15.63 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.168 179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.817 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.8 m -141.48 136.04 31.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 120.922 0.391 . . . . 0.0 111.312 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.648 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -96.12 112.76 28.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.769 178.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.539 HG12 HG21 ' A' ' 34' ' ' THR . 19.9 m -130.46 138.06 54.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.897 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.66 -60.52 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.322 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -80.89 -13.9 58.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.021 0.439 . . . . 0.0 110.376 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.527 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.91 -146.58 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.029 179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.61 -160.37 1.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.717 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.66 13.21 30.61 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.36 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.21 -1.92 37.51 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.54 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.474 HG22 ' OG1' ' A' ' 34' ' ' THR . 1.8 p -75.34 -6.41 49.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.975 0.417 . . . . 0.0 110.264 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.83 -23.48 18.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.341 177.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.02 -27.5 61.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.996 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.458 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.41 -55.59 29.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.31 179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -58.99 -34.85 72.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.573 178.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -62.58 -50.44 71.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.343 178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.413 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 14.5 p -63.39 -18.86 64.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.211 178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.605 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -72.9 -30.71 64.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.559 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -12.14 33.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.72 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.26 26.44 0.99 Allowed Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.829 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.682 HD11 ' HD2' ' A' ' 29' ' ' ARG . 2.4 tt -73.21 -160.75 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.671 -0.264 . . . . 0.0 110.873 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.606 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -51.01 99.9 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.842 0.353 . . . . 0.0 110.98 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.52 -32.58 78.42 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.596 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.2 t -88.25 -38.39 11.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.939 0.399 . . . . 0.0 110.543 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.588 ' HB2' ' HB3' ' A' ' 75' ' ' GLU . 6.1 m -95.81 90.65 5.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.76 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.568 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -79.43 137.75 37.37 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.092 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.083 HG21 HG22 ' A' ' 8' ' ' ILE . 1.7 mt -101.74 147.24 8.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.575 -176.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -86.01 72.02 10.51 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 172.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.686 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.9 t -80.79 56.66 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.124 -174.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -133.05 0.34 3.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.762 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.784 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 40.2 t0 -86.09 127.21 34.64 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.229 -177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.3 p -151.9 147.45 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 121.033 0.444 . . . . 0.0 111.792 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -133.73 100.82 4.89 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.216 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.492 ' HD3' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -82.01 83.46 7.27 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.964 178.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.554 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 0.0 OUTLIER -81.11 92.17 6.22 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 121.045 -0.262 . . . . 0.0 110.686 179.6 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.5 ptp . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.989 179.712 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ttm . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.957 0.408 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.54 -12.72 0.03 OUTLIER Glycine 0 CA--C 1.516 0.126 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.158 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.519 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 2.9 m-20 -94.08 161.51 14.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.933 0.397 . . . . 0.0 111.59 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.575 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -98.62 118.15 44.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.364 177.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 41.1 t -109.96 118.41 56.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 0.0 111.755 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.691 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.04 161.76 14.16 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.646 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 6.2 m -140.97 131.41 25.24 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.682 0.753 . . . . 0.0 112.687 -178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.041 HG22 HG21 ' A' ' 80' ' ' ILE . 3.8 mm -121.03 105.78 17.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 114.264 -1.335 . . . . 0.0 110.367 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.808 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -93.69 93.4 8.0 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -177.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.483 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.9 m -92.44 136.0 25.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.826 -177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.722 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -146.55 123.94 5.98 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-O 121.235 0.54 . . . . 0.0 111.444 179.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.64 ' CD ' HG13 ' A' ' 17' ' ' VAL . 14.1 Cg_exo -70.4 120.99 7.57 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.305 2.67 . . . . 0.0 111.854 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -56.69 -31.2 64.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.153 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.62 153.19 81.07 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.983 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.593 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 46.4 Cg_endo -68.58 -2.9 10.08 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.446 2.097 . . . . 0.0 112.366 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -91.71 43.12 1.13 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.248 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.64 HG13 ' CD ' ' A' ' 12' ' ' PRO . 97.0 t -65.64 76.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.408 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.517 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 3.7 m-20 -70.03 97.65 1.19 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.619 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -63.23 -45.74 90.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.816 -177.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.78 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 28.3 tt0 -70.7 -35.62 72.85 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 120.759 0.314 . . . . 0.0 110.678 -178.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.517 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -67.52 -39.2 85.08 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 176.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -66.57 -31.5 72.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.836 177.02 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.78 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -55.46 -48.61 74.26 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.115 -179.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.497 ' HG2' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -68.16 -40.76 82.26 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.522 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.589 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 29.8 mm-40 -64.75 -30.02 71.02 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.07 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.765 HG12 HG21 ' A' ' 53' ' ' VAL . 1.2 mt -62.61 -46.4 96.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.988 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -60.94 -36.19 78.69 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.413 -179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 9.9 pt-20 -77.16 -22.36 52.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.433 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.812 ' HD3' HD11 ' A' ' 74' ' ' ILE . 8.6 ptp180 -89.55 -9.19 50.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.253 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.553 HD11 HG11 ' A' ' 53' ' ' VAL . 34.6 mm -57.82 138.89 82.69 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.466 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.762 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.2 Cg_endo -50.91 117.23 3.17 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.711 2.274 . . . . 0.0 111.972 178.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -59.12 1.76 0.06 Allowed 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.457 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.12 -62.54 1.81 Allowed Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.83 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.53 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -109.43 -139.26 0.38 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.591 0.234 . . . . 0.0 110.844 -179.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -134.9 166.16 23.65 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.868 0.366 . . . . 0.0 110.839 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -75.56 -175.97 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.093 -179.369 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.546 ' ND1' HG22 ' A' ' 56' ' ' VAL . 73.7 t60 -131.25 -79.08 0.52 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.912 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 10.1 mmtt -161.69 137.81 7.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.687 -179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.641 HD12 HG22 ' A' ' 53' ' ' VAL . 2.4 mm -92.11 166.63 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.452 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.0 OUTLIER -130.03 123.22 30.01 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.165 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -84.88 67.67 10.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.875 0.369 . . . . 0.0 110.518 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.535 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -95.44 133.9 25.16 Favored Pre-proline 0 C--O 1.225 -0.205 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.579 -179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.773 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 60.6 Cg_endo -87.12 155.65 8.32 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.62 2.213 . . . . 0.0 112.686 -178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.712 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.8 mm -124.81 -82.56 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.378 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.664 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.4 -150.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.173 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -71.87 -29.95 64.92 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.849 0.357 . . . . 0.0 110.587 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.71 6.36 0.54 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.736 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.664 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.8 mt -91.45 100.91 13.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.975 0.417 . . . . 0.0 110.835 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 78.3 t -92.96 128.52 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.72 -178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.722 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.35 143.0 27.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.103 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.614 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 10.9 mp -101.53 119.46 38.81 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.251 178.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.479 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.8 m120 -91.66 96.19 10.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.312 0.577 . . . . 0.0 111.011 -178.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.765 HG21 HG12 ' A' ' 26' ' ' ILE . 39.6 t -84.51 103.12 11.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.15 -177.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.577 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 18.5 mtt -86.3 161.63 18.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.101 177.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.691 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.3 m -139.32 135.12 40.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.883 0.373 . . . . 0.0 111.193 -178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.546 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -95.04 115.78 34.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.006 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 4' ' ' VAL . 13.8 m -130.35 151.1 35.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.983 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.53 -74.22 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.534 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -81.38 -3.01 51.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.913 0.387 . . . . 0.0 110.713 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.53 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.21 -147.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.366 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -147.57 -166.08 2.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.855 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.69 15.62 24.35 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.668 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.82 -5.19 50.85 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.528 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.72 -3.76 33.42 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.94 0.4 . . . . 0.0 110.296 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -55.19 -23.11 20.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.142 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.19 -27.34 61.86 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.121 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.762 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.16 -55.09 36.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.482 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -58.21 -36.11 72.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.458 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -61.36 -51.03 70.49 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.345 178.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.518 ' OG ' HD12 ' A' ' 74' ' ' ILE . 0.9 OUTLIER -63.5 -19.16 64.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.443 178.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.679 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.34 -29.55 62.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.602 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.68 -12.07 31.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.772 179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.15 25.82 1.0 Allowed Glycine 0 N--CA 1.452 -0.24 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.619 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.812 HD11 ' HD3' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -73.48 -164.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.476 -0.362 . . . . 0.0 111.187 -178.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.645 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.6 OUTLIER -50.37 100.78 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 121.006 0.431 . . . . 0.0 111.114 179.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.28 -31.54 79.37 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.873 -178.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.3 t -85.84 -35.79 9.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.006 0.432 . . . . 0.0 110.307 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.645 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 43.8 t -95.77 90.5 5.68 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.614 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.584 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.24 133.2 38.93 Favored 'General case' 0 CA--C 1.505 -0.757 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 177.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.041 HG21 HG22 ' A' ' 8' ' ' ILE . 3.2 mp -101.56 148.76 7.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.686 -175.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.455 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -85.81 71.36 10.67 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 172.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.682 HG23 ' HB ' ' A' ' 80' ' ' ILE . 57.9 t -79.82 50.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.079 -174.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -133.13 7.18 3.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.249 -0.887 . . . . 0.0 111.359 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.646 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.5 m-20 -84.33 142.55 30.11 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.994 0.426 . . . . 0.0 111.207 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.7 p -147.51 157.03 9.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.057 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -145.32 105.09 4.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.41 -178.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.7 83.56 7.87 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.921 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 10.5 mp -81.21 85.26 6.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.721 -0.218 . . . . 0.0 110.516 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.942 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ttm . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.976 0.417 . . . . 0.0 111.323 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.38 -2.42 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.375 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.674 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 2.1 m-20 -93.6 127.24 39.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.733 0.301 . . . . 0.0 111.712 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.545 ' O ' HG22 ' A' ' 57' ' ' VAL . 2.5 t -97.43 104.03 15.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.764 0.316 . . . . 0.0 110.565 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.497 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 53.1 t -105.3 114.78 45.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.588 -178.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.695 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -97.01 165.74 11.93 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.765 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 13.4 m -143.25 128.84 19.15 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.542 0.687 . . . . 0.0 111.859 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.037 HG22 HG21 ' A' ' 80' ' ' ILE . 3.4 mm -120.54 107.7 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.759 -178.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.793 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.58 95.46 7.63 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -177.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.535 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.8 m -93.28 135.86 26.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.854 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -147.59 119.31 4.58 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-O 121.279 0.561 . . . . 0.0 111.97 179.261 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.671 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.1 Cg_exo -69.99 119.14 6.13 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.197 2.598 . . . . 0.0 112.034 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -56.91 -29.13 62.78 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.172 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.43 148.98 74.75 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.046 -179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.53 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 35.9 Cg_endo -64.69 -7.38 14.52 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.303 2.002 . . . . 0.0 111.804 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.63 34.78 0.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.6 179.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.612 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.4 87.25 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 121.776 0.798 . . . . 0.0 109.892 179.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.605 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 55.3 m-20 -67.9 104.59 1.75 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.139 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.553 ' O ' ' HD3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -60.93 -53.47 56.94 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.445 -178.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.512 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 35.7 tt0 -69.75 -36.5 75.86 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.046 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.572 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -68.61 -35.16 76.96 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.45 -0.5 . . . . 0.0 109.779 177.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.605 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -65.36 -33.36 75.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.518 177.237 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HD3' ' O ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -55.98 -46.74 78.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.471 178.768 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -66.12 -42.81 88.68 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.41 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.734 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 51.0 mm-40 -65.34 -30.23 71.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.37 0.605 . . . . 0.0 110.438 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.679 ' O ' HG12 ' A' ' 30' ' ' ILE . 3.4 mt -60.69 -47.05 94.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.597 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.78 -38.11 89.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.387 -178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.734 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -77.32 -21.08 54.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.48 -178.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.658 ' HB2' HD11 ' A' ' 74' ' ' ILE . 3.3 ptp85 -89.15 -13.45 38.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.077 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.679 HG12 ' O ' ' A' ' 26' ' ' ILE . 34.4 mm -61.08 136.92 93.99 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 177.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.618 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 15.7 Cg_endo -55.88 129.49 35.24 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.334 2.023 . . . . 0.0 112.614 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.6 0.1 0.22 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.125 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.58 -56.69 2.74 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.977 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.593 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -119.11 -144.74 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.321 . . . . 0.0 111.416 -179.396 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -133.83 170.1 16.1 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.957 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -75.32 -173.83 2.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.217 -179.134 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.533 ' ND1' HG22 ' A' ' 56' ' ' VAL . 85.3 t60 -130.9 -75.48 0.53 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.423 0.63 . . . . 0.0 110.944 -179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.488 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER -164.45 129.37 2.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.788 -178.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.645 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -92.59 158.23 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.166 0.508 . . . . 0.0 112.362 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.608 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 5.1 m-20 -123.41 124.72 43.54 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.517 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -86.78 72.58 10.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.782 0.325 . . . . 0.0 110.624 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.559 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -100.05 136.0 20.25 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.93 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.76 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 64.2 Cg_endo -86.25 158.08 9.71 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.71 2.274 . . . . 0.0 112.629 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.725 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.9 mm -127.28 -83.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.657 -177.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.756 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.83 -148.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.283 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -71.58 -32.81 68.48 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.826 0.346 . . . . 0.0 110.591 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.65 7.23 0.58 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.638 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.756 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.3 mt -91.41 102.33 15.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.905 0.383 . . . . 0.0 110.814 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.76 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 75.3 t -92.64 130.03 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.848 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -94.94 159.27 15.11 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.814 178.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.608 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 10.5 mp -117.93 119.12 33.88 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.397 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.568 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.7 m120 -89.66 91.13 8.53 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.35 0.595 . . . . 0.0 110.159 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.674 HG21 HG12 ' A' ' 26' ' ' ILE . 5.9 t -87.04 103.24 13.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.418 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 15.1 mtt -84.63 166.13 17.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.237 178.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.695 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.6 m -140.0 135.21 37.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.868 0.366 . . . . 0.0 111.616 -178.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.533 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.79 110.62 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.759 178.483 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 4' ' ' VAL . 11.3 m -130.3 144.71 37.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.043 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -171.24 -64.14 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.417 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -80.94 -6.92 59.31 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.882 0.372 . . . . 0.0 110.635 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.593 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.88 -147.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.058 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -147.69 -161.65 1.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.78 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.56 13.08 30.6 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.579 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.26 -7.65 60.59 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.511 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.29 -4.5 36.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.892 0.377 . . . . 0.0 110.216 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.64 -23.69 18.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.03 177.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.88 -28.83 62.34 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.038 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.618 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -59.87 -56.5 21.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.577 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -58.58 -35.51 72.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.492 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -61.33 -51.11 70.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.438 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 26.1 p -64.01 -17.9 63.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.533 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.74 HD22 HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.25 -31.13 62.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.533 179.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.93 -10.24 27.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.687 178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.02 26.76 1.01 Allowed Glycine 0 N--CA 1.451 -0.362 0 N-CA-C 111.514 -0.635 . . . . 0.0 111.514 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.74 HD13 HD22 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -73.2 -169.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.291 -0.455 . . . . 0.0 111.087 -179.226 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -50.58 97.93 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 111.193 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.99 -31.68 81.51 Favored Glycine 0 C--N 1.333 0.385 0 CA-C-N 115.778 -0.647 . . . . 0.0 112.927 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.3 t -85.59 -37.27 11.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.137 0.494 . . . . 0.0 109.982 179.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.671 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 1.5 m -95.37 87.8 4.91 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.039 179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.561 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -76.45 135.62 39.4 Favored 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.103 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.037 HG21 HG22 ' A' ' 8' ' ' ILE . 2.6 mt -101.45 148.58 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.566 -175.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.682 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 33.6 tp10 -85.95 69.89 10.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.701 HG23 ' HB ' ' A' ' 80' ' ' ILE . 61.7 t -80.69 57.86 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.679 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -132.76 -2.56 3.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.874 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.765 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 2.6 m-20 -85.3 131.51 34.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.267 -178.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.479 HG22 ' HD2' ' A' ' 87' ' ' ARG . 2.6 p -150.74 158.04 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.017 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 4.9 mtt180 -148.27 81.79 1.48 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.013 0.435 . . . . 0.0 111.06 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.479 ' HD2' HG22 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -78.16 82.28 4.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.132 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.674 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 10.3 mp -80.7 84.11 6.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.294 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.926 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.625 ' HG2' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.986 0.422 . . . . 0.0 111.311 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.405 ' H ' ' H ' ' A' ' 3' ' ' ASP . . . -173.54 10.97 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.581 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.679 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 1.0 OUTLIER -89.76 160.93 16.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.908 0.385 . . . . 0.0 111.49 -179.427 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.515 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.1 OUTLIER -107.87 128.65 62.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.32 177.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 83.2 t -129.54 115.25 33.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.055 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.537 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.56 165.98 12.07 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.76 179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.775 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.9 m -141.99 127.01 18.36 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.588 0.709 . . . . 0.0 111.898 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.006 HG22 HG21 ' A' ' 80' ' ' ILE . 8.3 mm -120.57 108.85 23.91 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.925 -178.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.817 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.77 96.85 8.52 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -178.1 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.613 ' CB ' HG12 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -92.85 139.98 17.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -176.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.643 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -146.14 122.57 5.82 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.249 179.328 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.598 ' HG2' HG13 ' A' ' 17' ' ' VAL . 11.6 Cg_exo -72.9 120.86 6.89 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.462 2.775 . . . . 0.0 112.383 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -57.57 -31.21 65.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.338 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.58 151.02 79.95 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.039 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.591 ' HA ' HD21 ' A' ' 48' ' ' LEU . 41.9 Cg_endo -66.86 -3.32 9.27 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.421 2.081 . . . . 0.0 112.003 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.16 42.69 1.11 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.353 179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.598 HG13 ' HG2' ' A' ' 12' ' ' PRO . 95.7 t -65.02 77.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.068 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 62.7 m-20 -68.93 100.86 1.26 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.165 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.76 ' HG ' HD11 ' A' ' 51' ' ' LEU . 3.1 tt -62.96 -49.21 75.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.481 -178.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -68.15 -38.26 81.94 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.739 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.491 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -69.78 -37.13 76.25 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.011 177.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -65.42 -34.12 77.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.697 177.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -47.26 85.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.285 -0.87 . . . . 0.0 111.088 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.487 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -69.32 -37.15 77.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.188 0.518 . . . . 0.0 110.388 179.146 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.487 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 12.5 mt-10 -66.26 -31.02 71.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.017 178.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.708 HG12 HG21 ' A' ' 53' ' ' VAL . 2.1 mt -62.38 -42.69 96.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.444 178.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.434 ' NE2' HG22 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -57.72 -39.66 77.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.443 179.343 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -74.83 -24.24 58.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.708 -178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.792 ' HB2' HD11 ' A' ' 74' ' ' ILE . 2.4 ptp180 -88.56 -12.84 41.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.758 -178.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.42 HG23 ' HD2' ' A' ' 31' ' ' PRO . 22.7 mm -57.65 135.44 82.58 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.791 -0.186 . . . . 0.0 110.577 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.626 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.5 Cg_endo -53.07 126.63 22.11 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.509 2.139 . . . . 0.0 112.335 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -58.05 -2.01 0.15 Allowed 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 115.835 -0.621 . . . . 0.0 112.401 -178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -81.83 -46.36 6.77 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.515 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.472 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.55 -142.51 0.24 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.672 0.272 . . . . 0.0 110.993 179.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -139.44 173.09 11.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.022 0.439 . . . . 0.0 110.855 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -74.44 -176.75 2.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.236 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.52 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 83.4 t60 -131.73 -71.92 0.55 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.475 0.655 . . . . 0.0 111.167 -178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.531 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -162.72 128.62 3.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.992 -177.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.683 HD13 HG22 ' A' ' 53' ' ' VAL . 2.5 mt -94.77 160.1 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.118 -177.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.662 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.1 t0 -127.38 128.79 46.44 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.633 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -87.34 73.38 9.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.789 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.511 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.2 OUTLIER -98.88 133.43 22.33 Favored Pre-proline 0 C--O 1.225 -0.22 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.309 179.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.794 ' HB3' HG22 ' A' ' 49' ' ' VAL . 62.6 Cg_endo -87.56 157.03 7.79 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.519 2.146 . . . . 0.0 113.086 -177.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.712 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.3 mm -124.74 -83.01 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.245 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.457 ' H ' ' HB ' ' A' ' 44' ' ' ILE . . . -67.3 -156.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.034 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -71.94 -25.1 61.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.625 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.51 0.98 0.33 Allowed Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.119 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.591 HD21 ' HA ' ' A' ' 15' ' ' PRO . 6.0 mt -92.01 100.24 12.92 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.887 0.375 . . . . 0.0 110.765 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.794 HG22 ' HB3' ' A' ' 43' ' ' PRO . 70.0 t -92.52 132.8 35.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.646 -178.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.712 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.86 162.0 13.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.006 178.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.76 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.2 mp -120.63 121.15 37.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.546 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.551 HD22 ' HB3' ' A' ' 9' ' ' LYS . 1.2 m120 -90.11 91.66 8.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.207 0.527 . . . . 0.0 110.042 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.708 HG21 HG12 ' A' ' 26' ' ' ILE . 11.3 t -86.73 104.34 13.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.531 -177.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.718 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -85.01 162.89 19.18 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.905 178.186 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.537 HG22 ' HB3' ' A' ' 6' ' ' ALA . 4.6 m -136.86 127.02 39.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.949 0.404 . . . . 0.0 111.116 -178.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.52 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 0.4 OUTLIER -94.36 109.86 22.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.938 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 4' ' ' VAL . 2.3 m -128.24 146.63 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.664 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.28 -61.94 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.536 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -80.21 -11.26 59.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.092 0.472 . . . . 0.0 110.239 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.472 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.89 -144.13 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.935 178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.45 -166.52 2.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.813 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.86 15.16 22.28 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.534 178.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.08 -0.54 28.56 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.521 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.44 HG22 ' OG1' ' A' ' 34' ' ' THR . 1.3 p -73.45 -3.45 27.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.944 0.402 . . . . 0.0 110.355 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.92 -23.72 20.22 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.163 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.17 -27.53 61.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.074 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -59.58 -56.28 23.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.488 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -57.88 -36.88 73.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.612 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.93 -51.86 67.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.552 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.422 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 54.7 p -64.59 -20.29 66.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.85 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.634 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -73.09 -27.96 62.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.834 -179.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -14.38 55.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.707 179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.35 28.16 0.97 Allowed Glycine 0 N--CA 1.452 -0.289 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.819 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.792 HD11 ' HB2' ' A' ' 29' ' ' ARG . 1.2 tt -72.97 -160.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.497 -0.351 . . . . 0.0 110.933 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.703 ' HB2' HH12 ' A' ' 29' ' ' ARG . 0.1 OUTLIER -50.07 91.15 0.0 OUTLIER 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.993 0.425 . . . . 0.0 111.011 179.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.3 -26.54 66.28 Favored Glycine 0 C--N 1.334 0.441 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.337 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.8 p -86.62 -39.59 13.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.282 0.563 . . . . 0.0 110.09 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.617 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 11.9 t -95.96 90.35 5.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.331 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.6 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -75.77 132.29 40.35 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.006 HG21 HG22 ' A' ' 8' ' ' ILE . 12.5 mt -101.08 147.3 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.479 -175.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.689 ' HG2' ' HB2' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -85.62 73.69 10.4 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 172.106 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.739 HG23 ' HB ' ' A' ' 80' ' ' ILE . 90.5 t -80.97 55.55 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.743 -174.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.68 2.91 3.79 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.403 179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.775 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 30.3 t0 -85.5 137.4 32.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.778 0.323 . . . . 0.0 110.854 -178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 p -146.66 160.6 9.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.1 -178.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.5 mtt-85 -148.92 89.29 1.66 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.839 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -78.8 109.42 13.03 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.723 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.679 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 10.2 mp -81.83 77.8 8.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.81 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 17.1 ptp . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.859 179.736 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.593 ' HG2' ' H ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 121.078 0.466 . . . . 0.0 111.027 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.593 ' H ' ' HG2' ' A' ' 1' ' ' MET . . . -161.17 -9.6 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.192 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -95.19 154.09 17.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.209 -0.495 . . . . 0.0 111.421 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.648 HG13 ' HA ' ' A' ' 87' ' ' ARG . 15.8 t -98.48 114.0 34.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.798 177.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.514 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 38.8 t -104.76 115.19 46.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.343 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.776 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -93.07 166.19 12.47 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.71 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 10.1 m -142.12 136.52 30.16 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 121.542 0.687 . . . . 0.0 112.44 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.975 HG22 HG21 ' A' ' 80' ' ' ILE . 8.3 mm -125.53 105.55 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.991 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.756 ' C ' HG23 ' A' ' 80' ' ' ILE . 2.2 mmmt -97.38 96.97 8.73 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -176.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.467 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.5 m -94.02 136.15 26.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.875 0.369 . . . . 0.0 111.931 -177.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.63 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -146.9 123.16 5.58 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.314 179.306 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.64 ' CD ' HG13 ' A' ' 17' ' ' VAL . 10.2 Cg_exo -73.86 122.25 7.58 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.562 2.841 . . . . 0.0 112.077 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -57.47 -32.04 66.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.448 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.35 152.32 81.38 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.032 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.552 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 42.2 Cg_endo -67.55 -3.23 9.79 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.417 2.078 . . . . 0.0 112.154 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.8 43.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.103 178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.64 HG13 ' CD ' ' A' ' 12' ' ' PRO . 93.7 t -65.29 75.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.389 -178.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 3.8 m-20 -70.33 88.88 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.651 -0.499 . . . . 0.0 109.651 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.879 HD13 ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.18 -38.43 91.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.825 -177.187 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.94 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 1.4 tt0 -70.67 -36.23 73.23 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.05 0.452 . . . . 0.0 110.086 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.61 -37.54 76.92 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.52 ' CD2' ' HG3' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -66.45 -30.19 70.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.843 -1.071 . . . . 0.0 109.909 177.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.94 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -54.53 -46.41 73.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.437 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 7.2 mtmt -67.14 -44.53 79.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.513 178.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -65.19 -25.96 67.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.566 -179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.741 HG12 HG21 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -60.47 -49.65 83.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.361 -179.368 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.478 ' OE1' HD22 ' A' ' 36' ' ' LEU . 6.1 mm-40 -62.97 -32.48 73.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.155 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 15.3 mt-10 -74.62 -24.08 58.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.024 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.734 ' HB2' HD11 ' A' ' 74' ' ' ILE . 1.2 ptp85 -91.95 -13.51 31.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.362 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 26' ' ' ILE . 10.1 mm -59.49 140.16 88.76 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.911 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.587 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.4 Cg_endo -51.44 112.7 0.87 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.744 2.296 . . . . 0.0 112.119 178.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.77 -0.87 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.253 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.03 -35.95 16.76 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.956 -178.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.5 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.3 -142.96 0.24 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.694 0.247 . . . . 0.0 110.96 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.412 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 8.1 mt-10 -135.12 167.01 21.75 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-O 120.883 0.373 . . . . 0.0 111.116 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.497 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -75.32 -179.89 4.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.384 -179.033 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.653 ' ND1' HG22 ' A' ' 56' ' ' VAL . 79.4 t60 -130.77 -75.81 0.53 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.96 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.615 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -165.43 131.84 2.75 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.744 -178.51 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.713 HG12 HG13 ' A' ' 53' ' ' VAL . 2.5 mt -91.41 155.93 3.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 121.202 0.525 . . . . 0.0 112.362 -176.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.601 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 61.0 m-20 -120.42 126.68 51.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.692 -178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.39 71.38 9.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.819 0.343 . . . . 0.0 110.304 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.521 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.81 134.25 21.14 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.796 -179.619 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.791 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 73.7 Cg_endo -87.07 157.69 8.5 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.575 2.184 . . . . 0.0 112.608 -178.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.727 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.5 mm -125.65 -82.64 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.36 -177.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.537 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.05 -153.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.969 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -71.74 -28.22 63.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.637 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.45 4.58 0.5 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.97 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.552 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.7 mt -92.34 102.61 15.09 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.859 0.361 . . . . 0.0 110.975 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.791 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 76.6 t -93.0 130.47 42.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.792 -178.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.727 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.21 153.31 17.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.916 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.601 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 10.5 mp -111.53 117.18 32.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.33 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.607 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.2 m120 -89.79 92.48 9.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.208 0.528 . . . . 0.0 110.379 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.741 HG21 HG12 ' A' ' 26' ' ' ILE . 4.0 t -86.81 105.82 15.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.274 -178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.486 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.1 OUTLIER -84.62 166.56 17.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.432 179.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.776 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.9 m -138.99 139.3 40.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.223 -178.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.653 HG22 ' ND1' ' A' ' 37' ' ' HIS . 1.9 t -93.57 106.61 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.137 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.617 HG13 HG23 ' A' ' 55' ' ' VAL . 2.8 m -127.82 155.61 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.793 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.79 -73.41 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.087 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.67 0.89 36.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.994 0.426 . . . . 0.0 110.494 178.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.492 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.02 -146.89 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.019 179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.82 -165.35 2.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.936 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.3 13.34 33.97 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.433 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.01 -4.23 47.75 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.938 -0.648 . . . . 0.0 112.536 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.6 p -75.04 -3.92 35.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.966 0.412 . . . . 0.0 110.105 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -55.43 -23.55 25.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.258 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.11 -29.63 60.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.874 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.587 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.78 -56.29 21.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.337 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.681 ' HA ' HD12 ' A' ' 71' ' ' LEU . 3.3 mt-10 -58.57 -33.92 70.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.431 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -51.85 65.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.261 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.58 -16.83 61.93 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.028 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.02 HD11 HG11 ' A' ' 82' ' ' VAL . 2.1 mt -72.3 -33.52 67.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.374 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.76 -9.7 15.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.0 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.08 26.73 1.0 Allowed Glycine 0 N--CA 1.453 -0.221 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.734 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.9 OUTLIER -73.3 -166.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.153 -0.523 . . . . 0.0 111.407 -178.437 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 2.7 mm-40 -51.61 101.65 0.04 OUTLIER 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.878 0.371 . . . . 0.0 110.901 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.75 -33.95 88.33 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.776 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -86.02 -39.45 13.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.989 0.423 . . . . 0.0 110.346 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.62 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 48.3 t -96.06 91.22 5.85 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.782 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.596 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.79 134.02 38.11 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.975 HG21 HG22 ' A' ' 8' ' ' ILE . 2.9 mp -101.38 148.34 7.38 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.379 -176.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.532 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.3 tp10 -86.02 69.32 10.51 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 173.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 1.02 HG11 HD11 ' A' ' 71' ' ' LEU . 47.7 t -81.12 51.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 114.378 -1.283 . . . . 0.0 111.18 -174.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.82 6.64 4.0 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.542 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.71 ' HB2' ' HB ' ' A' ' 7' ' ' THR . 2.3 m-20 -85.29 138.2 32.47 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.441 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.0 p -148.45 151.63 13.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.151 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.577 ' HB3' HD21 ' A' ' 88' ' ' LEU . 5.8 mtt180 -149.53 78.2 1.36 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.018 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.648 ' HA ' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -79.63 79.67 6.09 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.52 -179.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.577 HD21 ' HB3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -81.06 93.82 6.47 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.369 178.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.3 mtm . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.245 -0.884 . . . . 0.0 111.005 -179.924 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 121.424 0.63 . . . . 0.0 112.115 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.76 -13.19 0.04 OUTLIER Glycine 0 C--N 1.331 0.261 0 CA-C-N 115.021 -0.991 . . . . 0.0 111.409 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 1.6 m-20 -94.72 174.98 6.84 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.182 0.515 . . . . 0.0 111.943 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.444 ' HB ' HG23 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -103.17 132.22 49.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.361 177.262 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.635 ' HB ' ' HB2' ' A' ' 86' ' ' ARG . 42.1 t -128.62 128.09 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.701 0.286 . . . . 0.0 111.652 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.698 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -99.4 167.04 10.88 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 176.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.829 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.4 m -142.83 133.2 24.79 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.594 0.712 . . . . 0.0 112.386 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.977 HG22 HG21 ' A' ' 80' ' ' ILE . 5.9 mm -125.89 108.43 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 114.434 -1.257 . . . . 0.0 110.777 -178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.721 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -98.7 96.69 8.09 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.376 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.802 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.9 m -94.0 138.02 21.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -177.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.659 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.76 119.57 4.57 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 121.157 0.503 . . . . 0.0 111.806 179.41 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 21.1 Cg_exo -69.71 123.64 10.32 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 123.464 2.776 . . . . 0.0 112.007 178.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -57.17 -30.52 64.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.508 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.2 m -77.6 148.52 76.74 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.053 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.64 -6.6 14.21 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.419 2.079 . . . . 0.0 111.779 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -93.44 36.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.605 179.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.72 88.49 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-O 121.78 0.8 . . . . 0.0 110.134 -179.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.568 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 32.9 m-20 -68.25 104.27 1.79 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.034 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.792 ' HG ' HD11 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -61.24 -52.2 65.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.707 -178.146 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.743 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.5 OUTLIER -71.2 -34.37 70.81 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.277 -177.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -68.28 -35.93 78.61 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 177.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.568 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -66.16 -33.53 75.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.384 176.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.743 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -55.92 -46.61 78.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.132 178.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.57 -43.31 90.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.798 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.541 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 11.3 mt-10 -66.55 -30.73 71.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.257 0.551 . . . . 0.0 110.722 -179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.751 HG12 HG21 ' A' ' 53' ' ' VAL . 1.6 mt -61.75 -43.92 97.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.816 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -62.21 -38.8 90.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.063 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 10.6 pt-20 -77.84 -21.16 51.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.553 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.8 ' HB2' HD11 ' A' ' 74' ' ' ILE . 20.0 ptt85 -89.86 -9.57 48.55 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.19 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 26' ' ' ILE . 32.6 mm -59.7 138.16 89.92 Favored Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.281 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.639 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.2 Cg_endo -50.83 118.86 4.56 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.868 2.378 . . . . 0.0 112.279 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -59.13 -1.2 0.16 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.116 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.26 -42.82 8.39 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.918 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.688 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.49 -144.17 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.685 0.279 . . . . 0.0 110.951 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -133.35 167.08 21.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.874 0.368 . . . . 0.0 110.807 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.538 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.8 pt? -75.92 -176.01 3.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.23 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.58 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.8 t60 -130.85 -76.46 0.53 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.369 0.604 . . . . 0.0 111.195 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 2.2 tptt -164.53 133.52 3.63 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.794 -178.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.695 HG23 HG22 ' A' ' 53' ' ' VAL . 1.7 mt -93.09 158.2 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -176.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -123.79 125.51 44.83 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.318 -178.635 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.454 ' H ' ' HG3' ' A' ' 41' ' ' GLU . 0.9 OUTLIER -86.12 73.84 10.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.93 0.395 . . . . 0.0 110.508 178.216 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.493 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -98.94 131.02 26.27 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.295 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.82 ' HB3' HG22 ' A' ' 49' ' ' VAL . 59.0 Cg_endo -87.53 157.57 7.85 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.485 2.123 . . . . 0.0 112.949 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.705 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.4 mm -124.34 -82.31 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.107 -177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -67.25 -157.53 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.84 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -72.28 -22.82 61.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.666 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.57 -1.18 0.25 Allowed Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.039 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.593 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 8.8 mp -90.7 100.99 13.74 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.81 0.305 . . . . 0.0 110.966 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.82 HG22 ' HB3' ' A' ' 43' ' ' PRO . 93.4 t -94.57 132.94 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.971 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.705 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.38 162.9 13.29 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.847 178.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.792 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.2 mp -121.12 120.36 35.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.716 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.2 m120 -90.92 91.18 8.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.281 0.562 . . . . 0.0 110.027 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.751 HG21 HG12 ' A' ' 26' ' ' ILE . 5.0 t -87.48 104.11 14.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.32 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.709 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.3 OUTLIER -84.69 165.28 18.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.339 179.187 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.698 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.5 m -138.41 137.47 43.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.451 -178.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.58 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.2 OUTLIER -94.35 118.19 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.911 179.326 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.688 HG12 HG21 ' A' ' 34' ' ' THR . 35.4 m -130.2 142.4 43.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.95 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -162.4 -70.88 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.455 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -81.41 -5.76 58.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.014 0.435 . . . . 0.0 110.5 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.547 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.67 -152.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.196 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.413 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 0.0 OUTLIER -148.01 -162.35 1.53 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.803 -179.868 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -81.07 14.07 28.93 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.276 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.0 -3.73 45.42 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.36 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -74.67 -3.39 31.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.016 0.436 . . . . 0.0 110.097 178.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.99 -23.47 19.44 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.045 177.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.0 -26.87 60.98 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.11 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.639 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.6 -52.79 62.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.107 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -59.21 -37.32 77.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.308 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.52 -49.05 78.29 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.137 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.427 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -63.85 -19.78 65.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.327 178.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.599 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.0 -30.7 62.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.422 179.463 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.2 p -64.51 -9.52 19.43 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.739 179.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.14 22.05 0.98 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.108 -0.567 . . . . 0.0 111.968 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.8 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -72.82 -164.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 122.3 0.24 . . . . 0.0 110.666 -179.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.589 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -50.81 100.26 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.929 0.395 . . . . 0.0 110.981 179.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.4 -27.03 68.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.048 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.4 p -90.15 -36.83 8.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.094 0.473 . . . . 0.0 110.824 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.559 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 1.6 m -95.6 89.26 5.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.602 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.417 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.6 OUTLIER -76.32 132.1 39.59 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.655 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.977 HG21 HG22 ' A' ' 8' ' ' ILE . 15.7 mt -101.18 147.16 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.252 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.469 -175.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.634 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 16.3 tp10 -85.53 69.93 10.71 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 173.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.706 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.0 t -80.17 48.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.001 -174.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.85 9.29 4.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.291 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.829 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 8.6 t70 -85.92 151.42 23.78 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.856 0.36 . . . . 0.0 111.082 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.48 ' C ' ' HG2' ' A' ' 86' ' ' ARG . 3.1 p -147.82 160.04 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.17 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.635 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -146.32 95.24 2.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.048 -179.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -79.1 86.97 4.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.335 178.446 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.477 HD13 ' HB ' ' A' ' 5' ' ' VAL . 11.2 mp -81.96 76.78 8.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.86 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.1 mmt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.187 -0.911 . . . . 0.0 110.946 179.906 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.786 0.327 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 89' ' ' MET . . . 173.42 -10.09 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.38 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.422 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 11.6 p-10 -88.92 140.78 29.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 111.382 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.627 ' HB ' HG22 ' A' ' 57' ' ' VAL . 1.7 t -96.83 107.0 19.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.724 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 9.7 t -104.88 110.78 31.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.12 -179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.619 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -101.2 166.86 10.56 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.338 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.754 HG23 ' HG3' ' A' ' 54' ' ' MET . 8.5 m -143.33 129.16 19.41 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-O 121.699 0.762 . . . . 0.0 112.251 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.008 HG22 HG21 ' A' ' 80' ' ' ILE . 6.3 mm -121.91 107.97 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.523 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.772 ' C ' HG23 ' A' ' 80' ' ' ILE . 2.8 mmmt -97.28 94.56 7.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.503 ' N ' HG23 ' A' ' 80' ' ' ILE . 2.0 m -93.37 137.84 21.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.741 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.7 OUTLIER -147.31 119.53 4.72 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-O 121.306 0.574 . . . . 0.0 111.915 178.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 22.2 Cg_exo -68.51 121.89 8.85 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.372 2.715 . . . . 0.0 111.982 178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -56.25 -29.61 61.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.269 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.424 ' O ' HG12 ' A' ' 17' ' ' VAL . 1.3 p -76.97 151.16 81.81 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.173 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.596 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 48.4 Cg_endo -67.85 -6.47 17.0 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.165 1.91 . . . . 0.0 111.387 178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -92.6 33.92 1.1 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.565 179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.05 87.15 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.8 0.809 . . . . 0.0 110.015 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 15.6 m-20 -70.08 106.99 3.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.47 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.924 ' HG ' HD11 ' A' ' 51' ' ' LEU . 2.2 tt -62.16 -49.58 75.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.226 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -68.67 -37.55 79.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.864 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.537 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -70.95 -34.0 71.04 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.58 178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -65.34 -32.62 74.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.574 177.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.644 ' HA ' HD12 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -58.37 -44.49 88.89 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.604 178.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.5 -42.49 92.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.337 178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -65.63 -32.12 73.51 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.179 0.514 . . . . 0.0 110.337 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.662 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 9.7 mt -60.94 -44.35 97.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.745 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -59.96 -39.65 86.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.542 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -74.73 -24.31 58.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.379 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.847 HH22 ' HB ' ' A' ' 8' ' ' ILE . 24.7 ptt85 -91.06 -14.02 32.08 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -178.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.629 HD11 HG11 ' A' ' 53' ' ' VAL . 12.1 mm -58.16 137.78 84.38 Favored Pre-proline 0 C--N 1.332 -0.186 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.481 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.492 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 5.2 Cg_endo -45.3 119.03 2.34 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.807 2.338 . . . . 0.0 112.231 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -57.3 -4.55 0.23 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.076 -179.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.95 -45.15 6.8 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.516 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.43 -142.19 0.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.765 0.316 . . . . 0.0 111.135 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -138.7 175.55 9.47 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-O 120.968 0.413 . . . . 0.0 110.748 -179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.493 ' H ' HD23 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -74.69 -175.69 2.54 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.342 -178.862 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.563 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 85.5 t60 -131.35 -68.87 0.64 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.095 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -159.34 121.27 3.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.257 -177.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.675 HD13 HG22 ' A' ' 53' ' ' VAL . 2.5 mt -91.72 157.5 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.513 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.647 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.64 123.66 36.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.804 -178.164 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.496 ' HB3' HD11 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -85.22 70.71 10.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.927 0.394 . . . . 0.0 110.426 177.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.547 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -97.41 135.73 21.65 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.767 -179.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.782 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 64.3 Cg_endo -86.62 157.73 9.16 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.609 2.206 . . . . 0.0 112.739 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.706 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.8 mm -126.56 -83.27 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.444 -177.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.741 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.52 -149.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.12 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -70.75 -32.85 70.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.638 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.56 7.76 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.631 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.741 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.7 mt -90.9 101.56 14.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.915 0.388 . . . . 0.0 110.685 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.782 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 73.8 t -93.0 128.99 44.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.923 -178.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.741 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.64 156.6 16.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.853 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.924 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.1 mp -115.76 119.97 37.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.461 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.514 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.6 m120 -89.82 91.0 8.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.337 0.589 . . . . 0.0 110.016 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.675 HG22 HD13 ' A' ' 39' ' ' ILE . 14.2 t -87.37 102.35 12.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.539 -177.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.754 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.1 OUTLIER -84.61 166.93 16.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.852 178.102 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.619 HG22 ' HB3' ' A' ' 6' ' ' ALA . 4.4 m -138.72 126.4 27.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.089 0.471 . . . . 0.0 111.431 -178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.563 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 1.3 p -99.06 106.85 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.696 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.627 HG22 ' HB ' ' A' ' 4' ' ' VAL . 1.3 m -124.99 166.6 20.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.649 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.25 -64.93 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.41 -0.9 . . . . 0.0 112.729 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -80.41 -5.8 57.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.943 0.401 . . . . 0.0 110.58 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.66 -147.54 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.037 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.62 -162.56 1.57 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.764 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.8 14.11 27.11 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.429 178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.83 -4.28 46.7 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.46 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -74.31 -7.3 52.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.923 0.392 . . . . 0.0 110.26 179.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.93 -23.38 31.52 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.984 177.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.3 -24.52 55.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.847 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.11 -55.93 26.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.137 179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.25 -34.96 72.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.408 178.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -60.9 -50.97 71.26 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.387 178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.462 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 5.0 p -64.0 -20.92 66.25 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.544 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.594 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.11 -27.44 62.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.565 -179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.79 -14.37 58.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.749 179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.41 26.34 0.97 Allowed Glycine 0 N--CA 1.451 -0.3 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.897 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 29' ' ' ARG . 2.8 tt -73.24 -163.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.55 -0.325 . . . . 0.0 110.906 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.702 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -52.16 90.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.989 0.423 . . . . 0.0 110.862 179.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.08 -24.86 59.01 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.879 -0.601 . . . . 0.0 112.844 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.96 -35.76 9.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.174 0.511 . . . . 0.0 110.251 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.702 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.5 OUTLIER -95.63 90.39 5.69 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.771 -179.498 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.406 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.7 OUTLIER -75.06 130.25 38.99 Favored 'General case' 0 CA--C 1.507 -0.697 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 177.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.008 HG21 HG22 ' A' ' 8' ' ' ILE . 3.0 mp -100.93 149.12 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 CA-C-N 115.239 -0.891 . . . . 0.0 112.38 -175.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.478 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 28.4 tt0 -85.69 68.99 10.58 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 173.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.709 HG23 ' HB ' ' A' ' 80' ' ' ILE . 48.7 t -80.47 58.34 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 114.269 -1.332 . . . . 0.0 110.728 -175.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.36 -3.9 3.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.879 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.693 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 8.3 m-20 -85.15 124.3 31.66 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.03 -178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.2 p -148.83 136.58 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.241 0.543 . . . . 0.0 111.653 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.56 HH21 ' HB3' ' A' ' 84' ' ' ASP . 1.1 mpt_? -134.52 87.42 2.35 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.919 -178.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.42 82.2 7.96 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.301 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -82.93 90.46 6.98 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.642 -0.254 . . . . 0.0 110.663 179.26 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.447 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.449 ' N ' ' HB2' ' A' ' 88' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.485 1.291 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 3' ' ' ASP . . . -159.93 -3.27 0.06 OUTLIER Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.646 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.532 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 3.5 p30 -94.85 142.89 26.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.329 -0.435 . . . . 0.0 111.46 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.512 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 1.8 t -98.14 103.01 14.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.329 177.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.531 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 14.5 t -104.31 115.05 45.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-O 120.874 0.368 . . . . 0.0 111.752 -178.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.587 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -97.31 165.05 12.21 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.687 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 8.5 m -140.67 131.45 25.81 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.643 0.735 . . . . 0.0 112.019 179.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.035 HG22 HG21 ' A' ' 80' ' ' ILE . 2.6 mm -124.32 106.0 16.17 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 114.29 -1.323 . . . . 0.0 110.667 -177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.584 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.55 95.26 7.86 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -177.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.772 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.4 m -92.89 136.05 26.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.804 0.335 . . . . 0.0 111.897 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.656 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -146.41 120.1 5.18 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 121.142 0.496 . . . . 0.0 111.81 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.632 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.4 Cg_exo -69.34 122.88 9.67 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.419 2.746 . . . . 0.0 111.9 178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -57.57 -29.63 64.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.291 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.472 ' O ' HG12 ' A' ' 17' ' ' VAL . 1.5 p -76.34 151.09 83.19 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.143 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 46.5 Cg_endo -67.41 -6.77 17.26 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.237 1.958 . . . . 0.0 111.457 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.17 35.63 0.99 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.435 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -68.12 83.8 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.93 0.871 . . . . 0.0 110.588 -179.046 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.556 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 19.4 m-20 -73.08 98.38 2.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.902 177.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.793 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -63.66 -43.81 95.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.589 -178.068 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.884 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 4.1 tp10 -69.23 -37.0 77.8 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 120.85 0.357 . . . . 0.0 110.321 -178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.572 ' O ' ' HD3' ' A' ' 24' ' ' LYS . . . -68.8 -38.12 79.72 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.556 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.9 OUTLIER -68.12 -24.82 65.06 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.987 -1.006 . . . . 0.0 110.2 177.218 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.884 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -58.59 -44.9 89.99 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.24 -179.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.572 ' HD3' ' O ' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -68.62 -40.01 80.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.762 179.609 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.731 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 4.9 mm-40 -67.8 -29.4 68.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.336 0.588 . . . . 0.0 110.302 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.729 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.2 mt -63.92 -38.38 82.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.036 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.421 ' NE2' HG22 ' A' ' 26' ' ' ILE . 0.0 OUTLIER -60.85 -40.95 94.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.221 -179.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.731 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -77.77 -20.8 52.73 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.514 -178.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.792 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.23 -11.95 45.17 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.93 -179.342 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.639 HG12 ' O ' ' A' ' 26' ' ' ILE . 20.4 mm -60.11 138.28 91.26 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.239 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.608 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.2 Cg_endo -50.68 114.71 1.59 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.793 2.328 . . . . 0.0 112.062 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.33 2.43 0.06 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.47 -45.73 6.78 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.789 -179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.588 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -130.36 -133.35 0.21 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.664 0.232 . . . . 0.0 111.175 -179.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -136.63 170.08 16.66 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.905 0.383 . . . . 0.0 110.941 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.538 HD22 HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -75.59 -174.09 2.39 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.108 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.506 ' ND1' HG22 ' A' ' 56' ' ' VAL . 85.2 t60 -130.45 -76.03 0.53 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.328 0.585 . . . . 0.0 110.939 -179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.546 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.3 OUTLIER -164.91 126.67 2.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.868 -178.594 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.633 HD13 HG22 ' A' ' 53' ' ' VAL . 2.8 mt -90.8 159.82 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.986 0.422 . . . . 0.0 111.865 -177.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.634 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.12 124.75 39.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.946 -178.147 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.67 68.82 10.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.914 0.388 . . . . 0.0 110.216 177.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.55 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -97.11 137.41 21.24 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.616 -179.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.797 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 73.7 Cg_endo -86.03 156.72 9.93 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.486 2.124 . . . . 0.0 112.738 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.742 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.1 mm -124.56 -82.23 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.3 -177.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.526 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.02 -152.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.992 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -71.8 -28.12 63.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.707 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.92 4.62 0.46 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.101 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.556 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.5 mt -92.43 104.24 16.58 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.842 0.353 . . . . 0.0 110.966 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.797 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 76.3 t -93.12 131.35 40.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.858 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.25 164.19 12.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.072 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.793 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.3 mp -120.63 117.69 28.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.211 179.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.2 m120 -90.47 92.05 8.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.254 0.55 . . . . 0.0 110.422 -179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.684 HG21 HG12 ' A' ' 26' ' ' ILE . 4.3 t -87.31 101.96 11.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.583 -178.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.488 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 33.4 mtt -84.71 165.91 17.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.218 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.587 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.1 m -139.63 133.76 37.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.38 . . . . 0.0 111.678 -178.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.506 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -98.36 113.47 33.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 178.474 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.512 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 7.7 m -130.49 142.54 43.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.979 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.38 -62.12 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.583 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -80.92 -12.19 59.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.002 0.43 . . . . 0.0 110.706 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.588 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -68.07 -144.53 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.106 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.29 -166.82 2.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.72 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.71 15.28 20.7 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.682 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.67 -0.51 32.69 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 121.005 -0.616 . . . . 0.0 112.602 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.9 p -74.16 -2.21 23.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.972 0.415 . . . . 0.0 110.148 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -55.07 -24.41 25.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.348 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.78 -27.27 59.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.08 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.608 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.51 -56.12 23.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.809 0.338 . . . . 0.0 110.362 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -58.75 -34.22 71.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.362 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -61.53 -51.45 68.55 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.325 178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.7 p -63.19 -19.05 64.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.561 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.854 HD22 HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.59 -28.79 61.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.59 179.628 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.02 -13.51 47.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.531 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.9 30.92 1.0 Allowed Glycine 0 N--CA 1.451 -0.358 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.392 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.854 HD13 HD22 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -72.85 -166.62 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.165 -0.517 . . . . 0.0 111.173 -178.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.681 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 1.4 mp0 -51.05 100.33 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.888 0.375 . . . . 0.0 111.007 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.15 -30.83 71.41 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.794 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 7.3 t -87.92 -37.27 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.803 0.335 . . . . 0.0 110.744 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.681 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 32.2 t -95.77 92.42 6.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.844 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.427 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -76.58 132.26 39.37 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.306 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.035 HG21 HG22 ' A' ' 8' ' ' ILE . 8.0 mt -100.58 144.7 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.088 -175.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.518 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.3 tt0 -85.24 69.56 10.76 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.711 HG23 ' HB ' ' A' ' 80' ' ' ILE . 48.0 t -81.43 56.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 113.92 -1.491 . . . . 0.0 111.249 -174.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 m -132.44 -0.12 3.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.929 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.687 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 5.5 m-20 -85.45 135.82 33.7 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 120.571 -0.452 . . . . 0.0 111.251 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' A' ' 87' ' ' ARG . 5.3 p -149.57 152.1 12.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.554 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.593 ' HB3' HD21 ' A' ' 88' ' ' LEU . 6.8 mtt180 -149.41 75.2 1.27 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.264 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.475 ' HA ' HG13 ' A' ' 4' ' ' VAL . 0.8 OUTLIER -81.48 78.27 8.25 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.557 -178.847 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.593 HD21 ' HB3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -82.8 102.62 11.71 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.417 178.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.969 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 ttm . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.663 0.268 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.57 -10.04 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.49 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.613 ' OD1' HD12 ' A' ' 88' ' ' LEU . 12.4 p-10 -90.17 147.12 23.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.822 0.344 . . . . 0.0 111.26 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.62 HG13 ' HG3' ' A' ' 87' ' ' ARG . 2.7 t -98.18 125.88 51.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.35 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 21.7 t -113.92 109.74 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.427 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.666 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.66 165.41 12.52 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 177.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.803 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.6 m -141.9 132.63 25.62 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.715 0.769 . . . . 0.0 112.273 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.027 HG22 HG21 ' A' ' 80' ' ' ILE . 4.3 mm -123.77 106.79 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.457 -178.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.766 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.62 96.45 8.65 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -177.221 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.491 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.6 m -94.62 137.62 22.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.904 -177.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.673 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.2 OUTLIER -147.39 121.72 5.06 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 121.264 0.554 . . . . 0.0 111.984 179.251 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 18.7 Cg_exo -71.02 124.11 10.28 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.599 2.866 . . . . 0.0 112.15 178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -57.9 -31.42 66.75 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.444 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 56.2 m -77.64 150.64 79.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.04 -179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.571 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 40.1 Cg_endo -66.66 -6.51 15.6 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.379 2.052 . . . . 0.0 111.942 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.53 34.0 0.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.405 179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.52 84.54 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 121.774 0.797 . . . . 0.0 110.111 179.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 11.5 m-20 -71.64 108.73 5.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.197 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.605 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.4 OUTLIER -63.45 -43.62 96.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.793 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.605 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 20.6 tp10 -68.95 -39.19 79.68 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.655 -179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.519 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -69.92 -36.54 75.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.44 0.638 . . . . 0.0 109.93 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -66.48 -33.89 76.71 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.48 177.383 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -45.65 89.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.981 -1.008 . . . . 0.0 111.079 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.521 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -68.88 -39.85 79.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.138 0.494 . . . . 0.0 110.385 179.121 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.521 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 31.9 mm-40 -66.01 -29.34 69.7 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.254 178.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.714 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 2.1 mt -62.22 -44.42 99.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.964 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -59.72 -36.72 77.13 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.985 0.421 . . . . 0.0 110.539 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -75.37 -23.93 57.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.687 -178.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.762 ' HD2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.05 -14.27 39.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.524 -178.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 26' ' ' ILE . 39.1 mm -58.55 136.82 86.04 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.461 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.607 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 17.7 Cg_endo -58.89 131.24 40.72 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.372 2.048 . . . . 0.0 112.534 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -61.0 0.53 0.22 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.962 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.52 -59.03 2.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.708 -178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.569 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -117.9 -143.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.668 0.27 . . . . 0.0 110.885 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -136.41 167.8 20.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.87 0.367 . . . . 0.0 110.711 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.403 ' H ' ' CD2' ' A' ' 36' ' ' LEU . 1.6 pt? -75.08 -175.71 2.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.108 -179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.522 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 81.4 t60 -131.52 -75.88 0.52 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.315 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -159.37 132.08 6.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.048 -178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.664 HG23 HG22 ' A' ' 53' ' ' VAL . 1.7 mt -93.37 161.23 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.013 -177.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.625 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -127.76 123.52 35.5 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.593 -178.639 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -85.56 71.16 10.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.897 0.38 . . . . 0.0 110.674 178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.547 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.5 mt-10 -98.65 136.28 20.8 Favored Pre-proline 0 N--CA 1.463 0.176 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.739 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.777 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 61.5 Cg_endo -87.64 157.26 7.69 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.662 2.241 . . . . 0.0 112.877 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.717 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.2 mm -125.41 -82.75 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.428 -177.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.723 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.26 -150.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.16 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -71.36 -31.49 67.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.592 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.43 6.73 0.58 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.771 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.723 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 3.9 mt -91.11 102.26 15.01 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.822 0.344 . . . . 0.0 110.771 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.777 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 70.2 t -93.32 129.65 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.966 -178.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.717 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.42 155.96 16.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.889 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.625 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.3 mp -114.45 118.09 32.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.392 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.52 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.2 m120 -89.9 92.56 9.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.245 0.545 . . . . 0.0 110.09 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.698 HG21 HG12 ' A' ' 26' ' ' ILE . 6.3 t -86.54 105.77 15.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.445 -178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 50.6 mtt -84.46 166.67 17.09 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.409 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.666 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.5 m -138.78 127.57 29.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.237 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.522 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 0.7 OUTLIER -95.68 108.25 20.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.598 179.254 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.569 HG12 HG21 ' A' ' 34' ' ' THR . 3.3 m -125.41 167.03 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.817 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.73 -75.37 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.842 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -81.3 2.57 27.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.832 0.349 . . . . 0.0 110.99 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.453 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.78 -147.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.116 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -147.74 -166.48 2.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.683 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.91 15.16 22.54 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.591 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.39 -5.56 55.29 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.549 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.43 ' HA ' ' HB2' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -74.08 -4.6 36.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.908 0.385 . . . . 0.0 110.383 179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.02 -23.65 20.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.044 177.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.18 -27.78 62.23 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.937 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.607 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.54 -56.54 20.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.353 179.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -58.74 -34.83 71.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.447 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -60.71 -51.96 67.14 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.471 178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.418 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -64.04 -19.33 65.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.572 178.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.614 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -72.92 -28.76 62.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.559 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.0 -11.88 43.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.954 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.2 25.29 0.99 Allowed Glycine 0 C--N 1.331 0.251 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.75 179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.762 HD11 ' HD2' ' A' ' 29' ' ' ARG . 2.6 tt -73.32 -163.35 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.47 -0.365 . . . . 0.0 111.059 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.605 ' N ' HG23 ' A' ' 74' ' ' ILE . 1.8 mp0 -51.01 96.51 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.81 0.338 . . . . 0.0 111.003 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -62.43 -27.34 69.3 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.281 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -88.27 -37.94 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.173 0.511 . . . . 0.0 110.435 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -96.23 90.0 5.32 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.424 179.745 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.595 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.57 134.77 38.18 Favored 'General case' 0 CA--C 1.506 -0.744 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 178.472 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.027 HG21 HG22 ' A' ' 8' ' ' ILE . 1.7 mt -101.54 147.42 8.45 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.563 -176.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.534 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 9.7 tp10 -86.02 70.39 10.6 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 173.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.706 HG23 ' HB ' ' A' ' 80' ' ' ILE . 58.2 t -80.46 52.94 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 114.441 -1.254 . . . . 0.0 110.999 -174.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -133.0 3.61 3.73 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.575 179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.803 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 18.8 t0 -85.4 130.64 34.54 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.052 -178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.517 HG22 ' HD2' ' A' ' 87' ' ' ARG . 4.7 p -148.08 146.04 18.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.022 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -149.26 95.15 2.33 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.149 0.5 . . . . 0.0 109.967 -178.644 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.62 ' HG3' HG13 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -85.13 106.15 16.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.399 -177.316 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.613 HD12 ' OD1' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -86.7 89.17 7.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.172 176.171 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.6 ttm . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.252 -0.88 . . . . 0.0 111.026 179.984 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.428 ' HB3' ' OXT' ' A' ' 89' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.862 0.363 . . . . 0.0 111.298 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 89' ' ' MET . . . 173.72 -0.59 0.03 OUTLIER Glycine 0 N--CA 1.454 -0.153 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.692 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -90.19 156.8 18.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 111.464 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.88 128.69 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.741 178.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 13.1 t -125.54 118.34 52.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.609 -0.268 . . . . 0.0 111.039 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.581 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.74 169.76 9.93 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 178.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.69 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 10.0 m -143.04 131.85 22.71 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.587 0.708 . . . . 0.0 112.011 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.091 HG22 HG21 ' A' ' 80' ' ' ILE . 7.3 mm -122.98 107.52 19.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.896 -177.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.779 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -97.28 95.28 7.6 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -177.7 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.596 HG11 ' NH1' ' A' ' 29' ' ' ARG . 2.0 m -94.64 136.71 25.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.659 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.53 121.11 4.88 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-O 121.036 0.446 . . . . 0.0 111.76 179.475 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.583 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 17.2 Cg_exo -71.82 118.64 5.74 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.522 2.815 . . . . 0.0 111.946 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -56.21 -28.36 58.03 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.133 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.38 149.21 78.49 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.106 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 37.9 Cg_endo -66.03 -7.68 17.76 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.401 2.068 . . . . 0.0 111.92 179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.1 36.06 1.05 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.698 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.624 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.16 87.7 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-O 121.79 0.805 . . . . 0.0 110.09 -179.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 28.0 m-20 -68.32 107.19 2.74 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.336 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.732 HD12 ' NZ ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -60.45 -54.81 41.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.66 -178.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.527 ' HG2' ' N ' ' A' ' 21' ' ' ALA . 7.6 pm0 -71.29 -34.46 70.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.279 -177.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.642 ' HA ' ' HE3' ' A' ' 24' ' ' LYS . . . -67.92 -35.71 78.92 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -65.77 -35.25 80.19 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.234 176.159 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.732 ' NZ ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -55.93 -46.83 78.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.034 178.541 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.642 ' HE3' ' HA ' ' A' ' 21' ' ' ALA . 2.6 mtmt -66.41 -43.8 84.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.815 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.737 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 52.9 mt-10 -67.58 -27.0 66.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.247 0.546 . . . . 0.0 110.969 -179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.652 HG12 HG21 ' A' ' 53' ' ' VAL . 1.1 mt -63.06 -43.14 98.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.951 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -62.56 -37.57 86.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.26 -179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.737 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 1.4 pp20? -77.21 -22.67 51.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.405 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.846 ' HB2' HD11 ' A' ' 74' ' ' ILE . 4.3 ptp85 -90.6 -11.95 38.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.088 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.646 HG12 ' O ' ' A' ' 26' ' ' ILE . 10.9 mm -61.57 139.29 95.13 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.87 178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.667 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 7.3 Cg_endo -47.88 115.87 1.67 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.854 2.37 . . . . 0.0 112.445 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -59.38 0.74 0.1 Allowed 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.105 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.92 -43.15 7.78 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.003 -178.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.573 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.15 -139.01 0.22 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.712 0.292 . . . . 0.0 111.246 -179.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -135.64 169.9 16.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.881 0.372 . . . . 0.0 110.932 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.702 HD13 ' H ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -76.38 -175.91 3.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.229 -179.532 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.645 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.3 t60 -131.01 -74.74 0.53 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.412 0.625 . . . . 0.0 110.952 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.444 ' HB3' ' CD2' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -163.88 129.27 2.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.953 -1.022 . . . . 0.0 109.667 -178.926 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.696 HG12 HG13 ' A' ' 53' ' ' VAL . 2.8 mt -93.08 155.85 3.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -176.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.637 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.7 m-20 -117.97 123.0 44.69 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.971 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -88.34 67.68 8.73 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.96 0.409 . . . . 0.0 110.142 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.688 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.98 148.54 34.97 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.368 -178.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.772 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 30.6 Cg_endo -92.49 160.53 2.97 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.996 2.464 . . . . 0.0 113.266 -177.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.75 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.2 mm -128.85 -82.87 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.248 -177.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.56 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -66.91 -151.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.924 179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -72.27 -28.55 63.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.67 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.07 4.99 0.46 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.599 -0.81 . . . . 0.0 113.1 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.9 mt -92.1 106.1 18.19 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.89 0.345 . . . . 0.0 110.906 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 24.2 t -92.59 132.22 37.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.814 -178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.75 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.18 163.29 13.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.85 178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.637 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.0 mp -120.57 116.17 24.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.513 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.562 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.7 m120 -89.65 91.0 8.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.379 0.609 . . . . 0.0 110.046 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.696 HG13 HG12 ' A' ' 39' ' ' ILE . 3.8 t -87.16 105.65 15.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.576 -177.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 62.8 mtt -84.71 165.31 17.97 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.937 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.581 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.3 m -138.69 136.77 43.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.886 0.374 . . . . 0.0 111.581 -178.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.645 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.3 OUTLIER -94.74 108.42 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.778 178.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.434 HG12 ' CB ' ' A' ' 34' ' ' THR . 21.9 m -125.39 137.96 55.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.855 0.359 . . . . 0.0 110.975 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.89 -58.72 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.331 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -81.08 -16.58 52.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.084 0.469 . . . . 0.0 110.4 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.573 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -68.15 -144.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.17 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.5 -163.35 1.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.785 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.9 13.75 29.42 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.544 178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.37 -1.24 34.65 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.639 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.1 p -74.75 -4.14 35.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.968 0.413 . . . . 0.0 110.205 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -54.96 -23.91 21.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.337 177.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.07 -25.6 58.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.159 -179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.667 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.48 -56.59 18.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.8 0.334 . . . . 0.0 110.244 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -58.97 -34.0 71.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.276 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.94 -51.02 69.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.307 178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -18.23 63.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.263 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.702 HD22 HD13 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.65 -29.7 62.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.482 179.401 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -10.74 31.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.782 179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.1 25.08 1.0 Allowed Glycine 0 N--CA 1.452 -0.264 0 N-CA-C 111.536 -0.625 . . . . 0.0 111.536 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.846 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -73.32 -168.45 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.338 -0.431 . . . . 0.0 111.235 -179.04 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.558 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.5 OUTLIER -51.09 93.5 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.353 179.137 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.2 -26.32 61.23 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.018 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -87.99 -41.16 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.181 0.515 . . . . 0.0 110.186 178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -95.9 87.97 4.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.122 178.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.572 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.81 135.74 38.0 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.263 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.091 HG21 HG22 ' A' ' 8' ' ' ILE . 1.7 mt -101.5 147.72 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 CA-C-N 115.322 -0.854 . . . . 0.0 112.469 -176.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.586 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 7.2 tp10 -86.07 71.09 10.62 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 172.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.688 HG23 ' HB ' ' A' ' 80' ' ' ILE . 59.0 t -80.68 52.17 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.063 -174.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 m -132.8 4.57 3.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.402 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.69 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.2 m-20 -85.03 140.65 30.86 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.169 -178.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.3 p -148.15 157.67 8.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.221 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 8.8 mtt180 -149.24 90.64 1.76 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.107 -179.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.24 89.81 5.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.853 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.446 HD11 ' CG2' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -81.38 89.65 6.12 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.651 -0.249 . . . . 0.0 110.629 179.545 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.428 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 9.1 ptp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.964 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.873 0.368 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.41 ' HA2' ' OXT' ' A' ' 89' ' ' MET . . . 173.23 -20.55 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -95.4 164.66 12.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.152 -0.524 . . . . 0.0 111.138 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.823 HG12 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -97.95 117.68 43.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.048 0.452 . . . . 0.0 110.17 177.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 40.8 t -109.71 120.36 60.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.492 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.627 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.03 167.91 11.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.682 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 11.4 m -141.65 131.37 24.18 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-O 121.6 0.714 . . . . 0.0 112.185 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.069 HG22 HG21 ' A' ' 80' ' ' ILE . 2.1 mm -120.56 105.01 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 114.417 -1.265 . . . . 0.0 110.688 -178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.636 ' HD2' ' HB3' ' A' ' 52' ' ' ASN . 0.9 OUTLIER -96.38 93.98 7.16 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.745 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.4 m -92.02 136.91 23.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.84 -177.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.675 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.32 119.26 4.67 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 121.131 0.491 . . . . 0.0 111.878 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.587 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 17.8 Cg_exo -70.96 122.22 8.59 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.49 2.794 . . . . 0.0 112.198 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.89 -30.3 65.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.388 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.8 148.32 75.73 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.012 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.504 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 36.8 Cg_endo -64.74 -6.56 12.65 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.399 2.066 . . . . 0.0 111.774 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -92.03 34.05 1.03 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.6 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.3 87.0 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.832 0.825 . . . . 0.0 110.124 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 74.2 m-20 -69.11 104.14 2.08 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.043 -0.981 . . . . 0.0 110.127 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.871 ' HG ' HD11 ' A' ' 51' ' ' LEU . 1.4 tt -61.05 -52.17 66.08 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.539 -178.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.705 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -70.5 -36.32 73.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.079 -177.812 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.55 ' HB3' ' CB ' ' A' ' 18' ' ' ASP . . . -68.2 -34.63 76.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.157 0.503 . . . . 0.0 109.758 177.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -65.68 -32.12 73.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.861 177.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.705 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -54.71 -47.65 73.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.505 179.01 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.417 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -66.6 -42.48 86.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.736 179.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -65.55 -29.3 69.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.185 0.516 . . . . 0.0 110.391 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.695 HG12 HG21 ' A' ' 53' ' ' VAL . 2.0 mt -61.83 -45.58 98.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.217 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -60.49 -35.86 76.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.717 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 17.5 mm-40 -74.17 -23.74 59.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.559 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.819 ' HB2' HD11 ' A' ' 74' ' ' ILE . 2.4 ptp180 -92.57 -14.54 28.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.842 -178.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.552 HD11 HG11 ' A' ' 53' ' ' VAL . 15.2 mm -58.74 139.82 86.07 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.102 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.664 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.4 Cg_endo -50.82 112.16 0.71 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.838 2.359 . . . . 0.0 112.348 178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.35 0.6 0.11 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.98 -0.554 . . . . 0.0 112.341 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.08 -40.01 9.62 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.042 -178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.539 ' CB ' HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.36 -137.8 0.21 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.647 0.223 . . . . 0.0 110.882 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -136.63 166.9 22.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.83 0.348 . . . . 0.0 111.048 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.2 OUTLIER -76.01 -175.45 3.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.269 -179.323 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.603 ' ND1' HG22 ' A' ' 56' ' ' VAL . 82.4 t60 -130.73 -74.97 0.53 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.315 0.578 . . . . 0.0 110.829 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.584 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -164.22 132.6 3.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.998 -178.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.664 HG12 HG13 ' A' ' 53' ' ' VAL . 2.8 mt -94.39 158.38 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -177.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.691 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.1 t0 -123.88 128.55 49.63 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.381 -179.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.445 ' HG2' HD21 ' A' ' 19' ' ' LEU . 13.4 mt-10 -90.8 69.06 6.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.228 177.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.666 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -100.92 148.03 34.51 Favored Pre-proline 0 C--N 1.328 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.264 -178.437 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.783 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 21.2 Cg_endo -91.7 159.75 3.48 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.043 2.495 . . . . 0.0 113.362 -177.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.704 HD11 ' HB3' ' A' ' 50' ' ' ALA . 5.0 mm -127.95 -83.14 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.248 -178.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.474 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.34 -151.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.031 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -72.11 -28.76 63.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.73 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.2 3.98 0.41 Allowed Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.126 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.504 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 6.9 mt -91.21 106.09 18.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.892 0.377 . . . . 0.0 110.777 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.783 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 40.7 t -92.95 132.06 38.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.694 -178.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.704 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.27 164.09 12.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.093 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.871 HD11 ' HG ' ' A' ' 19' ' ' LEU . 11.3 mp -120.64 116.0 24.47 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.28 178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.636 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 1.1 m120 -89.86 91.93 8.81 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.315 0.579 . . . . 0.0 110.378 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.695 HG21 HG12 ' A' ' 26' ' ' ILE . 4.6 t -86.8 105.21 14.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.536 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.679 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.6 164.61 18.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.169 178.836 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.627 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.1 m -139.24 141.06 36.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.845 0.355 . . . . 0.0 111.572 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.603 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.9 t -93.07 100.4 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.668 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.823 HG23 HG12 ' A' ' 4' ' ' VAL . 27.2 m -130.15 140.35 49.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.046 0.45 . . . . 0.0 111.544 -179.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.32 -61.67 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.51 178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -81.34 -7.68 59.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.038 0.446 . . . . 0.0 110.625 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.535 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.77 -139.51 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.132 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -147.01 -166.27 2.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.77 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.58 12.88 31.79 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.638 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.15 -9.54 63.87 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.512 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.1 p -74.48 -5.99 45.79 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.857 0.361 . . . . 0.0 110.42 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -54.72 -23.79 19.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.056 177.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.93 -28.59 57.56 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.952 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.664 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.09 -57.59 11.9 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.401 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -59.53 -33.59 71.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.451 178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.85 -51.42 68.29 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.238 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.409 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 1.3 t -63.48 -18.03 63.36 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.139 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.678 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.23 -29.91 63.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.478 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.17 -12.86 44.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.709 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.26 27.41 0.99 Allowed Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.642 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.819 HD11 ' HB2' ' A' ' 29' ' ' ARG . 1.3 tt -73.17 -162.45 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.411 . . . . 0.0 111.187 -178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.633 ' OE1' HG12 ' A' ' 77' ' ' VAL . 1.7 mm-40 -50.89 94.13 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 121.141 0.496 . . . . 0.0 110.792 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -57.06 -32.42 62.8 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.692 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.633 HG12 ' OE1' ' A' ' 75' ' ' GLU . 0.4 OUTLIER -87.44 -36.82 10.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.083 0.468 . . . . 0.0 110.364 179.351 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.587 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -96.0 89.01 5.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.206 179.672 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.597 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -75.88 133.87 40.44 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.369 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.069 HG21 HG22 ' A' ' 8' ' ' ILE . 6.2 mt -101.12 144.82 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.068 -175.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.596 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 19.4 tp10 -85.34 69.96 10.77 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.693 HG23 ' HB ' ' A' ' 80' ' ' ILE . 49.1 t -80.8 48.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 114.08 -1.418 . . . . 0.0 111.035 -174.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.9 m -132.34 8.14 4.28 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.23 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.682 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.3 m-20 -84.11 150.37 25.59 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.88 0.371 . . . . 0.0 110.928 -178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.5 p -148.31 154.56 10.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.534 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -150.52 84.8 1.37 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.227 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.52 85.67 5.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.62 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.445 ' N ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -83.76 98.09 9.5 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.262 177.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.41 ' OXT' ' HA2' ' A' ' 2' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.85 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.828 0.347 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -178.87 7.87 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.786 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.765 ' HB2' HD12 ' A' ' 88' ' ' LEU . 3.7 m-20 -88.63 147.74 24.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.811 0.339 . . . . 0.0 111.268 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.618 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -106.92 107.84 23.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.0 178.183 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.57 ' HB ' ' HG2' ' A' ' 86' ' ' ARG . 2.6 t -107.59 113.53 43.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.657 0.265 . . . . 0.0 111.369 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.556 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -94.68 167.17 11.63 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.257 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.812 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 7.5 m -143.15 131.19 21.76 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-O 121.537 0.684 . . . . 0.0 112.312 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.0 HG22 HG21 ' A' ' 80' ' ' ILE . 3.5 mm -125.01 108.29 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 114.569 -1.196 . . . . 0.0 110.763 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.81 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.15 95.05 7.88 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.553 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.462 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.4 m -93.89 138.49 20.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.769 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.2 ptm -145.49 125.37 7.03 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.353 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.601 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.1 Cg_exo -71.47 121.92 8.16 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.155 2.57 . . . . 0.0 112.077 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.32 -32.36 66.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.345 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.25 152.57 79.09 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.078 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.584 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 41.1 Cg_endo -67.31 -3.36 9.81 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.388 2.059 . . . . 0.0 112.204 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -90.87 43.89 1.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.927 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.601 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 93.1 t -65.59 75.13 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.37 -178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.571 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 81.9 m-20 -70.49 95.73 1.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.915 177.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.527 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.9 OUTLIER -64.1 -43.63 94.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.5 -178.351 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.527 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 5.3 tp10 -68.36 -38.16 81.17 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 120.744 0.307 . . . . 0.0 110.412 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.471 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -69.62 -39.82 76.96 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.372 0.606 . . . . 0.0 109.815 177.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -67.62 -30.66 70.29 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.035 177.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.89 -46.75 81.7 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.775 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.527 ' HG3' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -69.26 -40.45 77.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.571 179.531 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.527 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 1.3 mt-10 -65.24 -28.04 69.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.117 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.886 HG22 HE21 ' A' ' 27' ' ' GLN . 0.5 OUTLIER -62.44 -47.12 94.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.354 179.913 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.886 HE21 HG22 ' A' ' 26' ' ' ILE . 6.2 mm-40 -62.68 -31.61 72.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.829 0.347 . . . . 0.0 110.721 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 17.7 mm-40 -74.72 -24.84 58.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.007 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.978 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.46 -14.52 37.71 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.333 -179.128 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.432 HG13 HD12 ' A' ' 36' ' ' LEU . 24.8 mm -57.61 137.29 82.37 Favored Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.716 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.451 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 4.5 Cg_endo -45.66 122.01 4.57 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.885 2.39 . . . . 0.0 112.169 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.37 -4.82 0.25 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.046 -179.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.03 -41.4 8.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.73 -179.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.511 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.43 -146.54 0.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.674 0.273 . . . . 0.0 111.198 -179.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -138.62 177.58 7.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.242 0.544 . . . . 0.0 111.185 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.715 HD13 ' H ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -74.96 -178.24 3.68 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.434 -179.183 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.535 ' ND1' HG22 ' A' ' 56' ' ' VAL . 72.4 t60 -131.13 -71.24 0.57 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.66 -179.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 7.2 mmtm -161.64 125.16 3.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.081 -179.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.651 HD13 HG22 ' A' ' 53' ' ' VAL . 2.8 mt -92.1 160.49 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.781 -178.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.65 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -129.17 125.0 36.06 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.726 -178.311 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -85.43 72.03 10.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.841 0.353 . . . . 0.0 110.548 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.524 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.4 mt-10 -98.09 134.73 21.82 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.621 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.771 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 56.8 Cg_endo -86.53 155.0 9.11 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.577 2.185 . . . . 0.0 112.782 -178.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.687 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.2 mm -123.87 -82.73 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.403 -177.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.606 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.21 -153.11 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.054 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -71.81 -27.99 63.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.805 0.336 . . . . 0.0 110.593 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.62 5.12 0.51 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.951 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.606 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.8 mt -92.22 101.36 13.87 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.784 0.326 . . . . 0.0 110.839 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.771 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 90.4 t -93.38 129.36 43.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.783 -178.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.769 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.24 162.94 13.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.022 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.65 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 11.2 mp -120.53 120.27 35.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.435 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.538 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.3 m120 -89.66 91.71 8.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.271 0.558 . . . . 0.0 109.813 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.847 HG21 HG12 ' A' ' 26' ' ' ILE . 12.4 t -86.82 106.35 15.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.793 -177.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.574 ' HG3' HG23 ' A' ' 7' ' ' THR . 6.2 mtt -85.63 165.23 17.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.031 178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.556 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.1 m -140.3 134.35 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.903 0.383 . . . . 0.0 111.245 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.535 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -96.55 113.21 30.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.06 179.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 4' ' ' VAL . 3.5 m -130.35 144.8 36.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.885 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -169.07 -63.22 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.25 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -81.09 -7.9 59.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.981 0.42 . . . . 0.0 110.402 179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.511 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.27 -147.93 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.992 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -148.56 -162.02 1.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.821 0.343 . . . . 0.0 110.782 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.62 11.91 37.16 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.38 178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.43 -3.01 45.72 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.585 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.6 p -74.03 -5.49 41.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.934 0.397 . . . . 0.0 110.358 179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -55.13 -24.36 25.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.193 177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . . . -57.2 -25.45 59.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.105 -179.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.77 -57.26 13.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.164 179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -59.37 -33.63 71.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.325 178.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 1.8 mm-40 -61.11 -52.13 66.21 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.501 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.78 -19.86 65.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.621 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.724 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.63 -28.08 62.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.69 -179.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.66 -15.1 57.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.731 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.39 29.33 0.96 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.978 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -73.08 -165.06 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.253 -0.474 . . . . 0.0 111.279 -178.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.771 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 3.0 pm0 -51.63 89.14 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.658 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 74' ' ' ILE . . . -59.46 -26.99 62.75 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.937 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.7 p -86.06 -34.76 8.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.254 0.549 . . . . 0.0 110.2 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.771 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 0.8 OUTLIER -95.71 89.07 5.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.626 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.403 ' ND2' ' N ' ' A' ' 80' ' ' ILE . 0.8 OUTLIER -74.68 128.86 36.58 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.206 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.0 HG21 HG22 ' A' ' 8' ' ' ILE . 1.9 mp -101.11 148.88 6.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.202 0 CA-C-N 114.922 -1.036 . . . . 0.0 112.576 -175.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.662 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.1 tp10 -85.78 71.44 10.67 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 172.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.705 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.5 t -80.06 50.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-N 114.282 -1.326 . . . . 0.0 111.036 -173.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 m -132.93 7.12 4.0 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.176 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.812 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 26.8 t0 -85.82 133.31 33.98 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.934 -178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 2.7 t -147.25 147.44 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.131 -178.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.57 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -145.45 81.56 1.62 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.878 0.847 . . . . 0.0 109.242 179.19 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.464 ' HB3' ' SD ' ' A' ' 89' ' ' MET . 0.9 OUTLIER -81.04 107.6 14.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.873 -177.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.765 HD12 ' HB2' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -86.12 86.67 7.35 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.438 177.145 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.464 ' SD ' ' HB3' ' A' ' 87' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.218 -0.896 . . . . 0.0 111.022 -179.626 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.483 ' N ' ' HB3' ' A' ' 88' ' ' LEU . 9.7 ttp . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.96 0.409 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.51 -8.4 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.201 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 3.5 m-20 -94.8 169.44 10.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.279 -0.461 . . . . 0.0 111.62 179.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.78 HG12 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -105.22 116.38 48.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.891 177.333 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.73 ' HB ' ' HB2' ' A' ' 86' ' ' ARG . 4.8 t -106.96 117.26 52.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 121.046 -0.261 . . . . 0.0 111.66 -178.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.696 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -92.68 162.27 14.22 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.043 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.81 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 11.3 m -143.16 131.06 21.58 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.592 0.71 . . . . 0.0 112.309 -178.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.021 HG22 HG21 ' A' ' 80' ' ' ILE . 2.7 mm -120.22 106.05 18.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.628 -178.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.834 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -93.62 92.35 7.49 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -178.326 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.609 HG12 HG12 ' A' ' 80' ' ' ILE . 0.7 OUTLIER -92.42 138.13 20.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.117 -177.019 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.64 ' HB2' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.73 119.05 5.29 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.074 179.312 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.613 ' CD ' HG13 ' A' ' 17' ' ' VAL . 14.9 Cg_exo -69.23 120.25 7.14 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.252 2.635 . . . . 0.0 112.137 179.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -57.42 -30.33 64.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.475 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.79 151.62 79.73 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.078 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.543 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 40.8 Cg_endo -66.81 -4.28 10.93 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.41 2.074 . . . . 0.0 112.001 179.65 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -91.84 42.35 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.321 179.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.613 HG13 ' CD ' ' A' ' 12' ' ' PRO . 90.9 t -65.14 78.17 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.166 -179.433 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.669 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -67.82 100.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.134 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.618 HD11 ' HE2' ' A' ' 23' ' ' LYS . 1.3 tp -61.54 -51.87 66.82 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.488 -178.125 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.782 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 8.6 pt-20 -71.54 -34.55 70.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.261 -177.33 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.669 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -67.82 -36.21 79.98 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.585 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -64.86 -34.74 79.1 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.363 176.557 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.782 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -55.59 -48.11 75.38 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.124 -0.943 . . . . 0.0 110.296 178.649 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 3.6 mtmt -65.25 -44.18 88.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.967 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -66.32 -28.72 68.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.172 0.51 . . . . 0.0 110.444 -179.199 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.838 HG12 HG21 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -61.39 -47.46 93.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.495 -179.62 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.539 ' OE1' HD22 ' A' ' 36' ' ' LEU . 7.0 mm100 -63.53 -33.29 75.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.829 0.347 . . . . 0.0 110.798 -178.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 15.4 mt-10 -75.19 -23.56 57.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.925 179.216 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.755 ' HB2' HD11 ' A' ' 74' ' ' ILE . 3.2 ptp180 -91.83 -14.66 29.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.414 -179.122 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.59 HG12 ' O ' ' A' ' 26' ' ' ILE . 11.0 mm -59.35 141.25 87.7 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.025 -179.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.716 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.2 Cg_endo -51.25 113.55 1.16 Allowed 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.844 2.363 . . . . 0.0 112.431 179.17 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.2 -1.61 0.21 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.328 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.11 -36.89 13.62 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.066 -178.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.542 ' CB ' HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.54 -140.31 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.725 0.263 . . . . 0.0 111.077 -179.32 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -136.67 166.11 24.33 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.852 0.358 . . . . 0.0 110.892 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.539 HD22 ' OE1' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -76.09 -175.03 2.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.355 -179.262 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.6 ' ND1' HG22 ' A' ' 56' ' ' VAL . 79.8 t60 -131.29 -76.78 0.52 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.278 0.561 . . . . 0.0 110.937 179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.1 OUTLIER -165.27 132.7 3.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.048 -178.793 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.742 HD13 HG22 ' A' ' 53' ' ' VAL . 2.6 mt -93.77 156.18 3.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.065 0.46 . . . . 0.0 112.197 -177.361 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.649 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 74.8 m-20 -122.72 119.2 29.97 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.465 -178.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -83.21 73.42 10.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.032 0.444 . . . . 0.0 110.608 178.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.559 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -97.33 132.95 24.48 Favored Pre-proline 0 C--O 1.225 -0.224 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.628 -179.993 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.779 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 44.2 Cg_endo -85.33 155.21 10.81 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.449 2.099 . . . . 0.0 112.875 -178.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.749 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.4 mm -124.03 -83.39 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.411 -177.502 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.459 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.16 -154.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.018 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.97 -26.54 62.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.579 179.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.65 1.78 0.36 Allowed Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.23 179.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.543 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.6 mt -92.44 102.41 14.88 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.851 0.358 . . . . 0.0 110.875 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.779 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 73.4 t -93.34 132.15 38.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.035 -178.126 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.749 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.93 153.77 17.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.816 177.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.649 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -117.39 120.8 39.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.518 179.377 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.575 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.3 m120 -89.73 93.89 9.63 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.109 -179.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.838 HG21 HG12 ' A' ' 26' ' ' ILE . 17.3 t -85.95 105.58 14.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.256 -0.883 . . . . 0.0 111.558 -177.851 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.566 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 44.2 mtt -86.52 160.51 18.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.35 178.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.696 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.8 m -139.05 140.7 37.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.101 -178.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.6 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.1 t -92.49 100.09 10.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.764 179.111 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.78 HG23 HG12 ' A' ' 4' ' ' VAL . 27.3 m -130.48 139.08 52.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.988 0.423 . . . . 0.0 111.473 -179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.73 -61.67 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.557 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.96 -5.4 58.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.953 0.406 . . . . 0.0 110.575 179.563 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.51 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.41 -139.52 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.125 179.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -146.83 -165.92 2.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.762 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.32 11.09 39.4 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.691 179.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.2 -11.32 67.23 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.526 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.52 -4.45 36.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 0.0 110.319 179.441 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -54.56 -23.9 18.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.387 0.613 . . . . 0.0 109.869 177.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.04 -28.17 56.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.94 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.716 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.96 -57.61 11.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.425 179.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -58.94 -34.06 71.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.455 178.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.96 -52.18 66.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.267 178.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.93 -20.38 65.81 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.508 179.034 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.72 HD22 HD13 ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.84 -26.1 61.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.659 -179.653 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.61 -17.02 63.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.556 178.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.48 31.74 0.93 Allowed Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.704 179.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.755 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -73.08 -161.84 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.278 -0.461 . . . . 0.0 111.24 -178.431 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.705 ' HG3' ' O ' ' A' ' 78' ' ' SER . 0.1 OUTLIER -51.55 88.13 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.219 0.533 . . . . 0.0 110.437 178.935 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 74' ' ' ILE . . . -60.26 -26.63 64.16 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.685 -0.689 . . . . 0.0 113.308 -177.658 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.7 p -85.44 -34.7 8.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.412 0.625 . . . . 0.0 110.177 179.502 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.705 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 0.3 OUTLIER -95.57 90.02 5.58 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.588 -179.314 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.611 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -73.49 128.38 35.34 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.153 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.021 HG21 HG22 ' A' ' 8' ' ' ILE . 2.1 mp -101.16 149.31 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-N 114.956 -1.02 . . . . 0.0 112.648 -174.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.68 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 5.8 tp10 -85.65 71.91 10.65 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 171.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.737 HG23 ' HB ' ' A' ' 80' ' ' ILE . 75.7 t -79.73 48.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.93 -173.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.7 m -133.1 7.26 3.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.97 -1.013 . . . . 0.0 110.93 178.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.81 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 22.0 t0 -85.64 137.4 32.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.869 0.366 . . . . 0.0 110.977 -178.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.501 HG22 ' H ' ' A' ' 86' ' ' ARG . 2.9 p -148.18 167.91 4.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.112 -179.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.73 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -147.13 107.64 4.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.169 0.509 . . . . 0.0 111.329 -179.036 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 -82.76 79.77 9.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.985 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.483 ' HB3' ' N ' ' A' ' 1' ' ' MET . 8.2 mp -81.6 86.35 6.39 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.721 179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.285 -0.864 . . . . 0.0 110.883 179.932 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 CA-C-O 120.838 0.351 . . . . 0.0 111.361 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.61 -4.56 0.03 OUTLIER Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.254 -179.876 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.562 ' OD1' HD12 ' A' ' 88' ' ' LEU . 13.2 p-10 -90.39 162.09 15.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.962 0.41 . . . . 0.0 111.375 -179.882 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.778 HG22 ' HG3' ' A' ' 87' ' ' ARG . 1.0 OUTLIER -104.27 134.82 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.958 179.614 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.779 ' HB ' ' HG2' ' A' ' 86' ' ' ARG . 57.5 t -124.06 120.18 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.746 0.308 . . . . 0.0 111.605 179.233 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.55 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -98.05 166.44 11.43 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 176.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.706 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 14.2 m -140.52 136.48 32.94 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.6 0.714 . . . . 0.0 112.267 -179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.077 HG22 HG21 ' A' ' 80' ' ' ILE . 2.3 mm -125.71 106.94 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-N 114.203 -1.362 . . . . 0.0 110.573 -178.055 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.822 ' C ' HG23 ' A' ' 80' ' ' ILE . 1.6 mmmt -95.79 93.83 7.31 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 120.816 0.341 . . . . 0.0 111.892 -178.075 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.493 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.9 m -93.71 135.4 28.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -176.521 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.648 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -145.36 124.88 6.91 Favored Pre-proline 0 C--O 1.237 0.401 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.038 178.363 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.643 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 12.7 Cg_exo -71.79 117.3 5.08 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.147 2.565 . . . . 0.0 111.747 179.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.02 -30.25 59.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.95 -179.665 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.96 155.1 80.39 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.72 179.454 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 3.8 Cg_exo -72.3 -0.96 9.42 Favored 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.562 2.175 . . . . 0.0 111.683 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -92.29 42.97 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.049 178.261 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.643 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 88.4 t -64.85 78.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.089 -178.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.659 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 2.3 m-20 -68.56 101.84 1.35 Allowed 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.322 178.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.58 -53.43 56.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.68 -179.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.555 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 23.5 tt0 -69.76 -35.33 74.85 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.019 -176.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.659 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -68.57 -36.81 79.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.584 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.1 OUTLIER -64.74 -34.11 77.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.469 177.071 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -57.41 -47.22 82.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.571 179.008 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 7.4 mttt -65.64 -41.92 92.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.649 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 21' ' ' ALA . 33.8 mt-10 -65.74 -31.49 72.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.197 0.523 . . . . 0.0 110.477 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.685 HD11 HD12 ' A' ' 51' ' ' LEU . 6.9 mt -61.38 -44.71 98.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.053 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -61.48 -38.41 87.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.951 0.405 . . . . 0.0 110.772 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 4.7 mm-40 -76.09 -21.94 56.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.689 -178.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.632 HH22 ' HB ' ' A' ' 8' ' ' ILE . 22.1 ptt85 -90.35 -13.59 34.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.643 -177.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.663 HG12 ' O ' ' A' ' 26' ' ' ILE . 29.4 mm -59.73 138.6 90.03 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.669 -0.242 . . . . 0.0 111.176 -179.438 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.1 Cg_endo -51.89 123.77 13.14 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.726 2.284 . . . . 0.0 112.496 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -62.25 2.92 0.21 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.262 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.36 -64.51 1.64 Allowed Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.01 -178.618 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.624 ' CB ' HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -112.6 -131.43 0.32 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.348 0.118 . . . . 0.0 110.913 -179.17 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -139.21 166.63 24.03 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.947 0.404 . . . . 0.0 111.013 -179.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.2 pt? -75.9 -172.41 1.95 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.971 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.575 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.0 t60 -130.36 -78.85 0.54 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.27 0.557 . . . . 0.0 111.481 -178.15 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.423 ' HB3' ' CD2' ' A' ' 37' ' ' HIS . 1.5 tptp -164.49 130.89 2.98 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.843 -178.322 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.672 HD13 HD13 ' A' ' 26' ' ' ILE . 2.6 mt -92.0 159.62 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -176.715 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.643 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -127.48 117.08 21.42 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.247 -179.39 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -81.87 72.6 8.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.991 0.424 . . . . 0.0 110.396 178.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.539 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -97.0 134.86 22.39 Favored Pre-proline 0 C--O 1.225 -0.222 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.69 -179.595 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.776 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 53.7 Cg_endo -85.43 155.4 10.69 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.39 2.06 . . . . 0.0 112.837 -178.73 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.777 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.6 mm -124.88 -83.42 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.269 -177.505 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.493 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -66.74 -155.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.764 179.487 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -72.47 -22.93 60.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.72 179.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.62 0.93 0.26 Allowed Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.443 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.52 ' CD2' ' HA ' ' A' ' 15' ' ' PRO . 5.6 mt -92.83 103.59 15.92 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.072 0.436 . . . . 0.0 111.138 -179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.776 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 72.8 t -93.5 129.14 44.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.891 -179.015 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.777 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.1 151.8 19.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.943 178.168 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.685 HD12 HD11 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -115.14 121.27 42.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.538 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.484 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 1.7 m120 -90.51 92.33 8.82 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.363 -179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.647 HG22 HD13 ' A' ' 39' ' ' ILE . 5.9 t -87.49 103.27 13.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.375 -178.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.581 ' HG3' HG23 ' A' ' 7' ' ' THR . 1.7 mpt? -84.41 164.89 18.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.268 178.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.55 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.2 m -137.73 136.89 45.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.365 -178.002 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.575 HG22 ' ND1' ' A' ' 37' ' ' HIS . 1.7 t -94.33 99.13 8.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.744 178.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.627 HG23 HG12 ' A' ' 4' ' ' VAL . 33.3 m -130.47 139.89 50.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.213 -179.794 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.86 -57.8 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.595 179.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -80.85 -11.04 59.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.513 179.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.431 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.62 -138.6 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.109 179.229 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -146.79 -164.38 1.98 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.757 -179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.36 13.07 29.5 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.738 179.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.44 -11.49 68.27 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.609 179.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -74.46 -4.1 34.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.802 0.335 . . . . 0.0 110.422 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -55.19 -23.86 23.97 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.399 0.618 . . . . 0.0 110.055 177.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.413 ' HA ' ' HB2' ' A' ' 69' ' ' GLU . . . -57.11 -25.09 58.22 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.174 -179.427 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.595 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.54 -57.03 13.71 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.327 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -58.77 -34.06 71.01 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.218 178.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 66' ' ' ALA . 2.5 mt-10 -62.17 -51.57 67.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.43 178.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.69 -18.95 64.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.401 178.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.63 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.19 -29.53 62.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.512 179.835 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -13.47 51.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.74 179.162 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.27 28.73 0.98 Allowed Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.672 179.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.63 ' HB ' ' HA ' ' A' ' 71' ' ' LEU . 1.2 tt -73.19 -164.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.445 -0.377 . . . . 0.0 110.854 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.64 ' HG3' ' HB2' ' A' ' 78' ' ' SER . 0.0 OUTLIER -51.96 95.3 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 121.089 0.471 . . . . 0.0 110.648 179.61 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -59.74 -30.84 69.98 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.452 -177.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 5.2 t -85.16 -35.12 9.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.921 0.391 . . . . 0.0 110.38 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.64 ' HB2' ' HG3' ' A' ' 75' ' ' GLU . 8.0 m -95.7 88.87 5.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.683 -179.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.57 129.97 38.06 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.491 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.077 HG21 HG22 ' A' ' 8' ' ' ILE . 3.2 mp -101.3 150.05 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.748 -175.269 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.527 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 52.4 tt0 -85.91 70.75 10.67 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 173.016 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.68 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.0 t -80.94 50.63 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.083 -174.53 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 m -132.9 10.5 4.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.891 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.706 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.3 m-20 -83.23 148.49 27.38 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 121.162 0.506 . . . . 0.0 111.227 -178.447 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.704 HG13 ' HD2' ' A' ' 87' ' ' ARG . 1.0 OUTLIER -147.83 139.15 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.214 -177.92 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.779 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -150.62 87.0 1.41 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.445 0.64 . . . . 0.0 110.609 -178.894 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.778 ' HG3' HG22 ' A' ' 4' ' ' VAL . 0.0 OUTLIER -82.52 107.89 15.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.076 -0.511 . . . . 0.0 112.074 -179.278 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.562 HD12 ' OD1' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -84.8 86.73 7.32 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.336 176.765 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.98 -179.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttt . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.764 0.316 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 3' ' ' ASP . . . 173.77 -4.32 0.03 OUTLIER Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.23 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.606 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 13.0 p-10 -92.16 146.96 23.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.765 0.317 . . . . 0.0 111.44 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.649 ' O ' HG22 ' A' ' 57' ' ' VAL . 1.0 OUTLIER -96.71 113.37 30.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.708 177.949 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 53.7 t -109.57 120.64 61.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.596 -178.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.576 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -96.39 166.0 11.91 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 177.087 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.816 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 8.1 m -143.04 130.09 20.69 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.57 0.7 . . . . 0.0 112.361 -179.196 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.025 HG22 HG21 ' A' ' 80' ' ' ILE . 6.7 mm -121.61 107.08 19.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-N 114.57 -1.195 . . . . 0.0 110.554 -179.11 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.813 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -95.6 94.15 7.57 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 120.933 0.396 . . . . 0.0 111.946 -177.87 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.518 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.7 m -93.54 136.54 24.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -176.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.772 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.2 ptm -144.72 126.15 7.84 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.303 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.611 ' HG2' ' HA ' ' A' ' 17' ' ' VAL . 10.4 Cg_exo -73.46 124.53 9.45 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.399 2.732 . . . . 0.0 112.37 -179.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.99 -33.82 69.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.357 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.4 m -78.28 154.41 79.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.213 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.582 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 52.9 Cg_endo -69.66 -3.41 11.88 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.428 2.085 . . . . 0.0 112.146 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.76 44.03 1.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.826 178.378 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.611 ' HA ' ' HG2' ' A' ' 12' ' ' PRO . 81.0 t -64.98 76.21 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.558 -178.418 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 6.3 m-20 -71.61 92.44 1.15 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 177.57 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.65 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -63.97 -42.08 97.37 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.303 -178.478 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.628 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 26.7 tt0 -68.3 -39.11 82.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.794 0.331 . . . . 0.0 110.253 -178.506 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.426 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -71.55 -36.75 71.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.053 0.454 . . . . 0.0 110.384 177.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.5 OUTLIER -67.79 -28.75 67.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.976 178.026 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -42.48 87.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.321 179.547 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.07 -43.82 86.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.246 178.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.57 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 2.2 mm-40 -65.79 -30.38 71.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.342 0.592 . . . . 0.0 110.207 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.782 HG12 HG21 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -60.66 -47.14 94.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.073 179.724 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.423 ' OE1' HD22 ' A' ' 36' ' ' LEU . 7.2 mm-40 -64.71 -35.24 80.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.193 -178.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 8.4 pt-20 -77.0 -20.79 55.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.907 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.832 ' HB2' HD11 ' A' ' 74' ' ' ILE . 4.2 ptp180 -90.51 -13.55 34.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.045 -179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 26' ' ' ILE . 14.2 mm -59.82 138.67 90.31 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.92 179.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.442 ' HD2' HG23 ' A' ' 30' ' ' ILE . 9.6 Cg_endo -50.81 119.3 5.07 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.708 2.272 . . . . 0.0 112.112 178.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.489 ' O ' ' HG2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -59.23 -1.27 0.18 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.24 -179.597 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -81.49 -39.64 12.1 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.968 -178.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.538 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -130.54 -147.41 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.668 0.271 . . . . 0.0 111.118 -179.714 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -131.9 170.06 15.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.998 0.428 . . . . 0.0 110.927 -179.309 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.518 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.5 OUTLIER -75.12 -177.2 3.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.123 -179.331 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.568 ' ND1' HG22 ' A' ' 56' ' ' VAL . 82.1 t60 -130.91 -76.38 0.53 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.294 0.569 . . . . 0.0 111.085 -179.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 2.0 tptt -164.64 130.34 2.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.996 -178.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.65 HD13 HG22 ' A' ' 53' ' ' VAL . 2.2 mt -94.13 160.99 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -176.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.634 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -127.35 122.54 33.99 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.485 -179.182 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -84.83 74.06 10.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.807 0.337 . . . . 0.0 110.602 178.311 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.557 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.0 OUTLIER -101.23 136.16 19.74 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.969 -179.6 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.774 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 61.4 Cg_endo -86.43 155.49 9.29 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.793 2.328 . . . . 0.0 112.724 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.735 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.0 mm -124.55 -83.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.614 -177.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.72 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.42 -148.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.355 -179.269 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -70.45 -33.54 71.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.959 0.409 . . . . 0.0 110.61 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.39 8.22 0.64 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.606 179.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.72 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mt -91.41 102.02 14.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.876 0.369 . . . . 0.0 110.748 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.774 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 87.3 t -93.23 128.89 44.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.94 -178.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.772 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.19 161.01 14.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.071 178.719 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.2 mp -120.27 119.96 34.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.405 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.535 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 2.0 m120 -89.74 91.4 8.62 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.305 0.574 . . . . 0.0 110.066 179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.782 HG21 HG12 ' A' ' 26' ' ' ILE . 6.1 t -87.5 104.67 14.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.23 -0.895 . . . . 0.0 111.736 -177.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 27.8 mtt -86.54 164.38 16.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.277 178.458 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.576 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.2 m -139.26 136.15 41.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.845 0.355 . . . . 0.0 111.354 -178.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.568 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -95.69 114.94 33.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.311 179.733 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 4' ' ' VAL . 3.6 m -130.24 148.59 33.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.694 178.579 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.92 -67.65 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.356 -179.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -80.71 -7.43 59.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.094 0.473 . . . . 0.0 110.64 179.442 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.455 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.66 -147.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.107 179.339 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.5 -165.33 2.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.875 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.13 14.04 29.47 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.523 178.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.9 -2.84 40.32 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.483 179.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.3 p -74.08 -3.66 30.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.855 0.359 . . . . 0.0 110.265 179.306 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -23.91 27.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.326 177.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.97 -25.7 58.52 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.262 -179.223 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.68 -49.3 78.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.635 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.686 ' HG3' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -61.72 -42.05 98.43 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.67 0.748 . . . . 0.0 109.53 176.996 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.686 ' N ' ' HG3' ' A' ' 68' ' ' GLU . 2.3 tm-20 -55.25 -46.62 76.08 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.518 -1.219 . . . . 0.0 109.821 179.457 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.2 p -68.42 -24.32 64.73 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.231 177.184 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.773 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -73.53 -30.23 62.95 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.608 179.901 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.1 p -63.41 -11.46 23.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.776 179.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.24 26.66 0.99 Allowed Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 179.085 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.832 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -73.33 -166.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.224 -0.488 . . . . 0.0 111.408 -178.606 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.585 ' N ' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -50.75 92.17 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.096 179.0 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.55 -26.16 64.19 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.476 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.07 -37.88 11.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.142 0.496 . . . . 0.0 110.114 178.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.58 ' HB2' ' HB3' ' A' ' 75' ' ' GLU . 1.5 m -96.15 89.92 5.33 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.531 179.708 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.48 130.0 37.33 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.025 HG21 HG22 ' A' ' 8' ' ' ILE . 3.4 mp -101.35 149.55 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.198 0 CA-C-N 115.168 -0.924 . . . . 0.0 112.539 -175.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.525 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.1 tt0 -85.75 71.15 10.72 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.694 HG23 ' HB ' ' A' ' 80' ' ' ILE . 58.3 t -80.26 50.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.031 -174.269 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.87 5.74 3.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.285 178.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.816 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 35.4 t0 -85.56 139.66 31.27 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.985 0.421 . . . . 0.0 111.008 -178.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.7 p -148.57 161.32 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.36 -179.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.8 mtt-85 -149.82 87.39 1.48 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.703 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.02 87.92 4.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.128 -179.514 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 11.1 mp -81.11 82.31 7.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.372 178.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.1 tpp . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.916 -179.283 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.5 ' HB3' ' HB2' ' A' ' 88' ' ' LEU . 14.4 tpt . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.884 0.373 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.5 -16.46 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.237 0 N-CA-C 111.273 -0.731 . . . . 0.0 111.273 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.441 ' O ' ' HG ' ' A' ' 88' ' ' LEU . 12.1 m-20 -95.24 157.4 15.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.193 -0.503 . . . . 0.0 111.321 179.043 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.514 ' HB ' ' CG2' ' A' ' 57' ' ' VAL . 1.9 t -106.67 112.31 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.833 177.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.659 ' HB ' ' HG2' ' A' ' 86' ' ' ARG . 1.0 OUTLIER -109.43 117.05 53.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-O 120.688 0.28 . . . . 0.0 111.754 -178.995 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.624 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -98.54 165.69 11.7 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.314 178.055 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.682 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 6.0 m -143.24 132.96 23.81 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.632 0.729 . . . . 0.0 112.407 -179.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.972 HG22 HG21 ' A' ' 80' ' ' ILE . 7.1 mm -126.28 108.12 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.499 -178.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.81 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -96.25 95.0 7.81 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.011 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.49 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.5 m -92.56 136.83 23.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.116 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.663 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -146.3 118.48 4.97 Favored Pre-proline 0 CA--C 1.538 0.502 0 CA-C-O 121.07 0.462 . . . . 0.0 111.717 179.896 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 21.1 Cg_exo -68.29 121.58 8.56 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.36 2.707 . . . . 0.0 111.822 178.529 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -57.89 -29.16 64.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.325 -179.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.84 150.37 78.42 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.556 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 37.7 Cg_endo -65.88 -7.85 18.02 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.463 2.109 . . . . 0.0 112.075 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -91.81 35.97 0.96 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.502 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.677 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -68.17 82.58 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.814 0.816 . . . . 0.0 110.532 -179.378 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 1.5 m-20 -73.74 99.31 3.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.805 178.038 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.851 ' HB2' HD11 ' A' ' 51' ' ' LEU . 0.4 OUTLIER -63.33 -44.11 95.83 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -178.025 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.806 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 4.4 tp10 -70.03 -36.15 74.84 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.868 0.366 . . . . 0.0 110.342 -178.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.5 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -69.16 -37.96 78.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.381 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.56 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.8 OUTLIER -67.72 -26.67 66.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.971 177.23 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.806 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -56.13 -46.13 79.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.235 179.13 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -41.22 85.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.705 179.259 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.725 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 52.9 mt-10 -66.74 -28.63 68.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.426 0.631 . . . . 0.0 110.151 179.006 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.831 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.2 mt -63.29 -39.2 84.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.163 178.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.451 ' NE2' HG22 ' A' ' 26' ' ' ILE . 0.3 OUTLIER -60.66 -41.72 95.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.075 -179.85 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.725 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -77.62 -21.32 52.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.937 -178.101 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.831 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.01 -12.43 44.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.061 -179.001 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.697 HG12 ' O ' ' A' ' 26' ' ' ILE . 22.6 mm -60.46 137.53 92.31 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.872 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.619 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 7.0 Cg_endo -47.45 121.5 5.56 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.748 2.298 . . . . 0.0 112.256 178.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -59.15 0.04 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.999 -0.546 . . . . 0.0 112.238 -179.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.0 -62.96 1.78 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.866 -179.023 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.481 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -111.77 -142.01 0.38 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.682 0.277 . . . . 0.0 111.183 -179.286 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -133.39 172.98 11.97 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.974 0.416 . . . . 0.0 111.069 -179.354 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.39 -177.65 3.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.329 -178.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.502 ' ND1' HG22 ' A' ' 56' ' ' VAL . 80.0 t60 -131.02 -76.29 0.53 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.062 -179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 20.2 mmtt -160.21 129.25 4.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.089 -178.732 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.725 HD13 HG22 ' A' ' 53' ' ' VAL . 1.6 mt -92.0 160.93 2.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.885 0.374 . . . . 0.0 111.616 -178.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.64 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -129.06 124.47 34.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.64 -178.606 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -85.85 71.93 10.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 0.0 110.653 178.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.533 ' C ' HG13 ' A' ' 49' ' ' VAL . 0.7 OUTLIER -99.22 136.21 20.55 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.593 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.787 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 59.7 Cg_endo -86.99 158.02 8.62 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.565 2.176 . . . . 0.0 112.785 -178.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.687 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.3 mm -126.16 -82.69 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.421 -177.607 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.566 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.41 -151.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.167 -179.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -71.35 -30.22 65.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.668 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.55 5.2 0.51 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.899 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.566 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.1 mt -91.78 103.13 15.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.938 0.399 . . . . 0.0 110.708 179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.787 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 76.0 t -92.92 131.76 39.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.88 -178.381 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.687 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.03 162.29 13.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.831 178.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.851 HD11 ' HB2' ' A' ' 19' ' ' LEU . 11.2 mp -120.66 119.7 33.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.333 179.391 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.488 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.3 m120 -89.88 91.83 8.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.255 0.55 . . . . 0.0 110.134 179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.754 HG21 HG12 ' A' ' 26' ' ' ILE . 12.4 t -86.5 102.3 11.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.583 -177.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.511 ' HG3' HG23 ' A' ' 7' ' ' THR . 24.8 mtt -84.59 164.46 18.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.169 178.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.624 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.0 m -139.35 135.86 40.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.862 0.363 . . . . 0.0 111.456 -178.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.502 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -98.61 115.98 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.211 178.932 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.514 ' CG2' ' HB ' ' A' ' 4' ' ' VAL . 2.8 m -130.67 148.14 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.702 178.861 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.6 -68.06 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.578 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -80.42 -8.51 59.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.059 0.457 . . . . 0.0 110.607 179.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.481 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.86 -144.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.057 179.21 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -147.52 -167.34 2.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.815 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.86 16.35 15.8 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.562 178.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.5 -1.36 36.32 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.491 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.4 p -74.81 -4.23 36.5 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.874 0.368 . . . . 0.0 110.246 179.228 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -55.05 -23.37 19.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.182 177.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.29 -26.29 60.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.134 -179.448 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.619 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.92 -55.94 27.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.338 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -58.33 -35.91 72.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.561 178.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -51.55 68.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.427 178.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 12.2 p -63.98 -20.81 66.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.487 179.023 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.549 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -72.22 -25.94 61.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.602 -179.802 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.01 -17.73 63.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.638 179.124 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.77 30.67 0.92 Allowed Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.05 179.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.764 HD11 ' HD2' ' A' ' 29' ' ' ARG . 4.3 tt -72.99 -160.83 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.571 -0.314 . . . . 0.0 111.01 -178.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.642 ' H ' HG12 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -51.61 94.96 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 121.035 0.445 . . . . 0.0 110.63 179.77 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -60.16 -30.85 71.5 Favored Glycine 0 C--N 1.332 0.33 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.485 -177.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 11.5 t -85.02 -33.9 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.943 0.401 . . . . 0.0 110.578 -179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.617 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 28.1 t -95.77 91.53 6.12 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.937 -179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.5 128.84 36.2 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.012 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.972 HG21 HG22 ' A' ' 8' ' ' ILE . 3.4 mp -101.01 149.31 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.423 -174.949 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.563 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.7 tt0 -85.66 70.41 10.72 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 173.07 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.698 HG23 ' HB ' ' A' ' 80' ' ' ILE . 59.9 t -79.92 50.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-N 114.246 -1.343 . . . . 0.0 110.881 -174.393 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.66 6.54 4.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.351 179.272 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.682 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 2.5 m-20 -85.3 131.15 34.45 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.913 -178.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.9 p -146.25 146.4 19.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.143 -179.123 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.659 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -148.98 81.58 1.43 Allowed 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.758 0.789 . . . . 0.0 109.325 -179.224 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -86.01 99.82 11.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.208 -0.905 . . . . 0.0 112.274 -177.147 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.541 ' CD2' ' HG3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -86.44 88.68 7.68 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.141 176.37 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 12.7 ptp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.914 -179.956 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.649 0.262 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.47 -2.33 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.291 -179.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.574 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 4.6 m-20 -91.49 158.9 16.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.781 0.324 . . . . 0.0 111.371 -179.933 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.562 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -99.28 121.87 50.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.609 177.567 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 78.9 t -119.85 122.52 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.49 -179.063 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.589 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.37 168.39 10.75 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.777 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 5.7 m -143.17 133.6 24.8 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.595 0.712 . . . . 0.0 112.235 -179.77 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.989 HG22 HG21 ' A' ' 80' ' ' ILE . 3.8 mm -126.52 106.51 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.24 -178.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.813 ' C ' HG23 ' A' ' 80' ' ' ILE . 2.5 mmmt -96.21 96.02 8.52 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -176.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.499 HG12 HG12 ' A' ' 80' ' ' ILE . 0.9 OUTLIER -94.23 135.71 27.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -177.537 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.671 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.0 OUTLIER -147.77 117.97 4.35 Favored Pre-proline 0 CA--C 1.539 0.533 0 CA-C-O 120.993 0.425 . . . . 0.0 111.414 178.97 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.636 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.3 Cg_exo -69.72 120.44 7.23 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.253 2.636 . . . . 0.0 111.964 178.515 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -57.61 -29.06 64.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.068 -179.765 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.55 150.57 79.52 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.882 -179.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 38.4 Cg_endo -66.34 -8.29 20.14 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.432 2.088 . . . . 0.0 112.063 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -91.92 36.51 0.97 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.634 179.313 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.626 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.8 86.18 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.811 0.815 . . . . 0.0 110.196 -179.87 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 55.9 m-20 -69.43 104.92 2.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.213 179.259 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.589 HD21 ' HG2' ' A' ' 41' ' ' GLU . 0.4 OUTLIER -60.74 -52.52 64.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.548 -178.341 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.794 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 9.9 pt-20 -71.03 -34.51 71.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.257 -177.716 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.528 ' HB3' ' CB ' ' A' ' 18' ' ' ASP . . . -68.0 -35.7 78.76 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.443 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.592 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.3 OUTLIER -66.03 -33.61 76.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.423 176.463 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.794 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER -55.91 -46.38 78.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.112 178.529 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.7 mtmt -66.14 -43.65 86.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.72 179.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.772 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 5.1 mm-40 -66.12 -28.06 68.52 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.404 0.621 . . . . 0.0 110.576 -179.787 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.878 HG12 HG21 ' A' ' 53' ' ' VAL . 1.1 mt -61.8 -46.54 96.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.267 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.739 ' NE2' HD22 ' A' ' 36' ' ' LEU . 5.9 mm100 -63.9 -35.32 80.28 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.297 -178.053 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.772 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.6 OUTLIER -76.63 -21.55 55.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.821 179.953 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.978 ' HD2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.25 -15.12 31.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.793 179.249 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.666 HG12 ' O ' ' A' ' 26' ' ' ILE . 15.8 mm -58.93 138.28 87.37 Favored Pre-proline 0 C--O 1.232 0.167 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.97 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.511 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 10.3 Cg_endo -50.27 117.23 3.0 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.884 2.389 . . . . 0.0 112.309 179.278 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -58.84 -2.07 0.21 Allowed 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.182 -179.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.417 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.79 -57.52 2.54 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.794 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.59 HG21 HG12 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -109.76 -142.62 0.38 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.694 0.283 . . . . 0.0 111.064 -179.588 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -135.65 170.0 16.65 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.929 0.395 . . . . 0.0 110.761 -179.411 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.739 HD22 ' NE2' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -75.3 -178.31 3.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.062 -179.333 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.544 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.5 t60 -130.85 -77.01 0.53 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.41 0.624 . . . . 0.0 110.926 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -164.83 130.87 2.81 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.983 -1.008 . . . . 0.0 109.791 -178.893 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.686 HG12 HG13 ' A' ' 53' ' ' VAL . 2.7 mt -92.67 157.92 2.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.039 0.447 . . . . 0.0 112.098 -177.097 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.631 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -124.75 117.32 23.93 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.379 -179.106 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.589 ' HG2' HD21 ' A' ' 19' ' ' LEU . 1.4 mt-10 -82.8 70.91 9.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.952 0.406 . . . . 0.0 110.514 178.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.545 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.7 mt-10 -95.66 135.84 22.77 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.356 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.772 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 56.7 Cg_endo -86.21 156.73 9.68 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.433 2.089 . . . . 0.0 112.933 -178.039 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.753 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.8 mm -125.53 -82.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.451 -177.168 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.603 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.22 -150.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.006 179.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -72.04 -30.52 65.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.848 0.356 . . . . 0.0 110.69 179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.28 4.97 0.53 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.804 179.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.603 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.5 mt -91.31 102.88 15.58 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.893 0.377 . . . . 0.0 110.732 179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.772 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 75.7 t -93.3 131.29 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.059 -177.829 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.753 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -96.08 150.72 20.18 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.719 177.785 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -113.84 117.91 32.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.358 179.6 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.45 ' HB3' ' HD2' ' A' ' 9' ' ' LYS . 6.8 m-20 -89.87 92.83 9.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.223 -178.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.878 HG21 HG12 ' A' ' 26' ' ' ILE . 5.1 t -86.85 102.11 11.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.624 -177.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.742 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.54 163.59 19.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.054 178.253 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.589 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.5 m -138.21 136.9 44.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.765 0.317 . . . . 0.0 111.367 -178.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.544 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -94.63 116.38 35.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.086 179.559 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.59 HG12 HG21 ' A' ' 34' ' ' THR . 6.2 m -130.27 148.36 33.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.966 179.272 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.64 -72.79 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.419 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -81.66 -2.7 51.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.87 0.367 . . . . 0.0 110.789 179.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.547 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.31 -150.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.303 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.58 -165.19 2.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.792 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.16 14.72 26.25 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.619 178.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.12 -3.33 44.56 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.495 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -74.42 -3.2 29.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.941 0.401 . . . . 0.0 110.274 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.68 -25.04 24.66 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.691 177.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.43 -25.16 59.21 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.953 -179.307 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -62.4 -55.25 29.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.863 0.363 . . . . 0.0 110.073 178.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.55 ' HA ' HD12 ' A' ' 71' ' ' LEU . 58.5 mt-10 -58.6 -33.55 70.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.286 178.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -62.51 -52.59 62.86 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.256 178.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.65 -16.62 61.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.117 178.308 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.028 HD11 HG11 ' A' ' 82' ' ' VAL . 1.3 mt -73.38 -33.11 64.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.49 179.201 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.75 -10.29 18.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.792 179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.08 28.6 1.0 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 178.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.978 HD11 ' HD2' ' A' ' 29' ' ' ARG . 7.3 tt -73.56 -166.68 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 114.834 -0.683 . . . . 0.0 111.269 -178.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.681 ' H ' HG12 ' A' ' 74' ' ' ILE . 0.8 OUTLIER -52.01 101.39 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.986 0.422 . . . . 0.0 111.042 -179.658 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.52 -32.42 83.27 Favored Glycine 0 C--N 1.332 0.351 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.812 -179.004 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 14.7 t -86.44 -36.38 10.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.985 0.421 . . . . 0.0 110.242 179.377 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.636 ' HA ' ' HA ' ' A' ' 12' ' ' PRO . 10.3 t -95.67 92.39 6.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.462 179.332 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.595 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.32 130.74 37.56 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.325 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.989 HG21 HG22 ' A' ' 8' ' ' ILE . 2.7 mp -101.4 148.73 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.413 -175.655 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.559 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 1.2 tp10 -85.65 70.25 10.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 173.105 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 1.028 HG11 HD11 ' A' ' 71' ' ' LEU . 55.2 t -79.7 44.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 114.335 -1.302 . . . . 0.0 111.055 -174.081 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -132.32 9.84 4.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.522 177.762 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.777 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 34.5 t0 -85.97 143.96 27.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.828 0.346 . . . . 0.0 110.869 -178.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 86' ' ' ARG . 3.7 p -148.19 164.68 5.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.179 -178.984 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.421 ' H ' HG22 ' A' ' 85' ' ' VAL . 0.7 OUTLIER -149.19 93.44 2.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.462 -179.995 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 -77.92 90.12 4.12 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.801 -179.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 11.2 mp -81.49 81.47 7.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.603 179.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 6.4 mtm . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.163 -0.923 . . . . 0.0 110.99 -179.738 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 121.009 0.433 . . . . 0.0 111.062 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -158.71 13.48 0.23 Allowed Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.548 -179.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.546 ' HB2' HD12 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -88.74 158.35 18.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.879 0.371 . . . . 0.0 111.301 -179.541 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.579 ' O ' HG22 ' A' ' 57' ' ' VAL . 0.2 OUTLIER -107.11 120.77 59.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.381 178.665 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.709 ' HB ' ' HG2' ' A' ' 86' ' ' ARG . 84.8 t -113.43 114.16 46.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.271 179.218 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.596 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -93.1 168.23 11.26 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 177.731 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.78 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 11.2 m -142.56 132.42 24.21 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-O 121.585 0.707 . . . . 0.0 112.505 -179.231 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.074 HG22 HG21 ' A' ' 80' ' ' ILE . 3.8 mm -120.61 105.24 16.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 114.3 -1.318 . . . . 0.0 110.276 -179.426 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.823 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -93.56 93.82 8.29 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.941 0.401 . . . . 0.0 112.009 -177.657 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.558 HG12 HG12 ' A' ' 80' ' ' ILE . 1.2 m -92.96 136.28 25.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.216 -0.447 . . . . 0.0 112.036 -177.211 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.728 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 0.6 OUTLIER -147.7 119.27 4.54 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-O 121.265 0.555 . . . . 0.0 111.508 178.712 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 19.1 Cg_exo -68.38 120.86 7.79 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.13 2.553 . . . . 0.0 111.622 178.688 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.93 -29.11 62.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.271 -179.222 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.476 ' O ' HG12 ' A' ' 17' ' ' VAL . 1.3 p -77.78 153.25 80.66 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.127 -179.848 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.549 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 51.3 Cg_endo -68.54 -7.21 19.68 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.178 1.919 . . . . 0.0 111.31 178.144 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -90.47 34.49 0.88 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.282 178.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -68.24 81.78 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.889 0.852 . . . . 0.0 110.523 -179.363 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.503 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 1.1 m-20 -74.05 97.96 2.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.897 177.726 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.884 HD13 ' H ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -64.53 -38.49 91.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.398 -178.473 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.884 ' H ' HD13 ' A' ' 19' ' ' LEU . 2.7 tp10 -69.11 -38.69 79.05 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -179.656 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -70.59 -38.24 73.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.414 0.626 . . . . 0.0 109.713 176.931 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.1 mt -68.08 -28.98 67.82 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.082 178.095 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.67 -46.66 80.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.032 -179.59 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 21' ' ' ALA . 0.1 OUTLIER -68.94 -40.91 78.72 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.186 0.517 . . . . 0.0 110.387 179.319 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.44 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 6.1 mm-40 -65.32 -28.05 69.04 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.359 179.524 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.538 HG12 HG21 ' A' ' 53' ' ' VAL . 2.1 mt -62.65 -45.66 98.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.106 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -59.52 -34.67 72.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.654 -179.565 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -75.02 -22.47 58.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.466 -179.378 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.806 ' HB2' HD11 ' A' ' 74' ' ' ILE . 1.9 ptp180 -88.55 -15.21 35.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.504 -178.697 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.466 HG23 ' HD2' ' A' ' 31' ' ' PRO . 43.5 mm -58.07 137.57 84.07 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.568 179.132 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.587 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 18.6 Cg_endo -58.05 130.71 39.46 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.506 2.137 . . . . 0.0 112.837 -179.501 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.32 0.12 0.31 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.0 179.49 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -81.98 -60.88 2.1 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.613 -0.804 . . . . 0.0 112.566 -178.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.496 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -113.96 -143.69 0.39 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.707 0.289 . . . . 0.0 111.08 -179.867 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -135.73 167.63 20.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.775 -179.671 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.542 ' O ' HG23 ' A' ' 56' ' ' VAL . 1.8 pt? -75.16 -176.16 2.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.04 -179.469 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.579 ' ND1' HG22 ' A' ' 56' ' ' VAL . 84.8 t60 -130.64 -77.43 0.53 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.374 0.606 . . . . 0.0 111.4 -178.195 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.54 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER -163.98 129.42 2.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.656 -178.417 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.687 HD13 HG22 ' A' ' 53' ' ' VAL . 2.5 mt -91.15 155.66 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.07 0.462 . . . . 0.0 112.145 -176.632 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.658 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -121.9 118.77 29.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.367 -179.025 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -82.19 71.71 9.25 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.055 0.455 . . . . 0.0 110.183 178.187 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.544 ' C ' HG13 ' A' ' 49' ' ' VAL . 1.2 mt-10 -96.46 135.06 22.63 Favored Pre-proline 0 C--O 1.224 -0.263 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.607 -179.665 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.785 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 52.8 Cg_endo -86.07 156.24 9.84 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.513 2.142 . . . . 0.0 112.796 -178.925 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.758 HD11 ' HB3' ' A' ' 50' ' ' ALA . 2.7 mm -125.83 -83.32 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.543 -177.447 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.684 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.37 -151.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.121 -179.861 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -71.91 -29.49 64.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.606 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.63 4.79 0.49 Allowed Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.932 179.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.684 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 4.1 mt -91.72 102.54 15.16 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.856 0.36 . . . . 0.0 110.787 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.785 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 69.6 t -93.7 129.62 43.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.913 -178.462 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.758 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.64 150.04 20.79 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.025 178.116 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.658 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -113.09 119.38 37.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.245 179.054 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 39' ' ' ILE . 1.5 m120 -89.81 94.43 9.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.522 -178.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.687 HG22 HD13 ' A' ' 39' ' ' ILE . 5.5 t -86.21 102.93 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.342 -178.663 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.677 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -84.69 167.73 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.455 179.208 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.596 HG22 ' HB3' ' A' ' 6' ' ' ALA . 4.2 m -139.28 135.01 41.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.449 -178.251 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.579 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.1 OUTLIER -95.7 113.89 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.824 178.843 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 4' ' ' VAL . 2.9 m -129.52 154.98 40.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.841 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.43 -68.07 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.195 -179.734 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.63 -6.35 58.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.108 0.48 . . . . 0.0 110.366 179.027 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.496 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.82 -151.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.125 179.443 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.421 ' HB2' ' H ' ' A' ' 62' ' ' GLY . 0.9 OUTLIER -150.27 -159.12 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.856 -179.956 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.421 ' H ' ' HB2' ' A' ' 61' ' ' GLU . . . -80.41 12.47 32.87 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.44 178.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.96 -8.0 60.36 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.43 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.27 -3.36 29.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.983 0.42 . . . . 0.0 110.087 179.006 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -54.71 -24.07 20.42 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.99 177.465 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.25 -27.26 61.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.978 -1.01 . . . . 0.0 110.897 -179.663 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.587 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.23 -56.92 15.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.364 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -58.89 -34.97 72.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.405 178.838 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.74 -51.23 70.22 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.383 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.2 t -63.7 -19.77 65.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.48 178.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.762 HD22 HD13 ' A' ' 74' ' ' ILE . 0.3 OUTLIER -72.83 -28.39 62.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.651 179.957 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.82 -14.23 51.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.766 179.157 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.26 28.69 0.98 Allowed Glycine 0 N--CA 1.452 -0.288 0 N-CA-C 111.486 -0.645 . . . . 0.0 111.486 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.806 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -73.41 -163.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.293 -0.453 . . . . 0.0 111.282 -178.698 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.7 OUTLIER -50.21 98.67 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.943 0.401 . . . . 0.0 110.918 179.513 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -64.62 -32.46 84.27 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.891 -0.595 . . . . 0.0 113.21 -178.302 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 13.3 t -85.66 -36.48 10.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.055 0.455 . . . . 0.0 110.205 179.606 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.63 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 42.4 t -95.64 90.08 5.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.455 179.225 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.586 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -77.17 133.34 38.97 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 178.1 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.074 HG21 HG22 ' A' ' 8' ' ' ILE . 2.2 mt -101.65 149.3 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.863 -175.485 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.531 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 5.3 tp10 -86.1 71.52 10.55 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 172.406 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.69 HG23 ' HB ' ' A' ' 80' ' ' ILE . 62.2 t -80.35 50.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.104 -174.216 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.8 m -132.92 5.96 3.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.349 178.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.78 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 46.9 t0 -86.03 139.01 31.54 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.984 0.421 . . . . 0.0 111.3 -178.147 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.0 p -147.99 152.36 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.923 -179.62 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.709 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -150.55 98.22 2.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.201 0.524 . . . . 0.0 110.47 -178.715 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.476 ' HD3' HG13 ' A' ' 4' ' ' VAL . 1.6 mmt85 -84.4 110.17 18.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.325 -179.641 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.586 HD11 HG23 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -82.9 86.71 6.9 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.501 178.045 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.9 ttm . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.964 179.934 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ttt . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 121.143 0.497 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 89' ' ' MET . . . 173.42 4.02 0.03 OUTLIER Glycine 0 C--N 1.33 0.232 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.538 -179.344 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.43 ' H ' ' H ' ' A' ' 2' ' ' GLY . 3.0 m-20 -93.25 164.87 13.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.943 0.401 . . . . 0.0 111.608 -179.695 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -98.46 136.98 27.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.615 177.842 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.542 ' CG2' HD11 ' A' ' 88' ' ' LEU . 2.1 t -128.48 116.41 41.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.73 179.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.44 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -96.37 166.3 11.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.28 178.897 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.683 ' HB ' ' CB ' ' A' ' 84' ' ' ASP . 25.6 m -142.05 132.6 25.31 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-O 121.569 0.7 . . . . 0.0 111.779 179.768 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.06 HG22 HG21 ' A' ' 80' ' ' ILE . 1.8 mm -120.46 106.46 18.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 114.301 -1.318 . . . . 0.0 110.615 -178.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.816 ' C ' HG23 ' A' ' 80' ' ' ILE . 0.0 OUTLIER -95.24 93.36 7.25 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -177.573 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.458 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -92.38 135.93 26.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.729 -177.667 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.823 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 1.0 OUTLIER -147.5 114.79 4.14 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 121.389 0.614 . . . . 0.0 111.974 179.801 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.517 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 35.5 Cg_exo -63.39 124.64 14.14 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.153 2.569 . . . . 0.0 112.055 178.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -57.52 -30.78 65.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.378 -179.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.32 150.81 77.49 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.205 -179.304 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.565 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 40.9 Cg_endo -66.67 -6.29 15.09 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.38 2.053 . . . . 0.0 111.89 179.211 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -92.01 32.7 1.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.586 179.211 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -66.82 85.82 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-O 121.65 0.738 . . . . 0.0 110.064 179.929 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.572 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 12.1 m-20 -70.76 104.21 2.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.278 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.906 HD12 HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -61.67 -49.56 76.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.237 -178.666 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.662 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 2.5 tp10 -70.11 -35.48 74.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.111 -178.163 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.629 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . . . -69.06 -35.93 77.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.294 0.569 . . . . 0.0 109.809 177.548 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.566 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.4 OUTLIER -66.54 -27.56 67.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.038 177.831 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.662 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -56.33 -46.72 79.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.44 179.051 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.629 ' HE2' ' HA ' ' A' ' 21' ' ' ALA . 1.2 mtmm -65.64 -41.86 92.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.847 179.731 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.716 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 33.3 mt-10 -66.71 -31.14 71.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.431 0.634 . . . . 0.0 110.356 179.526 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.815 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 3.2 mt -62.91 -41.62 93.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.93 179.757 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -62.64 -39.13 92.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.158 -179.222 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.716 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.3 OUTLIER -78.0 -21.02 51.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.669 -178.499 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.943 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -88.51 -12.11 43.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.273 -178.955 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.708 HG13 HD23 ' A' ' 36' ' ' LEU . 28.5 mm -61.0 138.09 94.09 Favored Pre-proline 0 N--CA 1.463 0.2 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.089 179.626 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.546 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.5 Cg_endo -51.19 125.26 15.9 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.744 2.296 . . . . 0.0 112.478 179.211 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -60.72 -2.86 0.6 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.419 -0.809 . . . . 0.0 112.039 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.22 -62.34 1.82 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.896 -178.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.675 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -111.01 -143.67 0.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.692 0.282 . . . . 0.0 111.152 -179.462 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -133.93 172.57 12.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.941 0.401 . . . . 0.0 110.823 -179.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.708 HD23 HG13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -74.43 -177.05 2.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.667 -179.811 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.627 ' ND1' HG22 ' A' ' 56' ' ' VAL . 66.5 t60 -131.3 -73.58 0.53 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.146 0.498 . . . . 0.0 111.059 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' A' ' 37' ' ' HIS . 29.1 mmtm -161.46 127.55 3.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.417 -178.733 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.67 HD13 HG22 ' A' ' 53' ' ' VAL . 2.9 mt -93.55 154.34 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.817 -178.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.643 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.2 m-20 -119.36 124.22 46.07 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.317 -178.769 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -89.17 66.5 7.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.96 0.41 . . . . 0.0 110.083 177.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.659 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.96 147.86 34.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.702 -178.035 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.77 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 35.1 Cg_endo -91.79 158.43 3.44 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 123.016 2.477 . . . . 0.0 112.861 -178.32 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.734 HD11 ' HB3' ' A' ' 50' ' ' ALA . 4.0 mm -127.59 -82.66 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.334 -178.177 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.689 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.15 -150.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.988 179.728 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -71.88 -27.46 62.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.737 179.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.28 7.89 0.3 Allowed Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 113.157 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.689 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.0 mt -92.39 105.41 17.6 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.784 0.326 . . . . 0.0 110.885 179.882 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.77 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 25.6 t -92.92 128.07 44.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.886 -178.477 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.823 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.07 148.94 21.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.275 179.163 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.906 HD21 HD12 ' A' ' 19' ' ' LEU . 11.1 mp -106.48 114.74 29.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.019 177.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.598 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 3.9 m-20 -89.28 92.31 9.11 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.231 0.539 . . . . 0.0 109.938 -179.422 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.678 HG21 HG12 ' A' ' 26' ' ' ILE . 11.3 t -85.79 106.35 15.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.625 -177.292 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.552 ' HG2' ' OG1' ' A' ' 7' ' ' THR . 37.4 mtt -85.24 164.15 18.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.078 178.499 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.6 m -140.71 136.77 35.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.31 -178.684 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.627 HG22 ' ND1' ' A' ' 37' ' ' HIS . 0.0 OUTLIER -94.46 111.95 26.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.715 178.738 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.437 HG12 ' OG1' ' A' ' 34' ' ' THR . 34.3 m -130.21 143.58 40.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.095 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -177.42 -64.51 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.314 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.75 -8.29 59.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 110.495 179.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.675 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.59 -146.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.248 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -147.69 -163.12 1.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.783 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.422 ' O ' ' HG2' ' A' ' 65' ' ' GLU . . . -80.45 12.2 34.51 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.575 -0.822 . . . . 0.0 111.559 178.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.11 -9.05 62.83 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.507 179.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -74.57 -5.15 41.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.861 0.362 . . . . 0.0 110.29 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 62' ' ' GLY . 3.7 pt-20 -54.94 -24.09 22.11 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.405 0.621 . . . . 0.0 110.11 177.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.04 -28.21 62.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.969 -179.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.546 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.67 -56.4 21.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.271 179.297 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -59.37 -35.02 73.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.469 178.447 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -50.91 70.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.415 178.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.447 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 5.1 t -64.65 -20.32 66.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.56 178.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.616 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -72.69 -28.31 62.61 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.71 -179.678 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -15.61 58.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.793 179.594 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.37 29.2 0.97 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.791 179.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.943 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.7 OUTLIER -73.5 -161.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.451 -0.374 . . . . 0.0 111.142 -178.933 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.604 ' N ' HG23 ' A' ' 74' ' ' ILE . 2.7 pm0 -51.6 91.45 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.173 0 CA-C-O 121.063 0.459 . . . . 0.0 110.749 179.358 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.17 -24.05 62.75 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.833 -0.621 . . . . 0.0 113.04 -178.334 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 3.5 p -86.58 -36.64 10.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.234 0.54 . . . . 0.0 110.381 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.575 ' HB3' ' HB2' ' A' ' 75' ' ' GLU . 4.2 t -95.88 93.01 6.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.592 -179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.61 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -75.94 131.0 39.34 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.438 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.06 HG21 HG22 ' A' ' 8' ' ' ILE . 3.5 mp -101.19 148.1 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.559 -174.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.773 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -85.87 71.4 10.65 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 173.256 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.7 HG23 ' HB ' ' A' ' 80' ' ' ILE . 58.6 t -80.71 52.33 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 114.233 -1.349 . . . . 0.0 111.076 -174.302 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.4 m -133.32 5.73 3.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.902 179.426 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.683 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.1 m-20 -84.68 131.69 34.55 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 120.571 -0.451 . . . . 0.0 111.379 -177.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.4 p -149.97 139.72 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.659 -179.587 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.546 ' HD2' ' N ' ' A' ' 86' ' ' ARG . 1.0 OUTLIER -134.46 104.83 6.27 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.242 -178.392 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.9 mmt180 -82.0 88.98 6.37 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.023 179.28 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.542 HD11 ' CG2' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -81.55 89.96 6.23 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.687 -0.233 . . . . 0.0 110.673 179.445 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.545 ' HA ' ' HA2' ' A' ' 2' ' ' GLY . 1.5 ttm . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.497 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.738 0.304 . . . . 0.0 111.345 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.55 -14.01 0.04 OUTLIER Glycine 0 CA--C 1.517 0.203 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.475 179.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.675 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 4.3 m-20 -94.6 128.7 41.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.81 0.338 . . . . 0.0 111.893 -179.273 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.713 ' HB ' HG22 ' A' ' 57' ' ' VAL . 2.9 t -94.96 107.53 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.531 177.498 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.661 ' HB ' ' HB2' ' A' ' 86' ' ' ARG . 84.7 t -104.8 107.58 22.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.268 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.514 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -97.12 141.04 30.74 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 177.753 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.805 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 16.2 m -122.49 133.03 54.6 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.749 0.785 . . . . 0.0 112.251 -178.229 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.05 HG22 HG21 ' A' ' 80' ' ' ILE . 5.6 mm -123.99 109.17 22.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 114.052 -1.431 . . . . 0.0 110.677 -178.173 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.801 ' C ' HG23 ' A' ' 80' ' ' ILE . 2.1 mmmt -99.57 95.61 7.1 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -177.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.642 HG11 ' HE ' ' A' ' 29' ' ' ARG . 1.4 m -93.32 136.73 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -177.533 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.699 ' O ' ' HG3' ' A' ' 11' ' ' MET . 0.4 OUTLIER -147.78 120.57 4.7 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 121.17 0.509 . . . . 0.0 111.72 178.751 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 20.6 Cg_exo -69.78 121.75 8.43 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.366 2.711 . . . . 0.0 112.143 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -30.58 64.2 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.207 -179.674 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.9 m -77.97 148.94 76.18 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.999 -179.732 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.546 ' HA ' ' CD2' ' A' ' 48' ' ' LEU . 38.1 Cg_endo -65.57 -6.79 14.5 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.416 2.077 . . . . 0.0 111.881 179.423 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -91.59 35.42 0.95 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.518 179.111 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 17' ' ' VAL . 0.2 OUTLIER -67.46 87.64 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.817 0.818 . . . . 0.0 110.184 -179.797 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.653 ' HB3' ' HB3' ' A' ' 21' ' ' ALA . 0.8 OUTLIER -67.69 105.28 1.86 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.059 -0.973 . . . . 0.0 109.926 178.824 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.662 HD12 ' HE2' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -60.65 -54.25 47.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.748 -177.96 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.658 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -70.85 -34.23 71.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.133 -177.43 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.653 ' HB3' ' HB3' ' A' ' 18' ' ' ASP . . . -68.74 -35.6 77.31 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 177.305 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.562 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -64.96 -35.53 81.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.138 176.524 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.662 ' HE2' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -55.44 -49.08 73.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.252 178.201 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.49 -39.34 85.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.092 -179.928 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.695 ' O ' ' HG3' ' A' ' 28' ' ' GLU . 2.9 mt-10 -66.51 -32.34 73.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.383 0.611 . . . . 0.0 110.166 179.099 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.743 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -63.55 -38.47 82.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.925 178.565 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -43.27 92.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.108 -179.72 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.695 ' HG3' ' O ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -78.06 -21.37 50.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.755 -178.575 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.753 HH22 ' HB ' ' A' ' 8' ' ' ILE . 18.9 ptt85 -89.06 -8.65 53.5 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.411 -178.488 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 26' ' ' ILE . 19.8 mm -60.11 137.55 91.21 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.966 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.635 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 9.1 Cg_endo -48.75 117.65 2.87 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.897 2.398 . . . . 0.0 112.206 178.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.47 1.09 0.09 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.391 -179.395 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -82.51 -63.95 1.73 Allowed Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.752 -179.117 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.411 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -110.24 -134.05 0.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.628 0.251 . . . . 0.0 111.086 -179.531 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -138.62 171.06 14.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.931 0.396 . . . . 0.0 110.669 -179.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.85 -177.57 3.34 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.018 -179.447 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.517 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 86.3 t60 -131.01 -73.31 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.322 0.582 . . . . 0.0 111.081 -179.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.509 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -163.46 126.64 2.68 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.046 -178.433 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.723 HG23 HG22 ' A' ' 53' ' ' VAL . 2.9 mt -94.13 157.04 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.161 -177.342 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.631 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 77.4 m-20 -122.62 124.17 42.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.384 -179.206 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.94 66.3 6.86 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.364 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.651 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -98.23 147.12 32.67 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.538 -177.539 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.766 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 18.6 Cg_endo -89.63 159.5 5.27 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 123.12 2.547 . . . . 0.0 113.211 -177.718 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.746 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.9 mm -129.03 -82.52 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.169 -178.121 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.577 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -67.07 -153.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.844 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -72.04 -24.65 61.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.835 0.35 . . . . 0.0 110.814 179.799 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.51 3.74 0.25 Allowed Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.509 -0.853 . . . . 0.0 113.285 179.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.577 ' HG ' ' HB3' ' A' ' 45' ' ' ALA . 5.3 mt -92.32 106.95 18.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.021 0.41 . . . . 0.0 111.045 -179.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.766 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 52.8 t -94.28 130.37 43.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.95 -178.314 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.746 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -95.46 162.01 13.83 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.567 179.478 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.631 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.4 OUTLIER -116.05 113.77 23.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.283 179.501 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.541 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.6 m120 -90.04 90.32 8.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.286 0.565 . . . . 0.0 110.011 178.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.723 HG22 HG23 ' A' ' 39' ' ' ILE . 5.5 t -88.63 102.17 12.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.809 -177.716 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.495 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 14.3 mtt -86.36 163.57 17.57 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.066 178.183 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 4.2 m -137.01 127.44 39.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.923 0.392 . . . . 0.0 111.216 -178.88 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.517 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 1.1 p -98.15 111.86 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.876 179.603 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.713 HG22 ' HB ' ' A' ' 4' ' ' VAL . 1.2 m -127.4 169.9 18.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.965 179.83 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -172.89 -69.84 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.467 179.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -80.92 0.24 36.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.969 0.414 . . . . 0.0 110.6 179.585 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.411 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.5 -154.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.272 179.722 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.65 -161.29 1.3 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.865 -179.865 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.87 13.56 30.2 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.477 178.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.52 -9.1 61.02 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.541 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.3 p -74.23 -4.0 33.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.04 0.448 . . . . 0.0 110.157 179.12 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -55.39 -23.37 24.24 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.072 177.676 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.86 -27.04 49.82 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.919 -179.644 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.635 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.5 -56.32 21.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.401 179.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -58.42 -34.58 70.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.541 178.595 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -62.25 -51.76 66.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.397 178.471 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.423 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -63.42 -17.85 63.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.318 179.013 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.586 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.4 OUTLIER -73.39 -30.56 63.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.652 179.71 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -11.47 35.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.93 179.452 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.38 26.13 0.97 Allowed Glycine 0 N--CA 1.453 -0.198 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.724 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.8 OUTLIER -73.28 -164.56 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.459 -0.371 . . . . 0.0 111.012 -179.27 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.639 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 0.8 OUTLIER -51.73 96.81 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.775 0.322 . . . . 0.0 111.106 179.586 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -61.33 -23.07 61.84 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.079 179.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.6 p -89.42 -40.0 12.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.036 0.446 . . . . 0.0 110.648 179.323 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.639 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 8.5 t -95.51 92.19 6.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.519 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.575 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -76.82 132.53 39.25 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 177.311 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.05 HG21 HG22 ' A' ' 8' ' ' ILE . 3.6 mp -101.15 149.68 6.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.447 -175.333 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.432 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 6.8 tt0 -85.78 69.56 10.6 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.331 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.694 HG23 ' HB ' ' A' ' 80' ' ' ILE . 54.5 t -80.87 55.43 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 114.42 -1.263 . . . . 0.0 110.805 -175.096 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.5 m -132.51 -1.37 3.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.61 179.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.805 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 11.4 t0 -86.36 131.8 34.12 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.611 -0.436 . . . . 0.0 110.738 -178.771 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.508 ' C ' ' HG2' ' A' ' 86' ' ' ARG . 2.0 p -151.41 160.6 3.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.37 -179.305 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.661 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 6.0 mmt180 -146.35 76.86 1.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.355 179.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.477 ' HA ' HG13 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -75.2 75.22 2.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.799 0.333 . . . . 0.0 111.341 -179.36 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.675 ' HB2' ' O ' ' A' ' 3' ' ' ASP . 9.9 mp -81.88 82.81 7.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.269 179.009 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.471 ' OXT' ' HG3' ' A' ' 1' ' ' MET . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.012 -179.536 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.949 0.404 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.76 -5.29 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.802 179.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -94.65 164.43 12.96 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.105 0.479 . . . . 0.0 111.612 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.847 HG12 HG23 ' A' ' 57' ' ' VAL . 0.9 OUTLIER -102.06 119.5 50.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.093 177.77 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.541 ' CG2' HD11 ' A' ' 88' ' ' LEU . 22.3 t -109.17 119.12 58.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.705 0.288 . . . . 0.0 111.484 -178.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.529 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.02 145.36 25.0 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.463 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.799 ' HB ' ' HB3' ' A' ' 84' ' ' ASP . 10.0 m -122.73 133.72 54.48 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.608 0.718 . . . . 0.0 112.427 -177.566 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.987 HG22 HG21 ' A' ' 80' ' ' ILE . 4.5 mm -123.01 104.68 14.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.386 -179.475 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.77 ' HB2' ' HG3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -95.94 98.18 10.2 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -177.217 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.79 ' HB ' HG12 ' A' ' 80' ' ' ILE . 1.5 m -96.18 138.4 21.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.82 -177.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.793 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 2.1 ptm -147.25 121.22 5.01 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-O 121.182 0.515 . . . . 0.0 111.878 179.751 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.534 ' HA ' ' HA ' ' A' ' 78' ' ' SER . 22.8 Cg_exo -68.02 126.93 15.19 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.362 2.708 . . . . 0.0 112.173 179.116 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -32.2 68.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.454 -179.882 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.7 m -77.42 146.88 74.68 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.926 -179.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.53 -6.93 13.02 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.402 2.068 . . . . 0.0 111.801 179.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -92.3 38.89 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.073 178.556 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.724 HG11 ' HA ' ' A' ' 48' ' ' LEU . 0.2 OUTLIER -68.03 85.8 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 122.013 0.911 . . . . 0.0 110.712 -178.52 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.579 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 17.1 m-20 -73.07 96.63 2.21 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.056 177.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.654 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -63.77 -41.36 97.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.637 -178.362 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.899 ' HA ' ' HD3' ' A' ' 23' ' ' LYS . 5.5 tp10 -69.8 -36.23 75.5 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 120.872 0.368 . . . . 0.0 110.371 -179.058 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 18' ' ' ASP . . . -69.81 -37.43 76.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.452 0.644 . . . . 0.0 109.309 176.272 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 18' ' ' ASP . 1.0 OUTLIER -68.18 -25.81 65.43 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.064 177.164 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.899 ' HD3' ' HA ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -56.31 -44.14 79.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.193 179.627 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.98 -44.81 83.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.451 178.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.594 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 40.8 mt-10 -65.09 -28.18 69.27 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.466 0.65 . . . . 0.0 110.44 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.812 HG12 HG21 ' A' ' 53' ' ' VAL . 1.7 mt -60.21 -49.62 83.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.403 -179.817 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.525 ' OE1' HD22 ' A' ' 36' ' ' LEU . 6.9 mm-40 -64.92 -32.95 74.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.476 -178.233 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.594 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 11.5 pt-20 -76.74 -21.27 55.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 110.751 179.617 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.95 ' HB2' HD11 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -90.55 -12.06 38.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.013 179.914 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.582 HG12 ' O ' ' A' ' 26' ' ' ILE . 27.2 mm -58.94 138.42 87.42 Favored Pre-proline 0 N--CA 1.464 0.24 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.256 179.684 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.62 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 11.0 Cg_endo -52.82 118.23 4.54 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.898 2.399 . . . . 0.0 112.433 178.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -59.67 1.21 0.1 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.321 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 31' ' ' PRO . . . -83.04 -43.73 7.43 Favored Glycine 0 C--N 1.33 0.221 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.181 -178.441 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.574 HG23 ' HB2' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -130.32 -139.75 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.621 0.248 . . . . 0.0 111.192 -178.868 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -133.55 168.58 18.4 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.947 0.403 . . . . 0.0 111.255 -178.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.525 HD22 ' OE1' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -75.91 -178.79 4.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.274 -179.299 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.693 ' ND1' HG22 ' A' ' 56' ' ' VAL . 59.1 t60 -131.4 -77.47 0.52 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.176 -179.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.452 ' HB2' ' HD2' ' A' ' 37' ' ' HIS . 30.7 mmtm -162.0 133.02 5.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.205 -179.035 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.631 HG12 HG13 ' A' ' 53' ' ' VAL . 2.7 mt -93.97 158.25 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.021 0.439 . . . . 0.0 112.108 -178.009 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.713 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 2.6 m-20 -122.77 120.77 34.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.122 -179.498 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.45 67.77 10.0 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.866 0.365 . . . . 0.0 110.057 178.698 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.673 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -99.2 148.81 35.13 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.671 -177.889 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.769 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 50.4 Cg_endo -94.34 159.12 2.03 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.117 2.545 . . . . 0.0 113.347 -177.553 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.757 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.0 mm -128.9 -81.11 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.997 -178.707 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.576 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -67.73 -149.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.938 179.196 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -72.23 -30.14 64.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.875 0.369 . . . . 0.0 110.615 179.471 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.7 6.26 0.54 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.621 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.724 ' HA ' HG11 ' A' ' 17' ' ' VAL . 9.6 mp -89.25 101.07 13.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.912 0.387 . . . . 0.0 110.854 -179.271 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.769 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 11.3 t -91.97 127.83 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.952 -0.567 . . . . 0.0 112.129 -177.659 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.793 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.35 144.35 25.97 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.829 177.695 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.713 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.7 OUTLIER -106.07 116.9 32.74 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.419 178.836 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.626 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -89.58 93.42 9.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.178 -178.893 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.812 HG21 HG12 ' A' ' 26' ' ' ILE . 5.7 t -85.98 106.19 15.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.527 -178.187 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.468 ' HA ' ' O ' ' A' ' 6' ' ' ALA . 34.9 mtt -84.53 162.92 19.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.136 178.836 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 6' ' ' ALA . 2.9 m -140.13 141.24 33.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.087 -178.789 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.693 HG22 ' ND1' ' A' ' 37' ' ' HIS . 2.3 t -91.04 101.51 12.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.491 179.096 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.847 HG23 HG12 ' A' ' 4' ' ' VAL . 29.7 m -129.99 140.9 47.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.068 0.461 . . . . 0.0 111.597 -179.14 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.42 -60.66 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.334 178.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -81.73 -7.56 59.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.018 0.437 . . . . 0.0 110.429 179.099 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.574 ' HB2' HG23 ' A' ' 34' ' ' THR . . . -67.4 -143.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.163 179.52 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -147.29 -165.27 2.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.803 -179.848 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.61 12.87 32.0 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.653 179.041 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.85 -6.84 57.53 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.44 179.621 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.2 p -74.44 -3.89 33.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.967 0.413 . . . . 0.0 110.228 179.248 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -54.63 -24.08 19.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.114 177.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.79 -29.24 62.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.103 -179.465 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.62 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -61.61 -55.14 33.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.381 179.425 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -59.1 -34.95 72.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.357 178.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -61.86 -50.36 72.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.336 178.559 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.1 t -62.94 -18.28 62.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.349 178.608 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.726 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.5 OUTLIER -74.37 -29.37 61.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.487 179.505 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.6 -11.62 36.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.598 178.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.1 27.57 1.0 Allowed Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.429 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.95 HD11 ' HB2' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -72.78 -166.77 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.366 -0.417 . . . . 0.0 111.099 -179.008 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.674 ' HB3' ' HB3' ' A' ' 78' ' ' SER . 2.3 mm-40 -50.96 97.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.941 0.401 . . . . 0.0 110.81 179.222 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -58.71 -27.06 61.02 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.369 -179.608 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.564 HG12 ' OE1' ' A' ' 75' ' ' GLU . 1.2 p -89.22 -38.21 10.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.977 0.418 . . . . 0.0 110.741 179.579 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.674 ' HB3' ' HB3' ' A' ' 75' ' ' GLU . 30.7 t -96.14 93.05 6.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.814 -179.712 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.437 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.5 OUTLIER -76.52 130.88 38.55 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.161 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.987 HG21 HG22 ' A' ' 8' ' ' ILE . 5.2 mt -100.23 140.9 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.337 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.666 -176.094 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.77 ' HG3' ' HB2' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -84.86 74.04 10.55 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 174.648 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.728 HG23 ' HB ' ' A' ' 80' ' ' ILE . 86.5 t -81.55 51.61 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 CA-C-N 113.731 -1.577 . . . . 0.0 111.187 -173.341 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.8 6.99 4.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.505 179.264 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.799 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 38.3 t0 -85.56 141.19 30.03 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.807 0.337 . . . . 0.0 111.082 -178.732 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.3 p -148.4 162.27 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.119 -179.412 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.667 ' HB3' HD21 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -147.14 110.33 4.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.057 0.456 . . . . 0.0 111.708 -178.445 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 4.1 mmt85 -89.13 79.58 7.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.845 179.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.667 HD21 ' HB3' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -84.29 88.48 7.24 Favored 'General case' 0 N--CA 1.462 0.163 0 C-N-CA 120.624 -0.43 . . . . 0.0 110.513 178.187 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 9.3 mtm . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.941 179.858 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.511 ' HB2' ' HB3' ' A' ' 88' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.83 0.348 . . . . 0.0 111.27 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.435 ' H ' ' H ' ' A' ' 3' ' ' ASP . . . 173.57 0.59 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.871 -179.925 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.517 ' O ' ' HB2' ' A' ' 88' ' ' LEU . 37.5 m-20 -89.99 158.68 17.26 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.713 0.292 . . . . 0.0 111.348 -179.796 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.525 ' HB ' HG22 ' A' ' 57' ' ' VAL . 2.6 t -106.75 115.3 47.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.823 177.477 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.768 ' HB ' ' HG2' ' A' ' 86' ' ' ARG . 14.2 t -106.15 108.76 25.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.053 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.659 ' HB3' HG22 ' A' ' 55' ' ' VAL . . . -95.01 165.12 12.6 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.013 177.898 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.739 HG23 ' HG3' ' A' ' 54' ' ' MET . 7.8 m -142.14 129.04 20.65 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.762 0.792 . . . . 0.0 112.276 179.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.035 HG22 HG21 ' A' ' 80' ' ' ILE . 3.1 mm -120.72 105.61 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 114.229 -1.351 . . . . 0.0 110.249 -179.445 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.797 ' C ' HG23 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -94.12 93.64 7.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -177.218 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.49 ' N ' HG23 ' A' ' 80' ' ' ILE . 1.7 m -93.63 138.85 19.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.839 -177.258 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.8 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 2.6 ptm -146.19 123.27 5.97 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.27 179.374 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.566 ' CD ' HG13 ' A' ' 17' ' ' VAL . 18.6 Cg_exo -67.68 125.96 14.03 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.064 2.509 . . . . 0.0 112.217 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.35 -32.48 66.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.276 -179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.5 m -77.71 150.13 78.5 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.03 -179.55 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -67.97 -4.62 12.81 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.486 2.124 . . . . 0.0 111.774 178.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -91.6 45.91 1.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.747 178.32 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.566 HG13 ' CD ' ' A' ' 12' ' ' PRO . 69.8 t -63.96 78.99 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.505 -178.189 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.567 ' HB2' ' HB3' ' A' ' 21' ' ' ALA . 0.2 OUTLIER -71.32 93.87 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.263 177.957 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.557 ' HG ' ' N ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -64.35 -41.53 96.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.622 0.249 . . . . 0.0 111.134 -179.333 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.557 ' N ' ' HG ' ' A' ' 19' ' ' LEU . 4.6 tp10 -68.05 -38.17 82.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.863 0.363 . . . . 0.0 110.22 -178.404 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.572 ' O ' ' HE2' ' A' ' 24' ' ' LYS . . . -70.92 -38.51 72.94 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.285 0.564 . . . . 0.0 110.112 177.541 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.972 HD23 ' HG2' ' A' ' 25' ' ' GLU . 0.5 OUTLIER -65.86 -28.07 68.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.213 178.411 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 0.0 OUTLIER -58.89 -46.57 87.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.922 -179.718 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.572 ' HE2' ' O ' ' A' ' 21' ' ' ALA . 0.3 OUTLIER -63.92 -41.02 97.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.683 -179.598 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.972 ' HG2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -65.07 -38.35 90.5 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.731 0.776 . . . . 0.0 110.012 179.756 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.854 ' HA ' ' HG2' ' A' ' 29' ' ' ARG . 4.2 mt -58.84 -40.88 81.19 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.838 -176.809 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -62.6 -37.02 84.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.067 0.461 . . . . 0.0 110.178 178.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 24' ' ' LYS . 3.2 mm-40 -76.05 -23.72 55.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.628 -179.505 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.854 ' HG2' ' HA ' ' A' ' 26' ' ' ILE . 0.0 OUTLIER -88.73 -11.92 43.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.663 -178.198 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 26' ' ' ILE . 24.8 mm -58.11 136.6 84.35 Favored Pre-proline 0 C--N 1.333 -0.138 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.889 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.503 ' HB3' ' HB2' ' A' ' 67' ' ' ALA . 1.3 Cg_endo -45.13 122.59 4.53 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.88 2.387 . . . . 0.0 112.134 179.186 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.448 ' H ' ' HB3' ' A' ' 66' ' ' ALA . 0.2 OUTLIER -56.96 -6.0 0.3 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.131 -178.936 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.55 -58.02 2.48 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.575 -179.589 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.44 -146.39 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.666 0.27 . . . . 0.0 111.001 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -136.78 175.82 9.26 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.052 0.453 . . . . 0.0 110.881 -179.714 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.29 -175.47 2.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.423 -178.798 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.541 ' ND1' ' HB ' ' A' ' 56' ' ' VAL . 85.0 t60 -130.94 -72.12 0.56 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.755 -179.544 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.518 ' HD2' ' O ' ' A' ' 39' ' ' ILE . 0.0 OUTLIER -163.83 128.54 2.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.986 -178.92 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.705 HD13 HG22 ' A' ' 53' ' ' VAL . 2.9 mt -93.56 155.13 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.17 -177.104 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.699 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.2 t0 -119.43 121.6 39.85 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.046 -179.714 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -86.28 67.77 10.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.931 0.396 . . . . 0.0 110.174 178.835 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.694 ' O ' HG13 ' A' ' 49' ' ' VAL . 0.0 OUTLIER -98.34 148.89 35.14 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.621 -177.887 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.76 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 31.6 Cg_endo -93.47 157.86 2.46 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.052 2.501 . . . . 0.0 113.443 -177.269 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.745 HD11 ' HB3' ' A' ' 50' ' ' ALA . 3.5 mm -128.42 -82.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.024 -178.973 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.579 ' HB3' ' HB2' ' A' ' 48' ' ' LEU . . . -67.64 -149.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.494 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -71.47 -31.85 67.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.609 179.646 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.34 7.39 0.62 Allowed Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.413 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . 8.8 mp -90.17 100.08 12.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.985 0.421 . . . . 0.0 110.799 -179.626 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.76 ' HA ' ' HA ' ' A' ' 43' ' ' PRO . 17.7 t -91.43 127.88 43.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.928 -177.765 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.8 ' HB2' ' HB3' ' A' ' 11' ' ' MET . . . -95.16 143.85 26.25 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.135 178.415 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.699 ' HA ' ' O ' ' A' ' 40' ' ' ASP . 0.6 OUTLIER -104.92 117.69 34.67 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.201 178.507 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.578 ' ND2' ' HB3' ' A' ' 9' ' ' LYS . 1.7 m120 -89.41 93.0 9.36 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.141 -178.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.705 HG22 HD13 ' A' ' 39' ' ' ILE . 10.9 t -85.9 102.63 11.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.67 -177.721 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.739 ' HG3' HG23 ' A' ' 7' ' ' THR . 0.1 OUTLIER -84.76 166.1 17.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.18 178.517 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.659 HG22 ' HB3' ' A' ' 6' ' ' ALA . 3.9 m -138.89 126.53 26.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.055 0.455 . . . . 0.0 111.231 -179.059 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.541 ' HB ' ' ND1' ' A' ' 37' ' ' HIS . 0.9 OUTLIER -97.72 107.49 20.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.836 179.363 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.525 HG22 ' HB ' ' A' ' 4' ' ' VAL . 1.6 m -123.66 171.79 12.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.568 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -178.04 -73.45 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.839 179.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -80.35 2.49 24.63 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.9 0.381 . . . . 0.0 110.795 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.14 -151.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.97 179.339 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -147.56 -161.9 1.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.807 179.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.58 12.32 34.76 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.488 178.839 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.07 -7.64 60.0 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.362 179.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 1.7 p -74.3 -5.35 41.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.966 0.412 . . . . 0.0 110.239 179.313 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.04 -23.91 22.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.227 177.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.448 ' HB3' ' H ' ' A' ' 32' ' ' GLU . . . -56.97 -26.37 59.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.136 -179.401 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.503 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -60.91 -56.63 18.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.267 179.49 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.92 -34.63 71.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.573 178.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.28 -51.55 68.43 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.444 178.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.465 ' O ' ' HB ' ' A' ' 74' ' ' ILE . 7.6 p -64.17 -20.42 65.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.649 179.005 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.6 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 0.6 OUTLIER -72.34 -27.11 62.21 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.623 -179.727 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.1 -16.23 61.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.805 179.435 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -151.53 29.34 0.95 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.728 179.475 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.821 HD11 ' HD2' ' A' ' 29' ' ' ARG . 1.7 tt -73.38 -162.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.524 -0.338 . . . . 0.0 111.213 -178.704 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.629 ' HG3' ' O ' ' A' ' 78' ' ' SER . 0.0 OUTLIER -51.39 90.21 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.084 0.468 . . . . 0.0 110.745 179.257 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -63.32 -24.71 67.72 Favored Glycine 0 C--N 1.334 0.424 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.927 -178.282 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 4.1 p -85.69 -35.92 10.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.408 0.623 . . . . 0.0 109.985 179.1 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.629 ' O ' ' HG3' ' A' ' 75' ' ' GLU . 1.4 m -96.0 90.52 5.6 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.405 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.611 HD22 ' N ' ' A' ' 80' ' ' ILE . 0.1 OUTLIER -74.8 129.85 38.42 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.692 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.035 HG21 HG22 ' A' ' 8' ' ' ILE . 1.8 mp -101.12 148.81 6.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.47 -175.319 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.586 ' HB3' ' HG3' ' A' ' 9' ' ' LYS . 2.8 tt0 -85.8 70.14 10.65 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 173.129 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.723 HG23 ' HB ' ' A' ' 80' ' ' ILE . 57.7 t -80.0 53.73 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.32 -1.309 . . . . 0.0 110.999 -174.411 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -132.92 2.29 3.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.454 179.297 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.674 ' CB ' ' HB ' ' A' ' 7' ' ' THR . 1.0 OUTLIER -85.61 132.44 34.17 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.313 -178.218 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 3.9 p -148.08 145.61 18.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.795 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.768 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -149.72 95.54 2.34 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.335 0.588 . . . . 0.0 110.346 -178.677 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.508 ' HG3' HG13 ' A' ' 4' ' ' VAL . 0.2 OUTLIER -82.02 110.39 17.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.542 -178.778 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.585 HD11 ' NE ' ' A' ' 86' ' ' ARG . 6.9 mp -82.06 79.06 8.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.347 177.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.3 mtm . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.998 -179.699 . . . . . . . . 0 0 . 1 stop_ save_